data_1ozi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ozi _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.63 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 22.7 t0 . . . . . 0 CA--C 1.497 -1.072 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 37.5 p -91.04 115.45 28.03 Favored 'General case' 0 N--CA 1.413 -2.295 0 O-C-N 123.858 0.724 . . . . 0.0 110.458 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.453 ' CE1' ' HD2' ' A' ' 103' ' ' LYS . 16.4 p90 -125.67 116.8 22.24 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.061 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 45.3 mt-10 -77.96 92.54 4.32 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.709 0.766 . . . . 0.0 109.397 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.473 HG13 HD13 ' A' ' 64' ' ' ILE . 9.6 p -74.81 138.13 21.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.269 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.534 ' HG2' ' CD2' ' A' ' 98' ' ' HIS . 38.5 mt-10 -96.45 96.29 8.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 175.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.8 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -96.6 111.11 23.38 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -176.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.96 130.39 40.08 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.101 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.432 ' HE2' ' HG ' ' A' ' 25' ' ' LEU . 94.9 mttt -86.01 127.87 34.74 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.729 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 t -77.63 -42.06 36.26 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -164.84 -68.8 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.11 0.481 . . . . 0.0 110.36 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.21 60.56 4.87 Favored Glycine 0 C--O 1.246 0.882 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.971 -173.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 89.8 p 62.01 -170.34 0.17 Allowed 'General case' 0 C--O 1.246 0.919 0 C-N-CA 126.521 1.928 . . . . 0.0 113.14 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.64 HD23 HD12 ' A' ' 18' ' ' LEU . 92.2 mt -68.65 150.68 47.68 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.155 0.502 . . . . 0.0 109.883 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.15 6.47 82.57 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.826 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.582 HG23 HG13 ' A' ' 52' ' ' ILE . 15.7 pt -103.52 128.98 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.754 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.255 -178.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.4 ' HB2' HD13 ' A' ' 53' ' ' ILE . 32.2 t -98.34 114.64 27.03 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 49' ' ' VAL . 35.0 m -112.2 157.81 12.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.364 -175.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.442 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 12.9 t -127.27 161.89 27.51 Favored 'General case' 0 N--CA 1.396 -3.134 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.623 ' HA ' HD12 ' A' ' 47' ' ' ILE . 2.0 p . . . . . 0 C--N 1.272 -2.775 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.496 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.806 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 33.8 mm -141.39 147.89 21.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 176.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -129.66 139.42 51.4 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 118.533 0.606 . . . . 0.0 111.715 177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.522 HG23 ' CG2' ' A' ' 64' ' ' ILE . 44.1 t -74.67 116.48 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 173.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -85.02 -37.06 20.83 Favored 'General case' 0 C--N 1.284 -2.283 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.29 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.711 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -165.38 163.97 19.77 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.538 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.84 HG22 ' HB2' ' A' ' 59' ' ' GLU . 1.9 mp -116.96 124.19 72.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 53' ' ' ILE . 2.0 mp -108.05 128.57 25.5 Favored Pre-proline 0 C--N 1.293 -1.863 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -17.25 -110.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.953 1 C-N-CA 126.123 4.548 . . . . 0.0 117.16 -173.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 53' ' ' ILE . 3.4 mptp? 70.69 -67.06 0.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.627 1.171 . . . . 0.0 110.183 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.15 -117.67 0.99 Allowed Glycine 0 N--CA 1.401 -3.682 1 N-CA-C 102.762 -4.135 . . . . 0.0 102.762 -172.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.794 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . 59.04 -110.29 0.49 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 164.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.8 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -68.27 -41.46 81.0 Favored 'General case' 0 C--O 1.255 1.367 0 C-N-CA 122.674 0.39 . . . . 0.0 111.513 -173.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.84 ' HB2' HG22 ' A' ' 52' ' ' ILE . 42.1 tt0 -73.73 -37.06 65.23 Favored 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 124.437 1.086 . . . . 0.0 110.794 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.7 t -70.88 -49.51 45.16 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.122 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.411 ' OD1' ' HG2' ' A' ' 63' ' ' ARG . 6.4 t70 -65.11 -31.28 72.4 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.02 35.25 54.17 Favored Glycine 0 CA--C 1.488 -1.653 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.989 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 6.7 mmp_? -103.02 -49.69 3.7 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.023 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 58' ' ' ALA . 65.9 mt -92.98 138.14 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.173 -172.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.436 ' CG ' ' H ' ' A' ' 66' ' ' LYS . 26.6 t-80 -126.38 -173.21 2.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 52.6 mtpt -79.76 43.35 0.58 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.422 1.089 . . . . 0.0 112.515 -172.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.579 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . -172.88 5.71 0.03 OUTLIER Glycine 0 C--N 1.301 -1.411 0 C-N-CA 118.836 -1.649 . . . . 0.0 115.066 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -74.66 144.37 43.84 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 117.728 0.764 . . . . 0.0 110.324 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.412 ' HD3' ' OE1' ' A' ' 102' ' ' GLU . 56.4 ttt180 -89.32 135.01 33.82 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.806 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 47.9 t -105.74 122.7 59.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.571 HD11 ' HG3' ' A' ' 102' ' ' GLU . 65.6 mt -97.04 -39.05 9.52 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.233 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 77' ' ' SER . . . -164.87 178.37 7.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.472 -174.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.592 HG21 HD12 ' A' ' 78' ' ' LEU . 48.0 t -121.04 112.9 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 10.4 p30 45.6 37.2 3.03 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 125.529 1.531 . . . . 0.0 113.828 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.84 -9.04 70.84 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 119.856 -1.164 . . . . 0.0 114.235 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.3 97.07 5.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.57 ' HA ' ' HB3' ' A' ' 72' ' ' ALA . 11.9 m -59.92 125.68 24.61 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.09 0.869 . . . . 0.0 112.436 -173.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.592 HD12 HG21 ' A' ' 73' ' ' VAL . 59.1 mt -94.89 69.68 3.34 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -111.0 104.68 13.27 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.695 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.34 26.71 11.71 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.74 146.05 30.31 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.483 HG22 ' HG2' ' A' ' 85' ' ' GLN . 11.8 t -88.2 164.11 15.81 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 170.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.522 ' HB3' ' N ' ' A' ' 31' ' ' VAL . 16.4 p-80 -51.15 -40.01 57.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -60.54 -39.89 89.54 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.615 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.483 ' HG2' HG22 ' A' ' 82' ' ' THR . 82.1 mm-40 -70.66 -36.48 73.38 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.261 0.553 . . . . 0.0 110.397 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.44 -52.37 65.88 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.75 174.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.57 -28.18 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.027 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -65.32 -39.2 92.14 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.0 m -70.96 -31.85 68.53 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.763 0.792 . . . . 0.0 109.079 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.436 HD21 HD23 ' A' ' 99' ' ' LEU . 96.0 mt -76.18 -11.68 59.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.126 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -99.09 -28.95 13.15 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.52 -30.1 70.35 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.026 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 p -76.78 144.84 38.91 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.719 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.66 -120.72 0.13 Allowed Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 116.139 1.216 . . . . 0.0 116.139 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -81.21 -45.08 16.86 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.452 0.701 . . . . 0.0 111.459 -172.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.73 124.23 72.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.066 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.404 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 7.4 t -108.42 139.22 31.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.782 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.534 ' CD2' ' HG2' ' A' ' 17' ' ' GLU . 66.6 m80 -101.49 125.46 48.14 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 6.5 mp -123.02 143.64 49.8 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.554 HD22 HD13 ' A' ' 71' ' ' LEU . 1.3 tt -96.46 109.5 22.04 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 13' ' ' THR . 10.8 mp -117.4 171.33 8.06 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.061 0.458 . . . . 0.0 112.134 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 48.1 mt-10 -130.52 143.37 50.72 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.453 ' HD2' ' CE1' ' A' ' 14' ' ' PHE . 28.1 mmmt -60.42 125.19 22.75 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.109 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . . . . . . 0 N--CA 1.425 -2.099 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.299 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.3 t70 . . . . . 0 CA--C 1.503 -0.849 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p -89.41 141.77 28.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.213 0.53 . . . . 0.0 111.552 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -149.28 146.56 27.62 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.753 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -100.13 125.4 46.23 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.1 t -113.3 129.08 69.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -98.36 81.99 2.83 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.863 HD11 ' HB1' ' A' ' 57' ' ' ALA . 1.6 tm? -85.14 126.7 33.84 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -171.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.09 110.1 21.47 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.823 ' HE3' HD12 ' A' ' 25' ' ' LEU . 15.0 ptmt -79.14 153.94 29.7 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.747 HG21 ' HB3' ' A' ' 55' ' ' LYS . 7.2 t -140.23 139.84 35.68 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.209 -176.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 3.7 m-20 71.63 9.33 6.32 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.948 0.899 . . . . 0.0 112.712 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.24 1.34 23.58 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.66 -0.781 . . . . 0.0 114.55 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.2 t -160.49 175.01 13.23 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.823 HD12 ' HE3' ' A' ' 20' ' ' LYS . 7.6 mp -89.49 177.48 6.55 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.12 33.43 5.09 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.471 ' HB ' HG12 ' A' ' 49' ' ' VAL . 19.5 pt -138.14 139.95 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.639 0 CA-C-O 121.949 0.88 . . . . 0.0 112.012 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.1 m -104.25 118.22 36.1 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 113.68 -1.6 . . . . 0.0 107.274 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.01 145.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.393 0.616 . . . . 0.0 111.731 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -122.9 172.23 8.63 Favored 'General case' 0 N--CA 1.403 -2.822 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 2.0 p . . . . . 0 C--N 1.258 -3.389 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.899 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 33.6 mm -131.12 142.48 43.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 174.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.435 ' OH ' ' HD3' ' A' ' 69' ' ' ARG . 45.8 m-85 -126.23 143.77 51.02 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' A' ' 27' ' ' ILE . 61.7 t -78.93 108.48 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -80.7 -37.28 30.97 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.783 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.19 153.0 31.87 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.122 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.18 113.63 40.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.2 mm -92.27 154.48 43.0 Favored Pre-proline 0 C--N 1.28 -2.456 0 C-N-CA 125.261 1.424 . . . . 0.0 109.726 -175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -56.4 -152.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.567 2.161 0 C-N-CA 123.446 2.764 . . . . 0.0 113.801 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.747 ' HB3' HG21 ' A' ' 21' ' ' THR . 3.7 mppt? 72.8 -44.97 0.61 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.614 1.166 . . . . 0.0 112.1 -169.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.02 -126.88 4.2 Favored Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 108.176 -1.969 . . . . 0.0 108.176 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.863 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 71.27 -99.48 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 171.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.861 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -73.12 -35.26 66.52 Favored 'General case' 0 C--O 1.265 1.906 0 O-C-N 121.86 -0.525 . . . . 0.0 111.576 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -74.95 -40.03 61.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 125.07 1.481 . . . . 0.0 107.448 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.8 t -67.97 -44.03 77.65 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.056 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.63 -39.69 80.67 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.44 27.0 49.68 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.725 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -108.91 -39.65 5.26 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.115 -1.034 . . . . 0.0 113.156 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.861 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.4 mt -94.97 127.25 47.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -132.3 178.41 6.84 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 123.5 0.5 . . . . 0.0 110.115 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -67.52 128.21 35.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.314 0.578 . . . . 0.0 111.94 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.611 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 101.05 -4.24 55.75 Favored Glycine 0 N--CA 1.422 -2.267 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.006 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.572 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 31.8 m-20 -68.93 146.07 53.1 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.458 HH21 ' CD ' ' A' ' 102' ' ' GLU . 34.7 ttp180 -96.65 129.21 44.09 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.795 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 59.0 t -101.77 118.3 48.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.76 -31.87 14.23 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.265 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.632 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -164.49 167.78 19.08 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.675 HG21 HD12 ' A' ' 78' ' ' LEU . 31.7 t -118.04 110.44 30.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 59.39 37.49 23.23 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.393 1.077 . . . . 0.0 109.966 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.46 -6.19 80.88 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.163 -0.926 . . . . 0.0 114.162 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.07 108.66 20.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.458 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 35.4 p -64.95 135.68 55.94 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.675 HD12 HG21 ' A' ' 73' ' ' VAL . 67.5 mt -106.75 25.71 10.92 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.469 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -53.88 -32.03 51.83 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.96 -1.473 . . . . 0.0 113.452 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.63 40.71 1.56 Allowed Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.15 155.63 17.06 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.325 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.553 HG21 ' HG2' ' A' ' 85' ' ' GLN . 9.0 t -92.72 160.75 14.83 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 167.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.417 ' O ' HG21 ' A' ' 87' ' ' VAL . 52.1 p-80 -51.28 -43.43 61.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.141 0.496 . . . . 0.0 111.917 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -59.72 -37.8 79.92 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.553 ' HG2' HG21 ' A' ' 82' ' ' THR . 14.9 mm100 -71.63 -36.05 70.62 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.52 -45.71 90.97 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.348 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 83' ' ' HIS . 64.1 t -66.24 -39.53 84.53 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.776 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -62.51 -39.09 92.41 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.847 0.355 . . . . 0.0 111.038 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.415 ' HB ' HG23 ' A' ' 73' ' ' VAL . 12.1 m -69.91 -38.13 76.16 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.884 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.851 HD13 HD11 ' A' ' 99' ' ' LEU . 19.2 tp -82.95 -3.08 56.67 Favored 'General case' 0 N--CA 1.415 -2.175 0 C-N-CA 125.154 1.382 . . . . 0.0 109.878 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.36 -21.05 13.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.487 172.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -82.84 -25.21 32.84 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.715 ' HG1' HG11 ' A' ' 97' ' ' VAL . 3.2 p -67.18 -177.81 0.72 Allowed 'General case' 0 C--O 1.255 1.359 0 C-N-CA 123.705 0.802 . . . . 0.0 110.517 174.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -78.56 -162.63 21.8 Favored Glycine 0 C--O 1.244 0.764 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.582 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 29.6 tt0 -73.41 -34.53 65.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.717 0.77 . . . . 0.0 108.969 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.8 t -90.19 110.83 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.715 HG11 ' HG1' ' A' ' 93' ' ' THR . 8.8 m -99.05 117.54 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.427 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.071 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -84.57 122.0 28.41 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.851 HD11 HD13 ' A' ' 90' ' ' LEU . 7.2 tp -127.35 146.14 50.56 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 53.1 tp -102.13 117.1 34.06 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.741 HD13 HD22 ' A' ' 99' ' ' LEU . 6.6 mp -123.47 165.63 16.76 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.667 0.746 . . . . 0.0 111.761 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.458 ' CD ' HH21 ' A' ' 69' ' ' ARG . 88.1 tt0 -132.95 143.93 49.79 Favored 'General case' 0 N--CA 1.391 -3.42 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.572 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 40.3 mmtt -64.3 125.6 25.11 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.09 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.611 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . . . . . . 0 N--CA 1.42 -2.376 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.377 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 28.7 t70 . . . . . 0 CA--C 1.494 -1.204 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 3.1 p -99.21 108.26 20.8 Favored 'General case' 0 N--CA 1.416 -2.164 0 O-C-N 123.895 0.747 . . . . 0.0 110.154 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -138.49 140.34 39.14 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.123 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 4.4 mp0 -75.53 106.36 7.04 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 59.5 t -69.47 122.51 21.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.841 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -96.16 93.96 7.24 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.555 HD12 ' CB ' ' A' ' 57' ' ' ALA . 2.6 tm? -100.53 115.14 29.43 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -177.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.84 117.3 33.86 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 24' ' ' SER . 99.5 mttt -54.52 121.16 7.8 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 124.185 0.928 . . . . 0.0 111.696 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.9 p -90.36 -84.0 0.24 Allowed 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.547 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.76 -54.83 2.41 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.506 ' CA ' ' HA2' ' A' ' 56' ' ' GLY . . . -87.87 25.73 8.34 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.698 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 39.7 t 76.69 -109.94 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 123.992 0.917 . . . . 0.0 113.326 172.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.708 ' HG ' HD11 ' A' ' 90' ' ' LEU . 3.3 mm? -85.38 -31.69 22.8 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 120.065 1.302 . . . . 0.0 110.403 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.523 ' CA ' ' HA3' ' A' ' 56' ' ' GLY . . . 73.55 21.58 79.33 Favored Glycine 0 N--CA 1.411 -2.986 0 C-N-CA 119.552 -1.309 . . . . 0.0 112.105 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.402 HG21 ' CD1' ' A' ' 52' ' ' ILE . 17.1 pt -128.71 121.86 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.696 0 CA-C-O 122.079 0.942 . . . . 0.0 112.825 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 25.7 t -90.26 112.18 23.63 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 49' ' ' VAL . 33.4 m -118.82 154.53 21.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -172.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.742 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 9.4 t -143.51 174.99 10.28 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.688 HG22 ' CD1' ' A' ' 47' ' ' ILE . 4.4 t . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' HG11 ' A' ' 31' ' ' VAL . . . . . . . . 0 N--CA 1.406 -3.357 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.718 HG13 ' HB3' ' A' ' 86' ' ' ALA . 21.0 mm -145.76 159.36 12.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 C-N-CA 125.273 1.429 . . . . 0.0 107.654 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -134.45 135.25 42.38 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 123.333 0.653 . . . . 0.0 110.612 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.436 HG21 ' CG2' ' A' ' 64' ' ' ILE . 51.6 t -79.67 108.84 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HB2' HG22 ' A' ' 30' ' ' THR . 63.1 tttp -80.8 -37.44 30.2 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.19 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 28' ' ' SER . . . -148.54 148.18 29.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.47 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.704 HG21 ' HB2' ' A' ' 59' ' ' GLU . 1.4 tp -110.86 131.97 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-O 121.4 0.619 . . . . 0.0 111.758 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.1 mp -106.25 126.44 30.52 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.937 ' HA ' ' HB3' ' A' ' 59' ' ' GLU . 33.8 Cg_exo -59.47 -77.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.133 2.555 . . . . 0.0 113.169 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.473 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 23.8 mmtp -55.13 -10.09 0.49 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 176.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.523 ' HA3' ' CA ' ' A' ' 26' ' ' GLY . . . -63.32 -59.37 9.0 Favored Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.555 ' CB ' HD12 ' A' ' 18' ' ' LEU . . . 167.25 -71.31 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.733 0 C-N-CA 125.117 1.367 . . . . 0.0 111.78 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.821 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . . . -48.66 -38.22 20.57 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -167.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.937 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 8.2 tp10 -74.49 -52.4 12.06 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.91 0.484 . . . . 0.0 111.222 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.6 m -76.96 -29.77 55.71 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.097 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -72.6 -45.87 56.97 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.88 59.24 1.61 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 114.301 -1.318 . . . . 0.0 114.882 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -128.7 -58.87 1.16 Allowed 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.598 0.714 . . . . 0.0 109.144 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.821 ' HB ' ' HB3' ' A' ' 58' ' ' ALA . 51.9 mt -94.1 141.61 14.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.89 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -137.31 168.53 19.45 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -58.26 125.29 22.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.687 0.28 . . . . 0.0 110.439 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.533 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 115.59 -21.19 12.93 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.968 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.493 ' OD1' ' HD2' ' A' ' 103' ' ' LYS . 54.2 m-20 -64.72 137.28 57.71 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.88 0.848 . . . . 0.0 113.228 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -96.47 132.33 42.15 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.0 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.3 t -108.72 126.06 65.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.5 -34.65 10.17 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.59 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -162.94 175.64 10.98 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.291 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.964 HG21 HD12 ' A' ' 78' ' ' LEU . 95.3 t -128.48 111.47 23.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.4 t30 51.73 58.72 5.17 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 124.821 1.248 . . . . 0.0 111.684 176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.7 -10.2 13.84 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 114.798 -1.092 . . . . 0.0 115.104 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 85.4 t -95.81 108.21 20.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 118.242 1.021 . . . . 0.0 108.828 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.499 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 34.7 m -62.42 137.06 58.19 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 123.818 0.699 . . . . 0.0 112.254 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.964 HD12 HG21 ' A' ' 73' ' ' VAL . 91.6 mt -104.97 16.19 26.37 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.456 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 38.8 mt-10 -72.17 94.76 1.58 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.58 14.1 13.35 Favored Glycine 0 C--N 1.304 -1.202 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 74.4 p -92.54 162.25 14.28 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.742 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 52.5 p-80 -51.47 -41.92 61.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.68 0.752 . . . . 0.0 109.807 174.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -37.07 75.59 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.149 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.402 ' HG2' ' OG1' ' A' ' 82' ' ' THR . 74.7 mm-40 -64.26 -40.32 95.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.347 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.718 ' HB3' HG13 ' A' ' 47' ' ' ILE . . . -55.48 -52.25 64.25 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.104 0.478 . . . . 0.0 110.417 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.0 t -64.54 -34.07 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.002 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -68.65 -30.0 68.6 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.04 0.448 . . . . 0.0 110.577 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.4 m -72.25 -37.51 69.09 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.708 HD11 ' HG ' ' A' ' 25' ' ' LEU . 97.9 mt -71.06 -25.44 62.64 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.577 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -77.76 -43.36 31.06 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.232 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.81 -46.97 64.53 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.984 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 p -48.24 -65.88 0.49 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.64 -154.18 24.96 Favored Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.825 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.467 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 57.9 tt0 -87.53 -43.8 11.75 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.505 0.669 . . . . 0.0 109.288 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.5 t -102.65 106.04 19.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -105.61 138.29 31.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.22 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.568 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 56.7 m80 -100.39 130.16 46.45 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.615 HD22 HD23 ' A' ' 90' ' ' LEU . 6.5 mp -124.21 141.4 52.1 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.54 106.31 18.41 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 13' ' ' THR . 8.4 mp -115.64 165.56 12.9 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.697 0.761 . . . . 0.0 112.36 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 42.6 tt0 -131.15 114.04 14.63 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 103.675 -2.713 . . . . 0.0 103.675 172.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.493 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 40.9 tptt -47.5 121.36 3.89 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.872 0.732 . . . . 0.0 110.643 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . . . . . . 0 CA--C 1.498 -0.973 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.446 -171.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 CA--C 1.502 -0.873 0 CA-C-O 120.574 0.226 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 p -92.77 117.46 30.04 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.8 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -133.89 154.52 51.01 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 120.815 0.34 . . . . 0.0 110.545 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -110.46 114.09 27.24 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.569 HG12 HD11 ' A' ' 64' ' ' ILE . 11.6 p -86.84 132.02 33.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.743 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -102.1 105.37 16.08 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.867 HD22 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -117.23 124.94 50.29 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -176.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.85 132.21 46.36 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.008 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.542 ' HE3' HG21 ' A' ' 97' ' ' VAL . 1.2 mptm? -65.73 139.46 58.36 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 123.484 0.714 . . . . 0.0 110.821 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.0 p -75.45 -68.94 0.51 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 170.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -105.75 -72.01 0.73 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -145.92 19.28 1.78 Allowed Glycine 0 C--N 1.306 -1.116 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 175.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.0 m -114.57 140.33 48.87 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.771 HD12 ' HB3' ' A' ' 18' ' ' LEU . 12.3 tp -93.66 -8.64 40.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.57 -7.4 76.67 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.944 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.633 HG22 HG21 ' A' ' 64' ' ' ILE . 20.1 pt -119.68 155.76 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 CA-C-O 121.914 0.864 . . . . 0.0 112.437 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -132.08 128.53 38.41 Favored 'General case' 0 N--CA 1.399 -3.001 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.206 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -109.18 162.4 6.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.206 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.65 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 14.1 t -141.39 168.78 18.95 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 175.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 82' ' ' THR . 4.5 t . . . . . 0 C--N 1.302 -1.485 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' VAL . . . . . . . . 0 N--CA 1.418 -2.52 0 CA-C-O 119.797 -0.446 . . . . 0.0 114.207 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.591 ' CD1' HG23 ' A' ' 31' ' ' VAL . 36.6 mm -94.63 125.97 47.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -129.21 147.09 51.02 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.5 t -72.66 113.2 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HB2' HG22 ' A' ' 30' ' ' THR . 55.7 tttm -86.02 -40.43 15.8 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.132 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.51 156.26 37.76 Favored 'General case' 0 C--O 1.25 1.091 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.242 -173.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -113.89 118.02 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.07 136.23 20.61 Favored Pre-proline 0 C--N 1.292 -1.932 0 C-N-CA 123.543 0.737 . . . . 0.0 109.518 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.46 ' O ' ' HD2' ' A' ' 55' ' ' LYS . 39.0 Cg_exo -65.25 78.55 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.253 2.635 . . . . 0.0 112.603 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' A' ' 54' ' ' PRO . 4.3 mptp? -135.53 20.81 3.35 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.0 -151.83 44.63 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.527 ' HB3' ' CD1' ' A' ' 18' ' ' LEU . . . 69.79 -103.48 0.05 OUTLIER 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.558 1.143 . . . . 0.0 113.393 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.867 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -66.48 -37.04 84.22 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 117.963 0.347 . . . . 0.0 111.887 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.59 -48.31 67.22 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.66 1.184 . . . . 0.0 109.009 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 m -68.9 -46.12 69.14 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.129 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.6 -25.31 62.12 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.12 36.2 51.76 Favored Glycine 0 CA--C 1.5 -0.898 0 CA-C-N 114.449 -1.251 . . . . 0.0 113.271 174.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 1.8 mmp_? -95.7 -48.99 5.55 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.034 0.445 . . . . 0.0 111.215 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.747 ' HB ' ' HB2' ' A' ' 58' ' ' ALA . 33.1 mm -100.54 137.44 28.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.661 -173.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -137.92 169.79 17.17 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 172.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -79.49 142.4 35.86 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.889 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.07 -17.72 12.64 Favored Glycine 0 C--N 1.306 -1.138 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.288 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.441 ' CG ' ' HZ2' ' A' ' 103' ' ' LYS . 2.3 m-20 -89.48 147.04 24.22 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-N 117.118 0.459 . . . . 0.0 110.619 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.515 ' HD3' ' OE1' ' A' ' 102' ' ' GLU . 4.3 ptm180 -106.98 158.39 17.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.148 0.499 . . . . 0.0 111.485 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.21 127.71 71.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.457 HD12 ' HB2' ' A' ' 102' ' ' GLU . 85.7 mt -96.27 -37.15 10.64 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.54 174.56 13.86 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.713 -176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 1.061 HG12 HG22 ' A' ' 89' ' ' THR . 2.7 p -124.08 105.37 15.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 C-N-CA 124.224 1.009 . . . . 0.0 108.549 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.0 t30 57.43 32.54 21.95 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.587 1.184 . . . . 0.0 110.564 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.27 -11.66 67.1 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.515 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.604 ' HB ' HG13 ' A' ' 73' ' ' VAL . 59.8 t -86.34 107.28 16.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m -72.31 119.34 16.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.938 0.399 . . . . 0.0 111.598 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.689 ' N ' HD21 ' A' ' 78' ' ' LEU . 1.4 pt? -119.18 83.52 2.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.965 0.888 . . . . 0.0 111.674 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.41 -35.88 11.56 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.744 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.62 36.66 4.01 Favored Glycine 0 CA--C 1.495 -1.165 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . -101.28 146.3 27.73 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.787 HG22 ' HG2' ' A' ' 85' ' ' GLN . 9.0 t -94.34 166.4 12.1 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 170.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.65 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 48.2 p-80 -51.54 -41.19 60.89 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 122.798 0.439 . . . . 0.0 111.347 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.07 -38.34 82.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.668 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.787 ' HG2' HG22 ' A' ' 82' ' ' THR . 13.6 mm100 -71.46 -47.81 53.29 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.65 75.64 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.209 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.5 -29.79 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.678 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -80.87 -16.24 54.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.34 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 1.061 HG22 HG12 ' A' ' 73' ' ' VAL . 25.4 m -73.16 -32.16 64.7 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.948 HD23 HD23 ' A' ' 99' ' ' LEU . 84.3 mt -76.45 -20.45 57.02 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.221 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -77.16 -44.15 31.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.419 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -64.41 -41.6 96.54 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.379 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.435 HG23 HG12 ' A' ' 97' ' ' VAL . 6.6 p -64.7 158.62 24.15 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.578 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -79.05 -150.62 5.5 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.912 -173.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -65.07 -42.23 94.37 Favored 'General case' 0 C--O 1.209 -1.052 0 C-N-CA 122.94 0.496 . . . . 0.0 109.807 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.2 t -114.4 122.51 68.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.542 HG21 ' HE3' ' A' ' 20' ' ' LYS . 5.9 t -112.58 149.89 14.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.481 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 48.0 m80 -115.13 132.85 56.47 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.948 HD23 HD23 ' A' ' 90' ' ' LEU . 6.4 mp -126.83 145.45 50.64 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tt -99.5 109.91 22.41 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.503 HD13 HG11 ' A' ' 16' ' ' VAL . 11.0 mp -112.59 170.71 7.99 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.607 0.718 . . . . 0.0 110.65 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.515 ' OE1' ' HD3' ' A' ' 69' ' ' ARG . 42.6 tt0 -129.87 132.18 46.34 Favored 'General case' 0 N--CA 1.404 -2.75 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.441 ' HZ2' ' CG ' ' A' ' 68' ' ' ASP . 19.4 tptp -57.38 122.24 12.1 Favored 'General case' 0 N--CA 1.421 -1.89 0 O-C-N 124.285 0.99 . . . . 0.0 110.17 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.614 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.054 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 26.1 t0 . . . . . 0 CA--C 1.502 -0.892 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 4.4 p -103.86 132.59 49.96 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 123.438 0.461 . . . . 0.0 112.209 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.99 147.64 24.3 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.266 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -77.46 98.58 5.35 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 7.2 p -71.94 130.25 35.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -95.26 95.0 8.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.896 HD23 ' HA ' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -101.72 120.44 40.35 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.034 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.82 117.82 31.28 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.451 ' HB3' HD21 ' A' ' 25' ' ' LEU . 5.8 ptmt -71.06 146.55 49.24 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.742 0.782 . . . . 0.0 113.032 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m -87.69 -51.43 5.88 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.294 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 23' ' ' GLY . 14.3 t70 -111.65 -154.84 0.55 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.442 ' H ' ' CG ' ' A' ' 22' ' ' ASP . . . -85.35 16.69 37.95 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.811 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -148.94 176.56 10.32 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.624 HD22 HD11 ' A' ' 18' ' ' LEU . 32.8 mt -93.2 152.31 19.29 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 118.19 0.45 . . . . 0.0 109.816 172.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -82.84 28.61 3.54 Favored Glycine 0 C--O 1.212 -1.259 0 CA-C-N 115.212 -0.903 . . . . 0.0 112.558 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.463 ' HB ' HG11 ' A' ' 49' ' ' VAL . 22.0 pt -131.71 133.95 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 CA-C-O 121.325 0.583 . . . . 0.0 110.826 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.3 t -91.13 117.88 29.98 Favored 'General case' 0 C--N 1.268 -2.968 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.467 ' HB ' ' CG2' ' A' ' 47' ' ' ILE . 30.8 m -109.3 136.12 46.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 O-C-N 123.656 0.597 . . . . 0.0 110.192 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.533 HG23 ' HB2' ' A' ' 50' ' ' LYS . 10.5 t -126.57 161.34 28.23 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.497 HG22 ' CD1' ' A' ' 47' ' ' ILE . 3.1 t . . . . . 0 C--N 1.293 -1.89 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.837 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.441 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.504 HG13 HD13 ' A' ' 78' ' ' LEU . 46.7 mm -101.52 147.21 8.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -136.11 136.4 40.08 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 123.788 0.835 . . . . 0.0 109.45 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.463 HG11 ' HB ' ' A' ' 27' ' ' ILE . 43.7 t -75.6 109.0 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.533 ' HB2' HG23 ' A' ' 30' ' ' THR . 61.3 tttp -83.93 -38.15 21.41 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.977 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.24 165.08 36.87 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.589 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.7 mm -111.87 120.1 61.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 55' ' ' LYS . 1.8 mp -67.78 136.0 92.4 Favored Pre-proline 0 C--N 1.315 -0.927 0 C-N-CA 123.187 0.595 . . . . 0.0 110.522 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.54 -25.88 20.66 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.511 3.474 . . . . 0.0 113.629 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.518 ' H ' HG22 ' A' ' 53' ' ' ILE . 44.1 tptt -82.51 63.8 6.84 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.704 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.66 -109.4 0.7 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 117.926 1.931 . . . . 0.0 117.926 171.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.571 ' HB2' HD12 ' A' ' 18' ' ' LEU . . . 37.66 -86.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 126.847 2.059 . . . . 0.0 113.987 -169.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.896 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -80.47 -28.01 37.7 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.3 -0.25 . . . . 0.0 110.416 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.73 -43.91 24.66 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.6 p -73.56 -38.89 65.06 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.811 -174.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -73.04 -33.28 65.61 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.78 49.95 5.16 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 114.216 -1.356 . . . . 0.0 113.667 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -118.19 -68.67 0.9 Allowed 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 58' ' ' ALA . 63.6 mt -74.13 140.22 18.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.845 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -123.33 159.15 29.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 133.87 40.26 Favored 'General case' 0 N--CA 1.419 -2.024 0 C-N-CA 118.554 -1.258 . . . . 0.0 108.854 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.81 -16.9 12.15 Favored Glycine 0 N--CA 1.425 -2.095 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -72.9 140.65 47.64 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.26 0.553 . . . . 0.0 111.361 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -92.6 133.05 36.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.796 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.499 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 38.3 t -107.68 118.55 55.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt -94.85 -34.85 12.3 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.422 -176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -158.71 172.43 18.29 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.547 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.803 HG23 HD12 ' A' ' 78' ' ' LEU . 88.5 t -123.17 104.29 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 123.564 0.745 . . . . 0.0 109.197 176.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 t30 61.36 34.19 18.5 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 109.417 171.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.2 -24.1 33.05 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.565 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.37 107.43 14.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.518 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 2.8 p -66.9 133.35 49.85 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.607 0.718 . . . . 0.0 112.891 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.803 HD12 HG23 ' A' ' 73' ' ' VAL . 77.4 mt -100.63 30.3 4.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.927 0.87 . . . . 0.0 108.86 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.78 -27.1 49.25 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 125.675 1.59 . . . . 0.0 112.67 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -141.03 44.94 0.99 Allowed Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.39 156.66 18.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.239 0.542 . . . . 0.0 112.199 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.423 ' HA ' HG23 ' A' ' 31' ' ' VAL . 11.4 t -113.49 177.24 4.7 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 170.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -51.26 -54.81 22.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.807 1.243 . . . . 0.0 111.467 -174.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -57.41 -39.22 75.69 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.316 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -70.56 -45.31 65.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.88 -56.42 20.78 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.13 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.426 ' HA ' HD21 ' A' ' 90' ' ' LEU . 90.4 t -62.18 -32.85 55.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.151 -177.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.04 -34.69 78.65 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.3 m -70.6 -35.62 73.1 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.078 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.577 HD11 HD23 ' A' ' 99' ' ' LEU . 3.6 mm? -68.14 -24.21 64.97 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 121.709 -0.62 . . . . 0.0 111.171 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -79.44 -40.14 30.62 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.231 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -71.08 -38.19 72.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.908 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.1 p -64.84 -58.12 7.03 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 149.92 -150.47 22.54 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 118.906 -1.616 . . . . 0.0 114.989 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 52.9 tt0 -84.38 -55.77 3.98 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.794 0.838 . . . . 0.0 110.405 -176.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.4 t -93.61 101.48 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.585 HG23 HD13 ' A' ' 25' ' ' LEU . 2.1 m -100.83 134.0 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.877 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.57 -173.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.691 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 12.0 m170 -101.37 139.62 36.78 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.577 HD23 HD11 ' A' ' 90' ' ' LEU . 5.9 mp -130.25 143.73 50.95 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 172.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.504 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 61.0 tp -86.65 107.2 18.09 Favored 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 13' ' ' THR . 8.4 mp -112.05 155.41 23.86 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.063 0.459 . . . . 0.0 110.431 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 31.7 tt0 -130.79 107.62 9.28 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -47.7 138.04 8.74 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.845 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.048 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.7 t0 . . . . . 0 C--O 1.255 1.381 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 p -98.9 114.48 27.11 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 170.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -109.73 107.33 17.3 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 121.656 0.741 . . . . 0.0 111.846 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -65.78 115.83 6.33 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 170.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.4 p -110.8 137.29 43.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.509 -171.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -107.0 117.52 34.28 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.862 HD23 ' HA ' ' A' ' 58' ' ' ALA . 1.1 tm? -117.87 123.88 46.94 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 118.679 -1.208 . . . . 0.0 108.953 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.45 119.38 35.88 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.698 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -59.85 132.37 53.74 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.415 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 t -66.43 -58.0 6.2 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.283 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -170.2 -50.35 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.69 50.32 2.6 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.715 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.698 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 21.5 t 69.1 -160.15 0.18 Allowed 'General case' 0 C--O 1.254 1.322 0 C-N-CA 124.336 1.054 . . . . 0.0 110.711 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.561 ' HG ' ' HE2' ' A' ' 20' ' ' LYS . 86.5 mt -65.7 142.19 58.1 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.24 0.543 . . . . 0.0 110.946 -178.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 56' ' ' GLY . . . -92.42 33.07 5.13 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.33 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 pt -135.37 135.18 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.579 0 CA-C-O 121.303 0.573 . . . . 0.0 110.127 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.439 ' HB2' HD12 ' A' ' 53' ' ' ILE . 19.4 t -102.37 102.07 12.37 Favored 'General case' 0 C--N 1.259 -3.355 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.5 m -92.2 159.59 2.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -140.57 172.15 13.11 Favored 'General case' 0 N--CA 1.413 -2.279 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--N 1.286 -2.182 0 CA-C-O 121.065 0.46 . . . . 0.0 111.751 -175.686 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.192 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.587 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 49.1 mm -109.7 141.78 24.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -136.17 148.77 48.32 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 66' ' ' LYS . 28.4 t -75.58 117.45 20.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -88.52 -34.15 17.51 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.85 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . . . -159.28 157.25 30.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.049 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.434 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 50.8 mm -105.94 120.59 57.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.445 ' CG2' ' HD3' ' A' ' 55' ' ' LYS . 51.7 mm -75.4 124.3 89.01 Favored Pre-proline 0 C--N 1.295 -1.783 0 C-N-CA 122.698 0.399 . . . . 0.0 110.823 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.0 -8.66 12.37 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 C-N-CA 124.149 3.233 . . . . 0.0 114.9 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HD3' ' CG2' ' A' ' 53' ' ' ILE . 1.1 mptm? -65.45 -28.42 69.21 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.459 ' O ' ' HA3' ' A' ' 26' ' ' GLY . . . 133.13 -147.43 18.98 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.172 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.731 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 75.98 -86.71 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 125.525 1.53 . . . . 0.0 110.916 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.862 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -78.67 -29.63 45.73 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.631 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.434 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 39.3 tt0 -78.85 -44.53 22.76 Favored 'General case' 0 N--CA 1.434 -1.264 0 O-C-N 124.673 1.233 . . . . 0.0 110.799 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.8 p -71.98 -40.53 68.53 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.968 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.63 -39.24 73.81 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.11 66.75 1.85 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.843 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.521 ' HG3' HG13 ' A' ' 64' ' ' ILE . 18.6 ptp180 -136.43 -39.19 0.66 Allowed 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.431 176.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 58' ' ' ALA . 61.2 mt -101.52 141.22 18.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.4 ' HA ' HD13 ' A' ' 52' ' ' ILE . 21.2 p-80 -133.55 173.42 11.51 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 51' ' ' ALA . 62.2 pttt -85.69 151.65 23.7 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.367 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.07 -20.2 43.94 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.477 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.949 ' HA ' ' HA3' ' A' ' 104' ' ' GLY 0.271 1.0 OUTLIER -78.7 152.93 31.31 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.7 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -92.5 134.21 35.19 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.921 -168.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.587 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 60.8 t -106.72 120.34 57.77 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.3 mt -96.79 -38.52 9.84 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.458 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.64 170.2 22.94 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.727 -175.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 87.0 t -129.27 120.35 51.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 63.96 27.64 14.36 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.354 1.074 . . . . 0.0 109.169 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.97 -7.16 60.3 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.606 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.91 113.6 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.9 m -64.68 131.0 45.71 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.683 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 86' ' ' ALA 0.42 0.3 OUTLIER -128.38 67.96 1.37 Allowed 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 122.875 1.321 . . . . 0.0 113.974 174.219 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -108.97 114.89 29.04 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.4 15.24 30.49 Favored Glycine 0 C--N 1.297 -1.589 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.89 -177.21 4.89 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.9 p -113.36 168.67 9.55 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -51.76 -50.79 59.98 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.8 -44.34 94.01 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.624 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.28 -41.57 80.8 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 118.314 0.506 . . . . 0.0 110.704 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.498 ' HA ' HD23 ' A' ' 78' ' ' LEU . . . -57.68 -56.55 20.46 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.975 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.99 -33.13 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.11 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -68.61 -33.65 74.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.921 178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.1 m -68.67 -33.3 73.75 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.642 HD21 HD21 ' A' ' 99' ' ' LEU . 92.9 mt -72.94 -17.23 61.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.833 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -91.87 -37.42 12.92 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -68.53 -27.48 66.13 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.53 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -46.91 65.68 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.86 -156.03 21.92 Favored Glycine 0 C--N 1.311 -0.834 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.08 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.498 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 34.8 tt0 -75.0 -48.11 25.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.934 0.367 . . . . 0.0 110.936 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.4 t -96.83 105.82 17.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 t -100.14 136.45 31.44 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -176.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -102.64 130.66 49.61 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.642 HD21 HD21 ' A' ' 90' ' ' LEU . 5.8 mp -126.98 154.85 44.05 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.1 tt -106.21 112.08 24.96 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.63 163.22 15.26 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.065 0.46 . . . . 0.0 111.972 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.546 ' HG2' ' HD3' ' A' ' 103' ' ' LYS . 30.2 tt0 -132.55 154.01 50.41 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.546 ' HD3' ' HG2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -50.6 121.83 6.33 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 121.802 0.81 . . . . 0.0 111.95 176.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.949 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 C--N 1.298 -1.542 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 t0 . . . . . 0 N--CA 1.442 -0.841 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.4 p -87.84 133.02 33.98 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.281 0.363 . . . . 0.0 111.475 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.62 119.4 4.08 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.325 0.583 . . . . 0.0 111.8 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -72.21 120.21 17.49 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.103 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.551 HG23 HD13 ' A' ' 64' ' ' ILE . 33.5 m -96.39 133.64 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.098 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.95 104.75 16.39 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 170.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.855 HD22 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -112.24 117.77 33.45 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 119.313 -0.955 . . . . 0.0 108.696 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.74 114.25 25.87 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 24' ' ' SER . 98.6 mttt -56.57 136.31 54.48 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 124.14 0.9 . . . . 0.0 112.398 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.523 HG22 ' HB2' ' A' ' 57' ' ' ALA . 61.2 p -91.71 -163.85 1.1 Allowed 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.84 -19.11 65.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.627 0.727 . . . . 0.0 109.106 174.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.596 ' HA3' ' HB2' ' A' ' 54' ' ' PRO . . . -104.5 19.21 42.84 Favored Glycine 0 N--CA 1.429 -1.832 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.59 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.588 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 73.8 m 72.4 -153.73 0.08 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.364 1.066 . . . . 0.0 111.054 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.705 HD22 ' HB3' ' A' ' 18' ' ' LEU . 89.5 mt -61.54 -24.55 66.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.726 ' HA2' ' HD2' ' A' ' 54' ' ' PRO . . . 86.82 -6.05 83.72 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.006 -1.093 . . . . 0.0 111.82 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.508 ' HB ' HG12 ' A' ' 49' ' ' VAL . 22.6 pt -109.51 136.08 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 C-N-CA 119.228 -0.989 . . . . 0.0 112.544 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.1 t -109.03 128.87 55.34 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.44 149.04 18.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 O-C-N 123.15 0.281 . . . . 0.0 111.037 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -130.83 161.21 32.29 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.68 HG13 HD13 ' A' ' 47' ' ' ILE . 31.2 m . . . . . 0 C--N 1.293 -1.872 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.685 -176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.685 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.872 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 48.7 mm -83.83 123.02 38.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -124.43 128.09 48.5 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.271 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.508 HG12 ' HB ' ' A' ' 27' ' ' ILE . 55.4 t -74.44 110.84 9.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -82.42 -35.93 27.13 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.291 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.44 161.04 35.46 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.97 HG21 ' HB2' ' A' ' 59' ' ' GLU . 16.2 mm -116.32 115.68 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.928 ' HB ' ' HD3' ' A' ' 54' ' ' PRO 0.301 2.1 mp -103.3 -89.38 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.673 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -170.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.928 ' HD3' ' HB ' ' A' ' 53' ' ' ILE . 8.5 Cg_endo -91.88 129.79 1.12 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.757 2.305 . . . . 0.0 115.352 -167.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 78.09 -63.62 0.31 Allowed 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 125.726 1.61 . . . . 0.0 110.901 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.08 -83.54 0.13 Allowed Glycine 0 N--CA 1.405 -3.41 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.751 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . 68.51 -83.11 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 125.652 1.581 . . . . 0.0 109.744 175.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.863 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -68.03 -38.3 82.37 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.97 ' HB2' HG21 ' A' ' 52' ' ' ILE . 39.3 tt0 -72.98 -43.94 61.65 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.986 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.6 p -76.88 -36.31 56.81 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.16 -34.12 70.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 174.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.47 43.85 11.89 Favored Glycine 0 N--CA 1.434 -1.489 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.18 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -110.83 -46.66 3.32 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.863 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 44.4 mt -104.42 127.01 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.465 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -125.57 157.84 36.12 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 136.3 51.3 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.451 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 112.12 -24.56 14.16 Favored Glycine 0 C--N 1.289 -2.058 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -171.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.752 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 78.2 m-20 -67.73 145.06 55.11 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.247 0.546 . . . . 0.0 111.745 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 70' ' ' VAL . 1.9 tmm_? -109.95 149.11 30.41 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.4 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.872 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.9 t -117.46 135.45 57.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.673 HD11 HD21 ' A' ' 100' ' ' LEU . 95.5 mt -98.24 -42.56 7.35 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.513 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.58 172.2 18.68 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.816 -172.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 1.053 HG11 HG22 ' A' ' 89' ' ' THR . 3.3 p -114.41 113.63 44.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.755 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 31.3 p30 39.4 42.37 0.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.36 1.464 . . . . 0.0 114.432 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.62 -15.01 62.6 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 120.567 -0.825 . . . . 0.0 114.592 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.531 ' HB ' HG12 ' A' ' 73' ' ' VAL . 46.9 t -92.8 110.07 22.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.5 m -67.62 127.22 31.92 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.727 HD11 HG13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.17 21.01 5.3 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.04 175.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -57.39 -27.34 62.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.118 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.51 23.77 21.62 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.726 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.97 157.55 16.74 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.9 t -83.7 170.93 13.71 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -49.96 -53.02 29.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.77 1.628 . . . . 0.0 110.787 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -63.33 -31.76 73.0 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.854 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -76.98 -39.18 51.43 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.259 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.676 ' HA ' HD22 ' A' ' 78' ' ' LEU . . . -52.09 -60.34 3.32 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.85 0.719 . . . . 0.0 109.896 173.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.14 -33.23 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.549 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.28 -34.72 79.01 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.271 0.558 . . . . 0.0 111.453 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 1.053 HG22 HG11 ' A' ' 73' ' ' VAL . 29.7 m -76.28 -33.95 59.1 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 62.5 mt -73.42 -20.07 60.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.609 0.719 . . . . 0.0 110.194 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -81.98 -40.52 22.05 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.593 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -69.78 -33.37 72.31 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.521 ' HG1' HG13 ' A' ' 97' ' ' VAL . 3.8 p -59.07 -63.07 1.44 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.24 -151.51 23.69 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.053 -1.07 . . . . 0.0 112.531 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -66.33 -45.33 80.63 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 124.071 0.512 . . . . 0.0 111.647 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.76 114.51 46.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.521 HG13 ' HG1' ' A' ' 93' ' ' THR . 6.0 t -107.44 136.54 42.32 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.755 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 54.2 m80 -104.14 131.77 51.08 Favored 'General case' 0 N--CA 1.4 -2.934 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.461 HD13 HD23 ' A' ' 90' ' ' LEU . 6.1 mp -127.09 156.71 41.28 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 173.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.673 HD21 HD11 ' A' ' 71' ' ' LEU . 1.8 tt -108.42 114.09 27.67 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.1 mp -109.21 165.47 11.59 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.933 0.873 . . . . 0.0 112.799 -175.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -130.27 108.99 10.43 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 102.418 -3.178 . . . . 0.0 102.418 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 38.8 tptt -44.31 129.31 6.4 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 123.962 0.789 . . . . 0.0 110.667 -174.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.752 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.43 -1.743 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 -169.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 10.1 t70 . . . . . 0 CA--C 1.503 -0.829 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.1 116.01 31.12 Favored 'General case' 0 C--N 1.285 -2.238 0 O-C-N 123.445 0.466 . . . . 0.0 110.386 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CE2' HG23 ' A' ' 16' ' ' VAL . 29.8 p90 -158.47 157.77 32.82 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 43.0 mt-10 -86.59 106.52 17.62 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.448 HG23 ' CE2' ' A' ' 14' ' ' PHE . 32.0 t -69.52 134.4 30.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.286 177.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -104.64 100.8 10.45 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.923 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -109.08 118.6 37.18 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.95 125.01 40.21 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.86 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -63.05 131.99 50.46 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.049 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 t -59.57 -50.72 72.79 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.339 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 177.15 -24.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.73 71.99 0.46 Allowed Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.168 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.86 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 21.1 t 68.0 -166.29 0.2 Allowed 'General case' 0 C--O 1.251 1.138 0 C-N-CA 125.099 1.36 . . . . 0.0 111.647 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 18' ' ' LEU . 96.2 mt -80.05 163.8 23.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.403 0.62 . . . . 0.0 110.518 -176.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.91 30.94 9.26 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -137.97 162.32 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.298 0 CA-C-O 121.624 0.726 . . . . 0.0 110.785 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 m -140.17 136.73 33.77 Favored 'General case' 0 N--CA 1.394 -3.269 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.877 172.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -109.77 -165.74 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.741 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.156 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.578 ' HA ' ' ND1' ' A' ' 83' ' ' HIS . 14.1 t -165.91 167.64 16.54 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 171.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 81' ' ' ALA . 13.5 p . . . . . 0 C--N 1.291 -1.972 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.824 0 N-CA-C 112.832 -0.107 . . . . 0.0 112.832 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.732 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.8 mm -100.33 126.48 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.54 ' HE1' ' HA2' ' A' ' 67' ' ' GLY . 1.5 t80 -120.11 114.31 21.78 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.393 -172.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.1 t -56.46 108.06 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -86.59 -36.31 18.93 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.117 -1.402 . . . . 0.0 110.697 -172.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.711 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -155.69 154.79 32.06 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.397 -174.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 65' ' ' HIS . 47.5 mm -109.12 114.35 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.681 HG22 ' HB2' ' A' ' 55' ' ' LYS . 1.7 mp -84.81 146.18 45.68 Favored Pre-proline 0 C--N 1.283 -2.302 0 C-N-CA 124.006 0.922 . . . . 0.0 112.059 -172.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . 0.261 16.4 Cg_exo -52.67 52.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.512 2.599 1 C-N-CA 126.456 4.77 . . . . 0.0 113.768 172.92 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.681 ' HB2' HG22 ' A' ' 53' ' ' ILE . 38.1 tptt -137.69 1.16 2.31 Favored 'General case' 0 N--CA 1.388 -3.528 0 O-C-N 121.764 -0.585 . . . . 0.0 109.594 -171.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.69 -136.75 24.85 Favored Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.163 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.71 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . 67.73 -90.5 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.094 0.958 . . . . 0.0 111.096 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.923 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -71.3 -34.37 70.56 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.479 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 40.5 tt0 -72.19 -42.79 65.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 124.325 1.015 . . . . 0.0 110.525 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -70.11 -50.03 44.85 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.348 -175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.7 -20.91 61.85 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.138 0.494 . . . . 0.0 110.182 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.89 43.8 97.02 Favored Glycine 0 CA--C 1.502 -0.742 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.006 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -105.06 -41.67 5.52 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.571 ' HB ' ' HB3' ' A' ' 58' ' ' ALA . 56.4 mt -115.64 136.34 52.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.612 ' HA ' HD12 ' A' ' 52' ' ' ILE . 63.4 t60 -138.41 172.09 13.41 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 55.0 mtmt -58.96 116.13 3.59 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.48 0.712 . . . . 0.0 110.552 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.54 ' HA2' ' HE1' ' A' ' 48' ' ' TYR . . . 116.26 -11.88 16.79 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 119.611 -1.281 . . . . 0.0 112.957 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.701 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 5.9 m-20 -64.57 137.42 57.84 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.751 0.786 . . . . 0.0 112.652 176.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -93.44 122.96 36.4 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.315 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.732 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 61.3 t -100.47 119.61 48.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.0 mt -97.83 -43.99 6.9 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.548 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . . . -154.96 172.07 18.68 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -173.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.881 HG23 HD23 ' A' ' 78' ' ' LEU . 39.5 t -121.06 114.05 41.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 172.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.2 p30 48.27 29.91 2.07 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.287 1.435 . . . . 0.0 112.9 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.58 -30.03 8.89 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.912 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.0 t -80.27 113.8 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 117.819 0.809 . . . . 0.0 109.821 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 12.9 p -74.98 131.46 40.67 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.881 HD23 HG23 ' A' ' 73' ' ' VAL . 1.9 mm? -85.27 9.46 15.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.349 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.59 106.5 5.39 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.25 2.74 24.65 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.512 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -106.52 155.21 19.84 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.9 t -91.78 172.28 8.58 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.578 ' ND1' ' HA ' ' A' ' 30' ' ' THR . 4.2 t60 -50.46 -50.01 53.59 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.26 1.024 . . . . 0.0 109.577 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.568 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 78.2 tttt -50.73 -50.32 55.75 Favored 'General case' 0 C--O 1.204 -1.328 0 O-C-N 124.476 1.11 . . . . 0.0 111.017 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -70.73 -34.9 72.37 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -172.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.586 ' HA ' HD13 ' A' ' 78' ' ' LEU . . . -56.72 -53.95 51.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.611 0.72 . . . . 0.0 109.385 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.519 ' HA ' HD12 ' A' ' 90' ' ' LEU . 97.9 t -65.94 -31.77 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.779 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 19.1 mm-40 -65.81 -31.26 72.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.046 0.451 . . . . 0.0 109.986 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.416 HG23 HG12 ' A' ' 73' ' ' VAL . 24.2 m -78.42 -30.66 47.76 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 87' ' ' VAL . 91.0 mt -71.23 -24.9 62.28 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.18 0.991 . . . . 0.0 109.45 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -86.03 -27.73 24.59 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.821 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -77.52 -34.37 54.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.405 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -58.5 -74.85 0.06 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.1 -131.83 4.1 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 119.714 -1.231 . . . . 0.0 112.658 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -73.35 -48.47 34.0 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.645 0.778 . . . . 0.0 112.151 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.64 128.74 75.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.453 0.644 . . . . 0.0 109.741 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.3 t -103.54 122.89 56.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.497 -175.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -94.28 111.57 23.31 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 172.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.645 HD13 ' HA ' ' A' ' 73' ' ' VAL . 8.5 tp -118.63 127.01 53.18 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.616 ' HB3' ' HB2' ' A' ' 72' ' ' ALA . 2.9 tt -85.87 111.6 20.36 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.651 HD23 ' HB3' ' A' ' 68' ' ' ASP . 11.1 mp -120.43 174.59 6.45 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 122.121 0.962 . . . . 0.0 111.578 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 36.1 tt0 -128.53 125.73 38.92 Favored 'General case' 0 N--CA 1.393 -3.318 0 N-CA-C 101.863 -3.384 . . . . 0.0 101.863 169.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 18.5 tptp -52.4 131.62 33.62 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 124.096 0.873 . . . . 0.0 111.191 -173.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.701 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.416 -2.666 0 N-CA-C 115.987 1.155 . . . . 0.0 115.987 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.591 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 4.2 t70 . . . . . 0 C--O 1.25 1.094 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 16.9 p -101.65 112.18 24.66 Favored 'General case' 0 N--CA 1.426 -1.636 0 O-C-N 123.738 0.648 . . . . 0.0 111.914 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -138.96 172.21 13.18 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.328 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 2.1 mp0 -104.61 117.87 35.19 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.4 m -87.95 117.55 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.318 0 CA-C-O 121.179 0.514 . . . . 0.0 110.358 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.793 ' HG2' ' HD2' ' A' ' 98' ' ' HIS . 42.4 mt-10 -86.76 98.65 11.28 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.522 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.653 HD11 ' HA ' ' A' ' 58' ' ' ALA . 3.5 mm? -111.13 120.54 42.65 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.662 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.21 140.74 29.19 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.514 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -68.04 90.82 0.33 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.27 0.557 . . . . 0.0 111.256 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.8 t -58.21 -31.23 67.13 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.069 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -162.78 -68.21 0.05 OUTLIER 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.152 0.501 . . . . 0.0 110.325 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.54 86.04 0.33 Allowed Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.5 t 79.01 -159.12 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.77 1.228 . . . . 0.0 109.572 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.577 HD23 ' CB ' ' A' ' 18' ' ' LEU . 63.8 mt -87.44 -4.26 59.01 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.045 0.45 . . . . 0.0 111.567 -174.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.92 13.24 78.14 Favored Glycine 0 N--CA 1.419 -2.481 0 C-N-CA 119.859 -1.163 . . . . 0.0 110.689 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.516 ' HB ' HG11 ' A' ' 49' ' ' VAL . 20.1 pt -119.99 130.44 74.24 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.666 0 CA-C-O 122.193 0.996 . . . . 0.0 112.584 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.421 ' OG ' HD13 ' A' ' 53' ' ' ILE . 45.0 m -96.09 110.76 22.96 Favored 'General case' 0 C--N 1.262 -3.233 0 CA-C-N 113.775 -1.557 . . . . 0.0 107.536 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.42 153.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.982 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.603 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 7.9 t -137.78 157.85 45.59 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 C--N 1.286 -2.17 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 -178.843 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.47 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 47.9 mm -110.11 139.81 31.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.309 -0.445 . . . . 0.0 109.997 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -129.53 148.33 51.42 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.634 HG23 HG21 ' A' ' 64' ' ' ILE . 49.1 t -81.6 116.61 26.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 175.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HB2' HG22 ' A' ' 30' ' ' THR . 61.5 tttp -79.15 -38.7 35.37 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.642 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.72 158.45 28.71 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.328 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.834 HG21 ' HB2' ' A' ' 59' ' ' GLU . 32.9 mm -109.07 121.79 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.454 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 48.4 mm -76.31 131.32 75.27 Favored Pre-proline 0 C--N 1.293 -1.872 0 C-N-CA 123.265 0.626 . . . . 0.0 110.698 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 24.6 Cg_exo -67.66 63.53 0.85 Allowed 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 124.067 3.178 . . . . 0.0 113.059 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -130.25 -55.76 1.1 Allowed 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.563 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 166.26 -160.74 34.35 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . 0.252 . . 71.26 -95.97 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 125.324 1.45 . . . . 0.0 113.114 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.653 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -61.33 -40.62 94.88 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.834 ' HB2' HG21 ' A' ' 52' ' ' ILE . 31.2 tt0 -86.32 -33.9 20.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.144 0.497 . . . . 0.0 110.559 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.563 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 29.5 m -74.72 -39.25 62.02 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.403 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.47 -32.32 48.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.97 64.25 1.81 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.874 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -121.65 -60.94 1.56 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.812 0.815 . . . . 0.0 108.926 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.634 HG21 HG23 ' A' ' 49' ' ' VAL . 34.7 mt -96.27 146.76 6.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.715 -174.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -136.58 -170.34 2.66 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -80.82 139.39 36.02 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.131 -1.027 . . . . 0.0 110.623 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.5 -10.31 61.08 Favored Glycine 0 N--CA 1.429 -1.828 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.957 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 30.9 m-20 -64.45 141.91 58.61 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 117.625 0.712 . . . . 0.0 112.271 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -92.41 121.86 34.29 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.239 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.583 HG23 HD11 ' A' ' 101' ' ' LEU . 49.6 t -100.09 111.63 30.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.72 -41.49 10.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.749 ' HB1' ' HB3' ' A' ' 100' ' ' LEU . . . -152.25 168.72 24.46 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.376 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.82 HG23 HD21 ' A' ' 78' ' ' LEU . 93.8 t -124.14 104.42 13.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 173.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 98' ' ' HIS 0.311 1.8 p-10 47.12 45.86 16.1 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 122.219 1.009 . . . . 0.0 113.711 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.1 -16.92 60.09 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.205 -1.361 . . . . 0.0 114.269 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.1 t -90.97 108.49 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 118.016 0.908 . . . . 0.0 108.78 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 5.0 p -78.28 137.24 37.99 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -174.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.82 HD21 HG23 ' A' ' 73' ' ' VAL . 2.2 mm? -93.09 97.51 10.73 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -110.52 -46.03 3.45 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.288 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.14 45.12 1.11 Allowed Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' A' ' 85' ' ' GLN . . . -95.55 -178.15 4.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.374 -0.413 . . . . 0.0 110.686 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.487 ' OG1' ' HG3' ' A' ' 85' ' ' GLN . 68.3 p -115.99 168.3 10.2 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 174.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.603 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 16.5 p-80 -53.58 -40.95 66.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.428 0.632 . . . . 0.0 110.192 173.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.04 -42.13 89.97 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.918 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.574 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 49.1 mt-30 -66.41 -32.47 73.87 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.507 0.594 . . . . 0.0 110.387 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.504 ' HB1' HG13 ' A' ' 47' ' ' ILE . . . -59.88 -50.46 73.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.494 0.664 . . . . 0.0 109.428 174.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.63 -30.55 50.56 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.098 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.57 -36.8 85.39 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.06 0.457 . . . . 0.0 110.22 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.1 m -69.62 -33.46 72.69 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.705 HD23 HD23 ' A' ' 99' ' ' LEU . 90.2 mt -76.54 -23.58 53.63 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.344 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -82.05 -30.99 31.1 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -62.0 -43.85 97.98 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.721 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.483 HG21 HG12 ' A' ' 97' ' ' VAL . 34.9 p -70.64 154.21 42.08 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.67 176.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.46 -114.29 0.78 Allowed Glycine 0 N--CA 1.422 -2.258 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.756 -173.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -86.54 -39.82 15.84 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.851 -0.674 . . . . 0.0 110.961 -172.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.23 127.65 75.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.514 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 4.0 t -114.74 152.31 16.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.793 ' HD2' ' HG2' ' A' ' 17' ' ' GLU . 29.5 m80 -123.93 71.47 1.11 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.705 HD23 HD23 ' A' ' 90' ' ' LEU . 4.8 mp -65.15 144.07 57.45 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.999 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.749 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 2.9 tm? -93.03 107.98 19.65 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -177.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.583 HD11 HG23 ' A' ' 70' ' ' VAL . 2.7 mp -122.6 147.84 45.94 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.872 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 35.3 tt0 -118.16 127.5 53.82 Favored 'General case' 0 N--CA 1.397 -3.086 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 172.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? -54.29 114.36 1.61 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.092 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.426 -1.99 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.338 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 37.6 t70 . . . . . 0 CA--C 1.5 -0.974 0 N-CA-C 111.246 0.091 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p -93.35 124.42 37.32 Favored 'General case' 0 N--CA 1.425 -1.722 0 O-C-N 124.079 0.862 . . . . 0.0 110.143 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.417 ' CE1' ' HD2' ' A' ' 63' ' ' ARG . 46.9 p90 -140.79 152.17 44.98 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.203 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.425 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 52.4 mt-10 -110.95 90.96 3.48 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.618 HG11 HD13 ' A' ' 64' ' ' ILE . 6.5 p -71.07 136.57 25.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.827 -175.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -96.13 93.58 7.03 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.875 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -97.56 116.85 30.56 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.63 131.37 44.26 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.9 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 22' ' ' ASP . 1.6 mptm? -66.8 124.25 22.4 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.081 172.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 t -113.75 10.57 17.88 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 34.1 t70 -155.47 -152.67 0.4 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' H ' ' CG ' ' A' ' 22' ' ' ASP . . . -104.81 15.54 48.43 Favored Glycine 0 C--N 1.296 -1.639 0 CA-C-N 119.83 1.196 . . . . 0.0 110.302 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -142.64 165.76 26.52 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.616 HD23 ' HB3' ' A' ' 18' ' ' LEU . 92.4 mt -85.7 173.74 9.88 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 170.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.83 32.66 5.46 Favored Glycine 0 C--N 1.289 -2.052 0 C-N-CA 120.024 -1.084 . . . . 0.0 111.141 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.726 HG23 HG21 ' A' ' 64' ' ' ILE . 15.0 pt -139.47 143.4 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-O 121.35 0.595 . . . . 0.0 111.905 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.405 ' HB2' HD11 ' A' ' 53' ' ' ILE . 32.9 t -103.01 128.3 49.9 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 49' ' ' VAL . 26.9 m -125.08 151.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-O 120.872 0.368 . . . . 0.0 110.691 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.409 ' HA ' ' CB ' ' A' ' 83' ' ' HIS . 11.7 t -133.25 173.53 11.35 Favored 'General case' 0 N--CA 1.392 -3.359 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.5 ' HB ' ' N ' ' A' ' 83' ' ' HIS . 10.0 p . . . . . 0 C--N 1.26 -3.302 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -171.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.957 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 86' ' ' ALA . 46.5 mm -123.72 149.29 27.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CE2' ' HG2' ' A' ' 69' ' ' ARG . 79.1 m-85 -130.22 139.35 50.81 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 122.036 -0.415 . . . . 0.0 111.089 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.402 ' HA ' HG12 ' A' ' 29' ' ' VAL . 58.2 t -72.39 110.8 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -78.38 -39.8 38.04 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.018 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.69 170.44 14.1 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 -174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.6 mm -102.65 115.47 44.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.405 HD11 ' HB2' ' A' ' 28' ' ' SER . 33.6 mm -75.25 124.8 89.4 Favored Pre-proline 0 C--N 1.31 -1.15 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.48 77.49 2.92 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 122.802 2.334 . . . . 0.0 112.479 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 50.5 mmtt -136.18 12.71 3.31 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.78 173.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.12 -139.6 19.24 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.731 ' HB3' HD11 ' A' ' 18' ' ' LEU . . . 67.51 -93.53 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 123.674 0.789 . . . . 0.0 112.0 173.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.875 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -75.1 -32.27 61.38 Favored 'General case' 0 C--O 1.256 1.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.21 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.49 -39.21 65.03 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 125.191 1.557 . . . . 0.0 110.003 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -73.75 -41.29 62.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.73 -31.13 69.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.37 34.37 79.69 Favored Glycine 0 CA--C 1.49 -1.517 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.707 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.457 ' HG2' ' CG2' ' A' ' 16' ' ' VAL . 15.8 tpp180 -101.23 -37.86 8.35 Favored 'General case' 1 N--CA 1.362 -4.837 0 CA-C-O 121.091 0.472 . . . . 0.0 110.876 -174.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.726 HG21 HG23 ' A' ' 27' ' ' ILE . 22.8 mm -96.29 138.12 22.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.011 -173.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -124.48 161.7 25.52 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -76.4 137.23 39.62 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.861 -1.136 . . . . 0.0 109.885 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.15 -10.61 47.63 Favored Glycine 0 N--CA 1.425 -2.1 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.469 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -68.15 143.39 55.41 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.442 0.639 . . . . 0.0 111.176 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.414 ' HG2' ' CE2' ' A' ' 48' ' ' TYR . 43.4 mtp180 -95.07 125.97 40.09 Favored 'General case' 0 CA--C 1.469 -2.147 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.347 -174.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.512 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 44.4 t -94.22 106.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.832 0 CA-C-N 114.077 -1.42 . . . . 0.0 107.477 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.614 HD11 HD21 ' A' ' 100' ' ' LEU . 56.2 mt -84.44 -35.86 22.74 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.74 -175.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 76' ' ' VAL . . . -166.8 170.81 12.0 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.836 ' HA ' HD13 ' A' ' 99' ' ' LEU . 49.0 t -111.56 103.16 15.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 174.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.971 ' HB3' ' HB2' ' A' ' 98' ' ' HIS 0.283 1.1 p-10 39.43 70.58 0.21 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -178.226 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.61 -32.19 2.91 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.098 -0.956 . . . . 0.0 114.645 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.441 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 60.3 t -81.39 108.38 14.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 118.008 0.904 . . . . 0.0 109.582 -176.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.7 p -63.28 139.18 58.74 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.603 HD13 HG22 ' A' ' 73' ' ' VAL . 71.9 mt -104.03 27.62 7.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.923 0.868 . . . . 0.0 109.158 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -49.63 -33.38 15.22 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.027 1.731 . . . . 0.0 113.081 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.78 46.15 1.07 Allowed Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.48 ' HB1' ' CG ' ' A' ' 85' ' ' GLN . . . -106.26 154.85 20.15 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.56 0.219 . . . . 0.0 111.155 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.405 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.2 t -100.71 160.52 14.29 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 168.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.5 ' N ' ' HB ' ' A' ' 31' ' ' VAL . 39.0 p-80 -51.23 -48.33 62.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 18.8 ptmt -67.46 -30.28 69.95 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.48 ' CG ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -73.97 -36.65 64.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.457 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.537 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.6 -46.61 83.85 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.71 -32.73 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.684 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 41.8 mt-10 -73.28 -26.46 61.1 Favored 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.198 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.434 HG23 HG13 ' A' ' 73' ' ' VAL . 47.4 m -74.19 -26.88 60.53 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.611 HD22 HG13 ' A' ' 97' ' ' VAL . 68.3 mt -74.93 -26.33 59.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -84.25 -28.77 26.98 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.11 -35.26 79.37 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.163 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.7 p -72.06 -66.33 0.66 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.392 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.38 -136.73 7.39 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.435 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.406 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 29.4 tt0 -69.9 -51.38 33.62 Favored 'General case' 0 C--O 1.211 -0.966 0 O-C-N 124.167 0.569 . . . . 0.0 111.117 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.0 125.46 66.08 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 117.863 -1.535 . . . . 0.0 111.348 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.611 HG13 HD22 ' A' ' 90' ' ' LEU . 35.4 t -113.18 126.19 70.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.4 -177.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.971 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 11.2 m170 -89.99 125.5 35.41 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 171.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.836 HD13 ' HA ' ' A' ' 73' ' ' VAL . 8.3 tp -123.77 136.28 54.32 Favored 'General case' 0 C--N 1.259 -3.339 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.614 HD21 HD11 ' A' ' 71' ' ' LEU . 1.3 tt -93.8 113.48 25.54 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.718 HD11 HD21 ' A' ' 99' ' ' LEU . 7.2 mp -125.25 165.78 17.68 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.341 0.591 . . . . 0.0 111.884 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 37.0 tt0 -130.99 134.06 46.35 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 54.4 mmtt -56.2 125.38 21.51 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.631 0.729 . . . . 0.0 112.823 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.094 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.883 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 . . . . . 0 CA--C 1.496 -1.126 0 CA-C-O 120.344 0.116 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 7.9 p -89.0 145.96 25.17 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.176 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -143.75 136.29 27.09 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -97.26 110.71 23.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 33.9 t -89.56 119.56 36.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.08 -172.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -101.62 88.6 3.46 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 169.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.785 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -93.22 117.0 29.56 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -174.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.54 116.77 29.17 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -62.9 139.06 58.71 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.981 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.567 HG22 ' HG3' ' A' ' 55' ' ' LYS . 1.8 m -67.34 -68.85 0.35 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.011 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -103.64 -79.21 0.54 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.44 16.49 2.27 Favored Glycine 0 C--N 1.3 -1.464 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m -117.78 144.11 45.64 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.453 -174.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.422 HD12 HD13 ' A' ' 90' ' ' LEU . 90.4 mt -86.14 175.69 8.38 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.497 ' HA3' ' H ' ' A' ' 58' ' ' ALA . . . -108.69 32.86 6.59 Favored Glycine 0 C--N 1.291 -1.93 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.145 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.6 pt -137.13 138.37 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.77 0 CA-C-O 121.222 0.534 . . . . 0.0 111.721 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.8 t -111.7 109.34 19.16 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 176.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 34.6 m -100.12 168.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.549 -174.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -147.8 169.01 20.69 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 171.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 82' ' ' THR . 11.1 p . . . . . 0 C--N 1.293 -1.887 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.305 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.767 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 48.1 mm -105.25 140.29 23.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.456 ' CE2' ' HG3' ' A' ' 69' ' ' ARG . 81.1 m-85 -135.33 112.71 10.59 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.674 HG21 HG22 ' A' ' 64' ' ' ILE . 59.9 t -46.33 120.14 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.587 0.708 . . . . 0.0 111.278 172.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -91.18 -34.6 14.95 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.491 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.69 158.2 39.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.203 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.0 mm -108.68 118.59 56.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 49.1 mm -87.84 134.29 35.76 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.518 ' HB2' ' H ' ' A' ' 55' ' ' LYS . 16.0 Cg_exo -69.19 -102.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 121.763 1.642 . . . . 0.0 111.836 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.567 ' HG3' HG22 ' A' ' 21' ' ' THR . 16.1 tppt? 67.86 -59.48 0.42 Allowed 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 125.719 1.608 . . . . 0.0 110.885 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.84 48.24 0.03 OUTLIER Glycine 0 N--CA 1.424 -2.127 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.775 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -135.59 -98.39 0.23 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.785 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -69.22 -33.59 73.53 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 118.171 0.441 . . . . 0.0 111.324 -174.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -70.42 -45.57 65.63 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 124.172 0.92 . . . . 0.0 109.193 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 t -72.5 -44.35 62.35 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.483 -174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -74.87 -19.21 60.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.898 0.856 . . . . 0.0 108.94 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.72 67.8 2.02 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.491 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.531 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -119.92 -67.54 0.97 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.097 0.475 . . . . 0.0 110.734 -179.158 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.674 HG22 HG21 ' A' ' 49' ' ' VAL . 63.7 mt -85.5 139.63 17.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.41 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -124.77 178.45 5.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -71.25 129.6 39.29 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.765 0.317 . . . . 0.0 110.697 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.55 -15.49 53.18 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.934 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 103' ' ' LYS . 75.9 m-20 -64.54 138.01 58.17 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 121.658 0.742 . . . . 0.0 112.033 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.456 ' HG3' ' CE2' ' A' ' 48' ' ' TYR . 36.3 ttm180 -90.41 129.38 36.61 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 114.603 -1.181 . . . . 0.0 110.376 -173.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.767 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.2 t -97.01 104.35 15.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.57 HD12 HD23 ' A' ' 100' ' ' LEU . 93.7 mt -78.09 -39.56 41.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.094 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 77' ' ' SER . . . -159.11 166.74 30.89 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.956 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.891 HG21 HD21 ' A' ' 78' ' ' LEU . 98.7 t -119.05 97.71 5.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 52.4 t30 54.2 60.37 3.63 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 124.247 1.019 . . . . 0.0 109.987 -178.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.89 -36.02 2.32 Favored Glycine 0 CA--C 1.548 2.105 0 CA-C-N 114.517 -1.219 . . . . 0.0 114.398 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.86 108.79 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 20.9 m -85.38 142.82 29.02 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.479 0.657 . . . . 0.0 112.602 -173.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.891 HD21 HG21 ' A' ' 73' ' ' VAL . 1.6 mm? -99.21 22.98 9.73 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.977 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -67.36 -22.24 65.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.114 0.483 . . . . 0.0 112.283 -175.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.55 25.68 8.97 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 174.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 85' ' ' GLN . . . -105.99 -172.03 2.01 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.515 0.674 . . . . 0.0 111.509 -176.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.649 ' HA ' HG21 ' A' ' 31' ' ' VAL . 6.6 t -144.91 178.85 7.72 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -50.55 -55.89 14.14 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.968 0.907 . . . . 0.0 111.847 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 33.0 mmtp -65.23 -25.09 67.53 Favored 'General case' 0 C--O 1.211 -0.969 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.502 ' HB2' ' H ' ' A' ' 82' ' ' THR . 16.3 mm100 -76.59 -44.89 32.55 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.502 ' HB3' HG13 ' A' ' 47' ' ' ILE . . . -58.26 -54.32 48.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.444 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.59 -27.69 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.827 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 84' ' ' LYS . 34.1 tt0 -70.88 -34.75 71.92 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 121.702 -0.624 . . . . 0.0 109.317 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.7 m -71.4 -30.59 66.27 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.722 HD21 HD21 ' A' ' 99' ' ' LEU . 94.0 mt -76.8 -12.28 59.95 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.203 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 91' ' ' ARG . 14.0 mmt180 -92.93 -31.7 14.83 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.75 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.01 -38.35 90.65 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.708 0.766 . . . . 0.0 109.199 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.2 p -74.42 146.35 42.96 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.91 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -79.16 -135.06 1.07 Allowed Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 121.453 -0.403 . . . . 0.0 113.65 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -72.87 -49.33 30.63 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.104 0.478 . . . . 0.0 110.484 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 45.8 t -98.93 112.73 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 t -108.52 137.94 37.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.124 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 12.7 m-70 -96.05 129.49 43.32 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 173.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.722 HD21 HD21 ' A' ' 90' ' ' LEU . 5.9 mp -127.11 141.81 51.67 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.57 HD23 HD12 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -99.78 113.81 26.55 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.652 ' HG ' ' HA ' ' A' ' 70' ' ' VAL . 7.3 mp -127.43 163.07 24.88 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 118.727 0.694 . . . . 0.0 112.299 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 36.0 tt0 -131.01 128.77 41.03 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.471 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 6.4 tptp -49.93 113.15 0.79 Allowed 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.267 0.979 . . . . 0.0 110.404 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.29 -1.996 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.936 -173.465 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 CA--C 1.499 -1.0 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 40.2 p -92.6 140.89 29.09 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -139.95 141.64 36.44 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.378 0.609 . . . . 0.0 111.343 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -83.89 108.47 16.9 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.356 -1.293 . . . . 0.0 107.953 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.24 125.8 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.063 0 CA-C-O 121.628 0.728 . . . . 0.0 111.519 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -102.37 113.63 27.11 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.448 HD11 ' CB ' ' A' ' 57' ' ' ALA . 2.7 tm? -109.57 116.27 31.44 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.43 118.54 33.16 Favored 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.448 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 94.1 mttt -59.51 119.29 7.24 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 124.059 0.849 . . . . 0.0 110.304 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.706 ' HB ' ' O ' ' A' ' 56' ' ' GLY . 19.0 m -76.13 -67.44 0.68 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.643 -176.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -152.65 -48.49 0.1 Allowed 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.73 35.65 2.68 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.253 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.8 p 71.64 -132.23 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.616 1.966 . . . . 0.0 111.977 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HG ' HD13 ' A' ' 90' ' ' LEU . 3.3 mm? -72.3 -30.64 64.98 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.836 0.826 . . . . 0.0 109.547 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.73 22.33 62.04 Favored Glycine 0 N--CA 1.402 -3.615 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.431 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.448 ' HB ' HG11 ' A' ' 49' ' ' VAL . 19.9 pt -135.2 143.26 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.692 0 CA-C-O 121.677 0.751 . . . . 0.0 111.056 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.3 t -97.11 118.01 32.57 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.72 140.89 47.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.416 0.627 . . . . 0.0 112.062 -173.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' HG22 ' A' ' 47' ' ' ILE . 11.4 t -138.61 -171.84 3.16 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -172.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.839 ' HA ' HD12 ' A' ' 47' ' ' ILE . 79.5 t . . . . . 0 C--N 1.301 -1.52 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.541 ' CA ' ' HA ' ' A' ' 79' ' ' GLU . . . . . . . . 0 CA--C 1.471 -2.704 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.839 HD12 ' HA ' ' A' ' 31' ' ' VAL . 17.4 mm -141.15 152.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.451 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 39.1 t80 -139.41 138.15 36.27 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.331 0.652 . . . . 0.0 111.094 -174.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.448 HG11 ' HB ' ' A' ' 27' ' ' ILE . 44.2 t -78.48 103.1 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HB2' HG22 ' A' ' 30' ' ' THR . 88.1 tttt -68.89 -41.24 78.57 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.844 -174.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.84 159.39 32.49 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.212 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.526 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 23.4 mm -113.24 134.87 54.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.44 128.4 75.35 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.55 -15.61 9.24 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 125.26 3.974 . . . . 0.0 115.27 -175.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -162.59 64.44 0.21 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.938 0.875 . . . . 0.0 109.644 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.706 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -114.49 -54.34 0.41 Allowed Glycine 0 C--N 1.303 -1.264 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.651 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.491 ' HB3' ' H ' ' A' ' 21' ' ' THR . . . 176.65 -68.13 0.01 OUTLIER 'General case' 0 C--O 1.173 -2.957 0 O-C-N 125.48 1.341 . . . . 0.0 111.641 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.902 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -49.47 -37.29 25.57 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -173.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.526 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -78.84 -48.6 14.41 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -71.6 -35.97 70.66 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.795 -172.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.56 -37.23 56.94 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.41 77.04 1.08 Allowed Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 114.418 -1.265 . . . . 0.0 114.001 173.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -157.98 -47.0 0.06 Allowed 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.902 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 77.1 mt -88.63 132.41 33.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -120.19 164.61 15.97 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 123.533 0.521 . . . . 0.0 109.61 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -63.44 128.96 38.19 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.568 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.612 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 98.92 -8.59 61.36 Favored Glycine 0 N--CA 1.419 -2.482 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.545 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.453 ' CG ' ' HZ1' ' A' ' 103' ' ' LYS . 80.7 m-20 -66.67 139.81 57.87 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-O 121.244 0.545 . . . . 0.0 110.603 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.632 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . 27.7 ttm-85 -98.67 143.63 28.84 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -174.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.474 HG12 HD21 ' A' ' 78' ' ' LEU . 48.5 t -109.9 120.03 60.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.558 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -177.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.502 ' HB2' HD11 ' A' ' 100' ' ' LEU . 57.6 mt -101.82 -33.8 9.67 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.963 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 100' ' ' LEU . . . -151.75 160.06 43.72 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.188 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 1.035 HG11 HG22 ' A' ' 89' ' ' THR . 2.6 p -116.65 104.6 16.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 174.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.462 ' HA ' ' ND1' ' A' ' 98' ' ' HIS . 61.6 t30 55.12 37.68 29.29 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.438 1.114 . . . . 0.0 109.901 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.68 -23.73 35.08 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 120.275 -0.964 . . . . 0.0 114.182 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.548 ' HB ' HG12 ' A' ' 73' ' ' VAL . 44.1 t -80.96 113.15 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 118.458 1.129 . . . . 0.0 109.021 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.3 t -72.82 109.61 6.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.106 0.479 . . . . 0.0 110.134 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.741 ' H ' HD22 ' A' ' 78' ' ' LEU . 1.5 pt? -97.63 33.12 2.12 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 122.233 1.016 . . . . 0.0 110.935 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.541 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 11.8 pt-20 -58.25 -28.65 65.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.131 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.9 30.97 7.07 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.54 -164.12 1.12 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.517 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 13.5 t -144.18 177.72 8.4 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -50.3 -53.15 30.68 Favored 'General case' 0 C--O 1.265 1.913 0 C-N-CA 124.897 1.279 . . . . 0.0 110.67 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 97.5 mttt -59.36 -47.92 83.59 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.019 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.495 ' HB2' ' H ' ' A' ' 82' ' ' THR . 28.8 mm-40 -64.3 -42.69 96.25 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.544 ' HA ' HD13 ' A' ' 78' ' ' LEU . . . -50.55 -60.32 3.14 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-O 121.428 0.632 . . . . 0.0 110.387 175.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.07 -31.8 55.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.428 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 42.6 mm-40 -69.58 -34.15 73.73 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 122.097 -0.377 . . . . 0.0 111.016 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 1.035 HG22 HG11 ' A' ' 73' ' ' VAL . 45.0 m -65.14 -38.48 90.74 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 177.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.772 HD23 HD23 ' A' ' 99' ' ' LEU . 81.6 mt -72.84 -23.49 60.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.731 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -84.11 -30.55 25.86 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.893 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.97 -41.13 87.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.089 0.471 . . . . 0.0 109.892 175.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 20.1 p -68.92 155.04 40.98 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.916 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -71.24 -147.57 0.51 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 114.84 0.696 . . . . 0.0 114.84 -176.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 62.4 tt0 -74.38 -35.89 63.51 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.21 -0.495 . . . . 0.0 110.907 -177.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.71 111.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 t -110.0 146.23 15.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.462 ' ND1' ' HA ' ' A' ' 74' ' ' ASN . 58.5 t-80 -109.68 134.47 51.94 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 175.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.772 HD23 HD23 ' A' ' 90' ' ' LEU . 6.4 mp -130.28 153.36 48.72 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 173.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.682 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 3.3 tm? -106.09 109.79 21.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' THR . 8.0 mp -111.38 171.43 7.48 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-O 121.668 0.747 . . . . 0.0 111.939 -175.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.632 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 29.3 tt0 -128.4 132.69 48.5 Favored 'General case' 0 N--CA 1.396 -3.164 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 175.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.453 ' HZ1' ' CG ' ' A' ' 68' ' ' ASP . 15.6 tppt? -63.05 112.79 2.76 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . . . . . . 0 N--CA 1.409 -3.163 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.31 -172.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 23.1 t0 . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.8 p -92.09 144.75 25.12 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 123.599 0.562 . . . . 0.0 109.706 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -157.77 153.67 26.89 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -110.73 89.2 2.97 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.44 HG12 HD13 ' A' ' 101' ' ' LEU . 14.1 p -81.47 143.18 12.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.433 -175.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HB3' ' HD2' ' A' ' 98' ' ' HIS . 11.1 pt-20 -104.2 111.4 23.98 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.767 HD22 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -111.34 126.72 55.22 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.054 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -101.47 142.05 33.43 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.461 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.733 ' HB2' ' HG3' ' A' ' 95' ' ' GLN . 29.5 mmtm -65.36 118.14 8.92 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.6 m -90.18 -61.39 1.69 Allowed 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.117 0.484 . . . . 0.0 111.804 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -152.88 -45.65 0.1 Allowed 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 121.762 0.792 . . . . 0.0 109.009 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.654 ' O ' ' HB2' ' A' ' 24' ' ' SER . . . -123.48 51.28 0.81 Allowed Glycine 0 N--CA 1.418 -2.51 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.57 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.654 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 25.7 m 80.45 -147.67 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.753 1.221 . . . . 0.0 110.279 175.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.65 HD23 ' HB3' ' A' ' 18' ' ' LEU . 28.6 mt -80.46 -10.95 59.74 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.135 0.493 . . . . 0.0 109.73 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.55 8.99 84.03 Favored Glycine 0 N--CA 1.42 -2.405 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.059 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.444 HG12 ' HB2' ' A' ' 25' ' ' LEU . 25.7 pt -114.76 134.33 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 121.997 0.903 . . . . 0.0 112.766 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.2 t -97.12 107.59 20.14 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.843 -1.526 . . . . 0.0 106.921 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.48 ' HB ' ' CG2' ' A' ' 47' ' ' ILE . 34.1 m -96.84 152.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 120.737 0.303 . . . . 0.0 110.561 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.427 HG23 ' HB2' ' A' ' 50' ' ' LYS . 11.1 t -142.84 156.03 44.88 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 81' ' ' ALA . 7.2 p . . . . . 0 C--N 1.283 -2.305 0 CA-C-O 121.38 0.61 . . . . 0.0 110.212 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.796 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.868 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 49.9 mm -114.35 154.18 15.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 123.433 0.693 . . . . 0.0 109.368 -175.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -128.35 133.5 48.68 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 122.941 0.496 . . . . 0.0 109.79 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.446 HG21 ' CG2' ' A' ' 64' ' ' ILE . 58.8 t -80.06 111.65 17.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.427 ' HB2' HG23 ' A' ' 30' ' ' THR . 38.7 ttpt -79.88 -41.71 25.68 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.034 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.64 41.41 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.848 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.459 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 46.0 mm -113.47 124.16 69.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -81.2 122.18 81.16 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.16 80.26 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.666 2.244 . . . . 0.0 112.099 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -143.3 -42.93 0.29 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.147 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.498 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 156.09 -160.17 29.89 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.359 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 67.67 -102.68 0.07 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.347 1.459 . . . . 0.0 112.819 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.767 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.79 -36.69 84.24 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.355 0.525 . . . . 0.0 111.081 -176.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.459 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 45.1 tt0 -67.56 -47.6 69.35 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.265 1.026 . . . . 0.0 111.289 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.498 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 52.1 m -69.74 -42.68 73.6 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.694 -177.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -71.17 -27.72 63.73 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.048 0.928 . . . . 0.0 108.887 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.51 43.33 94.86 Favored Glycine 0 CA--C 1.498 -0.981 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.657 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.534 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -107.19 -51.04 2.98 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.769 -178.491 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 58' ' ' ALA . 59.1 mt -101.66 126.67 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -125.23 166.19 16.94 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -63.13 125.73 25.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.32 -23.61 15.61 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.683 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.469 ' HB3' HD21 ' A' ' 101' ' ' LEU . 37.8 m-20 -66.82 141.53 57.66 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.32 0.581 . . . . 0.0 110.73 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 69' ' ' ARG . 31.3 mtp180 -106.4 143.79 34.01 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.545 -175.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.868 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 51.4 t -107.93 123.02 63.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.159 -175.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.532 HD12 ' HB2' ' A' ' 102' ' ' GLU . 90.1 mt -99.36 -33.8 10.56 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.84 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.619 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -160.65 163.7 32.33 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.945 HG22 HD12 ' A' ' 78' ' ' LEU . 94.2 t -111.4 115.47 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 173.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 47.03 39.35 7.67 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 126.996 2.119 . . . . 0.0 110.983 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.83 -18.46 56.56 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 119.848 -1.168 . . . . 0.0 114.78 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t -81.58 112.95 20.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.7 m -64.31 133.83 53.46 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.862 0.839 . . . . 0.0 113.06 -171.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.945 HD12 HG22 ' A' ' 73' ' ' VAL . 79.4 mt -107.39 15.49 24.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.733 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.26 97.54 1.57 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.81 25.79 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.436 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -86.45 142.96 28.01 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.0 t -85.56 168.09 14.8 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 172.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.449 ' O ' HG22 ' A' ' 87' ' ' VAL . 57.0 t-80 -50.38 -49.87 53.16 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.652 0.781 . . . . 0.0 110.915 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -53.79 -38.62 64.69 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.939 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -70.58 -51.8 25.89 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 120.707 -0.397 . . . . 0.0 109.951 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.57 -57.93 8.99 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 123.97 0.794 . . . . 0.0 111.804 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 83' ' ' HIS . 37.9 t -65.84 -43.35 93.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.359 -173.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -72.49 -30.58 64.65 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.756 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.632 ' O ' HG21 ' A' ' 93' ' ' THR . 93.6 m -68.22 -43.18 78.55 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.633 HD12 HD11 ' A' ' 25' ' ' LEU . 2.3 tp -75.25 -18.07 60.18 Favored 'General case' 0 N--CA 1.425 -1.712 0 C-N-CA 124.015 0.926 . . . . 0.0 111.445 -177.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -92.24 -33.35 14.7 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.829 -0.544 . . . . 0.0 109.729 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -82.32 -15.91 51.18 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.632 HG21 ' O ' ' A' ' 89' ' ' THR . 5.4 p -53.47 -63.17 1.23 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.442 0.639 . . . . 0.0 111.121 177.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.45 -162.92 32.25 Favored Glycine 0 N--CA 1.411 -2.97 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.733 ' HG3' ' HB2' ' A' ' 20' ' ' LYS . 63.5 tt0 -72.3 -44.59 62.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 117.257 0.529 . . . . 0.0 109.99 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 46.1 t -102.02 118.09 48.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.63 HG21 HD11 ' A' ' 90' ' ' LEU . 4.1 t -112.71 141.99 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.506 ' HD2' ' HB3' ' A' ' 17' ' ' GLU . 37.7 m80 -96.8 125.32 41.16 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 171.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.575 HD13 HG23 ' A' ' 73' ' ' VAL . 2.8 tp -120.58 132.91 55.38 Favored 'General case' 0 C--N 1.253 -3.597 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.4 tt -95.35 114.28 26.04 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.469 HD21 ' HB3' ' A' ' 68' ' ' ASP . 10.2 mp -119.64 171.3 8.47 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.556 0.693 . . . . 0.0 112.199 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.532 ' HB2' HD12 ' A' ' 71' ' ' LEU . 35.7 tt0 -131.4 123.08 27.44 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 101.618 -3.475 . . . . 0.0 101.618 171.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -58.13 126.34 27.06 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 123.683 0.614 . . . . 0.0 110.375 -173.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.687 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.197 -175.339 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 21.8 p -95.38 148.27 22.63 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.22 0.533 . . . . 0.0 111.34 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -149.42 147.69 28.56 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -103.91 98.06 7.96 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.463 HG12 HD11 ' A' ' 101' ' ' LEU . 8.4 p -82.87 127.56 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.825 -175.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.35 87.98 3.35 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.732 HD11 HD13 ' A' ' 25' ' ' LEU . 1.4 tm? -87.41 113.9 23.53 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -175.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.12 113.96 26.01 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.4 127.14 30.27 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 123.986 0.804 . . . . 0.0 110.455 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.6 p -82.3 -71.74 0.47 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.463 1.125 . . . . 0.0 111.506 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -156.61 -36.27 0.08 Allowed 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 113.547 -1.66 . . . . 0.0 106.678 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . -89.14 28.42 6.71 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.517 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.3 p 65.97 -142.31 0.18 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.103 1.761 . . . . 0.0 111.525 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.732 HD13 HD11 ' A' ' 18' ' ' LEU . 7.7 tp -67.82 -28.35 67.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.934 0.873 . . . . 0.0 109.306 -176.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.27 18.51 66.64 Favored Glycine 0 N--CA 1.411 -2.995 0 C-N-CA 119.951 -1.118 . . . . 0.0 114.693 172.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.451 HG21 ' HB2' ' A' ' 58' ' ' ALA . 12.3 pt -131.84 145.86 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 CA-C-O 121.303 0.573 . . . . 0.0 111.404 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.5 t -111.89 136.36 51.31 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 49' ' ' VAL . 32.1 m -126.14 149.9 31.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.581 0.705 . . . . 0.0 112.358 -175.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 13.5 t -125.41 145.36 50.09 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.475 HG22 HD12 ' A' ' 47' ' ' ILE . 46.0 t . . . . . 0 C--N 1.293 -1.872 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.053 -176.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.711 0 N-CA-C 112.034 -0.426 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.997 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 50.5 mm -87.26 121.74 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -121.31 131.17 54.05 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.547 -0.861 . . . . 0.0 113.3 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 29' ' ' VAL . 45.3 t -70.04 112.81 5.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 61.9 tttp -86.04 -36.86 19.44 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.359 -176.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.99 148.81 28.83 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.408 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.678 HG12 ' HB3' ' A' ' 66' ' ' LYS . 46.5 mm -110.57 127.73 67.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.68 HG23 ' H ' ' A' ' 55' ' ' LYS . 44.9 mm -83.62 138.61 40.99 Favored Pre-proline 0 C--N 1.286 -2.165 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.957 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -60.0 -16.52 39.48 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 124.13 3.22 . . . . 0.0 112.391 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.68 ' H ' HG23 ' A' ' 53' ' ' ILE . 51.3 tptt -121.16 35.97 4.74 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.87 128.57 6.73 Favored Glycine 1 N--CA 1.387 -4.575 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.445 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB3' HD12 ' A' ' 18' ' ' LEU . . . -45.91 -33.61 3.36 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 126.578 1.951 . . . . 0.0 114.392 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -60.16 -36.06 76.71 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.202 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.597 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 31.7 tt0 -91.97 -40.01 11.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.425 0.631 . . . . 0.0 109.646 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.1 m -75.71 -48.49 21.71 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.148 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -74.92 -36.88 62.15 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.35 67.77 1.16 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.757 -1.11 . . . . 0.0 113.103 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.429 ' HB3' HG22 ' A' ' 16' ' ' VAL . 18.8 mmt180 -132.64 -75.65 0.5 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.337 0.589 . . . . 0.0 111.119 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 58' ' ' ALA . 60.5 mt -78.62 146.76 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.099 0.959 . . . . 0.0 111.994 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -116.35 163.75 15.56 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.678 ' HB3' HG12 ' A' ' 52' ' ' ILE . 51.5 pttt -81.88 135.0 35.45 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.436 0.636 . . . . 0.0 110.581 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.33 -11.52 43.57 Favored Glycine 0 N--CA 1.424 -2.145 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.054 -174.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.551 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 18.3 m-20 -66.44 146.44 54.55 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -96.49 125.48 41.0 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.38 -1.736 . . . . 0.0 109.028 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.997 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 48.3 t -108.91 123.28 64.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.9 mt -96.8 -39.98 9.17 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.088 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.28 178.63 7.39 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.628 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.755 ' HA ' HD13 ' A' ' 99' ' ' LEU . 24.5 t -116.01 105.37 18.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.668 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 10.7 p30 50.02 34.15 7.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 124.387 1.075 . . . . 0.0 113.116 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.01 -21.69 43.56 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.569 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.43 100.67 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.644 ' HB2' ' HG2' ' A' ' 79' ' ' GLU . 2.9 p -58.39 128.64 38.18 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.212 1.005 . . . . 0.0 113.269 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.8 mt -97.04 21.26 10.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.516 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.644 ' HG2' ' HB2' ' A' ' 77' ' ' SER . 7.7 pt-20 -74.36 126.34 30.46 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.793 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.16 12.92 62.73 Favored Glycine 0 C--N 1.298 -1.563 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.35 142.39 38.76 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.6 t -96.25 174.15 7.03 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -51.3 -43.39 61.64 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -64.47 -33.4 75.8 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.408 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -72.62 -42.08 64.85 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.102 0.477 . . . . 0.0 109.848 -175.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.561 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -60.01 -53.94 51.91 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.252 176.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.479 ' HA ' HD12 ' A' ' 90' ' ' LEU . 57.9 t -67.07 -34.32 68.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -176.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -72.45 -26.85 61.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.27 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.9 m -70.35 -34.62 72.85 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 87.6 mt -71.69 -32.43 67.83 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.75 0.785 . . . . 0.0 109.8 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -69.05 -39.84 78.91 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.111 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -67.42 -40.19 85.5 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.482 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -65.32 147.37 53.56 Favored 'General case' 0 C--O 1.253 1.237 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 175.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.38 -133.68 0.22 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -172.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -74.26 -52.59 11.9 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.031 0.532 . . . . 0.0 111.293 -175.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.74 111.86 35.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.1 t -100.76 129.55 51.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.295 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.668 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 50.5 m80 -93.51 119.12 32.2 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.755 HD13 ' HA ' ' A' ' 73' ' ' VAL . 7.2 tp -121.98 138.48 54.41 Favored 'General case' 0 N--CA 1.401 -2.902 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.21 109.4 22.16 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.593 HD13 HD21 ' A' ' 99' ' ' LEU . 11.2 mp -118.32 169.02 10.08 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.982 0.896 . . . . 0.0 111.988 -177.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 36.0 tt0 -131.72 137.82 48.4 Favored 'General case' 0 N--CA 1.39 -3.459 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 173.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.551 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 15.7 tppt? -64.33 113.44 3.62 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -1.973 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.677 -173.63 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 120.416 0.151 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 p -87.18 117.5 25.97 Favored 'General case' 0 C--N 1.279 -2.465 0 O-C-N 124.064 0.852 . . . . 0.0 109.942 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -134.25 149.37 50.94 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 50.2 mt-10 -106.1 110.98 23.41 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.668 HG11 HD12 ' A' ' 64' ' ' ILE . 10.5 p -89.39 124.02 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.854 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -174.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.31 89.06 7.84 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.029 HD23 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -96.05 115.45 27.45 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -175.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.19 115.46 29.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.007 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -64.1 146.34 54.37 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.612 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -122.1 90.16 3.25 Favored 'General case' 0 N--CA 1.408 -2.574 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.094 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.7 t70 65.85 -65.81 0.17 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.51 1.524 . . . . 0.0 114.275 -177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.07 67.8 0.23 Allowed Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.515 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 84.8 p 70.34 -173.73 0.18 Allowed 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.794 1.638 . . . . 0.0 114.224 169.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 18' ' ' LEU . 80.9 mt -72.02 160.33 32.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.1 41.16 2.64 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.212 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.487 HG21 ' CB ' ' A' ' 58' ' ' ALA . 14.7 pt -135.13 137.6 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.806 0 CA-C-O 121.419 0.628 . . . . 0.0 111.426 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -94.87 123.63 38.44 Favored 'General case' 0 N--CA 1.41 -2.432 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.604 HG22 ' H ' ' A' ' 30' ' ' THR . 12.3 p -93.54 175.87 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 O-C-N 123.321 0.388 . . . . 0.0 110.064 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.91 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 14.8 t -166.12 148.75 7.16 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.755 HG21 ' HA ' ' A' ' 82' ' ' THR . 12.2 p . . . . . 0 N--CA 1.424 -1.74 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.871 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.605 HG13 ' HG ' ' A' ' 78' ' ' LEU . 43.4 mm -102.19 138.0 28.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -137.68 163.77 30.47 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.955 0.407 . . . . 0.0 110.122 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 64' ' ' ILE . 56.9 t -88.3 113.61 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.952 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 169.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.91 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 59.3 tttm -76.24 -35.4 59.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.602 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.717 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . . . -168.1 167.18 12.64 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.946 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.957 HG23 ' HB2' ' A' ' 59' ' ' GLU . 49.0 mm -108.47 122.82 63.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.0 mm -83.97 145.71 47.19 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -56.88 -133.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 123.548 2.832 . . . . 0.0 114.389 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 75.3 -52.23 0.66 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.556 1.142 . . . . 0.0 110.716 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.19 -50.19 0.87 Allowed Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.69 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . -8.97 -75.83 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 127.903 2.481 . . . . 0.0 116.149 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 1.029 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -96.02 -29.15 14.29 Favored 'General case' 0 C--O 1.255 1.359 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -172.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.957 ' HB2' HG23 ' A' ' 52' ' ' ILE . 39.6 tt0 -82.93 -53.21 6.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 123.331 0.394 . . . . 0.0 111.542 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 m -86.95 -35.14 19.05 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.633 -171.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 9.5 m-20 -101.3 -28.73 12.46 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.28 -174.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.94 -131.21 6.6 Favored Glycine 0 N--CA 1.398 -3.876 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -154.32 2.65 0.23 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.668 HD12 HG11 ' A' ' 16' ' ' VAL . 31.4 mt -90.45 148.44 4.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.525 -165.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -137.95 173.33 11.75 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.717 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 22.6 pttp -73.2 130.44 40.23 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.283 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.97 -20.77 8.5 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.115 -1.04 . . . . 0.0 113.507 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.63 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 53.9 m-20 -71.78 138.52 48.45 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 117.453 0.626 . . . . 0.0 110.619 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -90.54 135.04 33.95 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.41 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.415 ' HB ' HG21 ' A' ' 47' ' ' ILE . 57.8 t -106.41 120.9 58.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' A' ' 102' ' ' GLU . 62.7 mt -96.41 -37.97 10.23 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.582 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.717 ' HB1' ' HB3' ' A' ' 100' ' ' LEU . . . -154.64 162.29 41.2 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.495 -173.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.764 ' HA ' HD13 ' A' ' 99' ' ' LEU . 56.3 t -115.39 106.95 21.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.3 t30 62.56 31.85 16.72 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.368 1.08 . . . . 0.0 109.761 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.56 -21.46 45.57 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 114.855 -1.066 . . . . 0.0 114.162 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.6 t -82.97 114.36 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 117.736 0.768 . . . . 0.0 109.725 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.9 t -72.1 127.68 33.31 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 123.069 0.548 . . . . 0.0 110.723 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.686 ' N ' HD23 ' A' ' 78' ' ' LEU . 2.0 pt? -131.46 30.07 4.49 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -69.32 -11.31 60.71 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.618 0.723 . . . . 0.0 110.643 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.57 21.51 25.84 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.825 174.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -93.17 -154.48 0.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.177 0.513 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.755 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.1 t -146.36 173.0 12.66 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 175.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.508 ' CD2' HG13 ' A' ' 29' ' ' VAL . 51.7 t-80 -50.72 -60.29 3.2 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.78 1.232 . . . . 0.0 111.582 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -59.67 -36.98 77.52 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.576 0.75 . . . . 0.0 110.945 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -67.29 -45.06 77.69 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.399 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.447 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -60.21 -51.29 70.2 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.931 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 3.1 p -68.81 -34.63 65.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.085 -173.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.719 ' HA ' ' HG2' ' A' ' 91' ' ' ARG . 20.5 mm-40 -77.64 -23.47 49.73 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.436 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.5 m -70.91 -28.5 64.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.539 HD13 HD12 ' A' ' 25' ' ' LEU . 86.8 mt -73.58 -24.71 60.11 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.752 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.719 ' HG2' ' HA ' ' A' ' 88' ' ' GLU . 36.7 mmt180 -73.64 -49.84 24.04 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.65 -32.06 73.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.578 -174.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.482 HG22 HG13 ' A' ' 73' ' ' VAL . 1.3 p -63.87 -36.26 83.35 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.39 -140.42 13.41 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 119.712 -1.232 . . . . 0.0 113.427 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -88.46 -52.19 5.32 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.674 0.79 . . . . 0.0 109.933 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 65.5 t -99.31 111.49 29.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 43.6 t -105.86 120.94 57.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -93.08 70.54 4.54 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.764 HD13 ' HA ' ' A' ' 73' ' ' VAL . 6.7 tp -71.55 139.27 49.38 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 122.249 -0.282 . . . . 0.0 110.55 -172.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.717 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 55.9 tp -94.17 113.32 25.24 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.638 HD12 HD21 ' A' ' 99' ' ' LEU . 10.0 mp -117.66 166.66 12.14 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-O 121.551 0.691 . . . . 0.0 110.144 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.491 ' HB2' HD13 ' A' ' 71' ' ' LEU . 37.1 tt0 -128.48 124.44 36.12 Favored 'General case' 0 N--CA 1.389 -3.491 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 174.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 23.8 tptp -49.07 123.52 7.34 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 124.572 1.17 . . . . 0.0 110.409 -177.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.63 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.421 -2.322 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 27.0 t70 . . . . . 0 CA--C 1.505 -0.775 0 N-CA-C 110.816 -0.068 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -93.1 114.18 26.64 Favored 'General case' 0 N--CA 1.426 -1.667 0 O-C-N 123.491 0.494 . . . . 0.0 109.803 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.418 ' HE2' ' HD2' ' A' ' 63' ' ' ARG . 5.6 p90 -127.78 159.61 34.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.152 0.501 . . . . 0.0 111.463 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -106.05 130.44 53.97 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 12.4 t -110.88 132.3 59.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -175.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.533 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 26.1 mp0 -97.76 87.06 3.93 Favored 'General case' 0 C--O 1.248 1.009 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 171.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.087 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -96.94 116.64 29.54 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -92.9 125.12 37.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 86.7 mttt -67.66 163.92 20.37 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-O 121.844 0.831 . . . . 0.0 111.571 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER -88.52 33.1 0.76 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.616 175.591 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 20' ' ' LYS . 16.7 t70 67.99 -28.82 0.15 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.307 2.243 . . . . 0.0 113.024 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 21' ' ' THR . . . -77.04 -58.53 3.39 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 176.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 t -167.05 -175.29 2.95 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.63 HD11 HG12 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -85.85 139.55 31.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.328 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.48 43.02 2.84 Favored Glycine 0 C--N 1.295 -1.743 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.717 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.63 HG12 HD11 ' A' ' 25' ' ' LEU . 18.9 pt -138.32 148.69 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-N 118.133 0.967 . . . . 0.0 111.765 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.649 ' HB2' HD11 ' A' ' 53' ' ' ILE . 39.4 t -108.5 109.65 20.96 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.573 ' HB ' HG22 ' A' ' 47' ' ' ILE . 26.9 m -104.87 144.82 14.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 123.877 0.736 . . . . 0.0 110.296 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.512 HG23 ' HB2' ' A' ' 50' ' ' LYS . 12.8 t -144.0 157.88 44.06 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.537 HG21 HD12 ' A' ' 47' ' ' ILE . 56.1 t . . . . . 0 C--N 1.298 -1.648 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . . . . . . 0 CA--C 1.476 -2.398 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.573 HG22 ' HB ' ' A' ' 29' ' ' VAL . 18.9 mm -139.29 142.76 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 173.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.637 ' HH ' ' HA2' ' A' ' 67' ' ' GLY . 52.9 t80 -140.52 141.93 35.27 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.28 108.09 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.512 ' HB2' HG23 ' A' ' 30' ' ' THR . 53.3 tttp -82.27 -35.8 27.7 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.811 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.87 36.28 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.735 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 1.038 HG21 ' HB2' ' A' ' 59' ' ' GLU . 31.7 mm -111.7 113.45 44.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.649 HD11 ' HB2' ' A' ' 28' ' ' SER . 2.0 mp -83.41 128.33 64.77 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 53.2 Cg_exo -59.94 88.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 124.14 3.227 . . . . 0.0 115.142 -177.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.421 ' O ' HG23 ' A' ' 21' ' ' THR . 2.4 mptm? -125.09 -27.23 3.57 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.681 170.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.624 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 93.89 49.12 2.54 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -175.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.439 ' HB2' HD12 ' A' ' 18' ' ' LEU . . . -122.26 -77.77 0.59 Allowed 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.166 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 1.087 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -83.25 -31.44 26.98 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -170.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.038 ' HB2' HG21 ' A' ' 52' ' ' ILE . 40.0 tt0 -80.02 -45.39 18.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 124.645 1.216 . . . . 0.0 110.268 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.624 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 1.2 m -85.09 -47.86 9.76 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.264 -168.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -100.7 -21.5 15.2 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.931 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.84 -132.26 6.36 Favored Glycine 1 N--CA 1.393 -4.219 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.93 -173.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.418 ' HD2' ' HE2' ' A' ' 14' ' ' PHE . 40.1 mtt180 -156.24 -1.54 0.13 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -169.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.736 ' HB ' ' HB2' ' A' ' 58' ' ' ALA . 60.2 mt -96.22 132.05 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.145 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.546 -169.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.41 ' HA ' HG13 ' A' ' 52' ' ' ILE . 81.4 m-70 -139.67 170.48 15.82 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -69.22 129.79 40.84 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.459 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.637 ' HA2' ' HH ' ' A' ' 48' ' ' TYR . . . 123.8 -26.08 6.01 Favored Glycine 0 C--N 1.291 -1.972 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.848 -172.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.451 ' HB3' HD23 ' A' ' 101' ' ' LEU . 18.2 m-20 -72.86 133.91 44.62 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 4.5 ptm180 -100.84 151.15 22.06 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.536 HG21 ' HG ' ' A' ' 101' ' ' LEU . 47.3 t -112.83 127.2 70.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.443 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -176.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.9 mt -100.87 -34.3 9.86 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.345 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.55 175.11 13.64 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.466 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 1.053 HG11 HG21 ' A' ' 89' ' ' THR . 4.7 p -130.64 110.21 18.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 124.943 1.297 . . . . 0.0 109.523 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 62.68 30.17 16.86 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.412 1.101 . . . . 0.0 108.151 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.04 -18.69 46.59 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.259 -0.882 . . . . 0.0 114.079 -174.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.0 t -81.82 122.76 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.4 t -58.17 140.45 52.93 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.662 HD12 ' HB ' ' A' ' 73' ' ' VAL . 81.2 mt -118.06 -3.02 11.14 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.865 175.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.569 ' HA ' ' HA3' ' A' ' 46' ' ' GLY 0.261 1.0 OUTLIER -76.97 103.95 7.19 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 122.475 1.131 . . . . 0.0 110.43 177.888 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.45 -6.28 12.83 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -173.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.81 149.61 24.72 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.464 ' HA ' HG22 ' A' ' 31' ' ' VAL . 5.1 t -79.14 154.14 29.55 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.415 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 42.8 p-80 -51.55 -36.73 46.41 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 120.759 0.314 . . . . 0.0 111.826 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.436 ' HB2' HG23 ' A' ' 82' ' ' THR . 94.6 mttt -48.9 -53.61 18.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.36 173.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -66.89 -35.7 80.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 123.375 0.422 . . . . 0.0 111.458 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -58.47 -49.84 75.89 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.433 0.635 . . . . 0.0 109.805 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.92 -32.94 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.392 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 45.1 mt-10 -66.56 -34.14 77.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 110.091 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 1.053 HG21 HG11 ' A' ' 73' ' ' VAL . 50.6 m -71.01 -29.15 65.02 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.328 0.585 . . . . 0.0 109.491 174.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.1 mt -71.41 -24.03 61.97 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-O 121.077 0.465 . . . . 0.0 109.982 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -90.74 -15.49 30.12 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.058 0.456 . . . . 0.0 111.092 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.27 -35.08 31.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 p -75.01 154.67 37.94 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.169 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.27 -136.79 1.67 Allowed Glycine 0 C--N 1.314 -0.66 0 N-CA-C 114.349 0.5 . . . . 0.0 114.349 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.433 ' OE1' ' HB2' ' A' ' 20' ' ' LYS . 5.2 tp-100 -72.39 -46.84 53.48 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.745 0.784 . . . . 0.0 109.361 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 52.4 t -102.19 119.0 49.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.47 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 41.4 t -104.57 129.62 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.092 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.805 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.533 ' CD2' ' HG3' ' A' ' 17' ' ' GLU . 26.6 m170 -89.5 122.62 32.86 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 169.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.688 HD21 HD11 ' A' ' 101' ' ' LEU . 4.9 tp -130.0 147.86 51.8 Favored 'General case' 0 C--N 1.271 -2.844 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.7 tt -110.11 116.56 31.76 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.688 HD11 HD21 ' A' ' 99' ' ' LEU . 7.5 mp -122.64 175.38 6.53 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.472 0.653 . . . . 0.0 111.001 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 26.9 tt0 -128.3 119.99 26.19 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.502 ' HE3' ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -50.02 106.46 0.12 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.006 1.322 . . . . 0.0 110.656 -173.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.502 ' N ' ' HE3' ' A' ' 103' ' ' LYS . . . . . . . . 0 N--CA 1.424 -2.133 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.868 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 59.0 t0 . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 p -96.78 116.07 28.51 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 123.639 0.775 . . . . 0.0 110.397 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.35 132.44 21.64 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.35 0.595 . . . . 0.0 112.259 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 41.8 mt-10 -81.13 99.21 8.4 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.095 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 64' ' ' ILE . 55.5 t -68.38 131.08 33.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.143 -177.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -92.61 98.96 11.76 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.973 HD23 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -110.95 118.76 36.97 Favored 'General case' 0 N--CA 1.415 -2.207 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.998 -179.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.8 126.33 41.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.294 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.629 ' HE2' HD21 ' A' ' 25' ' ' LEU . 95.3 mttt -76.11 137.99 40.48 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.086 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -73.58 -41.04 63.41 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -173.05 -65.01 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.399 0.619 . . . . 0.0 109.844 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.85 63.7 3.17 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.555 -176.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.557 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 23.3 t 69.48 -168.11 0.17 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.867 1.267 . . . . 0.0 112.691 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.629 HD21 ' HE2' ' A' ' 20' ' ' LYS . 2.5 mm? -73.51 159.28 33.41 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.743 0.817 . . . . 0.0 110.757 -177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.7 38.37 3.13 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.417 HD11 HD13 ' A' ' 64' ' ' ILE . 23.8 pt -137.1 144.51 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.666 0 CA-C-O 121.454 0.645 . . . . 0.0 111.343 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.423 ' HB2' HG12 ' A' ' 53' ' ' ILE . 28.3 t -106.17 115.22 29.84 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.77 148.65 16.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.858 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.1 t -150.0 167.84 25.56 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.883 HG12 ' HA ' ' A' ' 82' ' ' THR . 13.6 p . . . . . 0 C--N 1.292 -1.898 0 CA-C-O 121.337 0.589 . . . . 0.0 110.227 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.424 ' O ' HG21 ' A' ' 31' ' ' VAL . . . . . . . . 0 C--O 1.217 -0.947 0 N-CA-C 113.693 0.237 . . . . 0.0 113.693 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.86 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.6 mm -101.87 148.67 7.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.412 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 79.7 t80 -125.13 128.02 47.78 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 122.004 -0.435 . . . . 0.0 111.679 -176.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.99 105.66 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 171.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.59 ' HB2' HG23 ' A' ' 30' ' ' THR . 87.1 tttt -77.93 -40.17 40.48 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.521 -175.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.6 165.06 33.56 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.781 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.1 mm -102.8 109.75 27.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.495 HG21 ' HD2' ' A' ' 54' ' ' PRO . 27.1 mm -72.86 154.24 91.06 Favored Pre-proline 0 C--N 1.294 -1.816 0 C-N-CA 124.601 1.161 . . . . 0.0 110.087 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.495 ' HD2' HG21 ' A' ' 53' ' ' ILE . 87.4 Cg_exo -52.4 -158.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.44 0 C-N-CA 123.383 2.722 . . . . 0.0 113.572 170.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? 76.53 -51.44 0.59 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.684 1.194 . . . . 0.0 111.273 -173.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 130.44 -120.5 3.04 Favored Glycine 0 N--CA 1.414 -2.798 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.78 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . 70.05 -91.13 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.102 0.961 . . . . 0.0 112.897 170.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.973 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -75.34 -37.42 60.7 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.61 -46.36 66.43 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 124.985 1.428 . . . . 0.0 108.702 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 m -70.41 -43.63 69.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.268 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -73.86 -30.12 62.49 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.1 33.44 36.28 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.514 175.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -95.21 -59.32 1.92 Allowed 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.716 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.708 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.7 mt -86.51 131.48 34.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -119.72 161.93 19.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -81.85 144.72 30.82 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 118.751 -1.18 . . . . 0.0 110.555 -177.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.412 ' HA2' ' CZ ' ' A' ' 48' ' ' TYR . . . 102.6 -6.94 52.99 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -176.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -87.4 154.21 20.84 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.39 0.614 . . . . 0.0 111.837 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 69' ' ' ARG . 28.4 mtp-105 -100.45 141.73 32.9 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.896 0.855 . . . . 0.0 112.784 -176.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.86 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 58.9 t -106.55 125.56 62.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.013 -1.448 . . . . 0.0 107.22 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.889 HD12 ' HB2' ' A' ' 102' ' ' GLU . 28.3 mt -100.94 -35.5 9.37 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.991 -176.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.527 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -160.7 166.52 28.65 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.87 HG22 HD12 ' A' ' 78' ' ' LEU . 48.1 t -119.13 108.09 23.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 124.841 1.256 . . . . 0.0 108.333 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.5 t30 56.98 52.9 8.62 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.048 0.939 . . . . 0.0 110.559 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.6 -25.08 3.45 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 114.85 -1.068 . . . . 0.0 114.33 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.9 t -81.11 110.85 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 117.686 0.743 . . . . 0.0 109.826 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.478 ' HA ' ' HB3' ' A' ' 72' ' ' ALA . 38.6 m -63.13 140.04 58.83 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.268 0.98 . . . . 0.0 112.106 -175.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.87 HD12 HG22 ' A' ' 73' ' ' VAL . 55.2 mt -110.52 76.32 0.98 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -107.1 125.47 51.1 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.27 32.96 81.16 Favored Glycine 0 C--N 1.31 -0.907 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.14 138.18 39.43 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.883 ' HA ' HG12 ' A' ' 31' ' ' VAL . 8.8 t -82.82 159.35 22.46 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 173.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.858 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 39.2 p-80 -52.09 -39.13 59.3 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 123.073 0.233 . . . . 0.0 111.599 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.99 -39.94 91.58 Favored 'General case' 0 C--O 1.206 -1.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.785 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.489 ' HG2' HG21 ' A' ' 82' ' ' THR . 74.8 mm-40 -67.23 -44.7 78.85 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.39 -51.51 69.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.421 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.492 ' HA ' HD11 ' A' ' 90' ' ' LEU . 85.6 t -68.16 -31.83 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.514 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -66.58 -30.67 71.02 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 121.768 -0.582 . . . . 0.0 110.243 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.8 m -76.74 -28.14 55.65 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.183 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 87' ' ' VAL . 95.9 mt -73.37 -33.54 65.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.75 0.785 . . . . 0.0 109.68 175.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.26 -29.45 57.48 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.526 176.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -72.63 -31.81 65.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.85 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.5 p -72.3 163.35 28.1 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.18 -123.8 0.5 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.887 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -94.64 -42.11 8.95 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 122.794 -0.239 . . . . 0.0 111.14 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.36 110.71 27.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.407 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 39.4 t -99.58 121.51 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.199 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.726 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.464 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 42.4 m80 -91.29 98.88 11.98 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 174.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.805 HD13 ' HA ' ' A' ' 73' ' ' VAL . 9.6 tp -101.13 129.36 47.02 Favored 'General case' 0 C--N 1.268 -2.959 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -172.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.746 HD23 HD11 ' A' ' 71' ' ' LEU . 1.8 tt -86.38 109.11 18.79 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.673 HD11 HD21 ' A' ' 99' ' ' LEU . 8.9 mp -115.62 164.89 13.67 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-O 121.504 0.669 . . . . 0.0 111.621 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.889 ' HB2' HD12 ' A' ' 71' ' ' LEU . 35.0 tt0 -131.25 135.64 47.52 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 172.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 39.5 tptt -58.67 114.78 2.66 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -1.984 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.79 -167.837 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 CA--C 1.504 -0.811 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.9 p -86.94 135.88 33.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 123.776 0.672 . . . . 0.0 110.534 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -146.85 145.88 30.01 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.078 0.466 . . . . 0.0 110.049 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.75 132.15 52.23 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.9 t -118.71 135.91 57.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.796 -175.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.523 ' HG2' HG12 ' A' ' 96' ' ' VAL . 43.6 tt0 -109.48 86.61 2.32 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 172.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.884 HD13 ' HB1' ' A' ' 57' ' ' ALA . 1.3 tm? -99.14 125.73 44.75 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.609 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -98.3 144.5 27.64 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 120.649 0.262 . . . . 0.0 111.076 -175.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.723 ' HE2' HD13 ' A' ' 25' ' ' LEU . 1.2 mptm? -68.2 143.52 55.3 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.966 177.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.589 HG21 ' HB3' ' A' ' 57' ' ' ALA . 59.0 p -91.58 -165.89 1.45 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.22 -26.11 49.97 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.126 0.57 . . . . 0.0 111.118 173.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.88 56.96 0.73 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.284 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.4 t 77.43 -168.59 0.06 Allowed 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.232 1.413 . . . . 0.0 109.429 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.723 HD13 ' HE2' ' A' ' 20' ' ' LYS . 4.3 mp -66.17 -76.81 0.07 Allowed 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 122.04 0.924 . . . . 0.0 109.787 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.939 ' HA2' ' HD2' ' A' ' 54' ' ' PRO . . . 147.31 -8.58 1.22 Allowed Glycine 0 CA--C 1.463 -3.187 0 C-N-CA 119.757 -1.211 . . . . 0.0 111.181 -172.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 pt -102.71 112.73 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.607 0 CA-C-O 122.722 1.248 . . . . 0.0 112.851 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.7 m -101.31 126.13 48.03 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-N 112.59 -2.096 . . . . 0.0 106.686 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 49' ' ' VAL . 33.7 m -110.91 153.87 12.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.055 0.455 . . . . 0.0 111.586 -173.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.675 ' HB ' ' HD3' ' A' ' 50' ' ' LYS . 11.2 t -121.31 156.46 32.5 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 174.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 82' ' ' THR . 33.1 m . . . . . 0 N--CA 1.42 -1.93 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.939 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.913 0 N-CA-C 113.662 0.225 . . . . 0.0 113.662 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.66 HG13 ' HG ' ' A' ' 78' ' ' LEU . 50.8 mm -102.37 123.78 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.057 -175.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.458 ' CZ ' ' HD3' ' A' ' 69' ' ' ARG . 81.4 m-85 -131.21 114.22 14.81 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.442 ' HA ' HG12 ' A' ' 29' ' ' VAL . 50.1 t -47.86 117.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.481 0.658 . . . . 0.0 109.983 171.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.675 ' HD3' ' HB ' ' A' ' 30' ' ' THR . 38.0 ttpt -92.76 -31.11 15.18 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.331 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -167.64 156.99 10.03 Favored 'General case' 0 C--O 1.249 1.03 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.759 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.814 HG23 ' HB2' ' A' ' 59' ' ' GLU . 16.7 mm -109.88 119.29 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.927 ' HB ' ' HD3' ' A' ' 54' ' ' PRO . 2.7 mp -108.43 -71.06 0.03 OUTLIER Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -172.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.939 ' HD2' ' HA2' ' A' ' 26' ' ' GLY . 45.3 Cg_exo -60.18 -163.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 124.882 3.722 . . . . 0.0 117.692 -172.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -35.61 -50.75 0.62 Allowed 'General case' 0 C--N 1.352 0.71 0 C-N-CA 127.892 2.477 . . . . 0.0 113.455 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.96 -98.77 0.11 Allowed Glycine 0 N--CA 1.415 -2.738 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.884 ' HB1' HD13 ' A' ' 18' ' ' LEU . . . 66.08 -92.34 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.051 1.34 . . . . 0.0 111.314 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.588 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -70.61 -39.84 73.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.814 ' HB2' HG23 ' A' ' 52' ' ' ILE . 35.4 tt0 -76.43 -42.58 43.6 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 123.556 0.535 . . . . 0.0 111.629 -178.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.0 p -74.94 -35.31 62.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.855 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -73.65 -26.57 60.82 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.326 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.07 44.94 86.64 Favored Glycine 0 CA--C 1.49 -1.483 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.996 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -111.25 -54.62 2.59 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.348 0.594 . . . . 0.0 109.556 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.55 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 64.9 mt -101.26 130.1 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.461 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -132.14 173.33 11.34 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -74.83 132.03 41.22 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.089 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.27 -20.66 13.8 Favored Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.729 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.44 ' OD1' ' HD2' ' A' ' 103' ' ' LYS . 78.8 m-20 -69.47 138.15 53.2 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.556 0.694 . . . . 0.0 111.683 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 33.1 ttp180 -95.5 133.88 38.99 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.313 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 71.0 t -101.74 103.94 15.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.474 HD12 ' HB2' ' A' ' 102' ' ' GLU . 84.9 mt -76.87 -36.01 57.04 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.217 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.51 167.36 19.52 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.16 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.7 HG22 HD23 ' A' ' 78' ' ' LEU . 44.3 t -113.33 115.53 50.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 172.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 10.6 p30 47.01 35.36 3.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.424 1.49 . . . . 0.0 112.768 -176.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.62 -6.24 82.18 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.506 -0.854 . . . . 0.0 114.092 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.8 t -92.6 109.64 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.7 m -69.64 134.67 48.99 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -173.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.7 HD23 HG22 ' A' ' 73' ' ' VAL . 1.6 pt? -130.34 17.24 5.45 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.099 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.9 97.89 0.12 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.518 175.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.01 17.35 5.02 Favored Glycine 0 N--CA 1.433 -1.524 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.598 -177.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.459 ' HB2' HD12 ' A' ' 47' ' ' ILE . . . -94.34 176.74 6.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.509 ' HA ' HG12 ' A' ' 31' ' ' VAL . 8.8 t -97.18 158.75 15.29 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 169.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -51.16 -44.19 61.41 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.595 0.758 . . . . 0.0 112.381 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 23.8 tptp -55.91 -43.45 77.34 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 123.92 0.888 . . . . 0.0 110.986 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -69.28 -43.9 72.93 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.624 ' HA ' HD13 ' A' ' 78' ' ' LEU . . . -55.24 -54.48 42.9 Favored 'General case' 0 C--O 1.243 0.72 0 O-C-N 124.08 0.862 . . . . 0.0 111.468 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.56 -26.75 36.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.919 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 91.0 mt-10 -72.04 -28.49 63.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.809 177.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.489 HG23 HG13 ' A' ' 73' ' ' VAL . 22.5 m -70.5 -31.41 68.5 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.3 mt -72.72 -24.4 60.98 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.105 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -79.56 -34.24 41.12 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -63.15 -40.63 98.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.71 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.436 ' OG1' HG21 ' A' ' 97' ' ' VAL . 19.4 p -68.94 138.25 54.45 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.8 -121.6 0.02 OUTLIER Glycine 0 CA--C 1.52 0.381 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.787 ' HG3' HG22 ' A' ' 96' ' ' VAL . 14.1 pt20 -77.11 -27.51 54.1 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.512 0.672 . . . . 0.0 110.463 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.787 HG22 ' HG3' ' A' ' 95' ' ' GLN . 21.5 t -125.44 150.02 30.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.53 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 35.8 t -120.26 126.03 74.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 122.921 0.489 . . . . 0.0 109.853 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 41.2 m80 -86.77 119.09 26.63 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 167.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.672 HD23 HD13 ' A' ' 101' ' ' LEU . 7.2 tp -127.93 147.91 50.49 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -110.71 117.86 34.6 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.672 HD13 HD23 ' A' ' 99' ' ' LEU . 6.0 mp -124.77 174.31 7.99 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.526 0.679 . . . . 0.0 111.37 -178.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.474 ' HB2' HD12 ' A' ' 71' ' ' LEU . 31.0 tt0 -131.6 130.62 42.42 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 102.761 -3.051 . . . . 0.0 102.761 173.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.44 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 40.6 tptt -64.09 126.25 27.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -175.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.378 0 C-N-CA 121.016 -0.612 . . . . 0.0 113.314 -172.898 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 17.3 p -102.3 111.13 23.3 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-O 121.74 0.781 . . . . 0.0 110.451 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CE2' ' HB ' ' A' ' 16' ' ' VAL . 44.8 p90 -125.61 162.96 23.81 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.858 -177.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 40.1 mt-10 -108.07 94.12 4.9 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 12.4 p -80.09 135.07 26.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.408 -175.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -90.18 108.33 19.68 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.597 HD22 ' HA ' ' A' ' 58' ' ' ALA . 2.1 tm? -113.9 108.12 16.62 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.32 149.69 22.88 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.528 ' HD2' ' HA ' ' A' ' 24' ' ' SER . 27.3 mmtp -71.07 114.9 9.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 56' ' ' GLY . 2.9 t -74.88 -33.06 62.0 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 118.173 -1.411 . . . . 0.0 108.722 -177.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -174.74 -35.85 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.676 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.7 48.52 0.98 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.673 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.528 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 22.6 t 58.93 -152.99 0.39 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.818 0.847 . . . . 0.0 110.561 177.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.589 HD11 HD12 ' A' ' 18' ' ' LEU . 2.9 mm? -71.33 111.01 6.32 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.57 ' H ' ' HB2' ' A' ' 57' ' ' ALA . . . -78.02 46.33 2.66 Favored Glycine 0 C--N 1.296 -1.692 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.401 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.747 HG21 HG13 ' A' ' 52' ' ' ILE . 14.1 pt -141.11 148.64 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 CA-C-O 121.253 0.549 . . . . 0.0 110.197 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 32.4 t -117.85 124.25 47.88 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.6 m -115.59 150.55 17.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.564 -175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.614 HG21 ' HB2' ' A' ' 50' ' ' LYS . 10.3 t -130.04 153.41 48.46 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 81' ' ' ALA . 8.3 p . . . . . 0 C--N 1.287 -2.113 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.715 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.471 -2.703 0 N-CA-C 104.507 -3.437 . . . . 0.0 104.507 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.761 HG13 HD12 ' A' ' 78' ' ' LEU . 38.6 mm -81.93 114.61 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 167.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.402 ' OH ' ' HA2' ' A' ' 67' ' ' GLY . 66.5 t80 -119.86 131.16 55.19 Favored 'General case' 0 C--N 1.275 -2.661 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.762 -169.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.484 HG22 ' CG2' ' A' ' 64' ' ' ILE . 46.5 t -75.16 107.38 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-O 121.557 0.694 . . . . 0.0 109.28 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.614 ' HB2' HG21 ' A' ' 30' ' ' THR . 87.2 tttt -89.06 -34.95 16.6 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.407 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 28' ' ' SER . . . -154.32 156.36 36.8 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.397 -176.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.872 HG22 ' HB2' ' A' ' 59' ' ' GLU . 1.9 mp -116.98 124.48 73.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 O-C-N 123.31 0.381 . . . . 0.0 110.093 174.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.38 121.93 85.79 Favored Pre-proline 0 C--O 1.257 1.491 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.181 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -55.12 129.19 33.96 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 123.368 2.712 . . . . 0.0 112.103 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 tptp 65.33 11.45 7.31 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.631 1.172 . . . . 0.0 112.049 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.584 ' O ' HG22 ' A' ' 21' ' ' THR . . . -76.43 -56.16 4.38 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.11 176.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.57 ' HB2' ' H ' ' A' ' 26' ' ' GLY . . . -178.23 -69.08 0.01 OUTLIER 'General case' 0 C--O 1.188 -2.14 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.597 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -50.31 -42.63 52.92 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.872 ' HB2' HG22 ' A' ' 52' ' ' ILE . 35.4 tt0 -82.86 -40.49 20.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.963 0.887 . . . . 0.0 109.869 -177.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.28 -44.0 66.06 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.899 -173.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.81 -34.41 57.92 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.078 0.942 . . . . 0.0 108.469 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.06 56.08 2.26 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.263 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -121.6 -73.41 0.65 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.813 0.816 . . . . 0.0 110.739 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.484 ' CG2' HG22 ' A' ' 49' ' ' VAL . 53.1 mt -94.74 148.01 5.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.266 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -143.8 172.6 12.62 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.462 1.105 . . . . 0.0 108.131 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' A' ' 50' ' ' LYS . 56.4 mtpt -64.78 133.01 51.11 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 123.521 0.513 . . . . 0.0 110.624 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.402 ' HA2' ' OH ' ' A' ' 48' ' ' TYR . . . 111.94 -20.73 21.6 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 119.966 -1.112 . . . . 0.0 113.833 176.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.517 ' OD2' ' HA ' ' A' ' 103' ' ' LYS . 0.5 OUTLIER -85.51 149.21 25.54 Favored 'General case' 0 C--O 1.253 1.268 0 CA-C-O 121.754 0.787 . . . . 0.0 113.099 -179.266 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.442 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 78.5 ttt180 -102.81 138.73 39.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.498 -171.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 58.7 t -111.04 127.1 68.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.68 HD12 ' HB2' ' A' ' 102' ' ' GLU . 66.1 mt -110.3 -30.78 7.56 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.796 0.808 . . . . 0.0 109.837 -177.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.733 ' HB1' ' HB3' ' A' ' 100' ' ' LEU . . . -161.22 172.4 16.74 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.325 -174.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.737 HG13 ' CG2' ' A' ' 89' ' ' THR . 4.7 p -118.32 114.35 44.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 125.261 1.424 . . . . 0.0 107.487 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.837 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 32.1 p30 35.26 46.39 0.24 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.98 -11.0 64.18 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.597 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.47 ' HB ' HG11 ' A' ' 73' ' ' VAL . 43.1 t -101.33 114.94 42.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.2 m -75.79 145.01 41.06 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -173.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.761 HD12 HG13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.25 31.67 4.59 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.693 -1.139 . . . . 0.0 112.113 174.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -69.04 95.18 0.7 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.275 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.02 16.63 7.76 Favored Glycine 0 C--N 1.302 -1.34 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.508 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -88.6 171.1 10.28 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.453 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 27.9 p -96.46 162.56 13.43 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 173.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -51.8 -41.12 61.47 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.35 0.595 . . . . 0.0 110.491 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.47 -36.95 79.71 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.75 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 11.9 mm-40 -66.39 -41.18 89.72 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.014 0.435 . . . . 0.0 110.255 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.544 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -52.75 -60.24 3.5 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.14 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.98 -30.65 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.219 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 91' ' ' ARG . 10.2 tp10 -67.76 -38.71 83.8 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.737 ' CG2' HG13 ' A' ' 73' ' ' VAL . 27.0 m -71.87 -36.62 70.16 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.5 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 61.5 mt -72.97 -19.46 61.22 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.454 0.645 . . . . 0.0 110.794 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -92.43 -26.8 17.84 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.451 0.643 . . . . 0.0 110.814 -179.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -84.31 -21.44 31.0 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -69.14 -42.93 75.33 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.33 -156.59 27.02 Favored Glycine 0 CA--C 1.487 -1.66 0 C-N-CA 120.263 -0.97 . . . . 0.0 110.928 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HA ' ' HG2' ' A' ' 20' ' ' LYS . 3.4 pt20 -88.06 -37.27 16.42 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.719 0.259 . . . . 0.0 111.515 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 43.9 t -106.91 109.47 28.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.66 119.67 60.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.613 -172.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.837 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 31.4 m170 -81.84 137.28 35.29 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 168.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 7.6 mp -122.41 148.88 44.57 Favored 'General case' 0 C--N 1.264 -3.131 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.733 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 3.4 tm? -99.04 109.05 21.85 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 13' ' ' THR . 7.3 mp -110.65 162.79 14.38 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.181 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.68 ' HB2' HD12 ' A' ' 71' ' ' LEU . 39.7 tt0 -123.34 124.76 43.67 Favored 'General case' 0 N--CA 1.404 -2.766 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 173.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.517 ' HA ' ' OD2' ' A' ' 68' ' ' ASP . 4.6 tmtm? -55.96 113.41 1.5 Allowed 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 124.286 0.991 . . . . 0.0 108.363 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.427 -1.925 0 CA-C-N 114.603 -1.18 . . . . 0.0 113.318 -174.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 24.0 t70 . . . . . 0 CA--C 1.51 -0.57 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.424 HG22 HD13 ' A' ' 71' ' ' LEU . 4.5 p -91.44 139.72 30.45 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 123.812 0.845 . . . . 0.0 111.335 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.583 ' HE2' ' HB2' ' A' ' 103' ' ' LYS . 48.2 p90 -157.51 154.43 28.62 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 39.7 mt-10 -110.06 148.51 31.57 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.5 HG22 HD12 ' A' ' 101' ' ' LEU . 59.9 t -127.25 124.97 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.513 ' HG2' ' HD2' ' A' ' 98' ' ' HIS . 43.1 mt-10 -96.76 91.56 5.74 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.914 HD22 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -102.57 122.03 43.57 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.21 141.51 31.89 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.112 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.419 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 1.5 mptm? -71.75 138.2 48.28 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.935 0.874 . . . . 0.0 112.526 177.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 23' ' ' GLY . 3.7 t -135.69 143.55 45.47 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 171.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 21' ' ' THR . 9.6 t70 77.93 -35.67 0.2 Allowed 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 123.651 0.781 . . . . 0.0 110.469 -173.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 21' ' ' THR . . . 119.7 11.39 7.18 Favored Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -127.6 151.53 48.8 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 115.241 -0.479 . . . . 0.0 109.897 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' ' 18' ' ' LEU . 13.7 tp -91.05 121.33 32.76 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 170.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -71.91 46.62 0.96 Allowed Glycine 0 C--O 1.211 -1.341 0 N-CA-C 115.451 0.941 . . . . 0.0 115.451 -173.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.407 HG21 ' CD1' ' A' ' 52' ' ' ILE . 6.9 pt -139.3 134.37 40.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 117.706 0.753 . . . . 0.0 111.461 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.511 ' HB2' HD13 ' A' ' 53' ' ' ILE . 33.7 t -104.09 119.26 38.55 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.451 HG11 HG22 ' A' ' 49' ' ' VAL . 22.7 m -114.23 151.44 16.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.028 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.4 t -134.7 177.2 7.97 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 172.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.581 HG11 HD11 ' A' ' 47' ' ' ILE . 16.2 m . . . . . 0 C--N 1.294 -1.808 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' HA3' ' HG2' ' A' ' 79' ' ' GLU . . . . . . . . 0 N--CA 1.431 -1.658 0 N-CA-C 113.474 0.15 . . . . 0.0 113.474 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.917 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.1 mm -119.13 142.78 32.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -128.7 113.37 15.29 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 174.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.451 HG22 HG11 ' A' ' 29' ' ' VAL . 58.8 t -51.47 114.97 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 169.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -91.11 -30.38 16.76 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.905 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -158.34 159.99 36.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.88 HG21 ' HB2' ' A' ' 59' ' ' GLU . 45.3 mm -110.1 120.49 61.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' A' ' 55' ' ' LYS . 1.8 mp -68.16 131.2 92.16 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.65 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 30.5 Cg_exo -69.35 60.12 1.45 Allowed 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 124.009 3.139 . . . . 0.0 112.267 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.523 ' HB2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -138.95 19.62 2.64 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.7 -147.28 25.1 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.492 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . 73.71 -91.05 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 125.329 1.452 . . . . 0.0 112.273 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.914 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -76.44 -36.85 57.74 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.326 -172.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.88 ' HB2' HG21 ' A' ' 52' ' ' ILE . 27.7 tt0 -78.85 -38.97 36.61 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 120.806 0.336 . . . . 0.0 110.655 -176.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -76.73 -27.83 55.57 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.109 0.481 . . . . 0.0 112.031 -175.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -87.98 -14.43 39.16 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.21 56.58 20.7 Favored Glycine 0 CA--C 1.497 -1.077 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.014 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -120.47 -46.48 2.38 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.168 0.509 . . . . 0.0 110.007 -177.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.54 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 53.3 mt -110.78 136.28 47.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.458 ' HA ' HD12 ' A' ' 52' ' ' ILE . 32.3 m-70 -134.56 177.85 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.814 0.696 . . . . 0.0 109.155 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -67.05 125.16 25.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.744 0.783 . . . . 0.0 110.237 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.82 21.0 17.19 Favored Glycine 0 N--CA 1.416 -2.669 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.016 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -97.58 142.44 29.39 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.962 -1.317 . . . . 0.0 110.424 167.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.614 ' HB2' ' HA3' ' A' ' 104' ' ' GLY . 6.7 ttm180 -92.83 138.58 31.36 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.917 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 55.9 t -106.93 115.67 48.95 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.462 HD12 HD21 ' A' ' 100' ' ' LEU . 96.8 mt -86.45 -37.54 18.22 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.955 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.721 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . . . -167.31 176.06 6.93 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.097 -175.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.527 ' HA ' HD12 ' A' ' 99' ' ' LEU . 21.1 t -118.94 118.69 58.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 175.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.6 p30 47.48 40.45 11.23 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 124.513 1.125 . . . . 0.0 113.771 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.65 -6.68 79.72 Favored Glycine 0 C--N 1.315 -0.636 0 C-N-CA 120.849 -0.691 . . . . 0.0 114.344 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 48.7 t -91.49 104.25 15.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.532 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 19.7 m -50.43 123.17 8.13 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.603 1.161 . . . . 0.0 113.3 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.721 ' HB3' ' HA ' ' A' ' 72' ' ' ALA . 22.3 tp -117.68 1.36 12.2 Favored 'General case' 1 N--CA 1.366 -4.64 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.844 -172.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.406 ' HG2' ' HA3' ' A' ' 46' ' ' GLY . 19.1 mt-10 -74.22 113.88 11.93 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.18 -0.16 11.54 Favored Glycine 0 C--N 1.298 -1.566 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -172.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.1 164.82 12.71 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.441 ' HA ' HG12 ' A' ' 31' ' ' VAL . 15.3 t -101.01 160.08 14.68 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 170.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 21.8 p80 -50.65 -45.43 57.89 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -58.94 -39.14 80.7 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.537 0.335 . . . . 0.0 110.1 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.44 ' HG2' HG22 ' A' ' 82' ' ' THR . 16.2 mm-40 -71.8 -36.41 70.28 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.106 0.479 . . . . 0.0 110.137 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.584 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.85 -47.09 87.12 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.419 ' HA ' HD13 ' A' ' 90' ' ' LEU . 95.8 t -67.48 -28.77 43.24 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.252 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.22 -30.2 69.22 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.26 0.552 . . . . 0.0 110.336 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -78.55 -25.21 45.36 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 80.8 mt -74.81 -23.51 58.49 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.712 0.768 . . . . 0.0 109.182 173.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -84.72 -29.34 25.64 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.462 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.66 -45.44 92.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.822 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.405 ' OG1' HG22 ' A' ' 97' ' ' VAL . 40.1 p -71.44 153.64 42.11 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.07 -119.55 0.91 Allowed Glycine 0 N--CA 1.426 -1.996 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.31 -175.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -79.8 -34.87 39.25 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.221 -0.489 . . . . 0.0 110.489 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -116.33 126.27 73.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.087 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.419 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 39.3 t -101.63 126.76 55.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.513 ' HD2' ' HG2' ' A' ' 17' ' ' GLU . 63.1 m80 -101.19 52.95 0.84 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.738 HD21 HD11 ' A' ' 101' ' ' LEU . 7.7 tp -61.84 149.47 40.11 Favored 'General case' 0 C--O 1.206 -1.227 0 C-N-CA 125.062 1.345 . . . . 0.0 111.18 -172.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.462 HD21 HD12 ' A' ' 71' ' ' LEU . 2.4 tt -110.43 118.77 37.16 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.738 HD11 HD21 ' A' ' 99' ' ' LEU . 6.4 mp -124.24 174.34 7.76 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.341 1.067 . . . . 0.0 112.567 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 30.8 tt0 -133.07 148.74 52.18 Favored 'General case' 0 N--CA 1.403 -2.824 0 N-CA-C 101.846 -3.39 . . . . 0.0 101.846 171.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.583 ' HB2' ' HE2' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -82.38 84.77 7.04 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 172.572 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.614 ' HA3' ' HB2' ' A' ' 69' ' ' ARG . . . . . . . . 0 CA--C 1.47 -2.732 0 CA-C-N 112.859 -1.973 . . . . 0.0 113.67 -170.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.3 t70 . . . . . 0 C--O 1.242 0.667 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 2.9 p -105.0 114.89 29.37 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.372 0.606 . . . . 0.0 112.026 -176.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.444 ' HE1' ' HB2' ' A' ' 103' ' ' LYS . 24.3 p90 -147.37 153.1 39.25 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.261 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.508 ' HG3' ' HG ' ' A' ' 100' ' ' LEU . 2.5 mp0 -91.26 108.57 19.97 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 t -76.1 136.47 24.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.49 96.47 8.01 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 175.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.69 ' HB3' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -117.66 117.59 29.8 Favored 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -178.227 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -104.09 171.07 7.55 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -176.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.82 111.81 6.53 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 172.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.9 m -117.16 97.41 5.91 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.62 -176.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t70 67.64 -61.45 0.36 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.711 1.204 . . . . 0.0 112.605 175.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.69 35.04 5.2 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 178.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.3 p 64.48 -155.43 0.3 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.986 1.714 . . . . 0.0 112.321 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.69 HD12 ' HB3' ' A' ' 18' ' ' LEU . 13.5 tp -73.6 104.63 4.61 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.606 ' H ' ' HB2' ' A' ' 57' ' ' ALA . . . -74.48 53.17 2.35 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.046 -0.979 . . . . 0.0 115.167 -174.052 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.562 HG21 ' HB3' ' A' ' 58' ' ' ALA . 4.8 pt -136.45 133.88 49.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.231 0.539 . . . . 0.0 111.763 177.35 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 t -104.15 111.32 23.87 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.7 m -106.4 152.9 7.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.039 -174.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.463 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.9 t -134.08 167.86 19.88 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.75 HG11 ' HA ' ' A' ' 82' ' ' THR . 5.7 p . . . . . 0 C--N 1.271 -2.805 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' HG21 ' A' ' 31' ' ' VAL . . . . . . . . 0 N--CA 1.429 -1.811 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.931 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.7 mm -102.53 143.14 15.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -178.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.476 ' CE2' ' HG3' ' A' ' 69' ' ' ARG . 79.4 m-85 -131.73 108.13 9.26 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.9 t -49.62 116.11 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.533 0.682 . . . . 0.0 109.675 171.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -92.2 -33.19 14.8 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.856 -175.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.73 153.29 31.03 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.029 -176.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.979 HG22 ' HB2' ' A' ' 59' ' ' GLU . 31.7 mm -110.67 132.07 60.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.8 mm -79.31 121.98 83.56 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.16 144.14 95.38 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 123.057 2.505 . . . . 0.0 111.146 178.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.53 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 24.0 tptp 59.27 30.16 19.85 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.883 1.325 . . . . 0.0 109.651 -178.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.87 -115.32 4.04 Favored Glycine 0 N--CA 1.406 -3.358 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.55 -177.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.606 ' HB2' ' H ' ' A' ' 26' ' ' GLY . . . -132.15 -65.1 0.75 Allowed 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.924 -0.638 . . . . 0.0 111.629 -172.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.762 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -54.33 -36.28 63.6 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -171.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.979 ' HB2' HG22 ' A' ' 52' ' ' ILE . 38.1 tt0 -95.54 -40.91 9.21 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 122.341 1.067 . . . . 0.0 110.304 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.6 m -79.71 -44.11 21.4 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.426 -168.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -101.17 -35.04 9.44 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.92 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.86 -128.64 6.43 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 116.519 1.368 . . . . 0.0 116.519 -167.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -147.79 -23.1 0.36 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.893 -1.153 . . . . 0.0 110.693 -165.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.762 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.6 mt -69.74 141.33 17.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.915 -173.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -134.64 -176.66 4.3 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.037 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -67.83 121.69 16.55 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 123.41 0.684 . . . . 0.0 111.296 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.58 -6.94 31.75 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.442 -0.885 . . . . 0.0 114.179 177.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.752 ' HB3' HD23 ' A' ' 101' ' ' LEU . 66.3 m-20 -64.64 130.96 45.58 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-O 121.682 0.753 . . . . 0.0 112.067 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.476 ' HG3' ' CE2' ' A' ' 48' ' ' TYR . 48.3 ttt180 -92.22 129.92 38.05 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.997 -174.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.931 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 64.3 t -109.36 126.65 66.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -107.43 -34.91 6.92 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.128 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . . . -150.32 157.07 42.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.596 0.713 . . . . 0.0 112.132 -176.107 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.786 ' HA ' HD12 ' A' ' 99' ' ' LEU . 61.7 t -109.82 100.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 173.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 t30 59.54 34.37 22.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.55 1.14 . . . . 0.0 110.504 176.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.22 -23.18 35.25 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.478 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.9 t -84.25 106.5 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 20.0 m -75.2 138.24 41.82 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 121.616 0.722 . . . . 0.0 112.106 -175.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.728 ' N ' HD23 ' A' ' 78' ' ' LEU . 1.1 pt? -130.75 74.22 1.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.649 1.214 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -90.39 96.36 10.62 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.084 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.29 39.18 4.31 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.1 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -103.5 147.38 27.22 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.75 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.9 t -69.04 146.66 52.47 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 18.4 p80 -50.95 -35.45 33.56 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -177.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 54.6 mtmt -62.48 -38.91 91.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.257 176.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -76.21 -31.27 58.33 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.464 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -55.29 -53.69 52.9 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.646 ' HA ' HD11 ' A' ' 90' ' ' LEU . 86.0 t -64.48 -29.02 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.002 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 43.6 mm-40 -70.85 -33.19 70.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.164 0.507 . . . . 0.0 110.253 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.6 m -69.67 -35.15 74.9 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.668 HD13 HD21 ' A' ' 25' ' ' LEU . 81.3 mt -67.66 -34.57 77.2 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 123.918 0.887 . . . . 0.0 109.375 178.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -66.9 -35.39 79.9 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.7 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.11 -34.32 66.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.122 176.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.408 HG21 HG12 ' A' ' 97' ' ' VAL . 18.6 m -57.77 -51.65 68.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 123.702 0.801 . . . . 0.0 110.636 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.19 -150.32 17.62 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 120.079 -1.058 . . . . 0.0 112.893 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -77.78 -39.64 43.34 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 122.961 0.504 . . . . 0.0 110.765 -178.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 60.3 t -106.7 119.73 56.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.2 175.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.598 HG11 HD23 ' A' ' 90' ' ' LEU . 58.2 t -104.26 127.54 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-O 121.509 0.671 . . . . 0.0 110.213 -176.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -97.4 120.22 37.36 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 169.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 73' ' ' VAL . 9.0 tp -121.54 133.3 55.02 Favored 'General case' 0 C--N 1.261 -3.24 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 72' ' ' ALA . 2.1 tt -94.15 110.31 22.04 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -175.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.752 HD23 ' HB3' ' A' ' 68' ' ' ASP . 10.1 mp -115.11 170.4 8.39 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.834 0.826 . . . . 0.0 111.774 -176.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 36.6 tt0 -129.64 103.33 6.79 Favored 'General case' 0 N--CA 1.4 -2.931 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 171.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.444 ' HB2' ' HE1' ' A' ' 14' ' ' PHE . 22.4 tptm -48.65 121.38 4.52 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 124.194 0.934 . . . . 0.0 112.353 -170.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.213 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.292 -172.598 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.597 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 32.1 t0 . . . . . 0 N--CA 1.442 -0.827 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.4 p -93.92 115.18 27.53 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-O 122.224 1.011 . . . . 0.0 110.375 177.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.548 ' CE1' ' HB ' ' A' ' 16' ' ' VAL . 44.8 p90 -123.49 159.72 28.48 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.699 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 41.2 mt-10 -102.1 109.11 20.73 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 7.5 p -89.98 119.83 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 121.378 0.609 . . . . 0.0 111.084 -174.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -87.47 91.92 8.9 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.516 -178.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.439 HD13 ' CB ' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -108.77 114.95 29.16 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.461 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.19 141.35 32.07 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.447 ' HE3' ' O ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -72.94 130.55 40.63 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.079 177.937 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.2 p -112.48 -158.78 0.66 Allowed 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -53.69 -30.01 41.56 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 123.497 0.719 . . . . 0.0 111.573 175.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.28 16.56 49.08 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.84 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 t 70.28 -143.9 0.08 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.648 ' HG ' HD11 ' A' ' 90' ' ' LEU . 3.6 mm? -64.44 -31.61 72.89 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.92 0.782 . . . . 0.0 109.725 177.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.36 5.14 79.88 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.152 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.0 pt -125.38 144.99 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-O 122.418 1.104 . . . . 0.0 113.193 -175.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 51' ' ' ALA . 66.0 m -104.63 114.69 29.07 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 113.081 -1.872 . . . . 0.0 106.861 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.4 m -102.85 147.94 8.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-O 121.134 0.493 . . . . 0.0 111.531 -178.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 13.6 t -118.08 171.05 8.36 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.793 ' HA ' HD11 ' A' ' 47' ' ' ILE . 4.1 t . . . . . 0 C--N 1.289 -2.042 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 177.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.151 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.793 HD11 ' HA ' ' A' ' 31' ' ' VAL . 24.7 mm -137.58 149.64 25.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 178.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -136.05 151.62 50.03 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 118.324 0.511 . . . . 0.0 110.688 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.529 HG21 ' CG2' ' A' ' 64' ' ' ILE . 21.6 t -79.31 109.03 13.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 87.6 tttt -83.14 -37.13 24.15 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.768 -175.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB2' ' HB2' ' A' ' 28' ' ' SER . . . -153.37 148.05 26.28 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.994 -178.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 49.8 mm -112.72 122.07 66.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.425 HD13 ' N ' ' A' ' 53' ' ' ILE . 1.9 mp -90.69 129.03 46.12 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.99 139.26 34.07 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.198 2.598 . . . . 0.0 111.299 177.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.0 tptt 67.8 -0.35 2.02 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.915 0.886 . . . . 0.0 111.803 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.42 102.57 2.94 Favored Glycine 0 N--CA 1.419 -2.484 0 CA-C-O 119.422 -0.654 . . . . 0.0 112.946 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 25' ' ' LEU . . . 26.49 -76.26 0.0 OUTLIER 'General case' 0 C--O 1.181 -2.526 0 C-N-CA 128.312 2.645 . . . . 0.0 115.028 170.16 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . . . -50.28 -39.0 44.08 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.554 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 9.7 tp10 -76.59 -43.66 37.7 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.136 0.575 . . . . 0.0 110.201 178.207 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -67.23 -50.27 61.35 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.29 -177.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.43 -36.96 79.81 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.5 179.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.72 53.99 4.76 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.088 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.493 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 1.0 OUTLIER -115.87 -74.61 0.6 Allowed 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.442 0.639 . . . . 0.0 109.341 -176.878 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.597 ' HB ' ' HB3' ' A' ' 58' ' ' ALA . 62.5 mt -86.26 140.95 15.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -144.71 -172.57 3.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.265 176.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.53 ' O ' ' HD2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -65.94 129.27 39.21 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.326 0.584 . . . . 0.0 112.522 -175.076 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.39 -7.77 62.01 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.203 174.257 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.594 ' HB3' HD21 ' A' ' 101' ' ' LEU . 10.1 m-20 -64.02 138.1 58.3 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-N 117.472 0.636 . . . . 0.0 112.452 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -88.19 115.86 25.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.779 -175.025 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.418 HG21 HD13 ' A' ' 101' ' ' LEU . 43.9 t -100.1 112.7 33.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.29 -37.55 10.94 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.594 -178.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 100' ' ' LEU . . . -157.99 -179.79 8.46 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.382 -175.105 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 1.057 HG11 HG23 ' A' ' 89' ' ' THR . 2.4 p -130.13 102.69 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 125.561 1.544 . . . . 0.0 110.192 -178.182 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t30 58.95 37.61 24.57 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.247 1.022 . . . . 0.0 111.057 174.084 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.9 -12.0 70.3 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.574 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.578 ' HB ' HG12 ' A' ' 73' ' ' VAL . 59.0 t -93.25 125.41 45.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.5 m -71.02 145.13 50.16 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.267 0.556 . . . . 0.0 112.457 -174.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 61.9 mt -111.91 27.21 9.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.721 0.772 . . . . 0.0 110.304 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -78.11 118.1 20.04 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.126 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.4 19.74 51.25 Favored Glycine 0 C--N 1.309 -0.917 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.98 -171.27 2.19 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.502 ' HA ' HG22 ' A' ' 31' ' ' VAL . 15.2 t -150.32 175.48 11.78 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.332 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -50.37 -55.58 15.05 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.892 0.745 . . . . 0.0 111.151 -179.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -53.26 -45.45 68.82 Favored 'General case' 0 C--O 1.21 -1.0 0 O-C-N 123.898 0.749 . . . . 0.0 110.92 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -70.12 -43.96 69.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.618 0.247 . . . . 0.0 111.466 -176.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -58.42 -50.05 75.1 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.492 178.194 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 89.5 t -66.83 -37.21 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.178 -178.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -63.45 -36.54 84.08 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.093 0.473 . . . . 0.0 109.981 178.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 1.057 HG23 HG11 ' A' ' 73' ' ' VAL . 89.8 m -68.89 -37.82 79.24 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.576 177.295 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.651 HD23 HD21 ' A' ' 99' ' ' LEU . 83.8 mt -71.23 -19.84 62.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.661 0.743 . . . . 0.0 109.858 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -85.29 -47.67 9.82 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.64 177.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.68 -12.09 60.13 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -29.98 65.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.09 -138.26 10.66 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.617 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.447 ' O ' ' HE3' ' A' ' 20' ' ' LYS . 24.3 tp60 -86.39 -35.7 19.62 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.858 0.361 . . . . 0.0 110.365 -176.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.4 t -124.44 147.76 28.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -175.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.0 t -129.46 146.72 33.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.552 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 11.9 m-70 -115.75 70.08 0.74 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.155 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.651 HD21 HD23 ' A' ' 90' ' ' LEU . 5.0 mp -63.61 150.98 42.89 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.727 -175.2 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.551 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 62.7 tp -93.99 108.98 20.74 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 68' ' ' ASP . 8.1 mp -127.1 147.39 50.17 Favored 'General case' 0 CA--C 1.474 -1.971 0 CA-C-O 121.476 0.655 . . . . 0.0 111.71 -175.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 38.0 tt0 -113.66 115.44 27.87 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 103.769 -2.678 . . . . 0.0 103.769 174.11 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.48 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 2.8 tmtm? -49.36 116.6 1.79 Allowed 'General case' 0 C--O 1.245 0.849 0 O-C-N 124.324 1.015 . . . . 0.0 111.721 -172.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.424 -2.146 0 CA-C-N 114.129 -1.396 . . . . 0.0 113.112 -174.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.443 HG21 HD11 ' A' ' 71' ' ' LEU . 18.5 p -88.05 110.52 20.69 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.372 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -114.51 143.45 44.94 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 121.308 0.575 . . . . 0.0 111.564 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -101.99 121.38 42.05 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.495 HG13 HD13 ' A' ' 64' ' ' ILE . 30.0 t -110.95 129.66 65.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.207 -174.441 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 95.39 5.8 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.013 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -97.06 119.37 35.41 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.808 -173.649 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.21 117.98 30.9 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 24' ' ' SER . 94.5 mttt -56.29 121.82 10.4 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.006 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.6 m -92.28 -78.95 0.4 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.437 -174.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -126.38 -56.32 1.42 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.51 30.83 6.52 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 177.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.543 ' HA ' ' HB3' ' A' ' 20' ' ' LYS 0.286 97.8 p 66.19 -105.97 0.11 Allowed 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 126.367 1.867 . . . . 0.0 112.107 -179.988 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.687 HD12 ' HB3' ' A' ' 90' ' ' LEU . 81.8 mt -96.83 128.43 43.78 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 176.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 52' ' ' ILE . . . -81.56 8.36 59.19 Favored Glycine 0 C--N 1.294 -1.804 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.761 -176.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.7 pt -99.55 115.69 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.32 -177.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.488 ' HB2' HG12 ' A' ' 53' ' ' ILE . 23.4 t -88.7 124.18 33.86 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 175.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.76 -174.68 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -173.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -170.75 150.48 3.28 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 178.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 82' ' ' THR . 7.3 p . . . . . 0 C--N 1.287 -2.148 0 CA-C-O 121.209 0.528 . . . . 0.0 110.252 177.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 79' ' ' GLU . . . . . . . . 0 N--CA 1.416 -2.696 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.831 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.5 mm -101.38 148.29 7.42 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 179.207 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -133.35 147.23 51.81 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 118.385 0.539 . . . . 0.0 109.874 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.413 HG23 HG23 ' A' ' 64' ' ' ILE . 59.7 t -81.29 115.3 23.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -85.69 -34.48 21.27 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.594 -177.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.93 169.85 12.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.04 -176.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 1.01 HG23 ' HB2' ' A' ' 59' ' ' GLU . 20.5 mm -114.36 116.2 51.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 177.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.828 ' HB ' ' HD3' ' A' ' 54' ' ' PRO . 42.2 mm -84.5 -71.91 0.1 OUTLIER Pre-proline 0 CA--C 1.562 1.426 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -169.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.828 ' HD3' ' HB ' ' A' ' 53' ' ' ILE . 6.2 Cg_exo -78.74 -160.87 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.715 2.277 . . . . 0.0 113.306 -172.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -36.44 -55.46 0.83 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.082 1.353 . . . . 0.0 112.132 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.61 ' HA3' ' OG ' ' A' ' 60' ' ' SER . . . -171.71 -87.26 0.07 OUTLIER Glycine 0 N--CA 1.403 -3.565 0 C-N-CA 119.556 -1.306 . . . . 0.0 111.964 176.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.663 ' HB2' HD13 ' A' ' 18' ' ' LEU . . . 68.53 -85.28 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 124.486 1.114 . . . . 0.0 108.949 -177.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 1.013 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -78.14 -29.44 48.74 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.717 -177.606 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.01 ' HB2' HG23 ' A' ' 52' ' ' ILE . 43.6 tt0 -73.75 -63.14 1.27 Allowed 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 124.602 1.189 . . . . 0.0 111.608 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.61 ' OG ' ' HA3' ' A' ' 56' ' ' GLY . 6.8 p -86.21 -30.38 22.44 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -168.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -100.54 -35.77 9.41 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -174.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.25 -128.52 3.35 Favored Glycine 1 N--CA 1.393 -4.229 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.301 -175.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -157.84 3.94 0.12 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -170.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.593 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 61.5 mt -94.78 138.94 19.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.388 -168.028 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.58 179.01 6.19 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -70.43 128.38 35.99 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.295 0.569 . . . . 0.0 109.999 176.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.13 -20.48 12.75 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.726 -178.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.628 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 50.5 m-20 -64.65 136.83 57.39 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.504 0.668 . . . . 0.0 112.411 -177.375 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -93.84 135.93 34.65 Favored 'General case' 0 C--O 1.195 -1.785 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.473 -176.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.831 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 62.2 t -106.53 119.51 56.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.589 HD13 HD23 ' A' ' 100' ' ' LEU . 82.8 mt -97.43 -44.38 6.88 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.55 -1.205 . . . . 0.0 108.781 -177.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . . . -152.26 165.08 36.01 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.011 -173.453 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.72 HG23 HD22 ' A' ' 78' ' ' LEU . 39.0 t -116.28 111.27 34.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 173.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.2 p30 47.27 35.91 4.22 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.02 1.328 . . . . 0.0 112.354 -176.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.09 -16.23 61.22 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.121 -1.038 . . . . 0.0 114.393 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.39 109.29 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -70.23 137.51 50.91 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.358 0.411 . . . . 0.0 111.235 -174.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.72 HD22 HG23 ' A' ' 73' ' ' VAL . 1.7 pt? -130.6 22.24 5.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.654 177.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.475 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 32.4 mt-10 -68.48 105.14 2.11 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.26 16.63 6.04 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.796 -176.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.61 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -98.94 167.52 10.69 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 175.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.618 ' HA ' HG13 ' A' ' 31' ' ' VAL . 9.0 t -90.78 170.17 10.34 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -50.3 -49.54 53.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.465 1.106 . . . . 0.0 109.667 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 10.9 mptt -64.13 -35.17 79.89 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.15 -176.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.532 ' HG3' HG21 ' A' ' 82' ' ' THR . 56.2 mt-30 -70.02 -42.59 72.79 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 78' ' ' LEU . . . -54.26 -58.79 6.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.023 178.096 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.42 -28.5 43.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.191 -177.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 66.1 mm-40 -68.75 -34.38 75.49 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.537 177.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.494 HG22 HG13 ' A' ' 73' ' ' VAL . 37.8 m -69.51 -29.94 67.68 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.687 ' HB3' HD12 ' A' ' 25' ' ' LEU . 81.4 mt -77.0 -16.55 59.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.961 177.22 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -93.25 -26.94 17.13 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.6 176.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -67.28 -42.22 84.15 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.6 p -65.92 146.23 54.97 Favored 'General case' 0 C--O 1.252 1.208 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.958 177.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.9 -128.98 0.88 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -172.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -69.3 -54.4 14.82 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.44 0.696 . . . . 0.0 111.803 -174.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -106.2 115.51 48.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.574 HG21 HD13 ' A' ' 25' ' ' LEU . 46.0 t -99.0 126.5 52.21 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -91.96 123.39 35.28 Favored 'General case' 0 N--CA 1.404 -2.729 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 175.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.713 HD11 ' HA ' ' A' ' 73' ' ' VAL . 7.6 tp -126.53 143.36 51.23 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.589 HD23 HD13 ' A' ' 71' ' ' LEU . 1.6 tt -105.1 116.1 31.39 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.565 HD13 HD23 ' A' ' 99' ' ' LEU . 6.6 mp -121.46 176.07 5.86 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.51 0.671 . . . . 0.0 111.873 -177.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -131.27 126.85 36.49 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 172.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.628 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 15.1 mmtt -57.3 127.01 29.83 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.545 0.528 . . . . 0.0 111.433 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.561 -178.6 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 38.0 t70 . . . . . 0 CA--C 1.494 -1.198 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.555 HG22 HD11 ' A' ' 71' ' ' LEU . 6.1 p -80.65 137.53 36.34 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.071 0.463 . . . . 0.0 111.887 -175.105 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -139.39 140.7 37.5 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.119 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.538 ' HB3' ' NE2' ' A' ' 98' ' ' HIS . 45.3 mt-10 -106.41 114.23 28.23 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.919 -179.168 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 101' ' ' LEU . 7.7 p -113.44 131.71 64.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.127 -175.31 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 98' ' ' HIS . 40.8 tt0 -110.52 99.56 8.53 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 175.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.901 HD23 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -93.66 124.14 37.45 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -173.17 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -98.31 116.07 29.75 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 14.9 ptmt -79.79 145.88 32.59 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.466 -175.009 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -84.87 -55.27 4.16 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.339 0.59 . . . . 0.0 109.963 -175.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.464 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 9.1 p-10 -111.11 -145.77 0.4 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.637 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.22 20.08 11.43 Favored Glycine 0 C--N 1.305 -1.189 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.237 178.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 20.0 m -122.42 130.38 53.03 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.763 HD11 ' HB3' ' A' ' 18' ' ' LEU . 22.0 tp -81.26 -5.28 57.61 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.012 0.911 . . . . 0.0 108.904 178.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.71 7.25 69.07 Favored Glycine 0 N--CA 1.421 -2.354 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.196 175.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.424 ' HB ' HG12 ' A' ' 49' ' ' VAL . 19.2 pt -132.59 148.21 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 CA-C-O 121.252 0.549 . . . . 0.0 110.495 179.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.5 t -116.79 120.41 38.46 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 176.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.97 170.34 3.89 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-O 120.71 0.29 . . . . 0.0 110.966 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -145.45 169.71 17.81 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 171.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 82' ' ' THR . 30.8 m . . . . . 0 C--N 1.299 -1.599 0 C-N-CA 118.709 -1.196 . . . . 0.0 108.858 173.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.168 0 N-CA-C 107.504 -2.238 . . . . 0.0 107.504 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.655 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 30.7 mm -145.24 134.49 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 174.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -125.45 139.88 53.26 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.554 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.483 HG22 ' CG2' ' A' ' 64' ' ' ILE . 40.1 t -75.17 117.76 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.169 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -93.02 -31.66 14.79 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.087 -174.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . . . -158.06 162.67 38.09 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.875 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 65' ' ' HIS . 49.4 mm -107.52 120.11 58.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 177.584 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 50.0 mm -77.53 124.15 86.71 Favored Pre-proline 0 C--O 1.252 1.216 0 C-N-CA 122.956 0.502 . . . . 0.0 110.741 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 4.9 Cg_exo -74.84 74.3 3.96 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 124.192 3.261 . . . . 0.0 115.53 -174.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HD3' HG23 ' A' ' 53' ' ' ILE . 2.1 mptm? -116.59 -82.3 0.62 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.204 0.526 . . . . 0.0 110.108 171.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.561 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 172.59 49.59 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 119.781 -1.2 . . . . 0.0 112.142 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . . . -126.36 -96.4 0.43 Allowed 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.967 -179.211 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.901 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -61.05 -36.13 78.77 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.609 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 40.5 tt0 -72.13 -46.87 54.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.557 0.743 . . . . 0.0 110.465 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.561 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 13.5 m -77.88 -35.85 50.42 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.209 -173.538 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.13 -23.89 47.63 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.9 59.77 4.93 Favored Glycine 0 CA--C 1.498 -1.03 0 CA-C-N 113.98 -1.464 . . . . 0.0 113.471 171.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -120.5 -69.81 0.82 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.948 0.88 . . . . 0.0 108.797 -178.581 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.483 ' CG2' HG22 ' A' ' 49' ' ' VAL . 68.6 mt -90.36 141.73 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.783 -178.377 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.718 ' HA ' HD12 ' A' ' 52' ' ' ILE . 33.1 t-80 -139.45 176.15 8.96 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 175.154 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 51' ' ' ALA . 51.5 pttt -73.56 142.87 46.63 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.835 -178.521 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.48 -22.68 21.86 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.931 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 39.1 m-20 -72.63 142.35 48.33 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.91 0.386 . . . . 0.0 112.035 -178.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -101.09 136.58 40.7 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.655 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.1 t -103.97 121.44 55.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -175.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.555 HD11 HG22 ' A' ' 13' ' ' THR . 90.2 mt -83.47 -42.16 17.21 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.452 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 76' ' ' VAL . . . -170.07 176.09 4.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.703 -175.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 1.1 HG12 HG22 ' A' ' 89' ' ' THR . 2.7 p -112.92 105.96 19.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 124.038 0.935 . . . . 0.0 109.901 178.18 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.457 ' H ' ' HA ' ' A' ' 99' ' ' LEU . 57.9 t30 52.41 40.95 30.45 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.771 1.272 . . . . 0.0 110.765 178.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.93 -18.24 41.09 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.538 -178.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.693 ' HB ' HG13 ' A' ' 73' ' ' VAL . 49.1 t -77.67 109.09 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.0 m -61.57 122.51 15.44 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.905 -173.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.0 mt -90.6 74.74 6.72 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -85.37 96.68 9.63 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.649 -174.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.17 47.86 69.27 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -178.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.72 147.57 24.42 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.688 HG22 ' HG2' ' A' ' 85' ' ' GLN . 13.9 t -91.06 164.55 13.91 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 172.118 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -43.48 -54.74 4.62 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.409 1.484 . . . . 0.0 112.538 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 36.8 ttmt -63.66 -34.99 79.07 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -176.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.688 ' HG2' HG22 ' A' ' 82' ' ' THR . 82.5 mm-40 -68.85 -43.26 75.79 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.168 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.593 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -55.0 -54.52 41.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.391 176.105 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.73 -35.88 76.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.725 -177.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 36.8 mt-10 -69.39 -32.53 71.62 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.521 179.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 1.1 HG22 HG12 ' A' ' 73' ' ' VAL . 60.2 m -66.86 -36.74 83.02 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 60.3 mt -75.74 -15.11 60.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 0.0 110.011 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -89.11 -45.83 9.3 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.607 176.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -69.18 -35.92 76.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.687 -176.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -53.41 -51.91 61.07 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 122.918 0.487 . . . . 0.0 112.185 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.57 -154.24 25.84 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.604 177.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 51.1 tt0 -76.61 -44.94 32.18 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.61 0.719 . . . . 0.0 109.748 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 21.3 t -106.08 116.31 49.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.8 131.97 65.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -174.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 9.5 t60 -96.91 136.97 36.71 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 175.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.533 HD12 HD22 ' A' ' 90' ' ' LEU . 6.5 mp -130.44 154.3 47.88 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.123 0.487 . . . . 0.0 109.823 174.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.497 ' HG ' ' HB2' ' A' ' 71' ' ' LEU . 55.3 tp -110.14 118.95 37.75 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.406 HD11 HG11 ' A' ' 16' ' ' VAL . 7.4 mp -130.25 178.83 6.28 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.377 0.608 . . . . 0.0 110.527 -178.189 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 9.2 pt-20 -130.49 153.43 48.82 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 172.582 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -61.52 109.95 1.33 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.931 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.431 -1.68 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.596 -177.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.251 1.153 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 p -89.1 109.06 19.96 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 166.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -109.55 100.59 9.62 Favored 'General case' 0 N--CA 1.408 -2.536 0 CA-C-O 122.334 1.064 . . . . 0.0 111.028 -173.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.734 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 45.4 mt-10 -71.51 91.87 1.08 Allowed 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.177 174.269 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.612 HG13 HD13 ' A' ' 101' ' ' LEU . 14.9 p -84.62 138.77 18.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.536 -174.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -108.13 107.73 18.5 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 177.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.842 ' HB3' HD12 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -116.38 130.94 57.03 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.441 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -103.77 132.34 50.11 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.231 -0.293 . . . . 0.0 110.873 -178.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.498 ' HD3' ' O ' ' A' ' 95' ' ' GLN . 1.7 mptm? -60.42 136.44 58.04 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.09 0.471 . . . . 0.0 112.097 175.332 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.6 p -104.11 100.3 10.05 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 169.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 t70 73.06 -49.44 0.7 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.875 1.27 . . . . 0.0 112.203 -177.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.96 0.78 0.03 OUTLIER Glycine 0 C--N 1.306 -1.138 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.927 177.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 39.3 m -108.21 144.0 36.26 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 122.169 -0.606 . . . . 0.0 110.207 -177.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.842 HD12 ' HB3' ' A' ' 18' ' ' LEU . 19.6 tp -93.98 -11.14 31.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.7 13.9 66.39 Favored Glycine 0 N--CA 1.429 -1.797 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.048 175.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.412 HG23 HD12 ' A' ' 52' ' ' ILE . 14.1 pt -139.66 146.25 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.667 0.746 . . . . 0.0 112.487 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.412 ' OG ' HD12 ' A' ' 53' ' ' ILE . 19.6 m -107.02 135.04 49.26 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.412 172.48 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.0 165.23 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 123.772 0.67 . . . . 0.0 109.64 -176.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 1.007 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 6.0 t -149.37 141.8 24.27 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 177.406 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.748 HG13 HD12 ' A' ' 47' ' ' ILE . 32.6 m . . . . . 0 C--N 1.299 -1.6 0 C-N-CA 119.204 -0.998 . . . . 0.0 113.514 -176.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.522 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.748 HD12 HG13 ' A' ' 31' ' ' VAL . 42.2 mm -115.43 136.12 53.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.561 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.715 ' HB3' ' HA ' ' A' ' 69' ' ' ARG 0.27 38.5 p90 -158.52 169.3 24.74 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 169.295 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.542 HG21 ' CG2' ' A' ' 64' ' ' ILE . 31.8 t -80.59 121.76 34.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.694 -178.111 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 1.007 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 57.8 tptt -91.32 -38.09 12.85 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.468 178.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -156.03 158.58 38.06 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.577 -175.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 65' ' ' HIS . 45.9 mm -104.05 117.97 50.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.242 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.461 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 43.6 mm -93.29 134.18 27.34 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.726 -179.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 14.9 Cg_exo -72.36 -172.68 0.94 Allowed 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 122.792 2.328 . . . . 0.0 112.186 178.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.5 tptt 92.74 5.35 0.05 Allowed 'General case' 0 C--O 1.242 0.661 0 C-N-CA 126.367 1.867 . . . . 0.0 109.309 176.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.564 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 124.89 -163.83 18.68 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 114.677 -1.147 . . . . 0.0 113.256 173.375 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.495 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 71.66 -114.04 0.07 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 171.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.798 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -60.42 -39.48 87.58 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 117.942 0.337 . . . . 0.0 111.354 -174.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.11 -55.88 16.2 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.38 1.472 . . . . 0.0 110.115 178.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.564 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 20.4 m -73.25 -36.68 66.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -171.349 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -74.17 -28.85 61.49 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.58 51.09 22.35 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.382 176.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.553 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 3.1 mmp_? -104.99 -56.85 2.11 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.672 0.748 . . . . 0.0 110.842 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.542 ' CG2' HG21 ' A' ' 49' ' ' VAL . 56.2 mt -95.04 144.06 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.243 -176.023 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.422 ' HA ' HD11 ' A' ' 52' ' ' ILE . 6.5 p80 -137.0 168.7 19.08 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 173.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -65.74 141.98 58.15 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.279 0.561 . . . . 0.0 111.215 -176.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.7 -40.71 2.44 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.027 -1.083 . . . . 0.0 113.77 176.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 48' ' ' TYR 0.289 8.1 m-20 -67.21 144.52 55.93 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -174.919 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.715 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 34.6 ttp180 -102.19 149.43 24.31 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.694 -165.506 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.5 HG22 ' HG ' ' A' ' 101' ' ' LEU . 22.0 t -115.52 133.36 62.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -173.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.449 HD11 HD23 ' A' ' 100' ' ' LEU . 85.1 mt -96.12 -37.23 10.68 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.148 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.852 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . . . -167.44 179.54 4.91 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.925 -176.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.856 HG23 HD21 ' A' ' 78' ' ' LEU . 60.3 t -123.89 110.33 25.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.021 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.4 t30 59.43 34.94 22.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.666 1.222 . . . . 0.0 109.923 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 -15.43 61.19 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.478 -1.237 . . . . 0.0 114.221 178.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 57.7 t -85.65 112.47 22.41 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.119 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.421 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 17.5 m -53.96 122.84 10.93 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 124.37 1.044 . . . . 0.0 112.354 -174.149 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.856 HD21 HG23 ' A' ' 73' ' ' VAL . 18.4 tp -118.11 8.95 12.53 Favored 'General case' 0 N--CA 1.379 -3.983 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.695 -173.07 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.74 118.09 15.24 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.47 20.03 11.53 Favored Glycine 0 C--N 1.302 -1.326 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.035 -176.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB3' HD11 ' A' ' 47' ' ' ILE . . . -101.01 149.84 23.52 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.424 ' C ' HG11 ' A' ' 31' ' ' VAL . 14.9 t -99.14 174.88 6.11 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -50.34 -54.17 23.52 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.785 0.834 . . . . 0.0 111.172 -173.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 59.2 mtpt -63.45 -32.39 73.82 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.063 -176.004 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -72.34 -46.54 55.09 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.529 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -54.88 -56.29 21.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.606 177.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.98 -29.32 46.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.932 -178.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 34.2 mm-40 -72.28 -26.85 62.14 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.967 177.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.1 m -72.78 -39.75 66.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.72 ' HG ' HG12 ' A' ' 97' ' ' VAL . 8.6 mp -69.97 -18.44 63.34 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.677 1.191 . . . . 0.0 110.883 176.752 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -82.15 -43.13 18.14 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.706 175.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -66.03 -36.07 82.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.316 -177.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.709 ' HG1' HG13 ' A' ' 97' ' ' VAL . 22.3 p -58.89 -55.22 37.89 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.368 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 134.35 -142.73 14.24 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 178.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.498 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 58.9 tt0 -73.09 -55.76 6.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.063 0.459 . . . . 0.0 110.615 178.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 61.6 t -92.09 113.44 27.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.367 -179.396 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.72 HG12 ' HG ' ' A' ' 90' ' ' LEU . 3.0 t -105.66 128.0 60.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.011 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.517 ' CE1' ' HB3' ' A' ' 15' ' ' GLU . 34.9 t-80 -99.16 130.62 45.48 Favored 'General case' 0 C--N 1.258 -3.372 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.48 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.632 HD23 HD13 ' A' ' 90' ' ' LEU . 5.2 mp -128.26 146.17 50.82 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.346 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.734 ' HG ' ' HG2' ' A' ' 15' ' ' GLU . 3.3 tt -98.91 112.67 24.71 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -177.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.612 HD13 HG13 ' A' ' 16' ' ' VAL . 9.9 mp -115.27 166.51 11.77 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.237 0.541 . . . . 0.0 111.727 -177.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -133.14 152.11 51.96 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 176.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.718 ' HB3' ' HZ3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -54.05 115.26 1.95 Allowed 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.543 0.687 . . . . 0.0 110.334 171.827 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' A' ' 69' ' ' ARG . . . . . . . . 0 C--N 1.292 -1.902 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 176.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 t70 . . . . . 0 CA--C 1.503 -0.841 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 p -91.18 133.45 35.36 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.383 0.611 . . . . 0.0 111.902 -174.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -143.88 149.22 36.57 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.425 177.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -106.33 117.84 35.09 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.75 115.63 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.08 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.406 178.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.5 91.28 5.38 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.229 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.964 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -100.7 119.69 38.96 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.138 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.44 124.09 34.16 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.133 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HG2' HD21 ' A' ' 25' ' ' LEU . 92.9 mttt -65.52 144.13 57.21 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.145 0.498 . . . . 0.0 111.607 -179.502 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.475 HG21 ' HG3' ' A' ' 55' ' ' LYS . 6.2 m -61.89 -42.1 98.67 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.568 177.139 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -163.05 -49.45 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.785 176.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.31 -9.24 0.68 Allowed Glycine 0 C--O 1.242 0.597 0 C-N-CA 119.524 -1.322 . . . . 0.0 113.538 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 m -132.73 150.64 52.13 Favored 'General case' 0 N--CA 1.433 -1.314 0 O-C-N 122.062 -0.669 . . . . 0.0 110.828 -175.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.612 HD13 HD22 ' A' ' 90' ' ' LEU . 72.6 mt -89.74 145.34 25.27 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 169.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.83 51.92 4.62 Favored Glycine 0 C--N 1.288 -2.116 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.902 -177.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.48 HD11 HD13 ' A' ' 64' ' ' ILE . 12.2 pt -140.58 142.29 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 CA-C-N 117.87 0.835 . . . . 0.0 111.904 177.569 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 t -117.53 140.95 48.93 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 175.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -126.28 147.96 31.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.761 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 15.1 t -118.84 158.31 25.9 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.612 HG23 ' HA ' ' A' ' 82' ' ' THR . 3.3 t . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -176.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.524 HD13 HG11 ' A' ' 31' ' ' VAL . 42.1 mm -101.53 133.44 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -176.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -129.25 120.3 25.48 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.48 HG22 ' CG2' ' A' ' 64' ' ' ILE . 28.6 t -47.84 113.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 122.036 0.922 . . . . 0.0 109.971 170.732 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.761 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 88.4 tttt -87.41 -37.95 16.57 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.994 -174.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.86 151.44 32.25 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.363 -176.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.562 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 47.4 mm -109.39 128.61 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 O-C-N 123.731 0.644 . . . . 0.0 109.444 178.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.0 mp -100.93 133.58 20.97 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 175.629 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.494 ' HB2' ' H ' ' A' ' 55' ' ' LYS . 22.6 Cg_exo -65.59 -86.6 0.01 OUTLIER 'Trans proline' 0 C--O 1.255 1.349 0 C-N-CA 121.907 1.738 . . . . 0.0 111.57 176.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' H ' ' HB2' ' A' ' 54' ' ' PRO . 17.8 tptp 65.04 -67.51 0.12 Allowed 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 127.605 2.362 . . . . 0.0 110.481 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.07 38.15 0.02 OUTLIER Glycine 0 C--N 1.277 -2.729 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -179.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.529 ' HB2' HD12 ' A' ' 18' ' ' LEU . . . -134.52 -99.39 0.25 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -174.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.964 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -68.71 -38.69 80.43 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -168.757 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.562 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 36.4 tt0 -84.54 -29.39 25.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.313 0.578 . . . . 0.0 110.162 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.8 m -71.92 -46.26 58.26 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.117 -177.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.57 -24.3 34.05 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.551 0.691 . . . . 0.0 109.853 178.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.08 53.43 14.55 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.263 175.046 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -98.96 -46.76 5.5 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.675 1.226 . . . . 0.0 109.345 178.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.48 ' CG2' HG22 ' A' ' 49' ' ' VAL . 39.8 mt -112.8 140.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-N 113.154 -1.839 . . . . 0.0 109.752 -171.706 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -133.87 154.93 50.7 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 176.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 144.25 56.36 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.48 -175.66 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.37 -16.45 38.08 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.975 -178.486 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -80.28 144.45 32.83 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-O 121.034 0.445 . . . . 0.0 111.081 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -90.93 137.33 32.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.813 -175.546 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.494 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 38.5 t -101.18 112.32 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 176.606 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.433 HD12 ' HG ' ' A' ' 100' ' ' LEU . 85.2 mt -85.29 -39.47 17.66 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.668 -177.352 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.681 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -163.37 175.06 11.2 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.144 -176.069 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.662 HG12 ' HG ' ' A' ' 99' ' ' LEU . 23.8 t -130.76 117.87 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 65.32 27.15 12.06 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.455 1.102 . . . . 0.0 110.093 176.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.87 -6.82 79.81 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.557 -177.017 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.21 105.06 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.606 ' HA ' ' HB3' ' A' ' 72' ' ' ALA . 47.6 m -62.07 130.79 47.14 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.355 -174.244 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.681 ' HG ' ' HA ' ' A' ' 72' ' ' ALA . 98.0 mt -87.74 40.54 0.94 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.797 0.808 . . . . 0.0 110.574 -178.093 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' HG3' ' HB3' ' A' ' 77' ' ' SER . 36.2 mt-10 -76.3 112.27 12.62 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.01 32.37 17.79 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -175.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.54 177.78 5.06 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.977 0.894 . . . . 0.0 110.92 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.612 ' HA ' HG23 ' A' ' 31' ' ' VAL . 10.0 t -153.87 -179.52 7.92 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -50.7 -54.17 25.28 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.064 0.853 . . . . 0.0 110.142 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -58.35 -43.6 88.41 Favored 'General case' 0 C--O 1.204 -1.298 0 O-C-N 123.596 0.56 . . . . 0.0 111.638 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.513 ' HG2' HG22 ' A' ' 82' ' ' THR . 13.1 mm-40 -66.23 -47.82 72.56 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.936 -176.427 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -56.91 -57.37 12.8 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.749 178.052 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.48 -32.68 58.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.378 -175.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -76.44 -19.48 58.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.656 178.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 m -76.44 -35.51 58.45 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.612 HD22 HD13 ' A' ' 25' ' ' LEU . 8.7 mp -70.22 -22.14 62.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.622 0.769 . . . . 0.0 110.239 175.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -84.61 -31.09 24.45 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.572 0.701 . . . . 0.0 109.729 174.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -70.33 -42.37 72.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.565 178.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.6 p -65.07 152.97 42.13 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.88 177.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.67 -157.05 1.07 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 114.678 0.631 . . . . 0.0 114.678 -179.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.402 ' HG3' HG23 ' A' ' 96' ' ' VAL . 20.2 pt20 -68.02 -35.22 77.94 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.463 -0.368 . . . . 0.0 111.581 -177.105 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.402 HG23 ' HG3' ' A' ' 95' ' ' GLN . 48.4 t -105.2 108.52 25.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.095 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.6 t -99.95 134.5 39.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.105 -173.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -104.29 128.09 52.02 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.662 ' HG ' HG12 ' A' ' 73' ' ' VAL . 5.4 mp -123.89 145.29 49.22 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 172.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 72' ' ' ALA . 56.5 tp -91.82 109.18 20.51 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 mp -117.66 160.2 21.69 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.401 0.62 . . . . 0.0 110.42 -177.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -131.69 156.6 45.59 Favored 'General case' 0 C--N 1.264 -3.111 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 170.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.45 117.1 6.23 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.215 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.637 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.693 -176.118 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 . . . . . 0 CA--C 1.488 -1.405 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 p -101.9 145.08 29.72 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 165.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -149.04 153.76 38.34 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.433 -176.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -103.47 133.46 48.47 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 179.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.487 HG12 HD13 ' A' ' 64' ' ' ILE . 11.0 p -131.56 132.47 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.143 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HG3' ' HD2' ' A' ' 98' ' ' HIS . 49.1 mt-10 -101.46 85.43 2.77 Favored 'General case' 0 CA--C 1.472 -2.039 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 174.582 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.786 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -77.32 120.91 23.0 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.624 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.74 123.61 36.14 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.243 -175.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -68.49 112.48 5.33 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.406 ' CG2' ' HA ' ' A' ' 57' ' ' ALA . 2.1 t -111.35 89.01 2.93 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.196 -175.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 t70 79.76 -40.37 0.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.797 -1.547 . . . . 0.0 113.641 178.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.76 -98.5 0.99 Allowed Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.489 -0.863 . . . . 0.0 114.078 -179.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.0 m -162.65 -162.17 0.77 Allowed 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 -173.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.786 HD11 ' HB3' ' A' ' 18' ' ' LEU . 1.6 tp -89.34 109.38 20.29 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 171.514 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.685 ' HA3' ' O ' ' A' ' 56' ' ' GLY . . . -75.07 50.85 2.36 Favored Glycine 0 C--N 1.292 -1.866 0 CA-C-N 114.697 -1.138 . . . . 0.0 115.383 -172.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.546 HG21 HG22 ' A' ' 64' ' ' ILE . 10.7 pt -130.11 122.11 53.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 121.749 0.785 . . . . 0.0 111.071 177.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.516 ' HB2' HD11 ' A' ' 53' ' ' ILE . 7.7 t -94.86 124.99 39.23 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 -178.087 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.537 HG22 ' HB2' ' A' ' 83' ' ' HIS . 33.7 m -118.67 156.56 20.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 120.687 0.28 . . . . 0.0 111.41 -174.39 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.409 HG23 ' HB2' ' A' ' 50' ' ' LYS . 10.2 t -141.74 159.37 42.35 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.398 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.702 ' CG2' HD12 ' A' ' 47' ' ' ILE . 21.4 t . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 120.915 0.388 . . . . 0.0 110.797 177.012 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.44 0 N-CA-C 115.477 0.951 . . . . 0.0 115.477 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.702 HD12 ' CG2' ' A' ' 31' ' ' VAL . 18.0 mm -100.33 147.22 7.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -164.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -129.43 107.68 9.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.94 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.4 t -48.15 121.76 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.608 0.718 . . . . 0.0 110.521 169.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.409 ' HB2' HG23 ' A' ' 30' ' ' THR . 85.5 tttt -92.63 -37.31 12.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.702 -178.598 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.85 161.83 34.54 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.825 -175.217 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.504 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 20.1 mm -116.08 125.73 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 28' ' ' SER . 2.0 mp -76.48 134.28 70.0 Favored Pre-proline 0 C--N 1.302 -1.469 0 C-N-CA 122.573 0.349 . . . . 0.0 111.473 -176.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 56' ' ' GLY . 52.8 Cg_exo -59.65 130.62 36.11 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 123.107 2.538 . . . . 0.0 110.034 175.634 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 69.74 -4.99 1.29 Allowed 'General case' 0 C--O 1.249 1.043 0 CA-C-O 122.006 0.907 . . . . 0.0 110.654 -177.207 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.685 ' O ' ' HA3' ' A' ' 26' ' ' GLY . . . -85.48 68.34 3.45 Favored Glycine 0 N--CA 1.403 -3.551 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.209 -175.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.503 ' HB3' ' CD1' ' A' ' 18' ' ' LEU . . . 58.82 -75.41 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.698 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 167.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.692 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -58.12 -35.11 70.98 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 125.219 1.407 . . . . 0.0 113.342 -171.793 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.504 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 34.7 tt0 -85.64 -39.96 16.72 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.032 0.444 . . . . 0.0 110.138 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -68.52 -37.32 79.94 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.282 -177.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -82.62 -34.61 27.52 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.714 177.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.89 52.02 3.81 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.688 -0.687 . . . . 0.0 114.242 175.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -116.58 -56.8 2.25 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.24 0.543 . . . . 0.0 111.658 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.546 HG22 HG21 ' A' ' 27' ' ' ILE . 21.2 mm -84.07 145.52 8.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.11 -176.635 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -125.33 162.61 24.38 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -77.97 143.1 37.87 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.42 -179.005 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.478 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 103.74 -28.0 17.28 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.478 -179.395 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.8 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 39.5 m-20 -64.53 146.91 53.87 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.687 0.756 . . . . 0.0 111.825 -176.709 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.532 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . 59.9 mtp180 -96.84 146.53 24.83 Favored 'General case' 0 CA--C 1.461 -2.456 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.017 -173.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.664 HG23 ' HB ' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -112.74 123.79 68.77 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.132 0 CA-C-N 114.229 -1.35 . . . . 0.0 107.461 176.191 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.557 ' HB2' HD13 ' A' ' 100' ' ' LEU . 65.9 mt -107.96 -24.23 11.7 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.792 -176.195 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -169.06 173.23 6.98 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.927 -176.032 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.815 HG23 ' HG ' ' A' ' 99' ' ' LEU . 99.4 t -130.29 116.98 38.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 173.56 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 98' ' ' HIS 0.265 10.3 p30 51.31 38.43 21.5 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.331 1.453 . . . . 0.0 112.513 -177.648 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.79 -8.02 77.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 119.928 -1.129 . . . . 0.0 113.881 -179.052 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.54 106.03 14.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.478 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 49.7 m -63.91 136.79 57.65 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.122 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.672 HD12 HG22 ' A' ' 73' ' ' VAL . 81.3 mt -118.95 16.85 13.4 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.584 178.355 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.38 119.47 12.27 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.472 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.5 15.16 58.91 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.301 -177.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.78 159.13 15.09 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 117.474 0.637 . . . . 0.0 109.587 179.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.9 t -97.0 158.78 15.26 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 171.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.537 ' HB2' HG22 ' A' ' 29' ' ' VAL 0.272 8.4 p80 -51.1 -45.4 61.49 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -172.197 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.579 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -64.56 -32.4 74.03 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.614 -178.651 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -67.14 -37.67 84.21 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.676 0.75 . . . . 0.0 109.718 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.493 ' HB1' HG13 ' A' ' 47' ' ' ILE . . . -63.61 -46.59 85.05 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.565 176.693 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.5 t -64.37 -34.44 69.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.985 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.137 -178.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.579 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 45.6 mt-10 -60.01 -47.34 86.24 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 93' ' ' THR . 14.0 m -60.7 -39.28 87.94 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.974 0.892 . . . . 0.0 109.739 178.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.602 HD11 ' HB2' ' A' ' 25' ' ' LEU . 4.2 tp -79.27 -9.8 59.66 Favored 'General case' 0 N--CA 1.413 -2.279 0 C-N-CA 124.224 1.01 . . . . 0.0 110.431 -177.105 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -101.13 -18.11 16.35 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -92.71 -11.8 33.07 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.817 179.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 89' ' ' THR . 32.1 p -73.16 -177.82 2.65 Favored 'General case' 0 C--O 1.252 1.195 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.407 173.281 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.52 -123.25 2.63 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.166 178.736 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -98.15 -45.86 6.06 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.8 m -95.9 118.07 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.658 0 CA-C-O 121.655 0.74 . . . . 0.0 109.374 176.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.504 HG21 HD13 ' A' ' 90' ' ' LEU . 45.8 t -101.15 113.3 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.481 -178.748 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.515 ' HD2' ' HG3' ' A' ' 17' ' ' GLU . 17.3 t-80 -84.31 58.35 4.76 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.815 ' HG ' HG23 ' A' ' 73' ' ' VAL . 3.8 tt -70.58 142.55 51.72 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.703 -172.42 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' A' ' 71' ' ' LEU . 3.0 tm? -101.77 114.3 28.24 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.475 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.486 HD12 HG11 ' A' ' 16' ' ' VAL . 7.7 mp -111.3 166.43 11.11 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.502 0.668 . . . . 0.0 112.758 -177.199 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 69' ' ' ARG . 36.5 tt0 -132.38 151.32 51.91 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.548 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HD3' ' C ' ' A' ' 103' ' ' LYS . 11.3 tmtt? -44.44 123.84 3.78 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 124.1 0.96 . . . . 0.0 111.811 171.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.8 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 C--N 1.295 -1.701 0 C-N-CA 119.605 -1.283 . . . . 0.0 111.312 171.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 20.9 t0 . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.3 p -91.09 144.92 25.13 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 123.899 0.749 . . . . 0.0 112.74 -174.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.549 ' HE1' ' HG2' ' A' ' 103' ' ' LYS . 17.8 p90 -168.82 134.44 1.69 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.291 175.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 46.1 mt-10 -88.11 104.01 16.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.657 0.742 . . . . 0.0 109.592 175.766 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 5.0 t -71.82 138.85 20.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.647 -178.23 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.18 95.25 5.99 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 173.303 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.701 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -102.5 125.88 49.36 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -174.333 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.47 143.72 27.9 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.525 0.678 . . . . 0.0 111.849 -177.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 1.2 mptm? -71.73 93.13 1.25 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 124.938 1.295 . . . . 0.0 112.417 176.393 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.429 HG22 ' HB1' ' A' ' 57' ' ' ALA . 13.3 t -64.88 -30.15 71.13 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-O 121.755 0.788 . . . . 0.0 109.466 169.019 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 16.4 t70 -112.13 -155.85 0.58 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -178.676 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.41 17.39 58.56 Favored Glycine 0 C--N 1.299 -1.518 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 176.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -155.65 174.75 14.83 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -177.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 18' ' ' LEU . 11.6 tp -94.14 150.31 20.44 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -178.256 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.613 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -81.26 41.52 2.65 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.173 -174.311 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.4 pt -137.39 130.93 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-O 121.625 0.726 . . . . 0.0 111.941 177.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.598 ' HB2' HD11 ' A' ' 53' ' ' ILE . 48.5 t -99.25 124.23 44.15 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.62 152.4 20.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.548 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 7.6 t -131.93 171.62 13.35 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.509 HG23 ' CD1' ' A' ' 47' ' ' ILE . 2.5 t . . . . . 0 C--N 1.303 -1.426 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.426 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.602 0 CA-C-O 120.253 -0.193 . . . . 0.0 113.177 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.509 ' CD1' HG23 ' A' ' 31' ' ' VAL . 38.0 mm -101.13 126.86 54.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.097 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.715 ' CE1' ' HG2' ' A' ' 69' ' ' ARG . 61.5 m-85 -132.85 124.17 27.45 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.953 -176.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.447 HG23 ' CG2' ' A' ' 64' ' ' ILE . 41.0 t -48.32 118.97 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 CA-C-O 121.547 0.689 . . . . 0.0 110.586 172.456 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -92.51 -35.46 13.6 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.97 -176.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.33 165.75 30.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.818 -177.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.931 HG22 ' HB2' ' A' ' 59' ' ' GLU . 42.6 mm -110.75 116.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.613 ' HB ' ' HA2' ' A' ' 26' ' ' GLY . 47.4 mm -70.43 116.88 49.63 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.851 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 6.9 Cg_exo -75.4 77.85 3.15 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 123.721 2.947 . . . . 0.0 114.015 -175.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.56 ' HD3' HG21 ' A' ' 53' ' ' ILE . 2.1 mptm? -122.53 -23.61 5.14 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.697 170.685 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.638 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 116.62 43.93 0.61 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.479 -179.207 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.45 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . . . -117.94 -87.92 0.62 Allowed 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 117.214 0.507 . . . . 0.0 110.897 -177.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.701 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -77.09 -27.85 54.34 Favored 'General case' 0 C--O 1.257 1.498 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -171.278 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.931 ' HB2' HG22 ' A' ' 52' ' ' ILE . 40.9 tt0 -83.0 -33.3 26.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.402 0.62 . . . . 0.0 109.808 -179.721 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.638 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 7.4 m -81.84 -26.89 33.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.559 0.695 . . . . 0.0 109.228 -178.373 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.1 -41.19 59.2 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.072 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.08 39.79 9.07 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.072 -1.422 . . . . 0.0 114.579 170.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -120.42 -45.53 2.42 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.067 178.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 58' ' ' ALA . 60.5 mt -94.02 132.16 38.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.003 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.547 ' HA ' HD11 ' A' ' 52' ' ' ILE . 16.4 t-80 -135.43 -174.87 3.75 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -73.54 131.53 41.85 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.27 0.557 . . . . 0.0 110.501 -176.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.03 -17.39 35.12 Favored Glycine 0 N--CA 1.425 -2.085 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.756 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.459 ' HB3' HD21 ' A' ' 101' ' ' LEU . 11.3 m-20 -63.89 136.02 57.03 Favored 'General case' 0 C--O 1.261 1.666 0 CA-C-O 122.031 0.92 . . . . 0.0 112.783 -177.512 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.715 ' HG2' ' CE1' ' A' ' 48' ' ' TYR . 41.8 mtp180 -86.17 118.79 25.85 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.373 -173.026 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.55 108.81 20.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.465 178.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.754 HD12 ' HB2' ' A' ' 102' ' ' GLU . 66.8 mt -86.79 -41.79 13.81 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . . . -160.4 177.19 10.83 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.607 -175.778 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 1.052 HG11 HG23 ' A' ' 89' ' ' THR . 2.9 p -128.95 102.17 7.55 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 C-N-CA 124.106 0.962 . . . . 0.0 109.51 177.426 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.7 t30 51.78 57.21 6.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.186 0.993 . . . . 0.0 109.897 179.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.47 -38.31 3.02 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 114.484 -1.235 . . . . 0.0 114.146 -178.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.446 ' HB ' HG12 ' A' ' 73' ' ' VAL . 43.2 t -72.84 111.57 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.066 0.933 . . . . 0.0 109.773 -175.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.3 p -81.59 113.45 19.62 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.298 0.571 . . . . 0.0 111.265 -178.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.793 HD23 ' H ' ' A' ' 78' ' ' LEU 0.269 0.7 OUTLIER -88.28 92.63 9.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 122.29 1.043 . . . . 0.0 108.957 176.865 . . . . . . . . 4 4 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -101.1 111.08 23.2 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.79 -169.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.8 46.31 94.29 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -177.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.543 ' HB2' ' HG3' ' A' ' 85' ' ' GLN . . . -89.73 167.16 13.1 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 -177.357 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 85' ' ' GLN . 70.8 p -79.7 144.99 33.19 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.725 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 11.1 p-80 -53.08 -37.45 61.68 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.388 0.613 . . . . 0.0 110.021 173.195 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 58.3 tttm -54.41 -54.54 39.32 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.297 -1.32 . . . . 0.0 110.633 173.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.543 ' HG3' ' HB2' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -72.51 -28.71 63.04 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.227 -175.624 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.67 -52.12 64.92 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.779 0.8 . . . . 0.0 109.388 174.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.65 -28.43 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.933 177.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 63.2 mm-40 -64.54 -35.8 82.14 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 176.079 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 1.052 HG23 HG11 ' A' ' 73' ' ' VAL . 23.1 m -69.03 -32.72 72.42 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.374 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.4 mt -72.12 -19.75 61.74 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.849 177.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -102.76 -6.12 22.96 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.167 175.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -90.33 -20.92 22.34 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 122.481 1.134 . . . . 0.0 108.435 178.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.545 HG22 HG13 ' A' ' 97' ' ' VAL . 2.2 p -83.07 171.12 14.09 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.486 -1.233 . . . . 0.0 109.923 176.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.22 -149.18 11.07 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.222 -176.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.611 ' HG3' HG21 ' A' ' 96' ' ' VAL . 3.7 pt20 -69.03 -36.64 77.96 Favored 'General case' 0 C--O 1.207 -1.176 0 CA-C-O 120.823 0.344 . . . . 0.0 110.787 -178.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.611 HG21 ' HG3' ' A' ' 95' ' ' GLN . 59.0 t -116.44 118.83 60.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.342 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.572 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 40.1 t -100.53 130.1 50.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.082 -177.784 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 47.6 m80 -93.99 117.17 29.74 Favored 'General case' 0 C--N 1.272 -2.802 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 172.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.773 HD22 HD12 ' A' ' 101' ' ' LEU . 5.2 tp -120.76 133.07 55.35 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -176.676 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 72' ' ' ALA . 45.9 tp -89.84 112.52 23.89 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -176.4 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.773 HD12 HD22 ' A' ' 99' ' ' LEU . 7.1 mp -124.06 165.56 17.28 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.329 0.585 . . . . 0.0 110.569 -179.577 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.754 ' HB2' HD12 ' A' ' 71' ' ' LEU . 28.3 tt0 -131.63 127.99 38.16 Favored 'General case' 0 N--CA 1.397 -3.079 0 N-CA-C 102.646 -3.094 . . . . 0.0 102.646 174.525 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.904 ' HE2' ' HA ' ' A' ' 103' ' ' LYS . 4.4 mmpt? -46.43 110.01 0.24 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -177.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.631 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.217 -175.418 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 18.2 t70 . . . . . 0 N--CA 1.439 -0.991 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 5.6 p -100.81 119.27 38.4 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 123.945 0.778 . . . . 0.0 110.346 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -150.72 145.84 26.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.555 -178.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 50.0 mt-10 -77.61 97.04 4.95 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.394 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 12.6 p -75.08 138.92 19.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.289 -178.684 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -107.0 114.56 28.71 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.926 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -115.34 124.03 50.24 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.659 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.67 111.59 23.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.484 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 99.1 mttt -58.65 153.12 17.12 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.727 HG23 ' H ' ' A' ' 23' ' ' GLY . 9.0 t -93.93 -164.86 1.23 Allowed 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 171.845 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.47 4.66 17.51 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 118.816 0.735 . . . . 0.0 110.718 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.727 ' H ' HG23 ' A' ' 21' ' ' THR . . . -140.03 56.37 0.62 Allowed Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.007 179.363 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.316 80.3 p 74.9 -176.63 0.15 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 126.404 1.882 . . . . 0.0 115.715 172.47 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.724 HD23 ' HB3' ' A' ' 18' ' ' LEU . 69.6 mt -65.78 -16.98 64.3 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -177.095 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.519 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . 78.52 24.84 62.08 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 178.372 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.589 HG21 HG23 ' A' ' 64' ' ' ILE . 19.3 pt -136.64 123.23 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 CA-C-O 121.992 0.901 . . . . 0.0 112.395 177.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.8 m -100.34 121.18 41.08 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 113.347 -1.752 . . . . 0.0 108.247 177.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 49' ' ' VAL . 32.0 m -114.73 152.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.269 -173.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 t -129.35 155.66 45.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 82' ' ' THR . 8.5 t . . . . . 0 C--N 1.297 -1.68 0 CA-C-N 119.242 0.928 . . . . 0.0 109.219 179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.12 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.91 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 43.0 mm -101.27 146.38 9.77 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.356 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.506 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 53.6 t80 -131.77 110.23 10.71 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -174.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.43 ' HA ' HG13 ' A' ' 29' ' ' VAL . 42.1 t -52.3 114.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 171.683 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -94.64 -32.8 13.23 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.805 -173.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.17 143.07 25.71 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -176.466 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.64 HG21 ' HB2' ' A' ' 59' ' ' GLU . 45.8 mm -104.83 125.21 59.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.261 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.519 ' HB ' ' HA2' ' A' ' 26' ' ' GLY . 30.0 mm -99.49 135.24 20.7 Favored Pre-proline 0 C--N 1.289 -2.029 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.033 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.12 -155.75 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.32 2.68 . . . . 0.0 112.448 174.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? 97.36 -44.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.629 1.572 . . . . 0.0 111.232 171.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . 156.2 35.52 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 118.12 -1.99 . . . . 0.0 115.452 176.337 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.557 ' HB1' HD13 ' A' ' 18' ' ' LEU . . . -129.51 -105.8 0.29 Allowed 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.348 177.595 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.926 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -62.87 -35.55 80.38 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -173.437 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.64 ' HB2' HG21 ' A' ' 52' ' ' ILE . 39.4 tt0 -86.43 -26.31 24.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.232 0.539 . . . . 0.0 109.789 -178.156 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.7 t -79.27 -46.17 18.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.812 -178.457 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.57 -31.0 66.5 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.51 44.41 8.62 Favored Glycine 0 CA--C 1.499 -0.954 0 CA-C-N 114.18 -1.373 . . . . 0.0 114.267 170.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -108.99 -62.34 1.49 Allowed 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.406 178.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.589 HG23 HG21 ' A' ' 27' ' ' ILE . 25.8 mm -72.11 137.37 23.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.648 -173.227 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -122.32 151.08 41.5 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 173.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 133.91 46.11 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.782 178.518 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.506 ' HA2' ' CZ ' ' A' ' 48' ' ' TYR . . . 111.64 -18.58 24.66 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -172.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.477 ' HB3' HD21 ' A' ' 101' ' ' LEU . 89.4 m-20 -66.41 131.23 45.62 Favored 'General case' 0 C--O 1.252 1.206 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 73.0 mtm-85 -93.12 138.07 31.89 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.86 0.838 . . . . 0.0 111.21 -177.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.91 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 49.2 t -99.75 111.84 30.49 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.531 HD12 ' HB2' ' A' ' 102' ' ' GLU . 48.2 mt -95.06 -33.68 12.6 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.633 -175.404 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -162.56 176.36 10.48 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.927 -177.635 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 1.14 HG12 HG23 ' A' ' 89' ' ' THR . 3.1 p -123.97 112.37 32.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 125.172 1.389 . . . . 0.0 107.793 175.187 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.9 p30 50.51 29.33 3.92 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 125.008 1.323 . . . . 0.0 113.582 177.141 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.05 -19.13 41.42 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.1 -177.219 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.504 ' HB ' HG13 ' A' ' 73' ' ' VAL . 52.5 t -86.19 113.86 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.0 m -61.97 136.69 58.07 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.317 0.579 . . . . 0.0 112.517 -175.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.473 HD11 ' HB ' ' A' ' 73' ' ' VAL . 76.2 mt -114.21 32.21 6.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.204 -178.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.51 113.28 22.3 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.108 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.97 16.43 35.76 Favored Glycine 0 C--N 1.303 -1.255 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.24 146.35 26.99 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -179.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.548 ' HA ' HG22 ' A' ' 31' ' ' VAL . 23.0 p -82.76 162.63 21.67 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 173.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -52.27 -42.95 64.14 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -61.09 -39.96 91.91 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.332 178.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.548 ' HG2' ' OG1' ' A' ' 82' ' ' THR . 14.7 mm100 -67.07 -47.14 72.2 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.206 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.643 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.3 -48.95 77.6 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.379 178.221 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.82 -28.66 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.122 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.48 -43.01 86.58 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 1.14 HG23 HG12 ' A' ' 73' ' ' VAL . 28.5 m -64.87 -34.34 78.14 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.589 176.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 68.7 mt -74.52 -17.95 60.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.23 0.538 . . . . 0.0 110.972 -178.645 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -94.02 -33.16 13.53 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.363 0.602 . . . . 0.0 110.296 174.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -75.85 -19.8 58.61 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.955 -178.106 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -75.94 -77.59 0.13 Allowed 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 171.84 -149.74 12.33 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.527 -179.301 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.484 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 46.1 tt0 -88.75 -39.94 13.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.711 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.58 104.76 16.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.042 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 25' ' ' LEU . 3.5 t -106.2 142.38 19.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.429 -174.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 78.4 m80 -110.27 127.95 55.27 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.481 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 5.8 mp -129.03 150.22 50.52 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.156 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.702 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.4 tm? -98.82 111.04 23.55 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 68' ' ' ASP . 10.5 mp -119.48 169.74 9.77 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.136 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.531 ' HB2' HD12 ' A' ' 71' ' ' LEU . 34.0 tt0 -130.45 128.23 40.86 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 172.626 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.502 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 26.5 tptt -59.03 123.79 17.76 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 123.991 0.807 . . . . 0.0 109.748 -177.369 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.043 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.575 -173.657 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 32.4 t70 . . . . . 0 CA--C 1.492 -1.266 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.2 p -103.42 126.15 50.42 Favored 'General case' 0 N--CA 1.413 -2.311 0 O-C-N 124.531 1.144 . . . . 0.0 110.35 178.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -137.02 160.61 38.43 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.836 -177.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -107.71 97.54 7.26 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 176.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.3 p -76.03 134.39 29.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.119 -176.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -91.71 97.69 11.17 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.596 HD22 ' HA ' ' A' ' 58' ' ' ALA . 2.4 tm? -101.76 111.35 23.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.02 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.67 118.9 31.99 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.285 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HE2' ' CD2' ' A' ' 25' ' ' LEU . 94.1 mttt -52.67 119.34 4.44 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 122.032 0.92 . . . . 0.0 112.811 -177.711 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.883 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 93.1 m -120.57 103.71 9.37 Favored 'General case' 0 N--CA 1.403 -2.824 0 CA-C-N 113.687 -1.597 . . . . 0.0 108.184 -175.61 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 t70 62.05 -73.51 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 177.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.97 26.47 12.83 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.468 ' HA ' ' HB3' ' A' ' 20' ' ' LYS 0.27 87.5 p 62.68 -98.45 0.07 Allowed 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.974 1.31 . . . . 0.0 112.881 178.922 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.619 ' HG ' HD12 ' A' ' 90' ' ' LEU . 2.7 mm? -100.92 110.38 22.43 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 118.63 0.65 . . . . 0.0 109.368 175.547 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.489 ' HA3' ' C ' ' A' ' 56' ' ' GLY . . . -84.25 36.07 2.94 Favored Glycine 0 C--N 1.295 -1.713 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.274 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.6 pt -125.4 121.13 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.903 0 CA-C-O 121.886 0.85 . . . . 0.0 112.085 -176.428 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.9 t -86.94 119.94 27.68 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 177.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.54 149.78 31.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.54 -173.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 t -128.63 179.6 5.59 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 172.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 8.9 m . . . . . 0 C--N 1.3 -1.556 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 174.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.321 0 CA-C-O 120.983 0.213 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.983 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 47.1 mm -116.85 156.16 18.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 C-N-CA 123.307 0.643 . . . . 0.0 109.807 -172.776 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -135.62 109.56 8.18 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 123.736 0.814 . . . . 0.0 109.562 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -51.25 109.46 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.861 0 CA-C-O 122.247 1.022 . . . . 0.0 110.623 171.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -80.65 -40.83 24.87 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 113.699 -1.591 . . . . 0.0 109.255 -176.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.6 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -160.23 161.58 33.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.246 -176.757 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.582 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 38.7 mm -115.75 139.8 40.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.6 mm -95.6 141.73 23.6 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -177.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.81 137.97 71.33 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.4 2.067 . . . . 0.0 109.483 171.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 5.2 tppp? 59.44 21.26 9.66 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 123.472 1.606 . . . . 0.0 108.393 -172.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.489 ' C ' ' HA3' ' A' ' 26' ' ' GLY . . . -109.18 81.84 0.29 Allowed Glycine 0 N--CA 1.396 -3.999 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.528 -175.178 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.883 ' HA ' ' HB ' ' A' ' 21' ' ' THR . . . 32.56 -72.45 0.0 OUTLIER 'General case' 0 C--O 1.186 -2.265 0 C-N-CA 127.817 2.447 . . . . 0.0 116.264 171.597 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.596 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -55.56 -32.11 62.73 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.734 0.814 . . . . 0.0 111.753 -177.647 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.582 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 6.5 tp10 -89.44 -37.87 14.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.172 0.511 . . . . 0.0 109.662 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 m -74.04 -44.73 53.3 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.49 -175.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -76.44 -36.77 57.78 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.76 59.56 1.5 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.833 176.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.403 ' HB2' ' H ' ' A' ' 64' ' ' ILE . 14.4 mmt180 -121.53 -87.02 0.65 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.619 0.723 . . . . 0.0 110.409 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.403 ' H ' ' HB2' ' A' ' 63' ' ' ARG . 53.1 mt -74.94 146.52 9.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.961 -176.351 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -129.95 172.57 11.57 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.6 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 35.8 mtmm -71.84 126.29 29.35 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 -177.615 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 120.15 -28.13 6.45 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.046 -1.073 . . . . 0.0 113.17 177.864 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.669 ' HB3' HD21 ' A' ' 101' ' ' LEU . 28.9 m-20 -64.45 133.34 52.29 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 122.043 0.925 . . . . 0.0 112.782 -176.183 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -91.88 135.4 33.96 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.127 -175.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.983 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 60.8 t -105.66 125.14 61.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -174.068 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.785 ' HB2' HD11 ' A' ' 100' ' ' LEU . 67.9 mt -104.64 -21.6 13.38 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.971 -177.313 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.725 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -168.35 167.62 11.87 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.044 0.449 . . . . 0.0 112.086 -177.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.676 ' HA ' HD12 ' A' ' 99' ' ' LEU . 46.7 t -120.83 117.88 54.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 174.412 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.353 30.7 p-10 38.44 63.4 0.87 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.411 1.484 . . . . 0.0 114.859 -179.375 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.05 -21.4 3.38 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.004 -0.998 . . . . 0.0 114.861 178.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.31 100.08 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.674 ' HA ' ' HB3' ' A' ' 72' ' ' ALA . 20.0 m -58.1 132.27 53.02 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.261 -178.28 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.725 ' HG ' ' HA ' ' A' ' 72' ' ' ALA . 74.5 mt -93.33 80.25 4.42 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.105 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -77.42 -30.16 53.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.49 -171.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.26 58.68 0.31 Allowed Glycine 0 CA--C 1.474 -2.53 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.67 138.07 40.06 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.178 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.721 HG22 ' HG2' ' A' ' 85' ' ' GLN . 14.6 t -85.05 161.35 19.75 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 171.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . 0.287 10.6 p80 -50.89 -41.67 58.51 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.431 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -67.85 -24.02 65.21 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 177.466 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.721 ' HG2' HG22 ' A' ' 82' ' ' THR . 30.1 mm-40 -70.8 -40.75 72.34 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -62.61 -45.06 94.59 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.463 176.498 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.407 ' HA ' HD13 ' A' ' 90' ' ' LEU . 91.6 t -69.03 -34.37 63.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.351 -177.645 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 85' ' ' GLN . 7.9 pt-20 -71.59 -27.89 63.44 Favored 'General case' 0 C--O 1.217 -0.623 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.193 178.404 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.8 m -72.74 -25.72 61.31 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.619 HD12 ' HG ' ' A' ' 25' ' ' LEU . 96.0 mt -79.41 -23.33 43.29 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.659 0.742 . . . . 0.0 109.727 174.592 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -79.12 -38.29 36.51 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.756 175.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -66.92 -36.52 82.43 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.317 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 p -69.56 159.23 33.75 Favored 'General case' 0 C--O 1.252 1.225 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.93 -129.32 0.29 Allowed Glycine 0 C--N 1.33 0.222 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.816 -175.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -87.78 -44.91 10.78 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.344 0.592 . . . . 0.0 110.436 -178.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.38 119.43 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 C-N-CA 118.824 -1.15 . . . . 0.0 110.053 -178.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.401 HG12 ' CD2' ' A' ' 90' ' ' LEU . 22.8 t -103.19 126.27 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.372 -176.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -94.43 115.71 27.94 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 174.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.0 tp -113.09 136.16 53.01 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.793 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.785 HD11 ' HB2' ' A' ' 71' ' ' LEU . 2.6 tm? -89.28 109.98 20.8 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 -176.343 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.669 HD21 ' HB3' ' A' ' 68' ' ' ASP . 11.0 mp -122.79 165.2 16.99 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.836 0.827 . . . . 0.0 112.673 -175.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 41.3 tt0 -131.74 142.66 49.84 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 174.859 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.558 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -51.53 130.0 26.8 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 177.0 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . . . . . . 0 N--CA 1.422 -2.267 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.457 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.563 ' HG2' ' HB2' ' A' ' 12' ' ' ASP . 20.2 ptmt . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.83 55.9 2.3 Favored 'Trans proline' 0 CA--C 1.554 1.516 0 C-N-CA 122.634 2.222 . . . . 0.0 113.145 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.94 35.85 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.63 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 22.7 t0 -101.82 148.57 25.14 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.461 -0.369 . . . . 0.0 110.462 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 37.5 p -91.04 115.45 28.03 Favored 'General case' 0 N--CA 1.413 -2.295 0 O-C-N 123.858 0.724 . . . . 0.0 110.458 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.453 ' CE1' ' HD2' ' A' ' 103' ' ' LYS . 16.4 p90 -125.67 116.8 22.24 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.061 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 45.3 mt-10 -77.96 92.54 4.32 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.709 0.766 . . . . 0.0 109.397 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.473 HG13 HD13 ' A' ' 64' ' ' ILE . 9.6 p -74.81 138.13 21.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.269 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.534 ' HG2' ' CD2' ' A' ' 98' ' ' HIS . 38.5 mt-10 -96.45 96.29 8.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 175.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.8 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -96.6 111.11 23.38 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -176.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.96 130.39 40.08 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.101 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.432 ' HE2' ' HG ' ' A' ' 25' ' ' LEU . 94.9 mttt -86.01 127.87 34.74 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.729 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 t -77.63 -42.06 36.26 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -164.84 -68.8 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.11 0.481 . . . . 0.0 110.36 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.21 60.56 4.87 Favored Glycine 0 C--O 1.246 0.882 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.971 -173.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 89.8 p 62.01 -170.34 0.17 Allowed 'General case' 0 C--O 1.246 0.919 0 C-N-CA 126.521 1.928 . . . . 0.0 113.14 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.64 HD23 HD12 ' A' ' 18' ' ' LEU . 92.2 mt -68.65 150.68 47.68 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.155 0.502 . . . . 0.0 109.883 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.15 6.47 82.57 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.826 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.582 HG23 HG13 ' A' ' 52' ' ' ILE . 15.7 pt -103.52 128.98 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.754 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.255 -178.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.4 ' HB2' HD13 ' A' ' 53' ' ' ILE . 32.2 t -98.34 114.64 27.03 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 49' ' ' VAL . 35.0 m -112.2 157.81 12.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.364 -175.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.607 HG21 ' HD1' ' A' ' 33' ' ' PHE . 12.9 t -127.27 161.89 27.51 Favored 'General case' 0 N--CA 1.396 -3.134 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.734 HG13 ' H ' ' A' ' 32' ' ' LEU . 2.0 p -73.1 -62.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.775 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.734 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -170.82 124.19 0.65 Allowed 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 173.07 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.607 ' HD1' HG21 ' A' ' 30' ' ' THR . 9.4 p90 -85.58 109.05 18.26 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 172.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.55 99.36 0.14 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -135.87 25.36 3.34 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.18 -111.76 3.83 Favored Glycine 0 N--CA 1.425 -2.045 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.242 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.57 131.01 1.89 Allowed Glycine 0 N--CA 1.425 -2.075 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.2 m -78.7 1.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.071 0.462 . . . . 0.0 111.961 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -166.17 -30.93 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 123.589 0.756 . . . . 0.0 110.182 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -130.25 101.13 5.64 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.046 0.451 . . . . 0.0 111.579 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.1 m -105.17 -46.26 4.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.371 0.605 . . . . 0.0 109.766 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.0 -25.01 14.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.871 0.843 . . . . 0.0 108.934 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -95.79 154.88 17.0 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -66.02 149.55 50.08 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.278 0.561 . . . . 0.0 111.319 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.615 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . -86.14 163.37 36.03 Favored Glycine 0 N--CA 1.415 -2.734 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 176.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.49 -98.19 2.51 Favored Glycine 0 N--CA 1.419 -2.496 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.806 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 33.8 mm -141.39 147.89 21.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 176.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CE1' ' HG ' ' A' ' 32' ' ' LEU . 67.6 m-85 -129.66 139.42 51.4 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 118.533 0.606 . . . . 0.0 111.715 177.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.522 HG23 ' CG2' ' A' ' 64' ' ' ILE . 44.1 t -74.67 116.48 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 173.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -85.02 -37.06 20.83 Favored 'General case' 0 C--N 1.284 -2.283 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.29 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.711 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -165.38 163.97 19.77 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.538 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.84 HG22 ' HB2' ' A' ' 59' ' ' GLU . 1.9 mp -116.96 124.19 72.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 53' ' ' ILE . 2.0 mp -108.05 128.57 25.5 Favored Pre-proline 0 C--N 1.293 -1.863 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -17.25 -110.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.953 1 C-N-CA 126.123 4.548 . . . . 0.0 117.16 -173.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 53' ' ' ILE . 3.4 mptp? 70.69 -67.06 0.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.627 1.171 . . . . 0.0 110.183 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.15 -117.67 0.99 Allowed Glycine 0 N--CA 1.401 -3.682 1 N-CA-C 102.762 -4.135 . . . . 0.0 102.762 -172.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.794 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . 59.04 -110.29 0.49 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 164.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.8 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -68.27 -41.46 81.0 Favored 'General case' 0 C--O 1.255 1.367 0 C-N-CA 122.674 0.39 . . . . 0.0 111.513 -173.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.84 ' HB2' HG22 ' A' ' 52' ' ' ILE . 42.1 tt0 -73.73 -37.06 65.23 Favored 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 124.437 1.086 . . . . 0.0 110.794 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.7 t -70.88 -49.51 45.16 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.122 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.411 ' OD1' ' HG2' ' A' ' 63' ' ' ARG . 6.4 t70 -65.11 -31.28 72.4 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.02 35.25 54.17 Favored Glycine 0 CA--C 1.488 -1.653 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.989 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 6.7 mmp_? -103.02 -49.69 3.7 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.023 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.565 ' HB ' ' HB3' ' A' ' 58' ' ' ALA . 65.9 mt -92.98 138.14 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.173 -172.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.436 ' CG ' ' H ' ' A' ' 66' ' ' LYS . 26.6 t-80 -126.38 -173.21 2.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 52.6 mtpt -79.76 43.35 0.58 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.422 1.089 . . . . 0.0 112.515 -172.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.579 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . -172.88 5.71 0.03 OUTLIER Glycine 0 C--N 1.301 -1.411 0 C-N-CA 118.836 -1.649 . . . . 0.0 115.066 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -74.66 144.37 43.84 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 117.728 0.764 . . . . 0.0 110.324 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.412 ' HD3' ' OE1' ' A' ' 102' ' ' GLU . 56.4 ttt180 -89.32 135.01 33.82 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.806 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 47.9 t -105.74 122.7 59.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.571 HD11 ' HG3' ' A' ' 102' ' ' GLU . 65.6 mt -97.04 -39.05 9.52 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.233 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 77' ' ' SER . . . -164.87 178.37 7.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.472 -174.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.592 HG21 HD12 ' A' ' 78' ' ' LEU . 48.0 t -121.04 112.9 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 10.4 p30 45.6 37.2 3.03 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 125.529 1.531 . . . . 0.0 113.828 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.84 -9.04 70.84 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 119.856 -1.164 . . . . 0.0 114.235 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.3 97.07 5.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.57 ' HA ' ' HB3' ' A' ' 72' ' ' ALA . 11.9 m -59.92 125.68 24.61 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.09 0.869 . . . . 0.0 112.436 -173.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.592 HD12 HG21 ' A' ' 73' ' ' VAL . 59.1 mt -94.89 69.68 3.34 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -111.0 104.68 13.27 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.695 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.34 26.71 11.71 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.74 146.05 30.31 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.483 HG22 ' HG2' ' A' ' 85' ' ' GLN . 11.8 t -88.2 164.11 15.81 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 170.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.522 ' HB3' ' N ' ' A' ' 31' ' ' VAL . 16.4 p-80 -51.15 -40.01 57.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -60.54 -39.89 89.54 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.615 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.483 ' HG2' HG22 ' A' ' 82' ' ' THR . 82.1 mm-40 -70.66 -36.48 73.38 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.261 0.553 . . . . 0.0 110.397 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.44 -52.37 65.88 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.75 174.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.2 t -66.57 -28.18 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.027 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -65.32 -39.2 92.14 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.0 m -70.96 -31.85 68.53 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.763 0.792 . . . . 0.0 109.079 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.436 HD21 HD23 ' A' ' 99' ' ' LEU . 96.0 mt -76.18 -11.68 59.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.126 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -99.09 -28.95 13.15 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.52 -30.1 70.35 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.026 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 p -76.78 144.84 38.91 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.719 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.66 -120.72 0.13 Allowed Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 116.139 1.216 . . . . 0.0 116.139 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -81.21 -45.08 16.86 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.452 0.701 . . . . 0.0 111.459 -172.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.73 124.23 72.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.066 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.404 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 7.4 t -108.42 139.22 31.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.782 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.534 ' CD2' ' HG2' ' A' ' 17' ' ' GLU . 66.6 m80 -101.49 125.46 48.14 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 6.5 mp -123.02 143.64 49.8 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.554 HD22 HD13 ' A' ' 71' ' ' LEU . 1.3 tt -96.46 109.5 22.04 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 13' ' ' THR . 10.8 mp -117.4 171.33 8.06 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.061 0.458 . . . . 0.0 112.134 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.63 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 48.1 mt-10 -130.52 143.37 50.72 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.453 ' HD2' ' CE1' ' A' ' 14' ' ' PHE . 28.1 mmmt -60.42 125.19 22.75 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.109 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.579 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . -103.06 -160.49 25.45 Favored Glycine 0 N--CA 1.425 -2.099 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.299 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.492 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 78.0 mm-40 -115.06 147.9 39.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.8 m -97.0 154.97 38.02 Favored Pre-proline 0 C--N 1.295 -1.796 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 C--O 1.251 1.166 0 C-N-CA 123.167 2.578 . . . . 0.0 111.481 179.347 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.735 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 95.5 mttt . . . . . 0 CA--C 1.495 -1.154 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.587 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 17.2 Cg_exo -67.38 125.6 13.67 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 N-CA-C 108.003 -1.576 . . . . 0.0 108.003 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.38 12.04 61.85 Favored Glycine 0 C--N 1.308 -1.021 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.108 -173.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.735 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 36.3 t70 -102.27 143.26 32.27 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p -89.41 141.77 28.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.213 0.53 . . . . 0.0 111.552 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -149.28 146.56 27.62 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.753 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -100.13 125.4 46.23 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.1 t -113.3 129.08 69.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -98.36 81.99 2.83 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.863 HD11 ' HB1' ' A' ' 57' ' ' ALA . 1.6 tm? -85.14 126.7 33.84 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -171.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.09 110.1 21.47 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.823 ' HE3' HD12 ' A' ' 25' ' ' LEU . 15.0 ptmt -79.14 153.94 29.7 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.747 HG21 ' HB3' ' A' ' 55' ' ' LYS . 7.2 t -140.23 139.84 35.68 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.209 -176.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 3.7 m-20 71.63 9.33 6.32 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.948 0.899 . . . . 0.0 112.712 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.24 1.34 23.58 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.66 -0.781 . . . . 0.0 114.55 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.2 t -160.49 175.01 13.23 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.823 HD12 ' HE3' ' A' ' 20' ' ' LYS . 7.6 mp -89.49 177.48 6.55 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.12 33.43 5.09 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.471 ' HB ' HG12 ' A' ' 49' ' ' VAL . 19.5 pt -138.14 139.95 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.639 0 CA-C-O 121.949 0.88 . . . . 0.0 112.012 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.1 m -104.25 118.22 36.1 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 113.68 -1.6 . . . . 0.0 107.274 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.01 145.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.393 0.616 . . . . 0.0 111.731 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -122.9 172.23 8.63 Favored 'General case' 0 N--CA 1.403 -2.822 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.573 HG13 ' H ' ' A' ' 32' ' ' LEU . 2.0 p -94.04 -63.64 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.258 -3.389 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.599 HD13 ' HA3' ' A' ' 45' ' ' GLY . 13.6 mt -172.04 151.4 2.69 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 128.139 2.576 . . . . 0.0 107.21 175.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -105.46 93.49 4.7 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -70.78 -41.87 71.11 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.607 0.718 . . . . 0.0 109.278 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.17 76.98 1.75 Allowed 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.65 -53.45 1.67 Allowed Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.08 -80.45 0.05 OUTLIER Glycine 0 N--CA 1.426 -1.971 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.6 t -80.84 124.94 39.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.451 ' C ' ' HG1' ' A' ' 40' ' ' THR . 2.5 p-10 -69.03 137.61 53.77 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.188 0.518 . . . . 0.0 109.985 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.451 ' HG1' ' C ' ' A' ' 39' ' ' ASN . 57.5 m -155.06 141.97 19.13 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.2 m -115.44 98.32 6.67 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.138 0.494 . . . . 0.0 110.635 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.4 t -95.07 132.45 39.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -80.66 121.82 26.33 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 77.3 132.38 0.05 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.039 1.736 . . . . 0.0 110.222 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.599 ' HA3' HD13 ' A' ' 32' ' ' LEU . . . -141.97 134.77 6.34 Favored Glycine 0 N--CA 1.414 -2.769 0 C-N-CA 120.054 -1.07 . . . . 0.0 112.585 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.09 -91.28 0.28 Allowed Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.581 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 33.6 mm -131.12 142.48 43.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 174.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.435 ' OH ' ' HD3' ' A' ' 69' ' ' ARG . 45.8 m-85 -126.23 143.77 51.02 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.471 HG12 ' HB ' ' A' ' 27' ' ' ILE . 61.7 t -78.93 108.48 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -80.7 -37.28 30.97 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.783 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.19 153.0 31.87 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.122 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.18 113.63 40.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.2 mm -92.27 154.48 43.0 Favored Pre-proline 0 C--N 1.28 -2.456 0 C-N-CA 125.261 1.424 . . . . 0.0 109.726 -175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -56.4 -152.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.567 2.161 0 C-N-CA 123.446 2.764 . . . . 0.0 113.801 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.747 ' HB3' HG21 ' A' ' 21' ' ' THR . 3.7 mppt? 72.8 -44.97 0.61 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.614 1.166 . . . . 0.0 112.1 -169.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.02 -126.88 4.2 Favored Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 108.176 -1.969 . . . . 0.0 108.176 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.863 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 71.27 -99.48 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 171.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.861 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -73.12 -35.26 66.52 Favored 'General case' 0 C--O 1.265 1.906 0 O-C-N 121.86 -0.525 . . . . 0.0 111.576 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -74.95 -40.03 61.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 125.07 1.481 . . . . 0.0 107.448 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.8 t -67.97 -44.03 77.65 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.056 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.63 -39.69 80.67 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.44 27.0 49.68 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.725 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -108.91 -39.65 5.26 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.115 -1.034 . . . . 0.0 113.156 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.861 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.4 mt -94.97 127.25 47.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -132.3 178.41 6.84 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 123.5 0.5 . . . . 0.0 110.115 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -67.52 128.21 35.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.314 0.578 . . . . 0.0 111.94 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.611 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 101.05 -4.24 55.75 Favored Glycine 0 N--CA 1.422 -2.267 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.006 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.572 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 31.8 m-20 -68.93 146.07 53.1 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.458 HH21 ' CD ' ' A' ' 102' ' ' GLU . 34.7 ttp180 -96.65 129.21 44.09 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.795 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.581 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 59.0 t -101.77 118.3 48.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.76 -31.87 14.23 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.265 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.632 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -164.49 167.78 19.08 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.675 HG21 HD12 ' A' ' 78' ' ' LEU . 31.7 t -118.04 110.44 30.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 59.39 37.49 23.23 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.393 1.077 . . . . 0.0 109.966 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.46 -6.19 80.88 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.163 -0.926 . . . . 0.0 114.162 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.07 108.66 20.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.458 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 35.4 p -64.95 135.68 55.94 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.675 HD12 HG21 ' A' ' 73' ' ' VAL . 67.5 mt -106.75 25.71 10.92 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.469 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -53.88 -32.03 51.83 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.96 -1.473 . . . . 0.0 113.452 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.63 40.71 1.56 Allowed Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.15 155.63 17.06 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.325 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.553 HG21 ' HG2' ' A' ' 85' ' ' GLN . 9.0 t -92.72 160.75 14.83 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 167.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.417 ' O ' HG21 ' A' ' 87' ' ' VAL . 52.1 p-80 -51.28 -43.43 61.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.141 0.496 . . . . 0.0 111.917 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -59.72 -37.8 79.92 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.553 ' HG2' HG21 ' A' ' 82' ' ' THR . 14.9 mm100 -71.63 -36.05 70.62 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.52 -45.71 90.97 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.348 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 83' ' ' HIS . 64.1 t -66.24 -39.53 84.53 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.776 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -62.51 -39.09 92.41 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.847 0.355 . . . . 0.0 111.038 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.415 ' HB ' HG23 ' A' ' 73' ' ' VAL . 12.1 m -69.91 -38.13 76.16 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.884 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.851 HD13 HD11 ' A' ' 99' ' ' LEU . 19.2 tp -82.95 -3.08 56.67 Favored 'General case' 0 N--CA 1.415 -2.175 0 C-N-CA 125.154 1.382 . . . . 0.0 109.878 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.36 -21.05 13.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.487 172.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -82.84 -25.21 32.84 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.715 ' HG1' HG11 ' A' ' 97' ' ' VAL . 3.2 p -67.18 -177.81 0.72 Allowed 'General case' 0 C--O 1.255 1.359 0 C-N-CA 123.705 0.802 . . . . 0.0 110.517 174.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -78.56 -162.63 21.8 Favored Glycine 0 C--O 1.244 0.764 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.582 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.414 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 29.6 tt0 -73.41 -34.53 65.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.717 0.77 . . . . 0.0 108.969 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.8 t -90.19 110.83 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.715 HG11 ' HG1' ' A' ' 93' ' ' THR . 8.8 m -99.05 117.54 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.427 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.071 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -84.57 122.0 28.41 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.851 HD11 HD13 ' A' ' 90' ' ' LEU . 7.2 tp -127.35 146.14 50.56 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.557 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 53.1 tp -102.13 117.1 34.06 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.741 HD13 HD22 ' A' ' 99' ' ' LEU . 6.6 mp -123.47 165.63 16.76 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.667 0.746 . . . . 0.0 111.761 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.458 ' CD ' HH21 ' A' ' 69' ' ' ARG . 88.1 tt0 -132.95 143.93 49.79 Favored 'General case' 0 N--CA 1.391 -3.42 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.587 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 40.3 mmtt -64.3 125.6 25.11 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.09 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.611 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . -91.22 -123.51 2.89 Favored Glycine 0 N--CA 1.42 -2.376 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.377 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -87.52 -45.91 10.05 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . 0.323 20.8 m 44.06 87.86 0.11 Allowed Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 C--O 1.247 0.963 0 C-N-CA 123.53 2.82 . . . . 0.0 110.522 178.653 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.478 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 28.2 mtpp . . . . . 0 N--CA 1.432 -1.329 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 58.0 Cg_endo -76.44 125.45 8.37 Favored 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 121.346 1.364 . . . . 0.0 109.389 169.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.723 ' H ' ' HB3' ' A' ' 103' ' ' LYS . . . 73.25 18.79 79.43 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.186 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 28.7 t70 -88.97 143.49 26.82 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 3.1 p -99.21 108.26 20.8 Favored 'General case' 0 N--CA 1.416 -2.164 0 O-C-N 123.895 0.747 . . . . 0.0 110.154 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -138.49 140.34 39.14 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.123 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 4.4 mp0 -75.53 106.36 7.04 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 59.5 t -69.47 122.51 21.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.841 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -96.16 93.96 7.24 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.555 HD12 ' CB ' ' A' ' 57' ' ' ALA . 2.6 tm? -100.53 115.14 29.43 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -177.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.84 117.3 33.86 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 24' ' ' SER . 99.5 mttt -54.52 121.16 7.8 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 124.185 0.928 . . . . 0.0 111.696 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.9 p -90.36 -84.0 0.24 Allowed 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.547 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.76 -54.83 2.41 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.506 ' CA ' ' HA2' ' A' ' 56' ' ' GLY . . . -87.87 25.73 8.34 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.698 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 39.7 t 76.69 -109.94 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 123.992 0.917 . . . . 0.0 113.326 172.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.708 ' HG ' HD11 ' A' ' 90' ' ' LEU . 3.3 mm? -85.38 -31.69 22.8 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 120.065 1.302 . . . . 0.0 110.403 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.523 ' CA ' ' HA3' ' A' ' 56' ' ' GLY . . . 73.55 21.58 79.33 Favored Glycine 0 N--CA 1.411 -2.986 0 C-N-CA 119.552 -1.309 . . . . 0.0 112.105 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.402 HG21 ' CD1' ' A' ' 52' ' ' ILE . 17.1 pt -128.71 121.86 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.696 0 CA-C-O 122.079 0.942 . . . . 0.0 112.825 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 25.7 t -90.26 112.18 23.63 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.426 HG13 ' HA ' ' A' ' 49' ' ' VAL . 33.4 m -118.82 154.53 21.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -172.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.742 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 9.4 t -143.51 174.99 10.28 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.688 HG22 ' CD1' ' A' ' 47' ' ' ILE . 4.4 t -102.24 147.0 9.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.54 ' HG ' ' HB2' ' A' ' 48' ' ' TYR . 64.9 mt -79.31 92.76 5.19 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.56 ' CD1' ' HB ' ' A' ' 31' ' ' VAL . 25.5 p90 -166.88 13.89 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.13 -80.58 0.08 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.496 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -169.89 115.84 0.54 Allowed 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.261 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.04 167.08 18.03 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -125.17 -51.93 0.18 Allowed Glycine 0 C--N 1.306 -1.116 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.574 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.8 t -104.83 36.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.2 t30 70.05 164.78 0.27 Allowed 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.304 -1.317 . . . . 0.0 109.864 -175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.6 m -141.05 109.91 6.09 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.3 t -59.85 -90.22 0.0 OUTLIER 'General case' 0 C--O 1.244 0.783 0 O-C-N 124.004 0.815 . . . . 0.0 109.091 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.9 p -41.23 110.77 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 122.094 0.949 . . . . 0.0 113.559 168.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -136.47 173.14 12.03 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.896 176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.6 t60 53.63 -102.14 0.13 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 124.281 1.033 . . . . 0.0 111.195 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.23 -52.28 1.4 Allowed Glycine 0 C--N 1.34 0.801 0 CA-C-O 121.219 0.344 . . . . 0.0 113.02 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' HG11 ' A' ' 31' ' ' VAL . . . 161.81 -70.63 0.22 Allowed Glycine 0 N--CA 1.406 -3.357 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.718 HG13 ' HB3' ' A' ' 86' ' ' ALA . 21.0 mm -145.76 159.36 12.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 C-N-CA 125.273 1.429 . . . . 0.0 107.654 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.54 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . 67.4 t80 -134.45 135.25 42.38 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 123.333 0.653 . . . . 0.0 110.612 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.436 HG21 ' CG2' ' A' ' 64' ' ' ILE . 51.6 t -79.67 108.84 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HB2' HG22 ' A' ' 30' ' ' THR . 63.1 tttp -80.8 -37.44 30.2 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.19 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 28' ' ' SER . . . -148.54 148.18 29.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.47 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.704 HG21 ' HB2' ' A' ' 59' ' ' GLU . 1.4 tp -110.86 131.97 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-O 121.4 0.619 . . . . 0.0 111.758 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.1 mp -106.25 126.44 30.52 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.937 ' HA ' ' HB3' ' A' ' 59' ' ' GLU . 33.8 Cg_exo -59.47 -77.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.133 2.555 . . . . 0.0 113.169 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.473 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 23.8 mmtp -55.13 -10.09 0.49 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 176.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.523 ' HA3' ' CA ' ' A' ' 26' ' ' GLY . . . -63.32 -59.37 9.0 Favored Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.555 ' CB ' HD12 ' A' ' 18' ' ' LEU . . . 167.25 -71.31 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.733 0 C-N-CA 125.117 1.367 . . . . 0.0 111.78 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.821 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . . . -48.66 -38.22 20.57 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -167.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.937 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 8.2 tp10 -74.49 -52.4 12.06 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.91 0.484 . . . . 0.0 111.222 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.6 m -76.96 -29.77 55.71 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.097 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -72.6 -45.87 56.97 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.88 59.24 1.61 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 114.301 -1.318 . . . . 0.0 114.882 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -128.7 -58.87 1.16 Allowed 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.598 0.714 . . . . 0.0 109.144 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.821 ' HB ' ' HB3' ' A' ' 58' ' ' ALA . 51.9 mt -94.1 141.61 14.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.89 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -137.31 168.53 19.45 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -58.26 125.29 22.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.687 0.28 . . . . 0.0 110.439 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.533 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 115.59 -21.19 12.93 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.968 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.493 ' OD1' ' HD2' ' A' ' 103' ' ' LYS . 54.2 m-20 -64.72 137.28 57.71 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.88 0.848 . . . . 0.0 113.228 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -96.47 132.33 42.15 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.0 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.3 t -108.72 126.06 65.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.5 -34.65 10.17 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.59 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -162.94 175.64 10.98 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.291 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.964 HG21 HD12 ' A' ' 78' ' ' LEU . 95.3 t -128.48 111.47 23.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.4 t30 51.73 58.72 5.17 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 124.821 1.248 . . . . 0.0 111.684 176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.7 -10.2 13.84 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 114.798 -1.092 . . . . 0.0 115.104 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 85.4 t -95.81 108.21 20.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 118.242 1.021 . . . . 0.0 108.828 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.499 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 34.7 m -62.42 137.06 58.19 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 123.818 0.699 . . . . 0.0 112.254 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.964 HD12 HG21 ' A' ' 73' ' ' VAL . 91.6 mt -104.97 16.19 26.37 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.456 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 38.8 mt-10 -72.17 94.76 1.58 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.58 14.1 13.35 Favored Glycine 0 C--N 1.304 -1.202 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 74.4 p -92.54 162.25 14.28 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.742 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 52.5 p-80 -51.47 -41.92 61.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.68 0.752 . . . . 0.0 109.807 174.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.0 -37.07 75.59 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.149 178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.402 ' HG2' ' OG1' ' A' ' 82' ' ' THR . 74.7 mm-40 -64.26 -40.32 95.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.347 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.718 ' HB3' HG13 ' A' ' 47' ' ' ILE . . . -55.48 -52.25 64.25 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.104 0.478 . . . . 0.0 110.417 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.0 t -64.54 -34.07 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.002 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -68.65 -30.0 68.6 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.04 0.448 . . . . 0.0 110.577 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.4 m -72.25 -37.51 69.09 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.708 HD11 ' HG ' ' A' ' 25' ' ' LEU . 97.9 mt -71.06 -25.44 62.64 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.577 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -77.76 -43.36 31.06 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.232 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.81 -46.97 64.53 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.984 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 p -48.24 -65.88 0.49 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.64 -154.18 24.96 Favored Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.825 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.467 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 57.9 tt0 -87.53 -43.8 11.75 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.505 0.669 . . . . 0.0 109.288 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.5 t -102.65 106.04 19.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -105.61 138.29 31.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.22 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.568 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 56.7 m80 -100.39 130.16 46.45 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.615 HD22 HD23 ' A' ' 90' ' ' LEU . 6.5 mp -124.21 141.4 52.1 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.54 106.31 18.41 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.513 ' O ' ' HA ' ' A' ' 13' ' ' THR . 8.4 mp -115.64 165.56 12.9 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.697 0.761 . . . . 0.0 112.36 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 42.6 tt0 -131.15 114.04 14.63 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 103.675 -2.713 . . . . 0.0 103.675 172.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.723 ' HB3' ' H ' ' A' ' 11' ' ' GLY . 40.9 tptt -47.5 121.36 3.89 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.872 0.732 . . . . 0.0 110.643 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . -93.93 32.41 5.88 Favored Glycine 0 CA--C 1.498 -0.973 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.446 -171.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -151.43 113.75 4.57 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.404 HG11 ' HB2' ' A' ' 10' ' ' PRO . 40.6 t -120.34 90.82 45.67 Favored Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 N--CA 1.43 -2.259 0 C-N-CA 123.105 2.537 . . . . 0.0 111.006 -178.89 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 31.8 mmtp . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 111.27 0.1 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.59 ' HG3' ' HB3' ' A' ' 107' ' ' PRO . 16.7 Cg_exo -70.1 44.38 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 124.388 3.392 . . . . 0.0 113.14 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.36 18.52 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.45 139.07 31.8 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 122.862 0.465 . . . . 0.0 110.802 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 p -92.77 117.46 30.04 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.8 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -133.89 154.52 51.01 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 120.815 0.34 . . . . 0.0 110.545 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -110.46 114.09 27.24 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.569 HG12 HD11 ' A' ' 64' ' ' ILE . 11.6 p -86.84 132.02 33.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.743 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -102.1 105.37 16.08 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.867 HD22 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -117.23 124.94 50.29 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -176.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.85 132.21 46.36 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.008 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.542 ' HE3' HG21 ' A' ' 97' ' ' VAL . 1.2 mptm? -65.73 139.46 58.36 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 123.484 0.714 . . . . 0.0 110.821 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.0 p -75.45 -68.94 0.51 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 170.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -105.75 -72.01 0.73 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -145.92 19.28 1.78 Allowed Glycine 0 C--N 1.306 -1.116 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 175.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.0 m -114.57 140.33 48.87 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.771 HD12 ' HB3' ' A' ' 18' ' ' LEU . 12.3 tp -93.66 -8.64 40.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.57 -7.4 76.67 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.944 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.633 HG22 HG21 ' A' ' 64' ' ' ILE . 20.1 pt -119.68 155.76 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 CA-C-O 121.914 0.864 . . . . 0.0 112.437 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -132.08 128.53 38.41 Favored 'General case' 0 N--CA 1.399 -3.001 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.206 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -109.18 162.4 6.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.206 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.65 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 14.1 t -141.39 168.78 18.95 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 175.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 82' ' ' THR . 4.5 t -103.05 119.95 52.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.05 85.97 2.32 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -95.33 -58.21 2.2 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.42 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -152.88 116.72 4.79 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.169 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -170.94 -50.41 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.07 81.98 0.05 OUTLIER Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.44 -157.79 22.34 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.661 HG22 ' H ' ' A' ' 39' ' ' ASN . 10.8 m -78.8 -84.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.661 ' H ' HG22 ' A' ' 38' ' ' VAL . 16.3 m120 -122.13 -69.37 0.84 Allowed 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.8 m -105.61 86.14 2.35 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.5 m -110.25 92.74 4.17 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.89 149.56 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.451 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -92.05 81.68 5.08 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -151.25 -81.55 0.1 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.32 150.97 23.08 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 106.442 -2.663 . . . . 0.0 106.442 172.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' VAL . . . -158.67 15.87 0.26 Allowed Glycine 0 N--CA 1.418 -2.52 0 C-N-CA 117.357 -2.354 . . . . 0.0 114.207 -170.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.591 ' CD1' HG23 ' A' ' 31' ' ' VAL . 36.6 mm -94.63 125.97 47.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -129.21 147.09 51.02 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 52.5 t -72.66 113.2 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HB2' HG22 ' A' ' 30' ' ' THR . 55.7 tttm -86.02 -40.43 15.8 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.132 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.51 156.26 37.76 Favored 'General case' 0 C--O 1.25 1.091 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.242 -173.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -113.89 118.02 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.07 136.23 20.61 Favored Pre-proline 0 C--N 1.292 -1.932 0 C-N-CA 123.543 0.737 . . . . 0.0 109.518 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.46 ' O ' ' HD2' ' A' ' 55' ' ' LYS . 39.0 Cg_exo -65.25 78.55 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.253 2.635 . . . . 0.0 112.603 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' A' ' 54' ' ' PRO . 4.3 mptp? -135.53 20.81 3.35 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.0 -151.83 44.63 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.527 ' HB3' ' CD1' ' A' ' 18' ' ' LEU . . . 69.79 -103.48 0.05 OUTLIER 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.558 1.143 . . . . 0.0 113.393 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.867 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -66.48 -37.04 84.22 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 117.963 0.347 . . . . 0.0 111.887 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.59 -48.31 67.22 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.66 1.184 . . . . 0.0 109.009 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 m -68.9 -46.12 69.14 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.129 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.6 -25.31 62.12 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.12 36.2 51.76 Favored Glycine 0 CA--C 1.5 -0.898 0 CA-C-N 114.449 -1.251 . . . . 0.0 113.271 174.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 1.8 mmp_? -95.7 -48.99 5.55 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.034 0.445 . . . . 0.0 111.215 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.747 ' HB ' ' HB2' ' A' ' 58' ' ' ALA . 33.1 mm -100.54 137.44 28.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.661 -173.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.509 ' NE2' ' HB ' ' A' ' 106' ' ' VAL . 7.7 p-80 -137.92 169.79 17.17 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 172.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -79.49 142.4 35.86 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.889 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.07 -17.72 12.64 Favored Glycine 0 C--N 1.306 -1.138 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.288 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.441 ' CG ' ' HZ2' ' A' ' 103' ' ' LYS . 2.3 m-20 -89.48 147.04 24.22 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-N 117.118 0.459 . . . . 0.0 110.619 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.515 ' HD3' ' OE1' ' A' ' 102' ' ' GLU . 4.3 ptm180 -106.98 158.39 17.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.148 0.499 . . . . 0.0 111.485 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.21 127.71 71.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.457 HD12 ' HB2' ' A' ' 102' ' ' GLU . 85.7 mt -96.27 -37.15 10.64 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -160.54 174.56 13.86 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.713 -176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 1.061 HG12 HG22 ' A' ' 89' ' ' THR . 2.7 p -124.08 105.37 15.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 C-N-CA 124.224 1.009 . . . . 0.0 108.549 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.0 t30 57.43 32.54 21.95 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.587 1.184 . . . . 0.0 110.564 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.27 -11.66 67.1 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.515 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.604 ' HB ' HG13 ' A' ' 73' ' ' VAL . 59.8 t -86.34 107.28 16.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m -72.31 119.34 16.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.938 0.399 . . . . 0.0 111.598 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.689 ' N ' HD21 ' A' ' 78' ' ' LEU . 1.4 pt? -119.18 83.52 2.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.965 0.888 . . . . 0.0 111.674 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.41 -35.88 11.56 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.744 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.62 36.66 4.01 Favored Glycine 0 CA--C 1.495 -1.165 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . -101.28 146.3 27.73 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.787 HG22 ' HG2' ' A' ' 85' ' ' GLN . 9.0 t -94.34 166.4 12.1 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 170.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.65 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 48.2 p-80 -51.54 -41.19 60.89 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 122.798 0.439 . . . . 0.0 111.347 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.07 -38.34 82.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.668 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.787 ' HG2' HG22 ' A' ' 82' ' ' THR . 13.6 mm100 -71.46 -47.81 53.29 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.65 75.64 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.209 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.5 -29.79 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.678 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -80.87 -16.24 54.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.34 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 1.061 HG22 HG12 ' A' ' 73' ' ' VAL . 25.4 m -73.16 -32.16 64.7 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.948 HD23 HD23 ' A' ' 99' ' ' LEU . 84.3 mt -76.45 -20.45 57.02 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.221 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -77.16 -44.15 31.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.419 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -64.41 -41.6 96.54 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.379 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.435 HG23 HG12 ' A' ' 97' ' ' VAL . 6.6 p -64.7 158.62 24.15 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.578 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -79.05 -150.62 5.5 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.912 -173.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -65.07 -42.23 94.37 Favored 'General case' 0 C--O 1.209 -1.052 0 C-N-CA 122.94 0.496 . . . . 0.0 109.807 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.2 t -114.4 122.51 68.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.542 HG21 ' HE3' ' A' ' 20' ' ' LYS . 5.9 t -112.58 149.89 14.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.481 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 48.0 m80 -115.13 132.85 56.47 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.948 HD23 HD23 ' A' ' 90' ' ' LEU . 6.4 mp -126.83 145.45 50.64 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 tt -99.5 109.91 22.41 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 -177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.503 HD13 HG11 ' A' ' 16' ' ' VAL . 11.0 mp -112.59 170.71 7.99 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.607 0.718 . . . . 0.0 110.65 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.515 ' OE1' ' HD3' ' A' ' 69' ' ' ARG . 42.6 tt0 -129.87 132.18 46.34 Favored 'General case' 0 N--CA 1.404 -2.75 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.441 ' HZ2' ' CG ' ' A' ' 68' ' ' ASP . 19.4 tptp -57.38 122.24 12.1 Favored 'General case' 0 N--CA 1.421 -1.89 0 O-C-N 124.285 0.99 . . . . 0.0 110.17 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.94 -122.72 4.95 Favored Glycine 0 N--CA 1.417 -2.614 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -71.4 170.37 13.35 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.509 ' HB ' ' NE2' ' A' ' 65' ' ' HIS . 35.3 t 52.02 80.0 0.32 Allowed Pre-proline 0 C--O 1.246 0.917 0 C-N-CA 124.87 1.268 . . . . 0.0 111.34 -175.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.59 ' HB3' ' HG3' ' A' ' 10' ' ' PRO . 5.2 Cg_exo . . . . . 0 N--CA 1.451 -1.026 0 C-N-CA 123.319 2.679 . . . . 0.0 110.994 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.937 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 53.2 mtpt . . . . . 0 N--CA 1.431 -1.378 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.937 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 1.2 Cg_endo -85.88 137.93 5.75 Favored 'Trans proline' 0 N--CA 1.435 -1.913 0 N-CA-C 107.827 -1.643 . . . . 0.0 107.827 171.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.58 8.27 80.66 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.083 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 26.1 t0 -98.05 144.45 27.55 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 4.4 p -103.86 132.59 49.96 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 123.438 0.461 . . . . 0.0 112.209 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.99 147.64 24.3 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.266 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -77.46 98.58 5.35 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 7.2 p -71.94 130.25 35.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -95.26 95.0 8.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.896 HD23 ' HA ' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -101.72 120.44 40.35 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.034 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.82 117.82 31.28 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.451 ' HB3' HD21 ' A' ' 25' ' ' LEU . 5.8 ptmt -71.06 146.55 49.24 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.742 0.782 . . . . 0.0 113.032 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m -87.69 -51.43 5.88 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.294 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 23' ' ' GLY . 14.3 t70 -111.65 -154.84 0.55 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.442 ' H ' ' CG ' ' A' ' 22' ' ' ASP . . . -85.35 16.69 37.95 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.811 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -148.94 176.56 10.32 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.624 HD22 HD11 ' A' ' 18' ' ' LEU . 32.8 mt -93.2 152.31 19.29 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 118.19 0.45 . . . . 0.0 109.816 172.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -82.84 28.61 3.54 Favored Glycine 0 C--O 1.212 -1.259 0 CA-C-N 115.212 -0.903 . . . . 0.0 112.558 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.463 ' HB ' HG11 ' A' ' 49' ' ' VAL . 22.0 pt -131.71 133.95 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 CA-C-O 121.325 0.583 . . . . 0.0 110.826 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.3 t -91.13 117.88 29.98 Favored 'General case' 0 C--N 1.268 -2.968 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.467 ' HB ' ' CG2' ' A' ' 47' ' ' ILE . 30.8 m -109.3 136.12 46.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 O-C-N 123.656 0.597 . . . . 0.0 110.192 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.533 HG23 ' HB2' ' A' ' 50' ' ' LYS . 10.5 t -126.57 161.34 28.23 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.497 HG22 ' CD1' ' A' ' 47' ' ' ILE . 3.1 t -103.99 114.77 44.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.837 -177.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mp -108.39 85.59 2.14 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 13.5 t80 -86.38 -164.64 1.08 Allowed 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.713 -171.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 43' ' ' ARG . 2.6 m-20 -68.11 90.83 0.34 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.866 0.841 . . . . 0.0 110.404 174.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -161.88 141.89 10.21 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.436 -1.711 . . . . 0.0 106.529 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.66 43.77 8.22 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.732 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.4 101.33 2.33 Favored Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.82 -50.64 4.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -77.14 -26.79 53.52 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.006 0.431 . . . . 0.0 110.432 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.9 p -148.88 169.2 21.06 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.5 m -88.47 -39.21 14.39 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 118.543 0.61 . . . . 0.0 110.282 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 p -87.62 147.35 5.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.499 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 1.0 OUTLIER -122.23 -34.82 3.24 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 62.34 17.07 9.07 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.342 1.057 . . . . 0.0 109.948 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . -69.34 143.49 39.2 Favored Glycine 0 N--CA 1.426 -2.001 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.759 -175.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.25 -108.21 1.59 Allowed Glycine 0 N--CA 1.419 -2.441 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.504 HG13 HD13 ' A' ' 78' ' ' LEU . 46.7 mm -101.52 147.21 8.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.474 ' HH ' ' HG2' ' A' ' 107' ' ' PRO . 45.1 t80 -136.11 136.4 40.08 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 123.788 0.835 . . . . 0.0 109.45 -177.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.463 HG11 ' HB ' ' A' ' 27' ' ' ILE . 43.7 t -75.6 109.0 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.533 ' HB2' HG23 ' A' ' 30' ' ' THR . 61.3 tttp -83.93 -38.15 21.41 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.977 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.24 165.08 36.87 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.589 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.7 mm -111.87 120.1 61.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 55' ' ' LYS . 1.8 mp -67.78 136.0 92.4 Favored Pre-proline 0 C--N 1.315 -0.927 0 C-N-CA 123.187 0.595 . . . . 0.0 110.522 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.54 -25.88 20.66 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.511 3.474 . . . . 0.0 113.629 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.518 ' H ' HG22 ' A' ' 53' ' ' ILE . 44.1 tptt -82.51 63.8 6.84 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.704 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.66 -109.4 0.7 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 117.926 1.931 . . . . 0.0 117.926 171.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.571 ' HB2' HD12 ' A' ' 18' ' ' LEU . . . 37.66 -86.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 126.847 2.059 . . . . 0.0 113.987 -169.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.896 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -80.47 -28.01 37.7 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.3 -0.25 . . . . 0.0 110.416 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -78.73 -43.91 24.66 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.6 p -73.56 -38.89 65.06 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.811 -174.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -73.04 -33.28 65.61 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.78 49.95 5.16 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 114.216 -1.356 . . . . 0.0 113.667 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -118.19 -68.67 0.9 Allowed 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 58' ' ' ALA . 63.6 mt -74.13 140.22 18.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.845 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -123.33 159.15 29.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 133.87 40.26 Favored 'General case' 0 N--CA 1.419 -2.024 0 C-N-CA 118.554 -1.258 . . . . 0.0 108.854 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.81 -16.9 12.15 Favored Glycine 0 N--CA 1.425 -2.095 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -72.9 140.65 47.64 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.26 0.553 . . . . 0.0 111.361 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -92.6 133.05 36.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.796 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.499 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 38.3 t -107.68 118.55 55.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt -94.85 -34.85 12.3 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.422 -176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.651 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -158.71 172.43 18.29 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.547 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.803 HG23 HD12 ' A' ' 78' ' ' LEU . 88.5 t -123.17 104.29 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 123.564 0.745 . . . . 0.0 109.197 176.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 t30 61.36 34.19 18.5 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 109.417 171.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.2 -24.1 33.05 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.565 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.37 107.43 14.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.518 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 2.8 p -66.9 133.35 49.85 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.607 0.718 . . . . 0.0 112.891 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.803 HD12 HG23 ' A' ' 73' ' ' VAL . 77.4 mt -100.63 30.3 4.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.927 0.87 . . . . 0.0 108.86 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.78 -27.1 49.25 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 125.675 1.59 . . . . 0.0 112.67 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -141.03 44.94 0.99 Allowed Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.39 156.66 18.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.239 0.542 . . . . 0.0 112.199 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.423 ' HA ' HG23 ' A' ' 31' ' ' VAL . 11.4 t -113.49 177.24 4.7 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 170.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -51.26 -54.81 22.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.807 1.243 . . . . 0.0 111.467 -174.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -57.41 -39.22 75.69 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.316 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -70.56 -45.31 65.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.88 -56.42 20.78 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.13 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.426 ' HA ' HD21 ' A' ' 90' ' ' LEU . 90.4 t -62.18 -32.85 55.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.151 -177.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.04 -34.69 78.65 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.3 m -70.6 -35.62 73.1 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.078 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.577 HD11 HD23 ' A' ' 99' ' ' LEU . 3.6 mm? -68.14 -24.21 64.97 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 121.709 -0.62 . . . . 0.0 111.171 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -79.44 -40.14 30.62 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.231 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -71.08 -38.19 72.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.908 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.1 p -64.84 -58.12 7.03 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 149.92 -150.47 22.54 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 118.906 -1.616 . . . . 0.0 114.989 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.434 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 52.9 tt0 -84.38 -55.77 3.98 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.794 0.838 . . . . 0.0 110.405 -176.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.4 t -93.61 101.48 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.585 HG23 HD13 ' A' ' 25' ' ' LEU . 2.1 m -100.83 134.0 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.877 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.57 -173.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.691 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 12.0 m170 -101.37 139.62 36.78 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.577 HD23 HD11 ' A' ' 90' ' ' LEU . 5.9 mp -130.25 143.73 50.95 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 172.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.504 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 61.0 tp -86.65 107.2 18.09 Favored 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.623 ' O ' ' HA ' ' A' ' 13' ' ' THR . 8.4 mp -112.05 155.41 23.86 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.063 0.459 . . . . 0.0 110.431 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 31.7 tt0 -130.79 107.62 9.28 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.718 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . 31.9 mmmt -47.7 138.04 8.74 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.67 -159.07 21.74 Favored Glycine 0 N--CA 1.413 -2.845 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.546 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 83.8 mm-40 -114.74 -172.07 2.05 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.4 m -108.91 88.94 5.93 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 105' ' ' GLN . 13.4 Cg_endo . . . . . 0 N--CA 1.436 -1.905 0 C-N-CA 123.285 2.656 . . . . 0.0 111.214 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HA ' ' HG3' ' A' ' 103' ' ' LYS . 20.4 Cg_endo -63.4 108.81 0.88 Allowed 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.451 2.101 . . . . 0.0 110.43 176.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.59 -11.18 7.12 Favored Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -79.8 129.37 34.43 Favored 'General case' 0 C--O 1.255 1.381 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 p -98.9 114.48 27.11 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 170.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -109.73 107.33 17.3 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 121.656 0.741 . . . . 0.0 111.846 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -65.78 115.83 6.33 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 170.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.4 p -110.8 137.29 43.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.509 -171.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -107.0 117.52 34.28 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.862 HD23 ' HA ' ' A' ' 58' ' ' ALA . 1.1 tm? -117.87 123.88 46.94 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 118.679 -1.208 . . . . 0.0 108.953 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.45 119.38 35.88 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.698 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -59.85 132.37 53.74 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.415 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 t -66.43 -58.0 6.2 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.283 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -170.2 -50.35 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.69 50.32 2.6 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.715 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.698 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 21.5 t 69.1 -160.15 0.18 Allowed 'General case' 0 C--O 1.254 1.322 0 C-N-CA 124.336 1.054 . . . . 0.0 110.711 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.561 ' HG ' ' HE2' ' A' ' 20' ' ' LYS . 86.5 mt -65.7 142.19 58.1 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.24 0.543 . . . . 0.0 110.946 -178.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 56' ' ' GLY . . . -92.42 33.07 5.13 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.33 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 pt -135.37 135.18 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.579 0 CA-C-O 121.303 0.573 . . . . 0.0 110.127 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.439 ' HB2' HD12 ' A' ' 53' ' ' ILE . 19.4 t -102.37 102.07 12.37 Favored 'General case' 0 C--N 1.259 -3.355 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.5 m -92.2 159.59 2.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -140.57 172.15 13.11 Favored 'General case' 0 N--CA 1.413 -2.279 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 p -113.24 136.91 48.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-O 121.065 0.46 . . . . 0.0 111.751 -175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.506 HD22 ' CD1' ' A' ' 48' ' ' TYR . 3.9 mm? -117.03 83.08 1.91 Allowed 'General case' 0 N--CA 1.422 -1.844 0 CA-C-O 122.473 1.13 . . . . 0.0 108.767 170.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.492 ' CD1' ' HA2' ' A' ' 80' ' ' GLY . 50.1 t80 -117.71 100.98 7.96 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.213 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.547 ' HB3' HG23 ' A' ' 38' ' ' VAL . 10.1 t70 -143.2 143.9 31.96 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -134.18 16.01 3.8 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.81 -35.53 0.31 Allowed Glycine 0 C--N 1.318 -0.459 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.169 -174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.29 -40.08 4.07 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.547 HG23 ' HB3' ' A' ' 34' ' ' ASP . 26.9 m -84.96 89.46 2.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 122.705 1.24 . . . . 0.0 110.768 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -115.32 -56.47 2.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.839 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.5 p -80.83 -35.53 32.77 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.252 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.48 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 13.5 m -87.7 105.93 17.7 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -89.79 134.42 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 C-N-CA 120.394 -0.523 . . . . 0.0 112.003 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.3 ptt85 -82.12 105.43 13.21 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.578 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 69' ' ' ARG . 65.2 m-70 -82.78 -18.19 41.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.364 0.602 . . . . 0.0 109.959 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.476 ' HA3' ' HG3' ' A' ' 69' ' ' ARG . . . -133.03 166.7 23.6 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.51 -40.87 1.83 Allowed Glycine 0 C--N 1.303 -1.286 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.952 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.587 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 49.1 mm -109.7 141.78 24.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.506 ' CD1' HD22 ' A' ' 32' ' ' LEU . 92.7 m-85 -136.17 148.77 48.32 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 66' ' ' LYS . 28.4 t -75.58 117.45 20.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -88.52 -34.15 17.51 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.85 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . . . -159.28 157.25 30.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.049 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.434 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 50.8 mm -105.94 120.59 57.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.445 ' CG2' ' HD3' ' A' ' 55' ' ' LYS . 51.7 mm -75.4 124.3 89.01 Favored Pre-proline 0 C--N 1.295 -1.783 0 C-N-CA 122.698 0.399 . . . . 0.0 110.823 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.0 -8.66 12.37 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 C-N-CA 124.149 3.233 . . . . 0.0 114.9 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HD3' ' CG2' ' A' ' 53' ' ' ILE . 1.1 mptm? -65.45 -28.42 69.21 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.459 ' O ' ' HA3' ' A' ' 26' ' ' GLY . . . 133.13 -147.43 18.98 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.172 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.731 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 75.98 -86.71 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 125.525 1.53 . . . . 0.0 110.916 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.862 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -78.67 -29.63 45.73 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.631 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.434 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 39.3 tt0 -78.85 -44.53 22.76 Favored 'General case' 0 N--CA 1.434 -1.264 0 O-C-N 124.673 1.233 . . . . 0.0 110.799 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.8 p -71.98 -40.53 68.53 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.968 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.63 -39.24 73.81 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.11 66.75 1.85 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.843 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.521 ' HG3' HG13 ' A' ' 64' ' ' ILE . 18.6 ptp180 -136.43 -39.19 0.66 Allowed 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.431 176.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.644 ' HB ' ' HB2' ' A' ' 58' ' ' ALA . 61.2 mt -101.52 141.22 18.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.4 ' HA ' HD13 ' A' ' 52' ' ' ILE . 21.2 p-80 -133.55 173.42 11.51 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.44 ' HD3' ' HA ' ' A' ' 51' ' ' ALA . 62.2 pttt -85.69 151.65 23.7 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.367 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.07 -20.2 43.94 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.477 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.949 ' HA ' ' HA3' ' A' ' 104' ' ' GLY 0.271 1.0 OUTLIER -78.7 152.93 31.31 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.7 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.476 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 41.9 ttm180 -92.5 134.21 35.19 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.921 -168.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.587 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 60.8 t -106.72 120.34 57.77 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.3 mt -96.79 -38.52 9.84 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.458 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.64 170.2 22.94 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.727 -175.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 87.0 t -129.27 120.35 51.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 63.96 27.64 14.36 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.354 1.074 . . . . 0.0 109.169 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.97 -7.16 60.3 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.606 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.91 113.6 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.9 m -64.68 131.0 45.71 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.683 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 86' ' ' ALA 0.42 0.3 OUTLIER -128.38 67.96 1.37 Allowed 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 122.875 1.321 . . . . 0.0 113.974 174.219 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -108.97 114.89 29.04 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.492 ' HA2' ' CD1' ' A' ' 33' ' ' PHE . . . 100.4 15.24 30.49 Favored Glycine 0 C--N 1.297 -1.589 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -174.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.89 -177.21 4.89 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.9 p -113.36 168.67 9.55 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -51.76 -50.79 59.98 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.8 -44.34 94.01 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.624 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.28 -41.57 80.8 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 118.314 0.506 . . . . 0.0 110.704 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.498 ' HA ' HD23 ' A' ' 78' ' ' LEU . . . -57.68 -56.55 20.46 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.975 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.99 -33.13 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.11 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -68.61 -33.65 74.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.921 178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.1 m -68.67 -33.3 73.75 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.642 HD21 HD21 ' A' ' 99' ' ' LEU . 92.9 mt -72.94 -17.23 61.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.833 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -91.87 -37.42 12.92 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -68.53 -27.48 66.13 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.53 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -46.91 65.68 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.86 -156.03 21.92 Favored Glycine 0 C--N 1.311 -0.834 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.08 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.498 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 34.8 tt0 -75.0 -48.11 25.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.934 0.367 . . . . 0.0 110.936 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.4 t -96.83 105.82 17.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 t -100.14 136.45 31.44 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -176.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -102.64 130.66 49.61 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.642 HD21 HD21 ' A' ' 90' ' ' LEU . 5.8 mp -126.98 154.85 44.05 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.1 tt -106.21 112.08 24.96 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.63 163.22 15.26 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.065 0.46 . . . . 0.0 111.972 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.546 ' HG2' ' HD3' ' A' ' 103' ' ' LYS . 30.2 tt0 -132.55 154.01 50.41 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.546 ' HD3' ' HG2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -50.6 121.83 6.33 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 121.802 0.81 . . . . 0.0 111.95 176.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.949 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -104.29 47.61 1.07 Allowed Glycine 0 C--N 1.298 -1.542 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.402 ' OE1' ' HB3' ' A' ' 10' ' ' PRO . 49.0 tt0 -66.31 -44.22 84.04 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.8 m -124.29 91.19 49.89 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo . . . . . 0 C--O 1.263 1.735 0 C-N-CA 123.137 2.558 . . . . 0.0 112.068 -175.835 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt . . . . . 0 N--CA 1.445 -0.695 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.4 73.64 2.73 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.294 1.996 . . . . 0.0 109.18 174.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.52 33.22 0.03 OUTLIER Glycine 0 C--N 1.287 -2.153 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -95.68 153.06 17.92 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.4 p -87.84 133.02 33.98 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.281 0.363 . . . . 0.0 111.475 -175.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.62 119.4 4.08 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.325 0.583 . . . . 0.0 111.8 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -72.21 120.21 17.49 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.103 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.551 HG23 HD13 ' A' ' 64' ' ' ILE . 33.5 m -96.39 133.64 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.098 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.95 104.75 16.39 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 170.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.855 HD22 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -112.24 117.77 33.45 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 119.313 -0.955 . . . . 0.0 108.696 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.74 114.25 25.87 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.54 ' HB3' ' HA ' ' A' ' 24' ' ' SER . 98.6 mttt -56.57 136.31 54.48 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 124.14 0.9 . . . . 0.0 112.398 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.523 HG22 ' HB2' ' A' ' 57' ' ' ALA . 61.2 p -91.71 -163.85 1.1 Allowed 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.84 -19.11 65.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.627 0.727 . . . . 0.0 109.106 174.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.596 ' HA3' ' HB2' ' A' ' 54' ' ' PRO . . . -104.5 19.21 42.84 Favored Glycine 0 N--CA 1.429 -1.832 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.59 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.588 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 73.8 m 72.4 -153.73 0.08 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.364 1.066 . . . . 0.0 111.054 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.705 HD22 ' HB3' ' A' ' 18' ' ' LEU . 89.5 mt -61.54 -24.55 66.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.726 ' HA2' ' HD2' ' A' ' 54' ' ' PRO . . . 86.82 -6.05 83.72 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.006 -1.093 . . . . 0.0 111.82 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.508 ' HB ' HG12 ' A' ' 49' ' ' VAL . 22.6 pt -109.51 136.08 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 C-N-CA 119.228 -0.989 . . . . 0.0 112.544 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.1 t -109.03 128.87 55.34 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.44 149.04 18.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 O-C-N 123.15 0.281 . . . . 0.0 111.037 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -130.83 161.21 32.29 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.68 HG13 HD13 ' A' ' 47' ' ' ILE . 31.2 m -106.15 127.49 61.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.685 -176.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.9 mt -103.13 164.94 11.32 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -127.96 132.19 49.23 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -79.69 158.94 26.85 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -116.25 18.87 15.14 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.972 0.891 . . . . 0.0 109.463 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.63 -61.17 4.6 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.38 160.97 19.03 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.445 ' HA ' HG11 ' A' ' 42' ' ' VAL . 5.2 p -107.36 -63.72 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 117.789 0.794 . . . . 0.0 112.373 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.55 ' O ' ' HB ' ' A' ' 40' ' ' THR . 26.2 t-20 63.39 -77.08 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.689 0.796 . . . . 0.0 109.458 -172.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 39' ' ' ASN . 5.8 t 165.84 -20.54 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.905 1.282 . . . . 0.0 109.581 176.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.2 m -80.46 33.25 0.3 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.177 0.591 . . . . 0.0 110.872 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 38' ' ' VAL . 13.0 p -136.43 148.29 27.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.747 -0.596 . . . . 0.0 110.775 -172.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -114.09 75.08 0.9 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -84.68 169.41 14.33 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.821 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.51 -138.91 9.83 Favored Glycine 0 N--CA 1.42 -2.425 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.183 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -161.05 -98.92 0.14 Allowed Glycine 0 CA--C 1.487 -1.685 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.872 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 48.7 mm -83.83 123.02 38.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -124.43 128.09 48.5 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.271 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.508 HG12 ' HB ' ' A' ' 27' ' ' ILE . 55.4 t -74.44 110.84 9.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -82.42 -35.93 27.13 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.291 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.44 161.04 35.46 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.97 HG21 ' HB2' ' A' ' 59' ' ' GLU . 16.2 mm -116.32 115.68 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.928 ' HB ' ' HD3' ' A' ' 54' ' ' PRO 0.301 2.1 mp -103.3 -89.38 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.673 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -170.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.928 ' HD3' ' HB ' ' A' ' 53' ' ' ILE . 8.5 Cg_endo -91.88 129.79 1.12 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.757 2.305 . . . . 0.0 115.352 -167.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 78.09 -63.62 0.31 Allowed 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 125.726 1.61 . . . . 0.0 110.901 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.08 -83.54 0.13 Allowed Glycine 0 N--CA 1.405 -3.41 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.751 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . 68.51 -83.11 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 125.652 1.581 . . . . 0.0 109.744 175.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.863 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -68.03 -38.3 82.37 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.97 ' HB2' HG21 ' A' ' 52' ' ' ILE . 39.3 tt0 -72.98 -43.94 61.65 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.986 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.6 p -76.88 -36.31 56.81 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.16 -34.12 70.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 174.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.47 43.85 11.89 Favored Glycine 0 N--CA 1.434 -1.489 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.18 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -110.83 -46.66 3.32 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.863 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 44.4 mt -104.42 127.01 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.465 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -125.57 157.84 36.12 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 136.3 51.3 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.451 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 112.12 -24.56 14.16 Favored Glycine 0 C--N 1.289 -2.058 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -171.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.752 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 78.2 m-20 -67.73 145.06 55.11 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.247 0.546 . . . . 0.0 111.745 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 70' ' ' VAL . 1.9 tmm_? -109.95 149.11 30.41 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.4 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.872 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.9 t -117.46 135.45 57.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.673 HD11 HD21 ' A' ' 100' ' ' LEU . 95.5 mt -98.24 -42.56 7.35 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.513 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.58 172.2 18.68 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.816 -172.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 1.053 HG11 HG22 ' A' ' 89' ' ' THR . 3.3 p -114.41 113.63 44.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.755 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 31.3 p30 39.4 42.37 0.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.36 1.464 . . . . 0.0 114.432 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.62 -15.01 62.6 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 120.567 -0.825 . . . . 0.0 114.592 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.531 ' HB ' HG12 ' A' ' 73' ' ' VAL . 46.9 t -92.8 110.07 22.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.5 m -67.62 127.22 31.92 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.727 HD11 HG13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.17 21.01 5.3 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.04 175.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -57.39 -27.34 62.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.118 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.51 23.77 21.62 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.726 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.97 157.55 16.74 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.9 t -83.7 170.93 13.71 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -49.96 -53.02 29.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.77 1.628 . . . . 0.0 110.787 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -63.33 -31.76 73.0 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.854 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -76.98 -39.18 51.43 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.259 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.676 ' HA ' HD22 ' A' ' 78' ' ' LEU . . . -52.09 -60.34 3.32 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.85 0.719 . . . . 0.0 109.896 173.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.14 -33.23 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.549 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.28 -34.72 79.01 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.271 0.558 . . . . 0.0 111.453 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 1.053 HG22 HG11 ' A' ' 73' ' ' VAL . 29.7 m -76.28 -33.95 59.1 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 62.5 mt -73.42 -20.07 60.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.609 0.719 . . . . 0.0 110.194 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -81.98 -40.52 22.05 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.593 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -69.78 -33.37 72.31 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.521 ' HG1' HG13 ' A' ' 97' ' ' VAL . 3.8 p -59.07 -63.07 1.44 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.24 -151.51 23.69 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.053 -1.07 . . . . 0.0 112.531 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -66.33 -45.33 80.63 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 124.071 0.512 . . . . 0.0 111.647 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.76 114.51 46.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.521 HG13 ' HG1' ' A' ' 93' ' ' THR . 6.0 t -107.44 136.54 42.32 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.755 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 54.2 m80 -104.14 131.77 51.08 Favored 'General case' 0 N--CA 1.4 -2.934 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.461 HD13 HD23 ' A' ' 90' ' ' LEU . 6.1 mp -127.09 156.71 41.28 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 173.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.673 HD21 HD11 ' A' ' 71' ' ' LEU . 1.8 tt -108.42 114.09 27.67 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.1 mp -109.21 165.47 11.59 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.933 0.873 . . . . 0.0 112.799 -175.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -130.27 108.99 10.43 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 102.418 -3.178 . . . . 0.0 102.418 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 38.8 tptt -44.31 129.31 6.4 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 123.962 0.789 . . . . 0.0 110.667 -174.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.752 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -77.52 175.53 54.18 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 -169.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -148.28 145.58 28.24 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 18.1 m -107.42 104.96 54.64 Favored Pre-proline 0 N--CA 1.421 -1.875 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 1.1 Cg_endo . . . . . 0 C--O 1.258 1.515 0 C-N-CA 122.841 2.36 . . . . 0.0 111.913 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.481 ' H1 ' ' HD3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.435 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 16.9 Cg_exo -71.28 45.77 0.67 Allowed 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 124.214 3.276 . . . . 0.0 113.363 -176.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.74 17.98 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.569 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 10.1 t70 -80.16 134.78 36.18 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.1 116.01 31.12 Favored 'General case' 0 C--N 1.285 -2.238 0 O-C-N 123.445 0.466 . . . . 0.0 110.386 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CE2' HG23 ' A' ' 16' ' ' VAL . 29.8 p90 -158.47 157.77 32.82 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.599 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 43.0 mt-10 -86.59 106.52 17.62 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.448 HG23 ' CE2' ' A' ' 14' ' ' PHE . 32.0 t -69.52 134.4 30.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.286 177.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -104.64 100.8 10.45 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.923 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -109.08 118.6 37.18 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.95 125.01 40.21 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.86 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -63.05 131.99 50.46 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.049 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 t -59.57 -50.72 72.79 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.339 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 177.15 -24.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.73 71.99 0.46 Allowed Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.168 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.86 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 21.1 t 68.0 -166.29 0.2 Allowed 'General case' 0 C--O 1.251 1.138 0 C-N-CA 125.099 1.36 . . . . 0.0 111.647 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 18' ' ' LEU . 96.2 mt -80.05 163.8 23.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.403 0.62 . . . . 0.0 110.518 -176.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.91 30.94 9.26 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -137.97 162.32 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.298 0 CA-C-O 121.624 0.726 . . . . 0.0 110.785 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 m -140.17 136.73 33.77 Favored 'General case' 0 N--CA 1.394 -3.269 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.877 172.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -109.77 -165.74 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.741 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.156 -176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.578 ' HA ' ' ND1' ' A' ' 83' ' ' HIS . 14.1 t -165.91 167.64 16.54 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 171.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 81' ' ' ALA . 13.5 p -117.24 137.05 52.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.18 121.22 41.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -89.98 -160.08 0.66 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.109 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -59.33 -36.51 75.82 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.094 0.473 . . . . 0.0 111.497 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -92.74 110.58 22.02 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.66 -46.26 70.0 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.788 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.3 -60.18 4.84 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -99.27 24.4 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 123.564 0.746 . . . . 0.0 109.193 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 78.69 129.82 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.781 1.632 . . . . 0.0 109.379 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 t -94.24 140.76 29.36 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.015 0.912 . . . . 0.0 112.31 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.1 m -128.2 22.08 6.16 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 172.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.0 77.16 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.018 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -92.33 -24.22 19.0 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -166.57 143.88 5.02 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.62 97.69 0.51 Allowed Glycine 0 C--N 1.306 -1.102 0 C-N-CA 120.31 -0.947 . . . . 0.0 111.58 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.31 -13.18 42.81 Favored Glycine 0 CA--C 1.501 -0.824 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.832 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.732 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.8 mm -100.33 126.48 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.54 ' HE1' ' HA2' ' A' ' 67' ' ' GLY . 1.5 t80 -120.11 114.31 21.78 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.393 -172.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.1 t -56.46 108.06 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -86.59 -36.31 18.93 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.117 -1.402 . . . . 0.0 110.697 -172.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.711 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -155.69 154.79 32.06 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.397 -174.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 65' ' ' HIS . 47.5 mm -109.12 114.35 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.681 HG22 ' HB2' ' A' ' 55' ' ' LYS . 1.7 mp -84.81 146.18 45.68 Favored Pre-proline 0 C--N 1.283 -2.302 0 C-N-CA 124.006 0.922 . . . . 0.0 112.059 -172.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . 0.261 16.4 Cg_exo -52.67 52.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.512 2.599 1 C-N-CA 126.456 4.77 . . . . 0.0 113.768 172.92 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.681 ' HB2' HG22 ' A' ' 53' ' ' ILE . 38.1 tptt -137.69 1.16 2.31 Favored 'General case' 0 N--CA 1.388 -3.528 0 O-C-N 121.764 -0.585 . . . . 0.0 109.594 -171.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.69 -136.75 24.85 Favored Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.163 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.71 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . 67.73 -90.5 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.094 0.958 . . . . 0.0 111.096 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.923 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -71.3 -34.37 70.56 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.479 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 40.5 tt0 -72.19 -42.79 65.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 124.325 1.015 . . . . 0.0 110.525 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -70.11 -50.03 44.85 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.348 -175.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.7 -20.91 61.85 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.138 0.494 . . . . 0.0 110.182 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.89 43.8 97.02 Favored Glycine 0 CA--C 1.502 -0.742 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.006 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -105.06 -41.67 5.52 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.571 ' HB ' ' HB3' ' A' ' 58' ' ' ALA . 56.4 mt -115.64 136.34 52.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.665 ' HD2' HG22 ' A' ' 106' ' ' VAL . 63.4 t60 -138.41 172.09 13.41 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 55.0 mtmt -58.96 116.13 3.59 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.48 0.712 . . . . 0.0 110.552 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.54 ' HA2' ' HE1' ' A' ' 48' ' ' TYR . . . 116.26 -11.88 16.79 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 119.611 -1.281 . . . . 0.0 112.957 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.701 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 5.9 m-20 -64.57 137.42 57.84 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.751 0.786 . . . . 0.0 112.652 176.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -93.44 122.96 36.4 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.315 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.732 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 61.3 t -100.47 119.61 48.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.0 mt -97.83 -43.99 6.9 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.548 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . . . -154.96 172.07 18.68 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -173.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.881 HG23 HD23 ' A' ' 78' ' ' LEU . 39.5 t -121.06 114.05 41.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 172.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.2 p30 48.27 29.91 2.07 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.287 1.435 . . . . 0.0 112.9 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.58 -30.03 8.89 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.912 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.0 t -80.27 113.8 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 117.819 0.809 . . . . 0.0 109.821 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 12.9 p -74.98 131.46 40.67 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.881 HD23 HG23 ' A' ' 73' ' ' VAL . 1.9 mm? -85.27 9.46 15.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.349 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.59 106.5 5.39 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.25 2.74 24.65 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.512 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -106.52 155.21 19.84 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.9 t -91.78 172.28 8.58 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.578 ' ND1' ' HA ' ' A' ' 30' ' ' THR . 4.2 t60 -50.46 -50.01 53.59 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.26 1.024 . . . . 0.0 109.577 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.568 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 78.2 tttt -50.73 -50.32 55.75 Favored 'General case' 0 C--O 1.204 -1.328 0 O-C-N 124.476 1.11 . . . . 0.0 111.017 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -70.73 -34.9 72.37 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -172.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.586 ' HA ' HD13 ' A' ' 78' ' ' LEU . . . -56.72 -53.95 51.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.611 0.72 . . . . 0.0 109.385 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.519 ' HA ' HD12 ' A' ' 90' ' ' LEU . 97.9 t -65.94 -31.77 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.779 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 19.1 mm-40 -65.81 -31.26 72.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.046 0.451 . . . . 0.0 109.986 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.416 HG23 HG12 ' A' ' 73' ' ' VAL . 24.2 m -78.42 -30.66 47.76 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 87' ' ' VAL . 91.0 mt -71.23 -24.9 62.28 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.18 0.991 . . . . 0.0 109.45 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -86.03 -27.73 24.59 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.821 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -77.52 -34.37 54.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.405 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -58.5 -74.85 0.06 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.1 -131.83 4.1 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 119.714 -1.231 . . . . 0.0 112.658 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -73.35 -48.47 34.0 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.645 0.778 . . . . 0.0 112.151 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.64 128.74 75.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.453 0.644 . . . . 0.0 109.741 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.3 t -103.54 122.89 56.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.497 -175.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -94.28 111.57 23.31 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 172.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.645 HD13 ' HA ' ' A' ' 73' ' ' VAL . 8.5 tp -118.63 127.01 53.18 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.616 ' HB3' ' HB2' ' A' ' 72' ' ' ALA . 2.9 tt -85.87 111.6 20.36 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.651 HD23 ' HB3' ' A' ' 68' ' ' ASP . 11.1 mp -120.43 174.59 6.45 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 122.121 0.962 . . . . 0.0 111.578 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 36.1 tt0 -128.53 125.73 38.92 Favored 'General case' 0 N--CA 1.393 -3.318 0 N-CA-C 101.863 -3.384 . . . . 0.0 101.863 169.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.448 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 18.5 tptp -52.4 131.62 33.62 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 124.096 0.873 . . . . 0.0 111.191 -173.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.701 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -76.47 -172.0 34.16 Favored Glycine 0 N--CA 1.416 -2.666 0 N-CA-C 115.987 1.155 . . . . 0.0 115.987 -175.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -65.41 -38.0 88.63 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.437 -1.381 . . . . 0.0 114.287 -173.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.665 HG22 ' HD2' ' A' ' 65' ' ' HIS . 30.6 m -126.55 135.09 26.74 Favored Pre-proline 0 C--N 1.307 -1.243 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.646 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.2 Cg_endo . . . . . 0 C--O 1.253 1.266 0 C-N-CA 123.468 2.778 . . . . 0.0 111.097 177.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.654 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 69.5 mmtt . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.654 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 59.6 Cg_endo -73.07 102.61 1.48 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 121.855 1.703 . . . . 0.0 114.548 -162.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.608 ' H ' ' HB3' ' A' ' 103' ' ' LYS . . . 80.88 13.5 81.18 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.27 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.591 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 4.2 t70 -90.28 143.71 26.51 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 16.9 p -101.65 112.18 24.66 Favored 'General case' 0 N--CA 1.426 -1.636 0 O-C-N 123.738 0.648 . . . . 0.0 111.914 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -138.96 172.21 13.18 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.328 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 2.1 mp0 -104.61 117.87 35.19 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.4 m -87.95 117.55 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.318 0 CA-C-O 121.179 0.514 . . . . 0.0 110.358 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.793 ' HG2' ' HD2' ' A' ' 98' ' ' HIS . 42.4 mt-10 -86.76 98.65 11.28 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.522 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.653 HD11 ' HA ' ' A' ' 58' ' ' ALA . 3.5 mm? -111.13 120.54 42.65 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.662 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.21 140.74 29.19 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.514 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -68.04 90.82 0.33 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.27 0.557 . . . . 0.0 111.256 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.8 t -58.21 -31.23 67.13 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.069 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -162.78 -68.21 0.05 OUTLIER 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.152 0.501 . . . . 0.0 110.325 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.54 86.04 0.33 Allowed Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.5 t 79.01 -159.12 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.77 1.228 . . . . 0.0 109.572 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.577 HD23 ' CB ' ' A' ' 18' ' ' LEU . 63.8 mt -87.44 -4.26 59.01 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.045 0.45 . . . . 0.0 111.567 -174.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.92 13.24 78.14 Favored Glycine 0 N--CA 1.419 -2.481 0 C-N-CA 119.859 -1.163 . . . . 0.0 110.689 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.516 ' HB ' HG11 ' A' ' 49' ' ' VAL . 20.1 pt -119.99 130.44 74.24 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.666 0 CA-C-O 122.193 0.996 . . . . 0.0 112.584 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.421 ' OG ' HD13 ' A' ' 53' ' ' ILE . 45.0 m -96.09 110.76 22.96 Favored 'General case' 0 C--N 1.262 -3.233 0 CA-C-N 113.775 -1.557 . . . . 0.0 107.536 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.42 153.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.982 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.603 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 7.9 t -137.78 157.85 45.59 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.78 127.5 52.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.696 HD12 ' HB2' ' A' ' 48' ' ' TYR . 9.8 mp -105.84 92.7 4.28 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 122.142 0.972 . . . . 0.0 109.806 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -100.57 -28.59 12.8 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.097 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -165.28 -41.78 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.205 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -95.95 142.84 27.7 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.155 -174.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 134.58 -17.0 4.26 Favored Glycine 0 CA--C 1.498 -0.994 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.36 -160.37 32.49 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 105.618 -2.993 . . . . 0.0 105.618 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.3 74.35 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 118.907 1.354 . . . . 0.0 109.047 173.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -116.94 42.55 2.48 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.357 -172.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.9 m -72.75 -33.9 66.66 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.9 p -79.48 147.28 32.3 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 171.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -148.8 85.12 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -167.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.84 69.7 6.48 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.1 0.476 . . . . 0.0 109.745 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.7 m80 69.39 162.65 0.23 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.902 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.529 ' HA3' ' HG3' ' A' ' 69' ' ' ARG . . . 88.39 76.05 1.29 Allowed Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.46 -36.69 54.37 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 47.9 mm -110.11 139.81 31.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.309 -0.445 . . . . 0.0 109.997 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.696 ' HB2' HD12 ' A' ' 32' ' ' LEU . 8.9 m-85 -129.53 148.33 51.42 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.634 HG23 HG21 ' A' ' 64' ' ' ILE . 49.1 t -81.6 116.61 26.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 175.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HB2' HG22 ' A' ' 30' ' ' THR . 61.5 tttp -79.15 -38.7 35.37 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.642 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.72 158.45 28.71 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.328 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.834 HG21 ' HB2' ' A' ' 59' ' ' GLU . 32.9 mm -109.07 121.79 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.454 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 48.4 mm -76.31 131.32 75.27 Favored Pre-proline 0 C--N 1.293 -1.872 0 C-N-CA 123.265 0.626 . . . . 0.0 110.698 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 24.6 Cg_exo -67.66 63.53 0.85 Allowed 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 124.067 3.178 . . . . 0.0 113.059 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -130.25 -55.76 1.1 Allowed 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.563 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 166.26 -160.74 34.35 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . 0.252 . . 71.26 -95.97 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 125.324 1.45 . . . . 0.0 113.114 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.653 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -61.33 -40.62 94.88 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.834 ' HB2' HG21 ' A' ' 52' ' ' ILE . 31.2 tt0 -86.32 -33.9 20.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.144 0.497 . . . . 0.0 110.559 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.563 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 29.5 m -74.72 -39.25 62.02 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.403 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.47 -32.32 48.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.97 64.25 1.81 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.874 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -121.65 -60.94 1.56 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.812 0.815 . . . . 0.0 108.926 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.634 HG21 HG23 ' A' ' 49' ' ' VAL . 34.7 mt -96.27 146.76 6.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.715 -174.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -136.58 -170.34 2.66 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -80.82 139.39 36.02 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.131 -1.027 . . . . 0.0 110.623 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.5 -10.31 61.08 Favored Glycine 0 N--CA 1.429 -1.828 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.957 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 30.9 m-20 -64.45 141.91 58.61 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 117.625 0.712 . . . . 0.0 112.271 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.529 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 40.5 ttm180 -92.41 121.86 34.29 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.239 -173.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.583 HG23 HD11 ' A' ' 101' ' ' LEU . 49.6 t -100.09 111.63 30.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.4 mt -91.72 -41.49 10.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.749 ' HB1' ' HB3' ' A' ' 100' ' ' LEU . . . -152.25 168.72 24.46 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.376 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.82 HG23 HD21 ' A' ' 78' ' ' LEU . 93.8 t -124.14 104.42 13.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 173.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.442 ' HB3' ' HB2' ' A' ' 98' ' ' HIS 0.311 1.8 p-10 47.12 45.86 16.1 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 122.219 1.009 . . . . 0.0 113.711 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.1 -16.92 60.09 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.205 -1.361 . . . . 0.0 114.269 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.1 t -90.97 108.49 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 118.016 0.908 . . . . 0.0 108.78 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 5.0 p -78.28 137.24 37.99 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -174.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.82 HD21 HG23 ' A' ' 73' ' ' VAL . 2.2 mm? -93.09 97.51 10.73 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -110.52 -46.03 3.45 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.288 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.14 45.12 1.11 Allowed Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' A' ' 85' ' ' GLN . . . -95.55 -178.15 4.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.374 -0.413 . . . . 0.0 110.686 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.487 ' OG1' ' HG3' ' A' ' 85' ' ' GLN . 68.3 p -115.99 168.3 10.2 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 174.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.603 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 16.5 p-80 -53.58 -40.95 66.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.428 0.632 . . . . 0.0 110.192 173.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.04 -42.13 89.97 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.918 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.574 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 49.1 mt-30 -66.41 -32.47 73.87 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.507 0.594 . . . . 0.0 110.387 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.504 ' HB1' HG13 ' A' ' 47' ' ' ILE . . . -59.88 -50.46 73.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.494 0.664 . . . . 0.0 109.428 174.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.63 -30.55 50.56 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.098 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.57 -36.8 85.39 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.06 0.457 . . . . 0.0 110.22 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.1 m -69.62 -33.46 72.69 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.705 HD23 HD23 ' A' ' 99' ' ' LEU . 90.2 mt -76.54 -23.58 53.63 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.344 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -82.05 -30.99 31.1 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -62.0 -43.85 97.98 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.721 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.483 HG21 HG12 ' A' ' 97' ' ' VAL . 34.9 p -70.64 154.21 42.08 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.67 176.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.46 -114.29 0.78 Allowed Glycine 0 N--CA 1.422 -2.258 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.756 -173.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -86.54 -39.82 15.84 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.851 -0.674 . . . . 0.0 110.961 -172.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.23 127.65 75.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.514 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 4.0 t -114.74 152.31 16.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.793 ' HD2' ' HG2' ' A' ' 17' ' ' GLU . 29.5 m80 -123.93 71.47 1.11 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.705 HD23 HD23 ' A' ' 90' ' ' LEU . 4.8 mp -65.15 144.07 57.45 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.999 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.749 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 2.9 tm? -93.03 107.98 19.65 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -177.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.583 HD11 HG23 ' A' ' 70' ' ' VAL . 2.7 mp -122.6 147.84 45.94 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.872 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 35.3 tt0 -118.16 127.5 53.82 Favored 'General case' 0 N--CA 1.397 -3.086 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 172.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.608 ' HB3' ' H ' ' A' ' 11' ' ' GLY . 5.5 tmtm? -54.29 114.36 1.61 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.092 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -87.96 86.03 1.5 Allowed Glycine 0 N--CA 1.426 -1.99 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.338 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -49.89 -62.48 1.54 Allowed 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.303 0.641 . . . . 0.0 110.342 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.9 t 63.47 125.96 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.187 0.995 . . . . 0.0 112.51 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.45 -1.052 0 C-N-CA 122.487 2.125 . . . . 0.0 109.943 174.663 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.473 ' C ' ' H ' ' A' ' 11' ' ' GLY . 51.1 mtpt . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.694 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 32.8 Cg_exo -68.91 42.48 0.29 Allowed 'Trans proline' 0 CA--C 1.56 1.814 0 C-N-CA 123.156 2.571 . . . . 0.0 111.789 172.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 9' ' ' LYS . . . -169.8 32.51 0.16 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 37.6 t70 -90.53 143.67 26.52 Favored 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 122.766 -0.256 . . . . 0.0 111.246 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p -93.35 124.42 37.32 Favored 'General case' 0 N--CA 1.425 -1.722 0 O-C-N 124.079 0.862 . . . . 0.0 110.143 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.417 ' CE1' ' HD2' ' A' ' 63' ' ' ARG . 46.9 p90 -140.79 152.17 44.98 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.203 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.425 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 52.4 mt-10 -110.95 90.96 3.48 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.618 HG11 HD13 ' A' ' 64' ' ' ILE . 6.5 p -71.07 136.57 25.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.827 -175.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -96.13 93.58 7.03 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.875 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -97.56 116.85 30.56 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.309 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.63 131.37 44.26 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.9 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 22' ' ' ASP . 1.6 mptm? -66.8 124.25 22.4 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.081 172.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 t -113.75 10.57 17.88 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 34.1 t70 -155.47 -152.67 0.4 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' H ' ' CG ' ' A' ' 22' ' ' ASP . . . -104.81 15.54 48.43 Favored Glycine 0 C--N 1.296 -1.639 0 CA-C-N 119.83 1.196 . . . . 0.0 110.302 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -142.64 165.76 26.52 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.616 HD23 ' HB3' ' A' ' 18' ' ' LEU . 92.4 mt -85.7 173.74 9.88 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 170.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.83 32.66 5.46 Favored Glycine 0 C--N 1.289 -2.052 0 C-N-CA 120.024 -1.084 . . . . 0.0 111.141 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.726 HG23 HG21 ' A' ' 64' ' ' ILE . 15.0 pt -139.47 143.4 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-O 121.35 0.595 . . . . 0.0 111.905 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.405 ' HB2' HD11 ' A' ' 53' ' ' ILE . 32.9 t -103.01 128.3 49.9 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.402 HG12 ' HA ' ' A' ' 49' ' ' VAL . 26.9 m -125.08 151.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-O 120.872 0.368 . . . . 0.0 110.691 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.409 ' HA ' ' CB ' ' A' ' 83' ' ' HIS . 11.7 t -133.25 173.53 11.35 Favored 'General case' 0 N--CA 1.392 -3.359 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.563 HG13 ' HG ' ' A' ' 32' ' ' LEU . 10.0 p -86.28 -48.14 15.99 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.302 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -171.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.563 ' HG ' HG13 ' A' ' 31' ' ' VAL . 1.4 pp -120.11 147.51 44.77 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -146.36 99.81 3.28 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 125.544 1.537 . . . . 0.0 107.177 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -119.55 108.27 14.3 Favored 'General case' 0 C--N 1.294 -1.804 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.646 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -112.35 31.65 6.14 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -99.05 -39.39 3.55 Favored Glycine 0 N--CA 1.424 -2.144 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.595 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.81 -88.42 0.46 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.6 -43.73 77.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -93.6 143.81 25.96 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.4 p -94.71 139.63 30.98 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-O 121.061 0.458 . . . . 0.0 111.905 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 m -79.04 104.64 9.82 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 171.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.35 -176.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -171.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.562 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 30.2 ttm180 -70.65 87.38 0.67 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.909 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.411 ' HB3' ' NH2' ' A' ' 69' ' ' ARG . 9.8 t60 -136.49 94.21 2.98 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.957 ' HA2' ' HA ' ' A' ' 71' ' ' LEU . . . 107.07 -96.07 1.06 Allowed Glycine 0 N--CA 1.412 -2.961 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.95 -37.69 2.01 Favored Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.524 HG13 ' HB3' ' A' ' 86' ' ' ALA . 46.5 mm -123.72 149.29 27.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CE2' ' HG2' ' A' ' 69' ' ' ARG . 79.1 m-85 -130.22 139.35 50.81 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 122.036 -0.415 . . . . 0.0 111.089 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.402 ' HA ' HG12 ' A' ' 29' ' ' VAL . 58.2 t -72.39 110.8 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -78.38 -39.8 38.04 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.018 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.69 170.44 14.1 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 -174.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.6 mm -102.65 115.47 44.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.405 HD11 ' HB2' ' A' ' 28' ' ' SER . 33.6 mm -75.25 124.8 89.4 Favored Pre-proline 0 C--N 1.31 -1.15 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -74.48 77.49 2.92 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 122.802 2.334 . . . . 0.0 112.479 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 55' ' ' LYS . 50.5 mmtt -136.18 12.71 3.31 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.78 173.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.12 -139.6 19.24 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.731 ' HB3' HD11 ' A' ' 18' ' ' LEU . . . 67.51 -93.53 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 123.674 0.789 . . . . 0.0 112.0 173.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.875 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -75.1 -32.27 61.38 Favored 'General case' 0 C--O 1.256 1.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.21 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.49 -39.21 65.03 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 125.191 1.557 . . . . 0.0 110.003 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -73.75 -41.29 62.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.73 -31.13 69.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.37 34.37 79.69 Favored Glycine 0 CA--C 1.49 -1.517 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.707 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.457 ' HG2' ' CG2' ' A' ' 16' ' ' VAL . 15.8 tpp180 -101.23 -37.86 8.35 Favored 'General case' 1 N--CA 1.362 -4.837 0 CA-C-O 121.091 0.472 . . . . 0.0 110.876 -174.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.726 HG21 HG23 ' A' ' 27' ' ' ILE . 22.8 mm -96.29 138.12 22.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.011 -173.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -124.48 161.7 25.52 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -76.4 137.23 39.62 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.861 -1.136 . . . . 0.0 109.885 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.15 -10.61 47.63 Favored Glycine 0 N--CA 1.425 -2.1 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.469 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -68.15 143.39 55.41 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.442 0.639 . . . . 0.0 111.176 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.414 ' HG2' ' CE2' ' A' ' 48' ' ' TYR . 43.4 mtp180 -95.07 125.97 40.09 Favored 'General case' 0 CA--C 1.469 -2.147 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.347 -174.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.512 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 44.4 t -94.22 106.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.832 0 CA-C-N 114.077 -1.42 . . . . 0.0 107.477 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.957 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 56.2 mt -84.44 -35.86 22.74 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.74 -175.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 76' ' ' VAL . . . -166.8 170.81 12.0 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.836 ' HA ' HD13 ' A' ' 99' ' ' LEU . 49.0 t -111.56 103.16 15.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 174.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.971 ' HB3' ' HB2' ' A' ' 98' ' ' HIS 0.283 1.1 p-10 39.43 70.58 0.21 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -178.226 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.61 -32.19 2.91 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.098 -0.956 . . . . 0.0 114.645 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.441 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 60.3 t -81.39 108.38 14.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 118.008 0.904 . . . . 0.0 109.582 -176.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.7 p -63.28 139.18 58.74 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.603 HD13 HG22 ' A' ' 73' ' ' VAL . 71.9 mt -104.03 27.62 7.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.923 0.868 . . . . 0.0 109.158 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.562 ' HB2' ' HD3' ' A' ' 43' ' ' ARG . 9.3 pt-20 -49.63 -33.38 15.22 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.027 1.731 . . . . 0.0 113.081 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.78 46.15 1.07 Allowed Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.48 ' HB1' ' CG ' ' A' ' 85' ' ' GLN . . . -106.26 154.85 20.15 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.56 0.219 . . . . 0.0 111.155 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.405 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.2 t -100.71 160.52 14.29 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 168.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.5 ' N ' ' HB ' ' A' ' 31' ' ' VAL . 39.0 p-80 -51.23 -48.33 62.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 18.8 ptmt -67.46 -30.28 69.95 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.48 ' CG ' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -73.97 -36.65 64.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.457 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.537 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.6 -46.61 83.85 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.71 -32.73 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.684 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 41.8 mt-10 -73.28 -26.46 61.1 Favored 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.198 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.434 HG23 HG13 ' A' ' 73' ' ' VAL . 47.4 m -74.19 -26.88 60.53 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.611 HD22 HG13 ' A' ' 97' ' ' VAL . 68.3 mt -74.93 -26.33 59.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -84.25 -28.77 26.98 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.11 -35.26 79.37 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.163 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.7 p -72.06 -66.33 0.66 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.392 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.38 -136.73 7.39 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.435 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.406 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 29.4 tt0 -69.9 -51.38 33.62 Favored 'General case' 0 C--O 1.211 -0.966 0 O-C-N 124.167 0.569 . . . . 0.0 111.117 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.0 125.46 66.08 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 117.863 -1.535 . . . . 0.0 111.348 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.611 HG13 HD22 ' A' ' 90' ' ' LEU . 35.4 t -113.18 126.19 70.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.4 -177.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.971 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 11.2 m170 -89.99 125.5 35.41 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 171.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.836 HD13 ' HA ' ' A' ' 73' ' ' VAL . 8.3 tp -123.77 136.28 54.32 Favored 'General case' 0 C--N 1.259 -3.339 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.614 HD21 HD11 ' A' ' 71' ' ' LEU . 1.3 tt -93.8 113.48 25.54 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.718 HD11 HD21 ' A' ' 99' ' ' LEU . 7.2 mp -125.25 165.78 17.68 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.341 0.591 . . . . 0.0 111.884 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 37.0 tt0 -130.99 134.06 46.35 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 54.4 mmtt -56.2 125.38 21.51 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.631 0.729 . . . . 0.0 112.823 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -113.26 67.91 0.24 Allowed Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.694 ' HB2' ' HB3' ' A' ' 10' ' ' PRO . 85.2 mt-30 -111.85 -150.03 0.46 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 122.89 -0.182 . . . . 0.0 110.658 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.7 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 49.6 t -88.89 -65.05 0.19 Allowed Pre-proline 0 CA--C 1.562 1.442 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -172.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.7 ' HD3' ' HB ' ' A' ' 106' ' ' VAL . 5.9 Cg_endo . . . . . 0 C--O 1.255 1.353 0 C-N-CA 122.269 1.979 . . . . 0.0 112.294 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp . . . . . 0 N--CA 1.434 -1.238 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.832 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 32.4 Cg_exo -62.67 135.76 54.42 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 N-CA-C 107.778 -1.662 . . . . 0.0 107.778 170.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.73 -1.63 52.52 Favored Glycine 0 N--CA 1.426 -2.011 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.051 -171.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -100.11 149.63 23.32 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-N 117.443 0.622 . . . . 0.0 111.242 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 7.9 p -89.0 145.96 25.17 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.176 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -143.75 136.29 27.09 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -97.26 110.71 23.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 33.9 t -89.56 119.56 36.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.08 -172.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -101.62 88.6 3.46 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 169.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.785 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -93.22 117.0 29.56 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -174.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.54 116.77 29.17 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -62.9 139.06 58.71 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.981 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.567 HG22 ' HG3' ' A' ' 55' ' ' LYS . 1.8 m -67.34 -68.85 0.35 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.011 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -103.64 -79.21 0.54 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.44 16.49 2.27 Favored Glycine 0 C--N 1.3 -1.464 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m -117.78 144.11 45.64 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.453 -174.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.422 HD12 HD13 ' A' ' 90' ' ' LEU . 90.4 mt -86.14 175.69 8.38 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.497 ' HA3' ' H ' ' A' ' 58' ' ' ALA . . . -108.69 32.86 6.59 Favored Glycine 0 C--N 1.291 -1.93 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.145 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.6 pt -137.13 138.37 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.77 0 CA-C-O 121.222 0.534 . . . . 0.0 111.721 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.8 t -111.7 109.34 19.16 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 176.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 34.6 m -100.12 168.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.549 -174.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -147.8 169.01 20.69 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 171.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 82' ' ' THR . 11.1 p -121.25 147.08 25.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.618 HD12 ' CD1' ' A' ' 48' ' ' TYR . 9.5 mp -91.47 92.94 8.76 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.582 1.182 . . . . 0.0 109.197 172.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -124.41 -50.42 1.77 Allowed 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 112.88 -1.964 . . . . 0.0 108.173 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.88 -38.57 32.36 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.825 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -102.34 150.2 23.57 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.59 -171.61 34.22 Favored Glycine 0 C--N 1.293 -1.85 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.2 -67.27 1.03 Allowed Glycine 0 C--N 1.3 -1.427 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 p -85.51 -43.7 16.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -64.19 -46.78 82.47 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -162.08 126.47 3.25 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.9 m -65.72 -54.2 30.53 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.032 0.444 . . . . 0.0 110.311 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.0 m -92.7 163.51 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.168 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.649 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 84.0 mtt180 -83.19 83.36 7.88 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.468 ' O ' ' HD3' ' A' ' 69' ' ' ARG . 12.1 t-80 -71.25 108.1 4.57 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 71' ' ' LEU . . . 87.13 -56.94 4.59 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -172.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.649 ' HA2' ' HB3' ' A' ' 43' ' ' ARG . . . 105.31 -49.59 0.89 Allowed Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.203 -0.499 . . . . 0.0 112.407 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.767 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 48.1 mm -105.25 140.29 23.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.618 ' CD1' HD12 ' A' ' 32' ' ' LEU . 81.1 m-85 -135.33 112.71 10.59 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.674 HG21 HG22 ' A' ' 64' ' ' ILE . 59.9 t -46.33 120.14 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.587 0.708 . . . . 0.0 111.278 172.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -91.18 -34.6 14.95 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.491 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.69 158.2 39.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.203 -176.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.0 mm -108.68 118.59 56.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 49.1 mm -87.84 134.29 35.76 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.518 ' HB2' ' H ' ' A' ' 55' ' ' LYS . 16.0 Cg_exo -69.19 -102.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 121.763 1.642 . . . . 0.0 111.836 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.567 ' HG3' HG22 ' A' ' 21' ' ' THR . 16.1 tppt? 67.86 -59.48 0.42 Allowed 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 125.719 1.608 . . . . 0.0 110.885 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.84 48.24 0.03 OUTLIER Glycine 0 N--CA 1.424 -2.127 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.775 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -135.59 -98.39 0.23 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.785 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -69.22 -33.59 73.53 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 118.171 0.441 . . . . 0.0 111.324 -174.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -70.42 -45.57 65.63 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 124.172 0.92 . . . . 0.0 109.193 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 t -72.5 -44.35 62.35 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.483 -174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -74.87 -19.21 60.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.898 0.856 . . . . 0.0 108.94 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.72 67.8 2.02 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.491 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.531 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -119.92 -67.54 0.97 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.097 0.475 . . . . 0.0 110.734 -179.158 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.674 HG22 HG21 ' A' ' 49' ' ' VAL . 63.7 mt -85.5 139.63 17.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.41 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -124.77 178.45 5.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -71.25 129.6 39.29 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.765 0.317 . . . . 0.0 110.697 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.55 -15.49 53.18 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.934 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 103' ' ' LYS . 75.9 m-20 -64.54 138.01 58.17 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 121.658 0.742 . . . . 0.0 112.033 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' A' ' 44' ' ' HIS . 36.3 ttm180 -90.41 129.38 36.61 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 114.603 -1.181 . . . . 0.0 110.376 -173.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.767 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.2 t -97.01 104.35 15.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.57 HD12 HD23 ' A' ' 100' ' ' LEU . 93.7 mt -78.09 -39.56 41.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.094 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 77' ' ' SER . . . -159.11 166.74 30.89 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.956 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.891 HG21 HD21 ' A' ' 78' ' ' LEU . 98.7 t -119.05 97.71 5.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 52.4 t30 54.2 60.37 3.63 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 124.247 1.019 . . . . 0.0 109.987 -178.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.89 -36.02 2.32 Favored Glycine 0 CA--C 1.548 2.105 0 CA-C-N 114.517 -1.219 . . . . 0.0 114.398 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.86 108.79 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 20.9 m -85.38 142.82 29.02 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.479 0.657 . . . . 0.0 112.602 -173.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.891 HD21 HG21 ' A' ' 73' ' ' VAL . 1.6 mm? -99.21 22.98 9.73 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.977 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 43' ' ' ARG . 26.5 mt-10 -67.36 -22.24 65.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.114 0.483 . . . . 0.0 112.283 -175.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.55 25.68 8.97 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 174.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 85' ' ' GLN . . . -105.99 -172.03 2.01 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.515 0.674 . . . . 0.0 111.509 -176.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.649 ' HA ' HG21 ' A' ' 31' ' ' VAL . 6.6 t -144.91 178.85 7.72 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -50.55 -55.89 14.14 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.968 0.907 . . . . 0.0 111.847 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 33.0 mmtp -65.23 -25.09 67.53 Favored 'General case' 0 C--O 1.211 -0.969 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.502 ' HB2' ' H ' ' A' ' 82' ' ' THR . 16.3 mm100 -76.59 -44.89 32.55 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.502 ' HB3' HG13 ' A' ' 47' ' ' ILE . . . -58.26 -54.32 48.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.444 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.59 -27.69 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.827 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 84' ' ' LYS . 34.1 tt0 -70.88 -34.75 71.92 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 121.702 -0.624 . . . . 0.0 109.317 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.7 m -71.4 -30.59 66.27 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.722 HD21 HD21 ' A' ' 99' ' ' LEU . 94.0 mt -76.8 -12.28 59.95 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.203 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 91' ' ' ARG . 14.0 mmt180 -92.93 -31.7 14.83 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.75 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.01 -38.35 90.65 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.708 0.766 . . . . 0.0 109.199 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.2 p -74.42 146.35 42.96 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.91 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -79.16 -135.06 1.07 Allowed Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 121.453 -0.403 . . . . 0.0 113.65 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -72.87 -49.33 30.63 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.104 0.478 . . . . 0.0 110.484 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 45.8 t -98.93 112.73 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 t -108.52 137.94 37.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.124 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 12.7 m-70 -96.05 129.49 43.32 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 173.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.722 HD21 HD21 ' A' ' 90' ' ' LEU . 5.9 mp -127.11 141.81 51.67 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.57 HD23 HD12 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -99.78 113.81 26.55 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.652 ' HG ' ' HA ' ' A' ' 70' ' ' VAL . 7.3 mp -127.43 163.07 24.88 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 118.727 0.694 . . . . 0.0 112.299 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 36.0 tt0 -131.01 128.77 41.03 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.832 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 6.4 tptp -49.93 113.15 0.79 Allowed 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.267 0.979 . . . . 0.0 110.404 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -115.48 18.28 15.55 Favored Glycine 0 C--N 1.29 -1.996 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.936 -173.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -63.32 107.13 1.02 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.345 0.593 . . . . 0.0 112.182 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 54.4 t -92.57 105.3 13.94 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.18 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 5.3 Cg_exo . . . . . 0 C--O 1.255 1.342 0 C-N-CA 123.239 2.626 . . . . 0.0 110.957 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.616 ' CB ' ' HD3' ' A' ' 10' ' ' PRO 0.362 66.6 mttm . . . . . 0 CA--C 1.54 0.587 0 CA-C-O 117.011 -1.471 . . . . 0.0 110.658 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.616 ' HD3' ' CB ' ' A' ' 9' ' ' LYS . 17.8 Cg_exo -67.06 134.8 35.34 Favored 'Trans proline' 0 C--N 1.377 2.044 0 CA-C-N 122.899 2.071 . . . . 0.0 110.093 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.21 -13.39 67.43 Favored Glycine 0 C--N 1.3 -1.457 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.227 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -82.59 141.41 32.58 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 40.2 p -92.6 140.89 29.09 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -139.95 141.64 36.44 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.378 0.609 . . . . 0.0 111.343 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -83.89 108.47 16.9 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.356 -1.293 . . . . 0.0 107.953 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.24 125.8 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.063 0 CA-C-O 121.628 0.728 . . . . 0.0 111.519 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -102.37 113.63 27.11 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.448 HD11 ' CB ' ' A' ' 57' ' ' ALA . 2.7 tm? -109.57 116.27 31.44 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.43 118.54 33.16 Favored 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.448 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 94.1 mttt -59.51 119.29 7.24 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 124.059 0.849 . . . . 0.0 110.304 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.706 ' HB ' ' O ' ' A' ' 56' ' ' GLY . 19.0 m -76.13 -67.44 0.68 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.643 -176.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -152.65 -48.49 0.1 Allowed 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.73 35.65 2.68 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.253 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.8 p 71.64 -132.23 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.616 1.966 . . . . 0.0 111.977 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.521 ' HG ' HD13 ' A' ' 90' ' ' LEU . 3.3 mm? -72.3 -30.64 64.98 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.836 0.826 . . . . 0.0 109.547 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.73 22.33 62.04 Favored Glycine 0 N--CA 1.402 -3.615 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.431 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.448 ' HB ' HG11 ' A' ' 49' ' ' VAL . 19.9 pt -135.2 143.26 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.692 0 CA-C-O 121.677 0.751 . . . . 0.0 111.056 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.3 t -97.11 118.01 32.57 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.72 140.89 47.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.416 0.627 . . . . 0.0 112.062 -173.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' HG22 ' A' ' 47' ' ' ILE . 11.4 t -138.61 -171.84 3.16 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -172.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.839 ' HA ' HD12 ' A' ' 47' ' ' ILE . 79.5 t -79.6 -51.08 17.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 174.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.617 HD13 ' HA ' ' A' ' 44' ' ' HIS . 46.1 mt -169.89 -57.15 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 127.784 2.433 . . . . 0.0 104.865 175.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.1 p90 179.71 165.66 1.13 Allowed 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -83.87 113.18 20.77 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.618 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.812 ' HE3' HG21 ' A' ' 42' ' ' VAL . 24.4 ttmm -94.4 -69.92 0.73 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.416 -175.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.34 -140.03 14.68 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.35 27.61 16.46 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.659 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 m -104.28 87.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.306 0.574 . . . . 0.0 111.937 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.8 t30 67.38 92.65 0.08 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.849 1.259 . . . . 0.0 111.152 -176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.2 t -103.24 13.2 34.45 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.921 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.3 t -85.6 16.43 3.89 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 122.083 0.944 . . . . 0.0 109.528 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.812 HG21 ' HE3' ' A' ' 35' ' ' LYS . 36.0 m -96.05 153.34 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.817 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -96.51 101.36 12.97 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.617 ' HA ' HD13 ' A' ' 32' ' ' LEU . 66.3 m80 -64.53 -38.88 92.54 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.95 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.26 -56.15 3.57 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 -173.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.541 ' CA ' ' HA ' ' A' ' 79' ' ' GLU . . . 155.22 -63.41 0.34 Allowed Glycine 0 CA--C 1.471 -2.704 0 CA-C-N 114.968 -0.616 . . . . 0.0 111.773 173.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.839 HD12 ' HA ' ' A' ' 31' ' ' VAL . 17.4 mm -141.15 152.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.534 ' HB2' HD21 ' A' ' 32' ' ' LEU . 39.1 t80 -139.41 138.15 36.27 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.331 0.652 . . . . 0.0 111.094 -174.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.448 HG11 ' HB ' ' A' ' 27' ' ' ILE . 44.2 t -78.48 103.1 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HB2' HG22 ' A' ' 30' ' ' THR . 88.1 tttt -68.89 -41.24 78.57 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.844 -174.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.84 159.39 32.49 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.212 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.526 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 23.4 mm -113.24 134.87 54.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.44 128.4 75.35 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.55 -15.61 9.24 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 125.26 3.974 . . . . 0.0 115.27 -175.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -162.59 64.44 0.21 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.938 0.875 . . . . 0.0 109.644 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.706 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -114.49 -54.34 0.41 Allowed Glycine 0 C--N 1.303 -1.264 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.651 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.491 ' HB3' ' H ' ' A' ' 21' ' ' THR . . . 176.65 -68.13 0.01 OUTLIER 'General case' 0 C--O 1.173 -2.957 0 O-C-N 125.48 1.341 . . . . 0.0 111.641 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.902 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -49.47 -37.29 25.57 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -173.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.526 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -78.84 -48.6 14.41 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -71.6 -35.97 70.66 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.795 -172.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.56 -37.23 56.94 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.41 77.04 1.08 Allowed Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 114.418 -1.265 . . . . 0.0 114.001 173.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -157.98 -47.0 0.06 Allowed 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.902 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 77.1 mt -88.63 132.41 33.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -120.19 164.61 15.97 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 123.533 0.521 . . . . 0.0 109.61 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -63.44 128.96 38.19 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.568 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.612 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 98.92 -8.59 61.36 Favored Glycine 0 N--CA 1.419 -2.482 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.545 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.453 ' CG ' ' HZ1' ' A' ' 103' ' ' LYS . 80.7 m-20 -66.67 139.81 57.87 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-O 121.244 0.545 . . . . 0.0 110.603 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.632 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . 27.7 ttm-85 -98.67 143.63 28.84 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -174.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.474 HG12 HD21 ' A' ' 78' ' ' LEU . 48.5 t -109.9 120.03 60.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.558 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -177.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.502 ' HB2' HD11 ' A' ' 100' ' ' LEU . 57.6 mt -101.82 -33.8 9.67 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.963 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' A' ' 100' ' ' LEU . . . -151.75 160.06 43.72 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.188 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 1.035 HG11 HG22 ' A' ' 89' ' ' THR . 2.6 p -116.65 104.6 16.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 174.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.462 ' HA ' ' ND1' ' A' ' 98' ' ' HIS . 61.6 t30 55.12 37.68 29.29 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.438 1.114 . . . . 0.0 109.901 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.68 -23.73 35.08 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 120.275 -0.964 . . . . 0.0 114.182 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.548 ' HB ' HG12 ' A' ' 73' ' ' VAL . 44.1 t -80.96 113.15 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 118.458 1.129 . . . . 0.0 109.021 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.3 t -72.82 109.61 6.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.106 0.479 . . . . 0.0 110.134 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.741 ' H ' HD22 ' A' ' 78' ' ' LEU . 1.5 pt? -97.63 33.12 2.12 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 122.233 1.016 . . . . 0.0 110.935 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.541 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 11.8 pt-20 -58.25 -28.65 65.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.131 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.9 30.97 7.07 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.54 -164.12 1.12 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.517 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 13.5 t -144.18 177.72 8.4 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -50.3 -53.15 30.68 Favored 'General case' 0 C--O 1.265 1.913 0 C-N-CA 124.897 1.279 . . . . 0.0 110.67 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 97.5 mttt -59.36 -47.92 83.59 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.019 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.495 ' HB2' ' H ' ' A' ' 82' ' ' THR . 28.8 mm-40 -64.3 -42.69 96.25 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.544 ' HA ' HD13 ' A' ' 78' ' ' LEU . . . -50.55 -60.32 3.14 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-O 121.428 0.632 . . . . 0.0 110.387 175.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.07 -31.8 55.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.428 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 42.6 mm-40 -69.58 -34.15 73.73 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 122.097 -0.377 . . . . 0.0 111.016 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 1.035 HG22 HG11 ' A' ' 73' ' ' VAL . 45.0 m -65.14 -38.48 90.74 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 177.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.772 HD23 HD23 ' A' ' 99' ' ' LEU . 81.6 mt -72.84 -23.49 60.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.731 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -84.11 -30.55 25.86 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.893 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.97 -41.13 87.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.089 0.471 . . . . 0.0 109.892 175.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 20.1 p -68.92 155.04 40.98 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.916 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -71.24 -147.57 0.51 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 114.84 0.696 . . . . 0.0 114.84 -176.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 62.4 tt0 -74.38 -35.89 63.51 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.21 -0.495 . . . . 0.0 110.907 -177.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.71 111.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 t -110.0 146.23 15.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.462 ' ND1' ' HA ' ' A' ' 74' ' ' ASN . 58.5 t-80 -109.68 134.47 51.94 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 175.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.772 HD23 HD23 ' A' ' 90' ' ' LEU . 6.4 mp -130.28 153.36 48.72 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 173.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.682 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 3.3 tm? -106.09 109.79 21.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' THR . 8.0 mp -111.38 171.43 7.48 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-O 121.668 0.747 . . . . 0.0 111.939 -175.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.632 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 29.3 tt0 -128.4 132.69 48.5 Favored 'General case' 0 N--CA 1.396 -3.164 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 175.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 15.6 tppt? -63.05 112.79 2.76 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . -91.32 -158.18 34.41 Favored Glycine 0 N--CA 1.409 -3.163 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.31 -172.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -161.31 -167.33 1.74 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -172.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.642 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 89.8 t -65.72 -55.2 24.48 Favored Pre-proline 0 CA--C 1.566 1.584 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.236 171.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 106' ' ' VAL . 4.3 Cg_exo . . . . . 0 C--N 1.371 1.748 0 C-N-CA 123.173 2.582 . . . . 0.0 111.899 176.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.59 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 63.4 mttp . . . . . 0 CA--C 1.547 0.858 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.59 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 12.2 Cg_exo -75.01 40.49 0.66 Allowed 'Trans proline' 0 C--N 1.395 3.003 0 C-N-CA 123.969 3.113 . . . . 0.0 113.05 -176.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.98 43.1 0.02 OUTLIER Glycine 0 C--N 1.283 -2.381 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 23.1 t0 -116.73 153.73 31.87 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.8 p -92.09 144.75 25.12 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 123.599 0.562 . . . . 0.0 109.706 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -157.77 153.67 26.89 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -110.73 89.2 2.97 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.44 HG12 HD13 ' A' ' 101' ' ' LEU . 14.1 p -81.47 143.18 12.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.433 -175.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.506 ' HB3' ' HD2' ' A' ' 98' ' ' HIS . 11.1 pt-20 -104.2 111.4 23.98 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.767 HD22 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -111.34 126.72 55.22 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.054 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -101.47 142.05 33.43 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.461 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.733 ' HB2' ' HG3' ' A' ' 95' ' ' GLN . 29.5 mmtm -65.36 118.14 8.92 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.6 m -90.18 -61.39 1.69 Allowed 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.117 0.484 . . . . 0.0 111.804 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -152.88 -45.65 0.1 Allowed 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 121.762 0.792 . . . . 0.0 109.009 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.654 ' O ' ' HB2' ' A' ' 24' ' ' SER . . . -123.48 51.28 0.81 Allowed Glycine 0 N--CA 1.418 -2.51 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.57 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.654 ' HB2' ' O ' ' A' ' 23' ' ' GLY . 25.7 m 80.45 -147.67 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.753 1.221 . . . . 0.0 110.279 175.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.65 HD23 ' HB3' ' A' ' 18' ' ' LEU . 28.6 mt -80.46 -10.95 59.74 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.135 0.493 . . . . 0.0 109.73 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.55 8.99 84.03 Favored Glycine 0 N--CA 1.42 -2.405 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.059 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.444 HG12 ' HB2' ' A' ' 25' ' ' LEU . 25.7 pt -114.76 134.33 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 121.997 0.903 . . . . 0.0 112.766 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.2 t -97.12 107.59 20.14 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.843 -1.526 . . . . 0.0 106.921 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.48 ' HB ' ' CG2' ' A' ' 47' ' ' ILE . 34.1 m -96.84 152.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 120.737 0.303 . . . . 0.0 110.561 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.427 HG23 ' HB2' ' A' ' 50' ' ' LYS . 11.1 t -142.84 156.03 44.88 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 81' ' ' ALA . 7.2 p -118.9 111.17 32.45 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 CA-C-O 121.38 0.61 . . . . 0.0 110.212 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.37 132.92 36.56 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.423 ' C ' ' H ' ' A' ' 35' ' ' LYS . 97.0 m-85 -97.15 1.03 49.4 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.745 -173.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -76.13 26.46 0.12 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' A' ' 33' ' ' PHE . 56.8 mttp -81.14 102.39 10.25 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.52 53.39 4.82 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.078 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.48 -46.92 2.57 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.1 159.24 9.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.438 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . 22.9 p-10 -69.52 142.78 53.6 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.315 0.578 . . . . 0.0 110.245 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.5 t -127.56 -115.2 0.27 Allowed 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.94 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -62.45 -58.11 8.8 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.1 m -84.62 168.92 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.682 175.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.438 ' HG2' ' HB2' ' A' ' 39' ' ' ASN . 84.5 mtt180 -137.78 140.19 40.46 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.415 ' CB ' ' HE3' ' A' ' 35' ' ' LYS . 35.6 m80 -122.33 -48.01 2.1 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.21 -81.92 1.04 Allowed Glycine 0 CA--C 1.495 -1.207 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.33 -80.28 0.09 OUTLIER Glycine 0 N--CA 1.414 -2.796 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.868 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 49.9 mm -114.35 154.18 15.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 123.433 0.693 . . . . 0.0 109.368 -175.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -128.35 133.5 48.68 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 122.941 0.496 . . . . 0.0 109.79 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.446 HG21 ' CG2' ' A' ' 64' ' ' ILE . 58.8 t -80.06 111.65 17.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.427 ' HB2' HG23 ' A' ' 30' ' ' THR . 38.7 ttpt -79.88 -41.71 25.68 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.034 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.64 41.41 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.848 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.459 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 46.0 mm -113.47 124.16 69.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -81.2 122.18 81.16 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.16 80.26 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.666 2.244 . . . . 0.0 112.099 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -143.3 -42.93 0.29 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.147 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.498 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 156.09 -160.17 29.89 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.359 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.507 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 67.67 -102.68 0.07 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.347 1.459 . . . . 0.0 112.819 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.767 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -65.79 -36.69 84.24 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.355 0.525 . . . . 0.0 111.081 -176.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.459 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 45.1 tt0 -67.56 -47.6 69.35 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.265 1.026 . . . . 0.0 111.289 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.498 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 52.1 m -69.74 -42.68 73.6 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.694 -177.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -71.17 -27.72 63.73 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.048 0.928 . . . . 0.0 108.887 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.51 43.33 94.86 Favored Glycine 0 CA--C 1.498 -0.981 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.657 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.534 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -107.19 -51.04 2.98 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.769 -178.491 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 58' ' ' ALA . 59.1 mt -101.66 126.67 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -125.23 166.19 16.94 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -63.13 125.73 25.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.32 -23.61 15.61 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.683 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.469 ' HB3' HD21 ' A' ' 101' ' ' LEU . 37.8 m-20 -66.82 141.53 57.66 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.32 0.581 . . . . 0.0 110.73 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 69' ' ' ARG . 31.3 mtp180 -106.4 143.79 34.01 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.545 -175.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.868 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 51.4 t -107.93 123.02 63.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.159 -175.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.532 HD12 ' HB2' ' A' ' 102' ' ' GLU . 90.1 mt -99.36 -33.8 10.56 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.84 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.619 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -160.65 163.7 32.33 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.945 HG22 HD12 ' A' ' 78' ' ' LEU . 94.2 t -111.4 115.47 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 173.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 47.03 39.35 7.67 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 126.996 2.119 . . . . 0.0 110.983 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.83 -18.46 56.56 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 119.848 -1.168 . . . . 0.0 114.78 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t -81.58 112.95 20.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 45.7 m -64.31 133.83 53.46 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.862 0.839 . . . . 0.0 113.06 -171.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.945 HD12 HG22 ' A' ' 73' ' ' VAL . 79.4 mt -107.39 15.49 24.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.733 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.26 97.54 1.57 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.81 25.79 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.436 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -86.45 142.96 28.01 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.0 t -85.56 168.09 14.8 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 172.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.449 ' O ' HG22 ' A' ' 87' ' ' VAL . 57.0 t-80 -50.38 -49.87 53.16 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.652 0.781 . . . . 0.0 110.915 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -53.79 -38.62 64.69 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.939 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -70.58 -51.8 25.89 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 120.707 -0.397 . . . . 0.0 109.951 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.57 -57.93 8.99 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 123.97 0.794 . . . . 0.0 111.804 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 83' ' ' HIS . 37.9 t -65.84 -43.35 93.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.359 -173.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -72.49 -30.58 64.65 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.756 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.632 ' O ' HG21 ' A' ' 93' ' ' THR . 93.6 m -68.22 -43.18 78.55 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.633 HD12 HD11 ' A' ' 25' ' ' LEU . 2.3 tp -75.25 -18.07 60.18 Favored 'General case' 0 N--CA 1.425 -1.712 0 C-N-CA 124.015 0.926 . . . . 0.0 111.445 -177.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -92.24 -33.35 14.7 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.829 -0.544 . . . . 0.0 109.729 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -82.32 -15.91 51.18 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.632 HG21 ' O ' ' A' ' 89' ' ' THR . 5.4 p -53.47 -63.17 1.23 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.442 0.639 . . . . 0.0 111.121 177.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.45 -162.92 32.25 Favored Glycine 0 N--CA 1.411 -2.97 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.733 ' HG3' ' HB2' ' A' ' 20' ' ' LYS . 63.5 tt0 -72.3 -44.59 62.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 117.257 0.529 . . . . 0.0 109.99 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 46.1 t -102.02 118.09 48.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.63 HG21 HD11 ' A' ' 90' ' ' LEU . 4.1 t -112.71 141.99 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.506 ' HD2' ' HB3' ' A' ' 17' ' ' GLU . 37.7 m80 -96.8 125.32 41.16 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 171.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.575 HD13 HG23 ' A' ' 73' ' ' VAL . 2.8 tp -120.58 132.91 55.38 Favored 'General case' 0 C--N 1.253 -3.597 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.4 tt -95.35 114.28 26.04 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.469 HD21 ' HB3' ' A' ' 68' ' ' ASP . 10.2 mp -119.64 171.3 8.47 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.556 0.693 . . . . 0.0 112.199 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.532 ' HB2' HD12 ' A' ' 71' ' ' LEU . 35.7 tt0 -131.4 123.08 27.44 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 101.618 -3.475 . . . . 0.0 101.618 171.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -58.13 126.34 27.06 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 123.683 0.614 . . . . 0.0 110.375 -173.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -113.78 24.81 11.54 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.197 -175.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.569 ' HG3' ' HB3' ' A' ' 10' ' ' PRO . 17.2 pt20 -69.39 115.15 8.32 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 121.545 0.688 . . . . 0.0 110.351 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 99.8 t -123.7 116.02 27.96 Favored Pre-proline 0 N--CA 1.424 -1.76 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.927 -175.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.439 -1.705 0 C-N-CA 122.497 2.132 . . . . 0.0 109.36 174.619 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.1 mttp . . . . . 0 N--CA 1.432 -1.331 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 85.4 Cg_exo -46.64 127.94 12.36 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.473 2.115 . . . . 0.0 112.587 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.43 -16.36 41.35 Favored Glycine 0 C--O 1.244 0.768 0 C-N-CA 120.55 -0.833 . . . . 0.0 114.635 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -87.5 142.48 27.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 117.85 0.825 . . . . 0.0 109.297 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 21.8 p -95.38 148.27 22.63 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.22 0.533 . . . . 0.0 111.34 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -149.42 147.69 28.56 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -103.91 98.06 7.96 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.463 HG12 HD11 ' A' ' 101' ' ' LEU . 8.4 p -82.87 127.56 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.825 -175.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.35 87.98 3.35 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.732 HD11 HD13 ' A' ' 25' ' ' LEU . 1.4 tm? -87.41 113.9 23.53 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -175.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.12 113.96 26.01 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.4 127.14 30.27 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 123.986 0.804 . . . . 0.0 110.455 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.6 p -82.3 -71.74 0.47 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.463 1.125 . . . . 0.0 111.506 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -156.61 -36.27 0.08 Allowed 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 113.547 -1.66 . . . . 0.0 106.678 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . -89.14 28.42 6.71 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.517 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.3 p 65.97 -142.31 0.18 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.103 1.761 . . . . 0.0 111.525 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.732 HD13 HD11 ' A' ' 18' ' ' LEU . 7.7 tp -67.82 -28.35 67.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.934 0.873 . . . . 0.0 109.306 -176.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.27 18.51 66.64 Favored Glycine 0 N--CA 1.411 -2.995 0 C-N-CA 119.951 -1.118 . . . . 0.0 114.693 172.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.451 HG21 ' HB2' ' A' ' 58' ' ' ALA . 12.3 pt -131.84 145.86 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 CA-C-O 121.303 0.573 . . . . 0.0 111.404 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.5 t -111.89 136.36 51.31 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 49' ' ' VAL . 32.1 m -126.14 149.9 31.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.581 0.705 . . . . 0.0 112.358 -175.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 13.5 t -125.41 145.36 50.09 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.475 HG22 HD12 ' A' ' 47' ' ' ILE . 46.0 t -121.05 148.63 24.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.053 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.494 HD11 ' HA ' ' A' ' 40' ' ' THR . 71.7 mt -95.51 115.15 27.03 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -147.58 -0.31 0.65 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.654 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -89.1 -167.11 1.78 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -72.19 -49.64 33.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.17 -144.27 44.37 Favored Glycine 0 N--CA 1.44 -1.1 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.337 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -169.36 -90.04 0.08 OUTLIER Glycine 0 C--N 1.299 -1.524 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' A' ' 40' ' ' THR . 28.1 m -111.16 153.54 12.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 75.96 -31.39 0.2 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 124.93 1.292 . . . . 0.0 111.236 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.494 ' HA ' HD11 ' A' ' 32' ' ' LEU . 38.5 p -83.55 74.43 10.12 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 123.4 0.68 . . . . 0.0 109.488 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.3 p -77.22 -78.56 0.13 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.061 0.458 . . . . 0.0 109.814 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.6 m -48.37 130.01 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 CA-C-N 114.25 -1.341 . . . . 0.0 112.055 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 14.1 ptp180 -139.28 -5.22 1.44 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.92 175.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.639 ' CD2' ' HB2' ' A' ' 79' ' ' GLU . 84.7 t60 -94.38 -53.39 3.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 172.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.57 -158.97 21.83 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.16 63.87 0.81 Allowed Glycine 0 N--CA 1.415 -2.711 0 C-N-CA 118.995 -1.574 . . . . 0.0 112.034 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.997 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 50.5 mm -87.26 121.74 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -121.31 131.17 54.05 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.547 -0.861 . . . . 0.0 113.3 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' HA ' HG12 ' A' ' 29' ' ' VAL . 45.3 t -70.04 112.81 5.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 61.9 tttp -86.04 -36.86 19.44 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.359 -176.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.99 148.81 28.83 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.408 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.678 HG12 ' HB3' ' A' ' 66' ' ' LYS . 46.5 mm -110.57 127.73 67.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.68 HG23 ' H ' ' A' ' 55' ' ' LYS . 44.9 mm -83.62 138.61 40.99 Favored Pre-proline 0 C--N 1.286 -2.165 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.957 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -60.0 -16.52 39.48 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 124.13 3.22 . . . . 0.0 112.391 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.68 ' H ' HG23 ' A' ' 53' ' ' ILE . 51.3 tptt -121.16 35.97 4.74 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.87 128.57 6.73 Favored Glycine 1 N--CA 1.387 -4.575 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.445 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB3' HD12 ' A' ' 18' ' ' LEU . . . -45.91 -33.61 3.36 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 126.578 1.951 . . . . 0.0 114.392 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.61 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -60.16 -36.06 76.71 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.202 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.597 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 31.7 tt0 -91.97 -40.01 11.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.425 0.631 . . . . 0.0 109.646 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.1 m -75.71 -48.49 21.71 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.148 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -74.92 -36.88 62.15 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.35 67.77 1.16 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.757 -1.11 . . . . 0.0 113.103 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.429 ' HB3' HG22 ' A' ' 16' ' ' VAL . 18.8 mmt180 -132.64 -75.65 0.5 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.337 0.589 . . . . 0.0 111.119 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 58' ' ' ALA . 60.5 mt -78.62 146.76 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.099 0.959 . . . . 0.0 111.994 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -116.35 163.75 15.56 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.678 ' HB3' HG12 ' A' ' 52' ' ' ILE . 51.5 pttt -81.88 135.0 35.45 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.436 0.636 . . . . 0.0 110.581 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.33 -11.52 43.57 Favored Glycine 0 N--CA 1.424 -2.145 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.054 -174.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.551 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 18.3 m-20 -66.44 146.44 54.55 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -96.49 125.48 41.0 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.38 -1.736 . . . . 0.0 109.028 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.997 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 48.3 t -108.91 123.28 64.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.9 mt -96.8 -39.98 9.17 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.088 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.28 178.63 7.39 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.628 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.755 ' HA ' HD13 ' A' ' 99' ' ' LEU . 24.5 t -116.01 105.37 18.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.668 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 10.7 p30 50.02 34.15 7.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 124.387 1.075 . . . . 0.0 113.116 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.01 -21.69 43.56 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.569 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.43 100.67 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.644 ' HB2' ' HG2' ' A' ' 79' ' ' GLU . 2.9 p -58.39 128.64 38.18 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.212 1.005 . . . . 0.0 113.269 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.8 mt -97.04 21.26 10.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.516 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.644 ' HG2' ' HB2' ' A' ' 77' ' ' SER . 7.7 pt-20 -74.36 126.34 30.46 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.793 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.16 12.92 62.73 Favored Glycine 0 C--N 1.298 -1.563 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.35 142.39 38.76 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.6 t -96.25 174.15 7.03 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -51.3 -43.39 61.64 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -64.47 -33.4 75.8 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.408 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -72.62 -42.08 64.85 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.102 0.477 . . . . 0.0 109.848 -175.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.561 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -60.01 -53.94 51.91 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.252 176.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.479 ' HA ' HD12 ' A' ' 90' ' ' LEU . 57.9 t -67.07 -34.32 68.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -176.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -72.45 -26.85 61.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.27 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.9 m -70.35 -34.62 72.85 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 87.6 mt -71.69 -32.43 67.83 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.75 0.785 . . . . 0.0 109.8 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -69.05 -39.84 78.91 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.111 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -67.42 -40.19 85.5 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.482 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -65.32 147.37 53.56 Favored 'General case' 0 C--O 1.253 1.237 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 175.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.38 -133.68 0.22 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -172.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -74.26 -52.59 11.9 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.031 0.532 . . . . 0.0 111.293 -175.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.74 111.86 35.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.1 t -100.76 129.55 51.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.295 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.668 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 50.5 m80 -93.51 119.12 32.2 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.755 HD13 ' HA ' ' A' ' 73' ' ' VAL . 7.2 tp -121.98 138.48 54.41 Favored 'General case' 0 N--CA 1.401 -2.902 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.21 109.4 22.16 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.593 HD13 HD21 ' A' ' 99' ' ' LEU . 11.2 mp -118.32 169.02 10.08 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.982 0.896 . . . . 0.0 111.988 -177.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 36.0 tt0 -131.72 137.82 48.4 Favored 'General case' 0 N--CA 1.39 -3.459 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 173.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.551 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 15.7 tppt? -64.33 113.44 3.62 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.81 6.86 17.69 Favored Glycine 0 CA--C 1.482 -1.973 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.677 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -57.71 143.6 41.11 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 121.355 0.598 . . . . 0.0 111.659 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.3 t -120.32 82.54 31.53 Favored Pre-proline 0 N--CA 1.417 -2.124 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 N--CA 1.436 -1.901 0 C-N-CA 122.599 2.199 . . . . 0.0 110.002 -179.764 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.549 ' H1 ' ' HB2' ' A' ' 12' ' ' ASP . 48.9 mtpt . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -68.34 42.78 0.27 Allowed 'Trans proline' 0 N--CA 1.509 2.404 0 C-N-CA 123.714 2.943 . . . . 0.0 112.028 172.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 9' ' ' LYS . . . -171.08 29.07 0.11 Allowed Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.549 ' HB2' ' H1 ' ' A' ' 9' ' ' LYS . 28.6 t70 -84.24 136.47 33.93 Favored 'General case' 0 CA--C 1.491 -1.324 0 C-N-CA 123.378 0.671 . . . . 0.0 110.936 -178.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 p -87.18 117.5 25.97 Favored 'General case' 0 C--N 1.279 -2.465 0 O-C-N 124.064 0.852 . . . . 0.0 109.942 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -134.25 149.37 50.94 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 50.2 mt-10 -106.1 110.98 23.41 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.668 HG11 HD12 ' A' ' 64' ' ' ILE . 10.5 p -89.39 124.02 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.854 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -174.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.31 89.06 7.84 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.029 HD23 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -96.05 115.45 27.45 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -175.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.19 115.46 29.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.007 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -64.1 146.34 54.37 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.612 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -122.1 90.16 3.25 Favored 'General case' 0 N--CA 1.408 -2.574 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.094 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.7 t70 65.85 -65.81 0.17 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.51 1.524 . . . . 0.0 114.275 -177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.07 67.8 0.23 Allowed Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.515 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 84.8 p 70.34 -173.73 0.18 Allowed 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.794 1.638 . . . . 0.0 114.224 169.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 18' ' ' LEU . 80.9 mt -72.02 160.33 32.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.1 41.16 2.64 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.212 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.487 HG21 ' CB ' ' A' ' 58' ' ' ALA . 14.7 pt -135.13 137.6 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.806 0 CA-C-O 121.419 0.628 . . . . 0.0 111.426 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -94.87 123.63 38.44 Favored 'General case' 0 N--CA 1.41 -2.432 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.604 HG22 ' H ' ' A' ' 30' ' ' THR . 12.3 p -93.54 175.87 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 O-C-N 123.321 0.388 . . . . 0.0 110.064 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.91 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 14.8 t -166.12 148.75 7.16 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.755 HG21 ' HA ' ' A' ' 82' ' ' THR . 12.2 p -113.66 122.83 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.517 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 90.5 mt -115.54 103.28 10.58 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -75.15 162.26 28.66 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.418 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.85 -8.49 43.31 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -66.95 139.77 57.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.659 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.81 -50.32 0.46 Allowed Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.76 -171.79 32.37 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.8 t -88.75 22.39 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 CA-C-O 122.512 1.148 . . . . 0.0 109.484 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -143.51 -64.58 0.38 Allowed 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.8 m 68.33 127.86 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.467 1.107 . . . . 0.0 112.116 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.3 p -66.98 -34.89 78.75 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.243 0.544 . . . . 0.0 110.668 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.517 ' CG1' ' HB3' ' A' ' 32' ' ' LEU . 59.3 t -56.21 137.82 17.47 Favored 'Isoleucine or valine' 0 C--O 1.255 1.373 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.212 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.5 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 3.0 mpt_? -74.7 117.38 16.47 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -56.37 134.4 53.63 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.888 0.743 . . . . 0.0 111.272 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.97 -107.68 0.27 Allowed Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.36 -83.1 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.704 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.605 HG13 ' HG ' ' A' ' 78' ' ' LEU . 43.4 mm -102.19 138.0 28.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -137.68 163.77 30.47 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.955 0.407 . . . . 0.0 110.122 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 64' ' ' ILE . 56.9 t -88.3 113.61 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.952 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 169.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.91 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 59.3 tttm -76.24 -35.4 59.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.602 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.717 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . . . -168.1 167.18 12.64 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.946 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.957 HG23 ' HB2' ' A' ' 59' ' ' GLU . 49.0 mm -108.47 122.82 63.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.0 mm -83.97 145.71 47.19 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -56.88 -133.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 123.548 2.832 . . . . 0.0 114.389 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 75.3 -52.23 0.66 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.556 1.142 . . . . 0.0 110.716 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.19 -50.19 0.87 Allowed Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.69 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . -8.97 -75.83 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 127.903 2.481 . . . . 0.0 116.149 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 1.029 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -96.02 -29.15 14.29 Favored 'General case' 0 C--O 1.255 1.359 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -172.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.957 ' HB2' HG23 ' A' ' 52' ' ' ILE . 39.6 tt0 -82.93 -53.21 6.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 123.331 0.394 . . . . 0.0 111.542 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 m -86.95 -35.14 19.05 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.633 -171.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 9.5 m-20 -101.3 -28.73 12.46 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.28 -174.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.94 -131.21 6.6 Favored Glycine 0 N--CA 1.398 -3.876 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -154.32 2.65 0.23 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.668 HD12 HG11 ' A' ' 16' ' ' VAL . 31.4 mt -90.45 148.44 4.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.525 -165.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -137.95 173.33 11.75 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.717 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 22.6 pttp -73.2 130.44 40.23 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.283 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.97 -20.77 8.5 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.115 -1.04 . . . . 0.0 113.507 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.63 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 53.9 m-20 -71.78 138.52 48.45 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 117.453 0.626 . . . . 0.0 110.619 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -90.54 135.04 33.95 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.41 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.415 ' HB ' HG21 ' A' ' 47' ' ' ILE . 57.8 t -106.41 120.9 58.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.491 HD13 ' HB2' ' A' ' 102' ' ' GLU . 62.7 mt -96.41 -37.97 10.23 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.582 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.717 ' HB1' ' HB3' ' A' ' 100' ' ' LEU . . . -154.64 162.29 41.2 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.495 -173.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.764 ' HA ' HD13 ' A' ' 99' ' ' LEU . 56.3 t -115.39 106.95 21.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.3 t30 62.56 31.85 16.72 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.368 1.08 . . . . 0.0 109.761 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.56 -21.46 45.57 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 114.855 -1.066 . . . . 0.0 114.162 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.6 t -82.97 114.36 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 117.736 0.768 . . . . 0.0 109.725 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.9 t -72.1 127.68 33.31 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 123.069 0.548 . . . . 0.0 110.723 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.686 ' N ' HD23 ' A' ' 78' ' ' LEU . 2.0 pt? -131.46 30.07 4.49 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -69.32 -11.31 60.71 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.618 0.723 . . . . 0.0 110.643 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.57 21.51 25.84 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.825 174.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.533 ' HB1' ' HB2' ' A' ' 78' ' ' LEU . . . -93.17 -154.48 0.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.177 0.513 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.755 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.1 t -146.36 173.0 12.66 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 175.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.508 ' CD2' HG13 ' A' ' 29' ' ' VAL . 51.7 t-80 -50.72 -60.29 3.2 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.78 1.232 . . . . 0.0 111.582 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -59.67 -36.98 77.52 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.576 0.75 . . . . 0.0 110.945 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -67.29 -45.06 77.69 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.399 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.447 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -60.21 -51.29 70.2 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.931 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 3.1 p -68.81 -34.63 65.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.085 -173.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.719 ' HA ' ' HG2' ' A' ' 91' ' ' ARG . 20.5 mm-40 -77.64 -23.47 49.73 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.436 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 86.5 m -70.91 -28.5 64.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.539 HD13 HD12 ' A' ' 25' ' ' LEU . 86.8 mt -73.58 -24.71 60.11 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.752 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.719 ' HG2' ' HA ' ' A' ' 88' ' ' GLU . 36.7 mmt180 -73.64 -49.84 24.04 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.65 -32.06 73.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.578 -174.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.482 HG22 HG13 ' A' ' 73' ' ' VAL . 1.3 p -63.87 -36.26 83.35 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.39 -140.42 13.41 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 119.712 -1.232 . . . . 0.0 113.427 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -88.46 -52.19 5.32 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.674 0.79 . . . . 0.0 109.933 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 65.5 t -99.31 111.49 29.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 43.6 t -105.86 120.94 57.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -93.08 70.54 4.54 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.764 HD13 ' HA ' ' A' ' 73' ' ' VAL . 6.7 tp -71.55 139.27 49.38 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 122.249 -0.282 . . . . 0.0 110.55 -172.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.717 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 55.9 tp -94.17 113.32 25.24 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.638 HD12 HD21 ' A' ' 99' ' ' LEU . 10.0 mp -117.66 166.66 12.14 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-O 121.551 0.691 . . . . 0.0 110.144 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.491 ' HB2' HD13 ' A' ' 71' ' ' LEU . 37.1 tt0 -128.48 124.44 36.12 Favored 'General case' 0 N--CA 1.389 -3.491 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 174.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.403 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 23.8 tptp -49.07 123.52 7.34 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 124.572 1.17 . . . . 0.0 110.409 -177.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.63 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -115.37 -168.26 15.47 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -157.65 -57.76 0.08 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 26.1 t -118.14 127.4 26.62 Favored Pre-proline 0 N--CA 1.436 -1.161 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.073 -177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo . . . . . 0 N--CA 1.445 -1.345 0 C-N-CA 122.988 2.459 . . . . 0.0 111.705 178.552 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.38 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.687 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 22.2 Cg_exo -63.78 139.9 71.17 Favored 'Trans proline' 0 C--O 1.245 0.848 0 C-N-CA 121.525 1.483 . . . . 0.0 111.918 -177.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.14 6.85 74.41 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.87 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 27.0 t70 -97.11 145.55 25.89 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 122.799 -0.236 . . . . 0.0 110.816 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -93.1 114.18 26.64 Favored 'General case' 0 N--CA 1.426 -1.667 0 O-C-N 123.491 0.494 . . . . 0.0 109.803 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.418 ' HE2' ' HD2' ' A' ' 63' ' ' ARG . 5.6 p90 -127.78 159.61 34.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.152 0.501 . . . . 0.0 111.463 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -106.05 130.44 53.97 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 12.4 t -110.88 132.3 59.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -175.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.533 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 26.1 mp0 -97.76 87.06 3.93 Favored 'General case' 0 C--O 1.248 1.009 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 171.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.087 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -96.94 116.64 29.54 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -92.9 125.12 37.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 86.7 mttt -67.66 163.92 20.37 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-O 121.844 0.831 . . . . 0.0 111.571 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.427 ' C ' ' H ' ' A' ' 23' ' ' GLY . 0.9 OUTLIER -88.52 33.1 0.76 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.616 175.591 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 20' ' ' LYS . 16.7 t70 67.99 -28.82 0.15 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.307 2.243 . . . . 0.0 113.024 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 21' ' ' THR . . . -77.04 -58.53 3.39 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 176.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 t -167.05 -175.29 2.95 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.63 HD11 HG12 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -85.85 139.55 31.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.328 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.48 43.02 2.84 Favored Glycine 0 C--N 1.295 -1.743 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.717 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.63 HG12 HD11 ' A' ' 25' ' ' LEU . 18.9 pt -138.32 148.69 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-N 118.133 0.967 . . . . 0.0 111.765 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.649 ' HB2' HD11 ' A' ' 53' ' ' ILE . 39.4 t -108.5 109.65 20.96 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.573 ' HB ' HG22 ' A' ' 47' ' ' ILE . 26.9 m -104.87 144.82 14.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 123.877 0.736 . . . . 0.0 110.296 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.512 HG23 ' HB2' ' A' ' 50' ' ' LYS . 12.8 t -144.0 157.88 44.06 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.537 HG21 HD12 ' A' ' 47' ' ' ILE . 56.1 t -89.6 113.29 25.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.9 mt -94.03 99.57 11.86 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.249 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -126.91 22.65 6.72 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -73.51 108.12 6.19 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.15 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -90.51 103.84 16.49 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.162 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 134.55 161.39 9.49 Favored Glycine 0 N--CA 1.425 -2.068 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.222 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.38 -139.11 4.57 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.5 t -79.65 -42.38 22.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -136.51 178.6 6.94 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 113.358 -1.746 . . . . 0.0 106.809 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.0 m -89.14 81.47 6.76 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 119.65 -0.82 . . . . 0.0 108.957 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.6 t -106.4 132.34 52.55 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.49 80.05 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 CA-C-O 122.505 1.145 . . . . 0.0 109.651 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -93.18 29.6 1.85 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.309 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -87.78 155.37 19.93 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 113.811 -1.541 . . . . 0.0 110.39 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.59 147.05 11.5 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . -53.37 -50.69 51.59 Favored Glycine 0 CA--C 1.476 -2.398 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 178.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.573 HG22 ' HB ' ' A' ' 29' ' ' VAL . 18.9 mm -139.29 142.76 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 173.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.637 ' HH ' ' HA2' ' A' ' 67' ' ' GLY . 52.9 t80 -140.52 141.93 35.27 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.28 108.09 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.512 ' HB2' HG23 ' A' ' 30' ' ' THR . 53.3 tttp -82.27 -35.8 27.7 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.811 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.87 36.28 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.735 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 1.038 HG21 ' HB2' ' A' ' 59' ' ' GLU . 31.7 mm -111.7 113.45 44.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.649 HD11 ' HB2' ' A' ' 28' ' ' SER . 2.0 mp -83.41 128.33 64.77 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 53.2 Cg_exo -59.94 88.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 124.14 3.227 . . . . 0.0 115.142 -177.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.421 ' O ' HG23 ' A' ' 21' ' ' THR . 2.4 mptm? -125.09 -27.23 3.57 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.681 170.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.624 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 93.89 49.12 2.54 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -175.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.439 ' HB2' HD12 ' A' ' 18' ' ' LEU . . . -122.26 -77.77 0.59 Allowed 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.166 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 1.087 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -83.25 -31.44 26.98 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -170.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.038 ' HB2' HG21 ' A' ' 52' ' ' ILE . 40.0 tt0 -80.02 -45.39 18.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 124.645 1.216 . . . . 0.0 110.268 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.624 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 1.2 m -85.09 -47.86 9.76 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.264 -168.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -100.7 -21.5 15.2 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.931 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.84 -132.26 6.36 Favored Glycine 1 N--CA 1.393 -4.219 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.93 -173.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.418 ' HD2' ' HE2' ' A' ' 14' ' ' PHE . 40.1 mtt180 -156.24 -1.54 0.13 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -169.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.736 ' HB ' ' HB2' ' A' ' 58' ' ' ALA . 60.2 mt -96.22 132.05 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.145 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.546 -169.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.41 ' HA ' HG13 ' A' ' 52' ' ' ILE . 81.4 m-70 -139.67 170.48 15.82 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -69.22 129.79 40.84 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.459 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.637 ' HA2' ' HH ' ' A' ' 48' ' ' TYR . . . 123.8 -26.08 6.01 Favored Glycine 0 C--N 1.291 -1.972 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.848 -172.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.451 ' HB3' HD23 ' A' ' 101' ' ' LEU . 18.2 m-20 -72.86 133.91 44.62 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 4.5 ptm180 -100.84 151.15 22.06 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.536 HG21 ' HG ' ' A' ' 101' ' ' LEU . 47.3 t -112.83 127.2 70.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.443 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -176.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.9 mt -100.87 -34.3 9.86 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.345 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -159.55 175.11 13.64 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.466 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 1.053 HG11 HG21 ' A' ' 89' ' ' THR . 4.7 p -130.64 110.21 18.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 124.943 1.297 . . . . 0.0 109.523 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 62.68 30.17 16.86 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.412 1.101 . . . . 0.0 108.151 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.04 -18.69 46.59 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.259 -0.882 . . . . 0.0 114.079 -174.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.0 t -81.82 122.76 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.4 t -58.17 140.45 52.93 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.662 HD12 ' HB ' ' A' ' 73' ' ' VAL . 81.2 mt -118.06 -3.02 11.14 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.865 175.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.569 ' HA ' ' HA3' ' A' ' 46' ' ' GLY 0.261 1.0 OUTLIER -76.97 103.95 7.19 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 122.475 1.131 . . . . 0.0 110.43 177.888 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.45 -6.28 12.83 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -173.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.81 149.61 24.72 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.464 ' HA ' HG22 ' A' ' 31' ' ' VAL . 5.1 t -79.14 154.14 29.55 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.415 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 42.8 p-80 -51.55 -36.73 46.41 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 120.759 0.314 . . . . 0.0 111.826 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.436 ' HB2' HG23 ' A' ' 82' ' ' THR . 94.6 mttt -48.9 -53.61 18.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.36 173.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -66.89 -35.7 80.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 123.375 0.422 . . . . 0.0 111.458 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -58.47 -49.84 75.89 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.433 0.635 . . . . 0.0 109.805 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.92 -32.94 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.392 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 45.1 mt-10 -66.56 -34.14 77.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 110.091 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 1.053 HG21 HG11 ' A' ' 73' ' ' VAL . 50.6 m -71.01 -29.15 65.02 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.328 0.585 . . . . 0.0 109.491 174.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.1 mt -71.41 -24.03 61.97 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-O 121.077 0.465 . . . . 0.0 109.982 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -90.74 -15.49 30.12 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.058 0.456 . . . . 0.0 111.092 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.27 -35.08 31.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 p -75.01 154.67 37.94 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.169 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.27 -136.79 1.67 Allowed Glycine 0 C--N 1.314 -0.66 0 N-CA-C 114.349 0.5 . . . . 0.0 114.349 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.433 ' OE1' ' HB2' ' A' ' 20' ' ' LYS . 5.2 tp-100 -72.39 -46.84 53.48 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.745 0.784 . . . . 0.0 109.361 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 52.4 t -102.19 119.0 49.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.47 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 41.4 t -104.57 129.62 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.092 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.805 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.533 ' CD2' ' HG3' ' A' ' 17' ' ' GLU . 26.6 m170 -89.5 122.62 32.86 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 169.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.688 HD21 HD11 ' A' ' 101' ' ' LEU . 4.9 tp -130.0 147.86 51.8 Favored 'General case' 0 C--N 1.271 -2.844 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.7 tt -110.11 116.56 31.76 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.688 HD11 HD21 ' A' ' 99' ' ' LEU . 7.5 mp -122.64 175.38 6.53 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.472 0.653 . . . . 0.0 111.001 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 26.9 tt0 -128.3 119.99 26.19 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.687 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -50.02 106.46 0.12 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.006 1.322 . . . . 0.0 110.656 -173.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.502 ' N ' ' HE3' ' A' ' 103' ' ' LYS . . . -113.13 89.85 0.53 Allowed Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.868 -177.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -95.88 100.33 12.03 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 173.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 47.4 t -126.03 115.77 24.03 Favored Pre-proline 0 C--N 1.292 -1.935 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.7 Cg_exo . . . . . 0 C--O 1.26 1.6 0 C-N-CA 122.703 2.269 . . . . 0.0 110.89 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.795 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 53.1 mtmt . . . . . 0 CA--C 1.547 0.843 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.795 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 53.8 Cg_endo -87.18 34.86 0.44 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.958 2.438 . . . . 0.0 112.889 -170.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.88 30.19 0.06 OUTLIER Glycine 0 C--N 1.292 -1.882 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 59.0 t0 -88.93 143.16 27.06 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -176.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 p -96.78 116.07 28.51 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 123.639 0.775 . . . . 0.0 110.397 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.35 132.44 21.64 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.35 0.595 . . . . 0.0 112.259 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 41.8 mt-10 -81.13 99.21 8.4 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.095 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 64' ' ' ILE . 55.5 t -68.38 131.08 33.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.143 -177.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -92.61 98.96 11.76 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.973 HD23 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -110.95 118.76 36.97 Favored 'General case' 0 N--CA 1.415 -2.207 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.998 -179.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.8 126.33 41.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.294 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.629 ' HE2' HD21 ' A' ' 25' ' ' LEU . 95.3 mttt -76.11 137.99 40.48 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.086 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -73.58 -41.04 63.41 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -173.05 -65.01 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.399 0.619 . . . . 0.0 109.844 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.85 63.7 3.17 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.555 -176.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.557 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 23.3 t 69.48 -168.11 0.17 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.867 1.267 . . . . 0.0 112.691 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.629 HD21 ' HE2' ' A' ' 20' ' ' LYS . 2.5 mm? -73.51 159.28 33.41 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.743 0.817 . . . . 0.0 110.757 -177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.7 38.37 3.13 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.417 HD11 HD13 ' A' ' 64' ' ' ILE . 23.8 pt -137.1 144.51 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.666 0 CA-C-O 121.454 0.645 . . . . 0.0 111.343 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.423 ' HB2' HG12 ' A' ' 53' ' ' ILE . 28.3 t -106.17 115.22 29.84 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.77 148.65 16.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.858 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.1 t -150.0 167.84 25.56 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.883 HG12 ' HA ' ' A' ' 82' ' ' THR . 13.6 p -120.88 114.12 42.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 121.337 0.589 . . . . 0.0 110.227 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.81 86.23 7.37 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 36' ' ' GLY . 55.8 t80 -161.82 108.37 1.34 Allowed 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.919 -174.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -88.59 -63.94 1.22 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -135.4 9.98 3.45 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 171.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . 162.72 -145.23 10.4 Favored Glycine 0 N--CA 1.423 -2.225 0 N-CA-C 107.989 -2.044 . . . . 0.0 107.989 -177.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.87 164.41 26.55 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.148 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 t -89.94 66.27 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 122.389 1.09 . . . . 0.0 108.759 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -144.26 108.5 4.79 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -82.25 79.57 8.69 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-O 121.985 0.898 . . . . 0.0 111.782 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.5 t -162.17 94.48 0.91 Allowed 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.5 t -139.65 89.64 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 -175.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -134.43 -58.09 0.84 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.018 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.535 ' HD2' HD23 ' A' ' 71' ' ' LEU . 1.7 p-80 -153.71 134.97 14.09 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.524 -176.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.761 ' HA3' ' HA ' ' A' ' 71' ' ' LEU . . . 71.69 -159.02 53.69 Favored Glycine 0 C--O 1.247 0.929 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.654 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.424 ' O ' HG21 ' A' ' 31' ' ' VAL . . . 156.71 26.95 0.03 OUTLIER Glycine 0 C--O 1.217 -0.947 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.693 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.86 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.6 mm -101.87 148.67 7.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.412 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 79.7 t80 -125.13 128.02 47.78 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 122.004 -0.435 . . . . 0.0 111.679 -176.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.99 105.66 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 171.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.59 ' HB2' HG23 ' A' ' 30' ' ' THR . 87.1 tttt -77.93 -40.17 40.48 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.521 -175.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.6 165.06 33.56 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.781 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.1 mm -102.8 109.75 27.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.495 HG21 ' HD2' ' A' ' 54' ' ' PRO . 27.1 mm -72.86 154.24 91.06 Favored Pre-proline 0 C--N 1.294 -1.816 0 C-N-CA 124.601 1.161 . . . . 0.0 110.087 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.495 ' HD2' HG21 ' A' ' 53' ' ' ILE . 87.4 Cg_exo -52.4 -158.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.44 0 C-N-CA 123.383 2.722 . . . . 0.0 113.572 170.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? 76.53 -51.44 0.59 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.684 1.194 . . . . 0.0 111.273 -173.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 130.44 -120.5 3.04 Favored Glycine 0 N--CA 1.414 -2.798 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.78 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . 70.05 -91.13 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.102 0.961 . . . . 0.0 112.897 170.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.973 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -75.34 -37.42 60.7 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.61 -46.36 66.43 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 124.985 1.428 . . . . 0.0 108.702 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 m -70.41 -43.63 69.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.268 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -73.86 -30.12 62.49 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.1 33.44 36.28 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.514 175.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -95.21 -59.32 1.92 Allowed 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.716 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.708 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.7 mt -86.51 131.48 34.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -119.72 161.93 19.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -81.85 144.72 30.82 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 118.751 -1.18 . . . . 0.0 110.555 -177.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.412 ' HA2' ' CZ ' ' A' ' 48' ' ' TYR . . . 102.6 -6.94 52.99 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -176.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -87.4 154.21 20.84 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.39 0.614 . . . . 0.0 111.837 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 69' ' ' ARG . 28.4 mtp-105 -100.45 141.73 32.9 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.896 0.855 . . . . 0.0 112.784 -176.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.86 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 58.9 t -106.55 125.56 62.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.013 -1.448 . . . . 0.0 107.22 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.889 HD12 ' HB2' ' A' ' 102' ' ' GLU . 28.3 mt -100.94 -35.5 9.37 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.991 -176.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.527 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -160.7 166.52 28.65 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.87 HG22 HD12 ' A' ' 78' ' ' LEU . 48.1 t -119.13 108.09 23.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 124.841 1.256 . . . . 0.0 108.333 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.5 t30 56.98 52.9 8.62 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.048 0.939 . . . . 0.0 110.559 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.6 -25.08 3.45 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 114.85 -1.068 . . . . 0.0 114.33 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.9 t -81.11 110.85 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 117.686 0.743 . . . . 0.0 109.826 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.478 ' HA ' ' HB3' ' A' ' 72' ' ' ALA . 38.6 m -63.13 140.04 58.83 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.268 0.98 . . . . 0.0 112.106 -175.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.87 HD12 HG22 ' A' ' 73' ' ' VAL . 55.2 mt -110.52 76.32 0.98 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.443 ' HG2' ' H ' ' A' ' 45' ' ' GLY . 38.9 mt-10 -107.1 125.47 51.1 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.27 32.96 81.16 Favored Glycine 0 C--N 1.31 -0.907 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.14 138.18 39.43 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.883 ' HA ' HG12 ' A' ' 31' ' ' VAL . 8.8 t -82.82 159.35 22.46 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 173.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.858 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 39.2 p-80 -52.09 -39.13 59.3 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 123.073 0.233 . . . . 0.0 111.599 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.99 -39.94 91.58 Favored 'General case' 0 C--O 1.206 -1.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.785 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.489 ' HG2' HG21 ' A' ' 82' ' ' THR . 74.8 mm-40 -67.23 -44.7 78.85 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.39 -51.51 69.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.421 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.492 ' HA ' HD11 ' A' ' 90' ' ' LEU . 85.6 t -68.16 -31.83 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.514 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -66.58 -30.67 71.02 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 121.768 -0.582 . . . . 0.0 110.243 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.8 m -76.74 -28.14 55.65 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.183 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 87' ' ' VAL . 95.9 mt -73.37 -33.54 65.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.75 0.785 . . . . 0.0 109.68 175.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.26 -29.45 57.48 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.526 176.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -72.63 -31.81 65.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.85 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.5 p -72.3 163.35 28.1 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.18 -123.8 0.5 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.887 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -94.64 -42.11 8.95 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 122.794 -0.239 . . . . 0.0 111.14 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.36 110.71 27.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.407 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 39.4 t -99.58 121.51 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.199 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.726 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.464 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 42.4 m80 -91.29 98.88 11.98 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 174.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.805 HD13 ' HA ' ' A' ' 73' ' ' VAL . 9.6 tp -101.13 129.36 47.02 Favored 'General case' 0 C--N 1.268 -2.959 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -172.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.746 HD23 HD11 ' A' ' 71' ' ' LEU . 1.8 tt -86.38 109.11 18.79 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.673 HD11 HD21 ' A' ' 99' ' ' LEU . 8.9 mp -115.62 164.89 13.67 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-O 121.504 0.669 . . . . 0.0 111.621 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.889 ' HB2' HD12 ' A' ' 71' ' ' LEU . 35.0 tt0 -131.25 135.64 47.52 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 172.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 39.5 tptt -58.67 114.78 2.66 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -104.17 12.05 51.94 Favored Glycine 0 CA--C 1.482 -1.984 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.79 -167.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -63.88 135.27 56.42 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 31.9 m -70.04 150.39 96.22 Favored Pre-proline 0 C--N 1.303 -1.415 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.534 -175.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.777 2.318 . . . . 0.0 110.992 179.171 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.55 ' CD ' ' HB2' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.422 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.73 ' HG3' HG22 ' A' ' 106' ' ' VAL . 17.1 Cg_endo -55.49 131.55 46.83 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.939 2.426 . . . . 0.0 112.977 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.2 8.44 71.75 Favored Glycine 0 C--N 1.314 -0.691 0 CA-C-N 116.047 -0.524 . . . . 0.0 113.066 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HB2' ' CD ' ' A' ' 9' ' ' LYS . 6.5 t70 -110.59 154.37 23.85 Favored 'General case' 0 CA--C 1.504 -0.811 0 O-C-N 122.395 -0.473 . . . . 0.0 110.001 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.9 p -86.94 135.88 33.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 123.776 0.672 . . . . 0.0 110.534 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -146.85 145.88 30.01 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.078 0.466 . . . . 0.0 110.049 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.75 132.15 52.23 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.9 t -118.71 135.91 57.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.796 -175.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.523 ' HG2' HG12 ' A' ' 96' ' ' VAL . 43.6 tt0 -109.48 86.61 2.32 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 172.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.884 HD13 ' HB1' ' A' ' 57' ' ' ALA . 1.3 tm? -99.14 125.73 44.75 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.609 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -98.3 144.5 27.64 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 120.649 0.262 . . . . 0.0 111.076 -175.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.723 ' HE2' HD13 ' A' ' 25' ' ' LEU . 1.2 mptm? -68.2 143.52 55.3 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.966 177.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.589 HG21 ' HB3' ' A' ' 57' ' ' ALA . 59.0 p -91.58 -165.89 1.45 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.22 -26.11 49.97 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.126 0.57 . . . . 0.0 111.118 173.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.88 56.96 0.73 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.284 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.4 t 77.43 -168.59 0.06 Allowed 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.232 1.413 . . . . 0.0 109.429 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.723 HD13 ' HE2' ' A' ' 20' ' ' LYS . 4.3 mp -66.17 -76.81 0.07 Allowed 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 122.04 0.924 . . . . 0.0 109.787 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.939 ' HA2' ' HD2' ' A' ' 54' ' ' PRO . . . 147.31 -8.58 1.22 Allowed Glycine 0 CA--C 1.463 -3.187 0 C-N-CA 119.757 -1.211 . . . . 0.0 111.181 -172.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 pt -102.71 112.73 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.607 0 CA-C-O 122.722 1.248 . . . . 0.0 112.851 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.7 m -101.31 126.13 48.03 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-N 112.59 -2.096 . . . . 0.0 106.686 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 49' ' ' VAL . 33.7 m -110.91 153.87 12.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.055 0.455 . . . . 0.0 111.586 -173.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.675 ' HB ' ' HD3' ' A' ' 50' ' ' LYS . 11.2 t -121.31 156.46 32.5 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 174.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 82' ' ' THR . 33.1 m -110.69 128.59 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.939 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 pp -163.48 -178.83 6.09 Favored 'General case' 0 C--N 1.271 -2.843 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 16.8 p90 -137.49 -34.73 0.69 Allowed 'General case' 0 C--N 1.274 -2.714 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.337 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -80.86 118.84 22.72 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 41' ' ' SER . 22.5 ttpp -140.37 147.8 40.32 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.92 -112.95 1.59 Allowed Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.76 -124.2 6.72 Favored Glycine 0 C--N 1.299 -1.478 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -81.96 -24.94 9.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.295 0.569 . . . . 0.0 110.8 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -135.46 159.74 40.63 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.4 m -72.07 93.79 1.44 Allowed 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.389 0.614 . . . . 0.0 109.863 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 35' ' ' LYS . 27.0 m -78.52 141.26 38.3 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.555 177.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.2 m -66.15 151.19 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.827 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.492 ' O ' ' HB2' ' A' ' 33' ' ' PHE . 1.9 ptm180 -94.62 1.89 55.6 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.224 -176.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -88.78 91.66 8.91 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 174.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.425 ' HA2' ' OE2' ' A' ' 79' ' ' GLU . . . -158.02 173.48 35.26 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.09 -54.42 0.05 OUTLIER Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.662 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.66 HG13 ' HG ' ' A' ' 78' ' ' LEU . 50.8 mm -102.37 123.78 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.057 -175.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.458 ' CZ ' ' HD3' ' A' ' 69' ' ' ARG . 81.4 m-85 -131.21 114.22 14.81 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.442 ' HA ' HG12 ' A' ' 29' ' ' VAL . 50.1 t -47.86 117.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.481 0.658 . . . . 0.0 109.983 171.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.675 ' HD3' ' HB ' ' A' ' 30' ' ' THR . 38.0 ttpt -92.76 -31.11 15.18 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.331 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -167.64 156.99 10.03 Favored 'General case' 0 C--O 1.249 1.03 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.759 -177.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.814 HG23 ' HB2' ' A' ' 59' ' ' GLU . 16.7 mm -109.88 119.29 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.927 ' HB ' ' HD3' ' A' ' 54' ' ' PRO . 2.7 mp -108.43 -71.06 0.03 OUTLIER Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -172.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.939 ' HD2' ' HA2' ' A' ' 26' ' ' GLY . 45.3 Cg_exo -60.18 -163.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 124.882 3.722 . . . . 0.0 117.692 -172.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -35.61 -50.75 0.62 Allowed 'General case' 0 C--N 1.352 0.71 0 C-N-CA 127.892 2.477 . . . . 0.0 113.455 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.96 -98.77 0.11 Allowed Glycine 0 N--CA 1.415 -2.738 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.884 ' HB1' HD13 ' A' ' 18' ' ' LEU . . . 66.08 -92.34 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.051 1.34 . . . . 0.0 111.314 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.588 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -70.61 -39.84 73.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.814 ' HB2' HG23 ' A' ' 52' ' ' ILE . 35.4 tt0 -76.43 -42.58 43.6 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 123.556 0.535 . . . . 0.0 111.629 -178.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.0 p -74.94 -35.31 62.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.855 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -73.65 -26.57 60.82 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.326 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.07 44.94 86.64 Favored Glycine 0 CA--C 1.49 -1.483 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.996 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -111.25 -54.62 2.59 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.348 0.594 . . . . 0.0 109.556 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.55 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 64.9 mt -101.26 130.1 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.461 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -132.14 173.33 11.34 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 61.3 pttt -74.83 132.03 41.22 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.089 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.27 -20.66 13.8 Favored Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.729 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.44 ' OD1' ' HD2' ' A' ' 103' ' ' LYS . 78.8 m-20 -69.47 138.15 53.2 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.556 0.694 . . . . 0.0 111.683 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.458 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 33.1 ttp180 -95.5 133.88 38.99 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.313 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 71.0 t -101.74 103.94 15.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.474 HD12 ' HB2' ' A' ' 102' ' ' GLU . 84.9 mt -76.87 -36.01 57.04 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.217 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.51 167.36 19.52 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.16 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.7 HG22 HD23 ' A' ' 78' ' ' LEU . 44.3 t -113.33 115.53 50.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 172.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 10.6 p30 47.01 35.36 3.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.424 1.49 . . . . 0.0 112.768 -176.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.62 -6.24 82.18 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.506 -0.854 . . . . 0.0 114.092 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.8 t -92.6 109.64 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.7 m -69.64 134.67 48.99 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -173.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.7 HD23 HG22 ' A' ' 73' ' ' VAL . 1.6 pt? -130.34 17.24 5.45 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.099 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.425 ' OE2' ' HA2' ' A' ' 45' ' ' GLY . 5.4 mm-40 -62.9 97.89 0.12 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.518 175.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.01 17.35 5.02 Favored Glycine 0 N--CA 1.433 -1.524 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.598 -177.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.459 ' HB2' HD12 ' A' ' 47' ' ' ILE . . . -94.34 176.74 6.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.509 ' HA ' HG12 ' A' ' 31' ' ' VAL . 8.8 t -97.18 158.75 15.29 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 169.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -51.16 -44.19 61.41 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.595 0.758 . . . . 0.0 112.381 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 23.8 tptp -55.91 -43.45 77.34 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 123.92 0.888 . . . . 0.0 110.986 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -69.28 -43.9 72.93 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.624 ' HA ' HD13 ' A' ' 78' ' ' LEU . . . -55.24 -54.48 42.9 Favored 'General case' 0 C--O 1.243 0.72 0 O-C-N 124.08 0.862 . . . . 0.0 111.468 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.56 -26.75 36.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.919 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 91.0 mt-10 -72.04 -28.49 63.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.809 177.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.489 HG23 HG13 ' A' ' 73' ' ' VAL . 22.5 m -70.5 -31.41 68.5 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.3 mt -72.72 -24.4 60.98 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.105 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -79.56 -34.24 41.12 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -63.15 -40.63 98.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.71 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.436 ' OG1' HG21 ' A' ' 97' ' ' VAL . 19.4 p -68.94 138.25 54.45 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.8 -121.6 0.02 OUTLIER Glycine 0 CA--C 1.52 0.381 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.787 ' HG3' HG22 ' A' ' 96' ' ' VAL . 14.1 pt20 -77.11 -27.51 54.1 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.512 0.672 . . . . 0.0 110.463 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.787 HG22 ' HG3' ' A' ' 95' ' ' GLN . 21.5 t -125.44 150.02 30.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.53 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 35.8 t -120.26 126.03 74.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 122.921 0.489 . . . . 0.0 109.853 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 41.2 m80 -86.77 119.09 26.63 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 167.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.672 HD23 HD13 ' A' ' 101' ' ' LEU . 7.2 tp -127.93 147.91 50.49 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -110.71 117.86 34.6 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.672 HD13 HD23 ' A' ' 99' ' ' LEU . 6.0 mp -124.77 174.31 7.99 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.526 0.679 . . . . 0.0 111.37 -178.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.474 ' HB2' HD12 ' A' ' 71' ' ' LEU . 31.0 tt0 -131.6 130.62 42.42 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 102.761 -3.051 . . . . 0.0 102.761 173.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.44 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 40.6 tptt -64.09 126.25 27.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -175.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.68 16.37 14.02 Favored Glycine 0 C--N 1.301 -1.378 0 C-N-CA 121.016 -0.612 . . . . 0.0 113.314 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -168.38 165.68 12.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.73 HG22 ' HG3' ' A' ' 10' ' ' PRO . 48.2 t -103.24 121.72 47.78 Favored Pre-proline 0 C--N 1.303 -1.413 0 O-C-N 123.148 0.28 . . . . 0.0 110.739 177.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo . . . . . 0 N--CA 1.437 -1.804 0 C-N-CA 122.671 2.248 . . . . 0.0 109.634 173.401 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 N--CA 1.446 -0.673 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.649 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 37.8 Cg_exo -56.57 128.85 31.73 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 121.143 1.229 . . . . 0.0 109.82 175.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.82 -13.81 45.74 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.178 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.23 134.29 42.69 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 117.053 0.426 . . . . 0.0 110.398 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 17.3 p -102.3 111.13 23.3 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-O 121.74 0.781 . . . . 0.0 110.451 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.407 ' CE2' ' HB ' ' A' ' 16' ' ' VAL . 44.8 p90 -125.61 162.96 23.81 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.858 -177.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 40.1 mt-10 -108.07 94.12 4.9 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 12.4 p -80.09 135.07 26.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.408 -175.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -90.18 108.33 19.68 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.597 HD22 ' HA ' ' A' ' 58' ' ' ALA . 2.1 tm? -113.9 108.12 16.62 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.32 149.69 22.88 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.528 ' HD2' ' HA ' ' A' ' 24' ' ' SER . 27.3 mmtp -71.07 114.9 9.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 56' ' ' GLY . 2.9 t -74.88 -33.06 62.0 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 118.173 -1.411 . . . . 0.0 108.722 -177.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -174.74 -35.85 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.676 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.7 48.52 0.98 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.673 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.528 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 22.6 t 58.93 -152.99 0.39 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.818 0.847 . . . . 0.0 110.561 177.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.589 HD11 HD12 ' A' ' 18' ' ' LEU . 2.9 mm? -71.33 111.01 6.32 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.57 ' H ' ' HB2' ' A' ' 57' ' ' ALA . . . -78.02 46.33 2.66 Favored Glycine 0 C--N 1.296 -1.692 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.401 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.747 HG21 HG13 ' A' ' 52' ' ' ILE . 14.1 pt -141.11 148.64 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 CA-C-O 121.253 0.549 . . . . 0.0 110.197 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 32.4 t -117.85 124.25 47.88 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.6 m -115.59 150.55 17.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.564 -175.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.614 HG21 ' HB2' ' A' ' 50' ' ' LYS . 10.3 t -130.04 153.41 48.46 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 81' ' ' ALA . 8.3 p -114.29 118.59 58.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.715 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.424 HD21 HG23 ' A' ' 30' ' ' THR . 1.9 mm? -121.88 118.83 29.89 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.606 -178.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -122.8 29.28 6.9 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 122.383 1.087 . . . . 0.0 108.886 173.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -80.96 166.71 20.59 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.989 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -111.75 155.53 23.36 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.68 115.21 5.63 Favored Glycine 0 C--O 1.241 0.561 0 O-C-N 123.833 0.708 . . . . 0.0 112.306 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.71 -25.53 2.82 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.432 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.13 -79.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.075 0.464 . . . . 0.0 110.657 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -97.55 -47.2 5.74 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -132.4 159.22 39.89 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.217 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.7 p -99.43 -37.18 9.32 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 121.199 0.524 . . . . 0.0 110.397 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.3 m -98.48 79.69 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -177.55 170.96 1.98 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.098 173.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -154.86 179.12 9.41 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.14 -163.29 32.77 Favored Glycine 0 N--CA 1.417 -2.627 0 C-N-CA 118.252 -1.928 . . . . 0.0 114.17 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -168.21 -101.95 0.15 Allowed Glycine 0 CA--C 1.471 -2.703 0 N-CA-C 104.507 -3.437 . . . . 0.0 104.507 178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.761 HG13 HD12 ' A' ' 78' ' ' LEU . 38.6 mm -81.93 114.61 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 167.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.402 ' OH ' ' HA2' ' A' ' 67' ' ' GLY . 66.5 t80 -119.86 131.16 55.19 Favored 'General case' 0 C--N 1.275 -2.661 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.762 -169.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.484 HG22 ' CG2' ' A' ' 64' ' ' ILE . 46.5 t -75.16 107.38 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-O 121.557 0.694 . . . . 0.0 109.28 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.614 ' HB2' HG21 ' A' ' 30' ' ' THR . 87.2 tttt -89.06 -34.95 16.6 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.407 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 28' ' ' SER . . . -154.32 156.36 36.8 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.397 -176.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.872 HG22 ' HB2' ' A' ' 59' ' ' GLU . 1.9 mp -116.98 124.48 73.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 O-C-N 123.31 0.381 . . . . 0.0 110.093 174.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.38 121.93 85.79 Favored Pre-proline 0 C--O 1.257 1.491 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.181 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -55.12 129.19 33.96 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 123.368 2.712 . . . . 0.0 112.103 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 tptp 65.33 11.45 7.31 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.631 1.172 . . . . 0.0 112.049 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.584 ' O ' HG22 ' A' ' 21' ' ' THR . . . -76.43 -56.16 4.38 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.11 176.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.57 ' HB2' ' H ' ' A' ' 26' ' ' GLY . . . -178.23 -69.08 0.01 OUTLIER 'General case' 0 C--O 1.188 -2.14 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.597 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -50.31 -42.63 52.92 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.872 ' HB2' HG22 ' A' ' 52' ' ' ILE . 35.4 tt0 -82.86 -40.49 20.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.963 0.887 . . . . 0.0 109.869 -177.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.28 -44.0 66.06 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.899 -173.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.81 -34.41 57.92 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.078 0.942 . . . . 0.0 108.469 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.06 56.08 2.26 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.263 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -121.6 -73.41 0.65 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.813 0.816 . . . . 0.0 110.739 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.484 ' CG2' HG22 ' A' ' 49' ' ' VAL . 53.1 mt -94.74 148.01 5.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.266 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -143.8 172.6 12.62 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.462 1.105 . . . . 0.0 108.131 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' A' ' 50' ' ' LYS . 56.4 mtpt -64.78 133.01 51.11 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 123.521 0.513 . . . . 0.0 110.624 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.402 ' HA2' ' OH ' ' A' ' 48' ' ' TYR . . . 111.94 -20.73 21.6 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 119.966 -1.112 . . . . 0.0 113.833 176.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.517 ' OD2' ' HA ' ' A' ' 103' ' ' LYS . 0.5 OUTLIER -85.51 149.21 25.54 Favored 'General case' 0 C--O 1.253 1.268 0 CA-C-O 121.754 0.787 . . . . 0.0 113.099 -179.266 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.442 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 78.5 ttt180 -102.81 138.73 39.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.498 -171.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 58.7 t -111.04 127.1 68.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.68 HD12 ' HB2' ' A' ' 102' ' ' GLU . 66.1 mt -110.3 -30.78 7.56 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.796 0.808 . . . . 0.0 109.837 -177.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.733 ' HB1' ' HB3' ' A' ' 100' ' ' LEU . . . -161.22 172.4 16.74 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.325 -174.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.737 HG13 ' CG2' ' A' ' 89' ' ' THR . 4.7 p -118.32 114.35 44.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 125.261 1.424 . . . . 0.0 107.487 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.837 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 32.1 p30 35.26 46.39 0.24 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.98 -11.0 64.18 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.597 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.47 ' HB ' HG11 ' A' ' 73' ' ' VAL . 43.1 t -101.33 114.94 42.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.2 m -75.79 145.01 41.06 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -173.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.761 HD12 HG13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.25 31.67 4.59 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.693 -1.139 . . . . 0.0 112.113 174.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -69.04 95.18 0.7 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.275 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.02 16.63 7.76 Favored Glycine 0 C--N 1.302 -1.34 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.508 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -88.6 171.1 10.28 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.453 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 27.9 p -96.46 162.56 13.43 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 173.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -51.8 -41.12 61.47 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.35 0.595 . . . . 0.0 110.491 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.47 -36.95 79.71 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.75 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 11.9 mm-40 -66.39 -41.18 89.72 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.014 0.435 . . . . 0.0 110.255 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.544 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -52.75 -60.24 3.5 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.14 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.98 -30.65 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.219 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 91' ' ' ARG . 10.2 tp10 -67.76 -38.71 83.8 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.737 ' CG2' HG13 ' A' ' 73' ' ' VAL . 27.0 m -71.87 -36.62 70.16 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.5 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 61.5 mt -72.97 -19.46 61.22 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.454 0.645 . . . . 0.0 110.794 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -92.43 -26.8 17.84 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.451 0.643 . . . . 0.0 110.814 -179.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -84.31 -21.44 31.0 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -69.14 -42.93 75.33 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.33 -156.59 27.02 Favored Glycine 0 CA--C 1.487 -1.66 0 C-N-CA 120.263 -0.97 . . . . 0.0 110.928 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HA ' ' HG2' ' A' ' 20' ' ' LYS . 3.4 pt20 -88.06 -37.27 16.42 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.719 0.259 . . . . 0.0 111.515 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 43.9 t -106.91 109.47 28.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.66 119.67 60.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.613 -172.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.837 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 31.4 m170 -81.84 137.28 35.29 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 168.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 7.6 mp -122.41 148.88 44.57 Favored 'General case' 0 C--N 1.264 -3.131 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.733 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 3.4 tm? -99.04 109.05 21.85 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 13' ' ' THR . 7.3 mp -110.65 162.79 14.38 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.181 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.68 ' HB2' HD12 ' A' ' 71' ' ' LEU . 39.7 tt0 -123.34 124.76 43.67 Favored 'General case' 0 N--CA 1.404 -2.766 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 173.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.649 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 4.6 tmtm? -55.96 113.41 1.5 Allowed 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 124.286 0.991 . . . . 0.0 108.363 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -84.36 -162.56 34.71 Favored Glycine 0 N--CA 1.427 -1.925 0 CA-C-N 114.603 -1.18 . . . . 0.0 113.318 -174.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -138.39 145.3 40.86 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -177.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.05 144.22 47.04 Favored Pre-proline 0 C--N 1.293 -1.89 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.49 -170.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.401 ' HG3' ' OH ' ' A' ' 48' ' ' TYR . 13.0 Cg_exo . . . . . 0 C--O 1.25 1.121 0 C-N-CA 122.8 2.334 . . . . 0.0 110.637 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.394 61.2 mtpt . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.896 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 87.2 Cg_exo -50.41 113.59 1.1 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.231 1.954 . . . . 0.0 112.13 171.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.01 9.41 65.79 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.699 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 24.0 t70 -121.39 162.21 20.79 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.424 HG22 HD13 ' A' ' 71' ' ' LEU . 4.5 p -91.44 139.72 30.45 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 123.812 0.845 . . . . 0.0 111.335 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.583 ' HE2' ' HB2' ' A' ' 103' ' ' LYS . 48.2 p90 -157.51 154.43 28.62 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 39.7 mt-10 -110.06 148.51 31.57 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.5 HG22 HD12 ' A' ' 101' ' ' LEU . 59.9 t -127.25 124.97 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.513 ' HG2' ' HD2' ' A' ' 98' ' ' HIS . 43.1 mt-10 -96.76 91.56 5.74 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.914 HD22 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -102.57 122.03 43.57 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.21 141.51 31.89 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.112 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.419 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 1.5 mptm? -71.75 138.2 48.28 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.935 0.874 . . . . 0.0 112.526 177.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 23' ' ' GLY . 3.7 t -135.69 143.55 45.47 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 171.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 21' ' ' THR . 9.6 t70 77.93 -35.67 0.2 Allowed 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 123.651 0.781 . . . . 0.0 110.469 -173.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 21' ' ' THR . . . 119.7 11.39 7.18 Favored Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -127.6 151.53 48.8 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 115.241 -0.479 . . . . 0.0 109.897 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.538 HD12 ' HB3' ' A' ' 18' ' ' LEU . 13.7 tp -91.05 121.33 32.76 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 170.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -71.91 46.62 0.96 Allowed Glycine 0 C--O 1.211 -1.341 0 N-CA-C 115.451 0.941 . . . . 0.0 115.451 -173.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.407 HG21 ' CD1' ' A' ' 52' ' ' ILE . 6.9 pt -139.3 134.37 40.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 117.706 0.753 . . . . 0.0 111.461 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.511 ' HB2' HD13 ' A' ' 53' ' ' ILE . 33.7 t -104.09 119.26 38.55 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.451 HG11 HG22 ' A' ' 49' ' ' VAL . 22.7 m -114.23 151.44 16.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.028 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.4 t -134.7 177.2 7.97 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 172.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.581 HG11 HD11 ' A' ' 47' ' ' ILE . 16.2 m -88.72 -56.55 5.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 17.5 mt -171.85 132.85 0.72 Allowed 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 128.059 2.544 . . . . 0.0 107.392 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -83.41 -36.63 24.11 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -127.03 96.66 4.68 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.301 0.572 . . . . 0.0 110.529 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -108.42 95.13 5.46 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 174.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.43 163.9 26.36 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.61 31.38 58.71 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 42' ' ' VAL . 39.7 t -107.06 82.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 CA-C-O 121.107 0.479 . . . . 0.0 110.448 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -128.3 -70.36 0.69 Allowed 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.6 p -91.3 -35.86 14.21 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 p -89.31 88.18 7.4 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.522 ' HA ' HG13 ' A' ' 38' ' ' VAL . 22.0 t -77.65 81.98 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 121.932 0.872 . . . . 0.0 109.542 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -99.7 82.35 2.6 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.954 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -110.78 148.16 32.94 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.4 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.606 ' HA3' ' HE1' ' A' ' 48' ' ' TYR . . . -147.64 144.26 12.23 Favored Glycine 0 N--CA 1.413 -2.841 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' HA3' ' HG2' ' A' ' 79' ' ' GLU . . . -67.59 -83.0 0.13 Allowed Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.474 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.917 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.1 mm -119.13 142.78 32.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.606 ' HE1' ' HA3' ' A' ' 45' ' ' GLY . 50.4 m-85 -128.7 113.37 15.29 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 174.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.451 HG22 HG11 ' A' ' 29' ' ' VAL . 58.8 t -51.47 114.97 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 169.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -91.11 -30.38 16.76 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.905 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -158.34 159.99 36.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.88 HG21 ' HB2' ' A' ' 59' ' ' GLU . 45.3 mm -110.1 120.49 61.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.523 HG22 ' HB2' ' A' ' 55' ' ' LYS . 1.8 mp -68.16 131.2 92.16 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.65 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 30.5 Cg_exo -69.35 60.12 1.45 Allowed 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 124.009 3.139 . . . . 0.0 112.267 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.523 ' HB2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -138.95 19.62 2.64 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.7 -147.28 25.1 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.492 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB3' HD13 ' A' ' 18' ' ' LEU . . . 73.71 -91.05 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 125.329 1.452 . . . . 0.0 112.273 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.914 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -76.44 -36.85 57.74 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.326 -172.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.88 ' HB2' HG21 ' A' ' 52' ' ' ILE . 27.7 tt0 -78.85 -38.97 36.61 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 120.806 0.336 . . . . 0.0 110.655 -176.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -76.73 -27.83 55.57 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.109 0.481 . . . . 0.0 112.031 -175.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -87.98 -14.43 39.16 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.21 56.58 20.7 Favored Glycine 0 CA--C 1.497 -1.077 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.014 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -120.47 -46.48 2.38 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.168 0.509 . . . . 0.0 110.007 -177.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.54 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 53.3 mt -110.78 136.28 47.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.458 ' HA ' HD12 ' A' ' 52' ' ' ILE . 32.3 m-70 -134.56 177.85 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.814 0.696 . . . . 0.0 109.155 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -67.05 125.16 25.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.744 0.783 . . . . 0.0 110.237 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.82 21.0 17.19 Favored Glycine 0 N--CA 1.416 -2.669 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.016 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -97.58 142.44 29.39 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.962 -1.317 . . . . 0.0 110.424 167.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.614 ' HB2' ' HA3' ' A' ' 104' ' ' GLY . 6.7 ttm180 -92.83 138.58 31.36 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.917 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 55.9 t -106.93 115.67 48.95 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.462 HD12 HD21 ' A' ' 100' ' ' LEU . 96.8 mt -86.45 -37.54 18.22 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.955 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.721 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . . . -167.31 176.06 6.93 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.097 -175.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.527 ' HA ' HD12 ' A' ' 99' ' ' LEU . 21.1 t -118.94 118.69 58.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 175.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.6 p30 47.48 40.45 11.23 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 124.513 1.125 . . . . 0.0 113.771 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.65 -6.68 79.72 Favored Glycine 0 C--N 1.315 -0.636 0 C-N-CA 120.849 -0.691 . . . . 0.0 114.344 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 48.7 t -91.49 104.25 15.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.532 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 19.7 m -50.43 123.17 8.13 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.603 1.161 . . . . 0.0 113.3 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.721 ' HB3' ' HA ' ' A' ' 72' ' ' ALA . 22.3 tp -117.68 1.36 12.2 Favored 'General case' 1 N--CA 1.366 -4.64 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.844 -172.88 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.406 ' HG2' ' HA3' ' A' ' 46' ' ' GLY . 19.1 mt-10 -74.22 113.88 11.93 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.18 -0.16 11.54 Favored Glycine 0 C--N 1.298 -1.566 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -172.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.1 164.82 12.71 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.441 ' HA ' HG12 ' A' ' 31' ' ' VAL . 15.3 t -101.01 160.08 14.68 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 170.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 21.8 p80 -50.65 -45.43 57.89 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -58.94 -39.14 80.7 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.537 0.335 . . . . 0.0 110.1 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.44 ' HG2' HG22 ' A' ' 82' ' ' THR . 16.2 mm-40 -71.8 -36.41 70.28 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.106 0.479 . . . . 0.0 110.137 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.584 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -59.85 -47.09 87.12 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.419 ' HA ' HD13 ' A' ' 90' ' ' LEU . 95.8 t -67.48 -28.77 43.24 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.252 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.22 -30.2 69.22 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.26 0.552 . . . . 0.0 110.336 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -78.55 -25.21 45.36 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 80.8 mt -74.81 -23.51 58.49 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.712 0.768 . . . . 0.0 109.182 173.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -84.72 -29.34 25.64 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.462 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.66 -45.44 92.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.822 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.405 ' OG1' HG22 ' A' ' 97' ' ' VAL . 40.1 p -71.44 153.64 42.11 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.07 -119.55 0.91 Allowed Glycine 0 N--CA 1.426 -1.996 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.31 -175.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -79.8 -34.87 39.25 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.221 -0.489 . . . . 0.0 110.489 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -116.33 126.27 73.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.087 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.419 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 39.3 t -101.63 126.76 55.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.513 ' HD2' ' HG2' ' A' ' 17' ' ' GLU . 63.1 m80 -101.19 52.95 0.84 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.738 HD21 HD11 ' A' ' 101' ' ' LEU . 7.7 tp -61.84 149.47 40.11 Favored 'General case' 0 C--O 1.206 -1.227 0 C-N-CA 125.062 1.345 . . . . 0.0 111.18 -172.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.462 HD21 HD12 ' A' ' 71' ' ' LEU . 2.4 tt -110.43 118.77 37.16 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.738 HD11 HD21 ' A' ' 99' ' ' LEU . 6.4 mp -124.24 174.34 7.76 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.341 1.067 . . . . 0.0 112.567 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 30.8 tt0 -133.07 148.74 52.18 Favored 'General case' 0 N--CA 1.403 -2.824 0 N-CA-C 101.846 -3.39 . . . . 0.0 101.846 171.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.896 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -82.38 84.77 7.04 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 172.572 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.614 ' HA3' ' HB2' ' A' ' 69' ' ' ARG . . . -77.07 102.13 1.65 Allowed Glycine 0 CA--C 1.47 -2.732 0 CA-C-N 112.859 -1.973 . . . . 0.0 113.67 -170.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -65.72 178.06 1.12 Allowed 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.211 0.529 . . . . 0.0 110.261 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.5 t -75.7 126.92 86.69 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo . . . . . 0 C--O 1.258 1.492 0 C-N-CA 123.127 2.551 . . . . 0.0 112.579 -178.017 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.971 ' HG3' ' HD3' ' A' ' 10' ' ' PRO 0.282 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.833 0 CA-C-O 119.506 -0.283 . . . . 0.0 111.625 . . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.971 ' HD3' ' HG3' ' A' ' 9' ' ' LYS . 21.4 Cg_exo -70.05 125.84 12.44 Favored 'Trans proline' 0 C--N 1.355 0.892 0 N-CA-C 108.247 -1.482 . . . . 0.0 108.247 169.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.18 7.78 84.66 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.135 -177.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.3 t70 -92.4 145.56 24.37 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 2.9 p -105.0 114.89 29.37 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.372 0.606 . . . . 0.0 112.026 -176.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.444 ' HE1' ' HB2' ' A' ' 103' ' ' LYS . 24.3 p90 -147.37 153.1 39.25 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.261 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.508 ' HG3' ' HG ' ' A' ' 100' ' ' LEU . 2.5 mp0 -91.26 108.57 19.97 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 t -76.1 136.47 24.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.49 96.47 8.01 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 175.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.69 ' HB3' HD12 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -117.66 117.59 29.8 Favored 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -178.227 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -104.09 171.07 7.55 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -176.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.82 111.81 6.53 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 172.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.9 m -117.16 97.41 5.91 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.62 -176.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t70 67.64 -61.45 0.36 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.711 1.204 . . . . 0.0 112.605 175.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.69 35.04 5.2 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 178.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.3 p 64.48 -155.43 0.3 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.986 1.714 . . . . 0.0 112.321 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.69 HD12 ' HB3' ' A' ' 18' ' ' LEU . 13.5 tp -73.6 104.63 4.61 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.606 ' H ' ' HB2' ' A' ' 57' ' ' ALA . . . -74.48 53.17 2.35 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.046 -0.979 . . . . 0.0 115.167 -174.052 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.562 HG21 ' HB3' ' A' ' 58' ' ' ALA . 4.8 pt -136.45 133.88 49.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.231 0.539 . . . . 0.0 111.763 177.35 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 t -104.15 111.32 23.87 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.7 m -106.4 152.9 7.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.039 -174.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.463 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.9 t -134.08 167.86 19.88 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.75 HG11 ' HA ' ' A' ' 82' ' ' THR . 5.7 p -121.13 147.15 25.17 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.498 HD21 ' CD1' ' A' ' 48' ' ' TYR . 4.6 mm? -99.52 88.02 3.75 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 122.042 0.925 . . . . 0.0 109.034 173.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -109.62 -36.17 6.02 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.937 -1.483 . . . . 0.0 107.523 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.3 75.07 9.36 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 175.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -163.19 -48.3 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -176.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.43 -144.38 24.43 Favored Glycine 0 N--CA 1.427 -1.916 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.143 175.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.85 25.92 26.56 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 -177.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.16 90.31 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.7 t30 173.81 -53.71 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -178.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 42' ' ' VAL . 1.4 m -118.58 178.51 4.44 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 178.177 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.3 m -78.79 -43.66 24.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 120.189 1.359 . . . . 0.0 108.158 175.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.555 ' O ' ' HB ' ' A' ' 40' ' ' THR . 27.7 m -82.24 159.1 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 171.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -98.31 23.36 8.46 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.777 0.798 . . . . 0.0 109.6 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -63.77 108.04 1.34 Allowed 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.361 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -142.6 108.03 0.51 Allowed Glycine 0 N--CA 1.412 -2.928 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -90.05 -130.05 4.12 Favored Glycine 0 N--CA 1.429 -1.811 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.931 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.7 mm -102.53 143.14 15.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -178.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.498 ' CD1' HD21 ' A' ' 32' ' ' LEU . 79.4 m-85 -131.73 108.13 9.26 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.9 t -49.62 116.11 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.533 0.682 . . . . 0.0 109.675 171.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -92.2 -33.19 14.8 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.856 -175.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.73 153.29 31.03 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.029 -176.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.979 HG22 ' HB2' ' A' ' 59' ' ' GLU . 31.7 mm -110.67 132.07 60.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.8 mm -79.31 121.98 83.56 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.16 144.14 95.38 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 123.057 2.505 . . . . 0.0 111.146 178.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.53 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 24.0 tptp 59.27 30.16 19.85 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.883 1.325 . . . . 0.0 109.651 -178.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.87 -115.32 4.04 Favored Glycine 0 N--CA 1.406 -3.358 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.55 -177.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.606 ' HB2' ' H ' ' A' ' 26' ' ' GLY . . . -132.15 -65.1 0.75 Allowed 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.924 -0.638 . . . . 0.0 111.629 -172.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.762 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -54.33 -36.28 63.6 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -171.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.979 ' HB2' HG22 ' A' ' 52' ' ' ILE . 38.1 tt0 -95.54 -40.91 9.21 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 122.341 1.067 . . . . 0.0 110.304 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.6 m -79.71 -44.11 21.4 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.426 -168.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -101.17 -35.04 9.44 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.92 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.86 -128.64 6.43 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 116.519 1.368 . . . . 0.0 116.519 -167.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -147.79 -23.1 0.36 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.893 -1.153 . . . . 0.0 110.693 -165.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.762 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.6 mt -69.74 141.33 17.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.915 -173.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -134.64 -176.66 4.3 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.037 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -67.83 121.69 16.55 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 123.41 0.684 . . . . 0.0 111.296 -179.434 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.58 -6.94 31.75 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.442 -0.885 . . . . 0.0 114.179 177.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.752 ' HB3' HD23 ' A' ' 101' ' ' LEU . 66.3 m-20 -64.64 130.96 45.58 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-O 121.682 0.753 . . . . 0.0 112.067 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.476 ' HG3' ' CE2' ' A' ' 48' ' ' TYR . 48.3 ttt180 -92.22 129.92 38.05 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.997 -174.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.931 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 64.3 t -109.36 126.65 66.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -107.43 -34.91 6.92 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.128 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . . . -150.32 157.07 42.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.596 0.713 . . . . 0.0 112.132 -176.107 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.786 ' HA ' HD12 ' A' ' 99' ' ' LEU . 61.7 t -109.82 100.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 173.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 t30 59.54 34.37 22.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.55 1.14 . . . . 0.0 110.504 176.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.22 -23.18 35.25 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.478 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.9 t -84.25 106.5 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 20.0 m -75.2 138.24 41.82 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 121.616 0.722 . . . . 0.0 112.106 -175.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.728 ' N ' HD23 ' A' ' 78' ' ' LEU . 1.1 pt? -130.75 74.22 1.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.649 1.214 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -90.39 96.36 10.62 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.084 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.29 39.18 4.31 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.1 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -103.5 147.38 27.22 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.75 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.9 t -69.04 146.66 52.47 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 18.4 p80 -50.95 -35.45 33.56 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -177.398 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.526 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 54.6 mtmt -62.48 -38.91 91.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.257 176.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -76.21 -31.27 58.33 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.464 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -55.29 -53.69 52.9 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.646 ' HA ' HD11 ' A' ' 90' ' ' LEU . 86.0 t -64.48 -29.02 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.002 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 43.6 mm-40 -70.85 -33.19 70.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.164 0.507 . . . . 0.0 110.253 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.6 m -69.67 -35.15 74.9 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.668 HD13 HD21 ' A' ' 25' ' ' LEU . 81.3 mt -67.66 -34.57 77.2 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 123.918 0.887 . . . . 0.0 109.375 178.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -66.9 -35.39 79.9 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.7 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.11 -34.32 66.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.122 176.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.408 HG21 HG12 ' A' ' 97' ' ' VAL . 18.6 m -57.77 -51.65 68.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 123.702 0.801 . . . . 0.0 110.636 -179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.19 -150.32 17.62 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 120.079 -1.058 . . . . 0.0 112.893 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -77.78 -39.64 43.34 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 122.961 0.504 . . . . 0.0 110.765 -178.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 60.3 t -106.7 119.73 56.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.2 175.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.598 HG11 HD23 ' A' ' 90' ' ' LEU . 58.2 t -104.26 127.54 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-O 121.509 0.671 . . . . 0.0 110.213 -176.411 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -97.4 120.22 37.36 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 169.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 73' ' ' VAL . 9.0 tp -121.54 133.3 55.02 Favored 'General case' 0 C--N 1.261 -3.24 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 72' ' ' ALA . 2.1 tt -94.15 110.31 22.04 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -175.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.752 HD23 ' HB3' ' A' ' 68' ' ' ASP . 10.1 mp -115.11 170.4 8.39 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.834 0.826 . . . . 0.0 111.774 -176.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 36.6 tt0 -129.64 103.33 6.79 Favored 'General case' 0 N--CA 1.4 -2.931 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 171.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.444 ' HB2' ' HE1' ' A' ' 14' ' ' PHE . 22.4 tptm -48.65 121.38 4.52 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 124.194 0.934 . . . . 0.0 112.353 -170.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.14 37.57 3.55 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.292 -172.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -93.33 154.2 18.12 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.45 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 34.8 m -73.47 129.23 85.97 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 123.363 0.414 . . . . 0.0 110.249 176.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 6.2 Cg_exo . . . . . 0 N--CA 1.444 -1.39 0 C-N-CA 122.898 2.398 . . . . 0.0 110.389 177.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.86 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 95.6 mttt . . . . . 0 CA--C 1.553 1.078 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.86 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 17.4 Cg_exo -63.43 111.87 1.59 Allowed 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.989 2.459 . . . . 0.0 114.462 -168.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.17 0.89 63.11 Favored Glycine 0 N--CA 1.427 -1.933 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.07 174.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.597 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 32.1 t0 -108.95 158.86 17.3 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.4 p -93.92 115.18 27.53 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-O 122.224 1.011 . . . . 0.0 110.375 177.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.548 ' CE1' ' HB ' ' A' ' 16' ' ' VAL . 44.8 p90 -123.49 159.72 28.48 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.699 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 41.2 mt-10 -102.1 109.11 20.73 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.552 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 7.5 p -89.98 119.83 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 121.378 0.609 . . . . 0.0 111.084 -174.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -87.47 91.92 8.9 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.516 -178.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.439 HD13 ' CB ' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -108.77 114.95 29.16 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.461 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.19 141.35 32.07 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.447 ' HE3' ' O ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -72.94 130.55 40.63 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.079 177.937 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.2 p -112.48 -158.78 0.66 Allowed 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -53.69 -30.01 41.56 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 123.497 0.719 . . . . 0.0 111.573 175.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.28 16.56 49.08 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.84 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 t 70.28 -143.9 0.08 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.648 ' HG ' HD11 ' A' ' 90' ' ' LEU . 3.6 mm? -64.44 -31.61 72.89 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.92 0.782 . . . . 0.0 109.725 177.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.36 5.14 79.88 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.152 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.0 pt -125.38 144.99 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-O 122.418 1.104 . . . . 0.0 113.193 -175.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.507 ' HB2' ' HB2' ' A' ' 51' ' ' ALA . 66.0 m -104.63 114.69 29.07 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 113.081 -1.872 . . . . 0.0 106.861 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.4 m -102.85 147.94 8.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-O 121.134 0.493 . . . . 0.0 111.531 -178.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.553 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 13.6 t -118.08 171.05 8.36 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.401 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.793 ' HA ' HD11 ' A' ' 47' ' ' ILE . 4.1 t -90.5 -41.48 13.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 177.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.528 HD21 ' HA ' ' A' ' 42' ' ' VAL . 23.4 tp -164.48 -21.08 0.03 OUTLIER 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.506 174.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -80.28 73.82 7.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.043 0.925 . . . . 0.0 113.118 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -87.24 143.41 27.29 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 172.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -75.58 113.86 13.48 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.237 0.541 . . . . 0.0 111.896 -174.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.57 -128.6 1.74 Allowed Glycine 0 N--CA 1.428 -1.889 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 177.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -118.05 -127.81 3.85 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 176.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.71 117.64 48.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.496 ' HA ' HG22 ' A' ' 42' ' ' VAL . 5.3 m-20 68.69 26.65 6.13 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.859 0.863 . . . . 0.0 112.913 178.037 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.3 m -70.19 -43.12 71.4 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 176.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.3 m -128.36 95.94 4.29 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.277 177.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.528 ' HA ' HD21 ' A' ' 32' ' ' LEU . 11.6 t -142.0 33.51 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 177.745 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -98.21 124.7 42.93 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 113.824 -1.534 . . . . 0.0 108.651 177.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -74.78 130.12 38.9 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.298 0.571 . . . . 0.0 112.062 -175.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.87 -50.13 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -178.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 145.82 -65.63 0.43 Allowed Glycine 0 CA--C 1.48 -2.151 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 174.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.793 HD11 ' HA ' ' A' ' 31' ' ' VAL . 24.7 mm -137.58 149.64 25.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 178.579 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -136.05 151.62 50.03 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 118.324 0.511 . . . . 0.0 110.688 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.529 HG21 ' CG2' ' A' ' 64' ' ' ILE . 21.6 t -79.31 109.03 13.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 87.6 tttt -83.14 -37.13 24.15 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.768 -175.282 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.507 ' HB2' ' HB2' ' A' ' 28' ' ' SER . . . -153.37 148.05 26.28 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.994 -178.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.554 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 49.8 mm -112.72 122.07 66.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.425 HD13 ' N ' ' A' ' 53' ' ' ILE . 1.9 mp -90.69 129.03 46.12 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.99 139.26 34.07 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.198 2.598 . . . . 0.0 111.299 177.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.0 tptt 67.8 -0.35 2.02 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.915 0.886 . . . . 0.0 111.803 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.42 102.57 2.94 Favored Glycine 0 N--CA 1.419 -2.484 0 CA-C-O 119.422 -0.654 . . . . 0.0 112.946 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 25' ' ' LEU . . . 26.49 -76.26 0.0 OUTLIER 'General case' 0 C--O 1.181 -2.526 0 C-N-CA 128.312 2.645 . . . . 0.0 115.028 170.16 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . . . -50.28 -39.0 44.08 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.554 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 9.7 tp10 -76.59 -43.66 37.7 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.136 0.575 . . . . 0.0 110.201 178.207 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -67.23 -50.27 61.35 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.29 -177.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.43 -36.96 79.81 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.5 179.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.72 53.99 4.76 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.088 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.493 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 1.0 OUTLIER -115.87 -74.61 0.6 Allowed 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.442 0.639 . . . . 0.0 109.341 -176.878 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.597 ' HB ' ' HB3' ' A' ' 58' ' ' ALA . 62.5 mt -86.26 140.95 15.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -144.71 -172.57 3.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.265 176.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.53 ' O ' ' HD2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -65.94 129.27 39.21 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.326 0.584 . . . . 0.0 112.522 -175.076 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.39 -7.77 62.01 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.203 174.257 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.594 ' HB3' HD21 ' A' ' 101' ' ' LEU . 10.1 m-20 -64.02 138.1 58.3 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-N 117.472 0.636 . . . . 0.0 112.452 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -88.19 115.86 25.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.779 -175.025 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.418 HG21 HD13 ' A' ' 101' ' ' LEU . 43.9 t -100.1 112.7 33.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.29 -37.55 10.94 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.594 -178.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 100' ' ' LEU . . . -157.99 -179.79 8.46 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.382 -175.105 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 1.057 HG11 HG23 ' A' ' 89' ' ' THR . 2.4 p -130.13 102.69 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 125.561 1.544 . . . . 0.0 110.192 -178.182 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t30 58.95 37.61 24.57 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.247 1.022 . . . . 0.0 111.057 174.084 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.9 -12.0 70.3 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.574 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.578 ' HB ' HG12 ' A' ' 73' ' ' VAL . 59.0 t -93.25 125.41 45.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.5 m -71.02 145.13 50.16 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.267 0.556 . . . . 0.0 112.457 -174.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 61.9 mt -111.91 27.21 9.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.721 0.772 . . . . 0.0 110.304 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -78.11 118.1 20.04 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.126 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.4 19.74 51.25 Favored Glycine 0 C--N 1.309 -0.917 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.98 -171.27 2.19 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.502 ' HA ' HG22 ' A' ' 31' ' ' VAL . 15.2 t -150.32 175.48 11.78 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.332 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -50.37 -55.58 15.05 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.892 0.745 . . . . 0.0 111.151 -179.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -53.26 -45.45 68.82 Favored 'General case' 0 C--O 1.21 -1.0 0 O-C-N 123.898 0.749 . . . . 0.0 110.92 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -70.12 -43.96 69.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.618 0.247 . . . . 0.0 111.466 -176.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -58.42 -50.05 75.1 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.492 178.194 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 89.5 t -66.83 -37.21 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.178 -178.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -63.45 -36.54 84.08 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.093 0.473 . . . . 0.0 109.981 178.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 1.057 HG23 HG11 ' A' ' 73' ' ' VAL . 89.8 m -68.89 -37.82 79.24 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.576 177.295 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.651 HD23 HD21 ' A' ' 99' ' ' LEU . 83.8 mt -71.23 -19.84 62.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.661 0.743 . . . . 0.0 109.858 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -85.29 -47.67 9.82 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.64 177.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.68 -12.09 60.13 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -29.98 65.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.09 -138.26 10.66 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.617 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.447 ' O ' ' HE3' ' A' ' 20' ' ' LYS . 24.3 tp60 -86.39 -35.7 19.62 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.858 0.361 . . . . 0.0 110.365 -176.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.4 t -124.44 147.76 28.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -175.527 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.0 t -129.46 146.72 33.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.552 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 11.9 m-70 -115.75 70.08 0.74 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.155 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.651 HD21 HD23 ' A' ' 90' ' ' LEU . 5.0 mp -63.61 150.98 42.89 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.727 -175.2 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.551 ' HB3' ' HB1' ' A' ' 72' ' ' ALA . 62.7 tp -93.99 108.98 20.74 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 68' ' ' ASP . 8.1 mp -127.1 147.39 50.17 Favored 'General case' 0 CA--C 1.474 -1.971 0 CA-C-O 121.476 0.655 . . . . 0.0 111.71 -175.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.597 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 38.0 tt0 -113.66 115.44 27.87 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 103.769 -2.678 . . . . 0.0 103.769 174.11 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.697 ' HD2' ' HG3' ' A' ' 105' ' ' GLN . 2.8 tmtm? -49.36 116.6 1.79 Allowed 'General case' 0 C--O 1.245 0.849 0 O-C-N 124.324 1.015 . . . . 0.0 111.721 -172.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -102.43 80.24 0.37 Allowed Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 114.129 -1.396 . . . . 0.0 113.112 -174.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.697 ' HG3' ' HD2' ' A' ' 103' ' ' LYS . 88.7 mt-30 -99.38 101.94 13.37 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.43 0.633 . . . . 0.0 110.112 175.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.8 m -127.81 103.2 21.67 Favored Pre-proline 0 N--CA 1.422 -1.864 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.59 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 C--O 1.244 0.784 0 C-N-CA 122.759 2.306 . . . . 0.0 110.27 178.008 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.1 mttt . . . . . 0 N--CA 1.422 -1.871 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 1.053 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 9.4 Cg_endo -51.5 131.48 37.01 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.257 2.638 . . . . 0.0 113.671 -177.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.63 4.84 60.41 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 116.222 -0.444 . . . . 0.0 113.009 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -106.93 152.12 24.36 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.443 HG21 HD11 ' A' ' 71' ' ' LEU . 18.5 p -88.05 110.52 20.69 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.372 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -114.51 143.45 44.94 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 121.308 0.575 . . . . 0.0 111.564 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -101.99 121.38 42.05 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.495 HG13 HD13 ' A' ' 64' ' ' ILE . 30.0 t -110.95 129.66 65.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.207 -174.441 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 95.39 5.8 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.013 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -97.06 119.37 35.41 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.808 -173.649 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.21 117.98 30.9 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.543 ' HB3' ' HA ' ' A' ' 24' ' ' SER . 94.5 mttt -56.29 121.82 10.4 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.006 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.6 m -92.28 -78.95 0.4 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.437 -174.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -126.38 -56.32 1.42 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.51 30.83 6.52 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 177.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.543 ' HA ' ' HB3' ' A' ' 20' ' ' LYS 0.286 97.8 p 66.19 -105.97 0.11 Allowed 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 126.367 1.867 . . . . 0.0 112.107 -179.988 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.687 HD12 ' HB3' ' A' ' 90' ' ' LEU . 81.8 mt -96.83 128.43 43.78 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 176.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 52' ' ' ILE . . . -81.56 8.36 59.19 Favored Glycine 0 C--N 1.294 -1.804 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.761 -176.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.7 pt -99.55 115.69 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.32 -177.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.488 ' HB2' HG12 ' A' ' 53' ' ' ILE . 23.4 t -88.7 124.18 33.86 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 175.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.76 -174.68 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -173.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -170.75 150.48 3.28 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 178.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG13 ' HA ' ' A' ' 82' ' ' THR . 7.3 p -120.79 117.45 53.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-O 121.209 0.528 . . . . 0.0 110.252 177.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.275 0.9 OUTLIER -128.98 95.08 3.98 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 122.282 1.039 . . . . 0.0 113.744 177.798 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -83.5 -18.16 39.45 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 169.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -174.81 142.12 0.66 Allowed 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 128.457 2.703 . . . . 0.0 104.785 174.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -144.34 13.73 1.6 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.97 81.56 0.53 Allowed Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -177.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -92.58 -172.7 41.26 Favored Glycine 0 C--N 1.301 -1.386 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.074 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.34 -36.97 15.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -169.71 34.33 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 175.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.2 m -85.15 94.46 8.88 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 113.044 -1.889 . . . . 0.0 108.229 -176.158 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.3 m -84.23 68.01 10.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.851 0.834 . . . . 0.0 112.792 -174.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.5 t -82.56 129.7 37.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -117.29 -43.36 2.84 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -117.22 115.99 26.39 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.66 140.59 11.75 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -178.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 79' ' ' GLU . . . -104.12 -134.18 8.08 Favored Glycine 0 N--CA 1.416 -2.696 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.127 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.831 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.5 mm -101.38 148.29 7.42 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 179.207 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -133.35 147.23 51.81 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 118.385 0.539 . . . . 0.0 109.874 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.413 HG23 HG23 ' A' ' 64' ' ' ILE . 59.7 t -81.29 115.3 23.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -85.69 -34.48 21.27 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.594 -177.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.93 169.85 12.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.04 -176.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 1.01 HG23 ' HB2' ' A' ' 59' ' ' GLU . 20.5 mm -114.36 116.2 51.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 177.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.828 ' HB ' ' HD3' ' A' ' 54' ' ' PRO . 42.2 mm -84.5 -71.91 0.1 OUTLIER Pre-proline 0 CA--C 1.562 1.426 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -169.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.828 ' HD3' ' HB ' ' A' ' 53' ' ' ILE . 6.2 Cg_exo -78.74 -160.87 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.715 2.277 . . . . 0.0 113.306 -172.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -36.44 -55.46 0.83 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.082 1.353 . . . . 0.0 112.132 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.61 ' HA3' ' OG ' ' A' ' 60' ' ' SER . . . -171.71 -87.26 0.07 OUTLIER Glycine 0 N--CA 1.403 -3.565 0 C-N-CA 119.556 -1.306 . . . . 0.0 111.964 176.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.663 ' HB2' HD13 ' A' ' 18' ' ' LEU . . . 68.53 -85.28 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 124.486 1.114 . . . . 0.0 108.949 -177.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 1.013 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -78.14 -29.44 48.74 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.717 -177.606 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.01 ' HB2' HG23 ' A' ' 52' ' ' ILE . 43.6 tt0 -73.75 -63.14 1.27 Allowed 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 124.602 1.189 . . . . 0.0 111.608 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.61 ' OG ' ' HA3' ' A' ' 56' ' ' GLY . 6.8 p -86.21 -30.38 22.44 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -168.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -100.54 -35.77 9.41 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -174.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.25 -128.52 3.35 Favored Glycine 1 N--CA 1.393 -4.229 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.301 -175.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -157.84 3.94 0.12 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -170.07 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.593 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 61.5 mt -94.78 138.94 19.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.388 -168.028 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.58 179.01 6.19 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -70.43 128.38 35.99 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.295 0.569 . . . . 0.0 109.999 176.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.13 -20.48 12.75 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.726 -178.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.628 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 50.5 m-20 -64.65 136.83 57.39 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.504 0.668 . . . . 0.0 112.411 -177.375 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -93.84 135.93 34.65 Favored 'General case' 0 C--O 1.195 -1.785 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.473 -176.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.831 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 62.2 t -106.53 119.51 56.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.589 HD13 HD23 ' A' ' 100' ' ' LEU . 82.8 mt -97.43 -44.38 6.88 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.55 -1.205 . . . . 0.0 108.781 -177.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . . . -152.26 165.08 36.01 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.011 -173.453 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.72 HG23 HD22 ' A' ' 78' ' ' LEU . 39.0 t -116.28 111.27 34.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 173.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.2 p30 47.27 35.91 4.22 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.02 1.328 . . . . 0.0 112.354 -176.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.09 -16.23 61.22 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.121 -1.038 . . . . 0.0 114.393 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.39 109.29 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -70.23 137.51 50.91 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.358 0.411 . . . . 0.0 111.235 -174.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.72 HD22 HG23 ' A' ' 73' ' ' VAL . 1.7 pt? -130.6 22.24 5.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.654 177.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.475 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 32.4 mt-10 -68.48 105.14 2.11 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.26 16.63 6.04 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.796 -176.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.61 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -98.94 167.52 10.69 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 175.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.618 ' HA ' HG13 ' A' ' 31' ' ' VAL . 9.0 t -90.78 170.17 10.34 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -50.3 -49.54 53.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.465 1.106 . . . . 0.0 109.667 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.408 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 10.9 mptt -64.13 -35.17 79.89 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.15 -176.119 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.532 ' HG3' HG21 ' A' ' 82' ' ' THR . 56.2 mt-30 -70.02 -42.59 72.79 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 78' ' ' LEU . . . -54.26 -58.79 6.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.023 178.096 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.42 -28.5 43.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.191 -177.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 66.1 mm-40 -68.75 -34.38 75.49 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.537 177.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.494 HG22 HG13 ' A' ' 73' ' ' VAL . 37.8 m -69.51 -29.94 67.68 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.687 ' HB3' HD12 ' A' ' 25' ' ' LEU . 81.4 mt -77.0 -16.55 59.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.961 177.22 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -93.25 -26.94 17.13 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.6 176.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -67.28 -42.22 84.15 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.6 p -65.92 146.23 54.97 Favored 'General case' 0 C--O 1.252 1.208 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.958 177.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.9 -128.98 0.88 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -172.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -69.3 -54.4 14.82 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.44 0.696 . . . . 0.0 111.803 -174.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -106.2 115.51 48.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.574 HG21 HD13 ' A' ' 25' ' ' LEU . 46.0 t -99.0 126.5 52.21 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -91.96 123.39 35.28 Favored 'General case' 0 N--CA 1.404 -2.729 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 175.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.713 HD11 ' HA ' ' A' ' 73' ' ' VAL . 7.6 tp -126.53 143.36 51.23 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.589 HD23 HD13 ' A' ' 71' ' ' LEU . 1.6 tt -105.1 116.1 31.39 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.5 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.565 HD13 HD23 ' A' ' 99' ' ' LEU . 6.6 mp -121.46 176.07 5.86 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.51 0.671 . . . . 0.0 111.873 -177.242 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -131.27 126.85 36.49 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 172.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 1.053 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 15.1 mmtt -57.3 127.01 29.83 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.545 0.528 . . . . 0.0 111.433 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -132.32 97.6 0.34 Allowed Glycine 0 N--CA 1.418 -2.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.561 -178.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -86.62 -172.18 3.89 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 171.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.83 83.68 59.17 Favored Pre-proline 0 C--N 1.295 -1.801 0 CA-C-O 121.474 0.654 . . . . 0.0 110.716 177.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 N--CA 1.433 -2.067 0 C-N-CA 123.205 2.603 . . . . 0.0 111.513 -177.287 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt . . . . . 0 CA--C 1.508 -0.646 0 N-CA-C 104.122 -2.548 . . . . 0.0 104.122 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 23.7 Cg_exo -63.31 130.29 28.12 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 CA-C-N 120.932 1.369 . . . . 0.0 109.875 177.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.39 9.22 87.18 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.222 -176.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 38.0 t70 -90.97 147.28 23.2 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.555 HG22 HD11 ' A' ' 71' ' ' LEU . 6.1 p -80.65 137.53 36.34 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.071 0.463 . . . . 0.0 111.887 -175.105 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -139.39 140.7 37.5 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.119 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.538 ' HB3' ' NE2' ' A' ' 98' ' ' HIS . 45.3 mt-10 -106.41 114.23 28.23 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.919 -179.168 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 101' ' ' LEU . 7.7 p -113.44 131.71 64.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.127 -175.31 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 98' ' ' HIS . 40.8 tt0 -110.52 99.56 8.53 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 175.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.901 HD23 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -93.66 124.14 37.45 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -173.17 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -98.31 116.07 29.75 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 14.9 ptmt -79.79 145.88 32.59 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.466 -175.009 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -84.87 -55.27 4.16 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.339 0.59 . . . . 0.0 109.963 -175.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 9.1 p-10 -111.11 -145.77 0.4 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.637 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.22 20.08 11.43 Favored Glycine 0 C--N 1.305 -1.189 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.237 178.344 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 20.0 m -122.42 130.38 53.03 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.763 HD11 ' HB3' ' A' ' 18' ' ' LEU . 22.0 tp -81.26 -5.28 57.61 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.012 0.911 . . . . 0.0 108.904 178.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.71 7.25 69.07 Favored Glycine 0 N--CA 1.421 -2.354 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.196 175.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.424 ' HB ' HG12 ' A' ' 49' ' ' VAL . 19.2 pt -132.59 148.21 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 CA-C-O 121.252 0.549 . . . . 0.0 110.495 179.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.5 t -116.79 120.41 38.46 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 176.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.97 170.34 3.89 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-O 120.71 0.29 . . . . 0.0 110.966 -176.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -145.45 169.71 17.81 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 171.414 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.598 HG23 ' H ' ' A' ' 32' ' ' LEU . 30.8 m -72.43 -65.67 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 118.709 -1.196 . . . . 0.0 108.858 173.271 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.598 ' H ' HG23 ' A' ' 31' ' ' VAL . 43.4 tp -172.21 146.4 1.88 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 172.431 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -156.8 -76.51 0.09 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.513 -176.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.71 145.88 29.35 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.805 -179.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -114.61 -1.07 13.44 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.81 -173.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.26 -104.65 1.78 Allowed Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -176.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -136.15 24.01 3.29 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.858 178.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.505 HG11 ' H ' ' A' ' 40' ' ' THR . 66.8 t -108.57 142.29 21.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -72.98 -33.03 65.57 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 122.783 0.433 . . . . 0.0 111.595 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.505 ' H ' HG11 ' A' ' 38' ' ' VAL . 4.8 t -118.0 96.43 5.34 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-O 122.456 1.122 . . . . 0.0 111.029 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -131.05 81.77 2.01 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.755 177.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 p -160.85 108.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.174 177.804 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -127.43 40.84 3.63 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -178.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.451 ' HB3' ' NH2' ' A' ' 69' ' ' ARG . 56.2 t-80 75.55 101.63 0.07 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 111.499 -2.591 . . . . 0.0 109.983 -172.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.628 ' HA2' ' HE1' ' A' ' 48' ' ' TYR . . . -81.12 73.25 2.61 Favored Glycine 0 N--CA 1.424 -2.139 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.862 -177.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.87 -75.75 0.79 Allowed Glycine 0 N--CA 1.423 -2.168 0 N-CA-C 107.504 -2.238 . . . . 0.0 107.504 175.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.655 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 30.7 mm -145.24 134.49 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 174.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.628 ' HE1' ' HA2' ' A' ' 45' ' ' GLY . 39.3 m-85 -125.45 139.88 53.26 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.483 HG22 ' CG2' ' A' ' 64' ' ' ILE . 40.1 t -75.17 117.76 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.169 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -93.02 -31.66 14.79 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.087 -174.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . . . -158.06 162.67 38.09 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.875 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.718 HD12 ' HA ' ' A' ' 65' ' ' HIS . 49.4 mm -107.52 120.11 58.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 177.584 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 50.0 mm -77.53 124.15 86.71 Favored Pre-proline 0 C--O 1.252 1.216 0 C-N-CA 122.956 0.502 . . . . 0.0 110.741 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 4.9 Cg_exo -74.84 74.3 3.96 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 124.192 3.261 . . . . 0.0 115.53 -174.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HD3' HG23 ' A' ' 53' ' ' ILE . 2.1 mptm? -116.59 -82.3 0.62 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.204 0.526 . . . . 0.0 110.108 171.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.561 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 172.59 49.59 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 119.781 -1.2 . . . . 0.0 112.142 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HB2' ' CD1' ' A' ' 18' ' ' LEU . . . -126.36 -96.4 0.43 Allowed 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.967 -179.211 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.901 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -61.05 -36.13 78.77 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.609 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 40.5 tt0 -72.13 -46.87 54.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.557 0.743 . . . . 0.0 110.465 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.561 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 13.5 m -77.88 -35.85 50.42 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.209 -173.538 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.13 -23.89 47.63 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.9 59.77 4.93 Favored Glycine 0 CA--C 1.498 -1.03 0 CA-C-N 113.98 -1.464 . . . . 0.0 113.471 171.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -120.5 -69.81 0.82 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.948 0.88 . . . . 0.0 108.797 -178.581 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.483 ' CG2' HG22 ' A' ' 49' ' ' VAL . 68.6 mt -90.36 141.73 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.783 -178.377 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.718 ' HA ' HD12 ' A' ' 52' ' ' ILE . 33.1 t-80 -139.45 176.15 8.96 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 175.154 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 51' ' ' ALA . 51.5 pttt -73.56 142.87 46.63 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.835 -178.521 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.48 -22.68 21.86 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.931 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 39.1 m-20 -72.63 142.35 48.33 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.91 0.386 . . . . 0.0 112.035 -178.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.451 ' NH2' ' HB3' ' A' ' 44' ' ' HIS . 1.3 tmt_? -101.09 136.58 40.7 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.018 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.655 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.1 t -103.97 121.44 55.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -175.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.555 HD11 HG22 ' A' ' 13' ' ' THR . 90.2 mt -83.47 -42.16 17.21 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.452 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 76' ' ' VAL . . . -170.07 176.09 4.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.703 -175.329 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 1.1 HG12 HG22 ' A' ' 89' ' ' THR . 2.7 p -112.92 105.96 19.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 124.038 0.935 . . . . 0.0 109.901 178.18 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.457 ' H ' ' HA ' ' A' ' 99' ' ' LEU . 57.9 t30 52.41 40.95 30.45 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.771 1.272 . . . . 0.0 110.765 178.849 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.93 -18.24 41.09 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.538 -178.497 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.693 ' HB ' HG13 ' A' ' 73' ' ' VAL . 49.1 t -77.67 109.09 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.0 m -61.57 122.51 15.44 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.905 -173.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.0 mt -90.6 74.74 6.72 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -85.37 96.68 9.63 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.649 -174.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.17 47.86 69.27 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -178.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.72 147.57 24.42 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.688 HG22 ' HG2' ' A' ' 85' ' ' GLN . 13.9 t -91.06 164.55 13.91 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 172.118 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -43.48 -54.74 4.62 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.409 1.484 . . . . 0.0 112.538 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 36.8 ttmt -63.66 -34.99 79.07 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -176.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.688 ' HG2' HG22 ' A' ' 82' ' ' THR . 82.5 mm-40 -68.85 -43.26 75.79 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.168 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.593 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -55.0 -54.52 41.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.391 176.105 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.73 -35.88 76.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.725 -177.082 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 36.8 mt-10 -69.39 -32.53 71.62 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.521 179.219 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 1.1 HG22 HG12 ' A' ' 73' ' ' VAL . 60.2 m -66.86 -36.74 83.02 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 60.3 mt -75.74 -15.11 60.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 0.0 110.011 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -89.11 -45.83 9.3 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.607 176.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -69.18 -35.92 76.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.687 -176.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -53.41 -51.91 61.07 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 122.918 0.487 . . . . 0.0 112.185 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.57 -154.24 25.84 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.604 177.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 51.1 tt0 -76.61 -44.94 32.18 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.61 0.719 . . . . 0.0 109.748 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 21.3 t -106.08 116.31 49.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.8 131.97 65.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -174.457 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 9.5 t60 -96.91 136.97 36.71 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 175.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.533 HD12 HD22 ' A' ' 90' ' ' LEU . 6.5 mp -130.44 154.3 47.88 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.123 0.487 . . . . 0.0 109.823 174.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.497 ' HG ' ' HB2' ' A' ' 71' ' ' LEU . 55.3 tp -110.14 118.95 37.75 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.406 HD11 HG11 ' A' ' 16' ' ' VAL . 7.4 mp -130.25 178.83 6.28 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.377 0.608 . . . . 0.0 110.527 -178.189 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 9.2 pt-20 -130.49 153.43 48.82 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 172.582 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 10' ' ' PRO . 5.6 tmtm? -61.52 109.95 1.33 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.931 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -73.95 -178.51 38.11 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.596 -177.084 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -147.58 132.31 17.91 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 -175.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 30.0 m -84.78 135.8 39.83 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -168.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 26.2 Cg_exo . . . . . 0 C--O 1.245 0.848 0 C-N-CA 123.472 2.781 . . . . 0.0 109.754 173.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt . . . . . 0 C--O 1.246 0.878 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.81 111.11 1.61 Allowed 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 121.819 1.68 . . . . 0.0 109.894 173.117 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 103' ' ' LYS . . . 119.21 3.07 13.32 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.314 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -92.36 148.26 22.27 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 122.55 -0.382 . . . . 0.0 110.116 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 p -89.1 109.06 19.96 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 166.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -109.55 100.59 9.62 Favored 'General case' 0 N--CA 1.408 -2.536 0 CA-C-O 122.334 1.064 . . . . 0.0 111.028 -173.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.734 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 45.4 mt-10 -71.51 91.87 1.08 Allowed 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.177 174.269 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.612 HG13 HD13 ' A' ' 101' ' ' LEU . 14.9 p -84.62 138.77 18.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.536 -174.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -108.13 107.73 18.5 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 177.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.842 ' HB3' HD12 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -116.38 130.94 57.03 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.441 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -103.77 132.34 50.11 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.231 -0.293 . . . . 0.0 110.873 -178.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.498 ' HD3' ' O ' ' A' ' 95' ' ' GLN . 1.7 mptm? -60.42 136.44 58.04 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.09 0.471 . . . . 0.0 112.097 175.332 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.6 p -104.11 100.3 10.05 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 169.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 t70 73.06 -49.44 0.7 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.875 1.27 . . . . 0.0 112.203 -177.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.96 0.78 0.03 OUTLIER Glycine 0 C--N 1.306 -1.138 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.927 177.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 39.3 m -108.21 144.0 36.26 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 122.169 -0.606 . . . . 0.0 110.207 -177.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.842 HD12 ' HB3' ' A' ' 18' ' ' LEU . 19.6 tp -93.98 -11.14 31.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.7 13.9 66.39 Favored Glycine 0 N--CA 1.429 -1.797 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.048 175.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.412 HG23 HD12 ' A' ' 52' ' ' ILE . 14.1 pt -139.66 146.25 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.667 0.746 . . . . 0.0 112.487 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.412 ' OG ' HD12 ' A' ' 53' ' ' ILE . 19.6 m -107.02 135.04 49.26 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.412 172.48 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.0 165.23 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 123.772 0.67 . . . . 0.0 109.64 -176.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 1.007 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 6.0 t -149.37 141.8 24.27 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 177.406 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.748 HG13 HD12 ' A' ' 47' ' ' ILE . 32.6 m -121.49 133.67 67.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.204 -0.998 . . . . 0.0 113.514 -176.207 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 43' ' ' ARG . 61.0 mt -110.53 93.97 4.76 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 171.318 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -142.02 -49.91 0.38 Allowed 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -178.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -81.51 162.79 23.08 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.136 173.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -70.23 107.28 3.65 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -178.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 168.46 -176.98 42.68 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.82 -131.44 43.28 Favored Glycine 0 C--O 1.249 1.032 0 O-C-N 124.087 0.522 . . . . 0.0 112.291 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.2 t -82.97 114.29 23.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 175.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -137.43 97.92 3.58 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.965 -175.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.1 p -77.01 -52.13 9.89 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 172.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 t -164.11 -49.05 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.0 p -106.5 166.45 3.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 173.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.493 ' HB3' ' HB3' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -99.87 140.5 33.99 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -176.634 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -84.35 118.01 23.96 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.83 -88.83 0.65 Allowed Glycine 0 N--CA 1.438 -1.19 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.573 177.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 32' ' ' LEU . . . 149.34 -48.32 0.6 Allowed Glycine 0 N--CA 1.418 -2.522 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -178.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.748 HD12 HG13 ' A' ' 31' ' ' VAL . 42.2 mm -115.43 136.12 53.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.561 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.715 ' HB3' ' HA ' ' A' ' 69' ' ' ARG 0.27 38.5 p90 -158.52 169.3 24.74 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 169.295 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.542 HG21 ' CG2' ' A' ' 64' ' ' ILE . 31.8 t -80.59 121.76 34.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.694 -178.111 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 1.007 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 57.8 tptt -91.32 -38.09 12.85 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.468 178.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -156.03 158.58 38.06 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.577 -175.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.422 HD11 ' HA ' ' A' ' 65' ' ' HIS . 45.9 mm -104.05 117.97 50.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.242 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.461 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 43.6 mm -93.29 134.18 27.34 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.726 -179.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 14.9 Cg_exo -72.36 -172.68 0.94 Allowed 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 122.792 2.328 . . . . 0.0 112.186 178.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.5 tptt 92.74 5.35 0.05 Allowed 'General case' 0 C--O 1.242 0.661 0 C-N-CA 126.367 1.867 . . . . 0.0 109.309 176.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.564 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 124.89 -163.83 18.68 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 114.677 -1.147 . . . . 0.0 113.256 173.375 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.495 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 71.66 -114.04 0.07 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 171.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.798 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -60.42 -39.48 87.58 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 117.942 0.337 . . . . 0.0 111.354 -174.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.11 -55.88 16.2 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.38 1.472 . . . . 0.0 110.115 178.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.564 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 20.4 m -73.25 -36.68 66.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -171.349 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -74.17 -28.85 61.49 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.58 51.09 22.35 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.382 176.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.553 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 3.1 mmp_? -104.99 -56.85 2.11 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.672 0.748 . . . . 0.0 110.842 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.542 ' CG2' HG21 ' A' ' 49' ' ' VAL . 56.2 mt -95.04 144.06 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.243 -176.023 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.422 ' HA ' HD11 ' A' ' 52' ' ' ILE . 6.5 p80 -137.0 168.7 19.08 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 173.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -65.74 141.98 58.15 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.279 0.561 . . . . 0.0 111.215 -176.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.7 -40.71 2.44 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.027 -1.083 . . . . 0.0 113.77 176.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 48' ' ' TYR 0.289 8.1 m-20 -67.21 144.52 55.93 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -174.919 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.715 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 34.6 ttp180 -102.19 149.43 24.31 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.694 -165.506 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.5 HG22 ' HG ' ' A' ' 101' ' ' LEU . 22.0 t -115.52 133.36 62.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -173.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.449 HD11 HD23 ' A' ' 100' ' ' LEU . 85.1 mt -96.12 -37.23 10.68 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.148 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.852 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . . . -167.44 179.54 4.91 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.925 -176.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.856 HG23 HD21 ' A' ' 78' ' ' LEU . 60.3 t -123.89 110.33 25.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.021 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.4 t30 59.43 34.94 22.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.666 1.222 . . . . 0.0 109.923 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 -15.43 61.19 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.478 -1.237 . . . . 0.0 114.221 178.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.517 ' O ' ' HB3' ' A' ' 72' ' ' ALA . 57.7 t -85.65 112.47 22.41 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.119 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.421 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 17.5 m -53.96 122.84 10.93 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 124.37 1.044 . . . . 0.0 112.354 -174.149 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.856 HD21 HG23 ' A' ' 73' ' ' VAL . 18.4 tp -118.11 8.95 12.53 Favored 'General case' 0 N--CA 1.379 -3.983 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.695 -173.07 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.74 118.09 15.24 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.47 20.03 11.53 Favored Glycine 0 C--N 1.302 -1.326 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.035 -176.295 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.564 ' HB3' HD11 ' A' ' 47' ' ' ILE . . . -101.01 149.84 23.52 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.424 ' C ' HG11 ' A' ' 31' ' ' VAL . 14.9 t -99.14 174.88 6.11 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -50.34 -54.17 23.52 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.785 0.834 . . . . 0.0 111.172 -173.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 59.2 mtpt -63.45 -32.39 73.82 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.063 -176.004 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -72.34 -46.54 55.09 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.529 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -54.88 -56.29 21.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.606 177.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.98 -29.32 46.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.932 -178.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 34.2 mm-40 -72.28 -26.85 62.14 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.967 177.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.1 m -72.78 -39.75 66.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.72 ' HG ' HG12 ' A' ' 97' ' ' VAL . 8.6 mp -69.97 -18.44 63.34 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.677 1.191 . . . . 0.0 110.883 176.752 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -82.15 -43.13 18.14 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.706 175.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -66.03 -36.07 82.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.316 -177.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.709 ' HG1' HG13 ' A' ' 97' ' ' VAL . 22.3 p -58.89 -55.22 37.89 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.368 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 134.35 -142.73 14.24 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 178.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.498 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 58.9 tt0 -73.09 -55.76 6.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.063 0.459 . . . . 0.0 110.615 178.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 61.6 t -92.09 113.44 27.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.367 -179.396 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.72 HG12 ' HG ' ' A' ' 90' ' ' LEU . 3.0 t -105.66 128.0 60.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.011 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.517 ' CE1' ' HB3' ' A' ' 15' ' ' GLU . 34.9 t-80 -99.16 130.62 45.48 Favored 'General case' 0 C--N 1.258 -3.372 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.48 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.632 HD23 HD13 ' A' ' 90' ' ' LEU . 5.2 mp -128.26 146.17 50.82 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.346 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.734 ' HG ' ' HG2' ' A' ' 15' ' ' GLU . 3.3 tt -98.91 112.67 24.71 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -177.758 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.612 HD13 HG13 ' A' ' 16' ' ' VAL . 9.9 mp -115.27 166.51 11.77 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.237 0.541 . . . . 0.0 111.727 -177.651 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -133.14 152.11 51.96 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 176.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.718 ' HB3' ' HZ3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -54.05 115.26 1.95 Allowed 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.543 0.687 . . . . 0.0 110.334 171.827 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' A' ' 69' ' ' ARG . . . -126.2 1.84 7.75 Favored Glycine 0 C--N 1.292 -1.902 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 176.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -49.93 -37.59 32.51 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 126.856 2.062 . . . . 0.0 111.98 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.79 98.75 49.58 Favored Pre-proline 0 N--CA 1.422 -1.833 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.825 -178.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 N--CA 1.448 -1.163 0 C-N-CA 122.12 1.88 . . . . 0.0 110.546 174.01 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.559 ' HZ1' ' HB2' ' A' ' 9' ' ' LYS . 9.8 mtmp? . . . . . 0 N--CA 1.427 -1.58 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.853 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 73.3 Cg_exo -50.76 128.62 24.74 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 121.481 1.454 . . . . 0.0 110.522 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.55 -15.54 58.54 Favored Glycine 0 C--N 1.31 -0.885 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.68 -175.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.9 131.57 41.6 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 p -91.18 133.45 35.36 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.383 0.611 . . . . 0.0 111.902 -174.128 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -143.88 149.22 36.57 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.425 177.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -106.33 117.84 35.09 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.75 115.63 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.08 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.406 178.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.5 91.28 5.38 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.229 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.964 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -100.7 119.69 38.96 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.138 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.44 124.09 34.16 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.133 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.454 ' HG2' HD21 ' A' ' 25' ' ' LEU . 92.9 mttt -65.52 144.13 57.21 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.145 0.498 . . . . 0.0 111.607 -179.502 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.475 HG21 ' HG3' ' A' ' 55' ' ' LYS . 6.2 m -61.89 -42.1 98.67 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.568 177.139 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -163.05 -49.45 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.785 176.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.31 -9.24 0.68 Allowed Glycine 0 C--O 1.242 0.597 0 C-N-CA 119.524 -1.322 . . . . 0.0 113.538 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 m -132.73 150.64 52.13 Favored 'General case' 0 N--CA 1.433 -1.314 0 O-C-N 122.062 -0.669 . . . . 0.0 110.828 -175.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.612 HD13 HD22 ' A' ' 90' ' ' LEU . 72.6 mt -89.74 145.34 25.27 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 169.081 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.83 51.92 4.62 Favored Glycine 0 C--N 1.288 -2.116 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.902 -177.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.48 HD11 HD13 ' A' ' 64' ' ' ILE . 12.2 pt -140.58 142.29 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 CA-C-N 117.87 0.835 . . . . 0.0 111.904 177.569 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 t -117.53 140.95 48.93 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 175.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -126.28 147.96 31.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.761 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 15.1 t -118.84 158.31 25.9 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.612 HG23 ' HA ' ' A' ' 82' ' ' THR . 3.3 t -114.04 127.7 71.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -176.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 mp -116.06 106.92 14.29 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.158 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -70.43 134.55 47.91 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.607 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.98 134.69 53.47 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -114.18 1.94 14.7 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.091 179.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.18 83.6 1.08 Allowed Glycine 0 CA--C 1.507 -0.452 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.418 -177.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -92.71 -6.93 63.45 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 121.226 -0.512 . . . . 0.0 113.955 -174.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.57 -60.04 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.125 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -166.13 -50.08 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.5 p -76.43 113.63 14.25 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.333 0.587 . . . . 0.0 110.757 177.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 m -118.26 140.19 50.19 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.429 -178.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.9 m -79.38 92.77 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-O 122.901 1.334 . . . . 0.0 108.306 174.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -97.43 171.37 8.44 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.663 -171.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.547 ' HB2' HD21 ' A' ' 71' ' ' LEU . 59.5 m80 74.31 95.64 0.07 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.296 173.409 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' A' ' 78' ' ' LEU . . . 87.92 -67.11 3.23 Favored Glycine 0 N--CA 1.426 -1.971 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.352 176.699 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.85 19.14 77.99 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -175.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.524 HD13 HG11 ' A' ' 31' ' ' VAL . 42.1 mm -101.53 133.44 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -176.811 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -129.25 120.3 25.48 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.48 HG22 ' CG2' ' A' ' 64' ' ' ILE . 28.6 t -47.84 113.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 122.036 0.922 . . . . 0.0 109.971 170.732 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.761 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 88.4 tttt -87.41 -37.95 16.57 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.994 -174.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.86 151.44 32.25 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.363 -176.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.562 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 47.4 mm -109.39 128.61 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 O-C-N 123.731 0.644 . . . . 0.0 109.444 178.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 53' ' ' ILE . 2.0 mp -100.93 133.58 20.97 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 175.629 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.494 ' HB2' ' H ' ' A' ' 55' ' ' LYS . 22.6 Cg_exo -65.59 -86.6 0.01 OUTLIER 'Trans proline' 0 C--O 1.255 1.349 0 C-N-CA 121.907 1.738 . . . . 0.0 111.57 176.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' H ' ' HB2' ' A' ' 54' ' ' PRO . 17.8 tptp 65.04 -67.51 0.12 Allowed 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 127.605 2.362 . . . . 0.0 110.481 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.07 38.15 0.02 OUTLIER Glycine 0 C--N 1.277 -2.729 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -179.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.529 ' HB2' HD12 ' A' ' 18' ' ' LEU . . . -134.52 -99.39 0.25 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -174.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.964 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -68.71 -38.69 80.43 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -168.757 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.562 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 36.4 tt0 -84.54 -29.39 25.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.313 0.578 . . . . 0.0 110.162 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.8 m -71.92 -46.26 58.26 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.117 -177.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.57 -24.3 34.05 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.551 0.691 . . . . 0.0 109.853 178.631 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.08 53.43 14.55 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.263 175.046 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -98.96 -46.76 5.5 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.675 1.226 . . . . 0.0 109.345 178.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.48 ' CG2' HG22 ' A' ' 49' ' ' VAL . 39.8 mt -112.8 140.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-N 113.154 -1.839 . . . . 0.0 109.752 -171.706 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -133.87 154.93 50.7 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 176.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 144.25 56.36 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.48 -175.66 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.37 -16.45 38.08 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.975 -178.486 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -80.28 144.45 32.83 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-O 121.034 0.445 . . . . 0.0 111.081 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -90.93 137.33 32.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.813 -175.546 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.494 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 38.5 t -101.18 112.32 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 176.606 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.547 HD21 ' HB2' ' A' ' 44' ' ' HIS . 85.2 mt -85.29 -39.47 17.66 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.668 -177.352 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.681 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -163.37 175.06 11.2 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.144 -176.069 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.662 HG12 ' HG ' ' A' ' 99' ' ' LEU . 23.8 t -130.76 117.87 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 65.32 27.15 12.06 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.455 1.102 . . . . 0.0 110.093 176.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.87 -6.82 79.81 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.557 -177.017 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.21 105.06 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.606 ' HA ' ' HB3' ' A' ' 72' ' ' ALA . 47.6 m -62.07 130.79 47.14 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.355 -174.244 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.681 ' HG ' ' HA ' ' A' ' 72' ' ' ALA . 98.0 mt -87.74 40.54 0.94 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.797 0.808 . . . . 0.0 110.574 -178.093 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' HG3' ' HB3' ' A' ' 77' ' ' SER . 36.2 mt-10 -76.3 112.27 12.62 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.01 32.37 17.79 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -175.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.54 177.78 5.06 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.977 0.894 . . . . 0.0 110.92 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.612 ' HA ' HG23 ' A' ' 31' ' ' VAL . 10.0 t -153.87 -179.52 7.92 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -50.7 -54.17 25.28 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.064 0.853 . . . . 0.0 110.142 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -58.35 -43.6 88.41 Favored 'General case' 0 C--O 1.204 -1.298 0 O-C-N 123.596 0.56 . . . . 0.0 111.638 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.513 ' HG2' HG22 ' A' ' 82' ' ' THR . 13.1 mm-40 -66.23 -47.82 72.56 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.936 -176.427 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 90' ' ' LEU . . . -56.91 -57.37 12.8 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.749 178.052 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.48 -32.68 58.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.378 -175.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -76.44 -19.48 58.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.656 178.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 m -76.44 -35.51 58.45 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.612 HD22 HD13 ' A' ' 25' ' ' LEU . 8.7 mp -70.22 -22.14 62.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.622 0.769 . . . . 0.0 110.239 175.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -84.61 -31.09 24.45 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.572 0.701 . . . . 0.0 109.729 174.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -70.33 -42.37 72.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.565 178.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.6 p -65.07 152.97 42.13 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.88 177.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.67 -157.05 1.07 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 114.678 0.631 . . . . 0.0 114.678 -179.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.402 ' HG3' HG23 ' A' ' 96' ' ' VAL . 20.2 pt20 -68.02 -35.22 77.94 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.463 -0.368 . . . . 0.0 111.581 -177.105 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.402 HG23 ' HG3' ' A' ' 95' ' ' GLN . 48.4 t -105.2 108.52 25.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.095 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.6 t -99.95 134.5 39.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.105 -173.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -104.29 128.09 52.02 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.662 ' HG ' HG12 ' A' ' 73' ' ' VAL . 5.4 mp -123.89 145.29 49.22 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 172.789 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 72' ' ' ALA . 56.5 tp -91.82 109.18 20.51 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 mp -117.66 160.2 21.69 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.401 0.62 . . . . 0.0 110.42 -177.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -131.69 156.6 45.59 Favored 'General case' 0 C--N 1.264 -3.111 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 170.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.853 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -63.45 117.1 6.23 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.215 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.34 -162.12 36.51 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.693 -176.118 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.505 HE21 ' HB3' ' A' ' 10' ' ' PRO . 20.5 mp0 -137.67 149.81 46.85 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.542 ' H ' ' HD2' ' A' ' 107' ' ' PRO . 92.3 t -90.57 -54.79 0.28 Allowed Pre-proline 0 C--N 1.288 -2.077 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.081 -179.495 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.542 ' HD2' ' H ' ' A' ' 106' ' ' VAL . 8.9 Cg_endo . . . . . 0 C--N 1.379 2.178 0 C-N-CA 123.767 2.978 . . . . 0.0 112.993 178.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.686 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 35.7 mmtp . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 3.2 Cg_exo -71.36 88.33 0.73 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.44 2.093 . . . . 0.0 114.625 -171.095 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.506 ' H ' ' HB2' ' A' ' 103' ' ' LYS . . . 118.0 -6.38 15.44 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.88 175.219 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -102.79 160.89 14.2 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -174.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 p -101.9 145.08 29.72 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 165.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -149.04 153.76 38.34 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.433 -176.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -103.47 133.46 48.47 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 179.145 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.487 HG12 HD13 ' A' ' 64' ' ' ILE . 11.0 p -131.56 132.47 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.143 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HG3' ' HD2' ' A' ' 98' ' ' HIS . 49.1 mt-10 -101.46 85.43 2.77 Favored 'General case' 0 CA--C 1.472 -2.039 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 174.582 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.786 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -77.32 120.91 23.0 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.624 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.74 123.61 36.14 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.243 -175.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -68.49 112.48 5.33 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.406 ' CG2' ' HA ' ' A' ' 57' ' ' ALA . 2.1 t -111.35 89.01 2.93 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.196 -175.968 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 t70 79.76 -40.37 0.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.797 -1.547 . . . . 0.0 113.641 178.259 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.76 -98.5 0.99 Allowed Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.489 -0.863 . . . . 0.0 114.078 -179.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.0 m -162.65 -162.17 0.77 Allowed 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 -173.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.786 HD11 ' HB3' ' A' ' 18' ' ' LEU . 1.6 tp -89.34 109.38 20.29 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 171.514 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.685 ' HA3' ' O ' ' A' ' 56' ' ' GLY . . . -75.07 50.85 2.36 Favored Glycine 0 C--N 1.292 -1.866 0 CA-C-N 114.697 -1.138 . . . . 0.0 115.383 -172.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.546 HG21 HG22 ' A' ' 64' ' ' ILE . 10.7 pt -130.11 122.11 53.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 121.749 0.785 . . . . 0.0 111.071 177.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.516 ' HB2' HD11 ' A' ' 53' ' ' ILE . 7.7 t -94.86 124.99 39.23 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 -178.087 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.537 HG22 ' HB2' ' A' ' 83' ' ' HIS . 33.7 m -118.67 156.56 20.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 120.687 0.28 . . . . 0.0 111.41 -174.39 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.409 HG23 ' HB2' ' A' ' 50' ' ' LYS . 10.2 t -141.74 159.37 42.35 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.398 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.702 ' CG2' HD12 ' A' ' 47' ' ' ILE . 21.4 t -120.93 115.65 47.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 120.915 0.388 . . . . 0.0 110.797 177.012 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.414 ' O ' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -142.65 122.0 13.11 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.206 178.453 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.528 ' HZ ' ' HA2' ' A' ' 46' ' ' GLY . 76.5 m-85 -113.54 -68.24 0.94 Allowed 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 176.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -156.23 -169.89 3.19 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -177.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -101.73 7.97 41.71 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.389 0.614 . . . . 0.0 110.983 -174.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.13 38.77 7.16 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -177.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.04 -111.9 0.35 Allowed Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.27 -176.41 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.7 98.71 4.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 122.025 0.916 . . . . 0.0 111.927 -178.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -138.91 136.56 35.61 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 177.6 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.9 t -82.21 73.23 9.25 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 122.902 1.334 . . . . 0.0 111.252 177.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 65.3 m -157.23 85.67 0.94 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.215 -1.357 . . . . 0.0 107.461 176.15 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 p -137.84 73.71 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 CA-C-O 123.362 1.553 . . . . 0.0 108.97 -176.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -91.43 126.19 36.43 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 113.857 -1.52 . . . . 0.0 107.434 178.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -71.68 120.21 16.94 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.067 0.46 . . . . 0.0 110.004 178.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.541 ' HA2' ' HG2' ' A' ' 79' ' ' GLU . . . 156.53 -132.04 3.17 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -178.298 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.528 ' HA2' ' HZ ' ' A' ' 33' ' ' PHE . . . -159.78 -68.08 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.44 0 C-N-CA 117.872 -2.109 . . . . 0.0 115.477 -179.765 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.702 HD12 ' CG2' ' A' ' 31' ' ' VAL . 18.0 mm -100.33 147.22 7.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -164.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -129.43 107.68 9.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.94 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.4 t -48.15 121.76 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.608 0.718 . . . . 0.0 110.521 169.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.409 ' HB2' HG23 ' A' ' 30' ' ' THR . 85.5 tttt -92.63 -37.31 12.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.702 -178.598 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.85 161.83 34.54 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.825 -175.217 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.504 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 20.1 mm -116.08 125.73 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.516 HD11 ' HB2' ' A' ' 28' ' ' SER . 2.0 mp -76.48 134.28 70.0 Favored Pre-proline 0 C--N 1.302 -1.469 0 C-N-CA 122.573 0.349 . . . . 0.0 111.473 -176.813 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 56' ' ' GLY . 52.8 Cg_exo -59.65 130.62 36.11 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 123.107 2.538 . . . . 0.0 110.034 175.634 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 69.74 -4.99 1.29 Allowed 'General case' 0 C--O 1.249 1.043 0 CA-C-O 122.006 0.907 . . . . 0.0 110.654 -177.207 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.685 ' O ' ' HA3' ' A' ' 26' ' ' GLY . . . -85.48 68.34 3.45 Favored Glycine 0 N--CA 1.403 -3.551 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.209 -175.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.503 ' HB3' ' CD1' ' A' ' 18' ' ' LEU . . . 58.82 -75.41 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.698 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 167.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.692 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -58.12 -35.11 70.98 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 125.219 1.407 . . . . 0.0 113.342 -171.793 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.504 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 34.7 tt0 -85.64 -39.96 16.72 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.032 0.444 . . . . 0.0 110.138 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -68.52 -37.32 79.94 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.282 -177.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -82.62 -34.61 27.52 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.714 177.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.89 52.02 3.81 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.688 -0.687 . . . . 0.0 114.242 175.256 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -116.58 -56.8 2.25 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.24 0.543 . . . . 0.0 111.658 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.546 HG22 HG21 ' A' ' 27' ' ' ILE . 21.2 mm -84.07 145.52 8.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.11 -176.635 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -125.33 162.61 24.38 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -77.97 143.1 37.87 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.42 -179.005 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.478 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 103.74 -28.0 17.28 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.478 -179.395 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.8 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 39.5 m-20 -64.53 146.91 53.87 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.687 0.756 . . . . 0.0 111.825 -176.709 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.532 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . 59.9 mtp180 -96.84 146.53 24.83 Favored 'General case' 0 CA--C 1.461 -2.456 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.017 -173.964 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.664 HG23 ' HB ' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -112.74 123.79 68.77 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.132 0 CA-C-N 114.229 -1.35 . . . . 0.0 107.461 176.191 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.557 ' HB2' HD13 ' A' ' 100' ' ' LEU . 65.9 mt -107.96 -24.23 11.7 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.792 -176.195 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.536 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -169.06 173.23 6.98 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.927 -176.032 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.815 HG23 ' HG ' ' A' ' 99' ' ' LEU . 99.4 t -130.29 116.98 38.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 173.56 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 98' ' ' HIS 0.265 10.3 p30 51.31 38.43 21.5 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.331 1.453 . . . . 0.0 112.513 -177.648 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.79 -8.02 77.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 119.928 -1.129 . . . . 0.0 113.881 -179.052 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.54 106.03 14.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.478 ' HA ' ' HB1' ' A' ' 72' ' ' ALA . 49.7 m -63.91 136.79 57.65 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.122 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.672 HD12 HG22 ' A' ' 73' ' ' VAL . 81.3 mt -118.95 16.85 13.4 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.584 178.355 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.541 ' HG2' ' HA2' ' A' ' 45' ' ' GLY . 44.2 mt-10 -67.38 119.47 12.27 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.472 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.5 15.16 58.91 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.301 -177.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.78 159.13 15.09 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 117.474 0.637 . . . . 0.0 109.587 179.42 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.9 t -97.0 158.78 15.26 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 171.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.537 ' HB2' HG22 ' A' ' 29' ' ' VAL 0.272 8.4 p80 -51.1 -45.4 61.49 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -172.197 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.579 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -64.56 -32.4 74.03 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.614 -178.651 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -67.14 -37.67 84.21 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.676 0.75 . . . . 0.0 109.718 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.493 ' HB1' HG13 ' A' ' 47' ' ' ILE . . . -63.61 -46.59 85.05 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.565 176.693 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.5 t -64.37 -34.44 69.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.985 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.137 -178.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.579 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 45.6 mt-10 -60.01 -47.34 86.24 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.518 ' O ' HG23 ' A' ' 93' ' ' THR . 14.0 m -60.7 -39.28 87.94 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.974 0.892 . . . . 0.0 109.739 178.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.602 HD11 ' HB2' ' A' ' 25' ' ' LEU . 4.2 tp -79.27 -9.8 59.66 Favored 'General case' 0 N--CA 1.413 -2.279 0 C-N-CA 124.224 1.01 . . . . 0.0 110.431 -177.105 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -101.13 -18.11 16.35 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -92.71 -11.8 33.07 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.817 179.456 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 89' ' ' THR . 32.1 p -73.16 -177.82 2.65 Favored 'General case' 0 C--O 1.252 1.195 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.407 173.281 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.52 -123.25 2.63 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.166 178.736 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -98.15 -45.86 6.06 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.8 m -95.9 118.07 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.658 0 CA-C-O 121.655 0.74 . . . . 0.0 109.374 176.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.504 HG21 HD13 ' A' ' 90' ' ' LEU . 45.8 t -101.15 113.3 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.481 -178.748 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.515 ' HD2' ' HG3' ' A' ' 17' ' ' GLU . 17.3 t-80 -84.31 58.35 4.76 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.815 ' HG ' HG23 ' A' ' 73' ' ' VAL . 3.8 tt -70.58 142.55 51.72 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.703 -172.42 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' A' ' 71' ' ' LEU . 3.0 tm? -101.77 114.3 28.24 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.475 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.486 HD12 HG11 ' A' ' 16' ' ' VAL . 7.7 mp -111.3 166.43 11.11 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.502 0.668 . . . . 0.0 112.758 -177.199 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 69' ' ' ARG . 36.5 tt0 -132.38 151.32 51.91 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.548 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.519 ' HE2' ' O ' ' A' ' 105' ' ' GLN . 11.3 tmtt? -44.44 123.84 3.78 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 124.1 0.96 . . . . 0.0 111.811 171.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.8 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -126.4 -10.22 4.2 Favored Glycine 0 C--N 1.295 -1.701 0 C-N-CA 119.605 -1.283 . . . . 0.0 111.312 171.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.519 ' O ' ' HE2' ' A' ' 103' ' ' LYS . 10.2 pt20 -89.12 151.17 22.36 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 123.768 0.827 . . . . 0.0 109.698 -178.4 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.4 t 52.84 84.99 0.2 Allowed Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.245 1.018 . . . . 0.0 110.789 -172.01 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo . . . . . 0 C--O 1.253 1.264 0 C-N-CA 124.254 3.303 . . . . 0.0 114.221 -175.964 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt . . . . . 0 C--O 1.242 0.682 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -71.21 135.66 27.54 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 N-CA-C 106.731 -2.065 . . . . 0.0 106.731 165.08 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.78 22.49 39.14 Favored Glycine 0 C--N 1.307 -1.07 0 C-N-CA 119.451 -1.357 . . . . 0.0 111.25 -171.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 20.9 t0 -111.59 147.09 36.2 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.851 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.3 p -91.09 144.92 25.13 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 123.899 0.749 . . . . 0.0 112.74 -174.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.549 ' HE1' ' HG2' ' A' ' 103' ' ' LYS . 17.8 p90 -168.82 134.44 1.69 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.291 175.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 46.1 mt-10 -88.11 104.01 16.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.657 0.742 . . . . 0.0 109.592 175.766 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 5.0 t -71.82 138.85 20.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.647 -178.23 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.18 95.25 5.99 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 173.303 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.701 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -102.5 125.88 49.36 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -174.333 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.47 143.72 27.9 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.525 0.678 . . . . 0.0 111.849 -177.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 1.2 mptm? -71.73 93.13 1.25 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 124.938 1.295 . . . . 0.0 112.417 176.393 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.429 HG22 ' HB1' ' A' ' 57' ' ' ALA . 13.3 t -64.88 -30.15 71.13 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-O 121.755 0.788 . . . . 0.0 109.466 169.019 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 16.4 t70 -112.13 -155.85 0.58 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -178.676 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.41 17.39 58.56 Favored Glycine 0 C--N 1.299 -1.518 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 176.155 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -155.65 174.75 14.83 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -177.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.701 HD11 ' HB3' ' A' ' 18' ' ' LEU . 11.6 tp -94.14 150.31 20.44 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -178.256 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.613 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -81.26 41.52 2.65 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.173 -174.311 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.4 pt -137.39 130.93 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-O 121.625 0.726 . . . . 0.0 111.941 177.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.598 ' HB2' HD11 ' A' ' 53' ' ' ILE . 48.5 t -99.25 124.23 44.15 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.62 152.4 20.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.548 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 7.6 t -131.93 171.62 13.35 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.509 HG23 ' CD1' ' A' ' 47' ' ' ILE . 2.5 t -110.45 134.79 51.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.426 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tt -140.1 71.66 1.38 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -114.92 19.54 15.76 Favored 'General case' 0 C--N 1.258 -3.384 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.898 -177.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -73.93 -17.76 60.98 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.743 -174.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -105.55 6.4 32.2 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.598 0.713 . . . . 0.0 110.522 178.129 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.63 35.93 4.73 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -135.95 94.81 0.24 Allowed Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.0 t -110.11 -73.92 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -139.26 -58.43 0.59 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.239 0.542 . . . . 0.0 109.745 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.471 HG22 HG11 ' A' ' 42' ' ' VAL . 8.8 t -116.25 153.26 32.23 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.342 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 m -69.29 104.39 2.22 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.389 0.614 . . . . 0.0 110.288 -178.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.471 HG11 HG22 ' A' ' 40' ' ' THR . 16.3 m -117.78 -4.1 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.788 176.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.421 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 2.8 tpm_? -118.4 122.58 43.14 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.562 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -105.54 160.77 14.91 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 174.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.88 -144.09 15.74 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -178.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.91 -19.98 7.29 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 119.709 -1.234 . . . . 0.0 113.177 174.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.509 ' CD1' HG23 ' A' ' 31' ' ' VAL . 38.0 mm -101.13 126.86 54.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.097 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.715 ' CE1' ' HG2' ' A' ' 69' ' ' ARG . 61.5 m-85 -132.85 124.17 27.45 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.953 -176.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.447 HG23 ' CG2' ' A' ' 64' ' ' ILE . 41.0 t -48.32 118.97 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 CA-C-O 121.547 0.689 . . . . 0.0 110.586 172.456 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -92.51 -35.46 13.6 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.97 -176.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.33 165.75 30.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.818 -177.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.931 HG22 ' HB2' ' A' ' 59' ' ' GLU . 42.6 mm -110.75 116.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.613 ' HB ' ' HA2' ' A' ' 26' ' ' GLY . 47.4 mm -70.43 116.88 49.63 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.851 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 6.9 Cg_exo -75.4 77.85 3.15 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 123.721 2.947 . . . . 0.0 114.015 -175.846 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.56 ' HD3' HG21 ' A' ' 53' ' ' ILE . 2.1 mptm? -122.53 -23.61 5.14 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.697 170.685 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.638 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 116.62 43.93 0.61 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.479 -179.207 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.45 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . . . -117.94 -87.92 0.62 Allowed 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 117.214 0.507 . . . . 0.0 110.897 -177.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.701 ' HA ' HD23 ' A' ' 18' ' ' LEU . . . -77.09 -27.85 54.34 Favored 'General case' 0 C--O 1.257 1.498 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -171.278 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.931 ' HB2' HG22 ' A' ' 52' ' ' ILE . 40.9 tt0 -83.0 -33.3 26.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.402 0.62 . . . . 0.0 109.808 -179.721 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.638 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 7.4 m -81.84 -26.89 33.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.559 0.695 . . . . 0.0 109.228 -178.373 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.1 -41.19 59.2 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.072 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.08 39.79 9.07 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.072 -1.422 . . . . 0.0 114.579 170.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -120.42 -45.53 2.42 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.067 178.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 58' ' ' ALA . 60.5 mt -94.02 132.16 38.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.003 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.547 ' HA ' HD11 ' A' ' 52' ' ' ILE . 16.4 t-80 -135.43 -174.87 3.75 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -73.54 131.53 41.85 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.27 0.557 . . . . 0.0 110.501 -176.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.03 -17.39 35.12 Favored Glycine 0 N--CA 1.425 -2.085 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.756 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.459 ' HB3' HD21 ' A' ' 101' ' ' LEU . 11.3 m-20 -63.89 136.02 57.03 Favored 'General case' 0 C--O 1.261 1.666 0 CA-C-O 122.031 0.92 . . . . 0.0 112.783 -177.512 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.715 ' HG2' ' CE1' ' A' ' 48' ' ' TYR . 41.8 mtp180 -86.17 118.79 25.85 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.373 -173.026 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.55 108.81 20.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.465 178.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.754 HD12 ' HB2' ' A' ' 102' ' ' GLU . 66.8 mt -86.79 -41.79 13.81 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . . . -160.4 177.19 10.83 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.607 -175.778 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 1.052 HG11 HG23 ' A' ' 89' ' ' THR . 2.9 p -128.95 102.17 7.55 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 C-N-CA 124.106 0.962 . . . . 0.0 109.51 177.426 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.7 t30 51.78 57.21 6.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.186 0.993 . . . . 0.0 109.897 179.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.47 -38.31 3.02 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 114.484 -1.235 . . . . 0.0 114.146 -178.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.446 ' HB ' HG12 ' A' ' 73' ' ' VAL . 43.2 t -72.84 111.57 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.066 0.933 . . . . 0.0 109.773 -175.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.3 p -81.59 113.45 19.62 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.298 0.571 . . . . 0.0 111.265 -178.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.793 HD23 ' H ' ' A' ' 78' ' ' LEU 0.269 0.7 OUTLIER -88.28 92.63 9.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 122.29 1.043 . . . . 0.0 108.957 176.865 . . . . . . . . 4 4 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -101.1 111.08 23.2 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.79 -169.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.8 46.31 94.29 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -177.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.543 ' HB2' ' HG3' ' A' ' 85' ' ' GLN . . . -89.73 167.16 13.1 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 -177.357 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 85' ' ' GLN . 70.8 p -79.7 144.99 33.19 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.725 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 11.1 p-80 -53.08 -37.45 61.68 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.388 0.613 . . . . 0.0 110.021 173.195 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 58.3 tttm -54.41 -54.54 39.32 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.297 -1.32 . . . . 0.0 110.633 173.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.543 ' HG3' ' HB2' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -72.51 -28.71 63.04 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.227 -175.624 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.67 -52.12 64.92 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.779 0.8 . . . . 0.0 109.388 174.048 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.65 -28.43 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.933 177.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 63.2 mm-40 -64.54 -35.8 82.14 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 176.079 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 1.052 HG23 HG11 ' A' ' 73' ' ' VAL . 23.1 m -69.03 -32.72 72.42 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.374 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.4 mt -72.12 -19.75 61.74 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.849 177.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -102.76 -6.12 22.96 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.167 175.265 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -90.33 -20.92 22.34 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 122.481 1.134 . . . . 0.0 108.435 178.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.545 HG22 HG13 ' A' ' 97' ' ' VAL . 2.2 p -83.07 171.12 14.09 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.486 -1.233 . . . . 0.0 109.923 176.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.22 -149.18 11.07 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.222 -176.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.611 ' HG3' HG21 ' A' ' 96' ' ' VAL . 3.7 pt20 -69.03 -36.64 77.96 Favored 'General case' 0 C--O 1.207 -1.176 0 CA-C-O 120.823 0.344 . . . . 0.0 110.787 -178.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.611 HG21 ' HG3' ' A' ' 95' ' ' GLN . 59.0 t -116.44 118.83 60.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.342 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.572 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 40.1 t -100.53 130.1 50.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.082 -177.784 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.511 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 47.6 m80 -93.99 117.17 29.74 Favored 'General case' 0 C--N 1.272 -2.802 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 172.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.773 HD22 HD12 ' A' ' 101' ' ' LEU . 5.2 tp -120.76 133.07 55.35 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -176.676 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 72' ' ' ALA . 45.9 tp -89.84 112.52 23.89 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -176.4 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.773 HD12 HD22 ' A' ' 99' ' ' LEU . 7.1 mp -124.06 165.56 17.28 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.329 0.585 . . . . 0.0 110.569 -179.577 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.754 ' HB2' HD12 ' A' ' 71' ' ' LEU . 28.3 tt0 -131.63 127.99 38.16 Favored 'General case' 0 N--CA 1.397 -3.079 0 N-CA-C 102.646 -3.094 . . . . 0.0 102.646 174.525 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.904 ' HE2' ' HA ' ' A' ' 103' ' ' LYS . 4.4 mmpt? -46.43 110.01 0.24 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -177.609 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -119.9 91.57 0.5 Allowed Glycine 0 N--CA 1.417 -2.631 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.217 -175.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -95.1 -9.13 34.55 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 122.491 1.138 . . . . 0.0 109.352 173.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 16.4 m -144.84 139.74 15.6 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 113.004 -1.907 . . . . 0.0 107.945 177.19 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 1.7 Cg_endo . . . . . 0 C--O 1.248 1.007 0 C-N-CA 123.151 2.567 . . . . 0.0 110.996 176.314 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.558 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 26.7 mtpp . . . . . 0 CA--C 1.56 1.361 0 CA-C-O 119.028 -0.51 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.881 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 26.5 Cg_exo -68.66 66.0 1.2 Allowed 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 121.785 1.657 . . . . 0.0 112.013 172.522 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.33 24.58 0.06 OUTLIER Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 175.062 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 18.2 t70 -90.38 139.76 30.36 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.884 -0.658 . . . . 0.0 110.474 -177.599 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 5.6 p -100.81 119.27 38.4 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 123.945 0.778 . . . . 0.0 110.346 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -150.72 145.84 26.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.555 -178.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 50.0 mt-10 -77.61 97.04 4.95 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.394 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 12.6 p -75.08 138.92 19.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.289 -178.684 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -107.0 114.56 28.71 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.926 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -115.34 124.03 50.24 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.659 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.67 111.59 23.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.484 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 99.1 mttt -58.65 153.12 17.12 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.86 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.727 HG23 ' H ' ' A' ' 23' ' ' GLY . 9.0 t -93.93 -164.86 1.23 Allowed 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 171.845 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.47 4.66 17.51 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 118.816 0.735 . . . . 0.0 110.718 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.727 ' H ' HG23 ' A' ' 21' ' ' THR . . . -140.03 56.37 0.62 Allowed Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.007 179.363 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.316 80.3 p 74.9 -176.63 0.15 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 126.404 1.882 . . . . 0.0 115.715 172.47 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.724 HD23 ' HB3' ' A' ' 18' ' ' LEU . 69.6 mt -65.78 -16.98 64.3 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -177.095 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.519 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . 78.52 24.84 62.08 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 178.372 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.589 HG21 HG23 ' A' ' 64' ' ' ILE . 19.3 pt -136.64 123.23 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 CA-C-O 121.992 0.901 . . . . 0.0 112.395 177.853 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.8 m -100.34 121.18 41.08 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 113.347 -1.752 . . . . 0.0 108.247 177.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 49' ' ' VAL . 32.0 m -114.73 152.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.269 -173.816 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 t -129.35 155.66 45.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.548 HG22 ' HA ' ' A' ' 82' ' ' THR . 8.5 t -95.94 129.77 45.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 119.242 0.928 . . . . 0.0 109.219 179.753 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.9 mt -105.09 88.23 2.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.571 174.395 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.652 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 26.0 m-85 -149.32 91.97 1.89 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 113.565 -1.652 . . . . 0.0 107.781 174.396 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -100.82 88.19 3.51 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 122.873 1.32 . . . . 0.0 109.826 179.334 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.477 ' HB3' ' HZ1' ' A' ' 35' ' ' LYS . 7.4 ttpm? -71.83 109.08 5.46 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.243 -177.551 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.55 -14.95 6.76 Favored Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -176.778 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.39 -94.81 1.16 Allowed Glycine 0 N--CA 1.431 -1.689 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.863 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.2 t -93.76 53.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 122.434 1.111 . . . . 0.0 108.623 -177.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -106.85 28.39 8.0 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.771 0.796 . . . . 0.0 110.054 -178.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.7 m -73.11 -42.48 62.88 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.7 m -106.47 126.45 52.26 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 172.668 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.0 t -130.5 13.12 2.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -176.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.55 161.64 23.3 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.53 -1.214 . . . . 0.0 107.951 -178.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 73.37 14.09 4.5 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.584 1.154 . . . . 0.0 112.158 177.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -142.34 -154.0 6.05 Favored Glycine 0 N--CA 1.432 -1.595 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.652 ' HA2' ' CE2' ' A' ' 33' ' ' PHE . . . 148.21 -95.77 0.17 Allowed Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 178.352 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.91 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 43.0 mm -101.27 146.38 9.77 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.356 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.506 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 53.6 t80 -131.77 110.23 10.71 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -174.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.43 ' HA ' HG13 ' A' ' 29' ' ' VAL . 42.1 t -52.3 114.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 171.683 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -94.64 -32.8 13.23 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.805 -173.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.17 143.07 25.71 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -176.466 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.64 HG21 ' HB2' ' A' ' 59' ' ' GLU . 45.8 mm -104.83 125.21 59.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.261 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.519 ' HB ' ' HA2' ' A' ' 26' ' ' GLY . 30.0 mm -99.49 135.24 20.7 Favored Pre-proline 0 C--N 1.289 -2.029 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.033 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.12 -155.75 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.32 2.68 . . . . 0.0 112.448 174.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? 97.36 -44.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.629 1.572 . . . . 0.0 111.232 171.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . 156.2 35.52 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 118.12 -1.99 . . . . 0.0 115.452 176.337 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.557 ' HB1' HD13 ' A' ' 18' ' ' LEU . . . -129.51 -105.8 0.29 Allowed 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.348 177.595 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.926 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -62.87 -35.55 80.38 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -173.437 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.64 ' HB2' HG21 ' A' ' 52' ' ' ILE . 39.4 tt0 -86.43 -26.31 24.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.232 0.539 . . . . 0.0 109.789 -178.156 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.7 t -79.27 -46.17 18.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.812 -178.457 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.57 -31.0 66.5 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.674 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.51 44.41 8.62 Favored Glycine 0 CA--C 1.499 -0.954 0 CA-C-N 114.18 -1.373 . . . . 0.0 114.267 170.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -108.99 -62.34 1.49 Allowed 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.406 178.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.589 HG23 HG21 ' A' ' 27' ' ' ILE . 25.8 mm -72.11 137.37 23.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.648 -173.227 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -122.32 151.08 41.5 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 173.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 133.91 46.11 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.782 178.518 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.506 ' HA2' ' CZ ' ' A' ' 48' ' ' TYR . . . 111.64 -18.58 24.66 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -172.637 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.477 ' HB3' HD21 ' A' ' 101' ' ' LEU . 89.4 m-20 -66.41 131.23 45.62 Favored 'General case' 0 C--O 1.252 1.206 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.592 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 73.0 mtm-85 -93.12 138.07 31.89 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.86 0.838 . . . . 0.0 111.21 -177.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.91 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 49.2 t -99.75 111.84 30.49 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.972 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.531 HD12 ' HB2' ' A' ' 102' ' ' GLU . 48.2 mt -95.06 -33.68 12.6 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.633 -175.404 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -162.56 176.36 10.48 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.927 -177.635 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 1.14 HG12 HG23 ' A' ' 89' ' ' THR . 3.1 p -123.97 112.37 32.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 125.172 1.389 . . . . 0.0 107.793 175.187 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.9 p30 50.51 29.33 3.92 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 125.008 1.323 . . . . 0.0 113.582 177.141 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.05 -19.13 41.42 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.1 -177.219 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.504 ' HB ' HG13 ' A' ' 73' ' ' VAL . 52.5 t -86.19 113.86 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.0 m -61.97 136.69 58.07 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.317 0.579 . . . . 0.0 112.517 -175.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.473 HD11 ' HB ' ' A' ' 73' ' ' VAL . 76.2 mt -114.21 32.21 6.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.204 -178.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.51 113.28 22.3 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.108 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.97 16.43 35.76 Favored Glycine 0 C--N 1.303 -1.255 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.24 146.35 26.99 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -179.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.548 ' HA ' HG22 ' A' ' 31' ' ' VAL . 23.0 p -82.76 162.63 21.67 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 173.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -52.27 -42.95 64.14 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -61.09 -39.96 91.91 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.332 178.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.548 ' HG2' ' OG1' ' A' ' 82' ' ' THR . 14.7 mm100 -67.07 -47.14 72.2 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.206 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.643 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.3 -48.95 77.6 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.379 178.221 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.82 -28.66 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.122 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.48 -43.01 86.58 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 1.14 HG23 HG12 ' A' ' 73' ' ' VAL . 28.5 m -64.87 -34.34 78.14 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.589 176.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 68.7 mt -74.52 -17.95 60.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.23 0.538 . . . . 0.0 110.972 -178.645 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -94.02 -33.16 13.53 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.363 0.602 . . . . 0.0 110.296 174.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -75.85 -19.8 58.61 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.955 -178.106 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -75.94 -77.59 0.13 Allowed 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 171.84 -149.74 12.33 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.527 -179.301 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.484 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 46.1 tt0 -88.75 -39.94 13.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.711 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.58 104.76 16.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.042 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 25' ' ' LEU . 3.5 t -106.2 142.38 19.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.429 -174.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 78.4 m80 -110.27 127.95 55.27 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.481 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 5.8 mp -129.03 150.22 50.52 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.156 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.702 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.4 tm? -98.82 111.04 23.55 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 68' ' ' ASP . 10.5 mp -119.48 169.74 9.77 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.136 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.531 ' HB2' HD12 ' A' ' 71' ' ' LEU . 34.0 tt0 -130.45 128.23 40.86 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 172.626 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.502 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 26.5 tptt -59.03 123.79 17.76 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 123.991 0.807 . . . . 0.0 109.748 -177.369 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -119.52 36.58 3.44 Favored Glycine 0 CA--C 1.497 -1.043 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.575 -173.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.881 ' HB2' ' HB3' ' A' ' 10' ' ' PRO . 46.8 mt-30 -81.0 29.1 0.34 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.592 0.757 . . . . 0.0 111.885 -179.105 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 11.8 m -143.73 129.22 9.86 Favored Pre-proline 0 C--N 1.28 -2.432 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -178.399 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.1 Cg_exo . . . . . 0 C--O 1.252 1.21 0 C-N-CA 122.755 2.303 . . . . 0.0 110.998 179.221 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 14.4 mmmm . . . . . 0 N--CA 1.442 -0.828 0 N-CA-C 102.433 -3.173 . . . . 0.0 102.433 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.68 115.64 3.18 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 CA-C-N 121.401 1.536 . . . . 0.0 110.656 -177.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.26 1.53 54.13 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.2 -176.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 32.4 t70 -83.11 134.56 35.0 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.054 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.2 p -103.42 126.15 50.42 Favored 'General case' 0 N--CA 1.413 -2.311 0 O-C-N 124.531 1.144 . . . . 0.0 110.35 178.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -137.02 160.61 38.43 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.836 -177.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -107.71 97.54 7.26 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 176.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.3 p -76.03 134.39 29.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.119 -176.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -91.71 97.69 11.17 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.596 HD22 ' HA ' ' A' ' 58' ' ' ALA . 2.4 tm? -101.76 111.35 23.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.02 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.67 118.9 31.99 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.285 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HE2' ' CD2' ' A' ' 25' ' ' LEU . 94.1 mttt -52.67 119.34 4.44 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 122.032 0.92 . . . . 0.0 112.811 -177.711 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.883 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 93.1 m -120.57 103.71 9.37 Favored 'General case' 0 N--CA 1.403 -2.824 0 CA-C-N 113.687 -1.597 . . . . 0.0 108.184 -175.61 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 t70 62.05 -73.51 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 177.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.97 26.47 12.83 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.468 ' HA ' ' HB3' ' A' ' 20' ' ' LYS 0.27 87.5 p 62.68 -98.45 0.07 Allowed 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.974 1.31 . . . . 0.0 112.881 178.922 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.619 ' HG ' HD12 ' A' ' 90' ' ' LEU . 2.7 mm? -100.92 110.38 22.43 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 118.63 0.65 . . . . 0.0 109.368 175.547 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.489 ' HA3' ' C ' ' A' ' 56' ' ' GLY . . . -84.25 36.07 2.94 Favored Glycine 0 C--N 1.295 -1.713 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.274 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.6 pt -125.4 121.13 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.903 0 CA-C-O 121.886 0.85 . . . . 0.0 112.085 -176.428 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.9 t -86.94 119.94 27.68 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 177.935 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.54 149.78 31.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.54 -173.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 t -128.63 179.6 5.59 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 172.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.467 HG21 ' H ' ' A' ' 32' ' ' LEU . 8.9 m -80.49 -53.45 12.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 174.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.467 ' H ' HG21 ' A' ' 31' ' ' VAL . 39.6 tp -170.86 -54.06 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 171.622 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -134.94 126.06 27.91 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 173.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -45.31 -56.34 5.01 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -172.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -140.63 100.06 3.77 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 177.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.21 -61.1 2.56 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 172.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.1 -79.25 0.28 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 116.169 1.228 . . . . 0.0 116.169 174.119 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.3 p -60.54 -27.76 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 123.955 0.902 . . . . 0.0 112.905 -173.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -126.16 146.15 50.07 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.8 m -90.05 80.26 6.38 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.53 175.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.0 m -90.27 -10.98 42.24 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 176.06 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.8 t -63.89 104.46 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 113.879 -1.51 . . . . 0.0 109.256 176.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -92.45 144.22 25.58 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.24 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -77.08 87.77 3.57 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.738 0.78 . . . . 0.0 112.51 -175.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.27 -70.85 0.1 Allowed Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 173.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.5 -91.45 0.13 Allowed Glycine 0 N--CA 1.421 -2.321 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.979 170.341 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.983 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 47.1 mm -116.85 156.16 18.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 C-N-CA 123.307 0.643 . . . . 0.0 109.807 -172.776 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 107' ' ' PRO . 68.9 t80 -135.62 109.56 8.18 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 123.736 0.814 . . . . 0.0 109.562 179.573 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -51.25 109.46 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.861 0 CA-C-O 122.247 1.022 . . . . 0.0 110.623 171.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -80.65 -40.83 24.87 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 113.699 -1.591 . . . . 0.0 109.255 -176.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.6 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -160.23 161.58 33.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.246 -176.757 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.582 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 38.7 mm -115.75 139.8 40.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.503 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.6 mm -95.6 141.73 23.6 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -177.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.81 137.97 71.33 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.4 2.067 . . . . 0.0 109.483 171.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 5.2 tppp? 59.44 21.26 9.66 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 123.472 1.606 . . . . 0.0 108.393 -172.836 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.489 ' C ' ' HA3' ' A' ' 26' ' ' GLY . . . -109.18 81.84 0.29 Allowed Glycine 0 N--CA 1.396 -3.999 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.528 -175.178 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.883 ' HA ' ' HB ' ' A' ' 21' ' ' THR . . . 32.56 -72.45 0.0 OUTLIER 'General case' 0 C--O 1.186 -2.265 0 C-N-CA 127.817 2.447 . . . . 0.0 116.264 171.597 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.596 ' HA ' HD22 ' A' ' 18' ' ' LEU . . . -55.56 -32.11 62.73 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.734 0.814 . . . . 0.0 111.753 -177.647 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.582 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 6.5 tp10 -89.44 -37.87 14.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.172 0.511 . . . . 0.0 109.662 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 m -74.04 -44.73 53.3 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.49 -175.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -76.44 -36.77 57.78 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.76 59.56 1.5 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.833 176.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.403 ' HB2' ' H ' ' A' ' 64' ' ' ILE . 14.4 mmt180 -121.53 -87.02 0.65 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.619 0.723 . . . . 0.0 110.409 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.403 ' H ' ' HB2' ' A' ' 63' ' ' ARG . 53.1 mt -74.94 146.52 9.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.961 -176.351 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -129.95 172.57 11.57 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.6 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 35.8 mtmm -71.84 126.29 29.35 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 -177.615 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.418 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 120.15 -28.13 6.45 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.046 -1.073 . . . . 0.0 113.17 177.864 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.669 ' HB3' HD21 ' A' ' 101' ' ' LEU . 28.9 m-20 -64.45 133.34 52.29 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 122.043 0.925 . . . . 0.0 112.782 -176.183 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -91.88 135.4 33.96 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.127 -175.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.983 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 60.8 t -105.66 125.14 61.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -174.068 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.785 ' HB2' HD11 ' A' ' 100' ' ' LEU . 67.9 mt -104.64 -21.6 13.38 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.971 -177.313 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.725 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -168.35 167.62 11.87 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.044 0.449 . . . . 0.0 112.086 -177.787 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.676 ' HA ' HD12 ' A' ' 99' ' ' LEU . 46.7 t -120.83 117.88 54.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 174.412 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.353 30.7 p-10 38.44 63.4 0.87 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.411 1.484 . . . . 0.0 114.859 -179.375 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.05 -21.4 3.38 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.004 -0.998 . . . . 0.0 114.861 178.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.31 100.08 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.674 ' HA ' ' HB3' ' A' ' 72' ' ' ALA . 20.0 m -58.1 132.27 53.02 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.261 -178.28 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.725 ' HG ' ' HA ' ' A' ' 72' ' ' ALA . 74.5 mt -93.33 80.25 4.42 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.105 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -77.42 -30.16 53.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.49 -171.434 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.26 58.68 0.31 Allowed Glycine 0 CA--C 1.474 -2.53 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.67 138.07 40.06 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.178 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.721 HG22 ' HG2' ' A' ' 85' ' ' GLN . 14.6 t -85.05 161.35 19.75 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 171.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . 0.287 10.6 p80 -50.89 -41.67 58.51 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.431 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -67.85 -24.02 65.21 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 177.466 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.721 ' HG2' HG22 ' A' ' 82' ' ' THR . 30.1 mm-40 -70.8 -40.75 72.34 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.619 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -62.61 -45.06 94.59 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.463 176.498 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.407 ' HA ' HD13 ' A' ' 90' ' ' LEU . 91.6 t -69.03 -34.37 63.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.351 -177.645 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.549 ' HG2' ' HA ' ' A' ' 85' ' ' GLN . 7.9 pt-20 -71.59 -27.89 63.44 Favored 'General case' 0 C--O 1.217 -0.623 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.193 178.404 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.8 m -72.74 -25.72 61.31 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.619 HD12 ' HG ' ' A' ' 25' ' ' LEU . 96.0 mt -79.41 -23.33 43.29 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.659 0.742 . . . . 0.0 109.727 174.592 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -79.12 -38.29 36.51 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.756 175.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -66.92 -36.52 82.43 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.317 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 p -69.56 159.23 33.75 Favored 'General case' 0 C--O 1.252 1.225 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.93 -129.32 0.29 Allowed Glycine 0 C--N 1.33 0.222 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.816 -175.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -87.78 -44.91 10.78 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.344 0.592 . . . . 0.0 110.436 -178.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.38 119.43 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 C-N-CA 118.824 -1.15 . . . . 0.0 110.053 -178.791 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.401 HG12 ' CD2' ' A' ' 90' ' ' LEU . 22.8 t -103.19 126.27 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.372 -176.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -94.43 115.71 27.94 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 174.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.0 tp -113.09 136.16 53.01 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.793 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.785 HD11 ' HB2' ' A' ' 71' ' ' LEU . 2.6 tm? -89.28 109.98 20.8 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 -176.343 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.669 HD21 ' HB3' ' A' ' 68' ' ' ASP . 11.0 mp -122.79 165.2 16.99 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.836 0.827 . . . . 0.0 112.673 -175.799 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 41.3 tt0 -131.74 142.66 49.84 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 174.859 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.558 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -51.53 130.0 26.8 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 177.0 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . -123.53 62.94 0.56 Allowed Glycine 0 N--CA 1.422 -2.267 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.457 176.446 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -72.99 -35.17 66.82 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 176.011 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 84.2 t -144.07 114.19 5.38 Favored Pre-proline 0 N--CA 1.422 -1.87 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 177.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.42 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 37.4 Cg_exo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 123.06 2.507 . . . . 0.0 111.661 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 22.7 t0 . . . . . 0 CA--C 1.497 -1.072 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 37.5 p -91.04 115.45 28.03 Favored 'General case' 0 N--CA 1.413 -2.295 0 O-C-N 123.858 0.724 . . . . 0.0 110.458 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.479 ' CE1' ' HD2' ' A' ' 103' ' ' LYS . 16.4 p90 -125.67 116.8 22.24 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.061 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 45.3 mt-10 -77.96 92.54 4.32 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.709 0.766 . . . . 0.0 109.397 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.486 HG11 HD11 ' A' ' 64' ' ' ILE . 9.6 p -74.81 138.13 21.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.269 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.45 96.29 8.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.841 HD11 ' HB1' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -96.6 111.11 23.38 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -176.167 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.96 130.39 40.08 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.101 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.452 ' HE2' ' HG ' ' A' ' 25' ' ' LEU . 94.9 mttt -86.01 127.87 34.74 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.729 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 t -77.63 -42.06 36.26 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -164.84 -68.8 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.11 0.481 . . . . 0.0 110.36 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.21 60.56 4.87 Favored Glycine 0 C--O 1.246 0.882 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.971 -173.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 89.8 p 62.01 -170.34 0.17 Allowed 'General case' 0 C--O 1.246 0.919 0 C-N-CA 126.521 1.928 . . . . 0.0 113.14 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.654 HD22 HD12 ' A' ' 18' ' ' LEU . 92.2 mt -68.65 150.68 47.68 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.155 0.502 . . . . 0.0 109.883 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.15 6.47 82.57 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.826 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.481 HG22 HG13 ' A' ' 52' ' ' ILE . 15.7 pt -103.52 128.98 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.754 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.255 -178.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.411 ' HB2' HD13 ' A' ' 53' ' ' ILE . 32.2 t -98.34 114.64 27.03 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 49' ' ' VAL . 35.0 m -112.2 157.81 12.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.364 -175.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.419 ' C ' ' HB3' ' A' ' 83' ' ' HIS . 12.9 t -127.27 161.89 27.51 Favored 'General case' 0 N--CA 1.396 -3.134 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.666 ' HA ' HD13 ' A' ' 47' ' ' ILE . 2.0 p . . . . . 0 C--N 1.272 -2.775 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.496 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.831 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 33.8 mm -141.39 147.89 21.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 176.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -129.66 139.42 51.4 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 118.533 0.606 . . . . 0.0 111.715 177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.59 ' HA ' HG12 ' A' ' 29' ' ' VAL . 44.1 t -74.67 116.48 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 173.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -85.02 -37.06 20.83 Favored 'General case' 0 C--N 1.284 -2.283 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.29 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -165.38 163.97 19.77 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.538 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.933 HG21 ' HB2' ' A' ' 59' ' ' GLU . 1.9 mp -116.96 124.19 72.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.43 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 2.0 mp -108.05 128.57 25.5 Favored Pre-proline 0 C--N 1.293 -1.863 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -17.25 -110.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.953 1 C-N-CA 126.123 4.548 . . . . 0.0 117.16 -173.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HD3' ' O ' ' A' ' 53' ' ' ILE . 3.4 mptp? 70.69 -67.06 0.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.627 1.171 . . . . 0.0 110.183 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.15 -117.67 0.99 Allowed Glycine 0 N--CA 1.401 -3.682 1 N-CA-C 102.762 -4.135 . . . . 0.0 102.762 -172.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.841 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 59.04 -110.29 0.49 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 164.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.795 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -68.27 -41.46 81.0 Favored 'General case' 0 C--O 1.255 1.367 0 C-N-CA 122.674 0.39 . . . . 0.0 111.513 -173.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.933 ' HB2' HG21 ' A' ' 52' ' ' ILE . 42.1 tt0 -73.73 -37.06 65.23 Favored 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 124.437 1.086 . . . . 0.0 110.794 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.7 t -70.88 -49.51 45.16 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.122 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 63' ' ' ARG . 6.4 t70 -65.11 -31.28 72.4 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.02 35.25 54.17 Favored Glycine 0 CA--C 1.488 -1.653 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.989 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 6.7 mmp_? -103.02 -49.69 3.7 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.023 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.64 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 65.9 mt -92.98 138.14 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.173 -172.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -126.38 -173.21 2.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.729 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 52.6 mtpt -79.76 43.35 0.58 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.422 1.089 . . . . 0.0 112.515 -172.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.581 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . -172.88 5.71 0.03 OUTLIER Glycine 0 C--N 1.301 -1.411 0 C-N-CA 118.836 -1.649 . . . . 0.0 115.066 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -74.66 144.37 43.84 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 117.728 0.764 . . . . 0.0 110.324 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 102' ' ' GLU . 56.4 ttt180 -89.32 135.01 33.82 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.831 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 47.9 t -105.74 122.7 59.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.589 HD12 HD22 ' A' ' 100' ' ' LEU . 65.6 mt -97.04 -39.05 9.52 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.233 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 77' ' ' SER . . . -164.87 178.37 7.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.472 -174.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.608 HG23 HD11 ' A' ' 78' ' ' LEU . 48.0 t -121.04 112.9 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 1.9 p-10 45.6 37.2 3.03 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 125.529 1.531 . . . . 0.0 113.828 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.84 -9.04 70.84 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 119.856 -1.164 . . . . 0.0 114.235 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.3 97.07 5.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.613 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 11.9 m -59.92 125.68 24.61 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.09 0.869 . . . . 0.0 112.436 -173.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.608 HD11 HG23 ' A' ' 73' ' ' VAL . 59.1 mt -94.89 69.68 3.34 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -111.0 104.68 13.27 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.695 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.34 26.71 11.71 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.74 146.05 30.31 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.507 HG22 ' HG2' ' A' ' 85' ' ' GLN . 11.8 t -88.2 164.11 15.81 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 170.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.53 ' HB3' ' N ' ' A' ' 31' ' ' VAL . 16.4 p-80 -51.15 -40.01 57.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 17.2 tppt? -60.54 -39.89 89.54 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.615 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.507 ' HG2' HG22 ' A' ' 82' ' ' THR . 82.1 mm-40 -70.66 -36.48 73.38 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.261 0.553 . . . . 0.0 110.397 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.403 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -59.44 -52.37 65.88 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.75 174.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 90' ' ' LEU . 60.2 t -66.57 -28.18 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.027 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 46.9 mm-40 -65.32 -39.2 92.14 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.0 m -70.96 -31.85 68.53 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.763 0.792 . . . . 0.0 109.079 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 96.0 mt -76.18 -11.68 59.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.126 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -99.09 -28.95 13.15 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -66.52 -30.1 70.35 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.026 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 p -76.78 144.84 38.91 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.719 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.66 -120.72 0.13 Allowed Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 116.139 1.216 . . . . 0.0 116.139 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -81.21 -45.08 16.86 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.452 0.701 . . . . 0.0 111.459 -172.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.73 124.23 72.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.066 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.416 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 7.4 t -108.42 139.22 31.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.782 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 93.0 m-70 -101.49 125.46 48.14 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 6.5 mp -123.02 143.64 49.8 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.589 HD22 HD12 ' A' ' 71' ' ' LEU . 1.3 tt -96.46 109.5 22.04 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 13' ' ' THR . 10.8 mp -117.4 171.33 8.06 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.061 0.458 . . . . 0.0 112.134 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 48.1 mt-10 -130.52 143.37 50.72 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HD2' ' CE1' ' A' ' 14' ' ' PHE . 28.1 mmmt -60.42 125.19 22.75 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.109 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.581 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . . . . . . 0 N--CA 1.425 -2.099 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.299 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 36.3 t70 . . . . . 0 CA--C 1.503 -0.849 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p -89.41 141.77 28.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.213 0.53 . . . . 0.0 111.552 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -149.28 146.56 27.62 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.753 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HB3' ' HE2' ' A' ' 98' ' ' HIS . 38.0 mt-10 -100.13 125.4 46.23 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.1 t -113.3 129.08 69.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -98.36 81.99 2.83 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.957 HD11 ' HB1' ' A' ' 57' ' ' ALA . 1.6 tm? -85.14 126.7 33.84 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -171.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.09 110.1 21.47 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.844 ' HE3' HD12 ' A' ' 25' ' ' LEU . 15.0 ptmt -79.14 153.94 29.7 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.767 HG23 ' HB3' ' A' ' 55' ' ' LYS . 7.2 t -140.23 139.84 35.68 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.209 -176.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 3.7 m-20 71.63 9.33 6.32 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.948 0.899 . . . . 0.0 112.712 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.24 1.34 23.58 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.66 -0.781 . . . . 0.0 114.55 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.2 t -160.49 175.01 13.23 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.844 HD12 ' HE3' ' A' ' 20' ' ' LYS . 7.6 mp -89.49 177.48 6.55 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.12 33.43 5.09 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' A' ' 49' ' ' VAL . 19.5 pt -138.14 139.95 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.639 0 CA-C-O 121.949 0.88 . . . . 0.0 112.012 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.1 m -104.25 118.22 36.1 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 113.68 -1.6 . . . . 0.0 107.274 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.01 145.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.393 0.616 . . . . 0.0 111.731 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -122.9 172.23 8.63 Favored 'General case' 0 N--CA 1.403 -2.822 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 2.0 p . . . . . 0 C--N 1.258 -3.389 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 31' ' ' VAL . . . . . . . . 0 N--CA 1.428 -1.899 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.611 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 33.6 mm -131.12 142.48 43.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 174.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.443 ' OH ' ' HD3' ' A' ' 69' ' ' ARG . 45.8 m-85 -126.23 143.77 51.02 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.456 HG13 ' HB ' ' A' ' 27' ' ' ILE . 61.7 t -78.93 108.48 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -80.7 -37.28 30.97 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.783 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.19 153.0 31.87 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.122 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.18 113.63 40.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.2 mm -92.27 154.48 43.0 Favored Pre-proline 0 C--N 1.28 -2.456 0 C-N-CA 125.261 1.424 . . . . 0.0 109.726 -175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -56.4 -152.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.567 2.161 0 C-N-CA 123.446 2.764 . . . . 0.0 113.801 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.767 ' HB3' HG23 ' A' ' 21' ' ' THR . 3.7 mppt? 72.8 -44.97 0.61 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.614 1.166 . . . . 0.0 112.1 -169.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.02 -126.88 4.2 Favored Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 108.176 -1.969 . . . . 0.0 108.176 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.957 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 71.27 -99.48 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 171.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.856 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -73.12 -35.26 66.52 Favored 'General case' 0 C--O 1.265 1.906 0 O-C-N 121.86 -0.525 . . . . 0.0 111.576 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -74.95 -40.03 61.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 125.07 1.481 . . . . 0.0 107.448 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.8 t -67.97 -44.03 77.65 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.056 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.63 -39.69 80.67 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.44 27.0 49.68 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.725 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -108.91 -39.65 5.26 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.115 -1.034 . . . . 0.0 113.156 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.856 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.4 mt -94.97 127.25 47.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -132.3 178.41 6.84 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 123.5 0.5 . . . . 0.0 110.115 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -67.52 128.21 35.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.314 0.578 . . . . 0.0 111.94 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.617 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 101.05 -4.24 55.75 Favored Glycine 0 N--CA 1.422 -2.267 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.006 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.589 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 31.8 m-20 -68.93 146.07 53.1 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.472 HH21 ' CD ' ' A' ' 102' ' ' GLU . 34.7 ttp180 -96.65 129.21 44.09 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.795 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.611 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 59.0 t -101.77 118.3 48.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.76 -31.87 14.23 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.265 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -164.49 167.78 19.08 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.7 ' HA ' HD12 ' A' ' 99' ' ' LEU . 31.7 t -118.04 110.44 30.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 59.39 37.49 23.23 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.393 1.077 . . . . 0.0 109.966 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.46 -6.19 80.88 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.163 -0.926 . . . . 0.0 114.162 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.07 108.66 20.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.514 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 35.4 p -64.95 135.68 55.94 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.699 HD11 HG23 ' A' ' 73' ' ' VAL . 67.5 mt -106.75 25.71 10.92 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.469 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -53.88 -32.03 51.83 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.96 -1.473 . . . . 0.0 113.452 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.63 40.71 1.56 Allowed Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.15 155.63 17.06 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.325 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.581 HG22 ' HG2' ' A' ' 85' ' ' GLN . 9.0 t -92.72 160.75 14.83 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 167.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.424 ' O ' HG23 ' A' ' 87' ' ' VAL . 52.1 p-80 -51.28 -43.43 61.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.141 0.496 . . . . 0.0 111.917 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -59.72 -37.8 79.92 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.581 ' HG2' HG22 ' A' ' 82' ' ' THR . 14.9 mm100 -71.63 -36.05 70.62 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.52 -45.71 90.97 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.348 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 83' ' ' HIS . 64.1 t -66.24 -39.53 84.53 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.776 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -62.51 -39.09 92.41 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.847 0.355 . . . . 0.0 111.038 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.443 ' HB ' HG21 ' A' ' 73' ' ' VAL . 12.1 m -69.91 -38.13 76.16 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.884 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.866 HD13 HD13 ' A' ' 99' ' ' LEU . 19.2 tp -82.95 -3.08 56.67 Favored 'General case' 0 N--CA 1.415 -2.175 0 C-N-CA 125.154 1.382 . . . . 0.0 109.878 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.36 -21.05 13.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.487 172.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -82.84 -25.21 32.84 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.458 ' OG1' HG12 ' A' ' 97' ' ' VAL . 3.2 p -67.18 -177.81 0.72 Allowed 'General case' 0 C--O 1.255 1.359 0 C-N-CA 123.705 0.802 . . . . 0.0 110.517 174.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -78.56 -162.63 21.8 Favored Glycine 0 C--O 1.244 0.764 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.582 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 29.6 tt0 -73.41 -34.53 65.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.717 0.77 . . . . 0.0 108.969 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.8 t -90.19 110.83 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.642 HG21 HD11 ' A' ' 25' ' ' LEU . 8.8 m -99.05 117.54 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.427 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.071 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 41.1 t-80 -84.57 122.0 28.41 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.866 HD13 HD13 ' A' ' 90' ' ' LEU . 7.2 tp -127.35 146.14 50.56 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 53.1 tp -102.13 117.1 34.06 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.751 HD11 HD23 ' A' ' 99' ' ' LEU . 6.6 mp -123.47 165.63 16.76 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.667 0.746 . . . . 0.0 111.761 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.472 ' CD ' HH21 ' A' ' 69' ' ' ARG . 88.1 tt0 -132.95 143.93 49.79 Favored 'General case' 0 N--CA 1.391 -3.42 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.589 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 40.3 mmtt -64.3 125.6 25.11 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.09 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . . . . . . 0 N--CA 1.42 -2.376 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.377 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 28.7 t70 . . . . . 0 CA--C 1.494 -1.204 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 3.1 p -99.21 108.26 20.8 Favored 'General case' 0 N--CA 1.416 -2.164 0 O-C-N 123.895 0.747 . . . . 0.0 110.154 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -138.49 140.34 39.14 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.123 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 4.4 mp0 -75.53 106.36 7.04 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 59.5 t -69.47 122.51 21.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.841 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -96.16 93.96 7.24 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.545 HD11 ' CB ' ' A' ' 57' ' ' ALA . 2.6 tm? -100.53 115.14 29.43 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -177.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.84 117.3 33.86 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 24' ' ' SER . 99.5 mttt -54.52 121.16 7.8 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 124.185 0.928 . . . . 0.0 111.696 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.9 p -90.36 -84.0 0.24 Allowed 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.547 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.76 -54.83 2.41 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.515 ' CA ' ' HA2' ' A' ' 56' ' ' GLY . . . -87.87 25.73 8.34 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.698 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 39.7 t 76.69 -109.94 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 123.992 0.917 . . . . 0.0 113.326 172.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.739 ' HG ' HD13 ' A' ' 90' ' ' LEU . 3.3 mm? -85.38 -31.69 22.8 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 120.065 1.302 . . . . 0.0 110.403 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.531 ' CA ' ' HA3' ' A' ' 56' ' ' GLY . . . 73.55 21.58 79.33 Favored Glycine 0 N--CA 1.411 -2.986 0 C-N-CA 119.552 -1.309 . . . . 0.0 112.105 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.537 HG22 ' CD1' ' A' ' 52' ' ' ILE . 17.1 pt -128.71 121.86 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.696 0 CA-C-O 122.079 0.942 . . . . 0.0 112.825 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.642 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 25.7 t -90.26 112.18 23.63 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 49' ' ' VAL . 33.4 m -118.82 154.53 21.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -172.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.744 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 9.4 t -143.51 174.99 10.28 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.699 HG22 ' CD1' ' A' ' 47' ' ' ILE . 4.4 t . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.476 ' O ' HG13 ' A' ' 31' ' ' VAL . . . . . . . . 0 N--CA 1.406 -3.357 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.74 HG13 ' HB2' ' A' ' 86' ' ' ALA . 21.0 mm -145.76 159.36 12.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 C-N-CA 125.273 1.429 . . . . 0.0 107.654 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -134.45 135.25 42.38 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 123.333 0.653 . . . . 0.0 110.612 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.49 ' HA ' HG12 ' A' ' 29' ' ' VAL . 51.6 t -79.67 108.84 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.497 ' HB2' HG22 ' A' ' 30' ' ' THR . 63.1 tttp -80.8 -37.44 30.2 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.19 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 28' ' ' SER . . . -148.54 148.18 29.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.47 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.835 HG23 ' HB2' ' A' ' 59' ' ' GLU . 1.4 tp -110.86 131.97 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-O 121.4 0.619 . . . . 0.0 111.758 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 56' ' ' GLY . 2.1 mp -106.25 126.44 30.52 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.967 ' HA ' ' HB3' ' A' ' 59' ' ' GLU . 33.8 Cg_exo -59.47 -77.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.133 2.555 . . . . 0.0 113.169 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 23.8 mmtp -55.13 -10.09 0.49 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 176.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.531 ' HA3' ' CA ' ' A' ' 26' ' ' GLY . . . -63.32 -59.37 9.0 Favored Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' CB ' HD11 ' A' ' 18' ' ' LEU . . . 167.25 -71.31 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.733 0 C-N-CA 125.117 1.367 . . . . 0.0 111.78 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.775 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -48.66 -38.22 20.57 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -167.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.967 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 8.2 tp10 -74.49 -52.4 12.06 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.91 0.484 . . . . 0.0 111.222 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.6 m -76.96 -29.77 55.71 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.097 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -72.6 -45.87 56.97 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.88 59.24 1.61 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 114.301 -1.318 . . . . 0.0 114.882 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -128.7 -58.87 1.16 Allowed 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.598 0.714 . . . . 0.0 109.144 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.775 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 51.9 mt -94.1 141.61 14.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.89 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -137.31 168.53 19.45 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -58.26 125.29 22.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.687 0.28 . . . . 0.0 110.439 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.544 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 115.59 -21.19 12.93 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.968 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.482 ' HB3' HD23 ' A' ' 101' ' ' LEU . 54.2 m-20 -64.72 137.28 57.71 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.88 0.848 . . . . 0.0 113.228 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -96.47 132.33 42.15 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.0 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 39.3 t -108.72 126.06 65.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.5 -34.65 10.17 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.635 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -162.94 175.64 10.98 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.291 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 78' ' ' LEU . 95.3 t -128.48 111.47 23.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.4 t30 51.73 58.72 5.17 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 124.821 1.248 . . . . 0.0 111.684 176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.7 -10.2 13.84 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 114.798 -1.092 . . . . 0.0 115.104 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.402 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 85.4 t -95.81 108.21 20.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 118.242 1.021 . . . . 0.0 108.828 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.548 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 34.7 m -62.42 137.06 58.19 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 123.818 0.699 . . . . 0.0 112.254 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.974 HD11 HG23 ' A' ' 73' ' ' VAL . 91.6 mt -104.97 16.19 26.37 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.456 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 38.8 mt-10 -72.17 94.76 1.58 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.58 14.1 13.35 Favored Glycine 0 C--N 1.304 -1.202 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.408 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 74.4 p -92.54 162.25 14.28 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.744 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 52.5 p-80 -51.47 -41.92 61.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.68 0.752 . . . . 0.0 109.807 174.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.401 ' NZ ' ' HB2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -70.0 -37.07 75.59 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.149 178.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.408 ' HG2' ' OG1' ' A' ' 82' ' ' THR . 74.7 mm-40 -64.26 -40.32 95.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.347 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.74 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -55.48 -52.25 64.25 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.104 0.478 . . . . 0.0 110.417 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.0 t -64.54 -34.07 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.002 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -68.65 -30.0 68.6 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.04 0.448 . . . . 0.0 110.577 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.4 m -72.25 -37.51 69.09 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.739 HD13 ' HG ' ' A' ' 25' ' ' LEU . 97.9 mt -71.06 -25.44 62.64 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.577 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -77.76 -43.36 31.06 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.232 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.81 -46.97 64.53 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.984 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 p -48.24 -65.88 0.49 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.64 -154.18 24.96 Favored Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.825 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.466 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 57.9 tt0 -87.53 -43.8 11.75 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.505 0.669 . . . . 0.0 109.288 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 55.5 t -102.65 106.04 19.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -105.61 138.29 31.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.22 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.553 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 56.7 m80 -100.39 130.16 46.45 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.608 HD21 HD21 ' A' ' 90' ' ' LEU . 6.5 mp -124.21 141.4 52.1 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.54 106.31 18.41 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' THR . 8.4 mp -115.64 165.56 12.9 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.697 0.761 . . . . 0.0 112.36 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 42.6 tt0 -131.15 114.04 14.63 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 103.675 -2.713 . . . . 0.0 103.675 172.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 40.9 tptt -47.5 121.36 3.89 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.872 0.732 . . . . 0.0 110.643 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . . . . . . 0 CA--C 1.498 -0.973 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.446 -171.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 CA--C 1.502 -0.873 0 CA-C-O 120.574 0.226 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 p -92.77 117.46 30.04 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.8 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -133.89 154.52 51.01 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 120.815 0.34 . . . . 0.0 110.545 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -110.46 114.09 27.24 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 64' ' ' ILE . 11.6 p -86.84 132.02 33.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.743 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -102.1 105.37 16.08 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.881 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -117.23 124.94 50.29 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -176.253 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -100.85 132.21 46.36 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.008 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HE3' HG21 ' A' ' 97' ' ' VAL . 1.2 mptm? -65.73 139.46 58.36 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 123.484 0.714 . . . . 0.0 110.821 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.0 p -75.45 -68.94 0.51 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 170.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -105.75 -72.01 0.73 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -145.92 19.28 1.78 Allowed Glycine 0 C--N 1.306 -1.116 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 175.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.0 m -114.57 140.33 48.87 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.783 HD11 ' HB3' ' A' ' 18' ' ' LEU . 12.3 tp -93.66 -8.64 40.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.57 -7.4 76.67 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.944 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.564 HG21 HG21 ' A' ' 64' ' ' ILE . 20.1 pt -119.68 155.76 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 CA-C-O 121.914 0.864 . . . . 0.0 112.437 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -132.08 128.53 38.41 Favored 'General case' 0 N--CA 1.399 -3.001 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.206 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -109.18 162.4 6.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.206 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.654 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 14.1 t -141.39 168.78 18.95 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 175.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.745 HG21 ' HA ' ' A' ' 82' ' ' THR . 4.5 t . . . . . 0 C--N 1.302 -1.485 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 31' ' ' VAL . . . . . . . . 0 N--CA 1.418 -2.52 0 CA-C-O 119.797 -0.446 . . . . 0.0 114.207 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.594 ' CD1' HG22 ' A' ' 31' ' ' VAL . 36.6 mm -94.63 125.97 47.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -129.21 147.09 51.02 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 64' ' ' ILE . 52.5 t -72.66 113.2 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HB2' HG22 ' A' ' 30' ' ' THR . 55.7 tttm -86.02 -40.43 15.8 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.132 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.51 156.26 37.76 Favored 'General case' 0 C--O 1.25 1.091 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.242 -173.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -113.89 118.02 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.07 136.23 20.61 Favored Pre-proline 0 C--N 1.292 -1.932 0 C-N-CA 123.543 0.737 . . . . 0.0 109.518 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.475 ' O ' ' HD2' ' A' ' 55' ' ' LYS . 39.0 Cg_exo -65.25 78.55 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.253 2.635 . . . . 0.0 112.603 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 54' ' ' PRO . 4.3 mptp? -135.53 20.81 3.35 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.0 -151.83 44.63 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.54 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 69.79 -103.48 0.05 OUTLIER 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.558 1.143 . . . . 0.0 113.393 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.881 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -66.48 -37.04 84.22 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 117.963 0.347 . . . . 0.0 111.887 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.59 -48.31 67.22 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.66 1.184 . . . . 0.0 109.009 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 m -68.9 -46.12 69.14 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.129 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.6 -25.31 62.12 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.12 36.2 51.76 Favored Glycine 0 CA--C 1.5 -0.898 0 CA-C-N 114.449 -1.251 . . . . 0.0 113.271 174.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 1.8 mmp_? -95.7 -48.99 5.55 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.034 0.445 . . . . 0.0 111.215 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.8 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 33.1 mm -100.54 137.44 28.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.661 -173.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -137.92 169.79 17.17 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 172.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -79.49 142.4 35.86 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.889 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.07 -17.72 12.64 Favored Glycine 0 C--N 1.306 -1.138 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.288 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.411 ' OD2' ' HA ' ' A' ' 103' ' ' LYS . 2.3 m-20 -89.48 147.04 24.22 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-N 117.118 0.459 . . . . 0.0 110.619 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.525 ' HD3' ' OE1' ' A' ' 102' ' ' GLU . 4.3 ptm180 -106.98 158.39 17.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.148 0.499 . . . . 0.0 111.485 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.21 127.71 71.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 102' ' ' GLU . 85.7 mt -96.27 -37.15 10.64 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 78' ' ' LEU . . . -160.54 174.56 13.86 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.713 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 1.021 HG11 HG21 ' A' ' 89' ' ' THR . 2.7 p -124.08 105.37 15.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 C-N-CA 124.224 1.009 . . . . 0.0 108.549 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.0 t30 57.43 32.54 21.95 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.587 1.184 . . . . 0.0 110.564 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.27 -11.66 67.1 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.515 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' A' ' 73' ' ' VAL . 59.8 t -86.34 107.28 16.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m -72.31 119.34 16.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.938 0.399 . . . . 0.0 111.598 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.4 pt? -119.18 83.52 2.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.965 0.888 . . . . 0.0 111.674 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.41 -35.88 11.56 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.744 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.62 36.66 4.01 Favored Glycine 0 CA--C 1.495 -1.165 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . -101.28 146.3 27.73 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.818 HG22 ' HG2' ' A' ' 85' ' ' GLN . 9.0 t -94.34 166.4 12.1 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 170.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.654 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 48.2 p-80 -51.54 -41.19 60.89 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 122.798 0.439 . . . . 0.0 111.347 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.07 -38.34 82.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.668 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.818 ' HG2' HG22 ' A' ' 82' ' ' THR . 13.6 mm100 -71.46 -47.81 53.29 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.65 75.64 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.209 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.5 -29.79 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.678 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -80.87 -16.24 54.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.34 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 1.021 HG21 HG11 ' A' ' 73' ' ' VAL . 25.4 m -73.16 -32.16 64.7 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.969 HD21 HD21 ' A' ' 99' ' ' LEU . 84.3 mt -76.45 -20.45 57.02 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.221 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -77.16 -44.15 31.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.419 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -64.41 -41.6 96.54 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.379 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.452 HG21 HG13 ' A' ' 97' ' ' VAL . 6.6 p -64.7 158.62 24.15 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.578 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -79.05 -150.62 5.5 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.912 -173.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -65.07 -42.23 94.37 Favored 'General case' 0 C--O 1.209 -1.052 0 C-N-CA 122.94 0.496 . . . . 0.0 109.807 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 48.2 t -114.4 122.51 68.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.567 HG21 ' HE3' ' A' ' 20' ' ' LYS . 5.9 t -112.58 149.89 14.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 48.0 m80 -115.13 132.85 56.47 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.969 HD21 HD21 ' A' ' 90' ' ' LEU . 6.4 mp -126.83 145.45 50.64 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.3 tt -99.5 109.91 22.41 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.524 HD13 HG12 ' A' ' 16' ' ' VAL . 11.0 mp -112.59 170.71 7.99 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.607 0.718 . . . . 0.0 110.65 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.525 ' OE1' ' HD3' ' A' ' 69' ' ' ARG . 42.6 tt0 -129.87 132.18 46.34 Favored 'General case' 0 N--CA 1.404 -2.75 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HA ' ' OD2' ' A' ' 68' ' ' ASP . 19.4 tptp -57.38 122.24 12.1 Favored 'General case' 0 N--CA 1.421 -1.89 0 O-C-N 124.285 0.99 . . . . 0.0 110.17 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.614 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.054 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 26.1 t0 . . . . . 0 CA--C 1.502 -0.892 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 4.4 p -103.86 132.59 49.96 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 123.438 0.461 . . . . 0.0 112.209 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.99 147.64 24.3 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.266 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -77.46 98.58 5.35 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 7.2 p -71.94 130.25 35.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -95.26 95.0 8.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.91 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -101.72 120.44 40.35 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.034 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.82 117.82 31.28 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 5.8 ptmt -71.06 146.55 49.24 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.742 0.782 . . . . 0.0 113.032 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m -87.69 -51.43 5.88 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.294 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -111.65 -154.84 0.55 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.35 16.69 37.95 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.811 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -148.94 176.56 10.32 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.637 HD22 HD12 ' A' ' 18' ' ' LEU . 32.8 mt -93.2 152.31 19.29 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 118.19 0.45 . . . . 0.0 109.816 172.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.409 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -82.84 28.61 3.54 Favored Glycine 0 C--O 1.212 -1.259 0 CA-C-N 115.212 -0.903 . . . . 0.0 112.558 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.454 ' HB ' HG13 ' A' ' 49' ' ' VAL . 22.0 pt -131.71 133.95 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 CA-C-O 121.325 0.583 . . . . 0.0 110.826 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.3 t -91.13 117.88 29.98 Favored 'General case' 0 C--N 1.268 -2.968 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.468 ' HB ' ' CG2' ' A' ' 47' ' ' ILE . 30.8 m -109.3 136.12 46.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 O-C-N 123.656 0.597 . . . . 0.0 110.192 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.552 HG22 ' HB2' ' A' ' 50' ' ' LYS . 10.5 t -126.57 161.34 28.23 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.499 HG22 ' CD1' ' A' ' 47' ' ' ILE . 3.1 t . . . . . 0 C--N 1.293 -1.89 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.837 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.441 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.538 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.7 mm -101.52 147.21 8.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -136.11 136.4 40.08 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 123.788 0.835 . . . . 0.0 109.45 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.454 HG13 ' HB ' ' A' ' 27' ' ' ILE . 43.7 t -75.6 109.0 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.552 ' HB2' HG22 ' A' ' 30' ' ' THR . 61.3 tttp -83.93 -38.15 21.41 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.977 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.24 165.08 36.87 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.589 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.401 HG21 ' HG2' ' A' ' 59' ' ' GLU . 40.7 mm -111.87 120.1 61.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.58 HG22 ' H ' ' A' ' 55' ' ' LYS . 1.8 mp -67.78 136.0 92.4 Favored Pre-proline 0 C--N 1.315 -0.927 0 C-N-CA 123.187 0.595 . . . . 0.0 110.522 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.54 -25.88 20.66 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.511 3.474 . . . . 0.0 113.629 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.58 ' H ' HG22 ' A' ' 53' ' ' ILE . 44.1 tptt -82.51 63.8 6.84 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.704 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.66 -109.4 0.7 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 117.926 1.931 . . . . 0.0 117.926 171.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.646 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 37.66 -86.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 126.847 2.059 . . . . 0.0 113.987 -169.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.91 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -80.47 -28.01 37.7 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.3 -0.25 . . . . 0.0 110.416 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.401 ' HG2' HG21 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -78.73 -43.91 24.66 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.6 p -73.56 -38.89 65.06 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.811 -174.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -73.04 -33.28 65.61 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.78 49.95 5.16 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 114.216 -1.356 . . . . 0.0 113.667 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -118.19 -68.67 0.9 Allowed 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.548 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 63.6 mt -74.13 140.22 18.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.845 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -123.33 159.15 29.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 133.87 40.26 Favored 'General case' 0 N--CA 1.419 -2.024 0 C-N-CA 118.554 -1.258 . . . . 0.0 108.854 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.81 -16.9 12.15 Favored Glycine 0 N--CA 1.425 -2.095 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -72.9 140.65 47.64 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.26 0.553 . . . . 0.0 111.361 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -92.6 133.05 36.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.796 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 38.3 t -107.68 118.55 55.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt -94.85 -34.85 12.3 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.422 -176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.672 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -158.71 172.43 18.29 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.547 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.824 HG23 HD11 ' A' ' 78' ' ' LEU . 88.5 t -123.17 104.29 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 123.564 0.745 . . . . 0.0 109.197 176.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 t30 61.36 34.19 18.5 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 109.417 171.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.2 -24.1 33.05 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.565 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.37 107.43 14.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.557 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 2.8 p -66.9 133.35 49.85 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.607 0.718 . . . . 0.0 112.891 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.824 HD11 HG23 ' A' ' 73' ' ' VAL . 77.4 mt -100.63 30.3 4.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.927 0.87 . . . . 0.0 108.86 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.78 -27.1 49.25 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 125.675 1.59 . . . . 0.0 112.67 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -141.03 44.94 0.99 Allowed Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.39 156.66 18.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.239 0.542 . . . . 0.0 112.199 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.461 ' HA ' HG21 ' A' ' 31' ' ' VAL . 11.4 t -113.49 177.24 4.7 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 170.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -51.26 -54.81 22.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.807 1.243 . . . . 0.0 111.467 -174.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -57.41 -39.22 75.69 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.316 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -70.56 -45.31 65.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.88 -56.42 20.78 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.13 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.445 ' HA ' HD23 ' A' ' 90' ' ' LEU . 90.4 t -62.18 -32.85 55.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.151 -177.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.04 -34.69 78.65 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.3 m -70.6 -35.62 73.1 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.078 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.593 HD11 HD21 ' A' ' 99' ' ' LEU . 3.6 mm? -68.14 -24.21 64.97 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 121.709 -0.62 . . . . 0.0 111.171 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -79.44 -40.14 30.62 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.231 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -71.08 -38.19 72.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.908 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.1 p -64.84 -58.12 7.03 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 149.92 -150.47 22.54 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 118.906 -1.616 . . . . 0.0 114.989 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.479 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 52.9 tt0 -84.38 -55.77 3.98 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.794 0.838 . . . . 0.0 110.405 -176.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.4 t -93.61 101.48 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 25' ' ' LEU . 2.1 m -100.83 134.0 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.877 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.57 -173.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.686 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 12.0 m170 -101.37 139.62 36.78 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 90' ' ' LEU . 5.9 mp -130.25 143.73 50.95 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 172.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 61.0 tp -86.65 107.2 18.09 Favored 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 13' ' ' THR . 8.4 mp -112.05 155.41 23.86 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.063 0.459 . . . . 0.0 110.431 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 31.7 tt0 -130.79 107.62 9.28 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -47.7 138.04 8.74 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.845 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.048 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.7 t0 . . . . . 0 C--O 1.255 1.381 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 p -98.9 114.48 27.11 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 170.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -109.73 107.33 17.3 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 121.656 0.741 . . . . 0.0 111.846 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -65.78 115.83 6.33 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 170.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.4 p -110.8 137.29 43.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.509 -171.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -107.0 117.52 34.28 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 58' ' ' ALA . 1.1 tm? -117.87 123.88 46.94 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 118.679 -1.208 . . . . 0.0 108.953 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.402 ' N ' HD13 ' A' ' 18' ' ' LEU . . . -97.45 119.38 35.88 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.728 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -59.85 132.37 53.74 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.415 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 t -66.43 -58.0 6.2 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.283 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -170.2 -50.35 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.69 50.32 2.6 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.715 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.728 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 21.5 t 69.1 -160.15 0.18 Allowed 'General case' 0 C--O 1.254 1.322 0 C-N-CA 124.336 1.054 . . . . 0.0 110.711 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.582 ' HG ' ' HE2' ' A' ' 20' ' ' LYS . 86.5 mt -65.7 142.19 58.1 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.24 0.543 . . . . 0.0 110.946 -178.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 56' ' ' GLY . . . -92.42 33.07 5.13 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.33 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 pt -135.37 135.18 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.579 0 CA-C-O 121.303 0.573 . . . . 0.0 110.127 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB2' HD11 ' A' ' 53' ' ' ILE . 19.4 t -102.37 102.07 12.37 Favored 'General case' 0 C--N 1.259 -3.355 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.5 m -92.2 159.59 2.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -140.57 172.15 13.11 Favored 'General case' 0 N--CA 1.413 -2.279 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--N 1.286 -2.182 0 CA-C-O 121.065 0.46 . . . . 0.0 111.751 -175.686 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.192 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.615 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 49.1 mm -109.7 141.78 24.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -136.17 148.77 48.32 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 66' ' ' LYS . 28.4 t -75.58 117.45 20.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -88.52 -34.15 17.51 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.85 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . . . -159.28 157.25 30.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.049 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.44 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 50.8 mm -105.94 120.59 57.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.5 HG22 ' H ' ' A' ' 55' ' ' LYS . 51.7 mm -75.4 124.3 89.01 Favored Pre-proline 0 C--N 1.295 -1.783 0 C-N-CA 122.698 0.399 . . . . 0.0 110.823 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.0 -8.66 12.37 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 C-N-CA 124.149 3.233 . . . . 0.0 114.9 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.5 ' H ' HG22 ' A' ' 53' ' ' ILE . 1.1 mptm? -65.45 -28.42 69.21 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.475 ' O ' ' HA3' ' A' ' 26' ' ' GLY . . . 133.13 -147.43 18.98 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.172 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 75.98 -86.71 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 125.525 1.53 . . . . 0.0 110.916 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.87 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -78.67 -29.63 45.73 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.631 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 39.3 tt0 -78.85 -44.53 22.76 Favored 'General case' 0 N--CA 1.434 -1.264 0 O-C-N 124.673 1.233 . . . . 0.0 110.799 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.8 p -71.98 -40.53 68.53 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.968 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.63 -39.24 73.81 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.11 66.75 1.85 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.843 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.553 ' HG3' HG13 ' A' ' 64' ' ' ILE . 18.6 ptp180 -136.43 -39.19 0.66 Allowed 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.431 176.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.656 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 61.2 mt -101.52 141.22 18.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 -133.55 173.42 11.51 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 51' ' ' ALA . 62.2 pttt -85.69 151.65 23.7 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.367 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.07 -20.2 43.94 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.477 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.936 ' HA ' ' HA3' ' A' ' 104' ' ' GLY 0.271 1.0 OUTLIER -78.7 152.93 31.31 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.7 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -92.5 134.21 35.19 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.921 -168.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.615 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 60.8 t -106.72 120.34 57.77 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.3 mt -96.79 -38.52 9.84 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.458 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.64 170.2 22.94 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.727 -175.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 87.0 t -129.27 120.35 51.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 63.96 27.64 14.36 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.354 1.074 . . . . 0.0 109.169 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.97 -7.16 60.3 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.606 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.91 113.6 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.9 m -64.68 131.0 45.71 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.683 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 86' ' ' ALA 0.42 0.3 OUTLIER -128.38 67.96 1.37 Allowed 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 122.875 1.321 . . . . 0.0 113.974 174.219 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -108.97 114.89 29.04 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.4 15.24 30.49 Favored Glycine 0 C--N 1.297 -1.589 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.89 -177.21 4.89 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.9 p -113.36 168.67 9.55 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -51.76 -50.79 59.98 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.8 -44.34 94.01 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.624 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.28 -41.57 80.8 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 118.314 0.506 . . . . 0.0 110.704 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.68 -56.55 20.46 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.975 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.99 -33.13 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.11 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -68.61 -33.65 74.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.921 178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.1 m -68.67 -33.3 73.75 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.613 HD21 HD21 ' A' ' 99' ' ' LEU . 92.9 mt -72.94 -17.23 61.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.833 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -91.87 -37.42 12.92 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -68.53 -27.48 66.13 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.53 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -46.91 65.68 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.86 -156.03 21.92 Favored Glycine 0 C--N 1.311 -0.834 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.08 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.5 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 34.8 tt0 -75.0 -48.11 25.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.934 0.367 . . . . 0.0 110.936 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.4 t -96.83 105.82 17.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 t -100.14 136.45 31.44 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -176.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -102.64 130.66 49.61 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.613 HD21 HD21 ' A' ' 90' ' ' LEU . 5.8 mp -126.98 154.85 44.05 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.1 tt -106.21 112.08 24.96 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.63 163.22 15.26 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.065 0.46 . . . . 0.0 111.972 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.602 ' HG2' ' HD3' ' A' ' 103' ' ' LYS . 30.2 tt0 -132.55 154.01 50.41 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.602 ' HD3' ' HG2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -50.6 121.83 6.33 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 121.802 0.81 . . . . 0.0 111.95 176.223 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.936 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 C--N 1.298 -1.542 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 t0 . . . . . 0 N--CA 1.442 -0.841 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 11.4 p -87.84 133.02 33.98 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.281 0.363 . . . . 0.0 111.475 -175.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.62 119.4 4.08 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.325 0.583 . . . . 0.0 111.8 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -72.21 120.21 17.49 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.103 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.568 HG21 HD11 ' A' ' 64' ' ' ILE . 33.5 m -96.39 133.64 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.098 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.95 104.75 16.39 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 170.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.862 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -112.24 117.77 33.45 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 119.313 -0.955 . . . . 0.0 108.696 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.74 114.25 25.87 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 24' ' ' SER . 98.6 mttt -56.57 136.31 54.48 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 124.14 0.9 . . . . 0.0 112.398 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.547 HG23 ' HB2' ' A' ' 57' ' ' ALA . 61.2 p -91.71 -163.85 1.1 Allowed 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.84 -19.11 65.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.627 0.727 . . . . 0.0 109.106 174.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 54' ' ' PRO . . . -104.5 19.21 42.84 Favored Glycine 0 N--CA 1.429 -1.832 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.59 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.556 ' HA ' ' HB3' ' A' ' 20' ' ' LYS . 73.8 m 72.4 -153.73 0.08 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.364 1.066 . . . . 0.0 111.054 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 18' ' ' LEU . 89.5 mt -61.54 -24.55 66.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.764 ' HA2' ' HD2' ' A' ' 54' ' ' PRO . . . 86.82 -6.05 83.72 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.006 -1.093 . . . . 0.0 111.82 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.491 ' HB ' HG13 ' A' ' 49' ' ' VAL . 22.6 pt -109.51 136.08 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 C-N-CA 119.228 -0.989 . . . . 0.0 112.544 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.1 t -109.03 128.87 55.34 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.44 149.04 18.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 O-C-N 123.15 0.281 . . . . 0.0 111.037 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -130.83 161.21 32.29 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.714 HG12 HD13 ' A' ' 47' ' ' ILE . 31.2 m . . . . . 0 C--N 1.293 -1.872 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.685 -176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.685 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.898 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 48.7 mm -83.83 123.02 38.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -124.43 128.09 48.5 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.271 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.491 HG13 ' HB ' ' A' ' 27' ' ' ILE . 55.4 t -74.44 110.84 9.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -82.42 -35.93 27.13 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.291 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.44 161.04 35.46 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.031 HG21 ' HB2' ' A' ' 59' ' ' GLU . 16.2 mm -116.32 115.68 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.905 ' HB ' ' HD3' ' A' ' 54' ' ' PRO 0.301 2.1 mp -103.3 -89.38 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.673 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -170.153 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.905 ' HD3' ' HB ' ' A' ' 53' ' ' ILE . 8.5 Cg_endo -91.88 129.79 1.12 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.757 2.305 . . . . 0.0 115.352 -167.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 78.09 -63.62 0.31 Allowed 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 125.726 1.61 . . . . 0.0 110.901 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.08 -83.54 0.13 Allowed Glycine 0 N--CA 1.405 -3.41 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.769 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 68.51 -83.11 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 125.652 1.581 . . . . 0.0 109.744 175.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.991 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -68.03 -38.3 82.37 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.031 ' HB2' HG21 ' A' ' 52' ' ' ILE . 39.3 tt0 -72.98 -43.94 61.65 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.986 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.6 p -76.88 -36.31 56.81 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.16 -34.12 70.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 174.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.47 43.85 11.89 Favored Glycine 0 N--CA 1.434 -1.489 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.18 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -110.83 -46.66 3.32 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.991 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 44.4 mt -104.42 127.01 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.465 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -125.57 157.84 36.12 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 136.3 51.3 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.451 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 112.12 -24.56 14.16 Favored Glycine 0 C--N 1.289 -2.058 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -171.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.747 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 78.2 m-20 -67.73 145.06 55.11 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.247 0.546 . . . . 0.0 111.745 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 70' ' ' VAL . 1.9 tmm_? -109.95 149.11 30.41 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.4 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.898 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.9 t -117.46 135.45 57.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.704 HD12 HD22 ' A' ' 100' ' ' LEU . 95.5 mt -98.24 -42.56 7.35 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.513 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.58 172.2 18.68 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.816 -172.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 1.0 HG11 HG21 ' A' ' 89' ' ' THR . 3.3 p -114.41 113.63 44.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.769 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 31.3 p30 39.4 42.37 0.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.36 1.464 . . . . 0.0 114.432 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.62 -15.01 62.6 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 120.567 -0.825 . . . . 0.0 114.592 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.557 ' HB ' HG13 ' A' ' 73' ' ' VAL . 46.9 t -92.8 110.07 22.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.5 m -67.62 127.22 31.92 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.739 HD13 HG13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.17 21.01 5.3 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.04 175.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -57.39 -27.34 62.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.118 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.51 23.77 21.62 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.726 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.97 157.55 16.74 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.9 t -83.7 170.93 13.71 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -49.96 -53.02 29.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.77 1.628 . . . . 0.0 110.787 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -63.33 -31.76 73.0 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.854 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -76.98 -39.18 51.43 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.259 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.693 ' HA ' HD22 ' A' ' 78' ' ' LEU . . . -52.09 -60.34 3.32 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.85 0.719 . . . . 0.0 109.896 173.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.14 -33.23 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.549 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.28 -34.72 79.01 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.271 0.558 . . . . 0.0 111.453 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 1.0 HG21 HG11 ' A' ' 73' ' ' VAL . 29.7 m -76.28 -33.95 59.1 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 62.5 mt -73.42 -20.07 60.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.609 0.719 . . . . 0.0 110.194 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -81.98 -40.52 22.05 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.593 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -69.78 -33.37 72.31 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.8 p -59.07 -63.07 1.44 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.24 -151.51 23.69 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.053 -1.07 . . . . 0.0 112.531 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -66.33 -45.33 80.63 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 124.071 0.512 . . . . 0.0 111.647 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.76 114.51 46.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.421 HG23 HD21 ' A' ' 25' ' ' LEU . 6.0 t -107.44 136.54 42.32 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.769 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 54.2 m80 -104.14 131.77 51.08 Favored 'General case' 0 N--CA 1.4 -2.934 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.475 HD11 HD22 ' A' ' 90' ' ' LEU . 6.1 mp -127.09 156.71 41.28 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 173.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.704 HD22 HD12 ' A' ' 71' ' ' LEU . 1.8 tt -108.42 114.09 27.67 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 13' ' ' THR . 11.1 mp -109.21 165.47 11.59 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.933 0.873 . . . . 0.0 112.799 -175.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -130.27 108.99 10.43 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 102.418 -3.178 . . . . 0.0 102.418 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.481 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 38.8 tptt -44.31 129.31 6.4 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 123.962 0.789 . . . . 0.0 110.667 -174.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.747 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.43 -1.743 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 -169.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 CA--C 1.503 -0.829 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.1 116.01 31.12 Favored 'General case' 0 C--N 1.285 -2.238 0 O-C-N 123.445 0.466 . . . . 0.0 110.386 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.454 ' CE2' HG22 ' A' ' 16' ' ' VAL . 29.8 p90 -158.47 157.77 32.82 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 43.0 mt-10 -86.59 106.52 17.62 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.454 HG22 ' CE2' ' A' ' 14' ' ' PHE . 32.0 t -69.52 134.4 30.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.286 177.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -104.64 100.8 10.45 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -109.08 118.6 37.18 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.95 125.01 40.21 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.849 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -63.05 131.99 50.46 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.049 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 t -59.57 -50.72 72.79 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.339 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 177.15 -24.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.73 71.99 0.46 Allowed Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.168 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.849 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 21.1 t 68.0 -166.29 0.2 Allowed 'General case' 0 C--O 1.251 1.138 0 C-N-CA 125.099 1.36 . . . . 0.0 111.647 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.492 HD22 HD12 ' A' ' 18' ' ' LEU . 96.2 mt -80.05 163.8 23.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.403 0.62 . . . . 0.0 110.518 -176.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.91 30.94 9.26 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -137.97 162.32 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.298 0 CA-C-O 121.624 0.726 . . . . 0.0 110.785 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 m -140.17 136.73 33.77 Favored 'General case' 0 N--CA 1.394 -3.269 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.877 172.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 49' ' ' VAL . 26.9 m -109.77 -165.74 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.741 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.156 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.608 ' HA ' ' ND1' ' A' ' 83' ' ' HIS . 14.1 t -165.91 167.64 16.54 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 171.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 81' ' ' ALA . 13.5 p . . . . . 0 C--N 1.291 -1.972 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.824 0 N-CA-C 112.832 -0.107 . . . . 0.0 112.832 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.758 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.8 mm -100.33 126.48 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HE1' ' HA2' ' A' ' 67' ' ' GLY . 1.5 t80 -120.11 114.31 21.78 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.393 -172.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.427 ' HA ' HG12 ' A' ' 29' ' ' VAL . 46.1 t -56.46 108.06 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 29' ' ' VAL . 37.5 ttpt -86.59 -36.31 18.93 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.117 -1.402 . . . . 0.0 110.697 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.757 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -155.69 154.79 32.06 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.397 -174.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.594 HD11 ' HA ' ' A' ' 65' ' ' HIS . 47.5 mm -109.12 114.35 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.713 HG22 ' HB2' ' A' ' 55' ' ' LYS . 1.7 mp -84.81 146.18 45.68 Favored Pre-proline 0 C--N 1.283 -2.302 0 C-N-CA 124.006 0.922 . . . . 0.0 112.059 -172.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . 0.261 16.4 Cg_exo -52.67 52.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.512 2.599 1 C-N-CA 126.456 4.77 . . . . 0.0 113.768 172.92 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.713 ' HB2' HG22 ' A' ' 53' ' ' ILE . 38.1 tptt -137.69 1.16 2.31 Favored 'General case' 0 N--CA 1.388 -3.528 0 O-C-N 121.764 -0.585 . . . . 0.0 109.594 -171.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.69 -136.75 24.85 Favored Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.163 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.743 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 67.73 -90.5 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.094 0.958 . . . . 0.0 111.096 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.916 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -71.3 -34.37 70.56 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.486 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 40.5 tt0 -72.19 -42.79 65.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 124.325 1.015 . . . . 0.0 110.525 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -70.11 -50.03 44.85 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.348 -175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.7 -20.91 61.85 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.138 0.494 . . . . 0.0 110.182 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.89 43.8 97.02 Favored Glycine 0 CA--C 1.502 -0.742 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.006 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -105.06 -41.67 5.52 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.616 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 56.4 mt -115.64 136.34 52.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.594 ' HA ' HD11 ' A' ' 52' ' ' ILE . 63.4 t60 -138.41 172.09 13.41 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.757 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 55.0 mtmt -58.96 116.13 3.59 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.48 0.712 . . . . 0.0 110.552 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.547 ' HA2' ' HE1' ' A' ' 48' ' ' TYR . . . 116.26 -11.88 16.79 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 119.611 -1.281 . . . . 0.0 112.957 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.728 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 5.9 m-20 -64.57 137.42 57.84 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.751 0.786 . . . . 0.0 112.652 176.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -93.44 122.96 36.4 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.315 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 61.3 t -100.47 119.61 48.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.0 mt -97.83 -43.99 6.9 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.548 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -154.96 172.07 18.68 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -173.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.897 HG23 HD21 ' A' ' 78' ' ' LEU . 39.5 t -121.06 114.05 41.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 172.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.2 p30 48.27 29.91 2.07 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.287 1.435 . . . . 0.0 112.9 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.58 -30.03 8.89 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.912 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.0 t -80.27 113.8 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 117.819 0.809 . . . . 0.0 109.821 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.9 p -74.98 131.46 40.67 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.897 HD21 HG23 ' A' ' 73' ' ' VAL . 1.9 mm? -85.27 9.46 15.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.349 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.59 106.5 5.39 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.25 2.74 24.65 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.482 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -106.52 155.21 19.84 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.9 t -91.78 172.28 8.58 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.608 ' ND1' ' HA ' ' A' ' 30' ' ' THR . 4.2 t60 -50.46 -50.01 53.59 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.26 1.024 . . . . 0.0 109.577 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 78.2 tttt -50.73 -50.32 55.75 Favored 'General case' 0 C--O 1.204 -1.328 0 O-C-N 124.476 1.11 . . . . 0.0 111.017 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -70.73 -34.9 72.37 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -172.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -56.72 -53.95 51.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.611 0.72 . . . . 0.0 109.385 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.531 ' HA ' HD12 ' A' ' 90' ' ' LEU . 97.9 t -65.94 -31.77 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.779 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 19.1 mm-40 -65.81 -31.26 72.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.046 0.451 . . . . 0.0 109.986 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.439 HG22 HG11 ' A' ' 73' ' ' VAL . 24.2 m -78.42 -30.66 47.76 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 87' ' ' VAL . 91.0 mt -71.23 -24.9 62.28 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.18 0.991 . . . . 0.0 109.45 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -86.03 -27.73 24.59 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.821 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -77.52 -34.37 54.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.405 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -58.5 -74.85 0.06 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.1 -131.83 4.1 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 119.714 -1.231 . . . . 0.0 112.658 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -73.35 -48.47 34.0 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.645 0.778 . . . . 0.0 112.151 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.64 128.74 75.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.453 0.644 . . . . 0.0 109.741 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.3 t -103.54 122.89 56.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.497 -175.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -94.28 111.57 23.31 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 172.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 73' ' ' VAL . 8.5 tp -118.63 127.01 53.18 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.9 tt -85.87 111.6 20.36 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.671 HD23 ' HB3' ' A' ' 68' ' ' ASP . 11.1 mp -120.43 174.59 6.45 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 122.121 0.962 . . . . 0.0 111.578 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -128.53 125.73 38.92 Favored 'General case' 0 N--CA 1.393 -3.318 0 N-CA-C 101.863 -3.384 . . . . 0.0 101.863 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.47 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 18.5 tptp -52.4 131.62 33.62 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 124.096 0.873 . . . . 0.0 111.191 -173.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.728 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.416 -2.666 0 N-CA-C 115.987 1.155 . . . . 0.0 115.987 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 4.2 t70 . . . . . 0 C--O 1.25 1.094 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 16.9 p -101.65 112.18 24.66 Favored 'General case' 0 N--CA 1.426 -1.636 0 O-C-N 123.738 0.648 . . . . 0.0 111.914 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -138.96 172.21 13.18 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.328 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 2.1 mp0 -104.61 117.87 35.19 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.4 HG21 HD11 ' A' ' 64' ' ' ILE . 13.4 m -87.95 117.55 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.318 0 CA-C-O 121.179 0.514 . . . . 0.0 110.358 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HG2' ' ND1' ' A' ' 98' ' ' HIS . 42.4 mt-10 -86.76 98.65 11.28 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.522 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.65 HD11 ' HA ' ' A' ' 58' ' ' ALA . 3.5 mm? -111.13 120.54 42.65 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.662 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.21 140.74 29.19 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.523 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -68.04 90.82 0.33 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.27 0.557 . . . . 0.0 111.256 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.8 t -58.21 -31.23 67.13 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.069 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -162.78 -68.21 0.05 OUTLIER 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.152 0.501 . . . . 0.0 110.325 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.54 86.04 0.33 Allowed Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.5 t 79.01 -159.12 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.77 1.228 . . . . 0.0 109.572 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.587 HD22 ' CB ' ' A' ' 18' ' ' LEU . 63.8 mt -87.44 -4.26 59.01 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.045 0.45 . . . . 0.0 111.567 -174.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.92 13.24 78.14 Favored Glycine 0 N--CA 1.419 -2.481 0 C-N-CA 119.859 -1.163 . . . . 0.0 110.689 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.507 ' HB ' HG13 ' A' ' 49' ' ' VAL . 20.1 pt -119.99 130.44 74.24 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.666 0 CA-C-O 122.193 0.996 . . . . 0.0 112.584 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.406 ' OG ' HD11 ' A' ' 53' ' ' ILE . 45.0 m -96.09 110.76 22.96 Favored 'General case' 0 C--N 1.262 -3.233 0 CA-C-N 113.775 -1.557 . . . . 0.0 107.536 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.42 153.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.982 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.588 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 7.9 t -137.78 157.85 45.59 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 C--N 1.286 -2.17 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 -178.843 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.47 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 47.9 mm -110.11 139.81 31.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.309 -0.445 . . . . 0.0 109.997 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -129.53 148.33 51.42 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.651 HG21 HG21 ' A' ' 64' ' ' ILE . 49.1 t -81.6 116.61 26.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 175.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' HG22 ' A' ' 30' ' ' THR . 61.5 tttp -79.15 -38.7 35.37 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.642 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.72 158.45 28.71 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.328 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.867 HG21 ' HB2' ' A' ' 59' ' ' GLU . 32.9 mm -109.07 121.79 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.468 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 48.4 mm -76.31 131.32 75.27 Favored Pre-proline 0 C--N 1.293 -1.872 0 C-N-CA 123.265 0.626 . . . . 0.0 110.698 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 24.6 Cg_exo -67.66 63.53 0.85 Allowed 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 124.067 3.178 . . . . 0.0 113.059 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -130.25 -55.76 1.1 Allowed 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.578 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 166.26 -160.74 34.35 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . 0.252 . . 71.26 -95.97 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 125.324 1.45 . . . . 0.0 113.114 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.65 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -61.33 -40.62 94.88 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.867 ' HB2' HG21 ' A' ' 52' ' ' ILE . 31.2 tt0 -86.32 -33.9 20.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.144 0.497 . . . . 0.0 110.559 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.578 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 29.5 m -74.72 -39.25 62.02 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.403 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.47 -32.32 48.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.97 64.25 1.81 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.874 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -121.65 -60.94 1.56 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.812 0.815 . . . . 0.0 108.926 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.651 HG21 HG21 ' A' ' 49' ' ' VAL . 34.7 mt -96.27 146.76 6.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.715 -174.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -136.58 -170.34 2.66 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -80.82 139.39 36.02 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.131 -1.027 . . . . 0.0 110.623 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.5 -10.31 61.08 Favored Glycine 0 N--CA 1.429 -1.828 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.957 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.478 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 30.9 m-20 -64.45 141.91 58.61 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 117.625 0.712 . . . . 0.0 112.271 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -92.41 121.86 34.29 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.239 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.591 HG22 HD11 ' A' ' 101' ' ' LEU . 49.6 t -100.09 111.63 30.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.413 ' HB2' HD12 ' A' ' 100' ' ' LEU . 83.4 mt -91.72 -41.49 10.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.772 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -152.25 168.72 24.46 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.376 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.847 HG23 HD21 ' A' ' 78' ' ' LEU . 93.8 t -124.14 104.42 13.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 173.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.455 ' HB3' ' HB2' ' A' ' 98' ' ' HIS 0.311 1.8 p-10 47.12 45.86 16.1 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 122.219 1.009 . . . . 0.0 113.711 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.1 -16.92 60.09 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.205 -1.361 . . . . 0.0 114.269 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.1 t -90.97 108.49 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 118.016 0.908 . . . . 0.0 108.78 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 5.0 p -78.28 137.24 37.99 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -174.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.847 HD21 HG23 ' A' ' 73' ' ' VAL . 2.2 mm? -93.09 97.51 10.73 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -110.52 -46.03 3.45 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.288 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.14 45.12 1.11 Allowed Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 85' ' ' GLN . . . -95.55 -178.15 4.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.374 -0.413 . . . . 0.0 110.686 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.486 ' OG1' ' HG3' ' A' ' 85' ' ' GLN . 68.3 p -115.99 168.3 10.2 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 174.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 16.5 p-80 -53.58 -40.95 66.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.428 0.632 . . . . 0.0 110.192 173.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.04 -42.13 89.97 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.918 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.591 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 49.1 mt-30 -66.41 -32.47 73.87 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.507 0.594 . . . . 0.0 110.387 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.504 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -59.88 -50.46 73.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.494 0.664 . . . . 0.0 109.428 174.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.63 -30.55 50.56 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.098 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.57 -36.8 85.39 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.06 0.457 . . . . 0.0 110.22 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.1 m -69.62 -33.46 72.69 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 99' ' ' LEU . 90.2 mt -76.54 -23.58 53.63 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.344 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -82.05 -30.99 31.1 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -62.0 -43.85 97.98 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.721 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.493 HG21 HG13 ' A' ' 97' ' ' VAL . 34.9 p -70.64 154.21 42.08 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.67 176.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.46 -114.29 0.78 Allowed Glycine 0 N--CA 1.422 -2.258 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.756 -173.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -86.54 -39.82 15.84 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.851 -0.674 . . . . 0.0 110.961 -172.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.23 127.65 75.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.523 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 4.0 t -114.74 152.31 16.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 77.8 m-70 -123.93 71.47 1.11 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 90' ' ' LEU . 4.8 mp -65.15 144.07 57.45 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.999 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.772 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.9 tm? -93.03 107.98 19.65 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.591 HD11 HG22 ' A' ' 70' ' ' VAL . 2.7 mp -122.6 147.84 45.94 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.872 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 35.3 tt0 -118.16 127.5 53.82 Favored 'General case' 0 N--CA 1.397 -3.086 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 172.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 103' ' ' LYS . 5.5 tmtm? -54.29 114.36 1.61 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.092 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.426 -1.99 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.338 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 37.6 t70 . . . . . 0 CA--C 1.5 -0.974 0 N-CA-C 111.246 0.091 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p -93.35 124.42 37.32 Favored 'General case' 0 N--CA 1.425 -1.722 0 O-C-N 124.079 0.862 . . . . 0.0 110.143 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CE1' ' HD2' ' A' ' 63' ' ' ARG . 46.9 p90 -140.79 152.17 44.98 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.203 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.472 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 52.4 mt-10 -110.95 90.96 3.48 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.645 HG11 HD11 ' A' ' 64' ' ' ILE . 6.5 p -71.07 136.57 25.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.827 -175.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -96.13 93.58 7.03 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.88 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -97.56 116.85 30.56 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.309 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.63 131.37 44.26 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.9 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HD2' HD23 ' A' ' 25' ' ' LEU . 1.6 mptm? -66.8 124.25 22.4 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.081 172.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 t -113.75 10.57 17.88 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 34.1 t70 -155.47 -152.67 0.4 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' H ' ' CG ' ' A' ' 22' ' ' ASP . . . -104.81 15.54 48.43 Favored Glycine 0 C--N 1.296 -1.639 0 CA-C-N 119.83 1.196 . . . . 0.0 110.302 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -142.64 165.76 26.52 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.63 HD22 HD12 ' A' ' 18' ' ' LEU . 92.4 mt -85.7 173.74 9.88 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 170.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.83 32.66 5.46 Favored Glycine 0 C--N 1.289 -2.052 0 C-N-CA 120.024 -1.084 . . . . 0.0 111.141 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 64' ' ' ILE . 15.0 pt -139.47 143.4 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-O 121.35 0.595 . . . . 0.0 111.905 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.41 ' HB2' HD11 ' A' ' 53' ' ' ILE . 32.9 t -103.01 128.3 49.9 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 49' ' ' VAL . 26.9 m -125.08 151.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-O 120.872 0.368 . . . . 0.0 110.691 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.7 t -133.25 173.53 11.35 Favored 'General case' 0 N--CA 1.392 -3.359 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.55 ' HB ' ' H ' ' A' ' 83' ' ' HIS . 10.0 p . . . . . 0 C--N 1.26 -3.302 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -171.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.957 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.5 mm -123.72 149.29 27.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.415 ' CE2' ' HG2' ' A' ' 69' ' ' ARG . 79.1 m-85 -130.22 139.35 50.81 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 122.036 -0.415 . . . . 0.0 111.089 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 29' ' ' VAL . 58.2 t -72.39 110.8 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -78.38 -39.8 38.04 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.018 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.69 170.44 14.1 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 -174.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.6 mm -102.65 115.47 44.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.494 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 33.6 mm -75.25 124.8 89.4 Favored Pre-proline 0 C--N 1.31 -1.15 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 5.6 Cg_exo -74.48 77.49 2.92 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 122.802 2.334 . . . . 0.0 112.479 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 50.5 mmtt -136.18 12.71 3.31 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.78 173.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.12 -139.6 19.24 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.72 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 67.51 -93.53 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 123.674 0.789 . . . . 0.0 112.0 173.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.88 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -75.1 -32.27 61.38 Favored 'General case' 0 C--O 1.256 1.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.21 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.49 -39.21 65.03 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 125.191 1.557 . . . . 0.0 110.003 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -73.75 -41.29 62.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.73 -31.13 69.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.37 34.37 79.69 Favored Glycine 0 CA--C 1.49 -1.517 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.707 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.431 ' HG2' ' CG2' ' A' ' 16' ' ' VAL . 15.8 tpp180 -101.23 -37.86 8.35 Favored 'General case' 1 N--CA 1.362 -4.837 0 CA-C-O 121.091 0.472 . . . . 0.0 110.876 -174.144 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 27' ' ' ILE . 22.8 mm -96.29 138.12 22.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.011 -173.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -124.48 161.7 25.52 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -76.4 137.23 39.62 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.861 -1.136 . . . . 0.0 109.885 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.15 -10.61 47.63 Favored Glycine 0 N--CA 1.425 -2.1 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.469 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -68.15 143.39 55.41 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.442 0.639 . . . . 0.0 111.176 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.415 ' HG2' ' CE2' ' A' ' 48' ' ' TYR . 43.4 mtp180 -95.07 125.97 40.09 Favored 'General case' 0 CA--C 1.469 -2.147 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.347 -174.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.545 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 44.4 t -94.22 106.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.832 0 CA-C-N 114.077 -1.42 . . . . 0.0 107.477 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.636 HD12 HD22 ' A' ' 100' ' ' LEU . 56.2 mt -84.44 -35.86 22.74 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.74 -175.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' A' ' 77' ' ' SER . . . -166.8 170.81 12.0 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.856 ' HA ' HD12 ' A' ' 99' ' ' LEU . 49.0 t -111.56 103.16 15.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 174.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.991 ' HB3' ' HB2' ' A' ' 98' ' ' HIS 0.283 1.1 p-10 39.43 70.58 0.21 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -178.226 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.61 -32.19 2.91 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.098 -0.956 . . . . 0.0 114.645 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.4 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 60.3 t -81.39 108.38 14.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 118.008 0.904 . . . . 0.0 109.582 -176.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.412 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 13.7 p -63.28 139.18 58.74 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.609 HD11 HG23 ' A' ' 73' ' ' VAL . 71.9 mt -104.03 27.62 7.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.923 0.868 . . . . 0.0 109.158 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -49.63 -33.38 15.22 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.027 1.731 . . . . 0.0 113.081 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.78 46.15 1.07 Allowed Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HB1' ' HG3' ' A' ' 85' ' ' GLN . . . -106.26 154.85 20.15 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.56 0.219 . . . . 0.0 111.155 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.497 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.2 t -100.71 160.52 14.29 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 168.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.55 ' H ' ' HB ' ' A' ' 31' ' ' VAL . 39.0 p-80 -51.23 -48.33 62.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 18.8 ptmt -67.46 -30.28 69.95 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.434 ' HG3' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -73.97 -36.65 64.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.457 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.548 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.6 -46.61 83.85 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.71 -32.73 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.684 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 41.8 mt-10 -73.28 -26.46 61.1 Favored 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.198 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.463 HG22 HG11 ' A' ' 73' ' ' VAL . 47.4 m -74.19 -26.88 60.53 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.638 HD22 HG11 ' A' ' 97' ' ' VAL . 68.3 mt -74.93 -26.33 59.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -84.25 -28.77 26.98 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.11 -35.26 79.37 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.163 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.7 p -72.06 -66.33 0.66 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.392 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.38 -136.73 7.39 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.435 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.425 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 29.4 tt0 -69.9 -51.38 33.62 Favored 'General case' 0 C--O 1.211 -0.966 0 O-C-N 124.167 0.569 . . . . 0.0 111.117 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.0 125.46 66.08 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 117.863 -1.535 . . . . 0.0 111.348 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.638 HG11 HD22 ' A' ' 90' ' ' LEU . 35.4 t -113.18 126.19 70.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.4 -177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.991 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 11.2 m170 -89.99 125.5 35.41 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 171.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.856 HD12 ' HA ' ' A' ' 73' ' ' VAL . 8.3 tp -123.77 136.28 54.32 Favored 'General case' 0 C--N 1.259 -3.339 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 71' ' ' LEU . 1.3 tt -93.8 113.48 25.54 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.738 HD11 HD23 ' A' ' 99' ' ' LEU . 7.2 mp -125.25 165.78 17.68 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.341 0.591 . . . . 0.0 111.884 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' A' ' 71' ' ' LEU . 37.0 tt0 -130.99 134.06 46.35 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 54.4 mmtt -56.2 125.38 21.51 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.631 0.729 . . . . 0.0 112.823 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.094 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.883 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 . . . . . 0 CA--C 1.496 -1.126 0 CA-C-O 120.344 0.116 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 7.9 p -89.0 145.96 25.17 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.176 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.403 ' CE1' ' HD2' ' A' ' 103' ' ' LYS . 2.6 p90 -143.75 136.29 27.09 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -97.26 110.71 23.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 33.9 t -89.56 119.56 36.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.08 -172.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -101.62 88.6 3.46 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 169.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.846 HD11 ' HB1' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -93.22 117.0 29.56 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -174.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.54 116.77 29.17 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -62.9 139.06 58.71 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.981 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.563 HG21 ' HG3' ' A' ' 55' ' ' LYS . 1.8 m -67.34 -68.85 0.35 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.011 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' H ' ' HB ' ' A' ' 21' ' ' THR . 20.7 t70 -103.64 -79.21 0.54 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.44 16.49 2.27 Favored Glycine 0 C--N 1.3 -1.464 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m -117.78 144.11 45.64 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.453 -174.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.435 HD12 HD13 ' A' ' 90' ' ' LEU . 90.4 mt -86.14 175.69 8.38 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.526 ' HA3' ' H ' ' A' ' 58' ' ' ALA . . . -108.69 32.86 6.59 Favored Glycine 0 C--N 1.291 -1.93 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.145 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.47 HG23 ' CB ' ' A' ' 58' ' ' ALA . 7.6 pt -137.13 138.37 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.77 0 CA-C-O 121.222 0.534 . . . . 0.0 111.721 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 11.8 t -111.7 109.34 19.16 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 176.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 34.6 m -100.12 168.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.549 -174.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -147.8 169.01 20.69 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 171.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 82' ' ' THR . 11.1 p . . . . . 0 C--N 1.293 -1.887 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.305 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.799 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 48.1 mm -105.25 140.29 23.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.447 ' CE2' ' HG3' ' A' ' 69' ' ' ARG . 81.1 m-85 -135.33 112.71 10.59 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.687 HG21 HG21 ' A' ' 64' ' ' ILE . 59.9 t -46.33 120.14 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.587 0.708 . . . . 0.0 111.278 172.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -91.18 -34.6 14.95 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.491 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 28' ' ' SER . . . -154.69 158.2 39.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.203 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.0 mm -108.68 118.59 56.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 49.1 mm -87.84 134.29 35.76 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.473 ' HB2' ' H ' ' A' ' 55' ' ' LYS . 16.0 Cg_exo -69.19 -102.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 121.763 1.642 . . . . 0.0 111.836 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HG3' HG21 ' A' ' 21' ' ' THR . 16.1 tppt? 67.86 -59.48 0.42 Allowed 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 125.719 1.608 . . . . 0.0 110.885 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.84 48.24 0.03 OUTLIER Glycine 0 N--CA 1.424 -2.127 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.846 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -135.59 -98.39 0.23 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.801 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -69.22 -33.59 73.53 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 118.171 0.441 . . . . 0.0 111.324 -174.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -70.42 -45.57 65.63 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 124.172 0.92 . . . . 0.0 109.193 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 t -72.5 -44.35 62.35 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.483 -174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -74.87 -19.21 60.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.898 0.856 . . . . 0.0 108.94 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.72 67.8 2.02 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.491 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.529 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -119.92 -67.54 0.97 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.097 0.475 . . . . 0.0 110.734 -179.158 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.687 HG21 HG21 ' A' ' 49' ' ' VAL . 63.7 mt -85.5 139.63 17.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.41 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -124.77 178.45 5.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -71.25 129.6 39.29 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.765 0.317 . . . . 0.0 110.697 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.55 -15.49 53.18 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.934 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.486 ' HA ' ' H ' ' A' ' 104' ' ' GLY . 75.9 m-20 -64.54 138.01 58.17 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 121.658 0.742 . . . . 0.0 112.033 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HG3' ' CE2' ' A' ' 48' ' ' TYR . 36.3 ttm180 -90.41 129.38 36.61 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 114.603 -1.181 . . . . 0.0 110.376 -173.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.799 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.2 t -97.01 104.35 15.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.609 HD12 HD22 ' A' ' 100' ' ' LEU . 93.7 mt -78.09 -39.56 41.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.094 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 77' ' ' SER . . . -159.11 166.74 30.89 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.956 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.911 HG23 HD21 ' A' ' 78' ' ' LEU . 98.7 t -119.05 97.71 5.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 52.4 t30 54.2 60.37 3.63 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 124.247 1.019 . . . . 0.0 109.987 -178.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.89 -36.02 2.32 Favored Glycine 0 CA--C 1.548 2.105 0 CA-C-N 114.517 -1.219 . . . . 0.0 114.398 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.86 108.79 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 20.9 m -85.38 142.82 29.02 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.479 0.657 . . . . 0.0 112.602 -173.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.911 HD21 HG23 ' A' ' 73' ' ' VAL . 1.6 mm? -99.21 22.98 9.73 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.977 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -67.36 -22.24 65.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.114 0.483 . . . . 0.0 112.283 -175.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.55 25.68 8.97 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 174.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 85' ' ' GLN . . . -105.99 -172.03 2.01 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.515 0.674 . . . . 0.0 111.509 -176.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.64 ' HA ' HG21 ' A' ' 31' ' ' VAL . 6.6 t -144.91 178.85 7.72 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -50.55 -55.89 14.14 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.968 0.907 . . . . 0.0 111.847 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 33.0 mmtp -65.23 -25.09 67.53 Favored 'General case' 0 C--O 1.211 -0.969 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HB2' ' H ' ' A' ' 82' ' ' THR . 16.3 mm100 -76.59 -44.89 32.55 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.498 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -58.26 -54.32 48.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.444 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.59 -27.69 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.827 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 84' ' ' LYS . 34.1 tt0 -70.88 -34.75 71.92 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 121.702 -0.624 . . . . 0.0 109.317 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.7 m -71.4 -30.59 66.27 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.72 HD21 HD21 ' A' ' 99' ' ' LEU . 94.0 mt -76.8 -12.28 59.95 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.203 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.456 ' HD3' ' HA ' ' A' ' 91' ' ' ARG . 14.0 mmt180 -92.93 -31.7 14.83 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.75 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.01 -38.35 90.65 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.708 0.766 . . . . 0.0 109.199 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.2 p -74.42 146.35 42.96 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.91 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -79.16 -135.06 1.07 Allowed Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 121.453 -0.403 . . . . 0.0 113.65 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -72.87 -49.33 30.63 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.104 0.478 . . . . 0.0 110.484 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 45.8 t -98.93 112.73 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 t -108.52 137.94 37.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.124 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 12.7 m-70 -96.05 129.49 43.32 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 173.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.72 HD21 HD21 ' A' ' 90' ' ' LEU . 5.9 mp -127.11 141.81 51.67 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.609 HD22 HD12 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -99.78 113.81 26.55 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.714 ' HG ' ' HA ' ' A' ' 70' ' ' VAL . 7.3 mp -127.43 163.07 24.88 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 118.727 0.694 . . . . 0.0 112.299 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.664 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 36.0 tt0 -131.01 128.77 41.03 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.482 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 6.4 tptp -49.93 113.15 0.79 Allowed 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.267 0.979 . . . . 0.0 110.404 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 C--N 1.29 -1.996 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.936 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 CA--C 1.499 -1.0 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 40.2 p -92.6 140.89 29.09 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -139.95 141.64 36.44 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.378 0.609 . . . . 0.0 111.343 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.675 ' HB3' ' HE2' ' A' ' 98' ' ' HIS . 3.1 mp0 -83.89 108.47 16.9 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.356 -1.293 . . . . 0.0 107.953 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.24 125.8 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.063 0 CA-C-O 121.628 0.728 . . . . 0.0 111.519 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -102.37 113.63 27.11 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 57' ' ' ALA . 2.7 tm? -109.57 116.27 31.44 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.43 118.54 33.16 Favored 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 94.1 mttt -59.51 119.29 7.24 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 124.059 0.849 . . . . 0.0 110.304 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.715 ' HB ' ' O ' ' A' ' 56' ' ' GLY . 19.0 m -76.13 -67.44 0.68 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.643 -176.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -152.65 -48.49 0.1 Allowed 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.73 35.65 2.68 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.253 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.8 p 71.64 -132.23 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.616 1.966 . . . . 0.0 111.977 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.542 ' HG ' HD13 ' A' ' 90' ' ' LEU . 3.3 mm? -72.3 -30.64 64.98 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.836 0.826 . . . . 0.0 109.547 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.73 22.33 62.04 Favored Glycine 0 N--CA 1.402 -3.615 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.431 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.449 ' HB ' HG13 ' A' ' 49' ' ' VAL . 19.9 pt -135.2 143.26 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.692 0 CA-C-O 121.677 0.751 . . . . 0.0 111.056 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.3 t -97.11 118.01 32.57 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.72 140.89 47.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.416 0.627 . . . . 0.0 112.062 -173.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 47' ' ' ILE . 11.4 t -138.61 -171.84 3.16 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -172.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.864 ' HA ' HD13 ' A' ' 47' ' ' ILE . 79.5 t . . . . . 0 C--N 1.301 -1.52 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 79' ' ' GLU . . . . . . . . 0 CA--C 1.471 -2.704 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.864 HD13 ' HA ' ' A' ' 31' ' ' VAL . 17.4 mm -141.15 152.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.46 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 39.1 t80 -139.41 138.15 36.27 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.331 0.652 . . . . 0.0 111.094 -174.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.449 HG13 ' HB ' ' A' ' 27' ' ' ILE . 44.2 t -78.48 103.1 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.459 ' HB2' HG22 ' A' ' 30' ' ' THR . 88.1 tttt -68.89 -41.24 78.57 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.844 -174.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.84 159.39 32.49 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.212 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 23.4 mm -113.24 134.87 54.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 55' ' ' LYS . 1.8 mp -79.44 128.4 75.35 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.55 -15.61 9.24 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 125.26 3.974 . . . . 0.0 115.27 -175.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' H ' HG22 ' A' ' 53' ' ' ILE . 22.9 tptm -162.59 64.44 0.21 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.938 0.875 . . . . 0.0 109.644 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.715 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -114.49 -54.34 0.41 Allowed Glycine 0 C--N 1.303 -1.264 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.651 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.554 ' HB2' ' H ' ' A' ' 21' ' ' THR . . . 176.65 -68.13 0.01 OUTLIER 'General case' 0 C--O 1.173 -2.957 0 O-C-N 125.48 1.341 . . . . 0.0 111.641 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.885 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -49.47 -37.29 25.57 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -173.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -78.84 -48.6 14.41 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -71.6 -35.97 70.66 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.795 -172.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.56 -37.23 56.94 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.41 77.04 1.08 Allowed Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 114.418 -1.265 . . . . 0.0 114.001 173.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -157.98 -47.0 0.06 Allowed 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.885 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 77.1 mt -88.63 132.41 33.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -120.19 164.61 15.97 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 123.533 0.521 . . . . 0.0 109.61 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -63.44 128.96 38.19 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.568 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.621 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 98.92 -8.59 61.36 Favored Glycine 0 N--CA 1.419 -2.482 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.545 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.441 ' HB3' HD23 ' A' ' 101' ' ' LEU . 80.7 m-20 -66.67 139.81 57.87 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-O 121.244 0.545 . . . . 0.0 110.603 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.656 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . 27.7 ttm-85 -98.67 143.63 28.84 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -174.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.44 HG12 HD21 ' A' ' 78' ' ' LEU . 48.5 t -109.9 120.03 60.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.558 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -177.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 100' ' ' LEU . 57.6 mt -101.82 -33.8 9.67 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.963 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -151.75 160.06 43.72 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.188 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.993 HG11 HG21 ' A' ' 89' ' ' THR . 2.6 p -116.65 104.6 16.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 174.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HA ' ' ND1' ' A' ' 98' ' ' HIS . 61.6 t30 55.12 37.68 29.29 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.438 1.114 . . . . 0.0 109.901 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.68 -23.73 35.08 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 120.275 -0.964 . . . . 0.0 114.182 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.562 ' HB ' HG13 ' A' ' 73' ' ' VAL . 44.1 t -80.96 113.15 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 118.458 1.129 . . . . 0.0 109.021 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.3 t -72.82 109.61 6.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.106 0.479 . . . . 0.0 110.134 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.77 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.5 pt? -97.63 33.12 2.12 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 122.233 1.016 . . . . 0.0 110.935 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.547 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 11.8 pt-20 -58.25 -28.65 65.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.131 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.9 30.97 7.07 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.54 -164.12 1.12 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.548 ' H ' ' HB2' ' A' ' 85' ' ' GLN . 13.5 t -144.18 177.72 8.4 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -50.3 -53.15 30.68 Favored 'General case' 0 C--O 1.265 1.913 0 C-N-CA 124.897 1.279 . . . . 0.0 110.67 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 97.5 mttt -59.36 -47.92 83.59 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.019 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.548 ' HB2' ' H ' ' A' ' 82' ' ' THR . 28.8 mm-40 -64.3 -42.69 96.25 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.542 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -50.55 -60.32 3.14 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-O 121.428 0.632 . . . . 0.0 110.387 175.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.07 -31.8 55.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.428 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 42.6 mm-40 -69.58 -34.15 73.73 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 122.097 -0.377 . . . . 0.0 111.016 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.993 HG21 HG11 ' A' ' 73' ' ' VAL . 45.0 m -65.14 -38.48 90.74 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 177.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.77 HD21 HD21 ' A' ' 99' ' ' LEU . 81.6 mt -72.84 -23.49 60.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.731 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -84.11 -30.55 25.86 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.893 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.97 -41.13 87.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.089 0.471 . . . . 0.0 109.892 175.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 20.1 p -68.92 155.04 40.98 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.916 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -71.24 -147.57 0.51 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 114.84 0.696 . . . . 0.0 114.84 -176.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 62.4 tt0 -74.38 -35.89 63.51 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.21 -0.495 . . . . 0.0 110.907 -177.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.71 111.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 t -110.0 146.23 15.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.675 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 58.5 t-80 -109.68 134.47 51.94 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 175.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.77 HD21 HD21 ' A' ' 90' ' ' LEU . 6.4 mp -130.28 153.36 48.72 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 173.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.739 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.3 tm? -106.09 109.79 21.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.441 HD23 ' HB3' ' A' ' 68' ' ' ASP . 8.0 mp -111.38 171.43 7.48 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-O 121.668 0.747 . . . . 0.0 111.939 -175.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.656 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 29.3 tt0 -128.4 132.69 48.5 Favored 'General case' 0 N--CA 1.396 -3.164 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 175.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -63.05 112.79 2.76 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . . . . . . 0 N--CA 1.409 -3.163 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.31 -172.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 23.1 t0 . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.8 p -92.09 144.75 25.12 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 123.599 0.562 . . . . 0.0 109.706 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -157.77 153.67 26.89 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 41.4 mt-10 -110.73 89.2 2.97 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.456 HG12 HD13 ' A' ' 101' ' ' LEU . 14.1 p -81.47 143.18 12.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.433 -175.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -104.2 111.4 23.98 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.784 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -111.34 126.72 55.22 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.054 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -101.47 142.05 33.43 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.461 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.748 ' HB2' ' HG3' ' A' ' 95' ' ' GLN . 29.5 mmtm -65.36 118.14 8.92 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.6 m -90.18 -61.39 1.69 Allowed 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.117 0.484 . . . . 0.0 111.804 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -152.88 -45.65 0.1 Allowed 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 121.762 0.792 . . . . 0.0 109.009 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 24' ' ' SER . . . -123.48 51.28 0.81 Allowed Glycine 0 N--CA 1.418 -2.51 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.57 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.543 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 25.7 m 80.45 -147.67 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.753 1.221 . . . . 0.0 110.279 175.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 90' ' ' LEU . 28.6 mt -80.46 -10.95 59.74 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.135 0.493 . . . . 0.0 109.73 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.55 8.99 84.03 Favored Glycine 0 N--CA 1.42 -2.405 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.059 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 25' ' ' LEU . 25.7 pt -114.76 134.33 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 121.997 0.903 . . . . 0.0 112.766 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.2 t -97.12 107.59 20.14 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.843 -1.526 . . . . 0.0 106.921 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.485 ' HB ' ' CG2' ' A' ' 47' ' ' ILE . 34.1 m -96.84 152.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 120.737 0.303 . . . . 0.0 110.561 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 50' ' ' LYS . 11.1 t -142.84 156.03 44.88 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 81' ' ' ALA . 7.2 p . . . . . 0 C--N 1.283 -2.305 0 CA-C-O 121.38 0.61 . . . . 0.0 110.212 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.796 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.897 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 49.9 mm -114.35 154.18 15.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 123.433 0.693 . . . . 0.0 109.368 -175.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -128.35 133.5 48.68 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 122.941 0.496 . . . . 0.0 109.79 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.456 HG21 ' CG2' ' A' ' 64' ' ' ILE . 58.8 t -80.06 111.65 17.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HB2' HG22 ' A' ' 30' ' ' THR . 38.7 ttpt -79.88 -41.71 25.68 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.034 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.64 41.41 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.848 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 46.0 mm -113.47 124.16 69.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -81.2 122.18 81.16 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 38.5 Cg_endo -69.16 80.26 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.666 2.244 . . . . 0.0 112.099 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -143.3 -42.93 0.29 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.147 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.51 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 156.09 -160.17 29.89 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.359 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.528 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 67.67 -102.68 0.07 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.347 1.459 . . . . 0.0 112.819 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.784 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -65.79 -36.69 84.24 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.355 0.525 . . . . 0.0 111.081 -176.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.464 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 45.1 tt0 -67.56 -47.6 69.35 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.265 1.026 . . . . 0.0 111.289 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 52.1 m -69.74 -42.68 73.6 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.694 -177.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -71.17 -27.72 63.73 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.048 0.928 . . . . 0.0 108.887 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.51 43.33 94.86 Favored Glycine 0 CA--C 1.498 -0.981 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.657 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.518 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -107.19 -51.04 2.98 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.769 -178.491 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.692 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 59.1 mt -101.66 126.67 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -125.23 166.19 16.94 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -63.13 125.73 25.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.32 -23.61 15.61 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.683 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.493 ' HB3' HD23 ' A' ' 101' ' ' LEU . 37.8 m-20 -66.82 141.53 57.66 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.32 0.581 . . . . 0.0 110.73 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -106.4 143.79 34.01 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.545 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.897 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 51.4 t -107.93 123.02 63.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.159 -175.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 102' ' ' GLU . 90.1 mt -99.36 -33.8 10.56 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.84 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.672 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -160.65 163.7 32.33 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.952 HG23 HD11 ' A' ' 78' ' ' LEU . 94.2 t -111.4 115.47 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 173.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 47.03 39.35 7.67 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 126.996 2.119 . . . . 0.0 110.983 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.83 -18.46 56.56 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 119.848 -1.168 . . . . 0.0 114.78 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t -81.58 112.95 20.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 45.7 m -64.31 133.83 53.46 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.862 0.839 . . . . 0.0 113.06 -171.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.952 HD11 HG23 ' A' ' 73' ' ' VAL . 79.4 mt -107.39 15.49 24.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.733 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.26 97.54 1.57 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.81 25.79 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.424 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -86.45 142.96 28.01 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.0 t -85.56 168.09 14.8 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 172.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . 57.0 t-80 -50.38 -49.87 53.16 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.652 0.781 . . . . 0.0 110.915 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -53.79 -38.62 64.69 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.939 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -70.58 -51.8 25.89 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 120.707 -0.397 . . . . 0.0 109.951 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.57 -57.93 8.99 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 123.97 0.794 . . . . 0.0 111.804 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 83' ' ' HIS . 37.9 t -65.84 -43.35 93.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.359 -173.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -72.49 -30.58 64.65 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.756 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.638 ' O ' HG23 ' A' ' 93' ' ' THR . 93.6 m -68.22 -43.18 78.55 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 25' ' ' LEU . 2.3 tp -75.25 -18.07 60.18 Favored 'General case' 0 N--CA 1.425 -1.712 0 C-N-CA 124.015 0.926 . . . . 0.0 111.445 -177.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -92.24 -33.35 14.7 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.829 -0.544 . . . . 0.0 109.729 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -82.32 -15.91 51.18 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 89' ' ' THR . 5.4 p -53.47 -63.17 1.23 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.442 0.639 . . . . 0.0 111.121 177.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.45 -162.92 32.25 Favored Glycine 0 N--CA 1.411 -2.97 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.748 ' HG3' ' HB2' ' A' ' 20' ' ' LYS . 63.5 tt0 -72.3 -44.59 62.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 117.257 0.529 . . . . 0.0 109.99 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 46.1 t -102.02 118.09 48.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 90' ' ' LEU . 4.1 t -112.71 141.99 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -96.8 125.32 41.16 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 171.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.623 HD11 HG22 ' A' ' 73' ' ' VAL . 2.8 tp -120.58 132.91 55.38 Favored 'General case' 0 C--N 1.253 -3.597 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.4 tt -95.35 114.28 26.04 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.493 HD23 ' HB3' ' A' ' 68' ' ' ASP . 10.2 mp -119.64 171.3 8.47 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.556 0.693 . . . . 0.0 112.199 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.552 ' HB2' HD11 ' A' ' 71' ' ' LEU . 35.7 tt0 -131.4 123.08 27.44 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 101.618 -3.475 . . . . 0.0 101.618 171.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -58.13 126.34 27.06 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 123.683 0.614 . . . . 0.0 110.375 -173.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.687 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.197 -175.339 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 21.8 p -95.38 148.27 22.63 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.22 0.533 . . . . 0.0 111.34 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -149.42 147.69 28.56 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -103.91 98.06 7.96 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.477 HG12 HD13 ' A' ' 101' ' ' LEU . 8.4 p -82.87 127.56 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.825 -175.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.35 87.98 3.35 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.785 HD12 HD12 ' A' ' 25' ' ' LEU . 1.4 tm? -87.41 113.9 23.53 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -175.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.12 113.96 26.01 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.4 127.14 30.27 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 123.986 0.804 . . . . 0.0 110.455 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.6 p -82.3 -71.74 0.47 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.463 1.125 . . . . 0.0 111.506 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -156.61 -36.27 0.08 Allowed 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 113.547 -1.66 . . . . 0.0 106.678 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . -89.14 28.42 6.71 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.517 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.3 p 65.97 -142.31 0.18 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.103 1.761 . . . . 0.0 111.525 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.785 HD12 HD12 ' A' ' 18' ' ' LEU . 7.7 tp -67.82 -28.35 67.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.934 0.873 . . . . 0.0 109.306 -176.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.27 18.51 66.64 Favored Glycine 0 N--CA 1.411 -2.995 0 C-N-CA 119.951 -1.118 . . . . 0.0 114.693 172.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.432 HG22 HD13 ' A' ' 52' ' ' ILE . 12.3 pt -131.84 145.86 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 CA-C-O 121.303 0.573 . . . . 0.0 111.404 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.5 t -111.89 136.36 51.31 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 49' ' ' VAL . 32.1 m -126.14 149.9 31.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.581 0.705 . . . . 0.0 112.358 -175.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 13.5 t -125.41 145.36 50.09 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 83' ' ' HIS . 46.0 t . . . . . 0 C--N 1.293 -1.872 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.053 -176.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.711 0 N-CA-C 112.034 -0.426 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.01 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 50.5 mm -87.26 121.74 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -121.31 131.17 54.05 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.547 -0.861 . . . . 0.0 113.3 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.508 ' HA ' HG12 ' A' ' 29' ' ' VAL . 45.3 t -70.04 112.81 5.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.465 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 61.9 tttp -86.04 -36.86 19.44 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.359 -176.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.99 148.81 28.83 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.408 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.679 HG12 ' HB3' ' A' ' 66' ' ' LYS . 46.5 mm -110.57 127.73 67.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.746 HG22 ' H ' ' A' ' 55' ' ' LYS . 44.9 mm -83.62 138.61 40.99 Favored Pre-proline 0 C--N 1.286 -2.165 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.957 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -60.0 -16.52 39.48 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 124.13 3.22 . . . . 0.0 112.391 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.746 ' H ' HG22 ' A' ' 53' ' ' ILE . 51.3 tptt -121.16 35.97 4.74 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.87 128.57 6.73 Favored Glycine 1 N--CA 1.387 -4.575 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.445 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 18' ' ' LEU . . . -45.91 -33.61 3.36 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 126.578 1.951 . . . . 0.0 114.392 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.624 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -60.16 -36.06 76.71 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.202 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.607 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 31.7 tt0 -91.97 -40.01 11.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.425 0.631 . . . . 0.0 109.646 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.1 m -75.71 -48.49 21.71 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.148 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -74.92 -36.88 62.15 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.35 67.77 1.16 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.757 -1.11 . . . . 0.0 113.103 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.443 ' HB3' HG23 ' A' ' 16' ' ' VAL . 18.8 mmt180 -132.64 -75.65 0.5 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.337 0.589 . . . . 0.0 111.119 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.46 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 60.5 mt -78.62 146.76 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.099 0.959 . . . . 0.0 111.994 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -116.35 163.75 15.56 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.679 ' HB3' HG12 ' A' ' 52' ' ' ILE . 51.5 pttt -81.88 135.0 35.45 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.436 0.636 . . . . 0.0 110.581 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.33 -11.52 43.57 Favored Glycine 0 N--CA 1.424 -2.145 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.054 -174.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.567 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 18.3 m-20 -66.44 146.44 54.55 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -96.49 125.48 41.0 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.38 -1.736 . . . . 0.0 109.028 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.01 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 48.3 t -108.91 123.28 64.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.9 mt -96.8 -39.98 9.17 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.088 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.28 178.63 7.39 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.628 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.798 ' HA ' HD12 ' A' ' 99' ' ' LEU . 24.5 t -116.01 105.37 18.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.693 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 1.9 p-10 50.02 34.15 7.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 124.387 1.075 . . . . 0.0 113.116 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.01 -21.69 43.56 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.569 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.43 100.67 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.66 ' HB2' ' HG2' ' A' ' 79' ' ' GLU . 2.9 p -58.39 128.64 38.18 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.212 1.005 . . . . 0.0 113.269 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.8 mt -97.04 21.26 10.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.516 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.66 ' HG2' ' HB2' ' A' ' 77' ' ' SER . 7.7 pt-20 -74.36 126.34 30.46 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.793 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.16 12.92 62.73 Favored Glycine 0 C--N 1.298 -1.563 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 85' ' ' GLN . . . -108.35 142.39 38.76 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 84' ' ' LYS . 7.6 t -96.25 174.15 7.03 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.414 ' HB3' HG23 ' A' ' 31' ' ' VAL . 17.2 p-80 -51.3 -43.39 61.64 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.4 ' HG2' HG23 ' A' ' 82' ' ' THR . 20.9 ptmt -64.47 -33.4 75.8 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.408 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.426 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 77.6 mm-40 -72.62 -42.08 64.85 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.102 0.477 . . . . 0.0 109.848 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -60.01 -53.94 51.91 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.252 176.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.493 ' HA ' HD12 ' A' ' 90' ' ' LEU . 57.9 t -67.07 -34.32 68.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -176.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -72.45 -26.85 61.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.27 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.9 m -70.35 -34.62 72.85 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 87.6 mt -71.69 -32.43 67.83 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.75 0.785 . . . . 0.0 109.8 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -69.05 -39.84 78.91 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.111 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -67.42 -40.19 85.5 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.482 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -65.32 147.37 53.56 Favored 'General case' 0 C--O 1.253 1.237 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 175.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.38 -133.68 0.22 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -172.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -74.26 -52.59 11.9 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.031 0.532 . . . . 0.0 111.293 -175.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.74 111.86 35.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.1 t -100.76 129.55 51.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.295 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 50.5 m80 -93.51 119.12 32.2 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.798 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.2 tp -121.98 138.48 54.41 Favored 'General case' 0 N--CA 1.401 -2.902 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.21 109.4 22.16 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.605 HD11 HD23 ' A' ' 99' ' ' LEU . 11.2 mp -118.32 169.02 10.08 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.982 0.896 . . . . 0.0 111.988 -177.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 36.0 tt0 -131.72 137.82 48.4 Favored 'General case' 0 N--CA 1.39 -3.459 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 173.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.567 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 15.7 tppt? -64.33 113.44 3.62 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -1.973 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.677 -173.63 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 120.416 0.151 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 p -87.18 117.5 25.97 Favored 'General case' 0 C--N 1.279 -2.465 0 O-C-N 124.064 0.852 . . . . 0.0 109.942 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -134.25 149.37 50.94 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 50.2 mt-10 -106.1 110.98 23.41 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.675 HG11 HD11 ' A' ' 64' ' ' ILE . 10.5 p -89.39 124.02 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.854 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -174.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.31 89.06 7.84 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.027 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -96.05 115.45 27.45 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -175.657 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.19 115.46 29.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.007 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.513 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -64.1 146.34 54.37 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.612 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -122.1 90.16 3.25 Favored 'General case' 0 N--CA 1.408 -2.574 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.094 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.7 t70 65.85 -65.81 0.17 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.51 1.524 . . . . 0.0 114.275 -177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.07 67.8 0.23 Allowed Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.513 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 84.8 p 70.34 -173.73 0.18 Allowed 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.794 1.638 . . . . 0.0 114.224 169.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.587 HD22 ' HB3' ' A' ' 18' ' ' LEU . 80.9 mt -72.02 160.33 32.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.1 41.16 2.64 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.212 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.515 HG23 ' CB ' ' A' ' 58' ' ' ALA . 14.7 pt -135.13 137.6 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.806 0 CA-C-O 121.419 0.628 . . . . 0.0 111.426 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -94.87 123.63 38.44 Favored 'General case' 0 N--CA 1.41 -2.432 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.527 HG22 ' H ' ' A' ' 30' ' ' THR . 12.3 p -93.54 175.87 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 O-C-N 123.321 0.388 . . . . 0.0 110.064 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.922 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 14.8 t -166.12 148.75 7.16 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' A' ' 82' ' ' THR . 12.2 p . . . . . 0 N--CA 1.424 -1.74 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . . . . . . 0 N--CA 1.428 -1.871 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.642 HG13 ' HG ' ' A' ' 78' ' ' LEU . 43.4 mm -102.19 138.0 28.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -137.68 163.77 30.47 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.955 0.407 . . . . 0.0 110.122 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.459 HG21 HG21 ' A' ' 64' ' ' ILE . 56.9 t -88.3 113.61 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.952 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 169.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.922 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 59.3 tttm -76.24 -35.4 59.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.602 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.734 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . . . -168.1 167.18 12.64 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.946 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.999 HG21 ' HB2' ' A' ' 59' ' ' GLU . 49.0 mm -108.47 122.82 63.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.0 mm -83.97 145.71 47.19 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -56.88 -133.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 123.548 2.832 . . . . 0.0 114.389 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 75.3 -52.23 0.66 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.556 1.142 . . . . 0.0 110.716 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.19 -50.19 0.87 Allowed Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.688 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -8.97 -75.83 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 127.903 2.481 . . . . 0.0 116.149 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.027 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -96.02 -29.15 14.29 Favored 'General case' 0 C--O 1.255 1.359 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -172.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.999 ' HB2' HG21 ' A' ' 52' ' ' ILE . 39.6 tt0 -82.93 -53.21 6.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 123.331 0.394 . . . . 0.0 111.542 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 m -86.95 -35.14 19.05 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.633 -171.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 9.5 m-20 -101.3 -28.73 12.46 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.28 -174.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.94 -131.21 6.6 Favored Glycine 0 N--CA 1.398 -3.876 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -154.32 2.65 0.23 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.675 HD11 HG11 ' A' ' 16' ' ' VAL . 31.4 mt -90.45 148.44 4.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.525 -165.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -137.95 173.33 11.75 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.734 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 22.6 pttp -73.2 130.44 40.23 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.283 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.97 -20.77 8.5 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.115 -1.04 . . . . 0.0 113.507 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.611 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 53.9 m-20 -71.78 138.52 48.45 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 117.453 0.626 . . . . 0.0 110.619 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -90.54 135.04 33.95 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.41 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 47' ' ' ILE . 57.8 t -106.41 120.9 58.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.505 HD11 ' HB2' ' A' ' 102' ' ' GLU . 62.7 mt -96.41 -37.97 10.23 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.582 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.756 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -154.64 162.29 41.2 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.495 -173.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.786 ' HA ' HD12 ' A' ' 99' ' ' LEU . 56.3 t -115.39 106.95 21.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.3 t30 62.56 31.85 16.72 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.368 1.08 . . . . 0.0 109.761 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.56 -21.46 45.57 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 114.855 -1.066 . . . . 0.0 114.162 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.6 t -82.97 114.36 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 117.736 0.768 . . . . 0.0 109.725 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.9 t -72.1 127.68 33.31 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 123.069 0.548 . . . . 0.0 110.723 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.642 ' HG ' HG13 ' A' ' 47' ' ' ILE . 2.0 pt? -131.46 30.07 4.49 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 42.5 mt-10 -69.32 -11.31 60.71 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.618 0.723 . . . . 0.0 110.643 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.57 21.51 25.84 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.825 174.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . -93.17 -154.48 0.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.177 0.513 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.751 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.1 t -146.36 173.0 12.66 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 175.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -50.72 -60.29 3.2 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.78 1.232 . . . . 0.0 111.582 -176.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.412 ' HA ' HG12 ' A' ' 87' ' ' VAL . 57.0 tptt -59.67 -36.98 77.52 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.576 0.75 . . . . 0.0 110.945 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.402 ' HB2' ' H ' ' A' ' 82' ' ' THR . 15.1 mm100 -67.29 -45.06 77.69 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.399 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.458 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -60.21 -51.29 70.2 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.931 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 3.1 p -68.81 -34.63 65.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.085 -173.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.718 ' HA ' ' HG2' ' A' ' 91' ' ' ARG . 20.5 mm-40 -77.64 -23.47 49.73 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.436 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.412 HG22 HG11 ' A' ' 73' ' ' VAL . 86.5 m -70.91 -28.5 64.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.555 HD13 HD12 ' A' ' 25' ' ' LEU . 86.8 mt -73.58 -24.71 60.11 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.752 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.718 ' HG2' ' HA ' ' A' ' 88' ' ' GLU . 36.7 mmt180 -73.64 -49.84 24.04 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.65 -32.06 73.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.578 -174.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.496 HG21 HG12 ' A' ' 73' ' ' VAL . 1.3 p -63.87 -36.26 83.35 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.39 -140.42 13.41 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 119.712 -1.232 . . . . 0.0 113.427 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -88.46 -52.19 5.32 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.674 0.79 . . . . 0.0 109.933 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 65.5 t -99.31 111.49 29.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 43.6 t -105.86 120.94 57.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -93.08 70.54 4.54 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 73' ' ' VAL . 6.7 tp -71.55 139.27 49.38 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 122.249 -0.282 . . . . 0.0 110.55 -172.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.756 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 55.9 tp -94.17 113.32 25.24 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.658 HD11 HD23 ' A' ' 99' ' ' LEU . 10.0 mp -117.66 166.66 12.14 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-O 121.551 0.691 . . . . 0.0 110.144 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.505 ' HB2' HD11 ' A' ' 71' ' ' LEU . 37.1 tt0 -128.48 124.44 36.12 Favored 'General case' 0 N--CA 1.389 -3.491 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 174.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -49.07 123.52 7.34 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 124.572 1.17 . . . . 0.0 110.409 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.421 -2.322 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 27.0 t70 . . . . . 0 CA--C 1.505 -0.775 0 N-CA-C 110.816 -0.068 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -93.1 114.18 26.64 Favored 'General case' 0 N--CA 1.426 -1.667 0 O-C-N 123.491 0.494 . . . . 0.0 109.803 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.433 ' HE2' ' HD2' ' A' ' 63' ' ' ARG . 5.6 p90 -127.78 159.61 34.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.152 0.501 . . . . 0.0 111.463 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -106.05 130.44 53.97 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.412 HG22 ' CE2' ' A' ' 14' ' ' PHE . 12.4 t -110.88 132.3 59.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -175.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 26.1 mp0 -97.76 87.06 3.93 Favored 'General case' 0 C--O 1.248 1.009 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 171.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.085 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -96.94 116.64 29.54 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.522 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -92.9 125.12 37.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 86.7 mttt -67.66 163.92 20.37 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-O 121.844 0.831 . . . . 0.0 111.571 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.422 HG21 ' O ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -88.52 33.1 0.76 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.616 175.591 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 t70 67.99 -28.82 0.15 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.307 2.243 . . . . 0.0 113.024 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.04 -58.53 3.39 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 t -167.05 -175.29 2.95 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.628 HD12 HG12 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -85.85 139.55 31.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.328 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.48 43.02 2.84 Favored Glycine 0 C--N 1.295 -1.743 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.717 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.628 HG12 HD12 ' A' ' 25' ' ' LEU . 18.9 pt -138.32 148.69 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-N 118.133 0.967 . . . . 0.0 111.765 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.67 ' HB2' HD11 ' A' ' 53' ' ' ILE . 39.4 t -108.5 109.65 20.96 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' HG23 ' A' ' 47' ' ' ILE . 26.9 m -104.87 144.82 14.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 123.877 0.736 . . . . 0.0 110.296 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 50' ' ' LYS . 12.8 t -144.0 157.88 44.06 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 46' ' ' GLY . 56.1 t . . . . . 0 C--N 1.298 -1.648 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.671 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . . . . . . 0 CA--C 1.476 -2.398 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.591 HG23 ' HB ' ' A' ' 29' ' ' VAL . 18.9 mm -139.29 142.76 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 173.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.468 ' OH ' ' HA2' ' A' ' 67' ' ' GLY . 52.9 t80 -140.52 141.93 35.27 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.28 108.09 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.53 ' HB2' HG22 ' A' ' 30' ' ' THR . 53.3 tttp -82.27 -35.8 27.7 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.811 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.87 36.28 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.735 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.068 HG21 ' HB2' ' A' ' 59' ' ' GLU . 31.7 mm -111.7 113.45 44.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 28' ' ' SER . 2.0 mp -83.41 128.33 64.77 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 53.2 Cg_exo -59.94 88.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 124.14 3.227 . . . . 0.0 115.142 -177.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' O ' HG21 ' A' ' 21' ' ' THR . 2.4 mptm? -125.09 -27.23 3.57 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.681 170.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.633 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 93.89 49.12 2.54 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -175.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -122.26 -77.77 0.59 Allowed 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.166 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.085 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -83.25 -31.44 26.98 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -170.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.068 ' HB2' HG21 ' A' ' 52' ' ' ILE . 40.0 tt0 -80.02 -45.39 18.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 124.645 1.216 . . . . 0.0 110.268 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.633 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 1.2 m -85.09 -47.86 9.76 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.264 -168.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -100.7 -21.5 15.2 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.931 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.84 -132.26 6.36 Favored Glycine 1 N--CA 1.393 -4.219 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.93 -173.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.433 ' HD2' ' HE2' ' A' ' 14' ' ' PHE . 40.1 mtt180 -156.24 -1.54 0.13 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -169.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.773 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 60.2 mt -96.22 132.05 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.145 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.546 -169.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.421 ' HA ' HG13 ' A' ' 52' ' ' ILE . 81.4 m-70 -139.67 170.48 15.82 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -69.22 129.79 40.84 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.459 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.468 ' HA2' ' OH ' ' A' ' 48' ' ' TYR . . . 123.8 -26.08 6.01 Favored Glycine 0 C--N 1.291 -1.972 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.848 -172.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.473 ' HB3' HD23 ' A' ' 101' ' ' LEU . 18.2 m-20 -72.86 133.91 44.62 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.471 ' CG ' ' HB3' ' A' ' 102' ' ' GLU . 4.5 ptm180 -100.84 151.15 22.06 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.536 HG22 ' HG ' ' A' ' 101' ' ' LEU . 47.3 t -112.83 127.2 70.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.443 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -176.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.9 mt -100.87 -34.3 9.86 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.345 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -159.55 175.11 13.64 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.466 -175.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.991 HG11 HG21 ' A' ' 89' ' ' THR . 4.7 p -130.64 110.21 18.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 124.943 1.297 . . . . 0.0 109.523 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 62.68 30.17 16.86 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.412 1.101 . . . . 0.0 108.151 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.04 -18.69 46.59 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.259 -0.882 . . . . 0.0 114.079 -174.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.0 t -81.82 122.76 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.4 t -58.17 140.45 52.93 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.686 HD11 ' HB ' ' A' ' 73' ' ' VAL . 81.2 mt -118.06 -3.02 11.14 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.865 175.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.671 ' HA ' ' HA3' ' A' ' 46' ' ' GLY 0.261 1.0 OUTLIER -76.97 103.95 7.19 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 122.475 1.131 . . . . 0.0 110.43 177.888 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.45 -6.28 12.83 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -173.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.81 149.61 24.72 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 84' ' ' LYS . 5.1 t -79.14 154.14 29.55 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 42.8 p-80 -51.55 -36.73 46.41 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 120.759 0.314 . . . . 0.0 111.826 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.447 ' HB2' HG23 ' A' ' 82' ' ' THR . 94.6 mttt -48.9 -53.61 18.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.36 173.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -66.89 -35.7 80.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 123.375 0.422 . . . . 0.0 111.458 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -58.47 -49.84 75.89 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.433 0.635 . . . . 0.0 109.805 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.92 -32.94 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.392 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 45.1 mt-10 -66.56 -34.14 77.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 110.091 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.991 HG21 HG11 ' A' ' 73' ' ' VAL . 50.6 m -71.01 -29.15 65.02 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.328 0.585 . . . . 0.0 109.491 174.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.1 mt -71.41 -24.03 61.97 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-O 121.077 0.465 . . . . 0.0 109.982 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -90.74 -15.49 30.12 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.058 0.456 . . . . 0.0 111.092 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.27 -35.08 31.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 p -75.01 154.67 37.94 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.169 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.27 -136.79 1.67 Allowed Glycine 0 C--N 1.314 -0.66 0 N-CA-C 114.349 0.5 . . . . 0.0 114.349 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.448 ' OE1' ' HB2' ' A' ' 20' ' ' LYS . 5.2 tp-100 -72.39 -46.84 53.48 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.745 0.784 . . . . 0.0 109.361 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 52.4 t -102.19 119.0 49.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.481 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 41.4 t -104.57 129.62 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.092 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.805 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.54 ' CD2' ' HG3' ' A' ' 17' ' ' GLU . 26.6 m170 -89.5 122.62 32.86 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 169.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.71 HD23 HD11 ' A' ' 101' ' ' LEU . 4.9 tp -130.0 147.86 51.8 Favored 'General case' 0 C--N 1.271 -2.844 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.7 tt -110.11 116.56 31.76 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -177.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.71 HD11 HD23 ' A' ' 99' ' ' LEU . 7.5 mp -122.64 175.38 6.53 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.472 0.653 . . . . 0.0 111.001 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 26.9 tt0 -128.3 119.99 26.19 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.512 ' HE3' ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -50.02 106.46 0.12 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.006 1.322 . . . . 0.0 110.656 -173.645 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.512 ' N ' ' HE3' ' A' ' 103' ' ' LYS . . . . . . . . 0 N--CA 1.424 -2.133 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.868 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 59.0 t0 . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 p -96.78 116.07 28.51 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 123.639 0.775 . . . . 0.0 110.397 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.35 132.44 21.64 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.35 0.595 . . . . 0.0 112.259 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.507 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 41.8 mt-10 -81.13 99.21 8.4 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.095 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.502 HG11 HG13 ' A' ' 64' ' ' ILE . 55.5 t -68.38 131.08 33.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.143 -177.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -92.61 98.96 11.76 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.977 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -110.95 118.76 36.97 Favored 'General case' 0 N--CA 1.415 -2.207 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.998 -179.237 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.8 126.33 41.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.294 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.644 ' HE2' HD22 ' A' ' 25' ' ' LEU . 95.3 mttt -76.11 137.99 40.48 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.086 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -73.58 -41.04 63.41 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -173.05 -65.01 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.399 0.619 . . . . 0.0 109.844 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.85 63.7 3.17 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.555 -176.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.547 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 23.3 t 69.48 -168.11 0.17 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.867 1.267 . . . . 0.0 112.691 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.644 HD22 ' HE2' ' A' ' 20' ' ' LYS . 2.5 mm? -73.51 159.28 33.41 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.743 0.817 . . . . 0.0 110.757 -177.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.7 38.37 3.13 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.472 HD13 HD13 ' A' ' 64' ' ' ILE . 23.8 pt -137.1 144.51 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.666 0 CA-C-O 121.454 0.645 . . . . 0.0 111.343 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB2' HG12 ' A' ' 53' ' ' ILE . 28.3 t -106.17 115.22 29.84 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.77 148.65 16.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.869 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.1 t -150.0 167.84 25.56 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 82' ' ' THR . 13.6 p . . . . . 0 C--N 1.292 -1.898 0 CA-C-O 121.337 0.589 . . . . 0.0 110.227 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 31' ' ' VAL . . . . . . . . 0 C--O 1.217 -0.947 0 N-CA-C 113.693 0.237 . . . . 0.0 113.693 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.889 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.6 mm -101.87 148.67 7.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 79.7 t80 -125.13 128.02 47.78 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 122.004 -0.435 . . . . 0.0 111.679 -176.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.99 105.66 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 171.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.6 ' HB2' HG22 ' A' ' 30' ' ' THR . 87.1 tttt -77.93 -40.17 40.48 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.521 -175.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.6 165.06 33.56 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.781 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.1 mm -102.8 109.75 27.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.509 HG23 ' HD2' ' A' ' 54' ' ' PRO . 27.1 mm -72.86 154.24 91.06 Favored Pre-proline 0 C--N 1.294 -1.816 0 C-N-CA 124.601 1.161 . . . . 0.0 110.087 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HD2' HG23 ' A' ' 53' ' ' ILE . 87.4 Cg_exo -52.4 -158.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.44 0 C-N-CA 123.383 2.722 . . . . 0.0 113.572 170.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? 76.53 -51.44 0.59 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.684 1.194 . . . . 0.0 111.273 -173.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 130.44 -120.5 3.04 Favored Glycine 0 N--CA 1.414 -2.798 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.821 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 70.05 -91.13 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.102 0.961 . . . . 0.0 112.897 170.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.977 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -75.34 -37.42 60.7 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.61 -46.36 66.43 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 124.985 1.428 . . . . 0.0 108.702 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 m -70.41 -43.63 69.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.268 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -73.86 -30.12 62.49 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.1 33.44 36.28 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.514 175.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -95.21 -59.32 1.92 Allowed 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.716 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.738 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.7 mt -86.51 131.48 34.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -119.72 161.93 19.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -81.85 144.72 30.82 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 118.751 -1.18 . . . . 0.0 110.555 -177.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.417 ' HA2' ' CZ ' ' A' ' 48' ' ' TYR . . . 102.6 -6.94 52.99 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -176.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -87.4 154.21 20.84 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.39 0.614 . . . . 0.0 111.837 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -100.45 141.73 32.9 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.896 0.855 . . . . 0.0 112.784 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.889 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 58.9 t -106.55 125.56 62.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.013 -1.448 . . . . 0.0 107.22 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 102' ' ' GLU . 28.3 mt -100.94 -35.5 9.37 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.991 -176.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -160.7 166.52 28.65 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.874 HG23 HD11 ' A' ' 78' ' ' LEU . 48.1 t -119.13 108.09 23.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 124.841 1.256 . . . . 0.0 108.333 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.5 t30 56.98 52.9 8.62 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.048 0.939 . . . . 0.0 110.559 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.6 -25.08 3.45 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 114.85 -1.068 . . . . 0.0 114.33 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.9 t -81.11 110.85 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 117.686 0.743 . . . . 0.0 109.826 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.532 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 38.6 m -63.13 140.04 58.83 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.268 0.98 . . . . 0.0 112.106 -175.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.874 HD11 HG23 ' A' ' 73' ' ' VAL . 55.2 mt -110.52 76.32 0.98 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -107.1 125.47 51.1 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.27 32.96 81.16 Favored Glycine 0 C--N 1.31 -0.907 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.14 138.18 39.43 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.858 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.8 t -82.82 159.35 22.46 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 173.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.869 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 39.2 p-80 -52.09 -39.13 59.3 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 123.073 0.233 . . . . 0.0 111.599 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.99 -39.94 91.58 Favored 'General case' 0 C--O 1.206 -1.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.785 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.52 ' HG2' HG22 ' A' ' 82' ' ' THR . 74.8 mm-40 -67.23 -44.7 78.85 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.39 -51.51 69.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.421 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.509 ' HA ' HD12 ' A' ' 90' ' ' LEU . 85.6 t -68.16 -31.83 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.514 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -66.58 -30.67 71.02 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 121.768 -0.582 . . . . 0.0 110.243 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.8 m -76.74 -28.14 55.65 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.183 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 87' ' ' VAL . 95.9 mt -73.37 -33.54 65.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.75 0.785 . . . . 0.0 109.68 175.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.26 -29.45 57.48 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.526 176.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -72.63 -31.81 65.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.85 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.5 p -72.3 163.35 28.1 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.18 -123.8 0.5 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.887 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -94.64 -42.11 8.95 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 122.794 -0.239 . . . . 0.0 111.14 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.36 110.71 27.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.42 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 39.4 t -99.58 121.51 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.199 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.726 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.439 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 95.9 m-70 -91.29 98.88 11.98 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 174.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.823 HD12 ' HA ' ' A' ' 73' ' ' VAL . 9.6 tp -101.13 129.36 47.02 Favored 'General case' 0 C--N 1.268 -2.959 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -172.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.767 HD22 HD12 ' A' ' 71' ' ' LEU . 1.8 tt -86.38 109.11 18.79 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.692 HD11 HD23 ' A' ' 99' ' ' LEU . 8.9 mp -115.62 164.89 13.67 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-O 121.504 0.669 . . . . 0.0 111.621 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.899 ' HB2' HD11 ' A' ' 71' ' ' LEU . 35.0 tt0 -131.25 135.64 47.52 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 172.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 39.5 tptt -58.67 114.78 2.66 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -1.984 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.79 -167.837 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 CA--C 1.504 -0.811 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.9 p -86.94 135.88 33.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 123.776 0.672 . . . . 0.0 110.534 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -146.85 145.88 30.01 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.078 0.466 . . . . 0.0 110.049 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.75 132.15 52.23 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.9 t -118.71 135.91 57.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.796 -175.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.544 ' HG2' HG11 ' A' ' 96' ' ' VAL . 43.6 tt0 -109.48 86.61 2.32 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 172.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.915 HD11 ' HB1' ' A' ' 57' ' ' ALA . 1.3 tm? -99.14 125.73 44.75 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -98.3 144.5 27.64 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 120.649 0.262 . . . . 0.0 111.076 -175.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.684 ' HE2' HD11 ' A' ' 25' ' ' LEU . 1.2 mptm? -68.2 143.52 55.3 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.966 177.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 57' ' ' ALA . 59.0 p -91.58 -165.89 1.45 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.22 -26.11 49.97 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.126 0.57 . . . . 0.0 111.118 173.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.88 56.96 0.73 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.284 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.4 t 77.43 -168.59 0.06 Allowed 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.232 1.413 . . . . 0.0 109.429 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.684 HD11 ' HE2' ' A' ' 20' ' ' LYS . 4.3 mp -66.17 -76.81 0.07 Allowed 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 122.04 0.924 . . . . 0.0 109.787 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.97 ' HA2' ' HD2' ' A' ' 54' ' ' PRO . . . 147.31 -8.58 1.22 Allowed Glycine 0 CA--C 1.463 -3.187 0 C-N-CA 119.757 -1.211 . . . . 0.0 111.181 -172.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.409 HG22 ' CD1' ' A' ' 52' ' ' ILE . 16.7 pt -102.71 112.73 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.607 0 CA-C-O 122.722 1.248 . . . . 0.0 112.851 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.7 m -101.31 126.13 48.03 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-N 112.59 -2.096 . . . . 0.0 106.686 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 49' ' ' VAL . 33.7 m -110.91 153.87 12.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.055 0.455 . . . . 0.0 111.586 -173.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.665 ' HB ' ' HD3' ' A' ' 50' ' ' LYS . 11.2 t -121.31 156.46 32.5 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 174.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.518 HG12 HD13 ' A' ' 47' ' ' ILE . 33.1 m . . . . . 0 N--CA 1.42 -1.93 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.939 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.402 ' HA3' ' N ' ' A' ' 80' ' ' GLY . . . . . . . . 0 N--CA 1.427 -1.913 0 N-CA-C 113.662 0.225 . . . . 0.0 113.662 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.689 HG13 ' HG ' ' A' ' 78' ' ' LEU . 50.8 mm -102.37 123.78 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.057 -175.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.467 ' CZ ' ' HD3' ' A' ' 69' ' ' ARG . 81.4 m-85 -131.21 114.22 14.81 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.506 ' HA ' HG12 ' A' ' 29' ' ' VAL . 50.1 t -47.86 117.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.481 0.658 . . . . 0.0 109.983 171.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.665 ' HD3' ' HB ' ' A' ' 30' ' ' THR . 38.0 ttpt -92.76 -31.11 15.18 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.331 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . . . -167.64 156.99 10.03 Favored 'General case' 0 C--O 1.249 1.03 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.759 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.862 HG21 ' HB2' ' A' ' 59' ' ' GLU . 16.7 mm -109.88 119.29 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.925 ' HB ' ' HD3' ' A' ' 54' ' ' PRO . 2.7 mp -108.43 -71.06 0.03 OUTLIER Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -172.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.97 ' HD2' ' HA2' ' A' ' 26' ' ' GLY . 45.3 Cg_exo -60.18 -163.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 124.882 3.722 . . . . 0.0 117.692 -172.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -35.61 -50.75 0.62 Allowed 'General case' 0 C--N 1.352 0.71 0 C-N-CA 127.892 2.477 . . . . 0.0 113.455 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.96 -98.77 0.11 Allowed Glycine 0 N--CA 1.415 -2.738 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.915 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 66.08 -92.34 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.051 1.34 . . . . 0.0 111.314 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.626 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -70.61 -39.84 73.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.862 ' HB2' HG21 ' A' ' 52' ' ' ILE . 35.4 tt0 -76.43 -42.58 43.6 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 123.556 0.535 . . . . 0.0 111.629 -178.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.0 p -74.94 -35.31 62.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.855 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -73.65 -26.57 60.82 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.326 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.07 44.94 86.64 Favored Glycine 0 CA--C 1.49 -1.483 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.996 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -111.25 -54.62 2.59 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.348 0.594 . . . . 0.0 109.556 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.626 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 64.9 mt -101.26 130.1 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.461 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -132.14 173.33 11.34 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 61.3 pttt -74.83 132.03 41.22 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.089 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.27 -20.66 13.8 Favored Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.729 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.429 ' OD1' ' HD2' ' A' ' 103' ' ' LYS . 78.8 m-20 -69.47 138.15 53.2 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.556 0.694 . . . . 0.0 111.683 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 33.1 ttp180 -95.5 133.88 38.99 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.313 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 71.0 t -101.74 103.94 15.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 102' ' ' GLU . 84.9 mt -76.87 -36.01 57.04 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.217 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.51 167.36 19.52 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.16 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.702 ' HA ' HD12 ' A' ' 99' ' ' LEU . 44.3 t -113.33 115.53 50.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 172.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 2.0 p-10 47.01 35.36 3.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.424 1.49 . . . . 0.0 112.768 -176.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.62 -6.24 82.18 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.506 -0.854 . . . . 0.0 114.092 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.8 t -92.6 109.64 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.7 m -69.64 134.67 48.99 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -173.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.689 ' HG ' HG13 ' A' ' 47' ' ' ILE . 1.6 pt? -130.34 17.24 5.45 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.099 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.9 97.89 0.12 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.518 175.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.402 ' N ' ' HA3' ' A' ' 46' ' ' GLY . . . 119.01 17.35 5.02 Favored Glycine 0 N--CA 1.433 -1.524 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.598 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.493 ' HB3' HD11 ' A' ' 47' ' ' ILE . . . -94.34 176.74 6.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.46 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.8 t -97.18 158.75 15.29 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 169.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -51.16 -44.19 61.41 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.595 0.758 . . . . 0.0 112.381 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 23.8 tptp -55.91 -43.45 77.34 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 123.92 0.888 . . . . 0.0 110.986 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -69.28 -43.9 72.93 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.622 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -55.24 -54.48 42.9 Favored 'General case' 0 C--O 1.243 0.72 0 O-C-N 124.08 0.862 . . . . 0.0 111.468 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.56 -26.75 36.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.919 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 91.0 mt-10 -72.04 -28.49 63.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.809 177.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.517 HG22 HG11 ' A' ' 73' ' ' VAL . 22.5 m -70.5 -31.41 68.5 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.3 mt -72.72 -24.4 60.98 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.105 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -79.56 -34.24 41.12 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -63.15 -40.63 98.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.71 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.441 ' OG1' HG22 ' A' ' 97' ' ' VAL . 19.4 p -68.94 138.25 54.45 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.8 -121.6 0.02 OUTLIER Glycine 0 CA--C 1.52 0.381 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.806 ' HG3' HG23 ' A' ' 96' ' ' VAL . 14.1 pt20 -77.11 -27.51 54.1 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.512 0.672 . . . . 0.0 110.463 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.806 HG23 ' HG3' ' A' ' 95' ' ' GLN . 21.5 t -125.44 150.02 30.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.533 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 35.8 t -120.26 126.03 74.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 122.921 0.489 . . . . 0.0 109.853 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 41.2 m80 -86.77 119.09 26.63 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 167.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.702 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.2 tp -127.93 147.91 50.49 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -110.71 117.86 34.6 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.699 HD11 HD23 ' A' ' 99' ' ' LEU . 6.0 mp -124.77 174.31 7.99 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.526 0.679 . . . . 0.0 111.37 -178.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HB2' HD11 ' A' ' 71' ' ' LEU . 31.0 tt0 -131.6 130.62 42.42 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 102.761 -3.051 . . . . 0.0 102.761 173.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 40.6 tptt -64.09 126.25 27.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -175.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.378 0 C-N-CA 121.016 -0.612 . . . . 0.0 113.314 -172.898 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 17.3 p -102.3 111.13 23.3 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-O 121.74 0.781 . . . . 0.0 110.451 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.415 ' CE2' ' HB ' ' A' ' 16' ' ' VAL . 44.8 p90 -125.61 162.96 23.81 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.858 -177.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 40.1 mt-10 -108.07 94.12 4.9 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 12.4 p -80.09 135.07 26.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.408 -175.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -90.18 108.33 19.68 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 58' ' ' ALA . 2.1 tm? -113.9 108.12 16.62 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.32 149.69 22.88 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.591 ' HD2' ' HA ' ' A' ' 24' ' ' SER . 27.3 mmtp -71.07 114.9 9.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 56' ' ' GLY . 2.9 t -74.88 -33.06 62.0 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 118.173 -1.411 . . . . 0.0 108.722 -177.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -174.74 -35.85 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.676 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.7 48.52 0.98 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.673 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.591 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 22.6 t 58.93 -152.99 0.39 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.818 0.847 . . . . 0.0 110.561 177.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.552 HD12 HD12 ' A' ' 18' ' ' LEU . 2.9 mm? -71.33 111.01 6.32 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.699 ' H ' ' HB3' ' A' ' 57' ' ' ALA . . . -78.02 46.33 2.66 Favored Glycine 0 C--N 1.296 -1.692 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.401 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.71 HG22 HG13 ' A' ' 52' ' ' ILE . 14.1 pt -141.11 148.64 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 CA-C-O 121.253 0.549 . . . . 0.0 110.197 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 32.4 t -117.85 124.25 47.88 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.6 m -115.59 150.55 17.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.564 -175.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.632 HG22 ' HB2' ' A' ' 50' ' ' LYS . 10.3 t -130.04 153.41 48.46 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.517 HG21 ' O ' ' A' ' 81' ' ' ALA . 8.3 p . . . . . 0 C--N 1.287 -2.113 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.715 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 31' ' ' VAL . . . . . . . . 0 CA--C 1.471 -2.703 0 N-CA-C 104.507 -3.437 . . . . 0.0 104.507 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.796 HG13 HD12 ' A' ' 78' ' ' LEU . 38.6 mm -81.93 114.61 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 167.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.41 ' OH ' ' HA2' ' A' ' 67' ' ' GLY . 66.5 t80 -119.86 131.16 55.19 Favored 'General case' 0 C--N 1.275 -2.661 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.762 -169.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.496 HG21 ' CG2' ' A' ' 64' ' ' ILE . 46.5 t -75.16 107.38 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-O 121.557 0.694 . . . . 0.0 109.28 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.632 ' HB2' HG22 ' A' ' 30' ' ' THR . 87.2 tttt -89.06 -34.95 16.6 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.407 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 28' ' ' SER . . . -154.32 156.36 36.8 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.397 -176.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.945 HG21 ' HB2' ' A' ' 59' ' ' GLU . 1.9 mp -116.98 124.48 73.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 O-C-N 123.31 0.381 . . . . 0.0 110.093 174.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.38 121.93 85.79 Favored Pre-proline 0 C--O 1.257 1.491 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.181 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -55.12 129.19 33.96 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 123.368 2.712 . . . . 0.0 112.103 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 tptp 65.33 11.45 7.31 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.631 1.172 . . . . 0.0 112.049 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.591 ' O ' HG22 ' A' ' 21' ' ' THR . . . -76.43 -56.16 4.38 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.11 176.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.699 ' HB3' ' H ' ' A' ' 26' ' ' GLY . . . -178.23 -69.08 0.01 OUTLIER 'General case' 0 C--O 1.188 -2.14 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.591 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -50.31 -42.63 52.92 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.945 ' HB2' HG21 ' A' ' 52' ' ' ILE . 35.4 tt0 -82.86 -40.49 20.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.963 0.887 . . . . 0.0 109.869 -177.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.28 -44.0 66.06 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.899 -173.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.81 -34.41 57.92 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.078 0.942 . . . . 0.0 108.469 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.06 56.08 2.26 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.263 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -121.6 -73.41 0.65 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.813 0.816 . . . . 0.0 110.739 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.496 ' CG2' HG21 ' A' ' 49' ' ' VAL . 53.1 mt -94.74 148.01 5.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.266 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -143.8 172.6 12.62 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.462 1.105 . . . . 0.0 108.131 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 50' ' ' LYS . 56.4 mtpt -64.78 133.01 51.11 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 123.521 0.513 . . . . 0.0 110.624 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.41 ' HA2' ' OH ' ' A' ' 48' ' ' TYR . . . 111.94 -20.73 21.6 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 119.966 -1.112 . . . . 0.0 113.833 176.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' OD2' ' HA ' ' A' ' 103' ' ' LYS . 0.5 OUTLIER -85.51 149.21 25.54 Favored 'General case' 0 C--O 1.253 1.268 0 CA-C-O 121.754 0.787 . . . . 0.0 113.099 -179.266 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.459 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 78.5 ttt180 -102.81 138.73 39.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.498 -171.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 58.7 t -111.04 127.1 68.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.692 HD11 ' HB2' ' A' ' 102' ' ' GLU . 66.1 mt -110.3 -30.78 7.56 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.796 0.808 . . . . 0.0 109.837 -177.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.756 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -161.22 172.4 16.74 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.325 -174.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.732 HG11 ' CG2' ' A' ' 89' ' ' THR . 4.7 p -118.32 114.35 44.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 125.261 1.424 . . . . 0.0 107.487 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.859 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 32.1 p30 35.26 46.39 0.24 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.98 -11.0 64.18 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.597 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.533 ' HB ' HG13 ' A' ' 73' ' ' VAL . 43.1 t -101.33 114.94 42.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.2 m -75.79 145.01 41.06 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -173.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.796 HD12 HG13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.25 31.67 4.59 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.693 -1.139 . . . . 0.0 112.113 174.442 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -69.04 95.18 0.7 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.275 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.02 16.63 7.76 Favored Glycine 0 C--N 1.302 -1.34 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.517 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -88.6 171.1 10.28 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 27.9 p -96.46 162.56 13.43 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 173.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -51.8 -41.12 61.47 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.35 0.595 . . . . 0.0 110.491 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.47 -36.95 79.71 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.75 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.486 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 11.9 mm-40 -66.39 -41.18 89.72 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.014 0.435 . . . . 0.0 110.255 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -52.75 -60.24 3.5 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.14 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.98 -30.65 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.219 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 91' ' ' ARG . 10.2 tp10 -67.76 -38.71 83.8 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.732 ' CG2' HG11 ' A' ' 73' ' ' VAL . 27.0 m -71.87 -36.62 70.16 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.5 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 61.5 mt -72.97 -19.46 61.22 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.454 0.645 . . . . 0.0 110.794 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -92.43 -26.8 17.84 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.451 0.643 . . . . 0.0 110.814 -179.702 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -84.31 -21.44 31.0 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -69.14 -42.93 75.33 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.33 -156.59 27.02 Favored Glycine 0 CA--C 1.487 -1.66 0 C-N-CA 120.263 -0.97 . . . . 0.0 110.928 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.491 ' HA ' ' HG2' ' A' ' 20' ' ' LYS . 16.8 pt20 -88.06 -37.27 16.42 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.719 0.259 . . . . 0.0 111.515 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 43.9 t -106.91 109.47 28.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.66 119.67 60.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.613 -172.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.859 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 31.4 m170 -81.84 137.28 35.29 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 168.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 7.6 mp -122.41 148.88 44.57 Favored 'General case' 0 C--N 1.264 -3.131 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.756 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.4 tm? -99.04 109.05 21.85 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 13' ' ' THR . 7.3 mp -110.65 162.79 14.38 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.181 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.692 ' HB2' HD11 ' A' ' 71' ' ' LEU . 39.7 tt0 -123.34 124.76 43.67 Favored 'General case' 0 N--CA 1.404 -2.766 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 173.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.52 ' HA ' ' OD2' ' A' ' 68' ' ' ASP . 4.6 tmtm? -55.96 113.41 1.5 Allowed 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 124.286 0.991 . . . . 0.0 108.363 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.427 -1.925 0 CA-C-N 114.603 -1.18 . . . . 0.0 113.318 -174.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 24.0 t70 . . . . . 0 CA--C 1.51 -0.57 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.442 HG22 HD11 ' A' ' 71' ' ' LEU . 4.5 p -91.44 139.72 30.45 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 123.812 0.845 . . . . 0.0 111.335 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.593 ' HE2' ' HB2' ' A' ' 103' ' ' LYS . 48.2 p90 -157.51 154.43 28.62 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 39.7 mt-10 -110.06 148.51 31.57 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.493 HG23 HD13 ' A' ' 101' ' ' LEU . 59.9 t -127.25 124.97 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -96.76 91.56 5.74 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.928 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -102.57 122.03 43.57 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.235 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.21 141.51 31.89 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.112 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 1.5 mptm? -71.75 138.2 48.28 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.935 0.874 . . . . 0.0 112.526 177.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 23' ' ' GLY . 3.7 t -135.69 143.55 45.47 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 171.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 21' ' ' THR . 9.6 t70 77.93 -35.67 0.2 Allowed 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 123.651 0.781 . . . . 0.0 110.469 -173.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 21' ' ' THR . . . 119.7 11.39 7.18 Favored Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -127.6 151.53 48.8 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 115.241 -0.479 . . . . 0.0 109.897 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.548 HD11 ' HB3' ' A' ' 18' ' ' LEU . 13.7 tp -91.05 121.33 32.76 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 170.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.433 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -71.91 46.62 0.96 Allowed Glycine 0 C--O 1.211 -1.341 0 N-CA-C 115.451 0.941 . . . . 0.0 115.451 -173.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.432 HG22 ' CD1' ' A' ' 52' ' ' ILE . 6.9 pt -139.3 134.37 40.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 117.706 0.753 . . . . 0.0 111.461 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 53' ' ' ILE . 33.7 t -104.09 119.26 38.55 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.469 HG12 HG22 ' A' ' 49' ' ' VAL . 22.7 m -114.23 151.44 16.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.028 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.4 t -134.7 177.2 7.97 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 172.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.632 HG12 HD13 ' A' ' 47' ' ' ILE . 16.2 m . . . . . 0 C--N 1.294 -1.808 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . . . . . . 0 N--CA 1.431 -1.658 0 N-CA-C 113.474 0.15 . . . . 0.0 113.474 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.942 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.1 mm -119.13 142.78 32.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -128.7 113.37 15.29 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 174.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 29' ' ' VAL . 58.8 t -51.47 114.97 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 169.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -91.11 -30.38 16.76 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.905 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -158.34 159.99 36.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.928 HG21 ' HB2' ' A' ' 59' ' ' GLU . 45.3 mm -110.1 120.49 61.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 55' ' ' LYS . 1.8 mp -68.16 131.2 92.16 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.65 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 30.5 Cg_exo -69.35 60.12 1.45 Allowed 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 124.009 3.139 . . . . 0.0 112.267 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -138.95 19.62 2.64 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.151 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.7 -147.28 25.1 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.492 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 73.71 -91.05 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 125.329 1.452 . . . . 0.0 112.273 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.928 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -76.44 -36.85 57.74 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.326 -172.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.928 ' HB2' HG21 ' A' ' 52' ' ' ILE . 27.7 tt0 -78.85 -38.97 36.61 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 120.806 0.336 . . . . 0.0 110.655 -176.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -76.73 -27.83 55.57 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.109 0.481 . . . . 0.0 112.031 -175.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -87.98 -14.43 39.16 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.21 56.58 20.7 Favored Glycine 0 CA--C 1.497 -1.077 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.014 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -120.47 -46.48 2.38 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.168 0.509 . . . . 0.0 110.007 -177.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.551 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 53.3 mt -110.78 136.28 47.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.408 ' HA ' HD11 ' A' ' 52' ' ' ILE . 32.3 m-70 -134.56 177.85 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.814 0.696 . . . . 0.0 109.155 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -67.05 125.16 25.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.744 0.783 . . . . 0.0 110.237 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.82 21.0 17.19 Favored Glycine 0 N--CA 1.416 -2.669 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.016 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -97.58 142.44 29.39 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.962 -1.317 . . . . 0.0 110.424 167.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.639 ' HB2' ' HA3' ' A' ' 104' ' ' GLY . 6.7 ttm180 -92.83 138.58 31.36 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.942 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 55.9 t -106.93 115.67 48.95 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.476 HD12 HD22 ' A' ' 100' ' ' LEU . 96.8 mt -86.45 -37.54 18.22 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.955 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.712 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . . . -167.31 176.06 6.93 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.097 -175.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.574 ' HA ' HD12 ' A' ' 99' ' ' LEU . 21.1 t -118.94 118.69 58.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 175.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 47.48 40.45 11.23 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 124.513 1.125 . . . . 0.0 113.771 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.65 -6.68 79.72 Favored Glycine 0 C--N 1.315 -0.636 0 C-N-CA 120.849 -0.691 . . . . 0.0 114.344 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 48.7 t -91.49 104.25 15.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.57 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 19.7 m -50.43 123.17 8.13 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.603 1.161 . . . . 0.0 113.3 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.712 ' HB3' ' HA ' ' A' ' 72' ' ' ALA . 22.3 tp -117.68 1.36 12.2 Favored 'General case' 1 N--CA 1.366 -4.64 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.844 -172.88 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.454 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 19.1 mt-10 -74.22 113.88 11.93 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.18 -0.16 11.54 Favored Glycine 0 C--N 1.298 -1.566 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -172.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.1 164.82 12.71 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.467 HG22 ' HG2' ' A' ' 85' ' ' GLN . 15.3 t -101.01 160.08 14.68 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 170.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 21.8 p80 -50.65 -45.43 57.89 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -58.94 -39.14 80.7 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.537 0.335 . . . . 0.0 110.1 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.467 ' HG2' HG22 ' A' ' 82' ' ' THR . 16.2 mm-40 -71.8 -36.41 70.28 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.106 0.479 . . . . 0.0 110.137 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.59 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -59.85 -47.09 87.12 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' A' ' 90' ' ' LEU . 95.8 t -67.48 -28.77 43.24 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.252 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.22 -30.2 69.22 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.26 0.552 . . . . 0.0 110.336 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -78.55 -25.21 45.36 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 80.8 mt -74.81 -23.51 58.49 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.712 0.768 . . . . 0.0 109.182 173.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -84.72 -29.34 25.64 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.462 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.66 -45.44 92.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.822 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.416 ' OG1' HG22 ' A' ' 97' ' ' VAL . 40.1 p -71.44 153.64 42.11 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.07 -119.55 0.91 Allowed Glycine 0 N--CA 1.426 -1.996 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.31 -175.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -79.8 -34.87 39.25 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.221 -0.489 . . . . 0.0 110.489 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -116.33 126.27 73.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.087 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.429 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 39.3 t -101.63 126.76 55.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -101.19 52.95 0.84 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.759 HD23 HD11 ' A' ' 101' ' ' LEU . 7.7 tp -61.84 149.47 40.11 Favored 'General case' 0 C--O 1.206 -1.227 0 C-N-CA 125.062 1.345 . . . . 0.0 111.18 -172.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.476 HD22 HD12 ' A' ' 71' ' ' LEU . 2.4 tt -110.43 118.77 37.16 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.759 HD11 HD23 ' A' ' 99' ' ' LEU . 6.4 mp -124.24 174.34 7.76 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.341 1.067 . . . . 0.0 112.567 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 30.8 tt0 -133.07 148.74 52.18 Favored 'General case' 0 N--CA 1.403 -2.824 0 N-CA-C 101.846 -3.39 . . . . 0.0 101.846 171.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.593 ' HB2' ' HE2' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -82.38 84.77 7.04 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 172.572 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 69' ' ' ARG . . . . . . . . 0 CA--C 1.47 -2.732 0 CA-C-N 112.859 -1.973 . . . . 0.0 113.67 -170.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.3 t70 . . . . . 0 C--O 1.242 0.667 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 2.9 p -105.0 114.89 29.37 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.372 0.606 . . . . 0.0 112.026 -176.336 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' HE1' ' HB2' ' A' ' 103' ' ' LYS . 24.3 p90 -147.37 153.1 39.25 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.261 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.531 ' HG3' ' HG ' ' A' ' 100' ' ' LEU . 2.5 mp0 -91.26 108.57 19.97 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 t -76.1 136.47 24.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.49 96.47 8.01 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 175.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.708 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -117.66 117.59 29.8 Favored 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -178.227 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.09 171.07 7.55 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -176.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.82 111.81 6.53 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 172.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.9 m -117.16 97.41 5.91 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.62 -176.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t70 67.64 -61.45 0.36 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.711 1.204 . . . . 0.0 112.605 175.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.69 35.04 5.2 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 178.227 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.3 p 64.48 -155.43 0.3 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.986 1.714 . . . . 0.0 112.321 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 18' ' ' LEU . 13.5 tp -73.6 104.63 4.61 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.737 ' H ' ' HB3' ' A' ' 57' ' ' ALA . . . -74.48 53.17 2.35 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.046 -0.979 . . . . 0.0 115.167 -174.052 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.488 HG23 ' HB2' ' A' ' 58' ' ' ALA . 4.8 pt -136.45 133.88 49.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.231 0.539 . . . . 0.0 111.763 177.35 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 t -104.15 111.32 23.87 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.002 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.7 m -106.4 152.9 7.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.039 -174.09 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.9 t -134.08 167.86 19.88 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.734 HG11 ' HA ' ' A' ' 82' ' ' THR . 5.7 p . . . . . 0 C--N 1.271 -2.805 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 31' ' ' VAL . . . . . . . . 0 N--CA 1.429 -1.811 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.959 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.7 mm -102.53 143.14 15.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -178.76 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.465 ' CE2' ' HG3' ' A' ' 69' ' ' ARG . 79.4 m-85 -131.73 108.13 9.26 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.9 t -49.62 116.11 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.533 0.682 . . . . 0.0 109.675 171.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 86.2 tttt -92.2 -33.19 14.8 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.856 -175.567 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.73 153.29 31.03 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.029 -176.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.015 HG21 ' HB2' ' A' ' 59' ' ' GLU . 31.7 mm -110.67 132.07 60.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.31 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.8 mm -79.31 121.98 83.56 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.16 144.14 95.38 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 123.057 2.505 . . . . 0.0 111.146 178.353 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 24.0 tptp 59.27 30.16 19.85 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.883 1.325 . . . . 0.0 109.651 -178.257 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.87 -115.32 4.04 Favored Glycine 0 N--CA 1.406 -3.358 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.55 -177.722 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.737 ' HB3' ' H ' ' A' ' 26' ' ' GLY . . . -132.15 -65.1 0.75 Allowed 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.924 -0.638 . . . . 0.0 111.629 -172.515 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.768 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -54.33 -36.28 63.6 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -171.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.015 ' HB2' HG21 ' A' ' 52' ' ' ILE . 38.1 tt0 -95.54 -40.91 9.21 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 122.341 1.067 . . . . 0.0 110.304 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.6 m -79.71 -44.11 21.4 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.426 -168.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -101.17 -35.04 9.44 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.92 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.86 -128.64 6.43 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 116.519 1.368 . . . . 0.0 116.519 -167.116 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -147.79 -23.1 0.36 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.893 -1.153 . . . . 0.0 110.693 -165.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.768 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.6 mt -69.74 141.33 17.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.915 -173.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -134.64 -176.66 4.3 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.037 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 50' ' ' LYS . 81.0 tttt -67.83 121.69 16.55 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 123.41 0.684 . . . . 0.0 111.296 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.58 -6.94 31.75 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.442 -0.885 . . . . 0.0 114.179 177.474 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.769 ' HB3' HD23 ' A' ' 101' ' ' LEU . 66.3 m-20 -64.64 130.96 45.58 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-O 121.682 0.753 . . . . 0.0 112.067 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.465 ' HG3' ' CE2' ' A' ' 48' ' ' TYR . 48.3 ttt180 -92.22 129.92 38.05 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.997 -174.556 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.959 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 64.3 t -109.36 126.65 66.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.239 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -107.43 -34.91 6.92 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.128 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.623 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -150.32 157.07 42.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.596 0.713 . . . . 0.0 112.132 -176.107 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.816 ' HA ' HD12 ' A' ' 99' ' ' LEU . 61.7 t -109.82 100.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 173.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 t30 59.54 34.37 22.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.55 1.14 . . . . 0.0 110.504 176.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.22 -23.18 35.25 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.478 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.9 t -84.25 106.5 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 20.0 m -75.2 138.24 41.82 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 121.616 0.722 . . . . 0.0 112.106 -175.507 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.1 pt? -130.75 74.22 1.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.649 1.214 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -90.39 96.36 10.62 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.084 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.29 39.18 4.31 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.1 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.5 147.38 27.22 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.106 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.734 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.9 t -69.04 146.66 52.47 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 18.4 p80 -50.95 -35.45 33.56 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -177.398 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 54.6 mtmt -62.48 -38.91 91.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.257 176.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -76.21 -31.27 58.33 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -55.29 -53.69 52.9 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.481 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.662 ' HA ' HD12 ' A' ' 90' ' ' LEU . 86.0 t -64.48 -29.02 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.002 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 43.6 mm-40 -70.85 -33.19 70.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.164 0.507 . . . . 0.0 110.253 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.6 m -69.67 -35.15 74.9 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.343 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.68 HD13 HD23 ' A' ' 25' ' ' LEU . 81.3 mt -67.66 -34.57 77.2 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 123.918 0.887 . . . . 0.0 109.375 178.296 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -66.9 -35.39 79.9 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.7 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.11 -34.32 66.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.122 176.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.6 m -57.77 -51.65 68.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 123.702 0.801 . . . . 0.0 110.636 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.19 -150.32 17.62 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 120.079 -1.058 . . . . 0.0 112.893 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -77.78 -39.64 43.34 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 122.961 0.504 . . . . 0.0 110.765 -178.753 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.3 t -106.7 119.73 56.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.2 175.527 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.62 HG11 HD22 ' A' ' 90' ' ' LEU . 58.2 t -104.26 127.54 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-O 121.509 0.671 . . . . 0.0 110.213 -176.411 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -97.4 120.22 37.36 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 169.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.816 HD12 ' HA ' ' A' ' 73' ' ' VAL . 9.0 tp -121.54 133.3 55.02 Favored 'General case' 0 C--N 1.261 -3.24 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.1 tt -94.15 110.31 22.04 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -175.235 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 68' ' ' ASP . 10.1 mp -115.11 170.4 8.39 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.834 0.826 . . . . 0.0 111.774 -176.04 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 36.6 tt0 -129.64 103.33 6.79 Favored 'General case' 0 N--CA 1.4 -2.931 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 171.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.451 ' HB2' ' HE1' ' A' ' 14' ' ' PHE . 22.4 tptm -48.65 121.38 4.52 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 124.194 0.934 . . . . 0.0 112.353 -170.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.213 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.292 -172.598 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.6 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 32.1 t0 . . . . . 0 N--CA 1.442 -0.827 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 10.4 p -93.92 115.18 27.53 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-O 122.224 1.011 . . . . 0.0 110.375 177.694 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.556 ' CE1' ' HB ' ' A' ' 16' ' ' VAL . 44.8 p90 -123.49 159.72 28.48 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.699 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 41.2 mt-10 -102.1 109.11 20.73 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.15 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.556 ' HB ' ' CE1' ' A' ' 14' ' ' PHE . 7.5 p -89.98 119.83 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 121.378 0.609 . . . . 0.0 111.084 -174.508 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HG3' ' CG1' ' A' ' 96' ' ' VAL . 33.3 tt0 -87.47 91.92 8.9 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.516 -178.585 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.463 HD12 HD13 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -108.77 114.95 29.16 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.461 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.19 141.35 32.07 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -72.94 130.55 40.63 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.079 177.937 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.2 p -112.48 -158.78 0.66 Allowed 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.422 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -53.69 -30.01 41.56 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 123.497 0.719 . . . . 0.0 111.573 175.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.28 16.56 49.08 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.84 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 t 70.28 -143.9 0.08 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.663 ' HG ' HD13 ' A' ' 90' ' ' LEU . 3.6 mm? -64.44 -31.61 72.89 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.92 0.782 . . . . 0.0 109.725 177.616 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.36 5.14 79.88 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.152 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.0 pt -125.38 144.99 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-O 122.418 1.104 . . . . 0.0 113.193 -175.854 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.577 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 66.0 m -104.63 114.69 29.07 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 113.081 -1.872 . . . . 0.0 106.861 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.4 m -102.85 147.94 8.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-O 121.134 0.493 . . . . 0.0 111.531 -178.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 13.6 t -118.08 171.05 8.36 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.401 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.852 ' HA ' HD13 ' A' ' 47' ' ' ILE . 4.1 t . . . . . 0 C--N 1.289 -2.042 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 177.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.151 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.852 HD13 ' HA ' ' A' ' 31' ' ' VAL . 24.7 mm -137.58 149.64 25.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 178.579 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -136.05 151.62 50.03 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 118.324 0.511 . . . . 0.0 110.688 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.539 HG21 ' CG2' ' A' ' 64' ' ' ILE . 21.6 t -79.31 109.03 13.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.555 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.55 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 87.6 tttt -83.14 -37.13 24.15 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.768 -175.282 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 28' ' ' SER . . . -153.37 148.05 26.28 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.994 -178.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.561 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 49.8 mm -112.72 122.07 66.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.932 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.69 129.03 46.12 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.99 139.26 34.07 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.198 2.598 . . . . 0.0 111.299 177.293 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.0 tptt 67.8 -0.35 2.02 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.915 0.886 . . . . 0.0 111.803 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.42 102.57 2.94 Favored Glycine 0 N--CA 1.419 -2.484 0 CA-C-O 119.422 -0.654 . . . . 0.0 112.946 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . 26.49 -76.26 0.0 OUTLIER 'General case' 0 C--O 1.181 -2.526 0 C-N-CA 128.312 2.645 . . . . 0.0 115.028 170.16 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -50.28 -39.0 44.08 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.561 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 9.7 tp10 -76.59 -43.66 37.7 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.136 0.575 . . . . 0.0 110.201 178.207 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -67.23 -50.27 61.35 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.29 -177.554 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.43 -36.96 79.81 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.5 179.234 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.72 53.99 4.76 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.088 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.489 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 1.0 OUTLIER -115.87 -74.61 0.6 Allowed 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.442 0.639 . . . . 0.0 109.341 -176.878 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.597 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 62.5 mt -86.26 140.95 15.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -144.71 -172.57 3.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.265 176.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.538 ' O ' ' HD2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -65.94 129.27 39.21 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.326 0.584 . . . . 0.0 112.522 -175.076 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.39 -7.77 62.01 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.203 174.257 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.607 ' HB3' HD23 ' A' ' 101' ' ' LEU . 10.1 m-20 -64.02 138.1 58.3 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-N 117.472 0.636 . . . . 0.0 112.452 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -88.19 115.86 25.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.779 -175.025 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.421 HG22 HD11 ' A' ' 101' ' ' LEU . 43.9 t -100.1 112.7 33.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.313 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.29 -37.55 10.94 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.594 -178.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -157.99 -179.79 8.46 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.382 -175.105 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.986 HG11 HG21 ' A' ' 89' ' ' THR . 2.4 p -130.13 102.69 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 125.561 1.544 . . . . 0.0 110.192 -178.182 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t30 58.95 37.61 24.57 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.247 1.022 . . . . 0.0 111.057 174.084 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.9 -12.0 70.3 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.574 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.596 ' HB ' HG13 ' A' ' 73' ' ' VAL . 59.0 t -93.25 125.41 45.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.5 m -71.02 145.13 50.16 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.267 0.556 . . . . 0.0 112.457 -174.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 61.9 mt -111.91 27.21 9.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.721 0.772 . . . . 0.0 110.304 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -78.11 118.1 20.04 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.126 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.4 19.74 51.25 Favored Glycine 0 C--N 1.309 -0.917 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.98 -171.27 2.19 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.51 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 15.2 t -150.32 175.48 11.78 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.332 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -50.37 -55.58 15.05 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.892 0.745 . . . . 0.0 111.151 -179.161 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -53.26 -45.45 68.82 Favored 'General case' 0 C--O 1.21 -1.0 0 O-C-N 123.898 0.749 . . . . 0.0 110.92 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -70.12 -43.96 69.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.618 0.247 . . . . 0.0 111.466 -176.086 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -58.42 -50.05 75.1 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.492 178.194 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 89.5 t -66.83 -37.21 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.178 -178.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -63.45 -36.54 84.08 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.093 0.473 . . . . 0.0 109.981 178.109 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.986 HG21 HG11 ' A' ' 73' ' ' VAL . 89.8 m -68.89 -37.82 79.24 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.576 177.295 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.663 HD13 ' HG ' ' A' ' 25' ' ' LEU . 83.8 mt -71.23 -19.84 62.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.661 0.743 . . . . 0.0 109.858 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -85.29 -47.67 9.82 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.64 177.209 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.68 -12.09 60.13 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.057 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -29.98 65.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.09 -138.26 10.66 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.617 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.46 ' O ' ' HE3' ' A' ' 20' ' ' LYS . 24.3 tp60 -86.39 -35.7 19.62 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.858 0.361 . . . . 0.0 110.365 -176.69 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.4 t -124.44 147.76 28.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -175.527 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.403 ' CG1' HG23 ' A' ' 73' ' ' VAL . 6.0 t -129.46 146.72 33.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.234 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 11.9 m-70 -115.75 70.08 0.74 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.155 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.61 HD21 HD21 ' A' ' 90' ' ' LEU . 5.0 mp -63.61 150.98 42.89 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.727 -175.2 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 62.7 tp -93.99 108.98 20.74 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 68' ' ' ASP . 8.1 mp -127.1 147.39 50.17 Favored 'General case' 0 CA--C 1.474 -1.971 0 CA-C-O 121.476 0.655 . . . . 0.0 111.71 -175.491 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 38.0 tt0 -113.66 115.44 27.87 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 103.769 -2.678 . . . . 0.0 103.769 174.11 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 2.8 tmtm? -49.36 116.6 1.79 Allowed 'General case' 0 C--O 1.245 0.849 0 O-C-N 124.324 1.015 . . . . 0.0 111.721 -172.66 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.424 -2.146 0 CA-C-N 114.129 -1.396 . . . . 0.0 113.112 -174.291 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.463 HG22 HD11 ' A' ' 71' ' ' LEU . 18.5 p -88.05 110.52 20.69 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.372 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -114.51 143.45 44.94 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 121.308 0.575 . . . . 0.0 111.564 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -101.99 121.38 42.05 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.501 HG11 HD11 ' A' ' 64' ' ' ILE . 30.0 t -110.95 129.66 65.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.207 -174.441 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 95.39 5.8 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.023 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -97.06 119.37 35.41 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.808 -173.649 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.21 117.98 30.9 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 24' ' ' SER . 94.5 mttt -56.29 121.82 10.4 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.006 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.6 m -92.28 -78.95 0.4 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.437 -174.12 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -126.38 -56.32 1.42 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.068 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.51 30.83 6.52 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 177.231 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.564 ' HA ' ' HB3' ' A' ' 20' ' ' LYS 0.286 97.8 p 66.19 -105.97 0.11 Allowed 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 126.367 1.867 . . . . 0.0 112.107 -179.988 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 90' ' ' LEU . 81.8 mt -96.83 128.43 43.78 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 176.551 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 52' ' ' ILE . . . -81.56 8.36 59.19 Favored Glycine 0 C--N 1.294 -1.804 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.761 -176.257 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.7 pt -99.55 115.69 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.32 -177.008 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.498 ' HB2' HG12 ' A' ' 53' ' ' ILE . 23.4 t -88.7 124.18 33.86 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 175.544 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.76 -174.68 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -173.306 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -170.75 150.48 3.28 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 178.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.618 HG11 ' HA ' ' A' ' 82' ' ' THR . 7.3 p . . . . . 0 C--N 1.287 -2.148 0 CA-C-O 121.209 0.528 . . . . 0.0 110.252 177.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 79' ' ' GLU . . . . . . . . 0 N--CA 1.416 -2.696 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.861 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.5 mm -101.38 148.29 7.42 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 179.207 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -133.35 147.23 51.81 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 118.385 0.539 . . . . 0.0 109.874 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.429 HG21 HG21 ' A' ' 64' ' ' ILE . 59.7 t -81.29 115.3 23.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.578 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -85.69 -34.48 21.27 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.594 -177.683 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.93 169.85 12.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.04 -176.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.063 HG21 ' HB2' ' A' ' 59' ' ' GLU . 20.5 mm -114.36 116.2 51.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 177.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.825 ' HB ' ' HD3' ' A' ' 54' ' ' PRO . 42.2 mm -84.5 -71.91 0.1 OUTLIER Pre-proline 0 CA--C 1.562 1.426 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -169.757 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 53' ' ' ILE . 6.2 Cg_exo -78.74 -160.87 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.715 2.277 . . . . 0.0 113.306 -172.879 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -36.44 -55.46 0.83 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.082 1.353 . . . . 0.0 112.132 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.617 ' HA3' ' OG ' ' A' ' 60' ' ' SER . . . -171.71 -87.26 0.07 OUTLIER Glycine 0 N--CA 1.403 -3.565 0 C-N-CA 119.556 -1.306 . . . . 0.0 111.964 176.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.674 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 68.53 -85.28 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 124.486 1.114 . . . . 0.0 108.949 -177.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.023 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -78.14 -29.44 48.74 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.717 -177.606 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.063 ' HB2' HG21 ' A' ' 52' ' ' ILE . 43.6 tt0 -73.75 -63.14 1.27 Allowed 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 124.602 1.189 . . . . 0.0 111.608 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.617 ' OG ' ' HA3' ' A' ' 56' ' ' GLY . 6.8 p -86.21 -30.38 22.44 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -168.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -100.54 -35.77 9.41 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -174.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.25 -128.52 3.35 Favored Glycine 1 N--CA 1.393 -4.229 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.301 -175.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -157.84 3.94 0.12 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -170.07 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.616 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 61.5 mt -94.78 138.94 19.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.388 -168.028 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.58 179.01 6.19 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -70.43 128.38 35.99 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.295 0.569 . . . . 0.0 109.999 176.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.13 -20.48 12.75 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.726 -178.2 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.641 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 50.5 m-20 -64.65 136.83 57.39 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.504 0.668 . . . . 0.0 112.411 -177.375 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -93.84 135.93 34.65 Favored 'General case' 0 C--O 1.195 -1.785 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.473 -176.175 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.861 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 62.2 t -106.53 119.51 56.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.601 HD12 HD22 ' A' ' 100' ' ' LEU . 82.8 mt -97.43 -44.38 6.88 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.55 -1.205 . . . . 0.0 108.781 -177.578 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -152.26 165.08 36.01 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.011 -173.453 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.753 ' HA ' HD12 ' A' ' 99' ' ' LEU . 39.0 t -116.28 111.27 34.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 173.5 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 98' ' ' HIS . 2.6 p-10 47.27 35.91 4.22 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.02 1.328 . . . . 0.0 112.354 -176.299 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.09 -16.23 61.22 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.121 -1.038 . . . . 0.0 114.393 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.39 109.29 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -70.23 137.51 50.91 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.358 0.411 . . . . 0.0 111.235 -174.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.609 HD22 HG23 ' A' ' 73' ' ' VAL . 1.7 pt? -130.6 22.24 5.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.654 177.734 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.523 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 32.4 mt-10 -68.48 105.14 2.11 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.26 16.63 6.04 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.796 -176.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.581 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -98.94 167.52 10.69 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 175.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.618 ' HA ' HG11 ' A' ' 31' ' ' VAL . 9.0 t -90.78 170.17 10.34 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -50.3 -49.54 53.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.465 1.106 . . . . 0.0 109.667 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 10.9 mptt -64.13 -35.17 79.89 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.15 -176.119 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.52 ' HG3' HG22 ' A' ' 82' ' ' THR . 56.2 mt-30 -70.02 -42.59 72.79 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -54.26 -58.79 6.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.023 178.096 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.42 -28.5 43.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.191 -177.244 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 66.1 mm-40 -68.75 -34.38 75.49 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.537 177.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.519 HG22 HG11 ' A' ' 73' ' ' VAL . 37.8 m -69.51 -29.94 67.68 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.5 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.694 ' HB3' HD12 ' A' ' 25' ' ' LEU . 81.4 mt -77.0 -16.55 59.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.961 177.22 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -93.25 -26.94 17.13 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.6 176.196 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -67.28 -42.22 84.15 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.123 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.6 p -65.92 146.23 54.97 Favored 'General case' 0 C--O 1.252 1.208 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.958 177.147 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.9 -128.98 0.88 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -172.649 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -69.3 -54.4 14.82 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.44 0.696 . . . . 0.0 111.803 -174.385 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -106.2 115.51 48.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.587 HG21 HD11 ' A' ' 25' ' ' LEU . 46.0 t -99.0 126.5 52.21 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 74' ' ' ASN . 53.8 t-80 -91.96 123.39 35.28 Favored 'General case' 0 N--CA 1.404 -2.729 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 175.216 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.753 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.6 tp -126.53 143.36 51.23 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.601 HD22 HD12 ' A' ' 71' ' ' LEU . 1.6 tt -105.1 116.1 31.39 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.5 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.596 HD11 HD23 ' A' ' 99' ' ' LEU . 6.6 mp -121.46 176.07 5.86 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.51 0.671 . . . . 0.0 111.873 -177.242 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -131.27 126.85 36.49 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 172.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.641 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 15.1 mmtt -57.3 127.01 29.83 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.545 0.528 . . . . 0.0 111.433 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.561 -178.6 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 38.0 t70 . . . . . 0 CA--C 1.494 -1.198 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.577 HG22 HD11 ' A' ' 71' ' ' LEU . 6.1 p -80.65 137.53 36.34 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.071 0.463 . . . . 0.0 111.887 -175.105 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -139.39 140.7 37.5 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.119 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.547 ' HB3' ' NE2' ' A' ' 98' ' ' HIS . 45.3 mt-10 -106.41 114.23 28.23 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.919 -179.168 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.409 HG12 HD13 ' A' ' 101' ' ' LEU . 7.7 p -113.44 131.71 64.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.127 -175.31 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.696 ' HA ' ' HA ' ' A' ' 98' ' ' HIS . 40.8 tt0 -110.52 99.56 8.53 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 175.062 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -93.66 124.14 37.45 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -173.17 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -98.31 116.07 29.75 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.814 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 14.9 ptmt -79.79 145.88 32.59 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.466 -175.009 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -84.87 -55.27 4.16 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.339 0.59 . . . . 0.0 109.963 -175.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.477 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 9.1 p-10 -111.11 -145.77 0.4 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.637 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.22 20.08 11.43 Favored Glycine 0 C--N 1.305 -1.189 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.237 178.344 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 20.0 m -122.42 130.38 53.03 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.764 HD11 ' HB3' ' A' ' 18' ' ' LEU . 22.0 tp -81.26 -5.28 57.61 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.012 0.911 . . . . 0.0 108.904 178.442 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.71 7.25 69.07 Favored Glycine 0 N--CA 1.421 -2.354 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.196 175.46 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.486 HG22 ' CD1' ' A' ' 52' ' ' ILE . 19.2 pt -132.59 148.21 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 CA-C-O 121.252 0.549 . . . . 0.0 110.495 179.559 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.5 t -116.79 120.41 38.46 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 176.117 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 49' ' ' VAL . 35.0 m -111.97 170.34 3.89 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-O 120.71 0.29 . . . . 0.0 110.966 -176.377 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -145.45 169.71 17.81 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 171.414 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 82' ' ' THR . 30.8 m . . . . . 0 C--N 1.299 -1.599 0 C-N-CA 118.709 -1.196 . . . . 0.0 108.858 173.271 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.168 0 N-CA-C 107.504 -2.238 . . . . 0.0 107.504 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.666 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 30.7 mm -145.24 134.49 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 174.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -125.45 139.88 53.26 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.554 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.493 HG21 ' CG2' ' A' ' 64' ' ' ILE . 40.1 t -75.17 117.76 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.169 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -93.02 -31.66 14.79 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.087 -174.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . . . -158.06 162.67 38.09 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.875 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 65' ' ' HIS . 49.4 mm -107.52 120.11 58.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 177.584 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.507 HG22 ' HD3' ' A' ' 55' ' ' LYS . 50.0 mm -77.53 124.15 86.71 Favored Pre-proline 0 C--O 1.252 1.216 0 C-N-CA 122.956 0.502 . . . . 0.0 110.741 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 4.9 Cg_exo -74.84 74.3 3.96 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 124.192 3.261 . . . . 0.0 115.53 -174.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HD3' HG22 ' A' ' 53' ' ' ILE . 2.1 mptm? -116.59 -82.3 0.62 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.204 0.526 . . . . 0.0 110.108 171.32 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.571 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 172.59 49.59 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 119.781 -1.2 . . . . 0.0 112.142 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . -126.36 -96.4 0.43 Allowed 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.967 -179.211 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.916 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -61.05 -36.13 78.77 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.325 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.617 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 40.5 tt0 -72.13 -46.87 54.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.557 0.743 . . . . 0.0 110.465 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.571 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 13.5 m -77.88 -35.85 50.42 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.209 -173.538 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.13 -23.89 47.63 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.9 59.77 4.93 Favored Glycine 0 CA--C 1.498 -1.03 0 CA-C-N 113.98 -1.464 . . . . 0.0 113.471 171.379 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -120.5 -69.81 0.82 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.948 0.88 . . . . 0.0 108.797 -178.581 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.493 ' CG2' HG21 ' A' ' 49' ' ' VAL . 68.6 mt -90.36 141.73 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.783 -178.377 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.672 ' HA ' HD11 ' A' ' 52' ' ' ILE . 33.1 t-80 -139.45 176.15 8.96 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 175.154 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 51' ' ' ALA . 51.5 pttt -73.56 142.87 46.63 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.835 -178.521 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.48 -22.68 21.86 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.957 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 39.1 m-20 -72.63 142.35 48.33 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.91 0.386 . . . . 0.0 112.035 -178.614 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -101.09 136.58 40.7 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.018 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.666 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.1 t -103.97 121.44 55.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -175.219 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD11 HG22 ' A' ' 13' ' ' THR . 90.2 mt -83.47 -42.16 17.21 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.452 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 76' ' ' VAL . . . -170.07 176.09 4.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.703 -175.329 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 1.054 HG11 HG21 ' A' ' 89' ' ' THR . 2.7 p -112.92 105.96 19.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 124.038 0.935 . . . . 0.0 109.901 178.18 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.9 t30 52.41 40.95 30.45 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.771 1.272 . . . . 0.0 110.765 178.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.93 -18.24 41.09 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.538 -178.497 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.71 ' HB ' HG13 ' A' ' 73' ' ' VAL . 49.1 t -77.67 109.09 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.0 m -61.57 122.51 15.44 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.905 -173.593 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.0 mt -90.6 74.74 6.72 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -85.37 96.68 9.63 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.649 -174.081 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.17 47.86 69.27 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -178.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.72 147.57 24.42 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.709 HG22 ' HG2' ' A' ' 85' ' ' GLN . 13.9 t -91.06 164.55 13.91 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 172.118 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -43.48 -54.74 4.62 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.409 1.484 . . . . 0.0 112.538 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 36.8 ttmt -63.66 -34.99 79.07 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -176.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.709 ' HG2' HG22 ' A' ' 82' ' ' THR . 82.5 mm-40 -68.85 -43.26 75.79 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.168 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.603 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -55.0 -54.52 41.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.391 176.105 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.73 -35.88 76.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.725 -177.082 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 36.8 mt-10 -69.39 -32.53 71.62 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.521 179.219 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' THR . . . . . 1.054 HG21 HG11 ' A' ' 73' ' ' VAL . 60.2 m -66.86 -36.74 83.02 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 60.3 mt -75.74 -15.11 60.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 0.0 110.011 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -89.11 -45.83 9.3 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.607 176.072 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -69.18 -35.92 76.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.687 -176.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -53.41 -51.91 61.07 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 122.918 0.487 . . . . 0.0 112.185 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.57 -154.24 25.84 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.604 177.39 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 51.1 tt0 -76.61 -44.94 32.18 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.61 0.719 . . . . 0.0 109.748 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 21.3 t -106.08 116.31 49.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.8 131.97 65.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -174.457 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 9.5 t60 -96.91 136.97 36.71 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 175.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.545 HD11 HD22 ' A' ' 90' ' ' LEU . 6.5 mp -130.44 154.3 47.88 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.123 0.487 . . . . 0.0 109.823 174.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HG ' ' HB2' ' A' ' 71' ' ' LEU . 55.3 tp -110.14 118.95 37.75 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.497 ' HG ' ' HA ' ' A' ' 70' ' ' VAL . 7.4 mp -130.25 178.83 6.28 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.377 0.608 . . . . 0.0 110.527 -178.189 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 9.2 pt-20 -130.49 153.43 48.82 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 172.582 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -61.52 109.95 1.33 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.957 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.431 -1.68 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.596 -177.084 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.251 1.153 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 p -89.1 109.06 19.96 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 166.138 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -109.55 100.59 9.62 Favored 'General case' 0 N--CA 1.408 -2.536 0 CA-C-O 122.334 1.064 . . . . 0.0 111.028 -173.793 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.774 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 45.4 mt-10 -71.51 91.87 1.08 Allowed 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.177 174.269 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.619 HG12 HD13 ' A' ' 101' ' ' LEU . 14.9 p -84.62 138.77 18.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.536 -174.566 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -108.13 107.73 18.5 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 177.377 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.83 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -116.38 130.94 57.03 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.441 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -103.77 132.34 50.11 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.231 -0.293 . . . . 0.0 110.873 -178.78 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 95' ' ' GLN . 1.7 mptm? -60.42 136.44 58.04 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.09 0.471 . . . . 0.0 112.097 175.332 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.411 HG21 ' HA3' ' A' ' 56' ' ' GLY . 17.6 p -104.11 100.3 10.05 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 169.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 t70 73.06 -49.44 0.7 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.875 1.27 . . . . 0.0 112.203 -177.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.96 0.78 0.03 OUTLIER Glycine 0 C--N 1.306 -1.138 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.927 177.228 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.3 m -108.21 144.0 36.26 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 122.169 -0.606 . . . . 0.0 110.207 -177.488 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.83 HD11 ' HB3' ' A' ' 18' ' ' LEU . 19.6 tp -93.98 -11.14 31.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.831 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.7 13.9 66.39 Favored Glycine 0 N--CA 1.429 -1.797 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.048 175.545 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.498 HG22 HD13 ' A' ' 52' ' ' ILE . 14.1 pt -139.66 146.25 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.667 0.746 . . . . 0.0 112.487 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.422 ' OG ' HD11 ' A' ' 53' ' ' ILE . 19.6 m -107.02 135.04 49.26 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.412 172.48 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.0 165.23 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 123.772 0.67 . . . . 0.0 109.64 -176.574 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.998 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 6.0 t -149.37 141.8 24.27 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 177.406 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.769 HG12 HD13 ' A' ' 47' ' ' ILE . 32.6 m . . . . . 0 C--N 1.299 -1.6 0 C-N-CA 119.204 -0.998 . . . . 0.0 113.514 -176.207 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.522 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.769 HD13 HG12 ' A' ' 31' ' ' VAL . 42.2 mm -115.43 136.12 53.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.561 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.669 ' HB3' ' HA ' ' A' ' 69' ' ' ARG 0.27 38.5 p90 -158.52 169.3 24.74 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 169.295 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.553 HG21 ' CG2' ' A' ' 64' ' ' ILE . 31.8 t -80.59 121.76 34.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.694 -178.111 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.998 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 57.8 tptt -91.32 -38.09 12.85 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.468 178.669 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -156.03 158.58 38.06 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.577 -175.406 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.498 HD13 HG22 ' A' ' 27' ' ' ILE . 45.9 mm -104.05 117.97 50.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.242 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 43.6 mm -93.29 134.18 27.34 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.726 -179.468 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 14.9 Cg_exo -72.36 -172.68 0.94 Allowed 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 122.792 2.328 . . . . 0.0 112.186 178.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.5 tptt 92.74 5.35 0.05 Allowed 'General case' 0 C--O 1.242 0.661 0 C-N-CA 126.367 1.867 . . . . 0.0 109.309 176.224 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.569 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 124.89 -163.83 18.68 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 114.677 -1.147 . . . . 0.0 113.256 173.375 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.503 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 71.66 -114.04 0.07 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 171.843 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.819 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -60.42 -39.48 87.58 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 117.942 0.337 . . . . 0.0 111.354 -174.673 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.11 -55.88 16.2 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.38 1.472 . . . . 0.0 110.115 178.15 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.569 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 20.4 m -73.25 -36.68 66.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -171.349 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -74.17 -28.85 61.49 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.58 51.09 22.35 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.382 176.466 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.561 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 3.1 mmp_? -104.99 -56.85 2.11 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.672 0.748 . . . . 0.0 110.842 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.553 ' CG2' HG21 ' A' ' 49' ' ' VAL . 56.2 mt -95.04 144.06 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.243 -176.023 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -137.0 168.7 19.08 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 173.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -65.74 141.98 58.15 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.279 0.561 . . . . 0.0 111.215 -176.337 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.7 -40.71 2.44 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.027 -1.083 . . . . 0.0 113.77 176.1 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 48' ' ' TYR 0.289 8.1 m-20 -67.21 144.52 55.93 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -174.919 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.669 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 34.6 ttp180 -102.19 149.43 24.31 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.694 -165.506 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 48' ' ' TYR . 22.0 t -115.52 133.36 62.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -173.58 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.487 HD12 HD22 ' A' ' 100' ' ' LEU . 85.1 mt -96.12 -37.23 10.68 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.148 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.837 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . . . -167.44 179.54 4.91 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.925 -176.472 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.858 HG23 HD22 ' A' ' 78' ' ' LEU . 60.3 t -123.89 110.33 25.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.021 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.4 t30 59.43 34.94 22.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.666 1.222 . . . . 0.0 109.923 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 -15.43 61.19 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.478 -1.237 . . . . 0.0 114.221 178.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 57.7 t -85.65 112.47 22.41 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.119 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 17.5 m -53.96 122.84 10.93 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 124.37 1.044 . . . . 0.0 112.354 -174.149 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.858 HD22 HG23 ' A' ' 73' ' ' VAL . 18.4 tp -118.11 8.95 12.53 Favored 'General case' 0 N--CA 1.379 -3.983 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.695 -173.07 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.74 118.09 15.24 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.47 20.03 11.53 Favored Glycine 0 C--N 1.302 -1.326 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.035 -176.295 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.54 ' HB3' HD11 ' A' ' 47' ' ' ILE . . . -101.01 149.84 23.52 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.435 ' C ' HG11 ' A' ' 31' ' ' VAL . 14.9 t -99.14 174.88 6.11 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -50.34 -54.17 23.52 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.785 0.834 . . . . 0.0 111.172 -173.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 59.2 mtpt -63.45 -32.39 73.82 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.063 -176.004 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -72.34 -46.54 55.09 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.526 ' O ' HD13 ' A' ' 90' ' ' LEU . . . -54.88 -56.29 21.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.606 177.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.98 -29.32 46.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.932 -178.728 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 34.2 mm-40 -72.28 -26.85 62.14 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.967 177.799 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.1 m -72.78 -39.75 66.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.633 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.748 ' HG ' HG11 ' A' ' 97' ' ' VAL . 8.6 mp -69.97 -18.44 63.34 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.677 1.191 . . . . 0.0 110.883 176.752 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -82.15 -43.13 18.14 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.706 175.712 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -66.03 -36.07 82.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.316 -177.644 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -58.89 -55.22 37.89 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.368 -179.486 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 134.35 -142.73 14.24 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 178.764 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.516 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 58.9 tt0 -73.09 -55.76 6.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.063 0.459 . . . . 0.0 110.615 178.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 61.6 t -92.09 113.44 27.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.367 -179.396 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.748 HG11 ' HG ' ' A' ' 90' ' ' LEU . 3.0 t -105.66 128.0 60.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.011 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.532 ' CE1' ' HB3' ' A' ' 15' ' ' GLU . 34.9 t-80 -99.16 130.62 45.48 Favored 'General case' 0 C--N 1.258 -3.372 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.48 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 90' ' ' LEU . 5.2 mp -128.26 146.17 50.82 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.346 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.774 ' HG ' ' HG2' ' A' ' 15' ' ' GLU . 3.3 tt -98.91 112.67 24.71 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -177.758 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.619 HD13 HG12 ' A' ' 16' ' ' VAL . 9.9 mp -115.27 166.51 11.77 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.237 0.541 . . . . 0.0 111.727 -177.651 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -133.14 152.11 51.96 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 176.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.486 ' NZ ' ' HB3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -54.05 115.26 1.95 Allowed 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.543 0.687 . . . . 0.0 110.334 171.827 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 69' ' ' ARG . . . . . . . . 0 C--N 1.292 -1.902 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 176.793 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 11.4 t70 . . . . . 0 CA--C 1.503 -0.841 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 p -91.18 133.45 35.36 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.383 0.611 . . . . 0.0 111.902 -174.128 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -143.88 149.22 36.57 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.425 177.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -106.33 117.84 35.09 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.741 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.75 115.63 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.08 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.406 178.922 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.5 91.28 5.38 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.229 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.983 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -100.7 119.69 38.96 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.138 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.44 124.09 34.16 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.133 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.479 ' HG2' HD23 ' A' ' 25' ' ' LEU . 92.9 mttt -65.52 144.13 57.21 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.145 0.498 . . . . 0.0 111.607 -179.502 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.564 HG21 ' HG3' ' A' ' 55' ' ' LYS . 6.2 m -61.89 -42.1 98.67 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.568 177.139 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -163.05 -49.45 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.785 176.959 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.31 -9.24 0.68 Allowed Glycine 0 C--O 1.242 0.597 0 C-N-CA 119.524 -1.322 . . . . 0.0 113.538 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 m -132.73 150.64 52.13 Favored 'General case' 0 N--CA 1.433 -1.314 0 O-C-N 122.062 -0.669 . . . . 0.0 110.828 -175.798 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.622 HD12 HD23 ' A' ' 90' ' ' LEU . 72.6 mt -89.74 145.34 25.27 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 169.081 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.83 51.92 4.62 Favored Glycine 0 C--N 1.288 -2.116 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.902 -177.405 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.541 HD13 HD13 ' A' ' 64' ' ' ILE . 12.2 pt -140.58 142.29 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 CA-C-N 117.87 0.835 . . . . 0.0 111.904 177.569 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 t -117.53 140.95 48.93 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 175.495 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 49' ' ' VAL . 27.1 m -126.28 147.96 31.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.4 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 15.1 t -118.84 158.31 25.9 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 82' ' ' THR . 3.3 t . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -176.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.529 HD13 HG13 ' A' ' 31' ' ' VAL . 42.1 mm -101.53 133.44 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -176.811 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -129.25 120.3 25.48 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.34 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.491 HG21 ' CG2' ' A' ' 64' ' ' ILE . 28.6 t -47.84 113.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 122.036 0.922 . . . . 0.0 109.971 170.732 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.769 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 88.4 tttt -87.41 -37.95 16.57 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.994 -174.484 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.86 151.44 32.25 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.363 -176.285 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 47.4 mm -109.39 128.61 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 O-C-N 123.731 0.644 . . . . 0.0 109.444 178.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.93 133.58 20.97 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 175.629 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 55' ' ' LYS . 22.6 Cg_exo -65.59 -86.6 0.01 OUTLIER 'Trans proline' 0 C--O 1.255 1.349 0 C-N-CA 121.907 1.738 . . . . 0.0 111.57 176.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HG3' HG21 ' A' ' 21' ' ' THR . 17.8 tptp 65.04 -67.51 0.12 Allowed 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 127.605 2.362 . . . . 0.0 110.481 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.07 38.15 0.02 OUTLIER Glycine 0 C--N 1.277 -2.729 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -179.56 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.587 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -134.52 -99.39 0.25 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -174.738 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.983 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -68.71 -38.69 80.43 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -168.757 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.571 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 36.4 tt0 -84.54 -29.39 25.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.313 0.578 . . . . 0.0 110.162 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.8 m -71.92 -46.26 58.26 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.117 -177.114 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.57 -24.3 34.05 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.551 0.691 . . . . 0.0 109.853 178.631 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.08 53.43 14.55 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.263 175.046 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -98.96 -46.76 5.5 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.675 1.226 . . . . 0.0 109.345 178.544 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.541 HD13 HD13 ' A' ' 27' ' ' ILE . 39.8 mt -112.8 140.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-N 113.154 -1.839 . . . . 0.0 109.752 -171.706 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -133.87 154.93 50.7 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 176.273 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 144.25 56.36 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.48 -175.66 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.37 -16.45 38.08 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.975 -178.486 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -80.28 144.45 32.83 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-O 121.034 0.445 . . . . 0.0 111.081 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -90.93 137.33 32.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.813 -175.546 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 38.5 t -101.18 112.32 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 176.606 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.444 HD12 ' HG ' ' A' ' 100' ' ' LEU . 85.2 mt -85.29 -39.47 17.66 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.668 -177.352 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.707 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -163.37 175.06 11.2 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.144 -176.069 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.708 HG13 ' HG ' ' A' ' 99' ' ' LEU . 23.8 t -130.76 117.87 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.824 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 65.32 27.15 12.06 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.455 1.102 . . . . 0.0 110.093 176.63 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.87 -6.82 79.81 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.557 -177.017 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.21 105.06 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.838 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.612 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 47.6 m -62.07 130.79 47.14 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.355 -174.244 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.707 ' HG ' ' HA ' ' A' ' 72' ' ' ALA . 98.0 mt -87.74 40.54 0.94 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.797 0.808 . . . . 0.0 110.574 -178.093 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 77' ' ' SER . 36.2 mt-10 -76.3 112.27 12.62 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.01 32.37 17.79 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -175.435 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.54 177.78 5.06 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.977 0.894 . . . . 0.0 110.92 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.649 ' HA ' HG21 ' A' ' 31' ' ' VAL . 10.0 t -153.87 -179.52 7.92 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -50.7 -54.17 25.28 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.064 0.853 . . . . 0.0 110.142 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 40.7 ttmt -58.35 -43.6 88.41 Favored 'General case' 0 C--O 1.204 -1.298 0 O-C-N 123.596 0.56 . . . . 0.0 111.638 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.543 ' HG2' HG22 ' A' ' 82' ' ' THR . 13.1 mm-40 -66.23 -47.82 72.56 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.936 -176.427 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.529 ' O ' HD13 ' A' ' 90' ' ' LEU . . . -56.91 -57.37 12.8 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.749 178.052 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.48 -32.68 58.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.378 -175.869 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 53.0 mm-40 -76.44 -19.48 58.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.656 178.27 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 m -76.44 -35.51 58.45 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.622 HD23 HD12 ' A' ' 25' ' ' LEU . 8.7 mp -70.22 -22.14 62.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.622 0.769 . . . . 0.0 110.239 175.504 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -84.61 -31.09 24.45 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.572 0.701 . . . . 0.0 109.729 174.811 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -70.33 -42.37 72.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.565 178.31 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.6 p -65.07 152.97 42.13 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.88 177.107 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.67 -157.05 1.07 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 114.678 0.631 . . . . 0.0 114.678 -179.34 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.443 ' HG3' HG23 ' A' ' 96' ' ' VAL . 20.2 pt20 -68.02 -35.22 77.94 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.463 -0.368 . . . . 0.0 111.581 -177.105 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.443 HG23 ' HG3' ' A' ' 95' ' ' GLN . 48.4 t -105.2 108.52 25.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.095 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.6 t -99.95 134.5 39.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.105 -173.88 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -104.29 128.09 52.02 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.359 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.708 ' HG ' HG13 ' A' ' 73' ' ' VAL . 5.4 mp -123.89 145.29 49.22 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 172.789 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 56.5 tp -91.82 109.18 20.51 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 mp -117.66 160.2 21.69 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.401 0.62 . . . . 0.0 110.42 -177.633 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 9.4 pt-20 -131.69 156.6 45.59 Favored 'General case' 0 C--N 1.264 -3.111 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 170.189 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.45 117.1 6.23 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.215 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.637 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.693 -176.118 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 . . . . . 0 CA--C 1.488 -1.405 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 p -101.9 145.08 29.72 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 165.959 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -149.04 153.76 38.34 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.433 -176.191 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -103.47 133.46 48.47 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 179.145 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 64' ' ' ILE . 11.0 p -131.56 132.47 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.143 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.5 ' HG3' ' HD2' ' A' ' 98' ' ' HIS . 49.1 mt-10 -101.46 85.43 2.77 Favored 'General case' 0 CA--C 1.472 -2.039 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 174.582 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -77.32 120.91 23.0 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.624 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.74 123.61 36.14 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.243 -175.778 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -68.49 112.48 5.33 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.509 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 t -111.35 89.01 2.93 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.196 -175.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 t70 79.76 -40.37 0.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.797 -1.547 . . . . 0.0 113.641 178.259 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.76 -98.5 0.99 Allowed Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.489 -0.863 . . . . 0.0 114.078 -179.275 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.0 m -162.65 -162.17 0.77 Allowed 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 -173.264 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.797 HD11 ' HB3' ' A' ' 18' ' ' LEU . 1.6 tp -89.34 109.38 20.29 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 171.514 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.586 ' HA3' ' O ' ' A' ' 56' ' ' GLY . . . -75.07 50.85 2.36 Favored Glycine 0 C--N 1.292 -1.866 0 CA-C-N 114.697 -1.138 . . . . 0.0 115.383 -172.917 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.504 HG21 HG21 ' A' ' 64' ' ' ILE . 10.7 pt -130.11 122.11 53.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 121.749 0.785 . . . . 0.0 111.071 177.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.531 ' HB2' HD11 ' A' ' 53' ' ' ILE . 7.7 t -94.86 124.99 39.23 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 -178.087 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 83' ' ' HIS . 33.7 m -118.67 156.56 20.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 120.687 0.28 . . . . 0.0 111.41 -174.39 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.421 HG22 ' HB2' ' A' ' 50' ' ' LYS . 10.2 t -141.74 159.37 42.35 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.398 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.591 ' CG2' HD13 ' A' ' 47' ' ' ILE . 21.4 t . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 120.915 0.388 . . . . 0.0 110.797 177.012 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.44 0 N-CA-C 115.477 0.951 . . . . 0.0 115.477 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.648 ' HB ' HG22 ' A' ' 70' ' ' VAL . 18.0 mm -100.33 147.22 7.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -164.534 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -129.43 107.68 9.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.94 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.4 t -48.15 121.76 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.608 0.718 . . . . 0.0 110.521 169.075 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.421 ' HB2' HG22 ' A' ' 30' ' ' THR . 85.5 tttt -92.63 -37.31 12.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.702 -178.598 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.85 161.83 34.54 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.825 -175.217 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 20.1 mm -116.08 125.73 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.531 HD11 ' HB2' ' A' ' 28' ' ' SER . 2.0 mp -76.48 134.28 70.0 Favored Pre-proline 0 C--N 1.302 -1.469 0 C-N-CA 122.573 0.349 . . . . 0.0 111.473 -176.813 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.65 130.62 36.11 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 123.107 2.538 . . . . 0.0 110.034 175.634 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 69.74 -4.99 1.29 Allowed 'General case' 0 C--O 1.249 1.043 0 CA-C-O 122.006 0.907 . . . . 0.0 110.654 -177.207 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.586 ' O ' ' HA3' ' A' ' 26' ' ' GLY . . . -85.48 68.34 3.45 Favored Glycine 0 N--CA 1.403 -3.551 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.209 -175.9 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 58.82 -75.41 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.698 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 167.739 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.677 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -58.12 -35.11 70.98 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 125.219 1.407 . . . . 0.0 113.342 -171.793 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.512 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 34.7 tt0 -85.64 -39.96 16.72 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.032 0.444 . . . . 0.0 110.138 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -68.52 -37.32 79.94 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.282 -177.678 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -82.62 -34.61 27.52 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.714 177.295 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.89 52.02 3.81 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.688 -0.687 . . . . 0.0 114.242 175.256 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -116.58 -56.8 2.25 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.24 0.543 . . . . 0.0 111.658 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.559 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 21.2 mm -84.07 145.52 8.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.11 -176.635 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -125.33 162.61 24.38 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.252 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -77.97 143.1 37.87 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.42 -179.005 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.488 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 103.74 -28.0 17.28 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.478 -179.395 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.756 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 39.5 m-20 -64.53 146.91 53.87 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.687 0.756 . . . . 0.0 111.825 -176.709 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . 59.9 mtp180 -96.84 146.53 24.83 Favored 'General case' 0 CA--C 1.461 -2.456 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.017 -173.964 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.648 HG22 ' HB ' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -112.74 123.79 68.77 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.132 0 CA-C-N 114.229 -1.35 . . . . 0.0 107.461 176.191 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HB2' HD12 ' A' ' 100' ' ' LEU . 65.9 mt -107.96 -24.23 11.7 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.792 -176.195 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -169.06 173.23 6.98 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.927 -176.032 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' HG ' ' A' ' 99' ' ' LEU . 99.4 t -130.29 116.98 38.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 173.56 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 98' ' ' HIS 0.265 1.5 p-10 51.31 38.43 21.5 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.331 1.453 . . . . 0.0 112.513 -177.648 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.79 -8.02 77.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 119.928 -1.129 . . . . 0.0 113.881 -179.052 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.54 106.03 14.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 49.7 m -63.91 136.79 57.65 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.122 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.705 HD11 HG23 ' A' ' 73' ' ' VAL . 81.3 mt -118.95 16.85 13.4 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.584 178.355 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.38 119.47 12.27 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.472 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.5 15.16 58.91 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.301 -177.266 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.78 159.13 15.09 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 117.474 0.637 . . . . 0.0 109.587 179.42 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.9 t -97.0 158.78 15.26 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 171.228 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.571 ' HB2' HG23 ' A' ' 29' ' ' VAL 0.272 8.4 p80 -51.1 -45.4 61.49 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -172.197 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.58 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -64.56 -32.4 74.03 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.614 -178.651 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -67.14 -37.67 84.21 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.676 0.75 . . . . 0.0 109.718 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -63.61 -46.59 85.05 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.565 176.693 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.5 t -64.37 -34.44 69.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.985 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.137 -178.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.58 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 45.6 mt-10 -60.01 -47.34 86.24 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.77 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 93' ' ' THR . 14.0 m -60.7 -39.28 87.94 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.974 0.892 . . . . 0.0 109.739 178.99 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 25' ' ' LEU . 4.2 tp -79.27 -9.8 59.66 Favored 'General case' 0 N--CA 1.413 -2.279 0 C-N-CA 124.224 1.01 . . . . 0.0 110.431 -177.105 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -101.13 -18.11 16.35 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.828 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -92.71 -11.8 33.07 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.817 179.456 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 89' ' ' THR . 32.1 p -73.16 -177.82 2.65 Favored 'General case' 0 C--O 1.252 1.195 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.407 173.281 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.52 -123.25 2.63 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.166 178.736 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -98.15 -45.86 6.06 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.583 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.8 m -95.9 118.07 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.658 0 CA-C-O 121.655 0.74 . . . . 0.0 109.374 176.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.523 HG21 HD12 ' A' ' 90' ' ' LEU . 45.8 t -101.15 113.3 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.481 -178.748 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.5 ' HD2' ' HG3' ' A' ' 17' ' ' GLU . 17.3 t-80 -84.31 58.35 4.76 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.184 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.815 ' HG ' HG22 ' A' ' 73' ' ' VAL . 3.8 tt -70.58 142.55 51.72 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.703 -172.42 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.592 HD12 ' HB2' ' A' ' 71' ' ' LEU . 3.0 tm? -101.77 114.3 28.24 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.475 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.48 HD13 HG12 ' A' ' 16' ' ' VAL . 7.7 mp -111.3 166.43 11.11 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.502 0.668 . . . . 0.0 112.758 -177.199 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 69' ' ' ARG . 36.5 tt0 -132.38 151.32 51.91 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.548 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.424 ' HD3' ' C ' ' A' ' 103' ' ' LYS . 11.3 tmtt? -44.44 123.84 3.78 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 124.1 0.96 . . . . 0.0 111.811 171.889 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.756 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 C--N 1.295 -1.701 0 C-N-CA 119.605 -1.283 . . . . 0.0 111.312 171.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 20.9 t0 . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.3 p -91.09 144.92 25.13 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 123.899 0.749 . . . . 0.0 112.74 -174.762 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.553 ' HE1' ' HG2' ' A' ' 103' ' ' LYS . 17.8 p90 -168.82 134.44 1.69 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.291 175.856 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 46.1 mt-10 -88.11 104.01 16.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.657 0.742 . . . . 0.0 109.592 175.766 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 5.0 t -71.82 138.85 20.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.647 -178.23 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.18 95.25 5.99 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 173.303 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.711 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -102.5 125.88 49.36 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -174.333 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -97.47 143.72 27.9 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.525 0.678 . . . . 0.0 111.849 -177.372 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 1.2 mptm? -71.73 93.13 1.25 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 124.938 1.295 . . . . 0.0 112.417 176.393 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.444 HG22 ' HB2' ' A' ' 57' ' ' ALA . 13.3 t -64.88 -30.15 71.13 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-O 121.755 0.788 . . . . 0.0 109.466 169.019 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 16.4 t70 -112.13 -155.85 0.58 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -178.676 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.41 17.39 58.56 Favored Glycine 0 C--N 1.299 -1.518 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 176.155 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -155.65 174.75 14.83 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -177.884 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 18' ' ' LEU . 11.6 tp -94.14 150.31 20.44 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -178.256 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.624 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -81.26 41.52 2.65 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.173 -174.311 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.4 pt -137.39 130.93 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-O 121.625 0.726 . . . . 0.0 111.941 177.512 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.609 ' HB2' HD11 ' A' ' 53' ' ' ILE . 48.5 t -99.25 124.23 44.15 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.763 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 49' ' ' VAL . 29.7 m -118.62 152.4 20.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.458 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.541 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 7.6 t -131.93 171.62 13.35 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.934 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.513 HG22 ' CD1' ' A' ' 47' ' ' ILE . 2.5 t . . . . . 0 C--N 1.303 -1.426 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.426 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.602 0 CA-C-O 120.253 -0.193 . . . . 0.0 113.177 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.513 ' CD1' HG22 ' A' ' 31' ' ' VAL . 38.0 mm -101.13 126.86 54.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.097 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.732 ' CE1' ' HG2' ' A' ' 69' ' ' ARG . 61.5 m-85 -132.85 124.17 27.45 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.953 -176.844 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.458 HG21 ' CG2' ' A' ' 64' ' ' ILE . 41.0 t -48.32 118.97 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 CA-C-O 121.547 0.689 . . . . 0.0 110.586 172.456 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -92.51 -35.46 13.6 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.97 -176.736 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.33 165.75 30.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.818 -177.294 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.946 HG21 ' HB2' ' A' ' 59' ' ' GLU . 42.6 mm -110.75 116.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.624 ' HB ' ' HA2' ' A' ' 26' ' ' GLY . 47.4 mm -70.43 116.88 49.63 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.851 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 6.9 Cg_exo -75.4 77.85 3.15 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 123.721 2.947 . . . . 0.0 114.015 -175.846 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HD3' HG22 ' A' ' 53' ' ' ILE . 2.1 mptm? -122.53 -23.61 5.14 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.697 170.685 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.647 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 116.62 43.93 0.61 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.479 -179.207 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . . . -117.94 -87.92 0.62 Allowed 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 117.214 0.507 . . . . 0.0 110.897 -177.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.711 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -77.09 -27.85 54.34 Favored 'General case' 0 C--O 1.257 1.498 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -171.278 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.946 ' HB2' HG21 ' A' ' 52' ' ' ILE . 40.9 tt0 -83.0 -33.3 26.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.402 0.62 . . . . 0.0 109.808 -179.721 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.647 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 7.4 m -81.84 -26.89 33.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.559 0.695 . . . . 0.0 109.228 -178.373 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.1 -41.19 59.2 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.072 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.08 39.79 9.07 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.072 -1.422 . . . . 0.0 114.579 170.92 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -120.42 -45.53 2.42 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.067 178.815 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.557 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 60.5 mt -94.02 132.16 38.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.003 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.488 ' HA ' HD11 ' A' ' 52' ' ' ILE . 16.4 t-80 -135.43 -174.87 3.75 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.962 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -73.54 131.53 41.85 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.27 0.557 . . . . 0.0 110.501 -176.099 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.03 -17.39 35.12 Favored Glycine 0 N--CA 1.425 -2.085 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.756 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.488 ' HB3' HD23 ' A' ' 101' ' ' LEU . 11.3 m-20 -63.89 136.02 57.03 Favored 'General case' 0 C--O 1.261 1.666 0 CA-C-O 122.031 0.92 . . . . 0.0 112.783 -177.512 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.732 ' HG2' ' CE1' ' A' ' 48' ' ' TYR . 41.8 mtp180 -86.17 118.79 25.85 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.373 -173.026 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.55 108.81 20.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.465 178.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 102' ' ' GLU . 66.8 mt -86.79 -41.79 13.81 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.83 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -160.4 177.19 10.83 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.607 -175.778 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 1.147 HG11 HG21 ' A' ' 89' ' ' THR . 2.9 p -128.95 102.17 7.55 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 C-N-CA 124.106 0.962 . . . . 0.0 109.51 177.426 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.7 t30 51.78 57.21 6.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.186 0.993 . . . . 0.0 109.897 179.536 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.47 -38.31 3.02 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 114.484 -1.235 . . . . 0.0 114.146 -178.01 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.473 ' HB ' HG13 ' A' ' 73' ' ' VAL . 43.2 t -72.84 111.57 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.066 0.933 . . . . 0.0 109.773 -175.845 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.3 p -81.59 113.45 19.62 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.298 0.571 . . . . 0.0 111.265 -178.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.869 HD23 ' H ' ' A' ' 78' ' ' LEU 0.269 0.7 OUTLIER -88.28 92.63 9.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 122.29 1.043 . . . . 0.0 108.957 176.865 . . . . . . . . 4 4 . 1 . 028 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -101.1 111.08 23.2 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.79 -169.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.8 46.31 94.29 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -177.11 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.605 ' HB1' ' HG3' ' A' ' 85' ' ' GLN . . . -89.73 167.16 13.1 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 -177.357 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 85' ' ' GLN . 70.8 p -79.7 144.99 33.19 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.725 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 11.1 p-80 -53.08 -37.45 61.68 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.388 0.613 . . . . 0.0 110.021 173.195 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 58.3 tttm -54.41 -54.54 39.32 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.297 -1.32 . . . . 0.0 110.633 173.364 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.605 ' HG3' ' HB1' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -72.51 -28.71 63.04 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.227 -175.624 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.67 -52.12 64.92 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.779 0.8 . . . . 0.0 109.388 174.048 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.65 -28.43 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.933 177.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 63.2 mm-40 -64.54 -35.8 82.14 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 176.079 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' THR . . . . . 1.147 HG21 HG11 ' A' ' 73' ' ' VAL . 23.1 m -69.03 -32.72 72.42 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.374 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.4 mt -72.12 -19.75 61.74 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.849 177.913 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -102.76 -6.12 22.96 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.167 175.265 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -90.33 -20.92 22.34 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 122.481 1.134 . . . . 0.0 108.435 178.138 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.574 HG21 HG13 ' A' ' 97' ' ' VAL . 2.2 p -83.07 171.12 14.09 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.486 -1.233 . . . . 0.0 109.923 176.917 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.22 -149.18 11.07 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.222 -176.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.624 ' HG3' HG23 ' A' ' 96' ' ' VAL . 3.7 pt20 -69.03 -36.64 77.96 Favored 'General case' 0 C--O 1.207 -1.176 0 CA-C-O 120.823 0.344 . . . . 0.0 110.787 -178.861 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.624 HG23 ' HG3' ' A' ' 95' ' ' GLN . 59.0 t -116.44 118.83 60.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.342 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.574 HG13 HG21 ' A' ' 93' ' ' THR . 40.1 t -100.53 130.1 50.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.082 -177.784 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 97.8 m-70 -93.99 117.17 29.74 Favored 'General case' 0 C--N 1.272 -2.802 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 172.333 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.795 HD23 HD11 ' A' ' 101' ' ' LEU . 5.2 tp -120.76 133.07 55.35 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -176.676 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 45.9 tp -89.84 112.52 23.89 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -176.4 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.795 HD11 HD23 ' A' ' 99' ' ' LEU . 7.1 mp -124.06 165.56 17.28 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.329 0.585 . . . . 0.0 110.569 -179.577 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.776 ' HB2' HD11 ' A' ' 71' ' ' LEU . 28.3 tt0 -131.63 127.99 38.16 Favored 'General case' 0 N--CA 1.397 -3.079 0 N-CA-C 102.646 -3.094 . . . . 0.0 102.646 174.525 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.922 ' HE2' ' HA ' ' A' ' 103' ' ' LYS . 4.4 mmpt? -46.43 110.01 0.24 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -177.609 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.631 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.217 -175.418 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 18.2 t70 . . . . . 0 N--CA 1.439 -0.991 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 5.6 p -100.81 119.27 38.4 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 123.945 0.778 . . . . 0.0 110.346 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -150.72 145.84 26.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.555 -178.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.489 ' HG3' HD23 ' A' ' 100' ' ' LEU . 50.0 mt-10 -77.61 97.04 4.95 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.394 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 12.6 p -75.08 138.92 19.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.289 -178.684 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -107.0 114.56 28.71 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.939 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -115.34 124.03 50.24 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.659 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.67 111.59 23.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 99.1 mttt -58.65 153.12 17.12 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.86 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.818 HG23 ' H ' ' A' ' 23' ' ' GLY . 9.0 t -93.93 -164.86 1.23 Allowed 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 171.845 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.47 4.66 17.51 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 118.816 0.735 . . . . 0.0 110.718 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.818 ' H ' HG23 ' A' ' 21' ' ' THR . . . -140.03 56.37 0.62 Allowed Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.007 179.363 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.316 80.3 p 74.9 -176.63 0.15 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 126.404 1.882 . . . . 0.0 115.715 172.47 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.743 HD22 ' HB3' ' A' ' 18' ' ' LEU . 69.6 mt -65.78 -16.98 64.3 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -177.095 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.535 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . 78.52 24.84 62.08 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 178.372 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.529 HG21 HG21 ' A' ' 64' ' ' ILE . 19.3 pt -136.64 123.23 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 CA-C-O 121.992 0.901 . . . . 0.0 112.395 177.853 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 69.8 m -100.34 121.18 41.08 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 113.347 -1.752 . . . . 0.0 108.247 177.769 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 49' ' ' VAL . 32.0 m -114.73 152.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.269 -173.816 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 t -129.35 155.66 45.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.137 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 82' ' ' THR . 8.5 t . . . . . 0 C--N 1.297 -1.68 0 CA-C-N 119.242 0.928 . . . . 0.0 109.219 179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.12 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.932 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 43.0 mm -101.27 146.38 9.77 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.356 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.518 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 53.6 t80 -131.77 110.23 10.71 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -174.835 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.505 ' HA ' HG12 ' A' ' 29' ' ' VAL . 42.1 t -52.3 114.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 171.683 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -94.64 -32.8 13.23 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.805 -173.649 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 28' ' ' SER . . . -149.17 143.07 25.71 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -176.466 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.653 HG22 ' HB2' ' A' ' 59' ' ' GLU . 45.8 mm -104.83 125.21 59.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.261 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.535 ' HB ' ' HA2' ' A' ' 26' ' ' GLY . 30.0 mm -99.49 135.24 20.7 Favored Pre-proline 0 C--N 1.289 -2.029 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.033 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.12 -155.75 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.32 2.68 . . . . 0.0 112.448 174.912 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? 97.36 -44.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.629 1.572 . . . . 0.0 111.232 171.66 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . 156.2 35.52 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 118.12 -1.99 . . . . 0.0 115.452 176.337 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -129.51 -105.8 0.29 Allowed 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.348 177.595 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.939 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -62.87 -35.55 80.38 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -173.437 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.653 ' HB2' HG22 ' A' ' 52' ' ' ILE . 39.4 tt0 -86.43 -26.31 24.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.232 0.539 . . . . 0.0 109.789 -178.156 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.7 t -79.27 -46.17 18.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.812 -178.457 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.57 -31.0 66.5 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.674 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.51 44.41 8.62 Favored Glycine 0 CA--C 1.499 -0.954 0 CA-C-N 114.18 -1.373 . . . . 0.0 114.267 170.77 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -108.99 -62.34 1.49 Allowed 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.406 178.33 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.576 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 25.8 mm -72.11 137.37 23.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.648 -173.227 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -122.32 151.08 41.5 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 173.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 133.91 46.11 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.782 178.518 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.518 ' HA2' ' CZ ' ' A' ' 48' ' ' TYR . . . 111.64 -18.58 24.66 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -172.637 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.502 ' HB3' HD23 ' A' ' 101' ' ' LEU . 89.4 m-20 -66.41 131.23 45.62 Favored 'General case' 0 C--O 1.252 1.206 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.592 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 73.0 mtm-85 -93.12 138.07 31.89 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.86 0.838 . . . . 0.0 111.21 -177.439 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.932 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 49.2 t -99.75 111.84 30.49 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.972 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 102' ' ' GLU . 48.2 mt -95.06 -33.68 12.6 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.633 -175.404 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -162.56 176.36 10.48 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.927 -177.635 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 1.07 HG11 HG21 ' A' ' 89' ' ' THR . 3.1 p -123.97 112.37 32.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 125.172 1.389 . . . . 0.0 107.793 175.187 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.9 p30 50.51 29.33 3.92 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 125.008 1.323 . . . . 0.0 113.582 177.141 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.05 -19.13 41.42 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.1 -177.219 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.521 ' HB ' HG13 ' A' ' 73' ' ' VAL . 52.5 t -86.19 113.86 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.0 m -61.97 136.69 58.07 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.317 0.579 . . . . 0.0 112.517 -175.589 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.493 HD11 ' HB ' ' A' ' 73' ' ' VAL . 76.2 mt -114.21 32.21 6.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.204 -178.708 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.51 113.28 22.3 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.108 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.97 16.43 35.76 Favored Glycine 0 C--N 1.303 -1.255 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.53 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.24 146.35 26.99 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -179.675 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.558 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 23.0 p -82.76 162.63 21.67 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 173.993 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -52.27 -42.95 64.14 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.063 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -61.09 -39.96 91.91 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.332 178.512 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.558 ' HG2' ' OG1' ' A' ' 82' ' ' THR . 14.7 mm100 -67.07 -47.14 72.2 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.206 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.3 -48.95 77.6 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.379 178.221 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.82 -28.66 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.122 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.48 -43.01 86.58 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.811 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' THR . . . . . 1.07 HG21 HG11 ' A' ' 73' ' ' VAL . 28.5 m -64.87 -34.34 78.14 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.589 176.748 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 68.7 mt -74.52 -17.95 60.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.23 0.538 . . . . 0.0 110.972 -178.645 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -94.02 -33.16 13.53 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.363 0.602 . . . . 0.0 110.296 174.699 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -75.85 -19.8 58.61 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.955 -178.106 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -75.94 -77.59 0.13 Allowed 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 171.84 -149.74 12.33 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.527 -179.301 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.481 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 46.1 tt0 -88.75 -39.94 13.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.711 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.58 104.76 16.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.042 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.492 HG23 HD21 ' A' ' 25' ' ' LEU . 3.5 t -106.2 142.38 19.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.429 -174.953 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 78.4 m80 -110.27 127.95 55.27 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.481 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.663 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 5.8 mp -129.03 150.22 50.52 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.156 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.4 tm? -98.82 111.04 23.55 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 68' ' ' ASP . 10.5 mp -119.48 169.74 9.77 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.136 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.557 ' HB2' HD11 ' A' ' 71' ' ' LEU . 34.0 tt0 -130.45 128.23 40.86 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 172.626 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.512 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 26.5 tptt -59.03 123.79 17.76 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 123.991 0.807 . . . . 0.0 109.748 -177.369 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.043 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.575 -173.657 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 32.4 t70 . . . . . 0 CA--C 1.492 -1.266 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.2 p -103.42 126.15 50.42 Favored 'General case' 0 N--CA 1.413 -2.311 0 O-C-N 124.531 1.144 . . . . 0.0 110.35 178.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -137.02 160.61 38.43 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.836 -177.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -107.71 97.54 7.26 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 176.435 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.407 HG12 HD13 ' A' ' 101' ' ' LEU . 13.3 p -76.03 134.39 29.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.119 -176.86 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -91.71 97.69 11.17 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.1 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.624 HD11 ' HB1' ' A' ' 57' ' ' ALA . 2.4 tm? -101.76 111.35 23.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.02 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.67 118.9 31.99 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.285 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HE2' ' CD2' ' A' ' 25' ' ' LEU . 94.1 mttt -52.67 119.34 4.44 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 122.032 0.92 . . . . 0.0 112.811 -177.711 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.828 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 93.1 m -120.57 103.71 9.37 Favored 'General case' 0 N--CA 1.403 -2.824 0 CA-C-N 113.687 -1.597 . . . . 0.0 108.184 -175.61 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 t70 62.05 -73.51 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 177.263 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.97 26.47 12.83 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 20' ' ' LYS 0.27 87.5 p 62.68 -98.45 0.07 Allowed 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.974 1.31 . . . . 0.0 112.881 178.922 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.638 ' HG ' HD13 ' A' ' 90' ' ' LEU . 2.7 mm? -100.92 110.38 22.43 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 118.63 0.65 . . . . 0.0 109.368 175.547 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.512 ' H ' ' HB3' ' A' ' 57' ' ' ALA . . . -84.25 36.07 2.94 Favored Glycine 0 C--N 1.295 -1.713 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.274 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.456 HD13 HG21 ' A' ' 27' ' ' ILE . 14.6 pt -125.4 121.13 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.903 0 CA-C-O 121.886 0.85 . . . . 0.0 112.085 -176.428 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.9 t -86.94 119.94 27.68 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 177.935 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.54 149.78 31.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.54 -173.487 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 t -128.63 179.6 5.59 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 172.368 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.467 HG12 HD13 ' A' ' 47' ' ' ILE . 8.9 m . . . . . 0 C--N 1.3 -1.556 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 174.786 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.321 0 CA-C-O 120.983 0.213 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.009 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 47.1 mm -116.85 156.16 18.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 C-N-CA 123.307 0.643 . . . . 0.0 109.807 -172.776 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -135.62 109.56 8.18 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 123.736 0.814 . . . . 0.0 109.562 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -51.25 109.46 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.861 0 CA-C-O 122.247 1.022 . . . . 0.0 110.623 171.184 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -80.65 -40.83 24.87 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 113.699 -1.591 . . . . 0.0 109.255 -176.944 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -160.23 161.58 33.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.246 -176.757 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.593 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 38.7 mm -115.75 139.8 40.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.503 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.6 mm -95.6 141.73 23.6 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -177.297 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.81 137.97 71.33 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.4 2.067 . . . . 0.0 109.483 171.869 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 5.2 tppp? 59.44 21.26 9.66 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 123.472 1.606 . . . . 0.0 108.393 -172.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.501 ' C ' ' HA3' ' A' ' 26' ' ' GLY . . . -109.18 81.84 0.29 Allowed Glycine 0 N--CA 1.396 -3.999 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.528 -175.178 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.828 ' HA ' ' HB ' ' A' ' 21' ' ' THR . . . 32.56 -72.45 0.0 OUTLIER 'General case' 0 C--O 1.186 -2.265 0 C-N-CA 127.817 2.447 . . . . 0.0 116.264 171.597 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -55.56 -32.11 62.73 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.734 0.814 . . . . 0.0 111.753 -177.647 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.593 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 6.5 tp10 -89.44 -37.87 14.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.172 0.511 . . . . 0.0 109.662 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 m -74.04 -44.73 53.3 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.49 -175.637 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -76.44 -36.77 57.78 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.672 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.76 59.56 1.5 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.833 176.543 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.419 ' HB2' ' H ' ' A' ' 64' ' ' ILE . 14.4 mmt180 -121.53 -87.02 0.65 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.619 0.723 . . . . 0.0 110.409 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.455 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 53.1 mt -74.94 146.52 9.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.961 -176.351 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -129.95 172.57 11.57 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.683 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.608 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 35.8 mtmm -71.84 126.29 29.35 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 -177.615 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 120.15 -28.13 6.45 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.046 -1.073 . . . . 0.0 113.17 177.864 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.693 ' HB3' HD23 ' A' ' 101' ' ' LEU . 28.9 m-20 -64.45 133.34 52.29 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 122.043 0.925 . . . . 0.0 112.782 -176.183 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -91.88 135.4 33.96 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.127 -175.37 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.009 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 60.8 t -105.66 125.14 61.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -174.068 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.819 ' HB2' HD12 ' A' ' 100' ' ' LEU . 67.9 mt -104.64 -21.6 13.38 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.971 -177.313 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.748 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -168.35 167.62 11.87 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.044 0.449 . . . . 0.0 112.086 -177.787 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.687 ' HA ' HD12 ' A' ' 99' ' ' LEU . 46.7 t -120.83 117.88 54.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 174.412 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.353 30.7 p-10 38.44 63.4 0.87 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.411 1.484 . . . . 0.0 114.859 -179.375 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.05 -21.4 3.38 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.004 -0.998 . . . . 0.0 114.861 178.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.31 100.08 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.714 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 20.0 m -58.1 132.27 53.02 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.261 -178.28 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.748 ' HG ' ' HA ' ' A' ' 72' ' ' ALA . 74.5 mt -93.33 80.25 4.42 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.105 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -77.42 -30.16 53.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.49 -171.434 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.26 58.68 0.31 Allowed Glycine 0 CA--C 1.474 -2.53 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.67 138.07 40.06 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.178 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.749 HG22 ' HG2' ' A' ' 85' ' ' GLN . 14.6 t -85.05 161.35 19.75 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 171.045 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.429 ' HA ' HD12 ' A' ' 47' ' ' ILE 0.287 10.6 p80 -50.89 -41.67 58.51 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.431 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -67.85 -24.02 65.21 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 177.466 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.749 ' HG2' HG22 ' A' ' 82' ' ' THR . 30.1 mm-40 -70.8 -40.75 72.34 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.619 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.554 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -62.61 -45.06 94.59 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.463 176.498 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.426 ' HA ' HD12 ' A' ' 90' ' ' LEU . 91.6 t -69.03 -34.37 63.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.351 -177.645 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 85' ' ' GLN . 7.9 pt-20 -71.59 -27.89 63.44 Favored 'General case' 0 C--O 1.217 -0.623 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.193 178.404 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.8 m -72.74 -25.72 61.31 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.084 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.638 HD13 ' HG ' ' A' ' 25' ' ' LEU . 96.0 mt -79.41 -23.33 43.29 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.659 0.742 . . . . 0.0 109.727 174.592 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -79.12 -38.29 36.51 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.756 175.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.92 -36.52 82.43 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.317 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 p -69.56 159.23 33.75 Favored 'General case' 0 C--O 1.252 1.225 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.26 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.93 -129.32 0.29 Allowed Glycine 0 C--N 1.33 0.222 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.816 -175.268 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -87.78 -44.91 10.78 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.344 0.592 . . . . 0.0 110.436 -178.414 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.38 119.43 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 C-N-CA 118.824 -1.15 . . . . 0.0 110.053 -178.791 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.411 HG11 ' CD2' ' A' ' 90' ' ' LEU . 22.8 t -103.19 126.27 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.372 -176.616 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -94.43 115.71 27.94 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 174.686 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.687 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.0 tp -113.09 136.16 53.01 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.793 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.819 HD12 ' HB2' ' A' ' 71' ' ' LEU . 2.6 tm? -89.28 109.98 20.8 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 -176.343 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.693 HD23 ' HB3' ' A' ' 68' ' ' ASP . 11.0 mp -122.79 165.2 16.99 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.836 0.827 . . . . 0.0 112.673 -175.799 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 41.3 tt0 -131.74 142.66 49.84 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 174.859 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -51.53 130.0 26.8 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 177.0 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . . . . . . 0 N--CA 1.422 -2.267 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.457 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.594 ' HG2' ' HB2' ' A' ' 12' ' ' ASP . 20.2 ptmt . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.83 55.9 2.3 Favored 'Trans proline' 0 CA--C 1.554 1.516 0 C-N-CA 122.634 2.222 . . . . 0.0 113.145 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.94 35.85 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 22.7 t0 -101.82 148.57 25.14 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.461 -0.369 . . . . 0.0 110.462 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 37.5 p -91.04 115.45 28.03 Favored 'General case' 0 N--CA 1.413 -2.295 0 O-C-N 123.858 0.724 . . . . 0.0 110.458 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.479 ' CE1' ' HD2' ' A' ' 103' ' ' LYS . 16.4 p90 -125.67 116.8 22.24 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.061 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 45.3 mt-10 -77.96 92.54 4.32 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.709 0.766 . . . . 0.0 109.397 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.486 HG11 HD11 ' A' ' 64' ' ' ILE . 9.6 p -74.81 138.13 21.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.269 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -96.45 96.29 8.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.841 HD11 ' HB1' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -96.6 111.11 23.38 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -176.167 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.96 130.39 40.08 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.101 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.452 ' HE2' ' HG ' ' A' ' 25' ' ' LEU . 94.9 mttt -86.01 127.87 34.74 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.729 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 t -77.63 -42.06 36.26 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -164.84 -68.8 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.11 0.481 . . . . 0.0 110.36 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.21 60.56 4.87 Favored Glycine 0 C--O 1.246 0.882 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.971 -173.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 89.8 p 62.01 -170.34 0.17 Allowed 'General case' 0 C--O 1.246 0.919 0 C-N-CA 126.521 1.928 . . . . 0.0 113.14 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.654 HD22 HD12 ' A' ' 18' ' ' LEU . 92.2 mt -68.65 150.68 47.68 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.155 0.502 . . . . 0.0 109.883 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.15 6.47 82.57 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.826 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.481 HG22 HG13 ' A' ' 52' ' ' ILE . 15.7 pt -103.52 128.98 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.754 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.255 -178.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.411 ' HB2' HD13 ' A' ' 53' ' ' ILE . 32.2 t -98.34 114.64 27.03 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 49' ' ' VAL . 35.0 m -112.2 157.81 12.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.364 -175.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.64 HG21 ' HD1' ' A' ' 33' ' ' PHE . 12.9 t -127.27 161.89 27.51 Favored 'General case' 0 N--CA 1.396 -3.134 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.667 HG13 ' H ' ' A' ' 32' ' ' LEU . 2.0 p -73.1 -62.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.775 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.667 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -170.82 124.19 0.65 Allowed 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 173.07 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.64 ' HD1' HG21 ' A' ' 30' ' ' THR . 9.4 p90 -85.58 109.05 18.26 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 172.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.55 99.36 0.14 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -135.87 25.36 3.34 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.18 -111.76 3.83 Favored Glycine 0 N--CA 1.425 -2.045 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.242 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.57 131.01 1.89 Allowed Glycine 0 N--CA 1.425 -2.075 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.442 HG23 HD22 ' A' ' 39' ' ' ASN . 27.2 m -78.7 1.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.071 0.462 . . . . 0.0 111.961 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.442 HD22 HG23 ' A' ' 38' ' ' VAL . 8.5 p30 -166.17 -30.93 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 123.589 0.756 . . . . 0.0 110.182 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -130.25 101.13 5.64 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.046 0.451 . . . . 0.0 111.579 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.1 m -105.17 -46.26 4.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.371 0.605 . . . . 0.0 109.766 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.0 -25.01 14.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.871 0.843 . . . . 0.0 108.934 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -95.79 154.88 17.0 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -66.02 149.55 50.08 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.278 0.561 . . . . 0.0 111.319 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.649 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . -86.14 163.37 36.03 Favored Glycine 0 N--CA 1.415 -2.734 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 176.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.49 -98.19 2.51 Favored Glycine 0 N--CA 1.419 -2.496 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.831 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 33.8 mm -141.39 147.89 21.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 176.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.503 ' CE1' ' HG ' ' A' ' 32' ' ' LEU . 67.6 m-85 -129.66 139.42 51.4 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 118.533 0.606 . . . . 0.0 111.715 177.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.59 ' HA ' HG12 ' A' ' 29' ' ' VAL . 44.1 t -74.67 116.48 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 173.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -85.02 -37.06 20.83 Favored 'General case' 0 C--N 1.284 -2.283 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.29 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -165.38 163.97 19.77 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.538 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.933 HG21 ' HB2' ' A' ' 59' ' ' GLU . 1.9 mp -116.96 124.19 72.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.43 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 2.0 mp -108.05 128.57 25.5 Favored Pre-proline 0 C--N 1.293 -1.863 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -17.25 -110.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.953 1 C-N-CA 126.123 4.548 . . . . 0.0 117.16 -173.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HD3' ' O ' ' A' ' 53' ' ' ILE . 3.4 mptp? 70.69 -67.06 0.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.627 1.171 . . . . 0.0 110.183 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.15 -117.67 0.99 Allowed Glycine 0 N--CA 1.401 -3.682 1 N-CA-C 102.762 -4.135 . . . . 0.0 102.762 -172.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.841 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 59.04 -110.29 0.49 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 164.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.795 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -68.27 -41.46 81.0 Favored 'General case' 0 C--O 1.255 1.367 0 C-N-CA 122.674 0.39 . . . . 0.0 111.513 -173.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.933 ' HB2' HG21 ' A' ' 52' ' ' ILE . 42.1 tt0 -73.73 -37.06 65.23 Favored 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 124.437 1.086 . . . . 0.0 110.794 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.7 t -70.88 -49.51 45.16 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.122 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 63' ' ' ARG . 6.4 t70 -65.11 -31.28 72.4 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.02 35.25 54.17 Favored Glycine 0 CA--C 1.488 -1.653 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.989 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 6.7 mmp_? -103.02 -49.69 3.7 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.023 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.64 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 65.9 mt -92.98 138.14 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.173 -172.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -126.38 -173.21 2.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.729 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 52.6 mtpt -79.76 43.35 0.58 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.422 1.089 . . . . 0.0 112.515 -172.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.581 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . -172.88 5.71 0.03 OUTLIER Glycine 0 C--N 1.301 -1.411 0 C-N-CA 118.836 -1.649 . . . . 0.0 115.066 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -74.66 144.37 43.84 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 117.728 0.764 . . . . 0.0 110.324 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 102' ' ' GLU . 56.4 ttt180 -89.32 135.01 33.82 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.831 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 47.9 t -105.74 122.7 59.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.589 HD12 HD22 ' A' ' 100' ' ' LEU . 65.6 mt -97.04 -39.05 9.52 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.233 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 77' ' ' SER . . . -164.87 178.37 7.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.472 -174.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.608 HG23 HD11 ' A' ' 78' ' ' LEU . 48.0 t -121.04 112.9 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 1.9 p-10 45.6 37.2 3.03 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 125.529 1.531 . . . . 0.0 113.828 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.84 -9.04 70.84 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 119.856 -1.164 . . . . 0.0 114.235 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.3 97.07 5.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.613 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 11.9 m -59.92 125.68 24.61 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.09 0.869 . . . . 0.0 112.436 -173.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.608 HD11 HG23 ' A' ' 73' ' ' VAL . 59.1 mt -94.89 69.68 3.34 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -111.0 104.68 13.27 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.695 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.34 26.71 11.71 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.74 146.05 30.31 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.507 HG22 ' HG2' ' A' ' 85' ' ' GLN . 11.8 t -88.2 164.11 15.81 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 170.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.53 ' HB3' ' N ' ' A' ' 31' ' ' VAL . 16.4 p-80 -51.15 -40.01 57.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 17.2 tppt? -60.54 -39.89 89.54 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.615 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.507 ' HG2' HG22 ' A' ' 82' ' ' THR . 82.1 mm-40 -70.66 -36.48 73.38 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.261 0.553 . . . . 0.0 110.397 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.403 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -59.44 -52.37 65.88 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.75 174.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 90' ' ' LEU . 60.2 t -66.57 -28.18 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.027 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 46.9 mm-40 -65.32 -39.2 92.14 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.0 m -70.96 -31.85 68.53 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.763 0.792 . . . . 0.0 109.079 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 96.0 mt -76.18 -11.68 59.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.126 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -99.09 -28.95 13.15 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -66.52 -30.1 70.35 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.026 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 p -76.78 144.84 38.91 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.719 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.66 -120.72 0.13 Allowed Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 116.139 1.216 . . . . 0.0 116.139 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -81.21 -45.08 16.86 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.452 0.701 . . . . 0.0 111.459 -172.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.73 124.23 72.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.066 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.416 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 7.4 t -108.42 139.22 31.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.782 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 93.0 m-70 -101.49 125.46 48.14 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 6.5 mp -123.02 143.64 49.8 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.589 HD22 HD12 ' A' ' 71' ' ' LEU . 1.3 tt -96.46 109.5 22.04 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 13' ' ' THR . 10.8 mp -117.4 171.33 8.06 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.061 0.458 . . . . 0.0 112.134 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 48.1 mt-10 -130.52 143.37 50.72 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HD2' ' CE1' ' A' ' 14' ' ' PHE . 28.1 mmmt -60.42 125.19 22.75 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.109 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.581 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . -103.06 -160.49 25.45 Favored Glycine 0 N--CA 1.425 -2.099 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.299 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.502 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 78.0 mm-40 -115.06 147.9 39.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 29.8 m -97.0 154.97 38.02 Favored Pre-proline 0 C--N 1.295 -1.796 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 -176.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 5.6 Cg_exo . . . . . 0 C--O 1.251 1.166 0 C-N-CA 123.167 2.578 . . . . 0.0 111.481 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.73 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 95.5 mttt . . . . . 0 CA--C 1.495 -1.154 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.596 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 17.2 Cg_exo -67.38 125.6 13.67 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 N-CA-C 108.003 -1.576 . . . . 0.0 108.003 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.38 12.04 61.85 Favored Glycine 0 C--N 1.308 -1.021 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.108 -173.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.73 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 36.3 t70 -102.27 143.26 32.27 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p -89.41 141.77 28.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.213 0.53 . . . . 0.0 111.552 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -149.28 146.56 27.62 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.753 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HB3' ' HE2' ' A' ' 98' ' ' HIS . 38.0 mt-10 -100.13 125.4 46.23 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.1 t -113.3 129.08 69.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -98.36 81.99 2.83 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.957 HD11 ' HB1' ' A' ' 57' ' ' ALA . 1.6 tm? -85.14 126.7 33.84 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -171.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.09 110.1 21.47 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.844 ' HE3' HD12 ' A' ' 25' ' ' LEU . 15.0 ptmt -79.14 153.94 29.7 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.767 HG23 ' HB3' ' A' ' 55' ' ' LYS . 7.2 t -140.23 139.84 35.68 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.209 -176.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 3.7 m-20 71.63 9.33 6.32 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.948 0.899 . . . . 0.0 112.712 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.24 1.34 23.58 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.66 -0.781 . . . . 0.0 114.55 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.2 t -160.49 175.01 13.23 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.844 HD12 ' HE3' ' A' ' 20' ' ' LYS . 7.6 mp -89.49 177.48 6.55 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.12 33.43 5.09 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' A' ' 49' ' ' VAL . 19.5 pt -138.14 139.95 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.639 0 CA-C-O 121.949 0.88 . . . . 0.0 112.012 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.1 m -104.25 118.22 36.1 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 113.68 -1.6 . . . . 0.0 107.274 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.01 145.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.393 0.616 . . . . 0.0 111.731 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -122.9 172.23 8.63 Favored 'General case' 0 N--CA 1.403 -2.822 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG13 ' H ' ' A' ' 32' ' ' LEU . 2.0 p -94.04 -63.64 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.258 -3.389 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.626 HD11 ' HA3' ' A' ' 45' ' ' GLY . 13.6 mt -172.04 151.4 2.69 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 128.139 2.576 . . . . 0.0 107.21 175.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -105.46 93.49 4.7 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -70.78 -41.87 71.11 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.607 0.718 . . . . 0.0 109.278 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.17 76.98 1.75 Allowed 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.65 -53.45 1.67 Allowed Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.08 -80.45 0.05 OUTLIER Glycine 0 N--CA 1.426 -1.971 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.6 t -80.84 124.94 39.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -69.03 137.61 53.77 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.188 0.518 . . . . 0.0 109.985 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.5 m -155.06 141.97 19.13 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.2 m -115.44 98.32 6.67 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.138 0.494 . . . . 0.0 110.635 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.4 t -95.07 132.45 39.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -80.66 121.82 26.33 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 77.3 132.38 0.05 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.039 1.736 . . . . 0.0 110.222 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.626 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -141.97 134.77 6.34 Favored Glycine 0 N--CA 1.414 -2.769 0 C-N-CA 120.054 -1.07 . . . . 0.0 112.585 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -137.09 -91.28 0.28 Allowed Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.611 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 33.6 mm -131.12 142.48 43.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 174.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.443 ' OH ' ' HD3' ' A' ' 69' ' ' ARG . 45.8 m-85 -126.23 143.77 51.02 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.456 HG13 ' HB ' ' A' ' 27' ' ' ILE . 61.7 t -78.93 108.48 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -80.7 -37.28 30.97 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.783 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.19 153.0 31.87 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.122 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.18 113.63 40.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.2 mm -92.27 154.48 43.0 Favored Pre-proline 0 C--N 1.28 -2.456 0 C-N-CA 125.261 1.424 . . . . 0.0 109.726 -175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -56.4 -152.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.567 2.161 0 C-N-CA 123.446 2.764 . . . . 0.0 113.801 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.767 ' HB3' HG23 ' A' ' 21' ' ' THR . 3.7 mppt? 72.8 -44.97 0.61 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.614 1.166 . . . . 0.0 112.1 -169.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.02 -126.88 4.2 Favored Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 108.176 -1.969 . . . . 0.0 108.176 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.957 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 71.27 -99.48 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 171.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.856 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -73.12 -35.26 66.52 Favored 'General case' 0 C--O 1.265 1.906 0 O-C-N 121.86 -0.525 . . . . 0.0 111.576 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -74.95 -40.03 61.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 125.07 1.481 . . . . 0.0 107.448 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.8 t -67.97 -44.03 77.65 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.056 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.63 -39.69 80.67 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.44 27.0 49.68 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.725 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -108.91 -39.65 5.26 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.115 -1.034 . . . . 0.0 113.156 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.856 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.4 mt -94.97 127.25 47.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -132.3 178.41 6.84 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 123.5 0.5 . . . . 0.0 110.115 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -67.52 128.21 35.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.314 0.578 . . . . 0.0 111.94 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.617 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 101.05 -4.24 55.75 Favored Glycine 0 N--CA 1.422 -2.267 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.006 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.589 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 31.8 m-20 -68.93 146.07 53.1 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.472 HH21 ' CD ' ' A' ' 102' ' ' GLU . 34.7 ttp180 -96.65 129.21 44.09 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.795 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.611 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 59.0 t -101.77 118.3 48.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.76 -31.87 14.23 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.265 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -164.49 167.78 19.08 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.7 ' HA ' HD12 ' A' ' 99' ' ' LEU . 31.7 t -118.04 110.44 30.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 59.39 37.49 23.23 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.393 1.077 . . . . 0.0 109.966 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.46 -6.19 80.88 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.163 -0.926 . . . . 0.0 114.162 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.07 108.66 20.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.514 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 35.4 p -64.95 135.68 55.94 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.699 HD11 HG23 ' A' ' 73' ' ' VAL . 67.5 mt -106.75 25.71 10.92 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.469 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -53.88 -32.03 51.83 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.96 -1.473 . . . . 0.0 113.452 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.63 40.71 1.56 Allowed Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.15 155.63 17.06 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.325 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.581 HG22 ' HG2' ' A' ' 85' ' ' GLN . 9.0 t -92.72 160.75 14.83 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 167.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.424 ' O ' HG23 ' A' ' 87' ' ' VAL . 52.1 p-80 -51.28 -43.43 61.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.141 0.496 . . . . 0.0 111.917 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -59.72 -37.8 79.92 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.581 ' HG2' HG22 ' A' ' 82' ' ' THR . 14.9 mm100 -71.63 -36.05 70.62 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.52 -45.71 90.97 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.348 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 83' ' ' HIS . 64.1 t -66.24 -39.53 84.53 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.776 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -62.51 -39.09 92.41 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.847 0.355 . . . . 0.0 111.038 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.443 ' HB ' HG21 ' A' ' 73' ' ' VAL . 12.1 m -69.91 -38.13 76.16 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.884 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.866 HD13 HD13 ' A' ' 99' ' ' LEU . 19.2 tp -82.95 -3.08 56.67 Favored 'General case' 0 N--CA 1.415 -2.175 0 C-N-CA 125.154 1.382 . . . . 0.0 109.878 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.36 -21.05 13.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.487 172.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -82.84 -25.21 32.84 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.458 ' OG1' HG12 ' A' ' 97' ' ' VAL . 3.2 p -67.18 -177.81 0.72 Allowed 'General case' 0 C--O 1.255 1.359 0 C-N-CA 123.705 0.802 . . . . 0.0 110.517 174.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -78.56 -162.63 21.8 Favored Glycine 0 C--O 1.244 0.764 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.582 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 29.6 tt0 -73.41 -34.53 65.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.717 0.77 . . . . 0.0 108.969 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.8 t -90.19 110.83 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.642 HG21 HD11 ' A' ' 25' ' ' LEU . 8.8 m -99.05 117.54 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.427 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.071 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 41.1 t-80 -84.57 122.0 28.41 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.866 HD13 HD13 ' A' ' 90' ' ' LEU . 7.2 tp -127.35 146.14 50.56 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 53.1 tp -102.13 117.1 34.06 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.751 HD11 HD23 ' A' ' 99' ' ' LEU . 6.6 mp -123.47 165.63 16.76 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.667 0.746 . . . . 0.0 111.761 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.472 ' CD ' HH21 ' A' ' 69' ' ' ARG . 88.1 tt0 -132.95 143.93 49.79 Favored 'General case' 0 N--CA 1.391 -3.42 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.596 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 40.3 mmtt -64.3 125.6 25.11 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.09 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . -91.22 -123.51 2.89 Favored Glycine 0 N--CA 1.42 -2.376 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.377 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -87.52 -45.91 10.05 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . 0.323 20.8 m 44.06 87.86 0.11 Allowed Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 C--O 1.247 0.963 0 C-N-CA 123.53 2.82 . . . . 0.0 110.522 178.653 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.495 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 28.2 mtpp . . . . . 0 N--CA 1.432 -1.329 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 58.0 Cg_endo -76.44 125.45 8.37 Favored 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 121.346 1.364 . . . . 0.0 109.389 169.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.754 ' H ' ' HB3' ' A' ' 103' ' ' LYS . . . 73.25 18.79 79.43 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.186 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 28.7 t70 -88.97 143.49 26.82 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 3.1 p -99.21 108.26 20.8 Favored 'General case' 0 N--CA 1.416 -2.164 0 O-C-N 123.895 0.747 . . . . 0.0 110.154 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -138.49 140.34 39.14 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.123 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 4.4 mp0 -75.53 106.36 7.04 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 59.5 t -69.47 122.51 21.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.841 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -96.16 93.96 7.24 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.545 HD11 ' CB ' ' A' ' 57' ' ' ALA . 2.6 tm? -100.53 115.14 29.43 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -177.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.84 117.3 33.86 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 24' ' ' SER . 99.5 mttt -54.52 121.16 7.8 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 124.185 0.928 . . . . 0.0 111.696 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.9 p -90.36 -84.0 0.24 Allowed 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.547 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.76 -54.83 2.41 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.515 ' CA ' ' HA2' ' A' ' 56' ' ' GLY . . . -87.87 25.73 8.34 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.698 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 39.7 t 76.69 -109.94 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 123.992 0.917 . . . . 0.0 113.326 172.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.739 ' HG ' HD13 ' A' ' 90' ' ' LEU . 3.3 mm? -85.38 -31.69 22.8 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 120.065 1.302 . . . . 0.0 110.403 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.531 ' CA ' ' HA3' ' A' ' 56' ' ' GLY . . . 73.55 21.58 79.33 Favored Glycine 0 N--CA 1.411 -2.986 0 C-N-CA 119.552 -1.309 . . . . 0.0 112.105 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.537 HG22 ' CD1' ' A' ' 52' ' ' ILE . 17.1 pt -128.71 121.86 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.696 0 CA-C-O 122.079 0.942 . . . . 0.0 112.825 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.642 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 25.7 t -90.26 112.18 23.63 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 49' ' ' VAL . 33.4 m -118.82 154.53 21.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -172.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.744 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 9.4 t -143.51 174.99 10.28 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.699 HG22 ' CD1' ' A' ' 47' ' ' ILE . 4.4 t -102.24 147.0 9.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.554 ' HG ' ' HB2' ' A' ' 48' ' ' TYR . 64.9 mt -79.31 92.76 5.19 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.569 ' CD1' ' HB ' ' A' ' 31' ' ' VAL . 25.5 p90 -166.88 13.89 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.13 -80.58 0.08 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.496 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -169.89 115.84 0.54 Allowed 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.261 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.04 167.08 18.03 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -125.17 -51.93 0.18 Allowed Glycine 0 C--N 1.306 -1.116 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.574 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.8 t -104.83 36.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.2 t30 70.05 164.78 0.27 Allowed 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.304 -1.317 . . . . 0.0 109.864 -175.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.6 m -141.05 109.91 6.09 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.3 t -59.85 -90.22 0.0 OUTLIER 'General case' 0 C--O 1.244 0.783 0 O-C-N 124.004 0.815 . . . . 0.0 109.091 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.9 p -41.23 110.77 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 122.094 0.949 . . . . 0.0 113.559 168.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -136.47 173.14 12.03 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.896 176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.6 t60 53.63 -102.14 0.13 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 124.281 1.033 . . . . 0.0 111.195 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.23 -52.28 1.4 Allowed Glycine 0 C--N 1.34 0.801 0 CA-C-O 121.219 0.344 . . . . 0.0 113.02 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.476 ' O ' HG13 ' A' ' 31' ' ' VAL . . . 161.81 -70.63 0.22 Allowed Glycine 0 N--CA 1.406 -3.357 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.74 HG13 ' HB2' ' A' ' 86' ' ' ALA . 21.0 mm -145.76 159.36 12.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 C-N-CA 125.273 1.429 . . . . 0.0 107.654 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.554 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . 67.4 t80 -134.45 135.25 42.38 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 123.333 0.653 . . . . 0.0 110.612 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.49 ' HA ' HG12 ' A' ' 29' ' ' VAL . 51.6 t -79.67 108.84 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.497 ' HB2' HG22 ' A' ' 30' ' ' THR . 63.1 tttp -80.8 -37.44 30.2 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.19 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 28' ' ' SER . . . -148.54 148.18 29.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.47 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.835 HG23 ' HB2' ' A' ' 59' ' ' GLU . 1.4 tp -110.86 131.97 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-O 121.4 0.619 . . . . 0.0 111.758 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 56' ' ' GLY . 2.1 mp -106.25 126.44 30.52 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.967 ' HA ' ' HB3' ' A' ' 59' ' ' GLU . 33.8 Cg_exo -59.47 -77.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.133 2.555 . . . . 0.0 113.169 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 23.8 mmtp -55.13 -10.09 0.49 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 176.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.531 ' HA3' ' CA ' ' A' ' 26' ' ' GLY . . . -63.32 -59.37 9.0 Favored Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' CB ' HD11 ' A' ' 18' ' ' LEU . . . 167.25 -71.31 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.733 0 C-N-CA 125.117 1.367 . . . . 0.0 111.78 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.775 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -48.66 -38.22 20.57 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -167.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.967 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 8.2 tp10 -74.49 -52.4 12.06 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.91 0.484 . . . . 0.0 111.222 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.6 m -76.96 -29.77 55.71 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.097 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -72.6 -45.87 56.97 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.88 59.24 1.61 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 114.301 -1.318 . . . . 0.0 114.882 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -128.7 -58.87 1.16 Allowed 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.598 0.714 . . . . 0.0 109.144 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.775 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 51.9 mt -94.1 141.61 14.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.89 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -137.31 168.53 19.45 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -58.26 125.29 22.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.687 0.28 . . . . 0.0 110.439 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.544 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 115.59 -21.19 12.93 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.968 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.482 ' HB3' HD23 ' A' ' 101' ' ' LEU . 54.2 m-20 -64.72 137.28 57.71 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.88 0.848 . . . . 0.0 113.228 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -96.47 132.33 42.15 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.0 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 39.3 t -108.72 126.06 65.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.5 -34.65 10.17 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.635 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -162.94 175.64 10.98 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.291 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 78' ' ' LEU . 95.3 t -128.48 111.47 23.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.4 t30 51.73 58.72 5.17 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 124.821 1.248 . . . . 0.0 111.684 176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.7 -10.2 13.84 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 114.798 -1.092 . . . . 0.0 115.104 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.402 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 85.4 t -95.81 108.21 20.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 118.242 1.021 . . . . 0.0 108.828 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.548 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 34.7 m -62.42 137.06 58.19 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 123.818 0.699 . . . . 0.0 112.254 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.974 HD11 HG23 ' A' ' 73' ' ' VAL . 91.6 mt -104.97 16.19 26.37 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.456 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 38.8 mt-10 -72.17 94.76 1.58 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.58 14.1 13.35 Favored Glycine 0 C--N 1.304 -1.202 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.408 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 74.4 p -92.54 162.25 14.28 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.744 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 52.5 p-80 -51.47 -41.92 61.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.68 0.752 . . . . 0.0 109.807 174.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.401 ' NZ ' ' HB2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -70.0 -37.07 75.59 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.149 178.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.408 ' HG2' ' OG1' ' A' ' 82' ' ' THR . 74.7 mm-40 -64.26 -40.32 95.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.347 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.74 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -55.48 -52.25 64.25 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.104 0.478 . . . . 0.0 110.417 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.0 t -64.54 -34.07 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.002 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -68.65 -30.0 68.6 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.04 0.448 . . . . 0.0 110.577 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.4 m -72.25 -37.51 69.09 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.739 HD13 ' HG ' ' A' ' 25' ' ' LEU . 97.9 mt -71.06 -25.44 62.64 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.577 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -77.76 -43.36 31.06 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.232 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.81 -46.97 64.53 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.984 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 p -48.24 -65.88 0.49 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.64 -154.18 24.96 Favored Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.825 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.466 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 57.9 tt0 -87.53 -43.8 11.75 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.505 0.669 . . . . 0.0 109.288 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 55.5 t -102.65 106.04 19.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -105.61 138.29 31.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.22 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.553 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 56.7 m80 -100.39 130.16 46.45 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.608 HD21 HD21 ' A' ' 90' ' ' LEU . 6.5 mp -124.21 141.4 52.1 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.54 106.31 18.41 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' THR . 8.4 mp -115.64 165.56 12.9 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.697 0.761 . . . . 0.0 112.36 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 42.6 tt0 -131.15 114.04 14.63 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 103.675 -2.713 . . . . 0.0 103.675 172.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.754 ' HB3' ' H ' ' A' ' 11' ' ' GLY . 40.9 tptt -47.5 121.36 3.89 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.872 0.732 . . . . 0.0 110.643 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . -93.93 32.41 5.88 Favored Glycine 0 CA--C 1.498 -0.973 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.446 -171.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -151.43 113.75 4.57 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 10' ' ' PRO . 40.6 t -120.34 90.82 45.67 Favored Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 N--CA 1.43 -2.259 0 C-N-CA 123.105 2.537 . . . . 0.0 111.006 -178.89 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 31.8 mmtp . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 111.27 0.1 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.61 ' HG3' ' HB3' ' A' ' 107' ' ' PRO . 16.7 Cg_exo -70.1 44.38 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 124.388 3.392 . . . . 0.0 113.14 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.36 18.52 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.45 139.07 31.8 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 122.862 0.465 . . . . 0.0 110.802 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 p -92.77 117.46 30.04 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.8 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -133.89 154.52 51.01 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 120.815 0.34 . . . . 0.0 110.545 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -110.46 114.09 27.24 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 64' ' ' ILE . 11.6 p -86.84 132.02 33.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.743 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -102.1 105.37 16.08 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.881 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -117.23 124.94 50.29 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -176.253 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -100.85 132.21 46.36 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.008 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HE3' HG21 ' A' ' 97' ' ' VAL . 1.2 mptm? -65.73 139.46 58.36 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 123.484 0.714 . . . . 0.0 110.821 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.0 p -75.45 -68.94 0.51 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 170.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -105.75 -72.01 0.73 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -145.92 19.28 1.78 Allowed Glycine 0 C--N 1.306 -1.116 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 175.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.0 m -114.57 140.33 48.87 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.783 HD11 ' HB3' ' A' ' 18' ' ' LEU . 12.3 tp -93.66 -8.64 40.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.57 -7.4 76.67 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.944 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.564 HG21 HG21 ' A' ' 64' ' ' ILE . 20.1 pt -119.68 155.76 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 CA-C-O 121.914 0.864 . . . . 0.0 112.437 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -132.08 128.53 38.41 Favored 'General case' 0 N--CA 1.399 -3.001 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.206 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -109.18 162.4 6.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.206 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.654 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 14.1 t -141.39 168.78 18.95 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 175.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.745 HG21 ' HA ' ' A' ' 82' ' ' THR . 4.5 t -103.05 119.95 52.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.05 85.97 2.32 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -95.33 -58.21 2.2 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.42 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -152.88 116.72 4.79 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.169 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -170.94 -50.41 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.07 81.98 0.05 OUTLIER Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.44 -157.79 22.34 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.658 HG23 ' H ' ' A' ' 39' ' ' ASN . 10.8 m -78.8 -84.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.658 ' H ' HG23 ' A' ' 38' ' ' VAL . 16.3 m120 -122.13 -69.37 0.84 Allowed 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.8 m -105.61 86.14 2.35 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.5 m -110.25 92.74 4.17 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.89 149.56 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.451 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -92.05 81.68 5.08 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -151.25 -81.55 0.1 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.32 150.97 23.08 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 106.442 -2.663 . . . . 0.0 106.442 172.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 31' ' ' VAL . . . -158.67 15.87 0.26 Allowed Glycine 0 N--CA 1.418 -2.52 0 C-N-CA 117.357 -2.354 . . . . 0.0 114.207 -170.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.594 ' CD1' HG22 ' A' ' 31' ' ' VAL . 36.6 mm -94.63 125.97 47.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -129.21 147.09 51.02 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 64' ' ' ILE . 52.5 t -72.66 113.2 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HB2' HG22 ' A' ' 30' ' ' THR . 55.7 tttm -86.02 -40.43 15.8 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.132 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.51 156.26 37.76 Favored 'General case' 0 C--O 1.25 1.091 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.242 -173.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -113.89 118.02 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.07 136.23 20.61 Favored Pre-proline 0 C--N 1.292 -1.932 0 C-N-CA 123.543 0.737 . . . . 0.0 109.518 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.475 ' O ' ' HD2' ' A' ' 55' ' ' LYS . 39.0 Cg_exo -65.25 78.55 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.253 2.635 . . . . 0.0 112.603 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 54' ' ' PRO . 4.3 mptp? -135.53 20.81 3.35 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.0 -151.83 44.63 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.54 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 69.79 -103.48 0.05 OUTLIER 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.558 1.143 . . . . 0.0 113.393 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.881 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -66.48 -37.04 84.22 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 117.963 0.347 . . . . 0.0 111.887 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.59 -48.31 67.22 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.66 1.184 . . . . 0.0 109.009 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 m -68.9 -46.12 69.14 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.129 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.6 -25.31 62.12 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.12 36.2 51.76 Favored Glycine 0 CA--C 1.5 -0.898 0 CA-C-N 114.449 -1.251 . . . . 0.0 113.271 174.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 1.8 mmp_? -95.7 -48.99 5.55 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.034 0.445 . . . . 0.0 111.215 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.8 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 33.1 mm -100.54 137.44 28.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.661 -173.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.517 ' NE2' ' HB ' ' A' ' 106' ' ' VAL . 7.7 p-80 -137.92 169.79 17.17 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 172.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -79.49 142.4 35.86 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.889 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.07 -17.72 12.64 Favored Glycine 0 C--N 1.306 -1.138 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.288 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.411 ' OD2' ' HA ' ' A' ' 103' ' ' LYS . 2.3 m-20 -89.48 147.04 24.22 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-N 117.118 0.459 . . . . 0.0 110.619 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.525 ' HD3' ' OE1' ' A' ' 102' ' ' GLU . 4.3 ptm180 -106.98 158.39 17.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.148 0.499 . . . . 0.0 111.485 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.21 127.71 71.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 102' ' ' GLU . 85.7 mt -96.27 -37.15 10.64 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 78' ' ' LEU . . . -160.54 174.56 13.86 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.713 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 1.021 HG11 HG21 ' A' ' 89' ' ' THR . 2.7 p -124.08 105.37 15.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 C-N-CA 124.224 1.009 . . . . 0.0 108.549 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.0 t30 57.43 32.54 21.95 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.587 1.184 . . . . 0.0 110.564 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.27 -11.66 67.1 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.515 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' A' ' 73' ' ' VAL . 59.8 t -86.34 107.28 16.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m -72.31 119.34 16.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.938 0.399 . . . . 0.0 111.598 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.4 pt? -119.18 83.52 2.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.965 0.888 . . . . 0.0 111.674 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.41 -35.88 11.56 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.744 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.62 36.66 4.01 Favored Glycine 0 CA--C 1.495 -1.165 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . -101.28 146.3 27.73 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.818 HG22 ' HG2' ' A' ' 85' ' ' GLN . 9.0 t -94.34 166.4 12.1 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 170.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.654 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 48.2 p-80 -51.54 -41.19 60.89 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 122.798 0.439 . . . . 0.0 111.347 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.07 -38.34 82.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.668 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.818 ' HG2' HG22 ' A' ' 82' ' ' THR . 13.6 mm100 -71.46 -47.81 53.29 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.65 75.64 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.209 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.5 -29.79 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.678 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -80.87 -16.24 54.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.34 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 1.021 HG21 HG11 ' A' ' 73' ' ' VAL . 25.4 m -73.16 -32.16 64.7 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.969 HD21 HD21 ' A' ' 99' ' ' LEU . 84.3 mt -76.45 -20.45 57.02 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.221 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -77.16 -44.15 31.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.419 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -64.41 -41.6 96.54 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.379 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.452 HG21 HG13 ' A' ' 97' ' ' VAL . 6.6 p -64.7 158.62 24.15 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.578 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -79.05 -150.62 5.5 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.912 -173.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -65.07 -42.23 94.37 Favored 'General case' 0 C--O 1.209 -1.052 0 C-N-CA 122.94 0.496 . . . . 0.0 109.807 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 48.2 t -114.4 122.51 68.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.567 HG21 ' HE3' ' A' ' 20' ' ' LYS . 5.9 t -112.58 149.89 14.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 48.0 m80 -115.13 132.85 56.47 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.969 HD21 HD21 ' A' ' 90' ' ' LEU . 6.4 mp -126.83 145.45 50.64 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.3 tt -99.5 109.91 22.41 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.524 HD13 HG12 ' A' ' 16' ' ' VAL . 11.0 mp -112.59 170.71 7.99 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.607 0.718 . . . . 0.0 110.65 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.525 ' OE1' ' HD3' ' A' ' 69' ' ' ARG . 42.6 tt0 -129.87 132.18 46.34 Favored 'General case' 0 N--CA 1.404 -2.75 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HA ' ' OD2' ' A' ' 68' ' ' ASP . 19.4 tptp -57.38 122.24 12.1 Favored 'General case' 0 N--CA 1.421 -1.89 0 O-C-N 124.285 0.99 . . . . 0.0 110.17 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.94 -122.72 4.95 Favored Glycine 0 N--CA 1.417 -2.614 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -71.4 170.37 13.35 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.517 ' HB ' ' NE2' ' A' ' 65' ' ' HIS . 35.3 t 52.02 80.0 0.32 Allowed Pre-proline 0 C--O 1.246 0.917 0 C-N-CA 124.87 1.268 . . . . 0.0 111.34 -175.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.61 ' HB3' ' HG3' ' A' ' 10' ' ' PRO . 5.2 Cg_exo . . . . . 0 N--CA 1.451 -1.026 0 C-N-CA 123.319 2.679 . . . . 0.0 110.994 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.919 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 53.2 mtpt . . . . . 0 N--CA 1.431 -1.378 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.919 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 1.2 Cg_endo -85.88 137.93 5.75 Favored 'Trans proline' 0 N--CA 1.435 -1.913 0 N-CA-C 107.827 -1.643 . . . . 0.0 107.827 171.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.58 8.27 80.66 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.083 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 26.1 t0 -98.05 144.45 27.55 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 4.4 p -103.86 132.59 49.96 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 123.438 0.461 . . . . 0.0 112.209 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.99 147.64 24.3 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.266 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -77.46 98.58 5.35 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 7.2 p -71.94 130.25 35.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -95.26 95.0 8.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.91 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -101.72 120.44 40.35 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.034 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.82 117.82 31.28 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 5.8 ptmt -71.06 146.55 49.24 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.742 0.782 . . . . 0.0 113.032 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m -87.69 -51.43 5.88 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.294 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -111.65 -154.84 0.55 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.35 16.69 37.95 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.811 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -148.94 176.56 10.32 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.637 HD22 HD12 ' A' ' 18' ' ' LEU . 32.8 mt -93.2 152.31 19.29 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 118.19 0.45 . . . . 0.0 109.816 172.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.409 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -82.84 28.61 3.54 Favored Glycine 0 C--O 1.212 -1.259 0 CA-C-N 115.212 -0.903 . . . . 0.0 112.558 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.454 ' HB ' HG13 ' A' ' 49' ' ' VAL . 22.0 pt -131.71 133.95 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 CA-C-O 121.325 0.583 . . . . 0.0 110.826 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.3 t -91.13 117.88 29.98 Favored 'General case' 0 C--N 1.268 -2.968 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.468 ' HB ' ' CG2' ' A' ' 47' ' ' ILE . 30.8 m -109.3 136.12 46.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 O-C-N 123.656 0.597 . . . . 0.0 110.192 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.552 HG22 ' HB2' ' A' ' 50' ' ' LYS . 10.5 t -126.57 161.34 28.23 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.499 HG22 ' CD1' ' A' ' 47' ' ' ILE . 3.1 t -103.99 114.77 44.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.837 -177.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mp -108.39 85.59 2.14 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 13.5 t80 -86.38 -164.64 1.08 Allowed 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.713 -171.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 43' ' ' ARG . 2.6 m-20 -68.11 90.83 0.34 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.866 0.841 . . . . 0.0 110.404 174.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -161.88 141.89 10.21 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.436 -1.711 . . . . 0.0 106.529 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.66 43.77 8.22 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.732 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.4 101.33 2.33 Favored Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.82 -50.64 4.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -77.14 -26.79 53.52 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.006 0.431 . . . . 0.0 110.432 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.9 p -148.88 169.2 21.06 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.5 m -88.47 -39.21 14.39 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 118.543 0.61 . . . . 0.0 110.282 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 p -87.62 147.35 5.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -122.23 -34.82 3.24 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 62.34 17.07 9.07 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.342 1.057 . . . . 0.0 109.948 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . -69.34 143.49 39.2 Favored Glycine 0 N--CA 1.426 -2.001 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.759 -175.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.25 -108.21 1.59 Allowed Glycine 0 N--CA 1.419 -2.441 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.538 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.7 mm -101.52 147.21 8.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -136.11 136.4 40.08 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 123.788 0.835 . . . . 0.0 109.45 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.454 HG13 ' HB ' ' A' ' 27' ' ' ILE . 43.7 t -75.6 109.0 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.552 ' HB2' HG22 ' A' ' 30' ' ' THR . 61.3 tttp -83.93 -38.15 21.41 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.977 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.24 165.08 36.87 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.589 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.401 HG21 ' HG2' ' A' ' 59' ' ' GLU . 40.7 mm -111.87 120.1 61.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.58 HG22 ' H ' ' A' ' 55' ' ' LYS . 1.8 mp -67.78 136.0 92.4 Favored Pre-proline 0 C--N 1.315 -0.927 0 C-N-CA 123.187 0.595 . . . . 0.0 110.522 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.54 -25.88 20.66 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.511 3.474 . . . . 0.0 113.629 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.58 ' H ' HG22 ' A' ' 53' ' ' ILE . 44.1 tptt -82.51 63.8 6.84 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.704 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.66 -109.4 0.7 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 117.926 1.931 . . . . 0.0 117.926 171.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.646 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 37.66 -86.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 126.847 2.059 . . . . 0.0 113.987 -169.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.91 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -80.47 -28.01 37.7 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.3 -0.25 . . . . 0.0 110.416 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.401 ' HG2' HG21 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -78.73 -43.91 24.66 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.6 p -73.56 -38.89 65.06 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.811 -174.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -73.04 -33.28 65.61 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.78 49.95 5.16 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 114.216 -1.356 . . . . 0.0 113.667 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -118.19 -68.67 0.9 Allowed 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.548 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 63.6 mt -74.13 140.22 18.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.845 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -123.33 159.15 29.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 133.87 40.26 Favored 'General case' 0 N--CA 1.419 -2.024 0 C-N-CA 118.554 -1.258 . . . . 0.0 108.854 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.81 -16.9 12.15 Favored Glycine 0 N--CA 1.425 -2.095 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -72.9 140.65 47.64 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.26 0.553 . . . . 0.0 111.361 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -92.6 133.05 36.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.796 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 38.3 t -107.68 118.55 55.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt -94.85 -34.85 12.3 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.422 -176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.672 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -158.71 172.43 18.29 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.547 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.824 HG23 HD11 ' A' ' 78' ' ' LEU . 88.5 t -123.17 104.29 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 123.564 0.745 . . . . 0.0 109.197 176.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 t30 61.36 34.19 18.5 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 109.417 171.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.2 -24.1 33.05 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.565 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.37 107.43 14.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.557 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 2.8 p -66.9 133.35 49.85 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.607 0.718 . . . . 0.0 112.891 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.824 HD11 HG23 ' A' ' 73' ' ' VAL . 77.4 mt -100.63 30.3 4.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.927 0.87 . . . . 0.0 108.86 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.78 -27.1 49.25 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 125.675 1.59 . . . . 0.0 112.67 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -141.03 44.94 0.99 Allowed Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.39 156.66 18.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.239 0.542 . . . . 0.0 112.199 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.461 ' HA ' HG21 ' A' ' 31' ' ' VAL . 11.4 t -113.49 177.24 4.7 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 170.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -51.26 -54.81 22.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.807 1.243 . . . . 0.0 111.467 -174.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -57.41 -39.22 75.69 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.316 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -70.56 -45.31 65.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.88 -56.42 20.78 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.13 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.445 ' HA ' HD23 ' A' ' 90' ' ' LEU . 90.4 t -62.18 -32.85 55.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.151 -177.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.04 -34.69 78.65 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.3 m -70.6 -35.62 73.1 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.078 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.593 HD11 HD21 ' A' ' 99' ' ' LEU . 3.6 mm? -68.14 -24.21 64.97 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 121.709 -0.62 . . . . 0.0 111.171 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -79.44 -40.14 30.62 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.231 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -71.08 -38.19 72.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.908 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.1 p -64.84 -58.12 7.03 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 149.92 -150.47 22.54 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 118.906 -1.616 . . . . 0.0 114.989 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.479 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 52.9 tt0 -84.38 -55.77 3.98 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.794 0.838 . . . . 0.0 110.405 -176.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.4 t -93.61 101.48 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 25' ' ' LEU . 2.1 m -100.83 134.0 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.877 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.57 -173.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.686 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 12.0 m170 -101.37 139.62 36.78 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 90' ' ' LEU . 5.9 mp -130.25 143.73 50.95 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 172.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 61.0 tp -86.65 107.2 18.09 Favored 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 13' ' ' THR . 8.4 mp -112.05 155.41 23.86 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.063 0.459 . . . . 0.0 110.431 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 31.7 tt0 -130.79 107.62 9.28 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.765 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . 31.9 mmmt -47.7 138.04 8.74 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.67 -159.07 21.74 Favored Glycine 0 N--CA 1.413 -2.845 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.552 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 83.8 mm-40 -114.74 -172.07 2.05 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.4 m -108.91 88.94 5.93 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 105' ' ' GLN . 13.4 Cg_endo . . . . . 0 N--CA 1.436 -1.905 0 C-N-CA 123.285 2.656 . . . . 0.0 111.214 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.545 ' HA ' ' HG3' ' A' ' 103' ' ' LYS . 20.4 Cg_endo -63.4 108.81 0.88 Allowed 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.451 2.101 . . . . 0.0 110.43 176.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.59 -11.18 7.12 Favored Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -79.8 129.37 34.43 Favored 'General case' 0 C--O 1.255 1.381 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 p -98.9 114.48 27.11 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 170.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -109.73 107.33 17.3 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 121.656 0.741 . . . . 0.0 111.846 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -65.78 115.83 6.33 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 170.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.4 p -110.8 137.29 43.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.509 -171.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -107.0 117.52 34.28 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 58' ' ' ALA . 1.1 tm? -117.87 123.88 46.94 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 118.679 -1.208 . . . . 0.0 108.953 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.402 ' N ' HD13 ' A' ' 18' ' ' LEU . . . -97.45 119.38 35.88 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.728 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -59.85 132.37 53.74 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.415 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 t -66.43 -58.0 6.2 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.283 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -170.2 -50.35 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.69 50.32 2.6 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.715 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.728 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 21.5 t 69.1 -160.15 0.18 Allowed 'General case' 0 C--O 1.254 1.322 0 C-N-CA 124.336 1.054 . . . . 0.0 110.711 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.582 ' HG ' ' HE2' ' A' ' 20' ' ' LYS . 86.5 mt -65.7 142.19 58.1 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.24 0.543 . . . . 0.0 110.946 -178.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 56' ' ' GLY . . . -92.42 33.07 5.13 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.33 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 pt -135.37 135.18 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.579 0 CA-C-O 121.303 0.573 . . . . 0.0 110.127 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB2' HD11 ' A' ' 53' ' ' ILE . 19.4 t -102.37 102.07 12.37 Favored 'General case' 0 C--N 1.259 -3.355 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.5 m -92.2 159.59 2.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -140.57 172.15 13.11 Favored 'General case' 0 N--CA 1.413 -2.279 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 p -113.24 136.91 48.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-O 121.065 0.46 . . . . 0.0 111.751 -175.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.516 HD23 ' CD1' ' A' ' 48' ' ' TYR . 3.9 mm? -117.03 83.08 1.91 Allowed 'General case' 0 N--CA 1.422 -1.844 0 CA-C-O 122.473 1.13 . . . . 0.0 108.767 170.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.502 ' CD1' ' HA2' ' A' ' 80' ' ' GLY . 50.1 t80 -117.71 100.98 7.96 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.213 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.554 ' HB3' HG22 ' A' ' 38' ' ' VAL . 10.1 t70 -143.2 143.9 31.96 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -134.18 16.01 3.8 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.81 -35.53 0.31 Allowed Glycine 0 C--N 1.318 -0.459 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.169 -174.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.29 -40.08 4.07 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.554 HG22 ' HB3' ' A' ' 34' ' ' ASP . 26.9 m -84.96 89.46 2.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 122.705 1.24 . . . . 0.0 110.768 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -115.32 -56.47 2.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.839 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.5 p -80.83 -35.53 32.77 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.252 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.491 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 13.5 m -87.7 105.93 17.7 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -89.79 134.42 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 C-N-CA 120.394 -0.523 . . . . 0.0 112.003 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.3 ptt85 -82.12 105.43 13.21 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.578 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 69' ' ' ARG . 65.2 m-70 -82.78 -18.19 41.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.364 0.602 . . . . 0.0 109.959 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.503 ' HA3' ' HG3' ' A' ' 69' ' ' ARG . . . -133.03 166.7 23.6 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.51 -40.87 1.83 Allowed Glycine 0 C--N 1.303 -1.286 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.952 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.615 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 49.1 mm -109.7 141.78 24.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.516 ' CD1' HD23 ' A' ' 32' ' ' LEU . 92.7 m-85 -136.17 148.77 48.32 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 66' ' ' LYS . 28.4 t -75.58 117.45 20.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -88.52 -34.15 17.51 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.85 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . . . -159.28 157.25 30.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.049 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.44 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 50.8 mm -105.94 120.59 57.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.5 HG22 ' H ' ' A' ' 55' ' ' LYS . 51.7 mm -75.4 124.3 89.01 Favored Pre-proline 0 C--N 1.295 -1.783 0 C-N-CA 122.698 0.399 . . . . 0.0 110.823 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.0 -8.66 12.37 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 C-N-CA 124.149 3.233 . . . . 0.0 114.9 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.5 ' H ' HG22 ' A' ' 53' ' ' ILE . 1.1 mptm? -65.45 -28.42 69.21 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.475 ' O ' ' HA3' ' A' ' 26' ' ' GLY . . . 133.13 -147.43 18.98 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.172 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 75.98 -86.71 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 125.525 1.53 . . . . 0.0 110.916 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.87 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -78.67 -29.63 45.73 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.631 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 39.3 tt0 -78.85 -44.53 22.76 Favored 'General case' 0 N--CA 1.434 -1.264 0 O-C-N 124.673 1.233 . . . . 0.0 110.799 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.8 p -71.98 -40.53 68.53 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.968 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.63 -39.24 73.81 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.11 66.75 1.85 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.843 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.553 ' HG3' HG13 ' A' ' 64' ' ' ILE . 18.6 ptp180 -136.43 -39.19 0.66 Allowed 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.431 176.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.656 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 61.2 mt -101.52 141.22 18.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 -133.55 173.42 11.51 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 51' ' ' ALA . 62.2 pttt -85.69 151.65 23.7 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.367 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.07 -20.2 43.94 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.477 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.936 ' HA ' ' HA3' ' A' ' 104' ' ' GLY 0.271 1.0 OUTLIER -78.7 152.93 31.31 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.7 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.503 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 41.9 ttm180 -92.5 134.21 35.19 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.921 -168.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.615 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 60.8 t -106.72 120.34 57.77 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.3 mt -96.79 -38.52 9.84 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.458 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.64 170.2 22.94 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.727 -175.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 87.0 t -129.27 120.35 51.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 63.96 27.64 14.36 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.354 1.074 . . . . 0.0 109.169 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.97 -7.16 60.3 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.606 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.91 113.6 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.9 m -64.68 131.0 45.71 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.683 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 86' ' ' ALA 0.42 0.3 OUTLIER -128.38 67.96 1.37 Allowed 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 122.875 1.321 . . . . 0.0 113.974 174.219 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -108.97 114.89 29.04 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.502 ' HA2' ' CD1' ' A' ' 33' ' ' PHE . . . 100.4 15.24 30.49 Favored Glycine 0 C--N 1.297 -1.589 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -174.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.89 -177.21 4.89 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.9 p -113.36 168.67 9.55 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -51.76 -50.79 59.98 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.8 -44.34 94.01 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.624 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.28 -41.57 80.8 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 118.314 0.506 . . . . 0.0 110.704 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.68 -56.55 20.46 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.975 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.99 -33.13 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.11 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -68.61 -33.65 74.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.921 178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.1 m -68.67 -33.3 73.75 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.613 HD21 HD21 ' A' ' 99' ' ' LEU . 92.9 mt -72.94 -17.23 61.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.833 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -91.87 -37.42 12.92 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -68.53 -27.48 66.13 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.53 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -46.91 65.68 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.86 -156.03 21.92 Favored Glycine 0 C--N 1.311 -0.834 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.08 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.5 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 34.8 tt0 -75.0 -48.11 25.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.934 0.367 . . . . 0.0 110.936 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.4 t -96.83 105.82 17.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 t -100.14 136.45 31.44 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -176.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -102.64 130.66 49.61 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.613 HD21 HD21 ' A' ' 90' ' ' LEU . 5.8 mp -126.98 154.85 44.05 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.1 tt -106.21 112.08 24.96 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.63 163.22 15.26 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.065 0.46 . . . . 0.0 111.972 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.602 ' HG2' ' HD3' ' A' ' 103' ' ' LYS . 30.2 tt0 -132.55 154.01 50.41 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.602 ' HD3' ' HG2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -50.6 121.83 6.33 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 121.802 0.81 . . . . 0.0 111.95 176.223 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.936 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -104.29 47.61 1.07 Allowed Glycine 0 C--N 1.298 -1.542 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.422 ' OE1' ' HB3' ' A' ' 10' ' ' PRO . 49.0 tt0 -66.31 -44.22 84.04 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.8 m -124.29 91.19 49.89 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo . . . . . 0 C--O 1.263 1.735 0 C-N-CA 123.137 2.558 . . . . 0.0 112.068 -175.835 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 70.4 mmtt . . . . . 0 N--CA 1.445 -0.695 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 9' ' ' LYS . 8.2 Cg_exo -72.4 73.64 2.73 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.294 1.996 . . . . 0.0 109.18 174.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.52 33.22 0.03 OUTLIER Glycine 0 C--N 1.287 -2.153 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -95.68 153.06 17.92 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 11.4 p -87.84 133.02 33.98 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.281 0.363 . . . . 0.0 111.475 -175.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.62 119.4 4.08 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.325 0.583 . . . . 0.0 111.8 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -72.21 120.21 17.49 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.103 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.568 HG21 HD11 ' A' ' 64' ' ' ILE . 33.5 m -96.39 133.64 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.098 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.95 104.75 16.39 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 170.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.862 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -112.24 117.77 33.45 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 119.313 -0.955 . . . . 0.0 108.696 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.74 114.25 25.87 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 24' ' ' SER . 98.6 mttt -56.57 136.31 54.48 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 124.14 0.9 . . . . 0.0 112.398 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.547 HG23 ' HB2' ' A' ' 57' ' ' ALA . 61.2 p -91.71 -163.85 1.1 Allowed 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.84 -19.11 65.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.627 0.727 . . . . 0.0 109.106 174.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 54' ' ' PRO . . . -104.5 19.21 42.84 Favored Glycine 0 N--CA 1.429 -1.832 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.59 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.556 ' HA ' ' HB3' ' A' ' 20' ' ' LYS . 73.8 m 72.4 -153.73 0.08 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.364 1.066 . . . . 0.0 111.054 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 18' ' ' LEU . 89.5 mt -61.54 -24.55 66.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.764 ' HA2' ' HD2' ' A' ' 54' ' ' PRO . . . 86.82 -6.05 83.72 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.006 -1.093 . . . . 0.0 111.82 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.491 ' HB ' HG13 ' A' ' 49' ' ' VAL . 22.6 pt -109.51 136.08 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 C-N-CA 119.228 -0.989 . . . . 0.0 112.544 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.1 t -109.03 128.87 55.34 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.44 149.04 18.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 O-C-N 123.15 0.281 . . . . 0.0 111.037 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -130.83 161.21 32.29 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.714 HG12 HD13 ' A' ' 47' ' ' ILE . 31.2 m -106.15 127.49 61.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.685 -176.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.9 mt -103.13 164.94 11.32 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -127.96 132.19 49.23 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -79.69 158.94 26.85 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -116.25 18.87 15.14 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.972 0.891 . . . . 0.0 109.463 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.63 -61.17 4.6 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.38 160.97 19.03 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.47 ' HA ' HG11 ' A' ' 42' ' ' VAL . 5.2 p -107.36 -63.72 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 117.789 0.794 . . . . 0.0 112.373 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.546 ' O ' ' HB ' ' A' ' 40' ' ' THR . 26.2 t-20 63.39 -77.08 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.689 0.796 . . . . 0.0 109.458 -172.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.546 ' HB ' ' O ' ' A' ' 39' ' ' ASN . 5.8 t 165.84 -20.54 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.905 1.282 . . . . 0.0 109.581 176.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.2 m -80.46 33.25 0.3 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.177 0.591 . . . . 0.0 110.872 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.47 HG11 ' HA ' ' A' ' 38' ' ' VAL . 13.0 p -136.43 148.29 27.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.747 -0.596 . . . . 0.0 110.775 -172.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -114.09 75.08 0.9 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -84.68 169.41 14.33 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.821 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.51 -138.91 9.83 Favored Glycine 0 N--CA 1.42 -2.425 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.183 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -161.05 -98.92 0.14 Allowed Glycine 0 CA--C 1.487 -1.685 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.898 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 48.7 mm -83.83 123.02 38.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -124.43 128.09 48.5 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.271 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.491 HG13 ' HB ' ' A' ' 27' ' ' ILE . 55.4 t -74.44 110.84 9.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -82.42 -35.93 27.13 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.291 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.44 161.04 35.46 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.031 HG21 ' HB2' ' A' ' 59' ' ' GLU . 16.2 mm -116.32 115.68 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.905 ' HB ' ' HD3' ' A' ' 54' ' ' PRO 0.301 2.1 mp -103.3 -89.38 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.673 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -170.153 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.905 ' HD3' ' HB ' ' A' ' 53' ' ' ILE . 8.5 Cg_endo -91.88 129.79 1.12 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.757 2.305 . . . . 0.0 115.352 -167.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 78.09 -63.62 0.31 Allowed 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 125.726 1.61 . . . . 0.0 110.901 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.08 -83.54 0.13 Allowed Glycine 0 N--CA 1.405 -3.41 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.769 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 68.51 -83.11 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 125.652 1.581 . . . . 0.0 109.744 175.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.991 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -68.03 -38.3 82.37 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.031 ' HB2' HG21 ' A' ' 52' ' ' ILE . 39.3 tt0 -72.98 -43.94 61.65 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.986 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.6 p -76.88 -36.31 56.81 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.16 -34.12 70.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 174.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.47 43.85 11.89 Favored Glycine 0 N--CA 1.434 -1.489 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.18 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -110.83 -46.66 3.32 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.991 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 44.4 mt -104.42 127.01 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.465 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -125.57 157.84 36.12 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 136.3 51.3 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.451 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 112.12 -24.56 14.16 Favored Glycine 0 C--N 1.289 -2.058 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -171.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.747 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 78.2 m-20 -67.73 145.06 55.11 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.247 0.546 . . . . 0.0 111.745 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 70' ' ' VAL . 1.9 tmm_? -109.95 149.11 30.41 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.4 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.898 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.9 t -117.46 135.45 57.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.704 HD12 HD22 ' A' ' 100' ' ' LEU . 95.5 mt -98.24 -42.56 7.35 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.513 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.58 172.2 18.68 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.816 -172.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 1.0 HG11 HG21 ' A' ' 89' ' ' THR . 3.3 p -114.41 113.63 44.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.769 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 31.3 p30 39.4 42.37 0.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.36 1.464 . . . . 0.0 114.432 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.62 -15.01 62.6 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 120.567 -0.825 . . . . 0.0 114.592 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.557 ' HB ' HG13 ' A' ' 73' ' ' VAL . 46.9 t -92.8 110.07 22.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.5 m -67.62 127.22 31.92 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.739 HD13 HG13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.17 21.01 5.3 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.04 175.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -57.39 -27.34 62.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.118 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.51 23.77 21.62 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.726 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.97 157.55 16.74 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.9 t -83.7 170.93 13.71 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -49.96 -53.02 29.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.77 1.628 . . . . 0.0 110.787 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -63.33 -31.76 73.0 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.854 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -76.98 -39.18 51.43 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.259 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.693 ' HA ' HD22 ' A' ' 78' ' ' LEU . . . -52.09 -60.34 3.32 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.85 0.719 . . . . 0.0 109.896 173.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.14 -33.23 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.549 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.28 -34.72 79.01 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.271 0.558 . . . . 0.0 111.453 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 1.0 HG21 HG11 ' A' ' 73' ' ' VAL . 29.7 m -76.28 -33.95 59.1 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 62.5 mt -73.42 -20.07 60.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.609 0.719 . . . . 0.0 110.194 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -81.98 -40.52 22.05 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.593 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -69.78 -33.37 72.31 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.8 p -59.07 -63.07 1.44 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.24 -151.51 23.69 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.053 -1.07 . . . . 0.0 112.531 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -66.33 -45.33 80.63 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 124.071 0.512 . . . . 0.0 111.647 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.76 114.51 46.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.421 HG23 HD21 ' A' ' 25' ' ' LEU . 6.0 t -107.44 136.54 42.32 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.769 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 54.2 m80 -104.14 131.77 51.08 Favored 'General case' 0 N--CA 1.4 -2.934 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.475 HD11 HD22 ' A' ' 90' ' ' LEU . 6.1 mp -127.09 156.71 41.28 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 173.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.704 HD22 HD12 ' A' ' 71' ' ' LEU . 1.8 tt -108.42 114.09 27.67 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 13' ' ' THR . 11.1 mp -109.21 165.47 11.59 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.933 0.873 . . . . 0.0 112.799 -175.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -130.27 108.99 10.43 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 102.418 -3.178 . . . . 0.0 102.418 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.481 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 38.8 tptt -44.31 129.31 6.4 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 123.962 0.789 . . . . 0.0 110.667 -174.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.747 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -77.52 175.53 54.18 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 -169.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -148.28 145.58 28.24 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.1 m -107.42 104.96 54.64 Favored Pre-proline 0 N--CA 1.421 -1.875 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 C--O 1.258 1.515 0 C-N-CA 122.841 2.36 . . . . 0.0 111.913 -177.759 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 16.9 Cg_exo -71.28 45.77 0.67 Allowed 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 124.214 3.276 . . . . 0.0 113.363 -176.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.74 17.98 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.569 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.16 134.78 36.18 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.1 116.01 31.12 Favored 'General case' 0 C--N 1.285 -2.238 0 O-C-N 123.445 0.466 . . . . 0.0 110.386 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.454 ' CE2' HG22 ' A' ' 16' ' ' VAL . 29.8 p90 -158.47 157.77 32.82 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 43.0 mt-10 -86.59 106.52 17.62 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.454 HG22 ' CE2' ' A' ' 14' ' ' PHE . 32.0 t -69.52 134.4 30.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.286 177.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -104.64 100.8 10.45 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -109.08 118.6 37.18 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.95 125.01 40.21 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.849 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -63.05 131.99 50.46 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.049 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 t -59.57 -50.72 72.79 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.339 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 177.15 -24.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.73 71.99 0.46 Allowed Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.168 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.849 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 21.1 t 68.0 -166.29 0.2 Allowed 'General case' 0 C--O 1.251 1.138 0 C-N-CA 125.099 1.36 . . . . 0.0 111.647 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.492 HD22 HD12 ' A' ' 18' ' ' LEU . 96.2 mt -80.05 163.8 23.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.403 0.62 . . . . 0.0 110.518 -176.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.91 30.94 9.26 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -137.97 162.32 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.298 0 CA-C-O 121.624 0.726 . . . . 0.0 110.785 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 m -140.17 136.73 33.77 Favored 'General case' 0 N--CA 1.394 -3.269 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.877 172.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 49' ' ' VAL . 26.9 m -109.77 -165.74 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.741 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.156 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.608 ' HA ' ' ND1' ' A' ' 83' ' ' HIS . 14.1 t -165.91 167.64 16.54 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 171.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 81' ' ' ALA . 13.5 p -117.24 137.05 52.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.18 121.22 41.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -89.98 -160.08 0.66 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.109 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -59.33 -36.51 75.82 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.094 0.473 . . . . 0.0 111.497 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -92.74 110.58 22.02 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.66 -46.26 70.0 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.788 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.3 -60.18 4.84 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -99.27 24.4 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 123.564 0.746 . . . . 0.0 109.193 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 78.69 129.82 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.781 1.632 . . . . 0.0 109.379 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 t -94.24 140.76 29.36 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.015 0.912 . . . . 0.0 112.31 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.1 m -128.2 22.08 6.16 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 172.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.0 77.16 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.018 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -92.33 -24.22 19.0 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -166.57 143.88 5.02 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.62 97.69 0.51 Allowed Glycine 0 C--N 1.306 -1.102 0 C-N-CA 120.31 -0.947 . . . . 0.0 111.58 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.31 -13.18 42.81 Favored Glycine 0 CA--C 1.501 -0.824 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.832 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.758 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.8 mm -100.33 126.48 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HE1' ' HA2' ' A' ' 67' ' ' GLY . 1.5 t80 -120.11 114.31 21.78 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.393 -172.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.427 ' HA ' HG12 ' A' ' 29' ' ' VAL . 46.1 t -56.46 108.06 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 29' ' ' VAL . 37.5 ttpt -86.59 -36.31 18.93 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.117 -1.402 . . . . 0.0 110.697 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.757 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -155.69 154.79 32.06 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.397 -174.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.594 HD11 ' HA ' ' A' ' 65' ' ' HIS . 47.5 mm -109.12 114.35 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.713 HG22 ' HB2' ' A' ' 55' ' ' LYS . 1.7 mp -84.81 146.18 45.68 Favored Pre-proline 0 C--N 1.283 -2.302 0 C-N-CA 124.006 0.922 . . . . 0.0 112.059 -172.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . 0.261 16.4 Cg_exo -52.67 52.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.512 2.599 1 C-N-CA 126.456 4.77 . . . . 0.0 113.768 172.92 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.713 ' HB2' HG22 ' A' ' 53' ' ' ILE . 38.1 tptt -137.69 1.16 2.31 Favored 'General case' 0 N--CA 1.388 -3.528 0 O-C-N 121.764 -0.585 . . . . 0.0 109.594 -171.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.69 -136.75 24.85 Favored Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.163 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.743 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 67.73 -90.5 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.094 0.958 . . . . 0.0 111.096 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.916 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -71.3 -34.37 70.56 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.486 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 40.5 tt0 -72.19 -42.79 65.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 124.325 1.015 . . . . 0.0 110.525 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -70.11 -50.03 44.85 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.348 -175.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.7 -20.91 61.85 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.138 0.494 . . . . 0.0 110.182 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.89 43.8 97.02 Favored Glycine 0 CA--C 1.502 -0.742 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.006 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -105.06 -41.67 5.52 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.616 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 56.4 mt -115.64 136.34 52.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.594 ' HA ' HD11 ' A' ' 52' ' ' ILE . 22.7 t-80 -138.41 172.09 13.41 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.757 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 55.0 mtmt -58.96 116.13 3.59 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.48 0.712 . . . . 0.0 110.552 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.547 ' HA2' ' HE1' ' A' ' 48' ' ' TYR . . . 116.26 -11.88 16.79 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 119.611 -1.281 . . . . 0.0 112.957 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.728 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 5.9 m-20 -64.57 137.42 57.84 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.751 0.786 . . . . 0.0 112.652 176.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -93.44 122.96 36.4 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.315 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 61.3 t -100.47 119.61 48.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.0 mt -97.83 -43.99 6.9 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.548 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -154.96 172.07 18.68 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -173.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.897 HG23 HD21 ' A' ' 78' ' ' LEU . 39.5 t -121.06 114.05 41.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 172.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.2 p30 48.27 29.91 2.07 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.287 1.435 . . . . 0.0 112.9 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.58 -30.03 8.89 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.912 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.0 t -80.27 113.8 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 117.819 0.809 . . . . 0.0 109.821 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.9 p -74.98 131.46 40.67 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.897 HD21 HG23 ' A' ' 73' ' ' VAL . 1.9 mm? -85.27 9.46 15.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.349 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.59 106.5 5.39 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.25 2.74 24.65 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.482 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -106.52 155.21 19.84 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.9 t -91.78 172.28 8.58 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.608 ' ND1' ' HA ' ' A' ' 30' ' ' THR . 4.2 t60 -50.46 -50.01 53.59 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.26 1.024 . . . . 0.0 109.577 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 78.2 tttt -50.73 -50.32 55.75 Favored 'General case' 0 C--O 1.204 -1.328 0 O-C-N 124.476 1.11 . . . . 0.0 111.017 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -70.73 -34.9 72.37 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -172.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -56.72 -53.95 51.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.611 0.72 . . . . 0.0 109.385 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.531 ' HA ' HD12 ' A' ' 90' ' ' LEU . 97.9 t -65.94 -31.77 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.779 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 19.1 mm-40 -65.81 -31.26 72.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.046 0.451 . . . . 0.0 109.986 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.439 HG22 HG11 ' A' ' 73' ' ' VAL . 24.2 m -78.42 -30.66 47.76 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 87' ' ' VAL . 91.0 mt -71.23 -24.9 62.28 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.18 0.991 . . . . 0.0 109.45 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -86.03 -27.73 24.59 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.821 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -77.52 -34.37 54.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.405 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -58.5 -74.85 0.06 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.1 -131.83 4.1 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 119.714 -1.231 . . . . 0.0 112.658 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -73.35 -48.47 34.0 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.645 0.778 . . . . 0.0 112.151 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.64 128.74 75.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.453 0.644 . . . . 0.0 109.741 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.3 t -103.54 122.89 56.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.497 -175.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -94.28 111.57 23.31 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 172.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 73' ' ' VAL . 8.5 tp -118.63 127.01 53.18 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.9 tt -85.87 111.6 20.36 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.671 HD23 ' HB3' ' A' ' 68' ' ' ASP . 11.1 mp -120.43 174.59 6.45 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 122.121 0.962 . . . . 0.0 111.578 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -128.53 125.73 38.92 Favored 'General case' 0 N--CA 1.393 -3.318 0 N-CA-C 101.863 -3.384 . . . . 0.0 101.863 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 18.5 tptp -52.4 131.62 33.62 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 124.096 0.873 . . . . 0.0 111.191 -173.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.728 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -76.47 -172.0 34.16 Favored Glycine 0 N--CA 1.416 -2.666 0 N-CA-C 115.987 1.155 . . . . 0.0 115.987 -175.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -65.41 -38.0 88.63 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.437 -1.381 . . . . 0.0 114.287 -173.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.492 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 30.6 m -126.55 135.09 26.74 Favored Pre-proline 0 C--N 1.307 -1.243 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.646 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.2 Cg_endo . . . . . 0 C--O 1.253 1.266 0 C-N-CA 123.468 2.778 . . . . 0.0 111.097 177.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.674 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 69.5 mmtt . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.674 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 59.6 Cg_endo -73.07 102.61 1.48 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 121.855 1.703 . . . . 0.0 114.548 -162.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.631 ' H ' ' HB3' ' A' ' 103' ' ' LYS . . . 80.88 13.5 81.18 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.27 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 4.2 t70 -90.28 143.71 26.51 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 16.9 p -101.65 112.18 24.66 Favored 'General case' 0 N--CA 1.426 -1.636 0 O-C-N 123.738 0.648 . . . . 0.0 111.914 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -138.96 172.21 13.18 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.328 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 2.1 mp0 -104.61 117.87 35.19 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.4 HG21 HD11 ' A' ' 64' ' ' ILE . 13.4 m -87.95 117.55 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.318 0 CA-C-O 121.179 0.514 . . . . 0.0 110.358 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HG2' ' ND1' ' A' ' 98' ' ' HIS . 42.4 mt-10 -86.76 98.65 11.28 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.522 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.65 HD11 ' HA ' ' A' ' 58' ' ' ALA . 3.5 mm? -111.13 120.54 42.65 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.662 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.21 140.74 29.19 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.523 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -68.04 90.82 0.33 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.27 0.557 . . . . 0.0 111.256 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.8 t -58.21 -31.23 67.13 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.069 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -162.78 -68.21 0.05 OUTLIER 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.152 0.501 . . . . 0.0 110.325 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.54 86.04 0.33 Allowed Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.5 t 79.01 -159.12 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.77 1.228 . . . . 0.0 109.572 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.587 HD22 ' CB ' ' A' ' 18' ' ' LEU . 63.8 mt -87.44 -4.26 59.01 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.045 0.45 . . . . 0.0 111.567 -174.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.92 13.24 78.14 Favored Glycine 0 N--CA 1.419 -2.481 0 C-N-CA 119.859 -1.163 . . . . 0.0 110.689 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.507 ' HB ' HG13 ' A' ' 49' ' ' VAL . 20.1 pt -119.99 130.44 74.24 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.666 0 CA-C-O 122.193 0.996 . . . . 0.0 112.584 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.406 ' OG ' HD11 ' A' ' 53' ' ' ILE . 45.0 m -96.09 110.76 22.96 Favored 'General case' 0 C--N 1.262 -3.233 0 CA-C-N 113.775 -1.557 . . . . 0.0 107.536 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.42 153.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.982 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.588 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 7.9 t -137.78 157.85 45.59 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.78 127.5 52.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 48' ' ' TYR . 9.8 mp -105.84 92.7 4.28 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 122.142 0.972 . . . . 0.0 109.806 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -100.57 -28.59 12.8 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.097 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -165.28 -41.78 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.205 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -95.95 142.84 27.7 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.155 -174.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 134.58 -17.0 4.26 Favored Glycine 0 CA--C 1.498 -0.994 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.36 -160.37 32.49 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 105.618 -2.993 . . . . 0.0 105.618 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.3 74.35 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 118.907 1.354 . . . . 0.0 109.047 173.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -116.94 42.55 2.48 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.357 -172.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.9 m -72.75 -33.9 66.66 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.9 p -79.48 147.28 32.3 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 171.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -148.8 85.12 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -167.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.84 69.7 6.48 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.1 0.476 . . . . 0.0 109.745 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.7 m80 69.39 162.65 0.23 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.902 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.569 ' HA3' ' HG3' ' A' ' 69' ' ' ARG . . . 88.39 76.05 1.29 Allowed Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.46 -36.69 54.37 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 47.9 mm -110.11 139.81 31.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.309 -0.445 . . . . 0.0 109.997 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.695 ' HB2' HD13 ' A' ' 32' ' ' LEU . 8.9 m-85 -129.53 148.33 51.42 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.651 HG21 HG21 ' A' ' 64' ' ' ILE . 49.1 t -81.6 116.61 26.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 175.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' HG22 ' A' ' 30' ' ' THR . 61.5 tttp -79.15 -38.7 35.37 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.642 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.72 158.45 28.71 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.328 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.867 HG21 ' HB2' ' A' ' 59' ' ' GLU . 32.9 mm -109.07 121.79 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.468 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 48.4 mm -76.31 131.32 75.27 Favored Pre-proline 0 C--N 1.293 -1.872 0 C-N-CA 123.265 0.626 . . . . 0.0 110.698 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 24.6 Cg_exo -67.66 63.53 0.85 Allowed 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 124.067 3.178 . . . . 0.0 113.059 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -130.25 -55.76 1.1 Allowed 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.578 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 166.26 -160.74 34.35 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . 0.252 . . 71.26 -95.97 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 125.324 1.45 . . . . 0.0 113.114 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.65 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -61.33 -40.62 94.88 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.867 ' HB2' HG21 ' A' ' 52' ' ' ILE . 31.2 tt0 -86.32 -33.9 20.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.144 0.497 . . . . 0.0 110.559 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.578 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 29.5 m -74.72 -39.25 62.02 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.403 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.47 -32.32 48.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.97 64.25 1.81 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.874 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -121.65 -60.94 1.56 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.812 0.815 . . . . 0.0 108.926 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.651 HG21 HG21 ' A' ' 49' ' ' VAL . 34.7 mt -96.27 146.76 6.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.715 -174.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -136.58 -170.34 2.66 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -80.82 139.39 36.02 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.131 -1.027 . . . . 0.0 110.623 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.5 -10.31 61.08 Favored Glycine 0 N--CA 1.429 -1.828 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.957 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.478 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 30.9 m-20 -64.45 141.91 58.61 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 117.625 0.712 . . . . 0.0 112.271 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.569 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 40.5 ttm180 -92.41 121.86 34.29 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.239 -173.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.591 HG22 HD11 ' A' ' 101' ' ' LEU . 49.6 t -100.09 111.63 30.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.413 ' HB2' HD12 ' A' ' 100' ' ' LEU . 83.4 mt -91.72 -41.49 10.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.772 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -152.25 168.72 24.46 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.376 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.847 HG23 HD21 ' A' ' 78' ' ' LEU . 93.8 t -124.14 104.42 13.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 173.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.455 ' HB3' ' HB2' ' A' ' 98' ' ' HIS 0.311 1.8 p-10 47.12 45.86 16.1 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 122.219 1.009 . . . . 0.0 113.711 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.1 -16.92 60.09 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.205 -1.361 . . . . 0.0 114.269 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.1 t -90.97 108.49 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 118.016 0.908 . . . . 0.0 108.78 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 5.0 p -78.28 137.24 37.99 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -174.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.847 HD21 HG23 ' A' ' 73' ' ' VAL . 2.2 mm? -93.09 97.51 10.73 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -110.52 -46.03 3.45 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.288 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.14 45.12 1.11 Allowed Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 85' ' ' GLN . . . -95.55 -178.15 4.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.374 -0.413 . . . . 0.0 110.686 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.486 ' OG1' ' HG3' ' A' ' 85' ' ' GLN . 68.3 p -115.99 168.3 10.2 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 174.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 16.5 p-80 -53.58 -40.95 66.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.428 0.632 . . . . 0.0 110.192 173.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.04 -42.13 89.97 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.918 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.591 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 49.1 mt-30 -66.41 -32.47 73.87 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.507 0.594 . . . . 0.0 110.387 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.504 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -59.88 -50.46 73.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.494 0.664 . . . . 0.0 109.428 174.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.63 -30.55 50.56 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.098 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.57 -36.8 85.39 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.06 0.457 . . . . 0.0 110.22 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.1 m -69.62 -33.46 72.69 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 99' ' ' LEU . 90.2 mt -76.54 -23.58 53.63 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.344 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -82.05 -30.99 31.1 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -62.0 -43.85 97.98 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.721 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.493 HG21 HG13 ' A' ' 97' ' ' VAL . 34.9 p -70.64 154.21 42.08 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.67 176.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.46 -114.29 0.78 Allowed Glycine 0 N--CA 1.422 -2.258 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.756 -173.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -86.54 -39.82 15.84 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.851 -0.674 . . . . 0.0 110.961 -172.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.23 127.65 75.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.523 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 4.0 t -114.74 152.31 16.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 77.8 m-70 -123.93 71.47 1.11 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 90' ' ' LEU . 4.8 mp -65.15 144.07 57.45 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.999 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.772 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.9 tm? -93.03 107.98 19.65 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.591 HD11 HG22 ' A' ' 70' ' ' VAL . 2.7 mp -122.6 147.84 45.94 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.872 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 35.3 tt0 -118.16 127.5 53.82 Favored 'General case' 0 N--CA 1.397 -3.086 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 172.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.631 ' HB3' ' H ' ' A' ' 11' ' ' GLY . 5.5 tmtm? -54.29 114.36 1.61 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.092 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -87.96 86.03 1.5 Allowed Glycine 0 N--CA 1.426 -1.99 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.338 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -49.89 -62.48 1.54 Allowed 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.303 0.641 . . . . 0.0 110.342 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.9 t 63.47 125.96 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.187 0.995 . . . . 0.0 112.51 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.45 -1.052 0 C-N-CA 122.487 2.125 . . . . 0.0 109.943 174.663 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.435 ' C ' ' H ' ' A' ' 11' ' ' GLY . 51.1 mtpt . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.722 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 32.8 Cg_exo -68.91 42.48 0.29 Allowed 'Trans proline' 0 CA--C 1.56 1.814 0 C-N-CA 123.156 2.571 . . . . 0.0 111.789 172.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 9' ' ' LYS . . . -169.8 32.51 0.16 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 37.6 t70 -90.53 143.67 26.52 Favored 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 122.766 -0.256 . . . . 0.0 111.246 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p -93.35 124.42 37.32 Favored 'General case' 0 N--CA 1.425 -1.722 0 O-C-N 124.079 0.862 . . . . 0.0 110.143 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CE1' ' HD2' ' A' ' 63' ' ' ARG . 46.9 p90 -140.79 152.17 44.98 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.203 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.472 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 52.4 mt-10 -110.95 90.96 3.48 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.645 HG11 HD11 ' A' ' 64' ' ' ILE . 6.5 p -71.07 136.57 25.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.827 -175.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -96.13 93.58 7.03 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.88 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -97.56 116.85 30.56 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.309 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.63 131.37 44.26 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.9 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HD2' HD23 ' A' ' 25' ' ' LEU . 1.6 mptm? -66.8 124.25 22.4 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.081 172.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 t -113.75 10.57 17.88 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 34.1 t70 -155.47 -152.67 0.4 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' H ' ' CG ' ' A' ' 22' ' ' ASP . . . -104.81 15.54 48.43 Favored Glycine 0 C--N 1.296 -1.639 0 CA-C-N 119.83 1.196 . . . . 0.0 110.302 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -142.64 165.76 26.52 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.63 HD22 HD12 ' A' ' 18' ' ' LEU . 92.4 mt -85.7 173.74 9.88 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 170.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.83 32.66 5.46 Favored Glycine 0 C--N 1.289 -2.052 0 C-N-CA 120.024 -1.084 . . . . 0.0 111.141 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 64' ' ' ILE . 15.0 pt -139.47 143.4 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-O 121.35 0.595 . . . . 0.0 111.905 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.41 ' HB2' HD11 ' A' ' 53' ' ' ILE . 32.9 t -103.01 128.3 49.9 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 49' ' ' VAL . 26.9 m -125.08 151.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-O 120.872 0.368 . . . . 0.0 110.691 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.7 t -133.25 173.53 11.35 Favored 'General case' 0 N--CA 1.392 -3.359 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.59 HG13 ' HG ' ' A' ' 32' ' ' LEU . 10.0 p -86.28 -48.14 15.99 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.302 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -171.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.59 ' HG ' HG13 ' A' ' 31' ' ' VAL . 1.4 pp -120.11 147.51 44.77 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -146.36 99.81 3.28 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 125.544 1.537 . . . . 0.0 107.177 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -119.55 108.27 14.3 Favored 'General case' 0 C--N 1.294 -1.804 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.646 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -112.35 31.65 6.14 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -99.05 -39.39 3.55 Favored Glycine 0 N--CA 1.424 -2.144 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.595 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.81 -88.42 0.46 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.6 -43.73 77.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -93.6 143.81 25.96 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.4 p -94.71 139.63 30.98 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-O 121.061 0.458 . . . . 0.0 111.905 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 m -79.04 104.64 9.82 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 171.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.35 -176.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -171.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.579 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 30.2 ttm180 -70.65 87.38 0.67 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.909 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.424 ' HB3' ' NH2' ' A' ' 69' ' ' ARG . 9.8 t60 -136.49 94.21 2.98 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.98 ' HA2' ' HA ' ' A' ' 71' ' ' LEU . . . 107.07 -96.07 1.06 Allowed Glycine 0 N--CA 1.412 -2.961 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.95 -37.69 2.01 Favored Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.5 mm -123.72 149.29 27.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.415 ' CE2' ' HG2' ' A' ' 69' ' ' ARG . 79.1 m-85 -130.22 139.35 50.81 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 122.036 -0.415 . . . . 0.0 111.089 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 29' ' ' VAL . 58.2 t -72.39 110.8 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -78.38 -39.8 38.04 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.018 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.69 170.44 14.1 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 -174.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.6 mm -102.65 115.47 44.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.494 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 33.6 mm -75.25 124.8 89.4 Favored Pre-proline 0 C--N 1.31 -1.15 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 5.6 Cg_exo -74.48 77.49 2.92 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 122.802 2.334 . . . . 0.0 112.479 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 50.5 mmtt -136.18 12.71 3.31 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.78 173.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.12 -139.6 19.24 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.72 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 67.51 -93.53 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 123.674 0.789 . . . . 0.0 112.0 173.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.88 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -75.1 -32.27 61.38 Favored 'General case' 0 C--O 1.256 1.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.21 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.49 -39.21 65.03 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 125.191 1.557 . . . . 0.0 110.003 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -73.75 -41.29 62.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.73 -31.13 69.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.37 34.37 79.69 Favored Glycine 0 CA--C 1.49 -1.517 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.707 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.431 ' HG2' ' CG2' ' A' ' 16' ' ' VAL . 15.8 tpp180 -101.23 -37.86 8.35 Favored 'General case' 1 N--CA 1.362 -4.837 0 CA-C-O 121.091 0.472 . . . . 0.0 110.876 -174.144 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 27' ' ' ILE . 22.8 mm -96.29 138.12 22.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.011 -173.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -124.48 161.7 25.52 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -76.4 137.23 39.62 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.861 -1.136 . . . . 0.0 109.885 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.15 -10.61 47.63 Favored Glycine 0 N--CA 1.425 -2.1 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.469 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -68.15 143.39 55.41 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.442 0.639 . . . . 0.0 111.176 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.424 ' NH2' ' HB3' ' A' ' 44' ' ' HIS . 43.4 mtp180 -95.07 125.97 40.09 Favored 'General case' 0 CA--C 1.469 -2.147 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.347 -174.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.545 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 44.4 t -94.22 106.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.832 0 CA-C-N 114.077 -1.42 . . . . 0.0 107.477 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.98 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 56.2 mt -84.44 -35.86 22.74 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.74 -175.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' A' ' 77' ' ' SER . . . -166.8 170.81 12.0 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.856 ' HA ' HD12 ' A' ' 99' ' ' LEU . 49.0 t -111.56 103.16 15.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 174.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.991 ' HB3' ' HB2' ' A' ' 98' ' ' HIS 0.283 1.1 p-10 39.43 70.58 0.21 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -178.226 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.61 -32.19 2.91 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.098 -0.956 . . . . 0.0 114.645 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.4 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 60.3 t -81.39 108.38 14.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 118.008 0.904 . . . . 0.0 109.582 -176.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.412 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 13.7 p -63.28 139.18 58.74 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.609 HD11 HG23 ' A' ' 73' ' ' VAL . 71.9 mt -104.03 27.62 7.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.923 0.868 . . . . 0.0 109.158 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.579 ' HB2' ' HD3' ' A' ' 43' ' ' ARG . 9.3 pt-20 -49.63 -33.38 15.22 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.027 1.731 . . . . 0.0 113.081 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.78 46.15 1.07 Allowed Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HB1' ' HG3' ' A' ' 85' ' ' GLN . . . -106.26 154.85 20.15 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.56 0.219 . . . . 0.0 111.155 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.497 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.2 t -100.71 160.52 14.29 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 168.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.55 ' H ' ' HB ' ' A' ' 31' ' ' VAL . 39.0 p-80 -51.23 -48.33 62.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 18.8 ptmt -67.46 -30.28 69.95 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.434 ' HG3' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -73.97 -36.65 64.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.457 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.548 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.6 -46.61 83.85 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.71 -32.73 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.684 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 41.8 mt-10 -73.28 -26.46 61.1 Favored 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.198 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.463 HG22 HG11 ' A' ' 73' ' ' VAL . 47.4 m -74.19 -26.88 60.53 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.638 HD22 HG11 ' A' ' 97' ' ' VAL . 68.3 mt -74.93 -26.33 59.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -84.25 -28.77 26.98 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.11 -35.26 79.37 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.163 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.7 p -72.06 -66.33 0.66 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.392 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.38 -136.73 7.39 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.435 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.425 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 29.4 tt0 -69.9 -51.38 33.62 Favored 'General case' 0 C--O 1.211 -0.966 0 O-C-N 124.167 0.569 . . . . 0.0 111.117 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.0 125.46 66.08 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 117.863 -1.535 . . . . 0.0 111.348 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.638 HG11 HD22 ' A' ' 90' ' ' LEU . 35.4 t -113.18 126.19 70.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.4 -177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.991 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 11.2 m170 -89.99 125.5 35.41 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 171.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.856 HD12 ' HA ' ' A' ' 73' ' ' VAL . 8.3 tp -123.77 136.28 54.32 Favored 'General case' 0 C--N 1.259 -3.339 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 71' ' ' LEU . 1.3 tt -93.8 113.48 25.54 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.738 HD11 HD23 ' A' ' 99' ' ' LEU . 7.2 mp -125.25 165.78 17.68 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.341 0.591 . . . . 0.0 111.884 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' A' ' 71' ' ' LEU . 37.0 tt0 -130.99 134.06 46.35 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 54.4 mmtt -56.2 125.38 21.51 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.631 0.729 . . . . 0.0 112.823 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -113.26 67.91 0.24 Allowed Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.722 ' HB2' ' HB3' ' A' ' 10' ' ' PRO . 85.2 mt-30 -111.85 -150.03 0.46 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 122.89 -0.182 . . . . 0.0 110.658 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.685 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 49.6 t -88.89 -65.05 0.19 Allowed Pre-proline 0 CA--C 1.562 1.442 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -172.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.685 ' HD3' ' HB ' ' A' ' 106' ' ' VAL . 5.9 Cg_endo . . . . . 0 C--O 1.255 1.353 0 C-N-CA 122.269 1.979 . . . . 0.0 112.294 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp . . . . . 0 N--CA 1.434 -1.238 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.876 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 32.4 Cg_exo -62.67 135.76 54.42 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 N-CA-C 107.778 -1.662 . . . . 0.0 107.778 170.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.73 -1.63 52.52 Favored Glycine 0 N--CA 1.426 -2.011 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.051 -171.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -100.11 149.63 23.32 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-N 117.443 0.622 . . . . 0.0 111.242 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 7.9 p -89.0 145.96 25.17 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.176 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.403 ' CE1' ' HD2' ' A' ' 103' ' ' LYS . 2.6 p90 -143.75 136.29 27.09 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -97.26 110.71 23.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 33.9 t -89.56 119.56 36.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.08 -172.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -101.62 88.6 3.46 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 169.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.846 HD11 ' HB1' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -93.22 117.0 29.56 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -174.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.54 116.77 29.17 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -62.9 139.06 58.71 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.981 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.563 HG21 ' HG3' ' A' ' 55' ' ' LYS . 1.8 m -67.34 -68.85 0.35 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.011 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' H ' ' HB ' ' A' ' 21' ' ' THR . 20.7 t70 -103.64 -79.21 0.54 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.44 16.49 2.27 Favored Glycine 0 C--N 1.3 -1.464 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m -117.78 144.11 45.64 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.453 -174.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.435 HD12 HD13 ' A' ' 90' ' ' LEU . 90.4 mt -86.14 175.69 8.38 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.526 ' HA3' ' H ' ' A' ' 58' ' ' ALA . . . -108.69 32.86 6.59 Favored Glycine 0 C--N 1.291 -1.93 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.145 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.47 HG23 ' CB ' ' A' ' 58' ' ' ALA . 7.6 pt -137.13 138.37 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.77 0 CA-C-O 121.222 0.534 . . . . 0.0 111.721 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 11.8 t -111.7 109.34 19.16 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 176.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 34.6 m -100.12 168.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.549 -174.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -147.8 169.01 20.69 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 171.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 82' ' ' THR . 11.1 p -121.25 147.08 25.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.628 HD13 ' CD1' ' A' ' 48' ' ' TYR . 9.5 mp -91.47 92.94 8.76 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.582 1.182 . . . . 0.0 109.197 172.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -124.41 -50.42 1.77 Allowed 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 112.88 -1.964 . . . . 0.0 108.173 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.88 -38.57 32.36 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.825 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -102.34 150.2 23.57 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.59 -171.61 34.22 Favored Glycine 0 C--N 1.293 -1.85 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.2 -67.27 1.03 Allowed Glycine 0 C--N 1.3 -1.427 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 p -85.51 -43.7 16.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -64.19 -46.78 82.47 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -162.08 126.47 3.25 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.9 m -65.72 -54.2 30.53 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.032 0.444 . . . . 0.0 110.311 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.0 m -92.7 163.51 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.168 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.677 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 84.0 mtt180 -83.19 83.36 7.88 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.47 ' O ' ' HD3' ' A' ' 69' ' ' ARG . 12.1 t-80 -71.25 108.1 4.57 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 71' ' ' LEU . . . 87.13 -56.94 4.59 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -172.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.677 ' HA2' ' HB3' ' A' ' 43' ' ' ARG . . . 105.31 -49.59 0.89 Allowed Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.203 -0.499 . . . . 0.0 112.407 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.799 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 48.1 mm -105.25 140.29 23.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.628 ' CD1' HD13 ' A' ' 32' ' ' LEU . 81.1 m-85 -135.33 112.71 10.59 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.687 HG21 HG21 ' A' ' 64' ' ' ILE . 59.9 t -46.33 120.14 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.587 0.708 . . . . 0.0 111.278 172.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -91.18 -34.6 14.95 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.491 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 28' ' ' SER . . . -154.69 158.2 39.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.203 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.0 mm -108.68 118.59 56.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 49.1 mm -87.84 134.29 35.76 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.473 ' HB2' ' H ' ' A' ' 55' ' ' LYS . 16.0 Cg_exo -69.19 -102.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 121.763 1.642 . . . . 0.0 111.836 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HG3' HG21 ' A' ' 21' ' ' THR . 16.1 tppt? 67.86 -59.48 0.42 Allowed 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 125.719 1.608 . . . . 0.0 110.885 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.84 48.24 0.03 OUTLIER Glycine 0 N--CA 1.424 -2.127 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.846 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -135.59 -98.39 0.23 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.801 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -69.22 -33.59 73.53 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 118.171 0.441 . . . . 0.0 111.324 -174.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -70.42 -45.57 65.63 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 124.172 0.92 . . . . 0.0 109.193 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 t -72.5 -44.35 62.35 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.483 -174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -74.87 -19.21 60.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.898 0.856 . . . . 0.0 108.94 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.72 67.8 2.02 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.491 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.529 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -119.92 -67.54 0.97 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.097 0.475 . . . . 0.0 110.734 -179.158 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.687 HG21 HG21 ' A' ' 49' ' ' VAL . 63.7 mt -85.5 139.63 17.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.41 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -124.77 178.45 5.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -71.25 129.6 39.29 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.765 0.317 . . . . 0.0 110.697 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.55 -15.49 53.18 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.934 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.486 ' HA ' ' H ' ' A' ' 104' ' ' GLY . 75.9 m-20 -64.54 138.01 58.17 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 121.658 0.742 . . . . 0.0 112.033 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 44' ' ' HIS . 36.3 ttm180 -90.41 129.38 36.61 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 114.603 -1.181 . . . . 0.0 110.376 -173.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.799 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.2 t -97.01 104.35 15.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.609 HD12 HD22 ' A' ' 100' ' ' LEU . 93.7 mt -78.09 -39.56 41.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.094 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 77' ' ' SER . . . -159.11 166.74 30.89 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.956 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.911 HG23 HD21 ' A' ' 78' ' ' LEU . 98.7 t -119.05 97.71 5.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 52.4 t30 54.2 60.37 3.63 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 124.247 1.019 . . . . 0.0 109.987 -178.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.89 -36.02 2.32 Favored Glycine 0 CA--C 1.548 2.105 0 CA-C-N 114.517 -1.219 . . . . 0.0 114.398 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.86 108.79 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 20.9 m -85.38 142.82 29.02 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.479 0.657 . . . . 0.0 112.602 -173.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.911 HD21 HG23 ' A' ' 73' ' ' VAL . 1.6 mm? -99.21 22.98 9.73 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.977 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 43' ' ' ARG . 26.5 mt-10 -67.36 -22.24 65.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.114 0.483 . . . . 0.0 112.283 -175.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.55 25.68 8.97 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 174.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 85' ' ' GLN . . . -105.99 -172.03 2.01 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.515 0.674 . . . . 0.0 111.509 -176.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.64 ' HA ' HG21 ' A' ' 31' ' ' VAL . 6.6 t -144.91 178.85 7.72 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -50.55 -55.89 14.14 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.968 0.907 . . . . 0.0 111.847 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 33.0 mmtp -65.23 -25.09 67.53 Favored 'General case' 0 C--O 1.211 -0.969 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HB2' ' H ' ' A' ' 82' ' ' THR . 16.3 mm100 -76.59 -44.89 32.55 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.498 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -58.26 -54.32 48.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.444 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.59 -27.69 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.827 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 84' ' ' LYS . 34.1 tt0 -70.88 -34.75 71.92 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 121.702 -0.624 . . . . 0.0 109.317 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.7 m -71.4 -30.59 66.27 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.72 HD21 HD21 ' A' ' 99' ' ' LEU . 94.0 mt -76.8 -12.28 59.95 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.203 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.456 ' HD3' ' HA ' ' A' ' 91' ' ' ARG . 14.0 mmt180 -92.93 -31.7 14.83 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.75 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.01 -38.35 90.65 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.708 0.766 . . . . 0.0 109.199 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.2 p -74.42 146.35 42.96 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.91 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -79.16 -135.06 1.07 Allowed Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 121.453 -0.403 . . . . 0.0 113.65 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -72.87 -49.33 30.63 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.104 0.478 . . . . 0.0 110.484 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 45.8 t -98.93 112.73 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 t -108.52 137.94 37.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.124 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 12.7 m-70 -96.05 129.49 43.32 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 173.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.72 HD21 HD21 ' A' ' 90' ' ' LEU . 5.9 mp -127.11 141.81 51.67 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.609 HD22 HD12 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -99.78 113.81 26.55 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.714 ' HG ' ' HA ' ' A' ' 70' ' ' VAL . 7.3 mp -127.43 163.07 24.88 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 118.727 0.694 . . . . 0.0 112.299 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.664 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 36.0 tt0 -131.01 128.77 41.03 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.876 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 6.4 tptp -49.93 113.15 0.79 Allowed 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.267 0.979 . . . . 0.0 110.404 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 68' ' ' ASP . . . -115.48 18.28 15.55 Favored Glycine 0 C--N 1.29 -1.996 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.936 -173.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -63.32 107.13 1.02 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.345 0.593 . . . . 0.0 112.182 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 54.4 t -92.57 105.3 13.94 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.18 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 5.3 Cg_exo . . . . . 0 C--O 1.255 1.342 0 C-N-CA 123.239 2.626 . . . . 0.0 110.957 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.585 ' CB ' ' HD3' ' A' ' 10' ' ' PRO 0.362 66.6 mttm . . . . . 0 CA--C 1.54 0.587 0 CA-C-O 117.011 -1.471 . . . . 0.0 110.658 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HD3' ' CB ' ' A' ' 9' ' ' LYS . 17.8 Cg_exo -67.06 134.8 35.34 Favored 'Trans proline' 0 C--N 1.377 2.044 0 CA-C-N 122.899 2.071 . . . . 0.0 110.093 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.21 -13.39 67.43 Favored Glycine 0 C--N 1.3 -1.457 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.227 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -82.59 141.41 32.58 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 40.2 p -92.6 140.89 29.09 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -139.95 141.64 36.44 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.378 0.609 . . . . 0.0 111.343 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.675 ' HB3' ' HE2' ' A' ' 98' ' ' HIS . 3.1 mp0 -83.89 108.47 16.9 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.356 -1.293 . . . . 0.0 107.953 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.24 125.8 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.063 0 CA-C-O 121.628 0.728 . . . . 0.0 111.519 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -102.37 113.63 27.11 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 57' ' ' ALA . 2.7 tm? -109.57 116.27 31.44 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.43 118.54 33.16 Favored 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 94.1 mttt -59.51 119.29 7.24 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 124.059 0.849 . . . . 0.0 110.304 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.715 ' HB ' ' O ' ' A' ' 56' ' ' GLY . 19.0 m -76.13 -67.44 0.68 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.643 -176.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -152.65 -48.49 0.1 Allowed 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.73 35.65 2.68 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.253 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.8 p 71.64 -132.23 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.616 1.966 . . . . 0.0 111.977 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.542 ' HG ' HD13 ' A' ' 90' ' ' LEU . 3.3 mm? -72.3 -30.64 64.98 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.836 0.826 . . . . 0.0 109.547 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.73 22.33 62.04 Favored Glycine 0 N--CA 1.402 -3.615 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.431 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.449 ' HB ' HG13 ' A' ' 49' ' ' VAL . 19.9 pt -135.2 143.26 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.692 0 CA-C-O 121.677 0.751 . . . . 0.0 111.056 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.3 t -97.11 118.01 32.57 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.72 140.89 47.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.416 0.627 . . . . 0.0 112.062 -173.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 47' ' ' ILE . 11.4 t -138.61 -171.84 3.16 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -172.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.864 ' HA ' HD13 ' A' ' 47' ' ' ILE . 79.5 t -79.6 -51.08 17.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 174.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.621 HD11 ' HA ' ' A' ' 44' ' ' HIS . 46.1 mt -169.89 -57.15 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 127.784 2.433 . . . . 0.0 104.865 175.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.1 p90 179.71 165.66 1.13 Allowed 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -83.87 113.18 20.77 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.618 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.832 ' HE3' HG21 ' A' ' 42' ' ' VAL . 24.4 ttmm -94.4 -69.92 0.73 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.416 -175.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.34 -140.03 14.68 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.35 27.61 16.46 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.659 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 m -104.28 87.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.306 0.574 . . . . 0.0 111.937 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.8 t30 67.38 92.65 0.08 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.849 1.259 . . . . 0.0 111.152 -176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.2 t -103.24 13.2 34.45 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.921 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.3 t -85.6 16.43 3.89 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 122.083 0.944 . . . . 0.0 109.528 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.832 HG21 ' HE3' ' A' ' 35' ' ' LYS . 36.0 m -96.05 153.34 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.817 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -96.51 101.36 12.97 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.621 ' HA ' HD11 ' A' ' 32' ' ' LEU . 96.5 m-70 -64.53 -38.88 92.54 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.95 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.26 -56.15 3.57 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 -173.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 79' ' ' GLU . . . 155.22 -63.41 0.34 Allowed Glycine 0 CA--C 1.471 -2.704 0 CA-C-N 114.968 -0.616 . . . . 0.0 111.773 173.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.864 HD13 ' HA ' ' A' ' 31' ' ' VAL . 17.4 mm -141.15 152.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.595 ' HB2' HD23 ' A' ' 32' ' ' LEU . 39.1 t80 -139.41 138.15 36.27 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.331 0.652 . . . . 0.0 111.094 -174.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.449 HG13 ' HB ' ' A' ' 27' ' ' ILE . 44.2 t -78.48 103.1 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.459 ' HB2' HG22 ' A' ' 30' ' ' THR . 88.1 tttt -68.89 -41.24 78.57 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.844 -174.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.84 159.39 32.49 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.212 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 23.4 mm -113.24 134.87 54.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 55' ' ' LYS . 1.8 mp -79.44 128.4 75.35 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.55 -15.61 9.24 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 125.26 3.974 . . . . 0.0 115.27 -175.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' H ' HG22 ' A' ' 53' ' ' ILE . 22.9 tptm -162.59 64.44 0.21 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.938 0.875 . . . . 0.0 109.644 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.715 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -114.49 -54.34 0.41 Allowed Glycine 0 C--N 1.303 -1.264 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.651 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' HB2' ' H ' ' A' ' 21' ' ' THR . . . 176.65 -68.13 0.01 OUTLIER 'General case' 0 C--O 1.173 -2.957 0 O-C-N 125.48 1.341 . . . . 0.0 111.641 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.885 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -49.47 -37.29 25.57 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -173.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -78.84 -48.6 14.41 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -71.6 -35.97 70.66 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.795 -172.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.56 -37.23 56.94 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.41 77.04 1.08 Allowed Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 114.418 -1.265 . . . . 0.0 114.001 173.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -157.98 -47.0 0.06 Allowed 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.885 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 77.1 mt -88.63 132.41 33.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -120.19 164.61 15.97 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 123.533 0.521 . . . . 0.0 109.61 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -63.44 128.96 38.19 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.568 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.621 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 98.92 -8.59 61.36 Favored Glycine 0 N--CA 1.419 -2.482 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.545 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.441 ' HB3' HD23 ' A' ' 101' ' ' LEU . 80.7 m-20 -66.67 139.81 57.87 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-O 121.244 0.545 . . . . 0.0 110.603 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.656 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . 27.7 ttm-85 -98.67 143.63 28.84 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -174.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.44 HG12 HD21 ' A' ' 78' ' ' LEU . 48.5 t -109.9 120.03 60.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.558 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -177.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 100' ' ' LEU . 57.6 mt -101.82 -33.8 9.67 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.963 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -151.75 160.06 43.72 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.188 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.993 HG11 HG21 ' A' ' 89' ' ' THR . 2.6 p -116.65 104.6 16.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 174.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HA ' ' ND1' ' A' ' 98' ' ' HIS . 61.6 t30 55.12 37.68 29.29 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.438 1.114 . . . . 0.0 109.901 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.68 -23.73 35.08 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 120.275 -0.964 . . . . 0.0 114.182 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.562 ' HB ' HG13 ' A' ' 73' ' ' VAL . 44.1 t -80.96 113.15 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 118.458 1.129 . . . . 0.0 109.021 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.3 t -72.82 109.61 6.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.106 0.479 . . . . 0.0 110.134 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.77 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.5 pt? -97.63 33.12 2.12 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 122.233 1.016 . . . . 0.0 110.935 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.547 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 11.8 pt-20 -58.25 -28.65 65.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.131 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.9 30.97 7.07 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.54 -164.12 1.12 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.548 ' H ' ' HB2' ' A' ' 85' ' ' GLN . 13.5 t -144.18 177.72 8.4 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -50.3 -53.15 30.68 Favored 'General case' 0 C--O 1.265 1.913 0 C-N-CA 124.897 1.279 . . . . 0.0 110.67 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 97.5 mttt -59.36 -47.92 83.59 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.019 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.548 ' HB2' ' H ' ' A' ' 82' ' ' THR . 28.8 mm-40 -64.3 -42.69 96.25 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.542 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -50.55 -60.32 3.14 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-O 121.428 0.632 . . . . 0.0 110.387 175.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.07 -31.8 55.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.428 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 42.6 mm-40 -69.58 -34.15 73.73 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 122.097 -0.377 . . . . 0.0 111.016 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.993 HG21 HG11 ' A' ' 73' ' ' VAL . 45.0 m -65.14 -38.48 90.74 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 177.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.77 HD21 HD21 ' A' ' 99' ' ' LEU . 81.6 mt -72.84 -23.49 60.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.731 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -84.11 -30.55 25.86 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.893 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.97 -41.13 87.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.089 0.471 . . . . 0.0 109.892 175.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 20.1 p -68.92 155.04 40.98 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.916 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -71.24 -147.57 0.51 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 114.84 0.696 . . . . 0.0 114.84 -176.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 62.4 tt0 -74.38 -35.89 63.51 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.21 -0.495 . . . . 0.0 110.907 -177.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.71 111.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 t -110.0 146.23 15.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.675 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 58.5 t-80 -109.68 134.47 51.94 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 175.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.77 HD21 HD21 ' A' ' 90' ' ' LEU . 6.4 mp -130.28 153.36 48.72 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 173.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.739 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.3 tm? -106.09 109.79 21.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.441 HD23 ' HB3' ' A' ' 68' ' ' ASP . 8.0 mp -111.38 171.43 7.48 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-O 121.668 0.747 . . . . 0.0 111.939 -175.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.656 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 29.3 tt0 -128.4 132.69 48.5 Favored 'General case' 0 N--CA 1.396 -3.164 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 175.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 15.6 tppt? -63.05 112.79 2.76 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . -91.32 -158.18 34.41 Favored Glycine 0 N--CA 1.409 -3.163 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.31 -172.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -161.31 -167.33 1.74 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -172.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.652 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 89.8 t -65.72 -55.2 24.48 Favored Pre-proline 0 CA--C 1.566 1.584 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.236 171.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.652 ' HD3' ' HB ' ' A' ' 106' ' ' VAL . 4.3 Cg_exo . . . . . 0 C--N 1.371 1.748 0 C-N-CA 123.173 2.582 . . . . 0.0 111.899 176.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.574 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 63.4 mttp . . . . . 0 CA--C 1.547 0.858 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.58 ' HB3' ' HG3' ' A' ' 105' ' ' GLN . 12.2 Cg_exo -75.01 40.49 0.66 Allowed 'Trans proline' 0 C--N 1.395 3.003 0 C-N-CA 123.969 3.113 . . . . 0.0 113.05 -176.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.98 43.1 0.02 OUTLIER Glycine 0 C--N 1.283 -2.381 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 23.1 t0 -116.73 153.73 31.87 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.8 p -92.09 144.75 25.12 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 123.599 0.562 . . . . 0.0 109.706 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -157.77 153.67 26.89 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 41.4 mt-10 -110.73 89.2 2.97 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.456 HG12 HD13 ' A' ' 101' ' ' LEU . 14.1 p -81.47 143.18 12.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.433 -175.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -104.2 111.4 23.98 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.784 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -111.34 126.72 55.22 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.054 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -101.47 142.05 33.43 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.461 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.748 ' HB2' ' HG3' ' A' ' 95' ' ' GLN . 29.5 mmtm -65.36 118.14 8.92 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.6 m -90.18 -61.39 1.69 Allowed 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.117 0.484 . . . . 0.0 111.804 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -152.88 -45.65 0.1 Allowed 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 121.762 0.792 . . . . 0.0 109.009 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 24' ' ' SER . . . -123.48 51.28 0.81 Allowed Glycine 0 N--CA 1.418 -2.51 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.57 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.543 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 25.7 m 80.45 -147.67 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.753 1.221 . . . . 0.0 110.279 175.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 90' ' ' LEU . 28.6 mt -80.46 -10.95 59.74 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.135 0.493 . . . . 0.0 109.73 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.55 8.99 84.03 Favored Glycine 0 N--CA 1.42 -2.405 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.059 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 25' ' ' LEU . 25.7 pt -114.76 134.33 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 121.997 0.903 . . . . 0.0 112.766 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.2 t -97.12 107.59 20.14 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.843 -1.526 . . . . 0.0 106.921 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.485 ' HB ' ' CG2' ' A' ' 47' ' ' ILE . 34.1 m -96.84 152.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 120.737 0.303 . . . . 0.0 110.561 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 50' ' ' LYS . 11.1 t -142.84 156.03 44.88 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 81' ' ' ALA . 7.2 p -118.9 111.17 32.45 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 CA-C-O 121.38 0.61 . . . . 0.0 110.212 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.37 132.92 36.56 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -97.15 1.03 49.4 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.745 -173.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -76.13 26.46 0.12 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HE3' ' CB ' ' A' ' 44' ' ' HIS . 56.8 mttp -81.14 102.39 10.25 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.52 53.39 4.82 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.078 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.48 -46.92 2.57 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.1 159.24 9.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.458 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . 22.9 p-10 -69.52 142.78 53.6 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.315 0.578 . . . . 0.0 110.245 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.5 t -127.56 -115.2 0.27 Allowed 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.94 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -62.45 -58.11 8.8 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.1 m -84.62 168.92 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.682 175.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.458 ' HG2' ' HB2' ' A' ' 39' ' ' ASN . 84.5 mtt180 -137.78 140.19 40.46 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.419 ' CB ' ' HE3' ' A' ' 35' ' ' LYS . 35.6 m80 -122.33 -48.01 2.1 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.21 -81.92 1.04 Allowed Glycine 0 CA--C 1.495 -1.207 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.33 -80.28 0.09 OUTLIER Glycine 0 N--CA 1.414 -2.796 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.897 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 49.9 mm -114.35 154.18 15.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 123.433 0.693 . . . . 0.0 109.368 -175.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -128.35 133.5 48.68 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 122.941 0.496 . . . . 0.0 109.79 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.456 HG21 ' CG2' ' A' ' 64' ' ' ILE . 58.8 t -80.06 111.65 17.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HB2' HG22 ' A' ' 30' ' ' THR . 38.7 ttpt -79.88 -41.71 25.68 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.034 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.64 41.41 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.848 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 46.0 mm -113.47 124.16 69.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -81.2 122.18 81.16 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 38.5 Cg_endo -69.16 80.26 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.666 2.244 . . . . 0.0 112.099 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -143.3 -42.93 0.29 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.147 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.51 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 156.09 -160.17 29.89 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.359 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.528 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 67.67 -102.68 0.07 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.347 1.459 . . . . 0.0 112.819 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.784 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -65.79 -36.69 84.24 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.355 0.525 . . . . 0.0 111.081 -176.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.464 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 45.1 tt0 -67.56 -47.6 69.35 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.265 1.026 . . . . 0.0 111.289 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 52.1 m -69.74 -42.68 73.6 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.694 -177.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -71.17 -27.72 63.73 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.048 0.928 . . . . 0.0 108.887 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.51 43.33 94.86 Favored Glycine 0 CA--C 1.498 -0.981 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.657 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.518 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -107.19 -51.04 2.98 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.769 -178.491 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.692 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 59.1 mt -101.66 126.67 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -125.23 166.19 16.94 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -63.13 125.73 25.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.32 -23.61 15.61 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.683 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.493 ' HB3' HD23 ' A' ' 101' ' ' LEU . 37.8 m-20 -66.82 141.53 57.66 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.32 0.581 . . . . 0.0 110.73 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -106.4 143.79 34.01 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.545 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.897 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 51.4 t -107.93 123.02 63.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.159 -175.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 102' ' ' GLU . 90.1 mt -99.36 -33.8 10.56 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.84 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.672 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -160.65 163.7 32.33 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.952 HG23 HD11 ' A' ' 78' ' ' LEU . 94.2 t -111.4 115.47 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 173.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 47.03 39.35 7.67 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 126.996 2.119 . . . . 0.0 110.983 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.83 -18.46 56.56 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 119.848 -1.168 . . . . 0.0 114.78 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t -81.58 112.95 20.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 45.7 m -64.31 133.83 53.46 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.862 0.839 . . . . 0.0 113.06 -171.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.952 HD11 HG23 ' A' ' 73' ' ' VAL . 79.4 mt -107.39 15.49 24.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.733 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.26 97.54 1.57 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.81 25.79 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.424 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -86.45 142.96 28.01 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.0 t -85.56 168.09 14.8 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 172.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . 57.0 t-80 -50.38 -49.87 53.16 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.652 0.781 . . . . 0.0 110.915 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -53.79 -38.62 64.69 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.939 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -70.58 -51.8 25.89 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 120.707 -0.397 . . . . 0.0 109.951 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.57 -57.93 8.99 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 123.97 0.794 . . . . 0.0 111.804 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 83' ' ' HIS . 37.9 t -65.84 -43.35 93.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.359 -173.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -72.49 -30.58 64.65 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.756 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.638 ' O ' HG23 ' A' ' 93' ' ' THR . 93.6 m -68.22 -43.18 78.55 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 25' ' ' LEU . 2.3 tp -75.25 -18.07 60.18 Favored 'General case' 0 N--CA 1.425 -1.712 0 C-N-CA 124.015 0.926 . . . . 0.0 111.445 -177.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -92.24 -33.35 14.7 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.829 -0.544 . . . . 0.0 109.729 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -82.32 -15.91 51.18 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 89' ' ' THR . 5.4 p -53.47 -63.17 1.23 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.442 0.639 . . . . 0.0 111.121 177.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.45 -162.92 32.25 Favored Glycine 0 N--CA 1.411 -2.97 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.748 ' HG3' ' HB2' ' A' ' 20' ' ' LYS . 63.5 tt0 -72.3 -44.59 62.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 117.257 0.529 . . . . 0.0 109.99 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 46.1 t -102.02 118.09 48.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 90' ' ' LEU . 4.1 t -112.71 141.99 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -96.8 125.32 41.16 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 171.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.623 HD11 HG22 ' A' ' 73' ' ' VAL . 2.8 tp -120.58 132.91 55.38 Favored 'General case' 0 C--N 1.253 -3.597 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.4 tt -95.35 114.28 26.04 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.493 HD23 ' HB3' ' A' ' 68' ' ' ASP . 10.2 mp -119.64 171.3 8.47 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.556 0.693 . . . . 0.0 112.199 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.552 ' HB2' HD11 ' A' ' 71' ' ' LEU . 35.7 tt0 -131.4 123.08 27.44 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 101.618 -3.475 . . . . 0.0 101.618 171.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -58.13 126.34 27.06 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 123.683 0.614 . . . . 0.0 110.375 -173.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -113.78 24.81 11.54 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.197 -175.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.58 ' HG3' ' HB3' ' A' ' 10' ' ' PRO . 17.2 pt20 -69.39 115.15 8.32 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 121.545 0.688 . . . . 0.0 110.351 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 99.8 t -123.7 116.02 27.96 Favored Pre-proline 0 N--CA 1.424 -1.76 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.927 -175.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.439 -1.705 0 C-N-CA 122.497 2.132 . . . . 0.0 109.36 174.619 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.1 mttp . . . . . 0 N--CA 1.432 -1.331 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 85.4 Cg_exo -46.64 127.94 12.36 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.473 2.115 . . . . 0.0 112.587 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.43 -16.36 41.35 Favored Glycine 0 C--O 1.244 0.768 0 C-N-CA 120.55 -0.833 . . . . 0.0 114.635 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -87.5 142.48 27.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 117.85 0.825 . . . . 0.0 109.297 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 21.8 p -95.38 148.27 22.63 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.22 0.533 . . . . 0.0 111.34 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -149.42 147.69 28.56 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -103.91 98.06 7.96 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.477 HG12 HD13 ' A' ' 101' ' ' LEU . 8.4 p -82.87 127.56 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.825 -175.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.35 87.98 3.35 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.785 HD12 HD12 ' A' ' 25' ' ' LEU . 1.4 tm? -87.41 113.9 23.53 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -175.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.12 113.96 26.01 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.4 127.14 30.27 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 123.986 0.804 . . . . 0.0 110.455 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.6 p -82.3 -71.74 0.47 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.463 1.125 . . . . 0.0 111.506 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -156.61 -36.27 0.08 Allowed 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 113.547 -1.66 . . . . 0.0 106.678 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . -89.14 28.42 6.71 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.517 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.3 p 65.97 -142.31 0.18 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.103 1.761 . . . . 0.0 111.525 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.785 HD12 HD12 ' A' ' 18' ' ' LEU . 7.7 tp -67.82 -28.35 67.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.934 0.873 . . . . 0.0 109.306 -176.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.27 18.51 66.64 Favored Glycine 0 N--CA 1.411 -2.995 0 C-N-CA 119.951 -1.118 . . . . 0.0 114.693 172.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.432 HG22 HD13 ' A' ' 52' ' ' ILE . 12.3 pt -131.84 145.86 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 CA-C-O 121.303 0.573 . . . . 0.0 111.404 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.5 t -111.89 136.36 51.31 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 49' ' ' VAL . 32.1 m -126.14 149.9 31.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.581 0.705 . . . . 0.0 112.358 -175.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 13.5 t -125.41 145.36 50.09 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 83' ' ' HIS . 46.0 t -121.05 148.63 24.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.053 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.509 HD13 ' HA ' ' A' ' 40' ' ' THR . 71.7 mt -95.51 115.15 27.03 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -147.58 -0.31 0.65 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.654 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -89.1 -167.11 1.78 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -72.19 -49.64 33.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.17 -144.27 44.37 Favored Glycine 0 N--CA 1.44 -1.1 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.337 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -169.36 -90.04 0.08 OUTLIER Glycine 0 C--N 1.299 -1.524 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 40' ' ' THR . 28.1 m -111.16 153.54 12.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 75.96 -31.39 0.2 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 124.93 1.292 . . . . 0.0 111.236 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.509 ' HA ' HD13 ' A' ' 32' ' ' LEU . 38.5 p -83.55 74.43 10.12 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 123.4 0.68 . . . . 0.0 109.488 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.3 p -77.22 -78.56 0.13 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.061 0.458 . . . . 0.0 109.814 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.6 m -48.37 130.01 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 CA-C-N 114.25 -1.341 . . . . 0.0 112.055 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 14.1 ptp180 -139.28 -5.22 1.44 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.92 175.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.646 ' CD2' ' HB2' ' A' ' 79' ' ' GLU . 84.7 t60 -94.38 -53.39 3.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 172.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.57 -158.97 21.83 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.16 63.87 0.81 Allowed Glycine 0 N--CA 1.415 -2.711 0 C-N-CA 118.995 -1.574 . . . . 0.0 112.034 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.01 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 50.5 mm -87.26 121.74 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -121.31 131.17 54.05 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.547 -0.861 . . . . 0.0 113.3 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.508 ' HA ' HG12 ' A' ' 29' ' ' VAL . 45.3 t -70.04 112.81 5.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.465 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 61.9 tttp -86.04 -36.86 19.44 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.359 -176.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.99 148.81 28.83 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.408 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.679 HG12 ' HB3' ' A' ' 66' ' ' LYS . 46.5 mm -110.57 127.73 67.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.746 HG22 ' H ' ' A' ' 55' ' ' LYS . 44.9 mm -83.62 138.61 40.99 Favored Pre-proline 0 C--N 1.286 -2.165 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.957 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -60.0 -16.52 39.48 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 124.13 3.22 . . . . 0.0 112.391 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.746 ' H ' HG22 ' A' ' 53' ' ' ILE . 51.3 tptt -121.16 35.97 4.74 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.87 128.57 6.73 Favored Glycine 1 N--CA 1.387 -4.575 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.445 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 18' ' ' LEU . . . -45.91 -33.61 3.36 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 126.578 1.951 . . . . 0.0 114.392 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.624 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -60.16 -36.06 76.71 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.202 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.607 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 31.7 tt0 -91.97 -40.01 11.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.425 0.631 . . . . 0.0 109.646 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.1 m -75.71 -48.49 21.71 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.148 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -74.92 -36.88 62.15 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.35 67.77 1.16 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.757 -1.11 . . . . 0.0 113.103 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.443 ' HB3' HG23 ' A' ' 16' ' ' VAL . 18.8 mmt180 -132.64 -75.65 0.5 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.337 0.589 . . . . 0.0 111.119 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.46 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 60.5 mt -78.62 146.76 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.099 0.959 . . . . 0.0 111.994 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -116.35 163.75 15.56 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.679 ' HB3' HG12 ' A' ' 52' ' ' ILE . 51.5 pttt -81.88 135.0 35.45 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.436 0.636 . . . . 0.0 110.581 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.33 -11.52 43.57 Favored Glycine 0 N--CA 1.424 -2.145 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.054 -174.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.567 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 18.3 m-20 -66.44 146.44 54.55 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -96.49 125.48 41.0 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.38 -1.736 . . . . 0.0 109.028 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.01 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 48.3 t -108.91 123.28 64.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.9 mt -96.8 -39.98 9.17 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.088 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.28 178.63 7.39 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.628 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.798 ' HA ' HD12 ' A' ' 99' ' ' LEU . 24.5 t -116.01 105.37 18.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.693 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 1.9 p-10 50.02 34.15 7.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 124.387 1.075 . . . . 0.0 113.116 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.01 -21.69 43.56 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.569 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.43 100.67 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.66 ' HB2' ' HG2' ' A' ' 79' ' ' GLU . 2.9 p -58.39 128.64 38.18 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.212 1.005 . . . . 0.0 113.269 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.8 mt -97.04 21.26 10.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.516 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.66 ' HG2' ' HB2' ' A' ' 77' ' ' SER . 7.7 pt-20 -74.36 126.34 30.46 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.793 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.16 12.92 62.73 Favored Glycine 0 C--N 1.298 -1.563 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 85' ' ' GLN . . . -108.35 142.39 38.76 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 84' ' ' LYS . 7.6 t -96.25 174.15 7.03 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.414 ' HB3' HG23 ' A' ' 31' ' ' VAL . 17.2 p-80 -51.3 -43.39 61.64 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.4 ' HG2' HG23 ' A' ' 82' ' ' THR . 20.9 ptmt -64.47 -33.4 75.8 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.408 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.426 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 77.6 mm-40 -72.62 -42.08 64.85 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.102 0.477 . . . . 0.0 109.848 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -60.01 -53.94 51.91 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.252 176.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.493 ' HA ' HD12 ' A' ' 90' ' ' LEU . 57.9 t -67.07 -34.32 68.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -176.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -72.45 -26.85 61.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.27 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.9 m -70.35 -34.62 72.85 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 87.6 mt -71.69 -32.43 67.83 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.75 0.785 . . . . 0.0 109.8 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -69.05 -39.84 78.91 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.111 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -67.42 -40.19 85.5 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.482 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -65.32 147.37 53.56 Favored 'General case' 0 C--O 1.253 1.237 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 175.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.38 -133.68 0.22 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -172.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -74.26 -52.59 11.9 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.031 0.532 . . . . 0.0 111.293 -175.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.74 111.86 35.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.1 t -100.76 129.55 51.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.295 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 50.5 m80 -93.51 119.12 32.2 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.798 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.2 tp -121.98 138.48 54.41 Favored 'General case' 0 N--CA 1.401 -2.902 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.21 109.4 22.16 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.605 HD11 HD23 ' A' ' 99' ' ' LEU . 11.2 mp -118.32 169.02 10.08 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.982 0.896 . . . . 0.0 111.988 -177.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 36.0 tt0 -131.72 137.82 48.4 Favored 'General case' 0 N--CA 1.39 -3.459 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 173.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.567 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 15.7 tppt? -64.33 113.44 3.62 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.81 6.86 17.69 Favored Glycine 0 CA--C 1.482 -1.973 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.677 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -57.71 143.6 41.11 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 121.355 0.598 . . . . 0.0 111.659 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.3 t -120.32 82.54 31.53 Favored Pre-proline 0 N--CA 1.417 -2.124 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 N--CA 1.436 -1.901 0 C-N-CA 122.599 2.199 . . . . 0.0 110.002 -179.764 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.481 ' HE2' ' HB3' ' A' ' 9' ' ' LYS . 48.9 mtpt . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -68.34 42.78 0.27 Allowed 'Trans proline' 0 N--CA 1.509 2.404 0 C-N-CA 123.714 2.943 . . . . 0.0 112.028 172.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 9' ' ' LYS . . . -171.08 29.07 0.11 Allowed Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -84.24 136.47 33.93 Favored 'General case' 0 CA--C 1.491 -1.324 0 C-N-CA 123.378 0.671 . . . . 0.0 110.936 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 p -87.18 117.5 25.97 Favored 'General case' 0 C--N 1.279 -2.465 0 O-C-N 124.064 0.852 . . . . 0.0 109.942 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -134.25 149.37 50.94 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 50.2 mt-10 -106.1 110.98 23.41 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.675 HG11 HD11 ' A' ' 64' ' ' ILE . 10.5 p -89.39 124.02 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.854 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -174.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.31 89.06 7.84 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.027 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -96.05 115.45 27.45 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -175.657 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.19 115.46 29.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.007 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.513 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -64.1 146.34 54.37 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.612 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -122.1 90.16 3.25 Favored 'General case' 0 N--CA 1.408 -2.574 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.094 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.7 t70 65.85 -65.81 0.17 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.51 1.524 . . . . 0.0 114.275 -177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.07 67.8 0.23 Allowed Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.513 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 84.8 p 70.34 -173.73 0.18 Allowed 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.794 1.638 . . . . 0.0 114.224 169.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.587 HD22 ' HB3' ' A' ' 18' ' ' LEU . 80.9 mt -72.02 160.33 32.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.1 41.16 2.64 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.212 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.515 HG23 ' CB ' ' A' ' 58' ' ' ALA . 14.7 pt -135.13 137.6 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.806 0 CA-C-O 121.419 0.628 . . . . 0.0 111.426 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -94.87 123.63 38.44 Favored 'General case' 0 N--CA 1.41 -2.432 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.527 HG22 ' H ' ' A' ' 30' ' ' THR . 12.3 p -93.54 175.87 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 O-C-N 123.321 0.388 . . . . 0.0 110.064 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.922 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 14.8 t -166.12 148.75 7.16 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' A' ' 82' ' ' THR . 12.2 p -113.66 122.83 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.527 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 90.5 mt -115.54 103.28 10.58 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -75.15 162.26 28.66 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.418 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.85 -8.49 43.31 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -66.95 139.77 57.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.659 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.81 -50.32 0.46 Allowed Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.76 -171.79 32.37 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 177.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.8 t -88.75 22.39 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 CA-C-O 122.512 1.148 . . . . 0.0 109.484 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -143.51 -64.58 0.38 Allowed 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.8 m 68.33 127.86 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.467 1.107 . . . . 0.0 112.116 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.3 p -66.98 -34.89 78.75 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.243 0.544 . . . . 0.0 110.668 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 32' ' ' LEU . 59.3 t -56.21 137.82 17.47 Favored 'Isoleucine or valine' 0 C--O 1.255 1.373 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.212 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 3.0 mpt_? -74.7 117.38 16.47 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -56.37 134.4 53.63 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.888 0.743 . . . . 0.0 111.272 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.97 -107.68 0.27 Allowed Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . 179.36 -83.1 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.704 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.642 HG13 ' HG ' ' A' ' 78' ' ' LEU . 43.4 mm -102.19 138.0 28.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -137.68 163.77 30.47 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.955 0.407 . . . . 0.0 110.122 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.459 HG21 HG21 ' A' ' 64' ' ' ILE . 56.9 t -88.3 113.61 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.952 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 169.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.922 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 59.3 tttm -76.24 -35.4 59.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.602 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.734 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . . . -168.1 167.18 12.64 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.946 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.999 HG21 ' HB2' ' A' ' 59' ' ' GLU . 49.0 mm -108.47 122.82 63.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.0 mm -83.97 145.71 47.19 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -56.88 -133.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 123.548 2.832 . . . . 0.0 114.389 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 75.3 -52.23 0.66 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.556 1.142 . . . . 0.0 110.716 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.19 -50.19 0.87 Allowed Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.688 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -8.97 -75.83 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 127.903 2.481 . . . . 0.0 116.149 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.027 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -96.02 -29.15 14.29 Favored 'General case' 0 C--O 1.255 1.359 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -172.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.999 ' HB2' HG21 ' A' ' 52' ' ' ILE . 39.6 tt0 -82.93 -53.21 6.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 123.331 0.394 . . . . 0.0 111.542 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 m -86.95 -35.14 19.05 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.633 -171.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 9.5 m-20 -101.3 -28.73 12.46 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.28 -174.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.94 -131.21 6.6 Favored Glycine 0 N--CA 1.398 -3.876 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -154.32 2.65 0.23 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.675 HD11 HG11 ' A' ' 16' ' ' VAL . 31.4 mt -90.45 148.44 4.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.525 -165.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -137.95 173.33 11.75 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.734 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 22.6 pttp -73.2 130.44 40.23 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.283 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.97 -20.77 8.5 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.115 -1.04 . . . . 0.0 113.507 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.611 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 53.9 m-20 -71.78 138.52 48.45 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 117.453 0.626 . . . . 0.0 110.619 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -90.54 135.04 33.95 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.41 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 47' ' ' ILE . 57.8 t -106.41 120.9 58.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.505 HD11 ' HB2' ' A' ' 102' ' ' GLU . 62.7 mt -96.41 -37.97 10.23 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.582 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.756 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -154.64 162.29 41.2 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.495 -173.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.786 ' HA ' HD12 ' A' ' 99' ' ' LEU . 56.3 t -115.39 106.95 21.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.3 t30 62.56 31.85 16.72 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.368 1.08 . . . . 0.0 109.761 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.56 -21.46 45.57 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 114.855 -1.066 . . . . 0.0 114.162 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.6 t -82.97 114.36 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 117.736 0.768 . . . . 0.0 109.725 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.9 t -72.1 127.68 33.31 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 123.069 0.548 . . . . 0.0 110.723 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.642 ' HG ' HG13 ' A' ' 47' ' ' ILE . 2.0 pt? -131.46 30.07 4.49 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 42.5 mt-10 -69.32 -11.31 60.71 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.618 0.723 . . . . 0.0 110.643 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.57 21.51 25.84 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.825 174.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . -93.17 -154.48 0.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.177 0.513 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.751 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.1 t -146.36 173.0 12.66 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 175.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -50.72 -60.29 3.2 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.78 1.232 . . . . 0.0 111.582 -176.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.412 ' HA ' HG12 ' A' ' 87' ' ' VAL . 57.0 tptt -59.67 -36.98 77.52 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.576 0.75 . . . . 0.0 110.945 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.402 ' HB2' ' H ' ' A' ' 82' ' ' THR . 15.1 mm100 -67.29 -45.06 77.69 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.399 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.458 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -60.21 -51.29 70.2 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.931 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 3.1 p -68.81 -34.63 65.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.085 -173.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.718 ' HA ' ' HG2' ' A' ' 91' ' ' ARG . 20.5 mm-40 -77.64 -23.47 49.73 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.436 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.412 HG22 HG11 ' A' ' 73' ' ' VAL . 86.5 m -70.91 -28.5 64.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.555 HD13 HD12 ' A' ' 25' ' ' LEU . 86.8 mt -73.58 -24.71 60.11 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.752 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.718 ' HG2' ' HA ' ' A' ' 88' ' ' GLU . 36.7 mmt180 -73.64 -49.84 24.04 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.65 -32.06 73.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.578 -174.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.496 HG21 HG12 ' A' ' 73' ' ' VAL . 1.3 p -63.87 -36.26 83.35 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.39 -140.42 13.41 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 119.712 -1.232 . . . . 0.0 113.427 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -88.46 -52.19 5.32 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.674 0.79 . . . . 0.0 109.933 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 65.5 t -99.31 111.49 29.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 43.6 t -105.86 120.94 57.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -93.08 70.54 4.54 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 73' ' ' VAL . 6.7 tp -71.55 139.27 49.38 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 122.249 -0.282 . . . . 0.0 110.55 -172.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.756 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 55.9 tp -94.17 113.32 25.24 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.658 HD11 HD23 ' A' ' 99' ' ' LEU . 10.0 mp -117.66 166.66 12.14 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-O 121.551 0.691 . . . . 0.0 110.144 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.505 ' HB2' HD11 ' A' ' 71' ' ' LEU . 37.1 tt0 -128.48 124.44 36.12 Favored 'General case' 0 N--CA 1.389 -3.491 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 174.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -49.07 123.52 7.34 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 124.572 1.17 . . . . 0.0 110.409 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -115.37 -168.26 15.47 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -157.65 -57.76 0.08 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 26.1 t -118.14 127.4 26.62 Favored Pre-proline 0 N--CA 1.436 -1.161 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.073 -177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo . . . . . 0 N--CA 1.445 -1.345 0 C-N-CA 122.988 2.459 . . . . 0.0 111.705 178.552 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.38 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.747 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 22.2 Cg_exo -63.78 139.9 71.17 Favored 'Trans proline' 0 C--O 1.245 0.848 0 C-N-CA 121.525 1.483 . . . . 0.0 111.918 -177.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.14 6.85 74.41 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.87 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 27.0 t70 -97.11 145.55 25.89 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 122.799 -0.236 . . . . 0.0 110.816 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -93.1 114.18 26.64 Favored 'General case' 0 N--CA 1.426 -1.667 0 O-C-N 123.491 0.494 . . . . 0.0 109.803 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.433 ' HE2' ' HD2' ' A' ' 63' ' ' ARG . 5.6 p90 -127.78 159.61 34.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.152 0.501 . . . . 0.0 111.463 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -106.05 130.44 53.97 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.412 HG22 ' CE2' ' A' ' 14' ' ' PHE . 12.4 t -110.88 132.3 59.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -175.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 26.1 mp0 -97.76 87.06 3.93 Favored 'General case' 0 C--O 1.248 1.009 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 171.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.085 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -96.94 116.64 29.54 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.522 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -92.9 125.12 37.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 86.7 mttt -67.66 163.92 20.37 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-O 121.844 0.831 . . . . 0.0 111.571 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.422 HG21 ' O ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -88.52 33.1 0.76 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.616 175.591 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 t70 67.99 -28.82 0.15 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.307 2.243 . . . . 0.0 113.024 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.04 -58.53 3.39 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 t -167.05 -175.29 2.95 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.628 HD12 HG12 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -85.85 139.55 31.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.328 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.48 43.02 2.84 Favored Glycine 0 C--N 1.295 -1.743 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.717 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.628 HG12 HD12 ' A' ' 25' ' ' LEU . 18.9 pt -138.32 148.69 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-N 118.133 0.967 . . . . 0.0 111.765 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.67 ' HB2' HD11 ' A' ' 53' ' ' ILE . 39.4 t -108.5 109.65 20.96 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' HG23 ' A' ' 47' ' ' ILE . 26.9 m -104.87 144.82 14.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 123.877 0.736 . . . . 0.0 110.296 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 50' ' ' LYS . 12.8 t -144.0 157.88 44.06 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 46' ' ' GLY . 56.1 t -89.6 113.29 25.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.9 mt -94.03 99.57 11.86 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.249 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -126.91 22.65 6.72 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -73.51 108.12 6.19 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.15 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -90.51 103.84 16.49 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.162 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 134.55 161.39 9.49 Favored Glycine 0 N--CA 1.425 -2.068 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.222 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.38 -139.11 4.57 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.5 t -79.65 -42.38 22.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -136.51 178.6 6.94 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 113.358 -1.746 . . . . 0.0 106.809 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.0 m -89.14 81.47 6.76 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 119.65 -0.82 . . . . 0.0 108.957 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.6 t -106.4 132.34 52.55 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.49 80.05 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 CA-C-O 122.505 1.145 . . . . 0.0 109.651 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -93.18 29.6 1.85 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.309 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -87.78 155.37 19.93 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 113.811 -1.541 . . . . 0.0 110.39 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.59 147.05 11.5 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.671 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . -53.37 -50.69 51.59 Favored Glycine 0 CA--C 1.476 -2.398 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 178.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.591 HG23 ' HB ' ' A' ' 29' ' ' VAL . 18.9 mm -139.29 142.76 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 173.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.468 ' OH ' ' HA2' ' A' ' 67' ' ' GLY . 52.9 t80 -140.52 141.93 35.27 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.28 108.09 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.53 ' HB2' HG22 ' A' ' 30' ' ' THR . 53.3 tttp -82.27 -35.8 27.7 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.811 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.87 36.28 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.735 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.068 HG21 ' HB2' ' A' ' 59' ' ' GLU . 31.7 mm -111.7 113.45 44.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 28' ' ' SER . 2.0 mp -83.41 128.33 64.77 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 53.2 Cg_exo -59.94 88.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 124.14 3.227 . . . . 0.0 115.142 -177.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' O ' HG21 ' A' ' 21' ' ' THR . 2.4 mptm? -125.09 -27.23 3.57 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.681 170.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.633 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 93.89 49.12 2.54 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -175.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -122.26 -77.77 0.59 Allowed 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.166 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.085 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -83.25 -31.44 26.98 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -170.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.068 ' HB2' HG21 ' A' ' 52' ' ' ILE . 40.0 tt0 -80.02 -45.39 18.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 124.645 1.216 . . . . 0.0 110.268 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.633 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 1.2 m -85.09 -47.86 9.76 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.264 -168.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -100.7 -21.5 15.2 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.931 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.84 -132.26 6.36 Favored Glycine 1 N--CA 1.393 -4.219 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.93 -173.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.433 ' HD2' ' HE2' ' A' ' 14' ' ' PHE . 40.1 mtt180 -156.24 -1.54 0.13 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -169.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.773 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 60.2 mt -96.22 132.05 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.145 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.546 -169.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.421 ' HA ' HG13 ' A' ' 52' ' ' ILE . 81.4 m-70 -139.67 170.48 15.82 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -69.22 129.79 40.84 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.459 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.468 ' HA2' ' OH ' ' A' ' 48' ' ' TYR . . . 123.8 -26.08 6.01 Favored Glycine 0 C--N 1.291 -1.972 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.848 -172.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.473 ' HB3' HD23 ' A' ' 101' ' ' LEU . 18.2 m-20 -72.86 133.91 44.62 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.471 ' CG ' ' HB3' ' A' ' 102' ' ' GLU . 4.5 ptm180 -100.84 151.15 22.06 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.536 HG22 ' HG ' ' A' ' 101' ' ' LEU . 47.3 t -112.83 127.2 70.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.443 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -176.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.9 mt -100.87 -34.3 9.86 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.345 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -159.55 175.11 13.64 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.466 -175.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.991 HG11 HG21 ' A' ' 89' ' ' THR . 4.7 p -130.64 110.21 18.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 124.943 1.297 . . . . 0.0 109.523 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 62.68 30.17 16.86 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.412 1.101 . . . . 0.0 108.151 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.04 -18.69 46.59 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.259 -0.882 . . . . 0.0 114.079 -174.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.0 t -81.82 122.76 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.4 t -58.17 140.45 52.93 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.686 HD11 ' HB ' ' A' ' 73' ' ' VAL . 81.2 mt -118.06 -3.02 11.14 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.865 175.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.671 ' HA ' ' HA3' ' A' ' 46' ' ' GLY 0.261 1.0 OUTLIER -76.97 103.95 7.19 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 122.475 1.131 . . . . 0.0 110.43 177.888 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.45 -6.28 12.83 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -173.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.81 149.61 24.72 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 84' ' ' LYS . 5.1 t -79.14 154.14 29.55 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 42.8 p-80 -51.55 -36.73 46.41 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 120.759 0.314 . . . . 0.0 111.826 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.447 ' HB2' HG23 ' A' ' 82' ' ' THR . 94.6 mttt -48.9 -53.61 18.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.36 173.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -66.89 -35.7 80.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 123.375 0.422 . . . . 0.0 111.458 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -58.47 -49.84 75.89 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.433 0.635 . . . . 0.0 109.805 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.92 -32.94 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.392 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 45.1 mt-10 -66.56 -34.14 77.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 110.091 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.991 HG21 HG11 ' A' ' 73' ' ' VAL . 50.6 m -71.01 -29.15 65.02 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.328 0.585 . . . . 0.0 109.491 174.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.1 mt -71.41 -24.03 61.97 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-O 121.077 0.465 . . . . 0.0 109.982 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -90.74 -15.49 30.12 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.058 0.456 . . . . 0.0 111.092 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.27 -35.08 31.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 p -75.01 154.67 37.94 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.169 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.27 -136.79 1.67 Allowed Glycine 0 C--N 1.314 -0.66 0 N-CA-C 114.349 0.5 . . . . 0.0 114.349 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.448 ' OE1' ' HB2' ' A' ' 20' ' ' LYS . 5.2 tp-100 -72.39 -46.84 53.48 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.745 0.784 . . . . 0.0 109.361 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 52.4 t -102.19 119.0 49.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.481 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 41.4 t -104.57 129.62 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.092 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.805 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.54 ' CD2' ' HG3' ' A' ' 17' ' ' GLU . 26.6 m170 -89.5 122.62 32.86 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 169.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.71 HD23 HD11 ' A' ' 101' ' ' LEU . 4.9 tp -130.0 147.86 51.8 Favored 'General case' 0 C--N 1.271 -2.844 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.7 tt -110.11 116.56 31.76 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -177.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.71 HD11 HD23 ' A' ' 99' ' ' LEU . 7.5 mp -122.64 175.38 6.53 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.472 0.653 . . . . 0.0 111.001 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 26.9 tt0 -128.3 119.99 26.19 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.747 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -50.02 106.46 0.12 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.006 1.322 . . . . 0.0 110.656 -173.645 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.512 ' N ' ' HE3' ' A' ' 103' ' ' LYS . . . -113.13 89.85 0.53 Allowed Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.868 -177.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.427 ' HG3' ' HD3' ' A' ' 103' ' ' LYS . 71.1 mt-30 -95.88 100.33 12.03 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 173.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 47.4 t -126.03 115.77 24.03 Favored Pre-proline 0 C--N 1.292 -1.935 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.7 Cg_exo . . . . . 0 C--O 1.26 1.6 0 C-N-CA 122.703 2.269 . . . . 0.0 110.89 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.783 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 53.1 mtmt . . . . . 0 CA--C 1.547 0.843 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.783 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 53.8 Cg_endo -87.18 34.86 0.44 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.958 2.438 . . . . 0.0 112.889 -170.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.88 30.19 0.06 OUTLIER Glycine 0 C--N 1.292 -1.882 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 59.0 t0 -88.93 143.16 27.06 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -176.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 p -96.78 116.07 28.51 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 123.639 0.775 . . . . 0.0 110.397 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.35 132.44 21.64 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.35 0.595 . . . . 0.0 112.259 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.507 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 41.8 mt-10 -81.13 99.21 8.4 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.095 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.502 HG11 HG13 ' A' ' 64' ' ' ILE . 55.5 t -68.38 131.08 33.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.143 -177.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -92.61 98.96 11.76 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.977 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -110.95 118.76 36.97 Favored 'General case' 0 N--CA 1.415 -2.207 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.998 -179.237 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.8 126.33 41.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.294 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.644 ' HE2' HD22 ' A' ' 25' ' ' LEU . 95.3 mttt -76.11 137.99 40.48 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.086 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -73.58 -41.04 63.41 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -173.05 -65.01 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.399 0.619 . . . . 0.0 109.844 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.85 63.7 3.17 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.555 -176.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.547 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 23.3 t 69.48 -168.11 0.17 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.867 1.267 . . . . 0.0 112.691 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.644 HD22 ' HE2' ' A' ' 20' ' ' LYS . 2.5 mm? -73.51 159.28 33.41 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.743 0.817 . . . . 0.0 110.757 -177.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.7 38.37 3.13 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.472 HD13 HD13 ' A' ' 64' ' ' ILE . 23.8 pt -137.1 144.51 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.666 0 CA-C-O 121.454 0.645 . . . . 0.0 111.343 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB2' HG12 ' A' ' 53' ' ' ILE . 28.3 t -106.17 115.22 29.84 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.77 148.65 16.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.869 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.1 t -150.0 167.84 25.56 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 82' ' ' THR . 13.6 p -120.88 114.12 42.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 121.337 0.589 . . . . 0.0 110.227 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.81 86.23 7.37 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 36' ' ' GLY . 55.8 t80 -161.82 108.37 1.34 Allowed 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.919 -174.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -88.59 -63.94 1.22 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -135.4 9.98 3.45 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 171.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . 162.72 -145.23 10.4 Favored Glycine 0 N--CA 1.423 -2.225 0 N-CA-C 107.989 -2.044 . . . . 0.0 107.989 -177.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.87 164.41 26.55 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.148 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 t -89.94 66.27 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 122.389 1.09 . . . . 0.0 108.759 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -144.26 108.5 4.79 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -82.25 79.57 8.69 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-O 121.985 0.898 . . . . 0.0 111.782 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.5 t -162.17 94.48 0.91 Allowed 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.5 t -139.65 89.64 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 -175.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -134.43 -58.09 0.84 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.018 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.54 ' HD2' HD22 ' A' ' 71' ' ' LEU . 1.7 p-80 -153.71 134.97 14.09 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.524 -176.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.786 ' HA3' ' HA ' ' A' ' 71' ' ' LEU . . . 71.69 -159.02 53.69 Favored Glycine 0 C--O 1.247 0.929 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.654 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 31' ' ' VAL . . . 156.71 26.95 0.03 OUTLIER Glycine 0 C--O 1.217 -0.947 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.693 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.889 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.6 mm -101.87 148.67 7.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 79.7 t80 -125.13 128.02 47.78 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 122.004 -0.435 . . . . 0.0 111.679 -176.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.99 105.66 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 171.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.6 ' HB2' HG22 ' A' ' 30' ' ' THR . 87.1 tttt -77.93 -40.17 40.48 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.521 -175.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.6 165.06 33.56 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.781 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.1 mm -102.8 109.75 27.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.509 HG23 ' HD2' ' A' ' 54' ' ' PRO . 27.1 mm -72.86 154.24 91.06 Favored Pre-proline 0 C--N 1.294 -1.816 0 C-N-CA 124.601 1.161 . . . . 0.0 110.087 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HD2' HG23 ' A' ' 53' ' ' ILE . 87.4 Cg_exo -52.4 -158.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.44 0 C-N-CA 123.383 2.722 . . . . 0.0 113.572 170.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? 76.53 -51.44 0.59 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.684 1.194 . . . . 0.0 111.273 -173.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 130.44 -120.5 3.04 Favored Glycine 0 N--CA 1.414 -2.798 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.821 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 70.05 -91.13 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.102 0.961 . . . . 0.0 112.897 170.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.977 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -75.34 -37.42 60.7 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.61 -46.36 66.43 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 124.985 1.428 . . . . 0.0 108.702 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 m -70.41 -43.63 69.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.268 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -73.86 -30.12 62.49 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.1 33.44 36.28 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.514 175.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -95.21 -59.32 1.92 Allowed 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.716 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.738 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.7 mt -86.51 131.48 34.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -119.72 161.93 19.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -81.85 144.72 30.82 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 118.751 -1.18 . . . . 0.0 110.555 -177.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.417 ' HA2' ' CZ ' ' A' ' 48' ' ' TYR . . . 102.6 -6.94 52.99 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -176.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -87.4 154.21 20.84 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.39 0.614 . . . . 0.0 111.837 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -100.45 141.73 32.9 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.896 0.855 . . . . 0.0 112.784 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.889 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 58.9 t -106.55 125.56 62.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.013 -1.448 . . . . 0.0 107.22 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 102' ' ' GLU . 28.3 mt -100.94 -35.5 9.37 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.991 -176.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -160.7 166.52 28.65 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.874 HG23 HD11 ' A' ' 78' ' ' LEU . 48.1 t -119.13 108.09 23.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 124.841 1.256 . . . . 0.0 108.333 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.5 t30 56.98 52.9 8.62 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.048 0.939 . . . . 0.0 110.559 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.6 -25.08 3.45 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 114.85 -1.068 . . . . 0.0 114.33 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.9 t -81.11 110.85 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 117.686 0.743 . . . . 0.0 109.826 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.532 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 38.6 m -63.13 140.04 58.83 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.268 0.98 . . . . 0.0 112.106 -175.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.874 HD11 HG23 ' A' ' 73' ' ' VAL . 55.2 mt -110.52 76.32 0.98 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.505 ' HG2' ' H ' ' A' ' 45' ' ' GLY . 38.9 mt-10 -107.1 125.47 51.1 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.27 32.96 81.16 Favored Glycine 0 C--N 1.31 -0.907 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.14 138.18 39.43 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.858 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.8 t -82.82 159.35 22.46 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 173.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.869 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 39.2 p-80 -52.09 -39.13 59.3 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 123.073 0.233 . . . . 0.0 111.599 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.99 -39.94 91.58 Favored 'General case' 0 C--O 1.206 -1.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.785 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.52 ' HG2' HG22 ' A' ' 82' ' ' THR . 74.8 mm-40 -67.23 -44.7 78.85 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.39 -51.51 69.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.421 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.509 ' HA ' HD12 ' A' ' 90' ' ' LEU . 85.6 t -68.16 -31.83 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.514 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -66.58 -30.67 71.02 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 121.768 -0.582 . . . . 0.0 110.243 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.8 m -76.74 -28.14 55.65 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.183 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 87' ' ' VAL . 95.9 mt -73.37 -33.54 65.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.75 0.785 . . . . 0.0 109.68 175.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.26 -29.45 57.48 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.526 176.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -72.63 -31.81 65.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.85 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.5 p -72.3 163.35 28.1 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.18 -123.8 0.5 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.887 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -94.64 -42.11 8.95 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 122.794 -0.239 . . . . 0.0 111.14 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.36 110.71 27.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.42 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 39.4 t -99.58 121.51 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.199 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.726 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.439 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 95.9 m-70 -91.29 98.88 11.98 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 174.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.823 HD12 ' HA ' ' A' ' 73' ' ' VAL . 9.6 tp -101.13 129.36 47.02 Favored 'General case' 0 C--N 1.268 -2.959 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -172.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.767 HD22 HD12 ' A' ' 71' ' ' LEU . 1.8 tt -86.38 109.11 18.79 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.692 HD11 HD23 ' A' ' 99' ' ' LEU . 8.9 mp -115.62 164.89 13.67 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-O 121.504 0.669 . . . . 0.0 111.621 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.899 ' HB2' HD11 ' A' ' 71' ' ' LEU . 35.0 tt0 -131.25 135.64 47.52 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 172.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 39.5 tptt -58.67 114.78 2.66 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -104.17 12.05 51.94 Favored Glycine 0 CA--C 1.482 -1.984 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.79 -167.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -63.88 135.27 56.42 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 31.9 m -70.04 150.39 96.22 Favored Pre-proline 0 C--N 1.303 -1.415 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.534 -175.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.777 2.318 . . . . 0.0 110.992 179.171 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.564 ' CD ' ' HB2' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.422 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.729 ' HG3' HG22 ' A' ' 106' ' ' VAL . 17.1 Cg_endo -55.49 131.55 46.83 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.939 2.426 . . . . 0.0 112.977 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.2 8.44 71.75 Favored Glycine 0 C--N 1.314 -0.691 0 CA-C-N 116.047 -0.524 . . . . 0.0 113.066 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.564 ' HB2' ' CD ' ' A' ' 9' ' ' LYS . 6.5 t70 -110.59 154.37 23.85 Favored 'General case' 0 CA--C 1.504 -0.811 0 O-C-N 122.395 -0.473 . . . . 0.0 110.001 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.9 p -86.94 135.88 33.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 123.776 0.672 . . . . 0.0 110.534 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -146.85 145.88 30.01 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.078 0.466 . . . . 0.0 110.049 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.75 132.15 52.23 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.9 t -118.71 135.91 57.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.796 -175.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.544 ' HG2' HG11 ' A' ' 96' ' ' VAL . 43.6 tt0 -109.48 86.61 2.32 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 172.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.915 HD11 ' HB1' ' A' ' 57' ' ' ALA . 1.3 tm? -99.14 125.73 44.75 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -98.3 144.5 27.64 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 120.649 0.262 . . . . 0.0 111.076 -175.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.684 ' HE2' HD11 ' A' ' 25' ' ' LEU . 1.2 mptm? -68.2 143.52 55.3 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.966 177.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 57' ' ' ALA . 59.0 p -91.58 -165.89 1.45 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.22 -26.11 49.97 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.126 0.57 . . . . 0.0 111.118 173.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.88 56.96 0.73 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.284 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.4 t 77.43 -168.59 0.06 Allowed 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.232 1.413 . . . . 0.0 109.429 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.684 HD11 ' HE2' ' A' ' 20' ' ' LYS . 4.3 mp -66.17 -76.81 0.07 Allowed 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 122.04 0.924 . . . . 0.0 109.787 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.97 ' HA2' ' HD2' ' A' ' 54' ' ' PRO . . . 147.31 -8.58 1.22 Allowed Glycine 0 CA--C 1.463 -3.187 0 C-N-CA 119.757 -1.211 . . . . 0.0 111.181 -172.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.409 HG22 ' CD1' ' A' ' 52' ' ' ILE . 16.7 pt -102.71 112.73 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.607 0 CA-C-O 122.722 1.248 . . . . 0.0 112.851 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.7 m -101.31 126.13 48.03 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-N 112.59 -2.096 . . . . 0.0 106.686 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 49' ' ' VAL . 33.7 m -110.91 153.87 12.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.055 0.455 . . . . 0.0 111.586 -173.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.665 ' HB ' ' HD3' ' A' ' 50' ' ' LYS . 11.2 t -121.31 156.46 32.5 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 174.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.518 HG12 HD13 ' A' ' 47' ' ' ILE . 33.1 m -110.69 128.59 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.939 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 pp -163.48 -178.83 6.09 Favored 'General case' 0 C--N 1.271 -2.843 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 16.8 p90 -137.49 -34.73 0.69 Allowed 'General case' 0 C--N 1.274 -2.714 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.337 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -80.86 118.84 22.72 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 41' ' ' SER . 22.5 ttpp -140.37 147.8 40.32 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.92 -112.95 1.59 Allowed Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.76 -124.2 6.72 Favored Glycine 0 C--N 1.299 -1.478 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -81.96 -24.94 9.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.295 0.569 . . . . 0.0 110.8 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -135.46 159.74 40.63 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.4 m -72.07 93.79 1.44 Allowed 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.389 0.614 . . . . 0.0 109.863 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 35' ' ' LYS . 27.0 m -78.52 141.26 38.3 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.555 177.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.2 m -66.15 151.19 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.827 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 33' ' ' PHE . 1.9 ptm180 -94.62 1.89 55.6 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.224 -176.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -88.78 91.66 8.91 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 174.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.439 ' HA2' ' OE2' ' A' ' 79' ' ' GLU . . . -158.02 173.48 35.26 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.402 ' HA3' ' N ' ' A' ' 80' ' ' GLY . . . -139.09 -54.42 0.05 OUTLIER Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.662 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.689 HG13 ' HG ' ' A' ' 78' ' ' LEU . 50.8 mm -102.37 123.78 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.057 -175.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.467 ' CZ ' ' HD3' ' A' ' 69' ' ' ARG . 81.4 m-85 -131.21 114.22 14.81 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.506 ' HA ' HG12 ' A' ' 29' ' ' VAL . 50.1 t -47.86 117.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.481 0.658 . . . . 0.0 109.983 171.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.665 ' HD3' ' HB ' ' A' ' 30' ' ' THR . 38.0 ttpt -92.76 -31.11 15.18 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.331 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . . . -167.64 156.99 10.03 Favored 'General case' 0 C--O 1.249 1.03 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.759 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.862 HG21 ' HB2' ' A' ' 59' ' ' GLU . 16.7 mm -109.88 119.29 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.925 ' HB ' ' HD3' ' A' ' 54' ' ' PRO . 2.7 mp -108.43 -71.06 0.03 OUTLIER Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -172.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.97 ' HD2' ' HA2' ' A' ' 26' ' ' GLY . 45.3 Cg_exo -60.18 -163.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 124.882 3.722 . . . . 0.0 117.692 -172.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -35.61 -50.75 0.62 Allowed 'General case' 0 C--N 1.352 0.71 0 C-N-CA 127.892 2.477 . . . . 0.0 113.455 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.96 -98.77 0.11 Allowed Glycine 0 N--CA 1.415 -2.738 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.915 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 66.08 -92.34 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.051 1.34 . . . . 0.0 111.314 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.626 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -70.61 -39.84 73.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.862 ' HB2' HG21 ' A' ' 52' ' ' ILE . 35.4 tt0 -76.43 -42.58 43.6 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 123.556 0.535 . . . . 0.0 111.629 -178.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.0 p -74.94 -35.31 62.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.855 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -73.65 -26.57 60.82 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.326 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.07 44.94 86.64 Favored Glycine 0 CA--C 1.49 -1.483 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.996 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -111.25 -54.62 2.59 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.348 0.594 . . . . 0.0 109.556 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.626 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 64.9 mt -101.26 130.1 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.461 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -132.14 173.33 11.34 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 61.3 pttt -74.83 132.03 41.22 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.089 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.27 -20.66 13.8 Favored Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.729 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.429 ' OD1' ' HD2' ' A' ' 103' ' ' LYS . 78.8 m-20 -69.47 138.15 53.2 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.556 0.694 . . . . 0.0 111.683 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 33.1 ttp180 -95.5 133.88 38.99 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.313 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 71.0 t -101.74 103.94 15.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 102' ' ' GLU . 84.9 mt -76.87 -36.01 57.04 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.217 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.51 167.36 19.52 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.16 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.702 ' HA ' HD12 ' A' ' 99' ' ' LEU . 44.3 t -113.33 115.53 50.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 172.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 2.0 p-10 47.01 35.36 3.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.424 1.49 . . . . 0.0 112.768 -176.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.62 -6.24 82.18 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.506 -0.854 . . . . 0.0 114.092 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.8 t -92.6 109.64 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.7 m -69.64 134.67 48.99 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -173.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.689 ' HG ' HG13 ' A' ' 47' ' ' ILE . 1.6 pt? -130.34 17.24 5.45 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.099 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.439 ' OE2' ' HA2' ' A' ' 45' ' ' GLY . 5.4 mm-40 -62.9 97.89 0.12 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.518 175.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' N ' ' HA3' ' A' ' 46' ' ' GLY . . . 119.01 17.35 5.02 Favored Glycine 0 N--CA 1.433 -1.524 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.598 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.493 ' HB3' HD11 ' A' ' 47' ' ' ILE . . . -94.34 176.74 6.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.46 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.8 t -97.18 158.75 15.29 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 169.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -51.16 -44.19 61.41 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.595 0.758 . . . . 0.0 112.381 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 23.8 tptp -55.91 -43.45 77.34 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 123.92 0.888 . . . . 0.0 110.986 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -69.28 -43.9 72.93 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.622 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -55.24 -54.48 42.9 Favored 'General case' 0 C--O 1.243 0.72 0 O-C-N 124.08 0.862 . . . . 0.0 111.468 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.56 -26.75 36.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.919 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 91.0 mt-10 -72.04 -28.49 63.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.809 177.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.517 HG22 HG11 ' A' ' 73' ' ' VAL . 22.5 m -70.5 -31.41 68.5 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.3 mt -72.72 -24.4 60.98 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.105 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -79.56 -34.24 41.12 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -63.15 -40.63 98.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.71 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.441 ' OG1' HG22 ' A' ' 97' ' ' VAL . 19.4 p -68.94 138.25 54.45 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.8 -121.6 0.02 OUTLIER Glycine 0 CA--C 1.52 0.381 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.806 ' HG3' HG23 ' A' ' 96' ' ' VAL . 14.1 pt20 -77.11 -27.51 54.1 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.512 0.672 . . . . 0.0 110.463 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.806 HG23 ' HG3' ' A' ' 95' ' ' GLN . 21.5 t -125.44 150.02 30.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.533 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 35.8 t -120.26 126.03 74.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 122.921 0.489 . . . . 0.0 109.853 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 41.2 m80 -86.77 119.09 26.63 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 167.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.702 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.2 tp -127.93 147.91 50.49 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -110.71 117.86 34.6 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.699 HD11 HD23 ' A' ' 99' ' ' LEU . 6.0 mp -124.77 174.31 7.99 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.526 0.679 . . . . 0.0 111.37 -178.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HB2' HD11 ' A' ' 71' ' ' LEU . 31.0 tt0 -131.6 130.62 42.42 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 102.761 -3.051 . . . . 0.0 102.761 173.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 40.6 tptt -64.09 126.25 27.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -175.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.68 16.37 14.02 Favored Glycine 0 C--N 1.301 -1.378 0 C-N-CA 121.016 -0.612 . . . . 0.0 113.314 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -168.38 165.68 12.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.729 HG22 ' HG3' ' A' ' 10' ' ' PRO . 48.2 t -103.24 121.72 47.78 Favored Pre-proline 0 C--N 1.303 -1.413 0 O-C-N 123.148 0.28 . . . . 0.0 110.739 177.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 5.1 Cg_endo . . . . . 0 N--CA 1.437 -1.804 0 C-N-CA 122.671 2.248 . . . . 0.0 109.634 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 N--CA 1.446 -0.673 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.669 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 37.8 Cg_exo -56.57 128.85 31.73 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 121.143 1.229 . . . . 0.0 109.82 175.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.82 -13.81 45.74 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.178 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.23 134.29 42.69 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 117.053 0.426 . . . . 0.0 110.398 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 17.3 p -102.3 111.13 23.3 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-O 121.74 0.781 . . . . 0.0 110.451 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.415 ' CE2' ' HB ' ' A' ' 16' ' ' VAL . 44.8 p90 -125.61 162.96 23.81 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.858 -177.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 40.1 mt-10 -108.07 94.12 4.9 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 12.4 p -80.09 135.07 26.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.408 -175.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -90.18 108.33 19.68 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 58' ' ' ALA . 2.1 tm? -113.9 108.12 16.62 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.32 149.69 22.88 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.591 ' HD2' ' HA ' ' A' ' 24' ' ' SER . 27.3 mmtp -71.07 114.9 9.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 56' ' ' GLY . 2.9 t -74.88 -33.06 62.0 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 118.173 -1.411 . . . . 0.0 108.722 -177.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -174.74 -35.85 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.676 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.7 48.52 0.98 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.673 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.591 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 22.6 t 58.93 -152.99 0.39 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.818 0.847 . . . . 0.0 110.561 177.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.552 HD12 HD12 ' A' ' 18' ' ' LEU . 2.9 mm? -71.33 111.01 6.32 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.699 ' H ' ' HB3' ' A' ' 57' ' ' ALA . . . -78.02 46.33 2.66 Favored Glycine 0 C--N 1.296 -1.692 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.401 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.71 HG22 HG13 ' A' ' 52' ' ' ILE . 14.1 pt -141.11 148.64 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 CA-C-O 121.253 0.549 . . . . 0.0 110.197 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 32.4 t -117.85 124.25 47.88 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.6 m -115.59 150.55 17.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.564 -175.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.632 HG22 ' HB2' ' A' ' 50' ' ' LYS . 10.3 t -130.04 153.41 48.46 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.517 HG21 ' O ' ' A' ' 81' ' ' ALA . 8.3 p -114.29 118.59 58.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.715 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.422 HD21 HG23 ' A' ' 30' ' ' THR . 1.9 mm? -121.88 118.83 29.89 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.606 -178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -122.8 29.28 6.9 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 122.383 1.087 . . . . 0.0 108.886 173.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -80.96 166.71 20.59 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.989 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -111.75 155.53 23.36 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.68 115.21 5.63 Favored Glycine 0 C--O 1.241 0.561 0 O-C-N 123.833 0.708 . . . . 0.0 112.306 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.71 -25.53 2.82 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.432 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.13 -79.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.075 0.464 . . . . 0.0 110.657 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -97.55 -47.2 5.74 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -132.4 159.22 39.89 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.217 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.7 p -99.43 -37.18 9.32 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 121.199 0.524 . . . . 0.0 110.397 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.3 m -98.48 79.69 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -177.55 170.96 1.98 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.098 173.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -154.86 179.12 9.41 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.14 -163.29 32.77 Favored Glycine 0 N--CA 1.417 -2.627 0 C-N-CA 118.252 -1.928 . . . . 0.0 114.17 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 31' ' ' VAL . . . -168.21 -101.95 0.15 Allowed Glycine 0 CA--C 1.471 -2.703 0 N-CA-C 104.507 -3.437 . . . . 0.0 104.507 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.796 HG13 HD12 ' A' ' 78' ' ' LEU . 38.6 mm -81.93 114.61 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 167.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.41 ' OH ' ' HA2' ' A' ' 67' ' ' GLY . 66.5 t80 -119.86 131.16 55.19 Favored 'General case' 0 C--N 1.275 -2.661 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.762 -169.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.496 HG21 ' CG2' ' A' ' 64' ' ' ILE . 46.5 t -75.16 107.38 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-O 121.557 0.694 . . . . 0.0 109.28 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.632 ' HB2' HG22 ' A' ' 30' ' ' THR . 87.2 tttt -89.06 -34.95 16.6 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.407 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 28' ' ' SER . . . -154.32 156.36 36.8 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.397 -176.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.945 HG21 ' HB2' ' A' ' 59' ' ' GLU . 1.9 mp -116.98 124.48 73.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 O-C-N 123.31 0.381 . . . . 0.0 110.093 174.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.38 121.93 85.79 Favored Pre-proline 0 C--O 1.257 1.491 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.181 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -55.12 129.19 33.96 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 123.368 2.712 . . . . 0.0 112.103 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 tptp 65.33 11.45 7.31 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.631 1.172 . . . . 0.0 112.049 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.591 ' O ' HG22 ' A' ' 21' ' ' THR . . . -76.43 -56.16 4.38 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.11 176.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.699 ' HB3' ' H ' ' A' ' 26' ' ' GLY . . . -178.23 -69.08 0.01 OUTLIER 'General case' 0 C--O 1.188 -2.14 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.591 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -50.31 -42.63 52.92 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.945 ' HB2' HG21 ' A' ' 52' ' ' ILE . 35.4 tt0 -82.86 -40.49 20.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.963 0.887 . . . . 0.0 109.869 -177.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.28 -44.0 66.06 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.899 -173.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.81 -34.41 57.92 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.078 0.942 . . . . 0.0 108.469 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.06 56.08 2.26 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.263 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -121.6 -73.41 0.65 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.813 0.816 . . . . 0.0 110.739 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.496 ' CG2' HG21 ' A' ' 49' ' ' VAL . 53.1 mt -94.74 148.01 5.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.266 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -143.8 172.6 12.62 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.462 1.105 . . . . 0.0 108.131 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 50' ' ' LYS . 56.4 mtpt -64.78 133.01 51.11 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 123.521 0.513 . . . . 0.0 110.624 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.41 ' HA2' ' OH ' ' A' ' 48' ' ' TYR . . . 111.94 -20.73 21.6 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 119.966 -1.112 . . . . 0.0 113.833 176.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' OD2' ' HA ' ' A' ' 103' ' ' LYS . 0.5 OUTLIER -85.51 149.21 25.54 Favored 'General case' 0 C--O 1.253 1.268 0 CA-C-O 121.754 0.787 . . . . 0.0 113.099 -179.266 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.459 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 78.5 ttt180 -102.81 138.73 39.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.498 -171.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 58.7 t -111.04 127.1 68.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.692 HD11 ' HB2' ' A' ' 102' ' ' GLU . 66.1 mt -110.3 -30.78 7.56 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.796 0.808 . . . . 0.0 109.837 -177.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.756 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -161.22 172.4 16.74 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.325 -174.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.732 HG11 ' CG2' ' A' ' 89' ' ' THR . 4.7 p -118.32 114.35 44.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 125.261 1.424 . . . . 0.0 107.487 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.859 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 32.1 p30 35.26 46.39 0.24 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.98 -11.0 64.18 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.597 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.533 ' HB ' HG13 ' A' ' 73' ' ' VAL . 43.1 t -101.33 114.94 42.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.2 m -75.79 145.01 41.06 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -173.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.796 HD12 HG13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.25 31.67 4.59 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.693 -1.139 . . . . 0.0 112.113 174.442 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -69.04 95.18 0.7 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.275 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.02 16.63 7.76 Favored Glycine 0 C--N 1.302 -1.34 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.517 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -88.6 171.1 10.28 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 27.9 p -96.46 162.56 13.43 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 173.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -51.8 -41.12 61.47 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.35 0.595 . . . . 0.0 110.491 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.47 -36.95 79.71 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.75 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.486 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 11.9 mm-40 -66.39 -41.18 89.72 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.014 0.435 . . . . 0.0 110.255 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -52.75 -60.24 3.5 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.14 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.98 -30.65 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.219 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 91' ' ' ARG . 10.2 tp10 -67.76 -38.71 83.8 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.732 ' CG2' HG11 ' A' ' 73' ' ' VAL . 27.0 m -71.87 -36.62 70.16 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.5 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 61.5 mt -72.97 -19.46 61.22 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.454 0.645 . . . . 0.0 110.794 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -92.43 -26.8 17.84 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.451 0.643 . . . . 0.0 110.814 -179.702 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -84.31 -21.44 31.0 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -69.14 -42.93 75.33 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.33 -156.59 27.02 Favored Glycine 0 CA--C 1.487 -1.66 0 C-N-CA 120.263 -0.97 . . . . 0.0 110.928 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.491 ' HA ' ' HG2' ' A' ' 20' ' ' LYS . 16.8 pt20 -88.06 -37.27 16.42 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.719 0.259 . . . . 0.0 111.515 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 43.9 t -106.91 109.47 28.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.66 119.67 60.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.613 -172.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.859 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 31.4 m170 -81.84 137.28 35.29 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 168.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 7.6 mp -122.41 148.88 44.57 Favored 'General case' 0 C--N 1.264 -3.131 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.756 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.4 tm? -99.04 109.05 21.85 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 13' ' ' THR . 7.3 mp -110.65 162.79 14.38 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.181 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.692 ' HB2' HD11 ' A' ' 71' ' ' LEU . 39.7 tt0 -123.34 124.76 43.67 Favored 'General case' 0 N--CA 1.404 -2.766 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 173.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.669 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 4.6 tmtm? -55.96 113.41 1.5 Allowed 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 124.286 0.991 . . . . 0.0 108.363 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -84.36 -162.56 34.71 Favored Glycine 0 N--CA 1.427 -1.925 0 CA-C-N 114.603 -1.18 . . . . 0.0 113.318 -174.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -138.39 145.3 40.86 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -177.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.05 144.22 47.04 Favored Pre-proline 0 C--N 1.293 -1.89 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.49 -170.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.408 ' HG3' ' OH ' ' A' ' 48' ' ' TYR . 13.0 Cg_exo . . . . . 0 C--O 1.25 1.121 0 C-N-CA 122.8 2.334 . . . . 0.0 110.637 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.394 61.2 mtpt . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.907 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 87.2 Cg_exo -50.41 113.59 1.1 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.231 1.954 . . . . 0.0 112.13 171.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.01 9.41 65.79 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.699 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 24.0 t70 -121.39 162.21 20.79 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.442 HG22 HD11 ' A' ' 71' ' ' LEU . 4.5 p -91.44 139.72 30.45 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 123.812 0.845 . . . . 0.0 111.335 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.593 ' HE2' ' HB2' ' A' ' 103' ' ' LYS . 48.2 p90 -157.51 154.43 28.62 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 39.7 mt-10 -110.06 148.51 31.57 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.493 HG23 HD13 ' A' ' 101' ' ' LEU . 59.9 t -127.25 124.97 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -96.76 91.56 5.74 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.928 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -102.57 122.03 43.57 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.235 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.21 141.51 31.89 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.112 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 1.5 mptm? -71.75 138.2 48.28 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.935 0.874 . . . . 0.0 112.526 177.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 23' ' ' GLY . 3.7 t -135.69 143.55 45.47 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 171.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 21' ' ' THR . 9.6 t70 77.93 -35.67 0.2 Allowed 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 123.651 0.781 . . . . 0.0 110.469 -173.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 21' ' ' THR . . . 119.7 11.39 7.18 Favored Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -127.6 151.53 48.8 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 115.241 -0.479 . . . . 0.0 109.897 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.548 HD11 ' HB3' ' A' ' 18' ' ' LEU . 13.7 tp -91.05 121.33 32.76 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 170.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.433 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -71.91 46.62 0.96 Allowed Glycine 0 C--O 1.211 -1.341 0 N-CA-C 115.451 0.941 . . . . 0.0 115.451 -173.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.432 HG22 ' CD1' ' A' ' 52' ' ' ILE . 6.9 pt -139.3 134.37 40.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 117.706 0.753 . . . . 0.0 111.461 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 53' ' ' ILE . 33.7 t -104.09 119.26 38.55 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.469 HG12 HG22 ' A' ' 49' ' ' VAL . 22.7 m -114.23 151.44 16.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.028 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.4 t -134.7 177.2 7.97 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 172.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.632 HG12 HD13 ' A' ' 47' ' ' ILE . 16.2 m -88.72 -56.55 5.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 17.5 mt -171.85 132.85 0.72 Allowed 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 128.059 2.544 . . . . 0.0 107.392 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -83.41 -36.63 24.11 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -127.03 96.66 4.68 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.301 0.572 . . . . 0.0 110.529 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -108.42 95.13 5.46 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 174.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.43 163.9 26.36 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.61 31.38 58.71 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 42' ' ' VAL . 39.7 t -107.06 82.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 CA-C-O 121.107 0.479 . . . . 0.0 110.448 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -128.3 -70.36 0.69 Allowed 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.6 p -91.3 -35.86 14.21 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 p -89.31 88.18 7.4 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.52 ' HA ' HG13 ' A' ' 38' ' ' VAL . 22.0 t -77.65 81.98 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 121.932 0.872 . . . . 0.0 109.542 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 43' ' ' ARG . 10.1 ptt180 -99.7 82.35 2.6 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.954 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -110.78 148.16 32.94 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.4 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.597 ' HA3' ' HE1' ' A' ' 48' ' ' TYR . . . -147.64 144.26 12.23 Favored Glycine 0 N--CA 1.413 -2.841 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . -67.59 -83.0 0.13 Allowed Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.474 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.942 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.1 mm -119.13 142.78 32.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.597 ' HE1' ' HA3' ' A' ' 45' ' ' GLY . 50.4 m-85 -128.7 113.37 15.29 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 174.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 29' ' ' VAL . 58.8 t -51.47 114.97 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 169.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -91.11 -30.38 16.76 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.905 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -158.34 159.99 36.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.928 HG21 ' HB2' ' A' ' 59' ' ' GLU . 45.3 mm -110.1 120.49 61.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 55' ' ' LYS . 1.8 mp -68.16 131.2 92.16 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.65 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 30.5 Cg_exo -69.35 60.12 1.45 Allowed 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 124.009 3.139 . . . . 0.0 112.267 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -138.95 19.62 2.64 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.151 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.7 -147.28 25.1 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.492 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 73.71 -91.05 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 125.329 1.452 . . . . 0.0 112.273 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.928 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -76.44 -36.85 57.74 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.326 -172.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.928 ' HB2' HG21 ' A' ' 52' ' ' ILE . 27.7 tt0 -78.85 -38.97 36.61 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 120.806 0.336 . . . . 0.0 110.655 -176.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -76.73 -27.83 55.57 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.109 0.481 . . . . 0.0 112.031 -175.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -87.98 -14.43 39.16 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.21 56.58 20.7 Favored Glycine 0 CA--C 1.497 -1.077 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.014 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -120.47 -46.48 2.38 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.168 0.509 . . . . 0.0 110.007 -177.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.551 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 53.3 mt -110.78 136.28 47.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.408 ' HA ' HD11 ' A' ' 52' ' ' ILE . 32.3 m-70 -134.56 177.85 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.814 0.696 . . . . 0.0 109.155 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -67.05 125.16 25.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.744 0.783 . . . . 0.0 110.237 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.82 21.0 17.19 Favored Glycine 0 N--CA 1.416 -2.669 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.016 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -97.58 142.44 29.39 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.962 -1.317 . . . . 0.0 110.424 167.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.639 ' HB2' ' HA3' ' A' ' 104' ' ' GLY . 6.7 ttm180 -92.83 138.58 31.36 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.942 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 55.9 t -106.93 115.67 48.95 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.476 HD12 HD22 ' A' ' 100' ' ' LEU . 96.8 mt -86.45 -37.54 18.22 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.955 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.712 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . . . -167.31 176.06 6.93 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.097 -175.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.574 ' HA ' HD12 ' A' ' 99' ' ' LEU . 21.1 t -118.94 118.69 58.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 175.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 47.48 40.45 11.23 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 124.513 1.125 . . . . 0.0 113.771 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.65 -6.68 79.72 Favored Glycine 0 C--N 1.315 -0.636 0 C-N-CA 120.849 -0.691 . . . . 0.0 114.344 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 48.7 t -91.49 104.25 15.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.57 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 19.7 m -50.43 123.17 8.13 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.603 1.161 . . . . 0.0 113.3 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.712 ' HB3' ' HA ' ' A' ' 72' ' ' ALA . 22.3 tp -117.68 1.36 12.2 Favored 'General case' 1 N--CA 1.366 -4.64 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.844 -172.88 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.454 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 19.1 mt-10 -74.22 113.88 11.93 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.18 -0.16 11.54 Favored Glycine 0 C--N 1.298 -1.566 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -172.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.1 164.82 12.71 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.467 HG22 ' HG2' ' A' ' 85' ' ' GLN . 15.3 t -101.01 160.08 14.68 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 170.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 21.8 p80 -50.65 -45.43 57.89 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -58.94 -39.14 80.7 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.537 0.335 . . . . 0.0 110.1 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.467 ' HG2' HG22 ' A' ' 82' ' ' THR . 16.2 mm-40 -71.8 -36.41 70.28 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.106 0.479 . . . . 0.0 110.137 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.59 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -59.85 -47.09 87.12 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' A' ' 90' ' ' LEU . 95.8 t -67.48 -28.77 43.24 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.252 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.22 -30.2 69.22 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.26 0.552 . . . . 0.0 110.336 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -78.55 -25.21 45.36 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 80.8 mt -74.81 -23.51 58.49 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.712 0.768 . . . . 0.0 109.182 173.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -84.72 -29.34 25.64 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.462 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.66 -45.44 92.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.822 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.416 ' OG1' HG22 ' A' ' 97' ' ' VAL . 40.1 p -71.44 153.64 42.11 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.07 -119.55 0.91 Allowed Glycine 0 N--CA 1.426 -1.996 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.31 -175.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -79.8 -34.87 39.25 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.221 -0.489 . . . . 0.0 110.489 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -116.33 126.27 73.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.087 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.429 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 39.3 t -101.63 126.76 55.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -101.19 52.95 0.84 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.759 HD23 HD11 ' A' ' 101' ' ' LEU . 7.7 tp -61.84 149.47 40.11 Favored 'General case' 0 C--O 1.206 -1.227 0 C-N-CA 125.062 1.345 . . . . 0.0 111.18 -172.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.476 HD22 HD12 ' A' ' 71' ' ' LEU . 2.4 tt -110.43 118.77 37.16 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.759 HD11 HD23 ' A' ' 99' ' ' LEU . 6.4 mp -124.24 174.34 7.76 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.341 1.067 . . . . 0.0 112.567 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 30.8 tt0 -133.07 148.74 52.18 Favored 'General case' 0 N--CA 1.403 -2.824 0 N-CA-C 101.846 -3.39 . . . . 0.0 101.846 171.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.907 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -82.38 84.77 7.04 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 172.572 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 69' ' ' ARG . . . -77.07 102.13 1.65 Allowed Glycine 0 CA--C 1.47 -2.732 0 CA-C-N 112.859 -1.973 . . . . 0.0 113.67 -170.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -65.72 178.06 1.12 Allowed 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.211 0.529 . . . . 0.0 110.261 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.5 t -75.7 126.92 86.69 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo . . . . . 0 C--O 1.258 1.492 0 C-N-CA 123.127 2.551 . . . . 0.0 112.579 -178.017 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.966 ' HG3' ' HD3' ' A' ' 10' ' ' PRO 0.282 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.833 0 CA-C-O 119.506 -0.283 . . . . 0.0 111.625 . . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.966 ' HD3' ' HG3' ' A' ' 9' ' ' LYS . 21.4 Cg_exo -70.05 125.84 12.44 Favored 'Trans proline' 0 C--N 1.355 0.892 0 N-CA-C 108.247 -1.482 . . . . 0.0 108.247 169.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.18 7.78 84.66 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.135 -177.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.3 t70 -92.4 145.56 24.37 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 2.9 p -105.0 114.89 29.37 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.372 0.606 . . . . 0.0 112.026 -176.336 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' HE1' ' HB2' ' A' ' 103' ' ' LYS . 24.3 p90 -147.37 153.1 39.25 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.261 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.531 ' HG3' ' HG ' ' A' ' 100' ' ' LEU . 2.5 mp0 -91.26 108.57 19.97 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 t -76.1 136.47 24.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.49 96.47 8.01 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 175.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.708 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -117.66 117.59 29.8 Favored 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -178.227 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.09 171.07 7.55 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -176.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.82 111.81 6.53 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 172.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.9 m -117.16 97.41 5.91 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.62 -176.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t70 67.64 -61.45 0.36 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.711 1.204 . . . . 0.0 112.605 175.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.69 35.04 5.2 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 178.227 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.3 p 64.48 -155.43 0.3 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.986 1.714 . . . . 0.0 112.321 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 18' ' ' LEU . 13.5 tp -73.6 104.63 4.61 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.737 ' H ' ' HB3' ' A' ' 57' ' ' ALA . . . -74.48 53.17 2.35 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.046 -0.979 . . . . 0.0 115.167 -174.052 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.488 HG23 ' HB2' ' A' ' 58' ' ' ALA . 4.8 pt -136.45 133.88 49.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.231 0.539 . . . . 0.0 111.763 177.35 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 t -104.15 111.32 23.87 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.002 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.7 m -106.4 152.9 7.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.039 -174.09 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.9 t -134.08 167.86 19.88 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.734 HG11 ' HA ' ' A' ' 82' ' ' THR . 5.7 p -121.13 147.15 25.17 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.511 HD23 ' CD1' ' A' ' 48' ' ' TYR . 4.6 mm? -99.52 88.02 3.75 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 122.042 0.925 . . . . 0.0 109.034 173.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -109.62 -36.17 6.02 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.937 -1.483 . . . . 0.0 107.523 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.3 75.07 9.36 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 175.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -163.19 -48.3 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -176.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.43 -144.38 24.43 Favored Glycine 0 N--CA 1.427 -1.916 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.143 175.193 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.85 25.92 26.56 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 -177.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.16 90.31 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.7 t30 173.81 -53.71 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -178.411 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 42' ' ' VAL . 1.4 m -118.58 178.51 4.44 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 178.177 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.3 m -78.79 -43.66 24.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 120.189 1.359 . . . . 0.0 108.158 175.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.566 ' O ' ' HB ' ' A' ' 40' ' ' THR . 27.7 m -82.24 159.1 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 171.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -98.31 23.36 8.46 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.777 0.798 . . . . 0.0 109.6 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -63.77 108.04 1.34 Allowed 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.361 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -142.6 108.03 0.51 Allowed Glycine 0 N--CA 1.412 -2.928 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -90.05 -130.05 4.12 Favored Glycine 0 N--CA 1.429 -1.811 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.959 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.7 mm -102.53 143.14 15.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -178.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.511 ' CD1' HD23 ' A' ' 32' ' ' LEU . 79.4 m-85 -131.73 108.13 9.26 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.9 t -49.62 116.11 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.533 0.682 . . . . 0.0 109.675 171.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 86.2 tttt -92.2 -33.19 14.8 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.856 -175.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.73 153.29 31.03 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.029 -176.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.015 HG21 ' HB2' ' A' ' 59' ' ' GLU . 31.7 mm -110.67 132.07 60.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.31 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.8 mm -79.31 121.98 83.56 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.16 144.14 95.38 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 123.057 2.505 . . . . 0.0 111.146 178.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 24.0 tptp 59.27 30.16 19.85 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.883 1.325 . . . . 0.0 109.651 -178.257 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.87 -115.32 4.04 Favored Glycine 0 N--CA 1.406 -3.358 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.55 -177.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.737 ' HB3' ' H ' ' A' ' 26' ' ' GLY . . . -132.15 -65.1 0.75 Allowed 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.924 -0.638 . . . . 0.0 111.629 -172.515 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.768 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -54.33 -36.28 63.6 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -171.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.015 ' HB2' HG21 ' A' ' 52' ' ' ILE . 38.1 tt0 -95.54 -40.91 9.21 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 122.341 1.067 . . . . 0.0 110.304 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.6 m -79.71 -44.11 21.4 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.426 -168.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -101.17 -35.04 9.44 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.92 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.86 -128.64 6.43 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 116.519 1.368 . . . . 0.0 116.519 -167.116 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -147.79 -23.1 0.36 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.893 -1.153 . . . . 0.0 110.693 -165.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.768 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.6 mt -69.74 141.33 17.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.915 -173.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -134.64 -176.66 4.3 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.037 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 50' ' ' LYS . 81.0 tttt -67.83 121.69 16.55 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 123.41 0.684 . . . . 0.0 111.296 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.58 -6.94 31.75 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.442 -0.885 . . . . 0.0 114.179 177.474 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.769 ' HB3' HD23 ' A' ' 101' ' ' LEU . 66.3 m-20 -64.64 130.96 45.58 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-O 121.682 0.753 . . . . 0.0 112.067 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.465 ' HG3' ' CE2' ' A' ' 48' ' ' TYR . 48.3 ttt180 -92.22 129.92 38.05 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.997 -174.556 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.959 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 64.3 t -109.36 126.65 66.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.239 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -107.43 -34.91 6.92 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.128 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.623 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -150.32 157.07 42.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.596 0.713 . . . . 0.0 112.132 -176.107 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.816 ' HA ' HD12 ' A' ' 99' ' ' LEU . 61.7 t -109.82 100.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 173.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 t30 59.54 34.37 22.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.55 1.14 . . . . 0.0 110.504 176.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.22 -23.18 35.25 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.478 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.9 t -84.25 106.5 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 20.0 m -75.2 138.24 41.82 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 121.616 0.722 . . . . 0.0 112.106 -175.507 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.1 pt? -130.75 74.22 1.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.649 1.214 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -90.39 96.36 10.62 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.084 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.29 39.18 4.31 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.1 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.5 147.38 27.22 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.106 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.734 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.9 t -69.04 146.66 52.47 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 18.4 p80 -50.95 -35.45 33.56 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -177.398 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 54.6 mtmt -62.48 -38.91 91.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.257 176.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -76.21 -31.27 58.33 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -55.29 -53.69 52.9 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.481 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.662 ' HA ' HD12 ' A' ' 90' ' ' LEU . 86.0 t -64.48 -29.02 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.002 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 43.6 mm-40 -70.85 -33.19 70.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.164 0.507 . . . . 0.0 110.253 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.6 m -69.67 -35.15 74.9 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.68 HD13 HD23 ' A' ' 25' ' ' LEU . 81.3 mt -67.66 -34.57 77.2 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 123.918 0.887 . . . . 0.0 109.375 178.296 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -66.9 -35.39 79.9 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.7 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.11 -34.32 66.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.122 176.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.6 m -57.77 -51.65 68.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 123.702 0.801 . . . . 0.0 110.636 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.19 -150.32 17.62 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 120.079 -1.058 . . . . 0.0 112.893 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -77.78 -39.64 43.34 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 122.961 0.504 . . . . 0.0 110.765 -178.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.3 t -106.7 119.73 56.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.2 175.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.62 HG11 HD22 ' A' ' 90' ' ' LEU . 58.2 t -104.26 127.54 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-O 121.509 0.671 . . . . 0.0 110.213 -176.411 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -97.4 120.22 37.36 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 169.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.816 HD12 ' HA ' ' A' ' 73' ' ' VAL . 9.0 tp -121.54 133.3 55.02 Favored 'General case' 0 C--N 1.261 -3.24 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.1 tt -94.15 110.31 22.04 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -175.235 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 68' ' ' ASP . 10.1 mp -115.11 170.4 8.39 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.834 0.826 . . . . 0.0 111.774 -176.04 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 36.6 tt0 -129.64 103.33 6.79 Favored 'General case' 0 N--CA 1.4 -2.931 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 171.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.451 ' HB2' ' HE1' ' A' ' 14' ' ' PHE . 22.4 tptm -48.65 121.38 4.52 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 124.194 0.934 . . . . 0.0 112.353 -170.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.14 37.57 3.55 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.292 -172.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -93.33 154.2 18.12 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.452 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 34.8 m -73.47 129.23 85.97 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 123.363 0.414 . . . . 0.0 110.249 176.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 6.2 Cg_exo . . . . . 0 N--CA 1.444 -1.39 0 C-N-CA 122.898 2.398 . . . . 0.0 110.389 177.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.867 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 95.6 mttt . . . . . 0 CA--C 1.553 1.078 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.867 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 17.4 Cg_exo -63.43 111.87 1.59 Allowed 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.989 2.459 . . . . 0.0 114.462 -168.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.17 0.89 63.11 Favored Glycine 0 N--CA 1.427 -1.933 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.07 174.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.6 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 32.1 t0 -108.95 158.86 17.3 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 10.4 p -93.92 115.18 27.53 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-O 122.224 1.011 . . . . 0.0 110.375 177.694 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.556 ' CE1' ' HB ' ' A' ' 16' ' ' VAL . 44.8 p90 -123.49 159.72 28.48 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.699 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 41.2 mt-10 -102.1 109.11 20.73 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.15 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.556 ' HB ' ' CE1' ' A' ' 14' ' ' PHE . 7.5 p -89.98 119.83 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 121.378 0.609 . . . . 0.0 111.084 -174.508 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HG3' ' CG1' ' A' ' 96' ' ' VAL . 33.3 tt0 -87.47 91.92 8.9 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.516 -178.585 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.463 HD12 HD13 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -108.77 114.95 29.16 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.461 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.19 141.35 32.07 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -72.94 130.55 40.63 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.079 177.937 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.2 p -112.48 -158.78 0.66 Allowed 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.422 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -53.69 -30.01 41.56 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 123.497 0.719 . . . . 0.0 111.573 175.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.28 16.56 49.08 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.84 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 t 70.28 -143.9 0.08 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.663 ' HG ' HD13 ' A' ' 90' ' ' LEU . 3.6 mm? -64.44 -31.61 72.89 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.92 0.782 . . . . 0.0 109.725 177.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.36 5.14 79.88 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.152 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.0 pt -125.38 144.99 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-O 122.418 1.104 . . . . 0.0 113.193 -175.854 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.577 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 66.0 m -104.63 114.69 29.07 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 113.081 -1.872 . . . . 0.0 106.861 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.4 m -102.85 147.94 8.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-O 121.134 0.493 . . . . 0.0 111.531 -178.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 13.6 t -118.08 171.05 8.36 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.401 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.852 ' HA ' HD13 ' A' ' 47' ' ' ILE . 4.1 t -90.5 -41.48 13.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 177.074 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 42' ' ' VAL . 23.4 tp -164.48 -21.08 0.03 OUTLIER 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.506 174.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -80.28 73.82 7.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.043 0.925 . . . . 0.0 113.118 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -87.24 143.41 27.29 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 172.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -75.58 113.86 13.48 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.237 0.541 . . . . 0.0 111.896 -174.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.57 -128.6 1.74 Allowed Glycine 0 N--CA 1.428 -1.889 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 177.31 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -118.05 -127.81 3.85 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 176.659 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.71 117.64 48.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HA ' HG23 ' A' ' 42' ' ' VAL . 5.3 m-20 68.69 26.65 6.13 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.859 0.863 . . . . 0.0 112.913 178.037 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.3 m -70.19 -43.12 71.4 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 176.553 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.3 m -128.36 95.94 4.29 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.277 177.014 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.502 ' HA ' HD21 ' A' ' 32' ' ' LEU . 11.6 t -142.0 33.51 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 177.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -98.21 124.7 42.93 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 113.824 -1.534 . . . . 0.0 108.651 177.482 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -74.78 130.12 38.9 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.298 0.571 . . . . 0.0 112.062 -175.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.87 -50.13 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -178.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 145.82 -65.63 0.43 Allowed Glycine 0 CA--C 1.48 -2.151 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 174.412 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.852 HD13 ' HA ' ' A' ' 31' ' ' VAL . 24.7 mm -137.58 149.64 25.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 178.579 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -136.05 151.62 50.03 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 118.324 0.511 . . . . 0.0 110.688 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.539 HG21 ' CG2' ' A' ' 64' ' ' ILE . 21.6 t -79.31 109.03 13.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.555 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 87.6 tttt -83.14 -37.13 24.15 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.768 -175.282 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 28' ' ' SER . . . -153.37 148.05 26.28 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.994 -178.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.561 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 49.8 mm -112.72 122.07 66.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.932 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.69 129.03 46.12 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.99 139.26 34.07 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.198 2.598 . . . . 0.0 111.299 177.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.0 tptt 67.8 -0.35 2.02 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.915 0.886 . . . . 0.0 111.803 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.42 102.57 2.94 Favored Glycine 0 N--CA 1.419 -2.484 0 CA-C-O 119.422 -0.654 . . . . 0.0 112.946 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . 26.49 -76.26 0.0 OUTLIER 'General case' 0 C--O 1.181 -2.526 0 C-N-CA 128.312 2.645 . . . . 0.0 115.028 170.16 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -50.28 -39.0 44.08 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.561 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 9.7 tp10 -76.59 -43.66 37.7 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.136 0.575 . . . . 0.0 110.201 178.207 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -67.23 -50.27 61.35 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.29 -177.554 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.43 -36.96 79.81 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.5 179.234 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.72 53.99 4.76 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.088 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.489 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 1.0 OUTLIER -115.87 -74.61 0.6 Allowed 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.442 0.639 . . . . 0.0 109.341 -176.878 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.597 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 62.5 mt -86.26 140.95 15.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -144.71 -172.57 3.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.265 176.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.538 ' O ' ' HD2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -65.94 129.27 39.21 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.326 0.584 . . . . 0.0 112.522 -175.076 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.39 -7.77 62.01 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.203 174.257 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.607 ' HB3' HD23 ' A' ' 101' ' ' LEU . 10.1 m-20 -64.02 138.1 58.3 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-N 117.472 0.636 . . . . 0.0 112.452 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -88.19 115.86 25.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.779 -175.025 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.421 HG22 HD11 ' A' ' 101' ' ' LEU . 43.9 t -100.1 112.7 33.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.313 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.29 -37.55 10.94 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.594 -178.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -157.99 -179.79 8.46 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.382 -175.105 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.986 HG11 HG21 ' A' ' 89' ' ' THR . 2.4 p -130.13 102.69 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 125.561 1.544 . . . . 0.0 110.192 -178.182 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t30 58.95 37.61 24.57 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.247 1.022 . . . . 0.0 111.057 174.084 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.9 -12.0 70.3 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.574 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.596 ' HB ' HG13 ' A' ' 73' ' ' VAL . 59.0 t -93.25 125.41 45.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.5 m -71.02 145.13 50.16 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.267 0.556 . . . . 0.0 112.457 -174.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 61.9 mt -111.91 27.21 9.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.721 0.772 . . . . 0.0 110.304 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -78.11 118.1 20.04 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.126 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.4 19.74 51.25 Favored Glycine 0 C--N 1.309 -0.917 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.98 -171.27 2.19 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.51 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 15.2 t -150.32 175.48 11.78 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.332 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -50.37 -55.58 15.05 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.892 0.745 . . . . 0.0 111.151 -179.161 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -53.26 -45.45 68.82 Favored 'General case' 0 C--O 1.21 -1.0 0 O-C-N 123.898 0.749 . . . . 0.0 110.92 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -70.12 -43.96 69.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.618 0.247 . . . . 0.0 111.466 -176.086 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -58.42 -50.05 75.1 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.492 178.194 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 89.5 t -66.83 -37.21 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.178 -178.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -63.45 -36.54 84.08 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.093 0.473 . . . . 0.0 109.981 178.109 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.986 HG21 HG11 ' A' ' 73' ' ' VAL . 89.8 m -68.89 -37.82 79.24 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.576 177.295 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.663 HD13 ' HG ' ' A' ' 25' ' ' LEU . 83.8 mt -71.23 -19.84 62.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.661 0.743 . . . . 0.0 109.858 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -85.29 -47.67 9.82 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.64 177.209 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.68 -12.09 60.13 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.057 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -29.98 65.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.09 -138.26 10.66 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.617 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.46 ' O ' ' HE3' ' A' ' 20' ' ' LYS . 24.3 tp60 -86.39 -35.7 19.62 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.858 0.361 . . . . 0.0 110.365 -176.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.4 t -124.44 147.76 28.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -175.527 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.403 ' CG1' HG23 ' A' ' 73' ' ' VAL . 6.0 t -129.46 146.72 33.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.234 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 11.9 m-70 -115.75 70.08 0.74 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.155 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.61 HD21 HD21 ' A' ' 90' ' ' LEU . 5.0 mp -63.61 150.98 42.89 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.727 -175.2 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 62.7 tp -93.99 108.98 20.74 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 68' ' ' ASP . 8.1 mp -127.1 147.39 50.17 Favored 'General case' 0 CA--C 1.474 -1.971 0 CA-C-O 121.476 0.655 . . . . 0.0 111.71 -175.491 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 38.0 tt0 -113.66 115.44 27.87 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 103.769 -2.678 . . . . 0.0 103.769 174.11 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.746 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 2.8 tmtm? -49.36 116.6 1.79 Allowed 'General case' 0 C--O 1.245 0.849 0 O-C-N 124.324 1.015 . . . . 0.0 111.721 -172.66 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -102.43 80.24 0.37 Allowed Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 114.129 -1.396 . . . . 0.0 113.112 -174.291 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.723 ' HG3' ' HD2' ' A' ' 103' ' ' LYS . 88.7 mt-30 -99.38 101.94 13.37 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.43 0.633 . . . . 0.0 110.112 175.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.8 m -127.81 103.2 21.67 Favored Pre-proline 0 N--CA 1.422 -1.864 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.59 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 C--O 1.244 0.784 0 C-N-CA 122.759 2.306 . . . . 0.0 110.27 178.008 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.1 mttt . . . . . 0 N--CA 1.422 -1.871 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 1.025 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 9.4 Cg_endo -51.5 131.48 37.01 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.257 2.638 . . . . 0.0 113.671 -177.4 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.63 4.84 60.41 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 116.222 -0.444 . . . . 0.0 113.009 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -106.93 152.12 24.36 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.463 HG22 HD11 ' A' ' 71' ' ' LEU . 18.5 p -88.05 110.52 20.69 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.372 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -114.51 143.45 44.94 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 121.308 0.575 . . . . 0.0 111.564 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -101.99 121.38 42.05 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.501 HG11 HD11 ' A' ' 64' ' ' ILE . 30.0 t -110.95 129.66 65.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.207 -174.441 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 95.39 5.8 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.023 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -97.06 119.37 35.41 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.808 -173.649 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.21 117.98 30.9 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 24' ' ' SER . 94.5 mttt -56.29 121.82 10.4 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.006 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.6 m -92.28 -78.95 0.4 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.437 -174.12 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -126.38 -56.32 1.42 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.068 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.51 30.83 6.52 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 177.231 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.564 ' HA ' ' HB3' ' A' ' 20' ' ' LYS 0.286 97.8 p 66.19 -105.97 0.11 Allowed 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 126.367 1.867 . . . . 0.0 112.107 -179.988 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 90' ' ' LEU . 81.8 mt -96.83 128.43 43.78 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 176.551 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 52' ' ' ILE . . . -81.56 8.36 59.19 Favored Glycine 0 C--N 1.294 -1.804 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.761 -176.257 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.7 pt -99.55 115.69 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.32 -177.008 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.498 ' HB2' HG12 ' A' ' 53' ' ' ILE . 23.4 t -88.7 124.18 33.86 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 175.544 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.76 -174.68 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -173.306 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -170.75 150.48 3.28 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 178.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG11 ' HA ' ' A' ' 82' ' ' THR . 7.3 p -120.79 117.45 53.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-O 121.209 0.528 . . . . 0.0 110.252 177.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.275 0.9 OUTLIER -128.98 95.08 3.98 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 122.282 1.039 . . . . 0.0 113.744 177.798 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -83.5 -18.16 39.45 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 169.441 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -174.81 142.12 0.66 Allowed 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 128.457 2.703 . . . . 0.0 104.785 174.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -144.34 13.73 1.6 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.97 81.56 0.53 Allowed Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -177.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -92.58 -172.7 41.26 Favored Glycine 0 C--N 1.301 -1.386 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.074 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.34 -36.97 15.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -169.71 34.33 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 175.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.2 m -85.15 94.46 8.88 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 113.044 -1.889 . . . . 0.0 108.229 -176.158 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.3 m -84.23 68.01 10.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.851 0.834 . . . . 0.0 112.792 -174.014 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.5 t -82.56 129.7 37.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.368 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -117.29 -43.36 2.84 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -117.22 115.99 26.39 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.66 140.59 11.75 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -178.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 79' ' ' GLU . . . -104.12 -134.18 8.08 Favored Glycine 0 N--CA 1.416 -2.696 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.127 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.861 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.5 mm -101.38 148.29 7.42 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 179.207 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -133.35 147.23 51.81 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 118.385 0.539 . . . . 0.0 109.874 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.429 HG21 HG21 ' A' ' 64' ' ' ILE . 59.7 t -81.29 115.3 23.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.578 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -85.69 -34.48 21.27 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.594 -177.683 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.93 169.85 12.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.04 -176.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.063 HG21 ' HB2' ' A' ' 59' ' ' GLU . 20.5 mm -114.36 116.2 51.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 177.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.825 ' HB ' ' HD3' ' A' ' 54' ' ' PRO . 42.2 mm -84.5 -71.91 0.1 OUTLIER Pre-proline 0 CA--C 1.562 1.426 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -169.757 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 53' ' ' ILE . 6.2 Cg_exo -78.74 -160.87 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.715 2.277 . . . . 0.0 113.306 -172.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -36.44 -55.46 0.83 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.082 1.353 . . . . 0.0 112.132 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.617 ' HA3' ' OG ' ' A' ' 60' ' ' SER . . . -171.71 -87.26 0.07 OUTLIER Glycine 0 N--CA 1.403 -3.565 0 C-N-CA 119.556 -1.306 . . . . 0.0 111.964 176.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.674 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 68.53 -85.28 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 124.486 1.114 . . . . 0.0 108.949 -177.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.023 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -78.14 -29.44 48.74 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.717 -177.606 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.063 ' HB2' HG21 ' A' ' 52' ' ' ILE . 43.6 tt0 -73.75 -63.14 1.27 Allowed 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 124.602 1.189 . . . . 0.0 111.608 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.617 ' OG ' ' HA3' ' A' ' 56' ' ' GLY . 6.8 p -86.21 -30.38 22.44 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -168.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -100.54 -35.77 9.41 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -174.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.25 -128.52 3.35 Favored Glycine 1 N--CA 1.393 -4.229 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.301 -175.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -157.84 3.94 0.12 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -170.07 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.616 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 61.5 mt -94.78 138.94 19.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.388 -168.028 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.58 179.01 6.19 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -70.43 128.38 35.99 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.295 0.569 . . . . 0.0 109.999 176.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.13 -20.48 12.75 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.726 -178.2 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.641 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 50.5 m-20 -64.65 136.83 57.39 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.504 0.668 . . . . 0.0 112.411 -177.375 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -93.84 135.93 34.65 Favored 'General case' 0 C--O 1.195 -1.785 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.473 -176.175 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.861 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 62.2 t -106.53 119.51 56.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.601 HD12 HD22 ' A' ' 100' ' ' LEU . 82.8 mt -97.43 -44.38 6.88 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.55 -1.205 . . . . 0.0 108.781 -177.578 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -152.26 165.08 36.01 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.011 -173.453 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.753 ' HA ' HD12 ' A' ' 99' ' ' LEU . 39.0 t -116.28 111.27 34.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 173.5 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 98' ' ' HIS . 2.6 p-10 47.27 35.91 4.22 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.02 1.328 . . . . 0.0 112.354 -176.299 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.09 -16.23 61.22 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.121 -1.038 . . . . 0.0 114.393 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.39 109.29 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -70.23 137.51 50.91 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.358 0.411 . . . . 0.0 111.235 -174.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.609 HD22 HG23 ' A' ' 73' ' ' VAL . 1.7 pt? -130.6 22.24 5.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.654 177.734 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.523 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 32.4 mt-10 -68.48 105.14 2.11 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.26 16.63 6.04 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.796 -176.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.581 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -98.94 167.52 10.69 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 175.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.618 ' HA ' HG11 ' A' ' 31' ' ' VAL . 9.0 t -90.78 170.17 10.34 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -50.3 -49.54 53.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.465 1.106 . . . . 0.0 109.667 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 10.9 mptt -64.13 -35.17 79.89 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.15 -176.119 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.52 ' HG3' HG22 ' A' ' 82' ' ' THR . 56.2 mt-30 -70.02 -42.59 72.79 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -54.26 -58.79 6.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.023 178.096 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.42 -28.5 43.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.191 -177.244 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 66.1 mm-40 -68.75 -34.38 75.49 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.537 177.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.519 HG22 HG11 ' A' ' 73' ' ' VAL . 37.8 m -69.51 -29.94 67.68 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.5 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.694 ' HB3' HD12 ' A' ' 25' ' ' LEU . 81.4 mt -77.0 -16.55 59.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.961 177.22 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -93.25 -26.94 17.13 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.6 176.196 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -67.28 -42.22 84.15 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.123 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.6 p -65.92 146.23 54.97 Favored 'General case' 0 C--O 1.252 1.208 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.958 177.147 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.9 -128.98 0.88 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -172.649 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -69.3 -54.4 14.82 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.44 0.696 . . . . 0.0 111.803 -174.385 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -106.2 115.51 48.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.587 HG21 HD11 ' A' ' 25' ' ' LEU . 46.0 t -99.0 126.5 52.21 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 74' ' ' ASN . 53.8 t-80 -91.96 123.39 35.28 Favored 'General case' 0 N--CA 1.404 -2.729 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 175.216 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.753 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.6 tp -126.53 143.36 51.23 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.601 HD22 HD12 ' A' ' 71' ' ' LEU . 1.6 tt -105.1 116.1 31.39 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.5 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.596 HD11 HD23 ' A' ' 99' ' ' LEU . 6.6 mp -121.46 176.07 5.86 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.51 0.671 . . . . 0.0 111.873 -177.242 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -131.27 126.85 36.49 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 172.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 1.025 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 15.1 mmtt -57.3 127.01 29.83 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.545 0.528 . . . . 0.0 111.433 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -132.32 97.6 0.34 Allowed Glycine 0 N--CA 1.418 -2.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.561 -178.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -86.62 -172.18 3.89 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 171.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.83 83.68 59.17 Favored Pre-proline 0 C--N 1.295 -1.801 0 CA-C-O 121.474 0.654 . . . . 0.0 110.716 177.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 N--CA 1.433 -2.067 0 C-N-CA 123.205 2.603 . . . . 0.0 111.513 -177.287 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt . . . . . 0 CA--C 1.508 -0.646 0 N-CA-C 104.122 -2.548 . . . . 0.0 104.122 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.31 130.29 28.12 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 CA-C-N 120.932 1.369 . . . . 0.0 109.875 177.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.39 9.22 87.18 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.222 -176.526 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 38.0 t70 -90.97 147.28 23.2 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.577 HG22 HD11 ' A' ' 71' ' ' LEU . 6.1 p -80.65 137.53 36.34 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.071 0.463 . . . . 0.0 111.887 -175.105 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -139.39 140.7 37.5 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.119 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.547 ' HB3' ' NE2' ' A' ' 98' ' ' HIS . 45.3 mt-10 -106.41 114.23 28.23 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.919 -179.168 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.409 HG12 HD13 ' A' ' 101' ' ' LEU . 7.7 p -113.44 131.71 64.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.127 -175.31 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.696 ' HA ' ' HA ' ' A' ' 98' ' ' HIS . 40.8 tt0 -110.52 99.56 8.53 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 175.062 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -93.66 124.14 37.45 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -173.17 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -98.31 116.07 29.75 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.814 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 14.9 ptmt -79.79 145.88 32.59 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.466 -175.009 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -84.87 -55.27 4.16 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.339 0.59 . . . . 0.0 109.963 -175.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.477 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 9.1 p-10 -111.11 -145.77 0.4 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.637 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.22 20.08 11.43 Favored Glycine 0 C--N 1.305 -1.189 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.237 178.344 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 20.0 m -122.42 130.38 53.03 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.764 HD11 ' HB3' ' A' ' 18' ' ' LEU . 22.0 tp -81.26 -5.28 57.61 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.012 0.911 . . . . 0.0 108.904 178.442 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.71 7.25 69.07 Favored Glycine 0 N--CA 1.421 -2.354 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.196 175.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.486 HG22 ' CD1' ' A' ' 52' ' ' ILE . 19.2 pt -132.59 148.21 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 CA-C-O 121.252 0.549 . . . . 0.0 110.495 179.559 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.5 t -116.79 120.41 38.46 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 176.117 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 49' ' ' VAL . 35.0 m -111.97 170.34 3.89 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-O 120.71 0.29 . . . . 0.0 110.966 -176.377 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -145.45 169.71 17.81 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 171.414 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.605 HG23 ' H ' ' A' ' 32' ' ' LEU . 30.8 m -72.43 -65.67 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 118.709 -1.196 . . . . 0.0 108.858 173.271 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.605 ' H ' HG23 ' A' ' 31' ' ' VAL . 43.4 tp -172.21 146.4 1.88 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 172.431 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -156.8 -76.51 0.09 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.513 -176.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.71 145.88 29.35 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.805 -179.034 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -114.61 -1.07 13.44 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.81 -173.571 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.26 -104.65 1.78 Allowed Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -176.302 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -136.15 24.01 3.29 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.858 178.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 40' ' ' THR . 66.8 t -108.57 142.29 21.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -72.98 -33.03 65.57 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 122.783 0.433 . . . . 0.0 111.595 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.556 ' H ' HG12 ' A' ' 38' ' ' VAL . 4.8 t -118.0 96.43 5.34 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-O 122.456 1.122 . . . . 0.0 111.029 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -131.05 81.77 2.01 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.755 177.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 p -160.85 108.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.174 177.804 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -127.43 40.84 3.63 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -178.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.447 ' HB3' ' NH2' ' A' ' 69' ' ' ARG . 56.2 t-80 75.55 101.63 0.07 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 111.499 -2.591 . . . . 0.0 109.983 -172.725 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.63 ' HA2' ' HE1' ' A' ' 48' ' ' TYR . . . -81.12 73.25 2.61 Favored Glycine 0 N--CA 1.424 -2.139 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.862 -177.366 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.87 -75.75 0.79 Allowed Glycine 0 N--CA 1.423 -2.168 0 N-CA-C 107.504 -2.238 . . . . 0.0 107.504 175.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.666 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 30.7 mm -145.24 134.49 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 174.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.63 ' HE1' ' HA2' ' A' ' 45' ' ' GLY . 39.3 m-85 -125.45 139.88 53.26 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.554 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.493 HG21 ' CG2' ' A' ' 64' ' ' ILE . 40.1 t -75.17 117.76 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.169 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -93.02 -31.66 14.79 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.087 -174.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . . . -158.06 162.67 38.09 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.875 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 65' ' ' HIS . 49.4 mm -107.52 120.11 58.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 177.584 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.507 HG22 ' HD3' ' A' ' 55' ' ' LYS . 50.0 mm -77.53 124.15 86.71 Favored Pre-proline 0 C--O 1.252 1.216 0 C-N-CA 122.956 0.502 . . . . 0.0 110.741 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 4.9 Cg_exo -74.84 74.3 3.96 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 124.192 3.261 . . . . 0.0 115.53 -174.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HD3' HG22 ' A' ' 53' ' ' ILE . 2.1 mptm? -116.59 -82.3 0.62 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.204 0.526 . . . . 0.0 110.108 171.32 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.571 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 172.59 49.59 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 119.781 -1.2 . . . . 0.0 112.142 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . -126.36 -96.4 0.43 Allowed 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.967 -179.211 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.916 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -61.05 -36.13 78.77 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.325 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.617 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 40.5 tt0 -72.13 -46.87 54.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.557 0.743 . . . . 0.0 110.465 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.571 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 13.5 m -77.88 -35.85 50.42 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.209 -173.538 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.13 -23.89 47.63 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.9 59.77 4.93 Favored Glycine 0 CA--C 1.498 -1.03 0 CA-C-N 113.98 -1.464 . . . . 0.0 113.471 171.379 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -120.5 -69.81 0.82 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.948 0.88 . . . . 0.0 108.797 -178.581 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.493 ' CG2' HG21 ' A' ' 49' ' ' VAL . 68.6 mt -90.36 141.73 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.783 -178.377 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.672 ' HA ' HD11 ' A' ' 52' ' ' ILE . 33.1 t-80 -139.45 176.15 8.96 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 175.154 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 51' ' ' ALA . 51.5 pttt -73.56 142.87 46.63 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.835 -178.521 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.48 -22.68 21.86 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.957 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 39.1 m-20 -72.63 142.35 48.33 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.91 0.386 . . . . 0.0 112.035 -178.614 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.447 ' NH2' ' HB3' ' A' ' 44' ' ' HIS . 1.3 tmt_? -101.09 136.58 40.7 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.018 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.666 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.1 t -103.97 121.44 55.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -175.219 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.577 HD11 HG22 ' A' ' 13' ' ' THR . 90.2 mt -83.47 -42.16 17.21 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.452 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 76' ' ' VAL . . . -170.07 176.09 4.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.703 -175.329 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 1.054 HG11 HG21 ' A' ' 89' ' ' THR . 2.7 p -112.92 105.96 19.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 124.038 0.935 . . . . 0.0 109.901 178.18 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.9 t30 52.41 40.95 30.45 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.771 1.272 . . . . 0.0 110.765 178.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.93 -18.24 41.09 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.538 -178.497 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.71 ' HB ' HG13 ' A' ' 73' ' ' VAL . 49.1 t -77.67 109.09 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.0 m -61.57 122.51 15.44 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.905 -173.593 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.0 mt -90.6 74.74 6.72 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -85.37 96.68 9.63 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.649 -174.081 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.17 47.86 69.27 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -178.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.72 147.57 24.42 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.709 HG22 ' HG2' ' A' ' 85' ' ' GLN . 13.9 t -91.06 164.55 13.91 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 172.118 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -43.48 -54.74 4.62 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.409 1.484 . . . . 0.0 112.538 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 36.8 ttmt -63.66 -34.99 79.07 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -176.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.709 ' HG2' HG22 ' A' ' 82' ' ' THR . 82.5 mm-40 -68.85 -43.26 75.79 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.168 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.603 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -55.0 -54.52 41.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.391 176.105 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.73 -35.88 76.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.725 -177.082 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 36.8 mt-10 -69.39 -32.53 71.62 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.521 179.219 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' THR . . . . . 1.054 HG21 HG11 ' A' ' 73' ' ' VAL . 60.2 m -66.86 -36.74 83.02 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 60.3 mt -75.74 -15.11 60.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 0.0 110.011 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -89.11 -45.83 9.3 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.607 176.072 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -69.18 -35.92 76.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.687 -176.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -53.41 -51.91 61.07 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 122.918 0.487 . . . . 0.0 112.185 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.57 -154.24 25.84 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.604 177.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 51.1 tt0 -76.61 -44.94 32.18 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.61 0.719 . . . . 0.0 109.748 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 21.3 t -106.08 116.31 49.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.8 131.97 65.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -174.457 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 9.5 t60 -96.91 136.97 36.71 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 175.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.545 HD11 HD22 ' A' ' 90' ' ' LEU . 6.5 mp -130.44 154.3 47.88 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.123 0.487 . . . . 0.0 109.823 174.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HG ' ' HB2' ' A' ' 71' ' ' LEU . 55.3 tp -110.14 118.95 37.75 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.497 ' HG ' ' HA ' ' A' ' 70' ' ' VAL . 7.4 mp -130.25 178.83 6.28 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.377 0.608 . . . . 0.0 110.527 -178.189 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 9.2 pt-20 -130.49 153.43 48.82 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 172.582 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -61.52 109.95 1.33 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.957 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -73.95 -178.51 38.11 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.596 -177.084 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -147.58 132.31 17.91 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 -175.046 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 30.0 m -84.78 135.8 39.83 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -168.076 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 26.2 Cg_exo . . . . . 0 C--O 1.245 0.848 0 C-N-CA 123.472 2.781 . . . . 0.0 109.754 173.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 51.8 mtpt . . . . . 0 C--O 1.246 0.878 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.81 111.11 1.61 Allowed 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 121.819 1.68 . . . . 0.0 109.894 173.117 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.488 ' H ' ' HB2' ' A' ' 103' ' ' LYS . . . 119.21 3.07 13.32 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.314 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -92.36 148.26 22.27 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 122.55 -0.382 . . . . 0.0 110.116 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 p -89.1 109.06 19.96 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 166.138 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -109.55 100.59 9.62 Favored 'General case' 0 N--CA 1.408 -2.536 0 CA-C-O 122.334 1.064 . . . . 0.0 111.028 -173.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.774 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 45.4 mt-10 -71.51 91.87 1.08 Allowed 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.177 174.269 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.619 HG12 HD13 ' A' ' 101' ' ' LEU . 14.9 p -84.62 138.77 18.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.536 -174.566 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -108.13 107.73 18.5 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 177.377 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.83 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -116.38 130.94 57.03 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.441 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -103.77 132.34 50.11 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.231 -0.293 . . . . 0.0 110.873 -178.78 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 95' ' ' GLN . 1.7 mptm? -60.42 136.44 58.04 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.09 0.471 . . . . 0.0 112.097 175.332 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.411 HG21 ' HA3' ' A' ' 56' ' ' GLY . 17.6 p -104.11 100.3 10.05 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 169.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 t70 73.06 -49.44 0.7 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.875 1.27 . . . . 0.0 112.203 -177.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.96 0.78 0.03 OUTLIER Glycine 0 C--N 1.306 -1.138 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.927 177.228 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.3 m -108.21 144.0 36.26 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 122.169 -0.606 . . . . 0.0 110.207 -177.488 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.83 HD11 ' HB3' ' A' ' 18' ' ' LEU . 19.6 tp -93.98 -11.14 31.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.831 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.7 13.9 66.39 Favored Glycine 0 N--CA 1.429 -1.797 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.048 175.545 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.498 HG22 HD13 ' A' ' 52' ' ' ILE . 14.1 pt -139.66 146.25 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.667 0.746 . . . . 0.0 112.487 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.422 ' OG ' HD11 ' A' ' 53' ' ' ILE . 19.6 m -107.02 135.04 49.26 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.412 172.48 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.0 165.23 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 123.772 0.67 . . . . 0.0 109.64 -176.574 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.998 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 6.0 t -149.37 141.8 24.27 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 177.406 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.769 HG12 HD13 ' A' ' 47' ' ' ILE . 32.6 m -121.49 133.67 67.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.204 -0.998 . . . . 0.0 113.514 -176.207 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 43' ' ' ARG . 61.0 mt -110.53 93.97 4.76 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 171.318 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -142.02 -49.91 0.38 Allowed 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -178.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -81.51 162.79 23.08 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.136 173.632 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -70.23 107.28 3.65 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -178.586 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 168.46 -176.98 42.68 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.277 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.82 -131.44 43.28 Favored Glycine 0 C--O 1.249 1.032 0 O-C-N 124.087 0.522 . . . . 0.0 112.291 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.2 t -82.97 114.29 23.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 175.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -137.43 97.92 3.58 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.965 -175.458 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.1 p -77.01 -52.13 9.89 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 172.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 t -164.11 -49.05 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.604 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.0 p -106.5 166.45 3.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 173.546 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.526 ' HB3' ' HB3' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -99.87 140.5 33.99 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -176.634 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -84.35 118.01 23.96 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.83 -88.83 0.65 Allowed Glycine 0 N--CA 1.438 -1.19 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.573 177.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 32' ' ' LEU . . . 149.34 -48.32 0.6 Allowed Glycine 0 N--CA 1.418 -2.522 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -178.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.769 HD13 HG12 ' A' ' 31' ' ' VAL . 42.2 mm -115.43 136.12 53.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.561 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.669 ' HB3' ' HA ' ' A' ' 69' ' ' ARG 0.27 38.5 p90 -158.52 169.3 24.74 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 169.295 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.553 HG21 ' CG2' ' A' ' 64' ' ' ILE . 31.8 t -80.59 121.76 34.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.694 -178.111 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.998 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 57.8 tptt -91.32 -38.09 12.85 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.468 178.669 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -156.03 158.58 38.06 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.577 -175.406 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.498 HD13 HG22 ' A' ' 27' ' ' ILE . 45.9 mm -104.05 117.97 50.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.242 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 43.6 mm -93.29 134.18 27.34 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.726 -179.468 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 14.9 Cg_exo -72.36 -172.68 0.94 Allowed 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 122.792 2.328 . . . . 0.0 112.186 178.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.5 tptt 92.74 5.35 0.05 Allowed 'General case' 0 C--O 1.242 0.661 0 C-N-CA 126.367 1.867 . . . . 0.0 109.309 176.224 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.569 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 124.89 -163.83 18.68 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 114.677 -1.147 . . . . 0.0 113.256 173.375 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.503 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 71.66 -114.04 0.07 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 171.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.819 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -60.42 -39.48 87.58 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 117.942 0.337 . . . . 0.0 111.354 -174.673 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.11 -55.88 16.2 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.38 1.472 . . . . 0.0 110.115 178.15 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.569 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 20.4 m -73.25 -36.68 66.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -171.349 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -74.17 -28.85 61.49 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.58 51.09 22.35 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.382 176.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.561 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 3.1 mmp_? -104.99 -56.85 2.11 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.672 0.748 . . . . 0.0 110.842 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.553 ' CG2' HG21 ' A' ' 49' ' ' VAL . 56.2 mt -95.04 144.06 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.243 -176.023 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -137.0 168.7 19.08 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 173.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -65.74 141.98 58.15 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.279 0.561 . . . . 0.0 111.215 -176.337 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.7 -40.71 2.44 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.027 -1.083 . . . . 0.0 113.77 176.1 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 48' ' ' TYR 0.289 8.1 m-20 -67.21 144.52 55.93 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -174.919 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.669 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 34.6 ttp180 -102.19 149.43 24.31 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.694 -165.506 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 48' ' ' TYR . 22.0 t -115.52 133.36 62.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -173.58 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.487 HD12 HD22 ' A' ' 100' ' ' LEU . 85.1 mt -96.12 -37.23 10.68 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.148 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.837 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . . . -167.44 179.54 4.91 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.925 -176.472 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.858 HG23 HD22 ' A' ' 78' ' ' LEU . 60.3 t -123.89 110.33 25.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.021 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.4 t30 59.43 34.94 22.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.666 1.222 . . . . 0.0 109.923 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 -15.43 61.19 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.478 -1.237 . . . . 0.0 114.221 178.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 57.7 t -85.65 112.47 22.41 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.119 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 17.5 m -53.96 122.84 10.93 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 124.37 1.044 . . . . 0.0 112.354 -174.149 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.858 HD22 HG23 ' A' ' 73' ' ' VAL . 18.4 tp -118.11 8.95 12.53 Favored 'General case' 0 N--CA 1.379 -3.983 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.695 -173.07 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.74 118.09 15.24 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.47 20.03 11.53 Favored Glycine 0 C--N 1.302 -1.326 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.035 -176.295 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.54 ' HB3' HD11 ' A' ' 47' ' ' ILE . . . -101.01 149.84 23.52 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.435 ' C ' HG11 ' A' ' 31' ' ' VAL . 14.9 t -99.14 174.88 6.11 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -50.34 -54.17 23.52 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.785 0.834 . . . . 0.0 111.172 -173.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 59.2 mtpt -63.45 -32.39 73.82 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.063 -176.004 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -72.34 -46.54 55.09 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.526 ' O ' HD13 ' A' ' 90' ' ' LEU . . . -54.88 -56.29 21.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.606 177.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.98 -29.32 46.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.932 -178.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 34.2 mm-40 -72.28 -26.85 62.14 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.967 177.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.1 m -72.78 -39.75 66.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.748 ' HG ' HG11 ' A' ' 97' ' ' VAL . 8.6 mp -69.97 -18.44 63.34 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.677 1.191 . . . . 0.0 110.883 176.752 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -82.15 -43.13 18.14 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.706 175.712 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -66.03 -36.07 82.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.316 -177.644 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -58.89 -55.22 37.89 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.368 -179.486 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 134.35 -142.73 14.24 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 178.764 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.516 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 58.9 tt0 -73.09 -55.76 6.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.063 0.459 . . . . 0.0 110.615 178.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 61.6 t -92.09 113.44 27.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.367 -179.396 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.748 HG11 ' HG ' ' A' ' 90' ' ' LEU . 3.0 t -105.66 128.0 60.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.011 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.532 ' CE1' ' HB3' ' A' ' 15' ' ' GLU . 34.9 t-80 -99.16 130.62 45.48 Favored 'General case' 0 C--N 1.258 -3.372 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.48 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 90' ' ' LEU . 5.2 mp -128.26 146.17 50.82 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.346 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.774 ' HG ' ' HG2' ' A' ' 15' ' ' GLU . 3.3 tt -98.91 112.67 24.71 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -177.758 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.619 HD13 HG12 ' A' ' 16' ' ' VAL . 9.9 mp -115.27 166.51 11.77 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.237 0.541 . . . . 0.0 111.727 -177.651 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -133.14 152.11 51.96 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 176.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.488 ' HB2' ' H ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -54.05 115.26 1.95 Allowed 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.543 0.687 . . . . 0.0 110.334 171.827 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 69' ' ' ARG . . . -126.2 1.84 7.75 Favored Glycine 0 C--N 1.292 -1.902 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 176.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -49.93 -37.59 32.51 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 126.856 2.062 . . . . 0.0 111.98 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.79 98.75 49.58 Favored Pre-proline 0 N--CA 1.422 -1.833 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.825 -178.596 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 N--CA 1.448 -1.163 0 C-N-CA 122.12 1.88 . . . . 0.0 110.546 174.01 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.414 ' HB2' ' NZ ' ' A' ' 9' ' ' LYS . 9.8 mtmp? . . . . . 0 N--CA 1.427 -1.58 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.829 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 73.3 Cg_exo -50.76 128.62 24.74 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 121.481 1.454 . . . . 0.0 110.522 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.55 -15.54 58.54 Favored Glycine 0 C--N 1.31 -0.885 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.68 -175.342 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 11.4 t70 -73.9 131.57 41.6 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 p -91.18 133.45 35.36 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.383 0.611 . . . . 0.0 111.902 -174.128 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -143.88 149.22 36.57 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.425 177.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -106.33 117.84 35.09 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.75 115.63 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.08 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.406 178.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.5 91.28 5.38 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.229 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.983 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -100.7 119.69 38.96 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.138 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.44 124.09 34.16 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.133 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.479 ' HG2' HD23 ' A' ' 25' ' ' LEU . 92.9 mttt -65.52 144.13 57.21 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.145 0.498 . . . . 0.0 111.607 -179.502 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.564 HG21 ' HG3' ' A' ' 55' ' ' LYS . 6.2 m -61.89 -42.1 98.67 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.568 177.139 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -163.05 -49.45 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.785 176.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.31 -9.24 0.68 Allowed Glycine 0 C--O 1.242 0.597 0 C-N-CA 119.524 -1.322 . . . . 0.0 113.538 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 m -132.73 150.64 52.13 Favored 'General case' 0 N--CA 1.433 -1.314 0 O-C-N 122.062 -0.669 . . . . 0.0 110.828 -175.798 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.622 HD12 HD23 ' A' ' 90' ' ' LEU . 72.6 mt -89.74 145.34 25.27 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 169.081 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.83 51.92 4.62 Favored Glycine 0 C--N 1.288 -2.116 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.902 -177.405 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.541 HD13 HD13 ' A' ' 64' ' ' ILE . 12.2 pt -140.58 142.29 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 CA-C-N 117.87 0.835 . . . . 0.0 111.904 177.569 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 t -117.53 140.95 48.93 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 175.495 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 49' ' ' VAL . 27.1 m -126.28 147.96 31.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.4 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 15.1 t -118.84 158.31 25.9 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 82' ' ' THR . 3.3 t -114.04 127.7 71.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -176.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 mp -116.06 106.92 14.29 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.158 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -70.43 134.55 47.91 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.607 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.98 134.69 53.47 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -114.18 1.94 14.7 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.091 179.533 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.18 83.6 1.08 Allowed Glycine 0 CA--C 1.507 -0.452 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.418 -177.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -92.71 -6.93 63.45 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 121.226 -0.512 . . . . 0.0 113.955 -174.866 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.57 -60.04 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.125 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -166.13 -50.08 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.393 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.5 p -76.43 113.63 14.25 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.333 0.587 . . . . 0.0 110.757 177.567 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 m -118.26 140.19 50.19 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.429 -178.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.9 m -79.38 92.77 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-O 122.901 1.334 . . . . 0.0 108.306 174.421 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -97.43 171.37 8.44 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.663 -171.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.582 ' HB2' HD22 ' A' ' 71' ' ' LEU . 59.5 m80 74.31 95.64 0.07 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.296 173.409 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 78' ' ' LEU . . . 87.92 -67.11 3.23 Favored Glycine 0 N--CA 1.426 -1.971 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.352 176.699 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.85 19.14 77.99 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -175.308 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.529 HD13 HG13 ' A' ' 31' ' ' VAL . 42.1 mm -101.53 133.44 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -176.811 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -129.25 120.3 25.48 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.34 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.491 HG21 ' CG2' ' A' ' 64' ' ' ILE . 28.6 t -47.84 113.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 122.036 0.922 . . . . 0.0 109.971 170.732 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.769 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 88.4 tttt -87.41 -37.95 16.57 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.994 -174.484 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.86 151.44 32.25 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.363 -176.285 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 47.4 mm -109.39 128.61 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 O-C-N 123.731 0.644 . . . . 0.0 109.444 178.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.93 133.58 20.97 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 175.629 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 55' ' ' LYS . 22.6 Cg_exo -65.59 -86.6 0.01 OUTLIER 'Trans proline' 0 C--O 1.255 1.349 0 C-N-CA 121.907 1.738 . . . . 0.0 111.57 176.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HG3' HG21 ' A' ' 21' ' ' THR . 17.8 tptp 65.04 -67.51 0.12 Allowed 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 127.605 2.362 . . . . 0.0 110.481 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.07 38.15 0.02 OUTLIER Glycine 0 C--N 1.277 -2.729 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -179.56 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.587 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -134.52 -99.39 0.25 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -174.738 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.983 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -68.71 -38.69 80.43 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -168.757 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.571 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 36.4 tt0 -84.54 -29.39 25.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.313 0.578 . . . . 0.0 110.162 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.8 m -71.92 -46.26 58.26 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.117 -177.114 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.57 -24.3 34.05 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.551 0.691 . . . . 0.0 109.853 178.631 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.08 53.43 14.55 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.263 175.046 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -98.96 -46.76 5.5 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.675 1.226 . . . . 0.0 109.345 178.544 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.541 HD13 HD13 ' A' ' 27' ' ' ILE . 39.8 mt -112.8 140.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-N 113.154 -1.839 . . . . 0.0 109.752 -171.706 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -133.87 154.93 50.7 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 176.273 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 144.25 56.36 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.48 -175.66 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.37 -16.45 38.08 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.975 -178.486 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -80.28 144.45 32.83 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-O 121.034 0.445 . . . . 0.0 111.081 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -90.93 137.33 32.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.813 -175.546 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 38.5 t -101.18 112.32 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 176.606 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.582 HD22 ' HB2' ' A' ' 44' ' ' HIS . 85.2 mt -85.29 -39.47 17.66 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.668 -177.352 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.707 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -163.37 175.06 11.2 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.144 -176.069 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.708 HG13 ' HG ' ' A' ' 99' ' ' LEU . 23.8 t -130.76 117.87 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 65.32 27.15 12.06 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.455 1.102 . . . . 0.0 110.093 176.63 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.87 -6.82 79.81 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.557 -177.017 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.21 105.06 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.838 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.612 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 47.6 m -62.07 130.79 47.14 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.355 -174.244 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.707 ' HG ' ' HA ' ' A' ' 72' ' ' ALA . 98.0 mt -87.74 40.54 0.94 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.797 0.808 . . . . 0.0 110.574 -178.093 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 77' ' ' SER . 36.2 mt-10 -76.3 112.27 12.62 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.01 32.37 17.79 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -175.435 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.54 177.78 5.06 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.977 0.894 . . . . 0.0 110.92 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.649 ' HA ' HG21 ' A' ' 31' ' ' VAL . 10.0 t -153.87 -179.52 7.92 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -50.7 -54.17 25.28 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.064 0.853 . . . . 0.0 110.142 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 40.7 ttmt -58.35 -43.6 88.41 Favored 'General case' 0 C--O 1.204 -1.298 0 O-C-N 123.596 0.56 . . . . 0.0 111.638 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.543 ' HG2' HG22 ' A' ' 82' ' ' THR . 13.1 mm-40 -66.23 -47.82 72.56 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.936 -176.427 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.529 ' O ' HD13 ' A' ' 90' ' ' LEU . . . -56.91 -57.37 12.8 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.749 178.052 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.48 -32.68 58.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.378 -175.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 53.0 mm-40 -76.44 -19.48 58.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.656 178.27 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 m -76.44 -35.51 58.45 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.622 HD23 HD12 ' A' ' 25' ' ' LEU . 8.7 mp -70.22 -22.14 62.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.622 0.769 . . . . 0.0 110.239 175.504 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -84.61 -31.09 24.45 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.572 0.701 . . . . 0.0 109.729 174.811 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -70.33 -42.37 72.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.565 178.31 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.6 p -65.07 152.97 42.13 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.88 177.107 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.67 -157.05 1.07 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 114.678 0.631 . . . . 0.0 114.678 -179.34 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.443 ' HG3' HG23 ' A' ' 96' ' ' VAL . 20.2 pt20 -68.02 -35.22 77.94 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.463 -0.368 . . . . 0.0 111.581 -177.105 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.443 HG23 ' HG3' ' A' ' 95' ' ' GLN . 48.4 t -105.2 108.52 25.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.095 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.6 t -99.95 134.5 39.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.105 -173.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -104.29 128.09 52.02 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.359 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.708 ' HG ' HG13 ' A' ' 73' ' ' VAL . 5.4 mp -123.89 145.29 49.22 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 172.789 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 56.5 tp -91.82 109.18 20.51 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 mp -117.66 160.2 21.69 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.401 0.62 . . . . 0.0 110.42 -177.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 9.4 pt-20 -131.69 156.6 45.59 Favored 'General case' 0 C--N 1.264 -3.111 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 170.189 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.829 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -63.45 117.1 6.23 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.215 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.34 -162.12 36.51 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.693 -176.118 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -137.67 149.81 46.85 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.54 ' H ' ' HD2' ' A' ' 107' ' ' PRO . 92.3 t -90.57 -54.79 0.28 Allowed Pre-proline 0 C--N 1.288 -2.077 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.081 -179.495 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.54 ' HD2' ' H ' ' A' ' 106' ' ' VAL . 8.9 Cg_endo . . . . . 0 C--N 1.379 2.178 0 C-N-CA 123.767 2.978 . . . . 0.0 112.993 178.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.672 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 35.7 mmtp . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 3.2 Cg_exo -71.36 88.33 0.73 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.44 2.093 . . . . 0.0 114.625 -171.095 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.55 ' H ' ' HB2' ' A' ' 103' ' ' LYS . . . 118.0 -6.38 15.44 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.88 175.219 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -102.79 160.89 14.2 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -174.99 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 p -101.9 145.08 29.72 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 165.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -149.04 153.76 38.34 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.433 -176.191 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -103.47 133.46 48.47 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 179.145 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 64' ' ' ILE . 11.0 p -131.56 132.47 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.143 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.5 ' HG3' ' HD2' ' A' ' 98' ' ' HIS . 49.1 mt-10 -101.46 85.43 2.77 Favored 'General case' 0 CA--C 1.472 -2.039 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 174.582 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -77.32 120.91 23.0 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.624 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.74 123.61 36.14 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.243 -175.778 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -68.49 112.48 5.33 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.509 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 t -111.35 89.01 2.93 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.196 -175.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 t70 79.76 -40.37 0.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.797 -1.547 . . . . 0.0 113.641 178.259 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.76 -98.5 0.99 Allowed Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.489 -0.863 . . . . 0.0 114.078 -179.275 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.0 m -162.65 -162.17 0.77 Allowed 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 -173.264 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.797 HD11 ' HB3' ' A' ' 18' ' ' LEU . 1.6 tp -89.34 109.38 20.29 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 171.514 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.586 ' HA3' ' O ' ' A' ' 56' ' ' GLY . . . -75.07 50.85 2.36 Favored Glycine 0 C--N 1.292 -1.866 0 CA-C-N 114.697 -1.138 . . . . 0.0 115.383 -172.917 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.504 HG21 HG21 ' A' ' 64' ' ' ILE . 10.7 pt -130.11 122.11 53.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 121.749 0.785 . . . . 0.0 111.071 177.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.531 ' HB2' HD11 ' A' ' 53' ' ' ILE . 7.7 t -94.86 124.99 39.23 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 -178.087 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 83' ' ' HIS . 33.7 m -118.67 156.56 20.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 120.687 0.28 . . . . 0.0 111.41 -174.39 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.421 HG22 ' HB2' ' A' ' 50' ' ' LYS . 10.2 t -141.74 159.37 42.35 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.398 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.591 ' CG2' HD13 ' A' ' 47' ' ' ILE . 21.4 t -120.93 115.65 47.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 120.915 0.388 . . . . 0.0 110.797 177.012 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.419 HD22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -142.65 122.0 13.11 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.206 178.453 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.528 ' HZ ' ' HA2' ' A' ' 46' ' ' GLY . 76.5 m-85 -113.54 -68.24 0.94 Allowed 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 176.881 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -156.23 -169.89 3.19 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -177.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -101.73 7.97 41.71 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.389 0.614 . . . . 0.0 110.983 -174.516 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.13 38.77 7.16 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -177.402 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.04 -111.9 0.35 Allowed Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.27 -176.41 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.7 98.71 4.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 122.025 0.916 . . . . 0.0 111.927 -178.696 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -138.91 136.56 35.61 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 177.6 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.9 t -82.21 73.23 9.25 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 122.902 1.334 . . . . 0.0 111.252 177.28 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 65.3 m -157.23 85.67 0.94 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.215 -1.357 . . . . 0.0 107.461 176.15 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 p -137.84 73.71 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 CA-C-O 123.362 1.553 . . . . 0.0 108.97 -176.115 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -91.43 126.19 36.43 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 113.857 -1.52 . . . . 0.0 107.434 178.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -71.68 120.21 16.94 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.067 0.46 . . . . 0.0 110.004 178.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.55 ' HA2' ' HG2' ' A' ' 79' ' ' GLU . . . 156.53 -132.04 3.17 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -178.298 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.528 ' HA2' ' HZ ' ' A' ' 33' ' ' PHE . . . -159.78 -68.08 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.44 0 C-N-CA 117.872 -2.109 . . . . 0.0 115.477 -179.765 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.648 ' HB ' HG22 ' A' ' 70' ' ' VAL . 18.0 mm -100.33 147.22 7.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -164.534 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -129.43 107.68 9.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.94 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.4 t -48.15 121.76 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.608 0.718 . . . . 0.0 110.521 169.075 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.421 ' HB2' HG22 ' A' ' 30' ' ' THR . 85.5 tttt -92.63 -37.31 12.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.702 -178.598 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.85 161.83 34.54 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.825 -175.217 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 20.1 mm -116.08 125.73 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.531 HD11 ' HB2' ' A' ' 28' ' ' SER . 2.0 mp -76.48 134.28 70.0 Favored Pre-proline 0 C--N 1.302 -1.469 0 C-N-CA 122.573 0.349 . . . . 0.0 111.473 -176.813 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.65 130.62 36.11 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 123.107 2.538 . . . . 0.0 110.034 175.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 69.74 -4.99 1.29 Allowed 'General case' 0 C--O 1.249 1.043 0 CA-C-O 122.006 0.907 . . . . 0.0 110.654 -177.207 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.586 ' O ' ' HA3' ' A' ' 26' ' ' GLY . . . -85.48 68.34 3.45 Favored Glycine 0 N--CA 1.403 -3.551 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.209 -175.9 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 58.82 -75.41 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.698 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 167.739 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.677 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -58.12 -35.11 70.98 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 125.219 1.407 . . . . 0.0 113.342 -171.793 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.512 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 34.7 tt0 -85.64 -39.96 16.72 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.032 0.444 . . . . 0.0 110.138 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -68.52 -37.32 79.94 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.282 -177.678 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -82.62 -34.61 27.52 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.714 177.295 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.89 52.02 3.81 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.688 -0.687 . . . . 0.0 114.242 175.256 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -116.58 -56.8 2.25 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.24 0.543 . . . . 0.0 111.658 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.559 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 21.2 mm -84.07 145.52 8.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.11 -176.635 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -125.33 162.61 24.38 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.252 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -77.97 143.1 37.87 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.42 -179.005 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.488 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 103.74 -28.0 17.28 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.478 -179.395 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.756 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 39.5 m-20 -64.53 146.91 53.87 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.687 0.756 . . . . 0.0 111.825 -176.709 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . 59.9 mtp180 -96.84 146.53 24.83 Favored 'General case' 0 CA--C 1.461 -2.456 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.017 -173.964 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.648 HG22 ' HB ' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -112.74 123.79 68.77 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.132 0 CA-C-N 114.229 -1.35 . . . . 0.0 107.461 176.191 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HB2' HD12 ' A' ' 100' ' ' LEU . 65.9 mt -107.96 -24.23 11.7 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.792 -176.195 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -169.06 173.23 6.98 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.927 -176.032 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' HG ' ' A' ' 99' ' ' LEU . 99.4 t -130.29 116.98 38.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 173.56 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 98' ' ' HIS 0.265 1.5 p-10 51.31 38.43 21.5 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.331 1.453 . . . . 0.0 112.513 -177.648 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.79 -8.02 77.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 119.928 -1.129 . . . . 0.0 113.881 -179.052 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.54 106.03 14.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 49.7 m -63.91 136.79 57.65 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.122 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.705 HD11 HG23 ' A' ' 73' ' ' VAL . 81.3 mt -118.95 16.85 13.4 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.584 178.355 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HG2' ' HA2' ' A' ' 45' ' ' GLY . 44.2 mt-10 -67.38 119.47 12.27 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.472 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.5 15.16 58.91 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.301 -177.266 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.78 159.13 15.09 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 117.474 0.637 . . . . 0.0 109.587 179.42 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.9 t -97.0 158.78 15.26 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 171.228 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.571 ' HB2' HG23 ' A' ' 29' ' ' VAL 0.272 8.4 p80 -51.1 -45.4 61.49 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -172.197 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.58 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -64.56 -32.4 74.03 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.614 -178.651 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -67.14 -37.67 84.21 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.676 0.75 . . . . 0.0 109.718 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -63.61 -46.59 85.05 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.565 176.693 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.5 t -64.37 -34.44 69.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.985 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.137 -178.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.58 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 45.6 mt-10 -60.01 -47.34 86.24 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.77 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 93' ' ' THR . 14.0 m -60.7 -39.28 87.94 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.974 0.892 . . . . 0.0 109.739 178.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 25' ' ' LEU . 4.2 tp -79.27 -9.8 59.66 Favored 'General case' 0 N--CA 1.413 -2.279 0 C-N-CA 124.224 1.01 . . . . 0.0 110.431 -177.105 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -101.13 -18.11 16.35 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -92.71 -11.8 33.07 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.817 179.456 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 89' ' ' THR . 32.1 p -73.16 -177.82 2.65 Favored 'General case' 0 C--O 1.252 1.195 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.407 173.281 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.52 -123.25 2.63 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.166 178.736 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -98.15 -45.86 6.06 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.8 m -95.9 118.07 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.658 0 CA-C-O 121.655 0.74 . . . . 0.0 109.374 176.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.523 HG21 HD12 ' A' ' 90' ' ' LEU . 45.8 t -101.15 113.3 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.481 -178.748 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.5 ' HD2' ' HG3' ' A' ' 17' ' ' GLU . 17.3 t-80 -84.31 58.35 4.76 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.184 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.815 ' HG ' HG22 ' A' ' 73' ' ' VAL . 3.8 tt -70.58 142.55 51.72 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.703 -172.42 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.592 HD12 ' HB2' ' A' ' 71' ' ' LEU . 3.0 tm? -101.77 114.3 28.24 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.475 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.48 HD13 HG12 ' A' ' 16' ' ' VAL . 7.7 mp -111.3 166.43 11.11 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.502 0.668 . . . . 0.0 112.758 -177.199 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 69' ' ' ARG . 36.5 tt0 -132.38 151.32 51.91 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.548 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.55 ' HB2' ' H ' ' A' ' 11' ' ' GLY . 11.3 tmtt? -44.44 123.84 3.78 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 124.1 0.96 . . . . 0.0 111.811 171.889 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.756 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -126.4 -10.22 4.2 Favored Glycine 0 C--N 1.295 -1.701 0 C-N-CA 119.605 -1.283 . . . . 0.0 111.312 171.941 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.526 ' O ' ' HE2' ' A' ' 103' ' ' LYS . 10.2 pt20 -89.12 151.17 22.36 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 123.768 0.827 . . . . 0.0 109.698 -178.4 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.4 t 52.84 84.99 0.2 Allowed Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.245 1.018 . . . . 0.0 110.789 -172.01 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo . . . . . 0 C--O 1.253 1.264 0 C-N-CA 124.254 3.303 . . . . 0.0 114.221 -175.964 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt . . . . . 0 C--O 1.242 0.682 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -71.21 135.66 27.54 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 N-CA-C 106.731 -2.065 . . . . 0.0 106.731 165.08 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.78 22.49 39.14 Favored Glycine 0 C--N 1.307 -1.07 0 C-N-CA 119.451 -1.357 . . . . 0.0 111.25 -171.437 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 20.9 t0 -111.59 147.09 36.2 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.851 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.3 p -91.09 144.92 25.13 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 123.899 0.749 . . . . 0.0 112.74 -174.762 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.553 ' HE1' ' HG2' ' A' ' 103' ' ' LYS . 17.8 p90 -168.82 134.44 1.69 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.291 175.856 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 46.1 mt-10 -88.11 104.01 16.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.657 0.742 . . . . 0.0 109.592 175.766 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 5.0 t -71.82 138.85 20.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.647 -178.23 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.18 95.25 5.99 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 173.303 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.711 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -102.5 125.88 49.36 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -174.333 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -97.47 143.72 27.9 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.525 0.678 . . . . 0.0 111.849 -177.372 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 1.2 mptm? -71.73 93.13 1.25 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 124.938 1.295 . . . . 0.0 112.417 176.393 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.444 HG22 ' HB2' ' A' ' 57' ' ' ALA . 13.3 t -64.88 -30.15 71.13 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-O 121.755 0.788 . . . . 0.0 109.466 169.019 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 16.4 t70 -112.13 -155.85 0.58 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -178.676 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.41 17.39 58.56 Favored Glycine 0 C--N 1.299 -1.518 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 176.155 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -155.65 174.75 14.83 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -177.884 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 18' ' ' LEU . 11.6 tp -94.14 150.31 20.44 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -178.256 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.624 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -81.26 41.52 2.65 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.173 -174.311 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.4 pt -137.39 130.93 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-O 121.625 0.726 . . . . 0.0 111.941 177.512 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.609 ' HB2' HD11 ' A' ' 53' ' ' ILE . 48.5 t -99.25 124.23 44.15 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.763 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 49' ' ' VAL . 29.7 m -118.62 152.4 20.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.458 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.541 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 7.6 t -131.93 171.62 13.35 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.513 HG22 ' CD1' ' A' ' 47' ' ' ILE . 2.5 t -110.45 134.79 51.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.426 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tt -140.1 71.66 1.38 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -114.92 19.54 15.76 Favored 'General case' 0 C--N 1.258 -3.384 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.898 -177.856 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -73.93 -17.76 60.98 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.743 -174.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -105.55 6.4 32.2 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.598 0.713 . . . . 0.0 110.522 178.129 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.63 35.93 4.73 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -135.95 94.81 0.24 Allowed Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.0 t -110.11 -73.92 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -139.26 -58.43 0.59 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.239 0.542 . . . . 0.0 109.745 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.489 HG23 HG13 ' A' ' 42' ' ' VAL . 8.8 t -116.25 153.26 32.23 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.342 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 m -69.29 104.39 2.22 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.389 0.614 . . . . 0.0 110.288 -178.81 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.489 HG13 HG23 ' A' ' 40' ' ' THR . 16.3 m -117.78 -4.1 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.788 176.783 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.442 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 2.8 tpm_? -118.4 122.58 43.14 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.562 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -105.54 160.77 14.91 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 174.215 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.88 -144.09 15.74 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -178.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.91 -19.98 7.29 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 119.709 -1.234 . . . . 0.0 113.177 174.401 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.513 ' CD1' HG22 ' A' ' 31' ' ' VAL . 38.0 mm -101.13 126.86 54.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.097 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.732 ' CE1' ' HG2' ' A' ' 69' ' ' ARG . 61.5 m-85 -132.85 124.17 27.45 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.953 -176.844 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.458 HG21 ' CG2' ' A' ' 64' ' ' ILE . 41.0 t -48.32 118.97 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 CA-C-O 121.547 0.689 . . . . 0.0 110.586 172.456 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -92.51 -35.46 13.6 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.97 -176.736 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.33 165.75 30.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.818 -177.294 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.946 HG21 ' HB2' ' A' ' 59' ' ' GLU . 42.6 mm -110.75 116.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.624 ' HB ' ' HA2' ' A' ' 26' ' ' GLY . 47.4 mm -70.43 116.88 49.63 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.851 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 6.9 Cg_exo -75.4 77.85 3.15 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 123.721 2.947 . . . . 0.0 114.015 -175.846 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HD3' HG22 ' A' ' 53' ' ' ILE . 2.1 mptm? -122.53 -23.61 5.14 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.697 170.685 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.647 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 116.62 43.93 0.61 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.479 -179.207 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . . . -117.94 -87.92 0.62 Allowed 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 117.214 0.507 . . . . 0.0 110.897 -177.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.711 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -77.09 -27.85 54.34 Favored 'General case' 0 C--O 1.257 1.498 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -171.278 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.946 ' HB2' HG21 ' A' ' 52' ' ' ILE . 40.9 tt0 -83.0 -33.3 26.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.402 0.62 . . . . 0.0 109.808 -179.721 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.647 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 7.4 m -81.84 -26.89 33.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.559 0.695 . . . . 0.0 109.228 -178.373 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.1 -41.19 59.2 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.072 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.08 39.79 9.07 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.072 -1.422 . . . . 0.0 114.579 170.92 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -120.42 -45.53 2.42 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.067 178.815 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.557 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 60.5 mt -94.02 132.16 38.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.003 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.488 ' HA ' HD11 ' A' ' 52' ' ' ILE . 16.4 t-80 -135.43 -174.87 3.75 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.962 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -73.54 131.53 41.85 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.27 0.557 . . . . 0.0 110.501 -176.099 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.03 -17.39 35.12 Favored Glycine 0 N--CA 1.425 -2.085 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.756 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.488 ' HB3' HD23 ' A' ' 101' ' ' LEU . 11.3 m-20 -63.89 136.02 57.03 Favored 'General case' 0 C--O 1.261 1.666 0 CA-C-O 122.031 0.92 . . . . 0.0 112.783 -177.512 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.732 ' HG2' ' CE1' ' A' ' 48' ' ' TYR . 41.8 mtp180 -86.17 118.79 25.85 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.373 -173.026 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.55 108.81 20.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.465 178.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 102' ' ' GLU . 66.8 mt -86.79 -41.79 13.81 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.83 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -160.4 177.19 10.83 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.607 -175.778 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 1.147 HG11 HG21 ' A' ' 89' ' ' THR . 2.9 p -128.95 102.17 7.55 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 C-N-CA 124.106 0.962 . . . . 0.0 109.51 177.426 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.7 t30 51.78 57.21 6.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.186 0.993 . . . . 0.0 109.897 179.536 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.47 -38.31 3.02 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 114.484 -1.235 . . . . 0.0 114.146 -178.01 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.473 ' HB ' HG13 ' A' ' 73' ' ' VAL . 43.2 t -72.84 111.57 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.066 0.933 . . . . 0.0 109.773 -175.845 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.3 p -81.59 113.45 19.62 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.298 0.571 . . . . 0.0 111.265 -178.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.869 HD23 ' H ' ' A' ' 78' ' ' LEU 0.269 0.7 OUTLIER -88.28 92.63 9.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 122.29 1.043 . . . . 0.0 108.957 176.865 . . . . . . . . 4 4 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -101.1 111.08 23.2 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.79 -169.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.8 46.31 94.29 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -177.11 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.605 ' HB1' ' HG3' ' A' ' 85' ' ' GLN . . . -89.73 167.16 13.1 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 -177.357 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 85' ' ' GLN . 70.8 p -79.7 144.99 33.19 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.725 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 11.1 p-80 -53.08 -37.45 61.68 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.388 0.613 . . . . 0.0 110.021 173.195 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 58.3 tttm -54.41 -54.54 39.32 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.297 -1.32 . . . . 0.0 110.633 173.364 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.605 ' HG3' ' HB1' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -72.51 -28.71 63.04 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.227 -175.624 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.67 -52.12 64.92 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.779 0.8 . . . . 0.0 109.388 174.048 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.65 -28.43 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.933 177.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 63.2 mm-40 -64.54 -35.8 82.14 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 176.079 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' THR . . . . . 1.147 HG21 HG11 ' A' ' 73' ' ' VAL . 23.1 m -69.03 -32.72 72.42 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.374 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.4 mt -72.12 -19.75 61.74 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.849 177.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -102.76 -6.12 22.96 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.167 175.265 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -90.33 -20.92 22.34 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 122.481 1.134 . . . . 0.0 108.435 178.138 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.574 HG21 HG13 ' A' ' 97' ' ' VAL . 2.2 p -83.07 171.12 14.09 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.486 -1.233 . . . . 0.0 109.923 176.917 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.22 -149.18 11.07 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.222 -176.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.624 ' HG3' HG23 ' A' ' 96' ' ' VAL . 3.7 pt20 -69.03 -36.64 77.96 Favored 'General case' 0 C--O 1.207 -1.176 0 CA-C-O 120.823 0.344 . . . . 0.0 110.787 -178.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.624 HG23 ' HG3' ' A' ' 95' ' ' GLN . 59.0 t -116.44 118.83 60.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.342 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.574 HG13 HG21 ' A' ' 93' ' ' THR . 40.1 t -100.53 130.1 50.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.082 -177.784 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 97.8 m-70 -93.99 117.17 29.74 Favored 'General case' 0 C--N 1.272 -2.802 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 172.333 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.795 HD23 HD11 ' A' ' 101' ' ' LEU . 5.2 tp -120.76 133.07 55.35 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -176.676 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 45.9 tp -89.84 112.52 23.89 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -176.4 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.795 HD11 HD23 ' A' ' 99' ' ' LEU . 7.1 mp -124.06 165.56 17.28 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.329 0.585 . . . . 0.0 110.569 -179.577 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.776 ' HB2' HD11 ' A' ' 71' ' ' LEU . 28.3 tt0 -131.63 127.99 38.16 Favored 'General case' 0 N--CA 1.397 -3.079 0 N-CA-C 102.646 -3.094 . . . . 0.0 102.646 174.525 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.922 ' HE2' ' HA ' ' A' ' 103' ' ' LYS . 4.4 mmpt? -46.43 110.01 0.24 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -177.609 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -119.9 91.57 0.5 Allowed Glycine 0 N--CA 1.417 -2.631 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.217 -175.418 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -95.1 -9.13 34.55 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 122.491 1.138 . . . . 0.0 109.352 173.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 16.4 m -144.84 139.74 15.6 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 113.004 -1.907 . . . . 0.0 107.945 177.19 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 1.7 Cg_endo . . . . . 0 C--O 1.248 1.007 0 C-N-CA 123.151 2.567 . . . . 0.0 110.996 176.314 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.563 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 26.7 mtpp . . . . . 0 CA--C 1.56 1.361 0 CA-C-O 119.028 -0.51 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.89 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 26.5 Cg_exo -68.66 66.0 1.2 Allowed 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 121.785 1.657 . . . . 0.0 112.013 172.522 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.33 24.58 0.06 OUTLIER Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 175.062 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 18.2 t70 -90.38 139.76 30.36 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.884 -0.658 . . . . 0.0 110.474 -177.599 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 5.6 p -100.81 119.27 38.4 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 123.945 0.778 . . . . 0.0 110.346 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -150.72 145.84 26.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.555 -178.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.489 ' HG3' HD23 ' A' ' 100' ' ' LEU . 50.0 mt-10 -77.61 97.04 4.95 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.394 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 12.6 p -75.08 138.92 19.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.289 -178.684 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -107.0 114.56 28.71 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.939 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -115.34 124.03 50.24 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.659 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.67 111.59 23.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 99.1 mttt -58.65 153.12 17.12 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.86 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.818 HG23 ' H ' ' A' ' 23' ' ' GLY . 9.0 t -93.93 -164.86 1.23 Allowed 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 171.845 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.47 4.66 17.51 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 118.816 0.735 . . . . 0.0 110.718 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.818 ' H ' HG23 ' A' ' 21' ' ' THR . . . -140.03 56.37 0.62 Allowed Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.007 179.363 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.316 80.3 p 74.9 -176.63 0.15 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 126.404 1.882 . . . . 0.0 115.715 172.47 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.743 HD22 ' HB3' ' A' ' 18' ' ' LEU . 69.6 mt -65.78 -16.98 64.3 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -177.095 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.535 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . 78.52 24.84 62.08 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 178.372 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.529 HG21 HG21 ' A' ' 64' ' ' ILE . 19.3 pt -136.64 123.23 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 CA-C-O 121.992 0.901 . . . . 0.0 112.395 177.853 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 69.8 m -100.34 121.18 41.08 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 113.347 -1.752 . . . . 0.0 108.247 177.769 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 49' ' ' VAL . 32.0 m -114.73 152.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.269 -173.816 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 t -129.35 155.66 45.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.137 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 82' ' ' THR . 8.5 t -95.94 129.77 45.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 119.242 0.928 . . . . 0.0 109.219 179.753 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.9 mt -105.09 88.23 2.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.571 174.395 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.662 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 26.0 m-85 -149.32 91.97 1.89 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 113.565 -1.652 . . . . 0.0 107.781 174.396 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -100.82 88.19 3.51 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 122.873 1.32 . . . . 0.0 109.826 179.334 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -71.83 109.08 5.46 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.243 -177.551 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.55 -14.95 6.76 Favored Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -176.778 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.39 -94.81 1.16 Allowed Glycine 0 N--CA 1.431 -1.689 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.863 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.2 t -93.76 53.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 122.434 1.111 . . . . 0.0 108.623 -177.57 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -106.85 28.39 8.0 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.771 0.796 . . . . 0.0 110.054 -178.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.7 m -73.11 -42.48 62.88 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.545 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.7 m -106.47 126.45 52.26 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 172.668 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.0 t -130.5 13.12 2.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -176.482 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.55 161.64 23.3 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.53 -1.214 . . . . 0.0 107.951 -178.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 73.37 14.09 4.5 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.584 1.154 . . . . 0.0 112.158 177.422 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -142.34 -154.0 6.05 Favored Glycine 0 N--CA 1.432 -1.595 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.662 ' HA2' ' CE2' ' A' ' 33' ' ' PHE . . . 148.21 -95.77 0.17 Allowed Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 178.352 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.932 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 43.0 mm -101.27 146.38 9.77 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.356 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.518 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 53.6 t80 -131.77 110.23 10.71 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -174.835 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.505 ' HA ' HG12 ' A' ' 29' ' ' VAL . 42.1 t -52.3 114.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 171.683 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -94.64 -32.8 13.23 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.805 -173.649 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 28' ' ' SER . . . -149.17 143.07 25.71 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -176.466 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.653 HG22 ' HB2' ' A' ' 59' ' ' GLU . 45.8 mm -104.83 125.21 59.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.261 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.535 ' HB ' ' HA2' ' A' ' 26' ' ' GLY . 30.0 mm -99.49 135.24 20.7 Favored Pre-proline 0 C--N 1.289 -2.029 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.033 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.12 -155.75 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.32 2.68 . . . . 0.0 112.448 174.912 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? 97.36 -44.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.629 1.572 . . . . 0.0 111.232 171.66 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . 156.2 35.52 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 118.12 -1.99 . . . . 0.0 115.452 176.337 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -129.51 -105.8 0.29 Allowed 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.348 177.595 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.939 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -62.87 -35.55 80.38 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -173.437 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.653 ' HB2' HG22 ' A' ' 52' ' ' ILE . 39.4 tt0 -86.43 -26.31 24.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.232 0.539 . . . . 0.0 109.789 -178.156 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.7 t -79.27 -46.17 18.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.812 -178.457 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.57 -31.0 66.5 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.674 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.51 44.41 8.62 Favored Glycine 0 CA--C 1.499 -0.954 0 CA-C-N 114.18 -1.373 . . . . 0.0 114.267 170.77 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -108.99 -62.34 1.49 Allowed 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.406 178.33 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.576 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 25.8 mm -72.11 137.37 23.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.648 -173.227 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -122.32 151.08 41.5 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 173.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 133.91 46.11 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.782 178.518 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.518 ' HA2' ' CZ ' ' A' ' 48' ' ' TYR . . . 111.64 -18.58 24.66 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -172.637 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.502 ' HB3' HD23 ' A' ' 101' ' ' LEU . 89.4 m-20 -66.41 131.23 45.62 Favored 'General case' 0 C--O 1.252 1.206 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.592 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 73.0 mtm-85 -93.12 138.07 31.89 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.86 0.838 . . . . 0.0 111.21 -177.439 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.932 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 49.2 t -99.75 111.84 30.49 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.972 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 102' ' ' GLU . 48.2 mt -95.06 -33.68 12.6 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.633 -175.404 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -162.56 176.36 10.48 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.927 -177.635 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 1.07 HG11 HG21 ' A' ' 89' ' ' THR . 3.1 p -123.97 112.37 32.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 125.172 1.389 . . . . 0.0 107.793 175.187 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.9 p30 50.51 29.33 3.92 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 125.008 1.323 . . . . 0.0 113.582 177.141 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.05 -19.13 41.42 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.1 -177.219 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.521 ' HB ' HG13 ' A' ' 73' ' ' VAL . 52.5 t -86.19 113.86 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.0 m -61.97 136.69 58.07 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.317 0.579 . . . . 0.0 112.517 -175.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.493 HD11 ' HB ' ' A' ' 73' ' ' VAL . 76.2 mt -114.21 32.21 6.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.204 -178.708 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.51 113.28 22.3 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.108 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.97 16.43 35.76 Favored Glycine 0 C--N 1.303 -1.255 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.53 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.24 146.35 26.99 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -179.675 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.558 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 23.0 p -82.76 162.63 21.67 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 173.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -52.27 -42.95 64.14 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.063 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -61.09 -39.96 91.91 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.332 178.512 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.558 ' HG2' ' OG1' ' A' ' 82' ' ' THR . 14.7 mm100 -67.07 -47.14 72.2 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.206 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.3 -48.95 77.6 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.379 178.221 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.82 -28.66 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.122 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.48 -43.01 86.58 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.811 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' THR . . . . . 1.07 HG21 HG11 ' A' ' 73' ' ' VAL . 28.5 m -64.87 -34.34 78.14 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.589 176.748 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 68.7 mt -74.52 -17.95 60.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.23 0.538 . . . . 0.0 110.972 -178.645 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -94.02 -33.16 13.53 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.363 0.602 . . . . 0.0 110.296 174.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -75.85 -19.8 58.61 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.955 -178.106 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -75.94 -77.59 0.13 Allowed 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 171.84 -149.74 12.33 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.527 -179.301 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.481 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 46.1 tt0 -88.75 -39.94 13.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.711 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.58 104.76 16.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.042 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.492 HG23 HD21 ' A' ' 25' ' ' LEU . 3.5 t -106.2 142.38 19.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.429 -174.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 78.4 m80 -110.27 127.95 55.27 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.481 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.663 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 5.8 mp -129.03 150.22 50.52 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.156 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.4 tm? -98.82 111.04 23.55 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 68' ' ' ASP . 10.5 mp -119.48 169.74 9.77 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.136 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.557 ' HB2' HD11 ' A' ' 71' ' ' LEU . 34.0 tt0 -130.45 128.23 40.86 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 172.626 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.512 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 26.5 tptt -59.03 123.79 17.76 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 123.991 0.807 . . . . 0.0 109.748 -177.369 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -119.52 36.58 3.44 Favored Glycine 0 CA--C 1.497 -1.043 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.575 -173.657 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.89 ' HB2' ' HB3' ' A' ' 10' ' ' PRO . 46.8 mt-30 -81.0 29.1 0.34 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.592 0.757 . . . . 0.0 111.885 -179.105 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 11.8 m -143.73 129.22 9.86 Favored Pre-proline 0 C--N 1.28 -2.432 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -178.399 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.1 Cg_exo . . . . . 0 C--O 1.252 1.21 0 C-N-CA 122.755 2.303 . . . . 0.0 110.998 179.221 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 14.4 mmmm . . . . . 0 N--CA 1.442 -0.828 0 N-CA-C 102.433 -3.173 . . . . 0.0 102.433 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.68 115.64 3.18 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 CA-C-N 121.401 1.536 . . . . 0.0 110.656 -177.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.26 1.53 54.13 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.2 -176.717 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 32.4 t70 -83.11 134.56 35.0 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.054 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.2 p -103.42 126.15 50.42 Favored 'General case' 0 N--CA 1.413 -2.311 0 O-C-N 124.531 1.144 . . . . 0.0 110.35 178.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -137.02 160.61 38.43 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.836 -177.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -107.71 97.54 7.26 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 176.435 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.407 HG12 HD13 ' A' ' 101' ' ' LEU . 13.3 p -76.03 134.39 29.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.119 -176.86 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -91.71 97.69 11.17 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.1 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.624 HD11 ' HB1' ' A' ' 57' ' ' ALA . 2.4 tm? -101.76 111.35 23.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.02 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.67 118.9 31.99 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.285 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HE2' ' CD2' ' A' ' 25' ' ' LEU . 94.1 mttt -52.67 119.34 4.44 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 122.032 0.92 . . . . 0.0 112.811 -177.711 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.828 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 93.1 m -120.57 103.71 9.37 Favored 'General case' 0 N--CA 1.403 -2.824 0 CA-C-N 113.687 -1.597 . . . . 0.0 108.184 -175.61 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 t70 62.05 -73.51 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 177.263 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.97 26.47 12.83 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 20' ' ' LYS 0.27 87.5 p 62.68 -98.45 0.07 Allowed 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.974 1.31 . . . . 0.0 112.881 178.922 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.638 ' HG ' HD13 ' A' ' 90' ' ' LEU . 2.7 mm? -100.92 110.38 22.43 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 118.63 0.65 . . . . 0.0 109.368 175.547 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.512 ' H ' ' HB3' ' A' ' 57' ' ' ALA . . . -84.25 36.07 2.94 Favored Glycine 0 C--N 1.295 -1.713 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.274 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.456 HD13 HG21 ' A' ' 27' ' ' ILE . 14.6 pt -125.4 121.13 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.903 0 CA-C-O 121.886 0.85 . . . . 0.0 112.085 -176.428 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.9 t -86.94 119.94 27.68 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 177.935 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.54 149.78 31.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.54 -173.487 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 t -128.63 179.6 5.59 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 172.368 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.467 HG12 HD13 ' A' ' 47' ' ' ILE . 8.9 m -80.49 -53.45 12.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 174.786 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.421 ' H ' HG23 ' A' ' 31' ' ' VAL . 39.6 tp -170.86 -54.06 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 171.622 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -134.94 126.06 27.91 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 173.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -45.31 -56.34 5.01 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -172.862 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 35' ' ' LYS . 52.6 mtpt -140.63 100.06 3.77 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 177.507 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.21 -61.1 2.56 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 172.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.1 -79.25 0.28 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 116.169 1.228 . . . . 0.0 116.169 174.119 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.3 p -60.54 -27.76 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 123.955 0.902 . . . . 0.0 112.905 -173.809 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -126.16 146.15 50.07 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.864 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.8 m -90.05 80.26 6.38 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.53 175.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.0 m -90.27 -10.98 42.24 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 176.06 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.8 t -63.89 104.46 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 113.879 -1.51 . . . . 0.0 109.256 176.451 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -92.45 144.22 25.58 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.24 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -77.08 87.77 3.57 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.738 0.78 . . . . 0.0 112.51 -175.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.27 -70.85 0.1 Allowed Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 173.787 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.5 -91.45 0.13 Allowed Glycine 0 N--CA 1.421 -2.321 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.979 170.341 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.009 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 47.1 mm -116.85 156.16 18.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 C-N-CA 123.307 0.643 . . . . 0.0 109.807 -172.776 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.439 ' CE1' ' HG3' ' A' ' 107' ' ' PRO . 68.9 t80 -135.62 109.56 8.18 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 123.736 0.814 . . . . 0.0 109.562 179.573 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -51.25 109.46 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.861 0 CA-C-O 122.247 1.022 . . . . 0.0 110.623 171.184 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -80.65 -40.83 24.87 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 113.699 -1.591 . . . . 0.0 109.255 -176.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -160.23 161.58 33.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.246 -176.757 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.593 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 38.7 mm -115.75 139.8 40.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.503 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.6 mm -95.6 141.73 23.6 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -177.297 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.81 137.97 71.33 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.4 2.067 . . . . 0.0 109.483 171.869 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 5.2 tppp? 59.44 21.26 9.66 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 123.472 1.606 . . . . 0.0 108.393 -172.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.501 ' C ' ' HA3' ' A' ' 26' ' ' GLY . . . -109.18 81.84 0.29 Allowed Glycine 0 N--CA 1.396 -3.999 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.528 -175.178 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.828 ' HA ' ' HB ' ' A' ' 21' ' ' THR . . . 32.56 -72.45 0.0 OUTLIER 'General case' 0 C--O 1.186 -2.265 0 C-N-CA 127.817 2.447 . . . . 0.0 116.264 171.597 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -55.56 -32.11 62.73 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.734 0.814 . . . . 0.0 111.753 -177.647 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.593 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 6.5 tp10 -89.44 -37.87 14.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.172 0.511 . . . . 0.0 109.662 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 m -74.04 -44.73 53.3 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.49 -175.637 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -76.44 -36.77 57.78 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.672 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.76 59.56 1.5 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.833 176.543 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.419 ' HB2' ' H ' ' A' ' 64' ' ' ILE . 14.4 mmt180 -121.53 -87.02 0.65 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.619 0.723 . . . . 0.0 110.409 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.455 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 53.1 mt -74.94 146.52 9.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.961 -176.351 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -129.95 172.57 11.57 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.683 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.608 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 35.8 mtmm -71.84 126.29 29.35 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 -177.615 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 120.15 -28.13 6.45 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.046 -1.073 . . . . 0.0 113.17 177.864 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.693 ' HB3' HD23 ' A' ' 101' ' ' LEU . 28.9 m-20 -64.45 133.34 52.29 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 122.043 0.925 . . . . 0.0 112.782 -176.183 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -91.88 135.4 33.96 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.127 -175.37 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.009 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 60.8 t -105.66 125.14 61.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -174.068 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.819 ' HB2' HD12 ' A' ' 100' ' ' LEU . 67.9 mt -104.64 -21.6 13.38 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.971 -177.313 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.748 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -168.35 167.62 11.87 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.044 0.449 . . . . 0.0 112.086 -177.787 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.687 ' HA ' HD12 ' A' ' 99' ' ' LEU . 46.7 t -120.83 117.88 54.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 174.412 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.353 30.7 p-10 38.44 63.4 0.87 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.411 1.484 . . . . 0.0 114.859 -179.375 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.05 -21.4 3.38 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.004 -0.998 . . . . 0.0 114.861 178.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.31 100.08 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.714 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 20.0 m -58.1 132.27 53.02 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.261 -178.28 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.748 ' HG ' ' HA ' ' A' ' 72' ' ' ALA . 74.5 mt -93.33 80.25 4.42 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.105 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -77.42 -30.16 53.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.49 -171.434 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.26 58.68 0.31 Allowed Glycine 0 CA--C 1.474 -2.53 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.67 138.07 40.06 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.178 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.749 HG22 ' HG2' ' A' ' 85' ' ' GLN . 14.6 t -85.05 161.35 19.75 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 171.045 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.429 ' HA ' HD12 ' A' ' 47' ' ' ILE 0.287 10.6 p80 -50.89 -41.67 58.51 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.431 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -67.85 -24.02 65.21 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 177.466 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.749 ' HG2' HG22 ' A' ' 82' ' ' THR . 30.1 mm-40 -70.8 -40.75 72.34 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.619 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.554 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -62.61 -45.06 94.59 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.463 176.498 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.426 ' HA ' HD12 ' A' ' 90' ' ' LEU . 91.6 t -69.03 -34.37 63.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.351 -177.645 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 85' ' ' GLN . 7.9 pt-20 -71.59 -27.89 63.44 Favored 'General case' 0 C--O 1.217 -0.623 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.193 178.404 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.8 m -72.74 -25.72 61.31 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.084 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.638 HD13 ' HG ' ' A' ' 25' ' ' LEU . 96.0 mt -79.41 -23.33 43.29 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.659 0.742 . . . . 0.0 109.727 174.592 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -79.12 -38.29 36.51 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.756 175.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.92 -36.52 82.43 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.317 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 p -69.56 159.23 33.75 Favored 'General case' 0 C--O 1.252 1.225 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.26 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.93 -129.32 0.29 Allowed Glycine 0 C--N 1.33 0.222 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.816 -175.268 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -87.78 -44.91 10.78 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.344 0.592 . . . . 0.0 110.436 -178.414 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.38 119.43 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 C-N-CA 118.824 -1.15 . . . . 0.0 110.053 -178.791 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.411 HG11 ' CD2' ' A' ' 90' ' ' LEU . 22.8 t -103.19 126.27 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.372 -176.616 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -94.43 115.71 27.94 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 174.686 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.687 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.0 tp -113.09 136.16 53.01 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.793 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.819 HD12 ' HB2' ' A' ' 71' ' ' LEU . 2.6 tm? -89.28 109.98 20.8 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 -176.343 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.693 HD23 ' HB3' ' A' ' 68' ' ' ASP . 11.0 mp -122.79 165.2 16.99 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.836 0.827 . . . . 0.0 112.673 -175.799 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 41.3 tt0 -131.74 142.66 49.84 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 174.859 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -51.53 130.0 26.8 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 177.0 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . -123.53 62.94 0.56 Allowed Glycine 0 N--CA 1.422 -2.267 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.457 176.446 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -72.99 -35.17 66.82 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 176.011 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 84.2 t -144.07 114.19 5.38 Favored Pre-proline 0 N--CA 1.422 -1.87 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 177.717 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.439 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 37.4 Cg_exo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 123.06 2.507 . . . . 0.0 111.661 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 22.7 t0 . . . . . 0 CA--C 1.497 -1.072 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 37.5 p -91.04 115.45 28.03 Favored 'General case' 0 N--CA 1.413 -2.295 0 O-C-N 123.858 0.724 . . . . 0.0 110.458 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.479 ' CE1' ' HD2' ' A' ' 103' ' ' LYS . 16.4 p90 -125.67 116.8 22.24 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.061 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 45.3 mt-10 -77.96 92.54 4.32 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.709 0.766 . . . . 0.0 109.397 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.486 HG11 HD11 ' A' ' 64' ' ' ILE . 9.6 p -74.81 138.13 21.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.269 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.559 ' HG2' ' CD2' ' A' ' 98' ' ' HIS . 38.5 mt-10 -96.45 96.29 8.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 175.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.841 HD11 ' HB1' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -96.6 111.11 23.38 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -176.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.96 130.39 40.08 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.101 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.452 ' HE2' ' HG ' ' A' ' 25' ' ' LEU . 94.9 mttt -86.01 127.87 34.74 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.729 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 t -77.63 -42.06 36.26 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -164.84 -68.8 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.11 0.481 . . . . 0.0 110.36 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.21 60.56 4.87 Favored Glycine 0 C--O 1.246 0.882 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.971 -173.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 89.8 p 62.01 -170.34 0.17 Allowed 'General case' 0 C--O 1.246 0.919 0 C-N-CA 126.521 1.928 . . . . 0.0 113.14 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.654 HD22 HD12 ' A' ' 18' ' ' LEU . 92.2 mt -68.65 150.68 47.68 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.155 0.502 . . . . 0.0 109.883 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.15 6.47 82.57 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.826 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.481 HG22 HG13 ' A' ' 52' ' ' ILE . 15.7 pt -103.52 128.98 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.754 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.255 -178.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.411 ' HB2' HD13 ' A' ' 53' ' ' ILE . 32.2 t -98.34 114.64 27.03 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 49' ' ' VAL . 35.0 m -112.2 157.81 12.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.364 -175.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.419 ' C ' ' HB3' ' A' ' 83' ' ' HIS . 12.9 t -127.27 161.89 27.51 Favored 'General case' 0 N--CA 1.396 -3.134 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.666 ' HA ' HD13 ' A' ' 47' ' ' ILE . 2.0 p . . . . . 0 C--N 1.272 -2.775 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.496 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.831 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 33.8 mm -141.39 147.89 21.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 176.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -129.66 139.42 51.4 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 118.533 0.606 . . . . 0.0 111.715 177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.59 ' HA ' HG12 ' A' ' 29' ' ' VAL . 44.1 t -74.67 116.48 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 173.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -85.02 -37.06 20.83 Favored 'General case' 0 C--N 1.284 -2.283 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.29 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -165.38 163.97 19.77 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.538 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.933 HG21 ' HB2' ' A' ' 59' ' ' GLU . 1.9 mp -116.96 124.19 72.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.43 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 2.0 mp -108.05 128.57 25.5 Favored Pre-proline 0 C--N 1.293 -1.863 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -17.25 -110.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.953 1 C-N-CA 126.123 4.548 . . . . 0.0 117.16 -173.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HD3' ' O ' ' A' ' 53' ' ' ILE . 3.4 mptp? 70.69 -67.06 0.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.627 1.171 . . . . 0.0 110.183 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.15 -117.67 0.99 Allowed Glycine 0 N--CA 1.401 -3.682 1 N-CA-C 102.762 -4.135 . . . . 0.0 102.762 -172.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.841 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 59.04 -110.29 0.49 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 164.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.795 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -68.27 -41.46 81.0 Favored 'General case' 0 C--O 1.255 1.367 0 C-N-CA 122.674 0.39 . . . . 0.0 111.513 -173.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.933 ' HB2' HG21 ' A' ' 52' ' ' ILE . 42.1 tt0 -73.73 -37.06 65.23 Favored 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 124.437 1.086 . . . . 0.0 110.794 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.7 t -70.88 -49.51 45.16 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.122 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 63' ' ' ARG . 6.4 t70 -65.11 -31.28 72.4 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.02 35.25 54.17 Favored Glycine 0 CA--C 1.488 -1.653 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.989 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 6.7 mmp_? -103.02 -49.69 3.7 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.023 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.64 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 65.9 mt -92.98 138.14 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.173 -172.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -126.38 -173.21 2.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.729 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 52.6 mtpt -79.76 43.35 0.58 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.422 1.089 . . . . 0.0 112.515 -172.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.581 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . -172.88 5.71 0.03 OUTLIER Glycine 0 C--N 1.301 -1.411 0 C-N-CA 118.836 -1.649 . . . . 0.0 115.066 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -74.66 144.37 43.84 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 117.728 0.764 . . . . 0.0 110.324 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 102' ' ' GLU . 56.4 ttt180 -89.32 135.01 33.82 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.831 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 47.9 t -105.74 122.7 59.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.589 HD12 HD22 ' A' ' 100' ' ' LEU . 65.6 mt -97.04 -39.05 9.52 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.233 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 77' ' ' SER . . . -164.87 178.37 7.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.472 -174.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.608 HG23 HD11 ' A' ' 78' ' ' LEU . 48.0 t -121.04 112.9 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 10.4 p30 45.6 37.2 3.03 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 125.529 1.531 . . . . 0.0 113.828 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.84 -9.04 70.84 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 119.856 -1.164 . . . . 0.0 114.235 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.3 97.07 5.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.613 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 11.9 m -59.92 125.68 24.61 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.09 0.869 . . . . 0.0 112.436 -173.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.608 HD11 HG23 ' A' ' 73' ' ' VAL . 59.1 mt -94.89 69.68 3.34 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -111.0 104.68 13.27 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.695 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.34 26.71 11.71 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.74 146.05 30.31 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.507 HG22 ' HG2' ' A' ' 85' ' ' GLN . 11.8 t -88.2 164.11 15.81 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 170.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.53 ' HB3' ' N ' ' A' ' 31' ' ' VAL . 16.4 p-80 -51.15 -40.01 57.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 17.2 tppt? -60.54 -39.89 89.54 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.615 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.507 ' HG2' HG22 ' A' ' 82' ' ' THR . 82.1 mm-40 -70.66 -36.48 73.38 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.261 0.553 . . . . 0.0 110.397 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.403 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -59.44 -52.37 65.88 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.75 174.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 90' ' ' LEU . 60.2 t -66.57 -28.18 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.027 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 46.9 mm-40 -65.32 -39.2 92.14 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.0 m -70.96 -31.85 68.53 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.763 0.792 . . . . 0.0 109.079 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 96.0 mt -76.18 -11.68 59.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.126 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -99.09 -28.95 13.15 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.52 -30.1 70.35 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.026 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 p -76.78 144.84 38.91 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.719 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.66 -120.72 0.13 Allowed Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 116.139 1.216 . . . . 0.0 116.139 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -81.21 -45.08 16.86 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.452 0.701 . . . . 0.0 111.459 -172.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.73 124.23 72.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.066 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.416 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 7.4 t -108.42 139.22 31.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.782 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.559 ' CD2' ' HG2' ' A' ' 17' ' ' GLU . 66.6 m80 -101.49 125.46 48.14 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 6.5 mp -123.02 143.64 49.8 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.589 HD22 HD12 ' A' ' 71' ' ' LEU . 1.3 tt -96.46 109.5 22.04 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 13' ' ' THR . 10.8 mp -117.4 171.33 8.06 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.061 0.458 . . . . 0.0 112.134 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 48.1 mt-10 -130.52 143.37 50.72 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HD2' ' CE1' ' A' ' 14' ' ' PHE . 28.1 mmmt -60.42 125.19 22.75 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.109 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.581 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . . . . . . 0 N--CA 1.425 -2.099 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.299 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 36.3 t70 . . . . . 0 CA--C 1.503 -0.849 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p -89.41 141.77 28.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.213 0.53 . . . . 0.0 111.552 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -149.28 146.56 27.62 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.753 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HB3' ' HE2' ' A' ' 98' ' ' HIS . 38.0 mt-10 -100.13 125.4 46.23 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.1 t -113.3 129.08 69.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -98.36 81.99 2.83 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.957 HD11 ' HB1' ' A' ' 57' ' ' ALA . 1.6 tm? -85.14 126.7 33.84 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -171.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.09 110.1 21.47 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.844 ' HE3' HD12 ' A' ' 25' ' ' LEU . 15.0 ptmt -79.14 153.94 29.7 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.767 HG23 ' HB3' ' A' ' 55' ' ' LYS . 7.2 t -140.23 139.84 35.68 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.209 -176.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 3.7 m-20 71.63 9.33 6.32 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.948 0.899 . . . . 0.0 112.712 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.24 1.34 23.58 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.66 -0.781 . . . . 0.0 114.55 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.2 t -160.49 175.01 13.23 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.844 HD12 ' HE3' ' A' ' 20' ' ' LYS . 7.6 mp -89.49 177.48 6.55 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.12 33.43 5.09 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' A' ' 49' ' ' VAL . 19.5 pt -138.14 139.95 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.639 0 CA-C-O 121.949 0.88 . . . . 0.0 112.012 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.1 m -104.25 118.22 36.1 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 113.68 -1.6 . . . . 0.0 107.274 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.01 145.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.393 0.616 . . . . 0.0 111.731 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -122.9 172.23 8.63 Favored 'General case' 0 N--CA 1.403 -2.822 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 47' ' ' ILE . 2.0 p . . . . . 0 C--N 1.258 -3.389 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 31' ' ' VAL . . . . . . . . 0 N--CA 1.428 -1.899 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.611 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 33.6 mm -131.12 142.48 43.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 174.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.443 ' OH ' ' HD3' ' A' ' 69' ' ' ARG . 45.8 m-85 -126.23 143.77 51.02 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.456 HG13 ' HB ' ' A' ' 27' ' ' ILE . 61.7 t -78.93 108.48 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -80.7 -37.28 30.97 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.783 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.19 153.0 31.87 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.122 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.18 113.63 40.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.2 mm -92.27 154.48 43.0 Favored Pre-proline 0 C--N 1.28 -2.456 0 C-N-CA 125.261 1.424 . . . . 0.0 109.726 -175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -56.4 -152.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.567 2.161 0 C-N-CA 123.446 2.764 . . . . 0.0 113.801 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.767 ' HB3' HG23 ' A' ' 21' ' ' THR . 3.7 mppt? 72.8 -44.97 0.61 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.614 1.166 . . . . 0.0 112.1 -169.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.02 -126.88 4.2 Favored Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 108.176 -1.969 . . . . 0.0 108.176 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.957 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 71.27 -99.48 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 171.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.856 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -73.12 -35.26 66.52 Favored 'General case' 0 C--O 1.265 1.906 0 O-C-N 121.86 -0.525 . . . . 0.0 111.576 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -74.95 -40.03 61.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 125.07 1.481 . . . . 0.0 107.448 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.8 t -67.97 -44.03 77.65 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.056 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.63 -39.69 80.67 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.44 27.0 49.68 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.725 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -108.91 -39.65 5.26 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.115 -1.034 . . . . 0.0 113.156 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.856 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.4 mt -94.97 127.25 47.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -132.3 178.41 6.84 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 123.5 0.5 . . . . 0.0 110.115 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -67.52 128.21 35.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.314 0.578 . . . . 0.0 111.94 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.617 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 101.05 -4.24 55.75 Favored Glycine 0 N--CA 1.422 -2.267 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.006 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.589 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 31.8 m-20 -68.93 146.07 53.1 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.472 HH21 ' CD ' ' A' ' 102' ' ' GLU . 34.7 ttp180 -96.65 129.21 44.09 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.795 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.611 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 59.0 t -101.77 118.3 48.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.76 -31.87 14.23 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.265 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -164.49 167.78 19.08 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.7 ' HA ' HD12 ' A' ' 99' ' ' LEU . 31.7 t -118.04 110.44 30.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 59.39 37.49 23.23 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.393 1.077 . . . . 0.0 109.966 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.46 -6.19 80.88 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.163 -0.926 . . . . 0.0 114.162 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.07 108.66 20.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.514 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 35.4 p -64.95 135.68 55.94 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.699 HD11 HG23 ' A' ' 73' ' ' VAL . 67.5 mt -106.75 25.71 10.92 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.469 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -53.88 -32.03 51.83 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.96 -1.473 . . . . 0.0 113.452 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.63 40.71 1.56 Allowed Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.15 155.63 17.06 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.325 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.581 HG22 ' HG2' ' A' ' 85' ' ' GLN . 9.0 t -92.72 160.75 14.83 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 167.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.424 ' O ' HG23 ' A' ' 87' ' ' VAL . 52.1 p-80 -51.28 -43.43 61.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.141 0.496 . . . . 0.0 111.917 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -59.72 -37.8 79.92 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.581 ' HG2' HG22 ' A' ' 82' ' ' THR . 14.9 mm100 -71.63 -36.05 70.62 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.52 -45.71 90.97 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.348 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 83' ' ' HIS . 64.1 t -66.24 -39.53 84.53 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.776 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -62.51 -39.09 92.41 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.847 0.355 . . . . 0.0 111.038 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.443 ' HB ' HG21 ' A' ' 73' ' ' VAL . 12.1 m -69.91 -38.13 76.16 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.884 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.866 HD13 HD13 ' A' ' 99' ' ' LEU . 19.2 tp -82.95 -3.08 56.67 Favored 'General case' 0 N--CA 1.415 -2.175 0 C-N-CA 125.154 1.382 . . . . 0.0 109.878 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.36 -21.05 13.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.487 172.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -82.84 -25.21 32.84 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.458 ' OG1' HG12 ' A' ' 97' ' ' VAL . 3.2 p -67.18 -177.81 0.72 Allowed 'General case' 0 C--O 1.255 1.359 0 C-N-CA 123.705 0.802 . . . . 0.0 110.517 174.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -78.56 -162.63 21.8 Favored Glycine 0 C--O 1.244 0.764 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.582 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 29.6 tt0 -73.41 -34.53 65.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.717 0.77 . . . . 0.0 108.969 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.8 t -90.19 110.83 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.642 HG21 HD11 ' A' ' 25' ' ' LEU . 8.8 m -99.05 117.54 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.427 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.071 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 41.1 t-80 -84.57 122.0 28.41 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.866 HD13 HD13 ' A' ' 90' ' ' LEU . 7.2 tp -127.35 146.14 50.56 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 53.1 tp -102.13 117.1 34.06 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.751 HD11 HD23 ' A' ' 99' ' ' LEU . 6.6 mp -123.47 165.63 16.76 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.667 0.746 . . . . 0.0 111.761 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.472 ' CD ' HH21 ' A' ' 69' ' ' ARG . 88.1 tt0 -132.95 143.93 49.79 Favored 'General case' 0 N--CA 1.391 -3.42 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.589 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 40.3 mmtt -64.3 125.6 25.11 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.09 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . . . . . . 0 N--CA 1.42 -2.376 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.377 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 28.7 t70 . . . . . 0 CA--C 1.494 -1.204 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 3.1 p -99.21 108.26 20.8 Favored 'General case' 0 N--CA 1.416 -2.164 0 O-C-N 123.895 0.747 . . . . 0.0 110.154 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -138.49 140.34 39.14 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.123 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 4.4 mp0 -75.53 106.36 7.04 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 59.5 t -69.47 122.51 21.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.841 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -96.16 93.96 7.24 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.545 HD11 ' CB ' ' A' ' 57' ' ' ALA . 2.6 tm? -100.53 115.14 29.43 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -177.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.84 117.3 33.86 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 24' ' ' SER . 99.5 mttt -54.52 121.16 7.8 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 124.185 0.928 . . . . 0.0 111.696 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.9 p -90.36 -84.0 0.24 Allowed 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.547 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.76 -54.83 2.41 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.515 ' CA ' ' HA2' ' A' ' 56' ' ' GLY . . . -87.87 25.73 8.34 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.698 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 39.7 t 76.69 -109.94 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 123.992 0.917 . . . . 0.0 113.326 172.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.739 ' HG ' HD13 ' A' ' 90' ' ' LEU . 3.3 mm? -85.38 -31.69 22.8 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 120.065 1.302 . . . . 0.0 110.403 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.531 ' CA ' ' HA3' ' A' ' 56' ' ' GLY . . . 73.55 21.58 79.33 Favored Glycine 0 N--CA 1.411 -2.986 0 C-N-CA 119.552 -1.309 . . . . 0.0 112.105 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.537 HG22 ' CD1' ' A' ' 52' ' ' ILE . 17.1 pt -128.71 121.86 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.696 0 CA-C-O 122.079 0.942 . . . . 0.0 112.825 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.642 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 25.7 t -90.26 112.18 23.63 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 49' ' ' VAL . 33.4 m -118.82 154.53 21.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -172.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.744 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 9.4 t -143.51 174.99 10.28 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.699 HG22 ' CD1' ' A' ' 47' ' ' ILE . 4.4 t . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.476 ' O ' HG13 ' A' ' 31' ' ' VAL . . . . . . . . 0 N--CA 1.406 -3.357 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.74 HG13 ' HB2' ' A' ' 86' ' ' ALA . 21.0 mm -145.76 159.36 12.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 C-N-CA 125.273 1.429 . . . . 0.0 107.654 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -134.45 135.25 42.38 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 123.333 0.653 . . . . 0.0 110.612 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.49 ' HA ' HG12 ' A' ' 29' ' ' VAL . 51.6 t -79.67 108.84 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.497 ' HB2' HG22 ' A' ' 30' ' ' THR . 63.1 tttp -80.8 -37.44 30.2 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.19 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 28' ' ' SER . . . -148.54 148.18 29.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.47 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.835 HG23 ' HB2' ' A' ' 59' ' ' GLU . 1.4 tp -110.86 131.97 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-O 121.4 0.619 . . . . 0.0 111.758 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 56' ' ' GLY . 2.1 mp -106.25 126.44 30.52 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.967 ' HA ' ' HB3' ' A' ' 59' ' ' GLU . 33.8 Cg_exo -59.47 -77.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.133 2.555 . . . . 0.0 113.169 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 23.8 mmtp -55.13 -10.09 0.49 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 176.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.531 ' HA3' ' CA ' ' A' ' 26' ' ' GLY . . . -63.32 -59.37 9.0 Favored Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' CB ' HD11 ' A' ' 18' ' ' LEU . . . 167.25 -71.31 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.733 0 C-N-CA 125.117 1.367 . . . . 0.0 111.78 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.775 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -48.66 -38.22 20.57 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -167.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.967 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 8.2 tp10 -74.49 -52.4 12.06 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.91 0.484 . . . . 0.0 111.222 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.6 m -76.96 -29.77 55.71 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.097 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -72.6 -45.87 56.97 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.88 59.24 1.61 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 114.301 -1.318 . . . . 0.0 114.882 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -128.7 -58.87 1.16 Allowed 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.598 0.714 . . . . 0.0 109.144 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.775 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 51.9 mt -94.1 141.61 14.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.89 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -137.31 168.53 19.45 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -58.26 125.29 22.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.687 0.28 . . . . 0.0 110.439 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.544 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 115.59 -21.19 12.93 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.968 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.482 ' HB3' HD23 ' A' ' 101' ' ' LEU . 54.2 m-20 -64.72 137.28 57.71 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.88 0.848 . . . . 0.0 113.228 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -96.47 132.33 42.15 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.0 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 39.3 t -108.72 126.06 65.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.5 -34.65 10.17 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.635 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -162.94 175.64 10.98 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.291 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 78' ' ' LEU . 95.3 t -128.48 111.47 23.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.4 t30 51.73 58.72 5.17 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 124.821 1.248 . . . . 0.0 111.684 176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.7 -10.2 13.84 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 114.798 -1.092 . . . . 0.0 115.104 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.402 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 85.4 t -95.81 108.21 20.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 118.242 1.021 . . . . 0.0 108.828 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.548 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 34.7 m -62.42 137.06 58.19 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 123.818 0.699 . . . . 0.0 112.254 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.974 HD11 HG23 ' A' ' 73' ' ' VAL . 91.6 mt -104.97 16.19 26.37 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.456 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 38.8 mt-10 -72.17 94.76 1.58 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.58 14.1 13.35 Favored Glycine 0 C--N 1.304 -1.202 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.408 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 74.4 p -92.54 162.25 14.28 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.744 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 52.5 p-80 -51.47 -41.92 61.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.68 0.752 . . . . 0.0 109.807 174.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.401 ' NZ ' ' HB2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -70.0 -37.07 75.59 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.149 178.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.408 ' HG2' ' OG1' ' A' ' 82' ' ' THR . 74.7 mm-40 -64.26 -40.32 95.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.347 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.74 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -55.48 -52.25 64.25 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.104 0.478 . . . . 0.0 110.417 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.0 t -64.54 -34.07 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.002 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -68.65 -30.0 68.6 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.04 0.448 . . . . 0.0 110.577 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.4 m -72.25 -37.51 69.09 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.739 HD13 ' HG ' ' A' ' 25' ' ' LEU . 97.9 mt -71.06 -25.44 62.64 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.577 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -77.76 -43.36 31.06 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.232 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.81 -46.97 64.53 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.984 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 p -48.24 -65.88 0.49 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.64 -154.18 24.96 Favored Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.825 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.466 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 57.9 tt0 -87.53 -43.8 11.75 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.505 0.669 . . . . 0.0 109.288 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 55.5 t -102.65 106.04 19.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -105.61 138.29 31.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.22 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.553 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 56.7 m80 -100.39 130.16 46.45 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.608 HD21 HD21 ' A' ' 90' ' ' LEU . 6.5 mp -124.21 141.4 52.1 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.54 106.31 18.41 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' THR . 8.4 mp -115.64 165.56 12.9 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.697 0.761 . . . . 0.0 112.36 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 42.6 tt0 -131.15 114.04 14.63 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 103.675 -2.713 . . . . 0.0 103.675 172.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HD2' ' OD1' ' A' ' 68' ' ' ASP . 40.9 tptt -47.5 121.36 3.89 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.872 0.732 . . . . 0.0 110.643 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . . . . . . 0 CA--C 1.498 -0.973 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.446 -171.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 CA--C 1.502 -0.873 0 CA-C-O 120.574 0.226 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 p -92.77 117.46 30.04 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.8 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -133.89 154.52 51.01 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 120.815 0.34 . . . . 0.0 110.545 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -110.46 114.09 27.24 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 64' ' ' ILE . 11.6 p -86.84 132.02 33.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.743 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -102.1 105.37 16.08 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.881 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -117.23 124.94 50.29 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -176.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -100.85 132.21 46.36 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.008 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HE3' HG21 ' A' ' 97' ' ' VAL . 1.2 mptm? -65.73 139.46 58.36 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 123.484 0.714 . . . . 0.0 110.821 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.0 p -75.45 -68.94 0.51 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 170.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -105.75 -72.01 0.73 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -145.92 19.28 1.78 Allowed Glycine 0 C--N 1.306 -1.116 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 175.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.0 m -114.57 140.33 48.87 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.783 HD11 ' HB3' ' A' ' 18' ' ' LEU . 12.3 tp -93.66 -8.64 40.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.57 -7.4 76.67 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.944 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.564 HG21 HG21 ' A' ' 64' ' ' ILE . 20.1 pt -119.68 155.76 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 CA-C-O 121.914 0.864 . . . . 0.0 112.437 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -132.08 128.53 38.41 Favored 'General case' 0 N--CA 1.399 -3.001 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.206 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -109.18 162.4 6.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.206 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.654 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 14.1 t -141.39 168.78 18.95 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 175.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.745 HG21 ' HA ' ' A' ' 82' ' ' THR . 4.5 t . . . . . 0 C--N 1.302 -1.485 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 31' ' ' VAL . . . . . . . . 0 N--CA 1.418 -2.52 0 CA-C-O 119.797 -0.446 . . . . 0.0 114.207 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.594 ' CD1' HG22 ' A' ' 31' ' ' VAL . 36.6 mm -94.63 125.97 47.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -129.21 147.09 51.02 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 64' ' ' ILE . 52.5 t -72.66 113.2 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HB2' HG22 ' A' ' 30' ' ' THR . 55.7 tttm -86.02 -40.43 15.8 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.132 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.51 156.26 37.76 Favored 'General case' 0 C--O 1.25 1.091 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.242 -173.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -113.89 118.02 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.07 136.23 20.61 Favored Pre-proline 0 C--N 1.292 -1.932 0 C-N-CA 123.543 0.737 . . . . 0.0 109.518 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.475 ' O ' ' HD2' ' A' ' 55' ' ' LYS . 39.0 Cg_exo -65.25 78.55 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.253 2.635 . . . . 0.0 112.603 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 54' ' ' PRO . 4.3 mptp? -135.53 20.81 3.35 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.0 -151.83 44.63 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.54 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 69.79 -103.48 0.05 OUTLIER 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.558 1.143 . . . . 0.0 113.393 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.881 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -66.48 -37.04 84.22 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 117.963 0.347 . . . . 0.0 111.887 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.59 -48.31 67.22 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.66 1.184 . . . . 0.0 109.009 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 m -68.9 -46.12 69.14 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.129 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.6 -25.31 62.12 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.12 36.2 51.76 Favored Glycine 0 CA--C 1.5 -0.898 0 CA-C-N 114.449 -1.251 . . . . 0.0 113.271 174.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 1.8 mmp_? -95.7 -48.99 5.55 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.034 0.445 . . . . 0.0 111.215 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.8 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 33.1 mm -100.54 137.44 28.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.661 -173.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -137.92 169.79 17.17 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 172.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -79.49 142.4 35.86 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.889 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.07 -17.72 12.64 Favored Glycine 0 C--N 1.306 -1.138 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.288 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.411 ' OD2' ' HA ' ' A' ' 103' ' ' LYS . 2.3 m-20 -89.48 147.04 24.22 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-N 117.118 0.459 . . . . 0.0 110.619 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.525 ' HD3' ' OE1' ' A' ' 102' ' ' GLU . 4.3 ptm180 -106.98 158.39 17.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.148 0.499 . . . . 0.0 111.485 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.21 127.71 71.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 102' ' ' GLU . 85.7 mt -96.27 -37.15 10.64 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 78' ' ' LEU . . . -160.54 174.56 13.86 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.713 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 1.021 HG11 HG21 ' A' ' 89' ' ' THR . 2.7 p -124.08 105.37 15.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 C-N-CA 124.224 1.009 . . . . 0.0 108.549 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.0 t30 57.43 32.54 21.95 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.587 1.184 . . . . 0.0 110.564 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.27 -11.66 67.1 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.515 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' A' ' 73' ' ' VAL . 59.8 t -86.34 107.28 16.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m -72.31 119.34 16.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.938 0.399 . . . . 0.0 111.598 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.4 pt? -119.18 83.52 2.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.965 0.888 . . . . 0.0 111.674 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.41 -35.88 11.56 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.744 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.62 36.66 4.01 Favored Glycine 0 CA--C 1.495 -1.165 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . -101.28 146.3 27.73 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.818 HG22 ' HG2' ' A' ' 85' ' ' GLN . 9.0 t -94.34 166.4 12.1 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 170.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.654 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 48.2 p-80 -51.54 -41.19 60.89 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 122.798 0.439 . . . . 0.0 111.347 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.07 -38.34 82.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.668 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.818 ' HG2' HG22 ' A' ' 82' ' ' THR . 13.6 mm100 -71.46 -47.81 53.29 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.65 75.64 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.209 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.5 -29.79 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.678 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -80.87 -16.24 54.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.34 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 1.021 HG21 HG11 ' A' ' 73' ' ' VAL . 25.4 m -73.16 -32.16 64.7 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.969 HD21 HD21 ' A' ' 99' ' ' LEU . 84.3 mt -76.45 -20.45 57.02 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.221 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -77.16 -44.15 31.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.419 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -64.41 -41.6 96.54 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.379 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.452 HG21 HG13 ' A' ' 97' ' ' VAL . 6.6 p -64.7 158.62 24.15 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.578 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -79.05 -150.62 5.5 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.912 -173.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -65.07 -42.23 94.37 Favored 'General case' 0 C--O 1.209 -1.052 0 C-N-CA 122.94 0.496 . . . . 0.0 109.807 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 48.2 t -114.4 122.51 68.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.567 HG21 ' HE3' ' A' ' 20' ' ' LYS . 5.9 t -112.58 149.89 14.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 48.0 m80 -115.13 132.85 56.47 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.969 HD21 HD21 ' A' ' 90' ' ' LEU . 6.4 mp -126.83 145.45 50.64 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.3 tt -99.5 109.91 22.41 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.524 HD13 HG12 ' A' ' 16' ' ' VAL . 11.0 mp -112.59 170.71 7.99 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.607 0.718 . . . . 0.0 110.65 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.525 ' OE1' ' HD3' ' A' ' 69' ' ' ARG . 42.6 tt0 -129.87 132.18 46.34 Favored 'General case' 0 N--CA 1.404 -2.75 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HA ' ' OD2' ' A' ' 68' ' ' ASP . 19.4 tptp -57.38 122.24 12.1 Favored 'General case' 0 N--CA 1.421 -1.89 0 O-C-N 124.285 0.99 . . . . 0.0 110.17 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.614 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.054 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 26.1 t0 . . . . . 0 CA--C 1.502 -0.892 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 4.4 p -103.86 132.59 49.96 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 123.438 0.461 . . . . 0.0 112.209 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.99 147.64 24.3 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.266 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -77.46 98.58 5.35 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 7.2 p -71.94 130.25 35.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -95.26 95.0 8.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.91 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -101.72 120.44 40.35 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.82 117.82 31.28 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 5.8 ptmt -71.06 146.55 49.24 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.742 0.782 . . . . 0.0 113.032 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m -87.69 -51.43 5.88 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.294 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -111.65 -154.84 0.55 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.35 16.69 37.95 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.811 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -148.94 176.56 10.32 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.637 HD22 HD12 ' A' ' 18' ' ' LEU . 32.8 mt -93.2 152.31 19.29 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 118.19 0.45 . . . . 0.0 109.816 172.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.409 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -82.84 28.61 3.54 Favored Glycine 0 C--O 1.212 -1.259 0 CA-C-N 115.212 -0.903 . . . . 0.0 112.558 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.454 ' HB ' HG13 ' A' ' 49' ' ' VAL . 22.0 pt -131.71 133.95 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 CA-C-O 121.325 0.583 . . . . 0.0 110.826 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.3 t -91.13 117.88 29.98 Favored 'General case' 0 C--N 1.268 -2.968 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.468 ' HB ' ' CG2' ' A' ' 47' ' ' ILE . 30.8 m -109.3 136.12 46.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 O-C-N 123.656 0.597 . . . . 0.0 110.192 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.552 HG22 ' HB2' ' A' ' 50' ' ' LYS . 10.5 t -126.57 161.34 28.23 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.499 HG22 ' CD1' ' A' ' 47' ' ' ILE . 3.1 t . . . . . 0 C--N 1.293 -1.89 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.837 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.441 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.538 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.7 mm -101.52 147.21 8.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -136.11 136.4 40.08 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 123.788 0.835 . . . . 0.0 109.45 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.454 HG13 ' HB ' ' A' ' 27' ' ' ILE . 43.7 t -75.6 109.0 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.552 ' HB2' HG22 ' A' ' 30' ' ' THR . 61.3 tttp -83.93 -38.15 21.41 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.977 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.24 165.08 36.87 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.589 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.401 HG21 ' HG2' ' A' ' 59' ' ' GLU . 40.7 mm -111.87 120.1 61.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.58 HG22 ' H ' ' A' ' 55' ' ' LYS . 1.8 mp -67.78 136.0 92.4 Favored Pre-proline 0 C--N 1.315 -0.927 0 C-N-CA 123.187 0.595 . . . . 0.0 110.522 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.54 -25.88 20.66 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.511 3.474 . . . . 0.0 113.629 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.58 ' H ' HG22 ' A' ' 53' ' ' ILE . 44.1 tptt -82.51 63.8 6.84 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.704 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.66 -109.4 0.7 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 117.926 1.931 . . . . 0.0 117.926 171.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.646 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 37.66 -86.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 126.847 2.059 . . . . 0.0 113.987 -169.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.91 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -80.47 -28.01 37.7 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.3 -0.25 . . . . 0.0 110.416 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.401 ' HG2' HG21 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -78.73 -43.91 24.66 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.6 p -73.56 -38.89 65.06 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.811 -174.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -73.04 -33.28 65.61 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.78 49.95 5.16 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 114.216 -1.356 . . . . 0.0 113.667 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -118.19 -68.67 0.9 Allowed 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.548 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 63.6 mt -74.13 140.22 18.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.845 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -123.33 159.15 29.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 133.87 40.26 Favored 'General case' 0 N--CA 1.419 -2.024 0 C-N-CA 118.554 -1.258 . . . . 0.0 108.854 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.81 -16.9 12.15 Favored Glycine 0 N--CA 1.425 -2.095 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -72.9 140.65 47.64 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.26 0.553 . . . . 0.0 111.361 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -92.6 133.05 36.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.796 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 38.3 t -107.68 118.55 55.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt -94.85 -34.85 12.3 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.422 -176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.672 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -158.71 172.43 18.29 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.547 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.824 HG23 HD11 ' A' ' 78' ' ' LEU . 88.5 t -123.17 104.29 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 123.564 0.745 . . . . 0.0 109.197 176.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 t30 61.36 34.19 18.5 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 109.417 171.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.2 -24.1 33.05 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.565 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.37 107.43 14.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.557 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 2.8 p -66.9 133.35 49.85 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.607 0.718 . . . . 0.0 112.891 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.824 HD11 HG23 ' A' ' 73' ' ' VAL . 77.4 mt -100.63 30.3 4.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.927 0.87 . . . . 0.0 108.86 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.78 -27.1 49.25 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 125.675 1.59 . . . . 0.0 112.67 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -141.03 44.94 0.99 Allowed Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.39 156.66 18.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.239 0.542 . . . . 0.0 112.199 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.461 ' HA ' HG21 ' A' ' 31' ' ' VAL . 11.4 t -113.49 177.24 4.7 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 170.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -51.26 -54.81 22.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.807 1.243 . . . . 0.0 111.467 -174.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -57.41 -39.22 75.69 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.316 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -70.56 -45.31 65.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.88 -56.42 20.78 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.13 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.445 ' HA ' HD23 ' A' ' 90' ' ' LEU . 90.4 t -62.18 -32.85 55.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.151 -177.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.04 -34.69 78.65 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.3 m -70.6 -35.62 73.1 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.078 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.593 HD11 HD21 ' A' ' 99' ' ' LEU . 3.6 mm? -68.14 -24.21 64.97 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 121.709 -0.62 . . . . 0.0 111.171 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -79.44 -40.14 30.62 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.231 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -71.08 -38.19 72.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.908 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.1 p -64.84 -58.12 7.03 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 149.92 -150.47 22.54 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 118.906 -1.616 . . . . 0.0 114.989 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.479 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 52.9 tt0 -84.38 -55.77 3.98 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.794 0.838 . . . . 0.0 110.405 -176.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.4 t -93.61 101.48 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 25' ' ' LEU . 2.1 m -100.83 134.0 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.877 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.57 -173.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.686 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 12.0 m170 -101.37 139.62 36.78 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 90' ' ' LEU . 5.9 mp -130.25 143.73 50.95 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 172.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 61.0 tp -86.65 107.2 18.09 Favored 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 13' ' ' THR . 8.4 mp -112.05 155.41 23.86 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.063 0.459 . . . . 0.0 110.431 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 31.7 tt0 -130.79 107.62 9.28 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -47.7 138.04 8.74 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.413 -2.845 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.048 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.7 t0 . . . . . 0 C--O 1.255 1.381 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 p -98.9 114.48 27.11 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 170.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -109.73 107.33 17.3 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 121.656 0.741 . . . . 0.0 111.846 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -65.78 115.83 6.33 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 170.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.4 p -110.8 137.29 43.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.509 -171.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -107.0 117.52 34.28 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 58' ' ' ALA . 1.1 tm? -117.87 123.88 46.94 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 118.679 -1.208 . . . . 0.0 108.953 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.402 ' N ' HD13 ' A' ' 18' ' ' LEU . . . -97.45 119.38 35.88 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.728 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -59.85 132.37 53.74 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.415 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 t -66.43 -58.0 6.2 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.283 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -170.2 -50.35 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.69 50.32 2.6 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.715 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.728 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 21.5 t 69.1 -160.15 0.18 Allowed 'General case' 0 C--O 1.254 1.322 0 C-N-CA 124.336 1.054 . . . . 0.0 110.711 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.582 ' HG ' ' HE2' ' A' ' 20' ' ' LYS . 86.5 mt -65.7 142.19 58.1 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.24 0.543 . . . . 0.0 110.946 -178.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 56' ' ' GLY . . . -92.42 33.07 5.13 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.33 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 pt -135.37 135.18 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.579 0 CA-C-O 121.303 0.573 . . . . 0.0 110.127 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB2' HD11 ' A' ' 53' ' ' ILE . 19.4 t -102.37 102.07 12.37 Favored 'General case' 0 C--N 1.259 -3.355 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.5 m -92.2 159.59 2.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -140.57 172.15 13.11 Favored 'General case' 0 N--CA 1.413 -2.279 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 C--N 1.286 -2.182 0 CA-C-O 121.065 0.46 . . . . 0.0 111.751 -175.686 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.192 0 N-CA-C 111.952 -0.459 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.615 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 49.1 mm -109.7 141.78 24.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -136.17 148.77 48.32 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 66' ' ' LYS . 28.4 t -75.58 117.45 20.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -88.52 -34.15 17.51 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.85 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . . . -159.28 157.25 30.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.049 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.44 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 50.8 mm -105.94 120.59 57.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.5 HG22 ' H ' ' A' ' 55' ' ' LYS . 51.7 mm -75.4 124.3 89.01 Favored Pre-proline 0 C--N 1.295 -1.783 0 C-N-CA 122.698 0.399 . . . . 0.0 110.823 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.0 -8.66 12.37 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 C-N-CA 124.149 3.233 . . . . 0.0 114.9 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.5 ' H ' HG22 ' A' ' 53' ' ' ILE . 1.1 mptm? -65.45 -28.42 69.21 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.475 ' O ' ' HA3' ' A' ' 26' ' ' GLY . . . 133.13 -147.43 18.98 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.172 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 75.98 -86.71 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 125.525 1.53 . . . . 0.0 110.916 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.87 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -78.67 -29.63 45.73 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.631 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 39.3 tt0 -78.85 -44.53 22.76 Favored 'General case' 0 N--CA 1.434 -1.264 0 O-C-N 124.673 1.233 . . . . 0.0 110.799 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.8 p -71.98 -40.53 68.53 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.968 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.63 -39.24 73.81 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.11 66.75 1.85 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.843 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.553 ' HG3' HG13 ' A' ' 64' ' ' ILE . 18.6 ptp180 -136.43 -39.19 0.66 Allowed 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.431 176.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.656 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 61.2 mt -101.52 141.22 18.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 -133.55 173.42 11.51 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 51' ' ' ALA . 62.2 pttt -85.69 151.65 23.7 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.367 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.07 -20.2 43.94 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.477 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.936 ' HA ' ' HA3' ' A' ' 104' ' ' GLY 0.271 1.0 OUTLIER -78.7 152.93 31.31 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.7 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -92.5 134.21 35.19 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.921 -168.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.615 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 60.8 t -106.72 120.34 57.77 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.3 mt -96.79 -38.52 9.84 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.458 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.64 170.2 22.94 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.727 -175.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 87.0 t -129.27 120.35 51.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 63.96 27.64 14.36 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.354 1.074 . . . . 0.0 109.169 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.97 -7.16 60.3 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.606 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.91 113.6 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.9 m -64.68 131.0 45.71 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.683 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 86' ' ' ALA 0.42 0.3 OUTLIER -128.38 67.96 1.37 Allowed 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 122.875 1.321 . . . . 0.0 113.974 174.219 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -108.97 114.89 29.04 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 100.4 15.24 30.49 Favored Glycine 0 C--N 1.297 -1.589 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.89 -177.21 4.89 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.9 p -113.36 168.67 9.55 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -51.76 -50.79 59.98 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.8 -44.34 94.01 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.624 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.28 -41.57 80.8 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 118.314 0.506 . . . . 0.0 110.704 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.68 -56.55 20.46 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.975 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.99 -33.13 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.11 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -68.61 -33.65 74.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.921 178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.1 m -68.67 -33.3 73.75 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.613 HD21 HD21 ' A' ' 99' ' ' LEU . 92.9 mt -72.94 -17.23 61.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.833 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -91.87 -37.42 12.92 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -68.53 -27.48 66.13 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.53 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -46.91 65.68 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.86 -156.03 21.92 Favored Glycine 0 C--N 1.311 -0.834 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.08 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.5 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 34.8 tt0 -75.0 -48.11 25.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.934 0.367 . . . . 0.0 110.936 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.4 t -96.83 105.82 17.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 t -100.14 136.45 31.44 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -176.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -102.64 130.66 49.61 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.613 HD21 HD21 ' A' ' 90' ' ' LEU . 5.8 mp -126.98 154.85 44.05 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.1 tt -106.21 112.08 24.96 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.63 163.22 15.26 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.065 0.46 . . . . 0.0 111.972 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.602 ' HG2' ' HD3' ' A' ' 103' ' ' LYS . 30.2 tt0 -132.55 154.01 50.41 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.602 ' HD3' ' HG2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -50.6 121.83 6.33 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 121.802 0.81 . . . . 0.0 111.95 176.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.936 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 C--N 1.298 -1.542 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 t0 . . . . . 0 N--CA 1.442 -0.841 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 11.4 p -87.84 133.02 33.98 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.281 0.363 . . . . 0.0 111.475 -175.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.62 119.4 4.08 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.325 0.583 . . . . 0.0 111.8 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -72.21 120.21 17.49 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.103 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.568 HG21 HD11 ' A' ' 64' ' ' ILE . 33.5 m -96.39 133.64 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.098 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.95 104.75 16.39 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 170.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.862 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -112.24 117.77 33.45 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 119.313 -0.955 . . . . 0.0 108.696 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.74 114.25 25.87 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 24' ' ' SER . 98.6 mttt -56.57 136.31 54.48 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 124.14 0.9 . . . . 0.0 112.398 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.547 HG23 ' HB2' ' A' ' 57' ' ' ALA . 61.2 p -91.71 -163.85 1.1 Allowed 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.84 -19.11 65.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.627 0.727 . . . . 0.0 109.106 174.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 54' ' ' PRO . . . -104.5 19.21 42.84 Favored Glycine 0 N--CA 1.429 -1.832 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.59 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.556 ' HA ' ' HB3' ' A' ' 20' ' ' LYS . 73.8 m 72.4 -153.73 0.08 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.364 1.066 . . . . 0.0 111.054 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 18' ' ' LEU . 89.5 mt -61.54 -24.55 66.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.764 ' HA2' ' HD2' ' A' ' 54' ' ' PRO . . . 86.82 -6.05 83.72 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.006 -1.093 . . . . 0.0 111.82 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.491 ' HB ' HG13 ' A' ' 49' ' ' VAL . 22.6 pt -109.51 136.08 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 C-N-CA 119.228 -0.989 . . . . 0.0 112.544 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.1 t -109.03 128.87 55.34 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.44 149.04 18.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 O-C-N 123.15 0.281 . . . . 0.0 111.037 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -130.83 161.21 32.29 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.714 HG12 HD13 ' A' ' 47' ' ' ILE . 31.2 m . . . . . 0 C--N 1.293 -1.872 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.685 -176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.685 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.898 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 48.7 mm -83.83 123.02 38.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -124.43 128.09 48.5 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.271 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.491 HG13 ' HB ' ' A' ' 27' ' ' ILE . 55.4 t -74.44 110.84 9.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -82.42 -35.93 27.13 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.291 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.44 161.04 35.46 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.031 HG21 ' HB2' ' A' ' 59' ' ' GLU . 16.2 mm -116.32 115.68 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.905 ' HB ' ' HD3' ' A' ' 54' ' ' PRO 0.301 2.1 mp -103.3 -89.38 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.673 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -170.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.905 ' HD3' ' HB ' ' A' ' 53' ' ' ILE . 8.5 Cg_endo -91.88 129.79 1.12 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.757 2.305 . . . . 0.0 115.352 -167.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 78.09 -63.62 0.31 Allowed 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 125.726 1.61 . . . . 0.0 110.901 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.08 -83.54 0.13 Allowed Glycine 0 N--CA 1.405 -3.41 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.769 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 68.51 -83.11 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 125.652 1.581 . . . . 0.0 109.744 175.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.991 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -68.03 -38.3 82.37 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.031 ' HB2' HG21 ' A' ' 52' ' ' ILE . 39.3 tt0 -72.98 -43.94 61.65 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.986 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.6 p -76.88 -36.31 56.81 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.16 -34.12 70.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 174.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.47 43.85 11.89 Favored Glycine 0 N--CA 1.434 -1.489 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.18 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -110.83 -46.66 3.32 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.991 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 44.4 mt -104.42 127.01 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.465 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -125.57 157.84 36.12 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 136.3 51.3 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.451 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 112.12 -24.56 14.16 Favored Glycine 0 C--N 1.289 -2.058 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -171.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.747 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 78.2 m-20 -67.73 145.06 55.11 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.247 0.546 . . . . 0.0 111.745 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 70' ' ' VAL . 1.9 tmm_? -109.95 149.11 30.41 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.4 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.898 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.9 t -117.46 135.45 57.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.704 HD12 HD22 ' A' ' 100' ' ' LEU . 95.5 mt -98.24 -42.56 7.35 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.513 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.58 172.2 18.68 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.816 -172.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 1.0 HG11 HG21 ' A' ' 89' ' ' THR . 3.3 p -114.41 113.63 44.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.769 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 31.3 p30 39.4 42.37 0.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.36 1.464 . . . . 0.0 114.432 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.62 -15.01 62.6 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 120.567 -0.825 . . . . 0.0 114.592 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.557 ' HB ' HG13 ' A' ' 73' ' ' VAL . 46.9 t -92.8 110.07 22.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.5 m -67.62 127.22 31.92 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.739 HD13 HG13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.17 21.01 5.3 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.04 175.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -57.39 -27.34 62.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.118 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.51 23.77 21.62 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.726 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.97 157.55 16.74 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.9 t -83.7 170.93 13.71 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -49.96 -53.02 29.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.77 1.628 . . . . 0.0 110.787 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -63.33 -31.76 73.0 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.854 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -76.98 -39.18 51.43 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.259 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.693 ' HA ' HD22 ' A' ' 78' ' ' LEU . . . -52.09 -60.34 3.32 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.85 0.719 . . . . 0.0 109.896 173.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.14 -33.23 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.549 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.28 -34.72 79.01 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.271 0.558 . . . . 0.0 111.453 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 1.0 HG21 HG11 ' A' ' 73' ' ' VAL . 29.7 m -76.28 -33.95 59.1 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 62.5 mt -73.42 -20.07 60.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.609 0.719 . . . . 0.0 110.194 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -81.98 -40.52 22.05 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.593 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -69.78 -33.37 72.31 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.8 p -59.07 -63.07 1.44 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.24 -151.51 23.69 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.053 -1.07 . . . . 0.0 112.531 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -66.33 -45.33 80.63 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 124.071 0.512 . . . . 0.0 111.647 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.76 114.51 46.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.421 HG23 HD21 ' A' ' 25' ' ' LEU . 6.0 t -107.44 136.54 42.32 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.769 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 54.2 m80 -104.14 131.77 51.08 Favored 'General case' 0 N--CA 1.4 -2.934 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.475 HD11 HD22 ' A' ' 90' ' ' LEU . 6.1 mp -127.09 156.71 41.28 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 173.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.704 HD22 HD12 ' A' ' 71' ' ' LEU . 1.8 tt -108.42 114.09 27.67 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 13' ' ' THR . 11.1 mp -109.21 165.47 11.59 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.933 0.873 . . . . 0.0 112.799 -175.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -130.27 108.99 10.43 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 102.418 -3.178 . . . . 0.0 102.418 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.481 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 38.8 tptt -44.31 129.31 6.4 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 123.962 0.789 . . . . 0.0 110.667 -174.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.747 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.43 -1.743 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 -169.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 CA--C 1.503 -0.829 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.1 116.01 31.12 Favored 'General case' 0 C--N 1.285 -2.238 0 O-C-N 123.445 0.466 . . . . 0.0 110.386 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.454 ' CE2' HG22 ' A' ' 16' ' ' VAL . 29.8 p90 -158.47 157.77 32.82 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 43.0 mt-10 -86.59 106.52 17.62 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.454 HG22 ' CE2' ' A' ' 14' ' ' PHE . 32.0 t -69.52 134.4 30.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.286 177.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -104.64 100.8 10.45 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -109.08 118.6 37.18 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.95 125.01 40.21 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.849 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -63.05 131.99 50.46 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.049 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 t -59.57 -50.72 72.79 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.339 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 177.15 -24.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.73 71.99 0.46 Allowed Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.168 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.849 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 21.1 t 68.0 -166.29 0.2 Allowed 'General case' 0 C--O 1.251 1.138 0 C-N-CA 125.099 1.36 . . . . 0.0 111.647 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.492 HD22 HD12 ' A' ' 18' ' ' LEU . 96.2 mt -80.05 163.8 23.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.403 0.62 . . . . 0.0 110.518 -176.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.91 30.94 9.26 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -137.97 162.32 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.298 0 CA-C-O 121.624 0.726 . . . . 0.0 110.785 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 m -140.17 136.73 33.77 Favored 'General case' 0 N--CA 1.394 -3.269 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.877 172.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 49' ' ' VAL . 26.9 m -109.77 -165.74 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.741 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.156 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.608 ' HA ' ' ND1' ' A' ' 83' ' ' HIS . 14.1 t -165.91 167.64 16.54 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 171.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 81' ' ' ALA . 13.5 p . . . . . 0 C--N 1.291 -1.972 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.824 0 N-CA-C 112.832 -0.107 . . . . 0.0 112.832 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.758 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.8 mm -100.33 126.48 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HE1' ' HA2' ' A' ' 67' ' ' GLY . 1.5 t80 -120.11 114.31 21.78 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.393 -172.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.427 ' HA ' HG12 ' A' ' 29' ' ' VAL . 46.1 t -56.46 108.06 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 29' ' ' VAL . 37.5 ttpt -86.59 -36.31 18.93 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.117 -1.402 . . . . 0.0 110.697 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.757 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -155.69 154.79 32.06 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.397 -174.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.594 HD11 ' HA ' ' A' ' 65' ' ' HIS . 47.5 mm -109.12 114.35 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.713 HG22 ' HB2' ' A' ' 55' ' ' LYS . 1.7 mp -84.81 146.18 45.68 Favored Pre-proline 0 C--N 1.283 -2.302 0 C-N-CA 124.006 0.922 . . . . 0.0 112.059 -172.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . 0.261 16.4 Cg_exo -52.67 52.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.512 2.599 1 C-N-CA 126.456 4.77 . . . . 0.0 113.768 172.92 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.713 ' HB2' HG22 ' A' ' 53' ' ' ILE . 38.1 tptt -137.69 1.16 2.31 Favored 'General case' 0 N--CA 1.388 -3.528 0 O-C-N 121.764 -0.585 . . . . 0.0 109.594 -171.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.69 -136.75 24.85 Favored Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.163 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.743 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 67.73 -90.5 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.094 0.958 . . . . 0.0 111.096 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.916 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -71.3 -34.37 70.56 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.486 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 40.5 tt0 -72.19 -42.79 65.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 124.325 1.015 . . . . 0.0 110.525 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -70.11 -50.03 44.85 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.348 -175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.7 -20.91 61.85 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.138 0.494 . . . . 0.0 110.182 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.89 43.8 97.02 Favored Glycine 0 CA--C 1.502 -0.742 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.006 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -105.06 -41.67 5.52 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.616 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 56.4 mt -115.64 136.34 52.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.594 ' HA ' HD11 ' A' ' 52' ' ' ILE . 63.4 t60 -138.41 172.09 13.41 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.757 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 55.0 mtmt -58.96 116.13 3.59 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.48 0.712 . . . . 0.0 110.552 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.547 ' HA2' ' HE1' ' A' ' 48' ' ' TYR . . . 116.26 -11.88 16.79 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 119.611 -1.281 . . . . 0.0 112.957 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.728 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 5.9 m-20 -64.57 137.42 57.84 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.751 0.786 . . . . 0.0 112.652 176.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -93.44 122.96 36.4 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.315 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 61.3 t -100.47 119.61 48.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.0 mt -97.83 -43.99 6.9 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.548 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -154.96 172.07 18.68 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -173.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.897 HG23 HD21 ' A' ' 78' ' ' LEU . 39.5 t -121.06 114.05 41.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 172.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.2 p30 48.27 29.91 2.07 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.287 1.435 . . . . 0.0 112.9 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.58 -30.03 8.89 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.912 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.0 t -80.27 113.8 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 117.819 0.809 . . . . 0.0 109.821 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.9 p -74.98 131.46 40.67 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.897 HD21 HG23 ' A' ' 73' ' ' VAL . 1.9 mm? -85.27 9.46 15.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.349 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.59 106.5 5.39 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.25 2.74 24.65 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.482 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -106.52 155.21 19.84 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.9 t -91.78 172.28 8.58 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.608 ' ND1' ' HA ' ' A' ' 30' ' ' THR . 4.2 t60 -50.46 -50.01 53.59 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.26 1.024 . . . . 0.0 109.577 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 78.2 tttt -50.73 -50.32 55.75 Favored 'General case' 0 C--O 1.204 -1.328 0 O-C-N 124.476 1.11 . . . . 0.0 111.017 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -70.73 -34.9 72.37 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -172.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -56.72 -53.95 51.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.611 0.72 . . . . 0.0 109.385 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.531 ' HA ' HD12 ' A' ' 90' ' ' LEU . 97.9 t -65.94 -31.77 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.779 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 19.1 mm-40 -65.81 -31.26 72.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.046 0.451 . . . . 0.0 109.986 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.439 HG22 HG11 ' A' ' 73' ' ' VAL . 24.2 m -78.42 -30.66 47.76 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 87' ' ' VAL . 91.0 mt -71.23 -24.9 62.28 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.18 0.991 . . . . 0.0 109.45 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -86.03 -27.73 24.59 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.821 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -77.52 -34.37 54.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.405 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -58.5 -74.85 0.06 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.1 -131.83 4.1 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 119.714 -1.231 . . . . 0.0 112.658 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -73.35 -48.47 34.0 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.645 0.778 . . . . 0.0 112.151 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.64 128.74 75.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.453 0.644 . . . . 0.0 109.741 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.3 t -103.54 122.89 56.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.497 -175.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -94.28 111.57 23.31 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 172.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 73' ' ' VAL . 8.5 tp -118.63 127.01 53.18 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.9 tt -85.87 111.6 20.36 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.671 HD23 ' HB3' ' A' ' 68' ' ' ASP . 11.1 mp -120.43 174.59 6.45 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 122.121 0.962 . . . . 0.0 111.578 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -128.53 125.73 38.92 Favored 'General case' 0 N--CA 1.393 -3.318 0 N-CA-C 101.863 -3.384 . . . . 0.0 101.863 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.47 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 18.5 tptp -52.4 131.62 33.62 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 124.096 0.873 . . . . 0.0 111.191 -173.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.728 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.416 -2.666 0 N-CA-C 115.987 1.155 . . . . 0.0 115.987 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 4.2 t70 . . . . . 0 C--O 1.25 1.094 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 16.9 p -101.65 112.18 24.66 Favored 'General case' 0 N--CA 1.426 -1.636 0 O-C-N 123.738 0.648 . . . . 0.0 111.914 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -138.96 172.21 13.18 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.328 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 2.1 mp0 -104.61 117.87 35.19 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.4 HG21 HD11 ' A' ' 64' ' ' ILE . 13.4 m -87.95 117.55 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.318 0 CA-C-O 121.179 0.514 . . . . 0.0 110.358 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.795 ' HG2' ' HD2' ' A' ' 98' ' ' HIS . 42.4 mt-10 -86.76 98.65 11.28 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.522 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.65 HD11 ' HA ' ' A' ' 58' ' ' ALA . 3.5 mm? -111.13 120.54 42.65 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.662 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.21 140.74 29.19 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.523 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -68.04 90.82 0.33 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.27 0.557 . . . . 0.0 111.256 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.8 t -58.21 -31.23 67.13 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.069 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -162.78 -68.21 0.05 OUTLIER 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.152 0.501 . . . . 0.0 110.325 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.54 86.04 0.33 Allowed Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.5 t 79.01 -159.12 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.77 1.228 . . . . 0.0 109.572 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.587 HD22 ' CB ' ' A' ' 18' ' ' LEU . 63.8 mt -87.44 -4.26 59.01 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.045 0.45 . . . . 0.0 111.567 -174.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.92 13.24 78.14 Favored Glycine 0 N--CA 1.419 -2.481 0 C-N-CA 119.859 -1.163 . . . . 0.0 110.689 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.507 ' HB ' HG13 ' A' ' 49' ' ' VAL . 20.1 pt -119.99 130.44 74.24 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.666 0 CA-C-O 122.193 0.996 . . . . 0.0 112.584 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.406 ' OG ' HD11 ' A' ' 53' ' ' ILE . 45.0 m -96.09 110.76 22.96 Favored 'General case' 0 C--N 1.262 -3.233 0 CA-C-N 113.775 -1.557 . . . . 0.0 107.536 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.42 153.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.982 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.588 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 7.9 t -137.78 157.85 45.59 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 C--N 1.286 -2.17 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 -178.843 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.47 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 47.9 mm -110.11 139.81 31.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.309 -0.445 . . . . 0.0 109.997 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -129.53 148.33 51.42 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.651 HG21 HG21 ' A' ' 64' ' ' ILE . 49.1 t -81.6 116.61 26.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 175.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' HG22 ' A' ' 30' ' ' THR . 61.5 tttp -79.15 -38.7 35.37 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.642 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.72 158.45 28.71 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.328 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.867 HG21 ' HB2' ' A' ' 59' ' ' GLU . 32.9 mm -109.07 121.79 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.468 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 48.4 mm -76.31 131.32 75.27 Favored Pre-proline 0 C--N 1.293 -1.872 0 C-N-CA 123.265 0.626 . . . . 0.0 110.698 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 24.6 Cg_exo -67.66 63.53 0.85 Allowed 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 124.067 3.178 . . . . 0.0 113.059 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -130.25 -55.76 1.1 Allowed 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.578 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 166.26 -160.74 34.35 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . 0.252 . . 71.26 -95.97 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 125.324 1.45 . . . . 0.0 113.114 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.65 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -61.33 -40.62 94.88 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.867 ' HB2' HG21 ' A' ' 52' ' ' ILE . 31.2 tt0 -86.32 -33.9 20.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.144 0.497 . . . . 0.0 110.559 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.578 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 29.5 m -74.72 -39.25 62.02 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.403 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.47 -32.32 48.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.97 64.25 1.81 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.874 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -121.65 -60.94 1.56 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.812 0.815 . . . . 0.0 108.926 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.651 HG21 HG21 ' A' ' 49' ' ' VAL . 34.7 mt -96.27 146.76 6.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.715 -174.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -136.58 -170.34 2.66 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -80.82 139.39 36.02 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.131 -1.027 . . . . 0.0 110.623 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.5 -10.31 61.08 Favored Glycine 0 N--CA 1.429 -1.828 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.957 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.478 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 30.9 m-20 -64.45 141.91 58.61 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 117.625 0.712 . . . . 0.0 112.271 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -92.41 121.86 34.29 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.239 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.591 HG22 HD11 ' A' ' 101' ' ' LEU . 49.6 t -100.09 111.63 30.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.413 ' HB2' HD12 ' A' ' 100' ' ' LEU . 83.4 mt -91.72 -41.49 10.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.772 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -152.25 168.72 24.46 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.376 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.847 HG23 HD21 ' A' ' 78' ' ' LEU . 93.8 t -124.14 104.42 13.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 173.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.455 ' HB3' ' HB2' ' A' ' 98' ' ' HIS 0.311 1.8 p-10 47.12 45.86 16.1 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 122.219 1.009 . . . . 0.0 113.711 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.1 -16.92 60.09 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.205 -1.361 . . . . 0.0 114.269 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.1 t -90.97 108.49 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 118.016 0.908 . . . . 0.0 108.78 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 5.0 p -78.28 137.24 37.99 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -174.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.847 HD21 HG23 ' A' ' 73' ' ' VAL . 2.2 mm? -93.09 97.51 10.73 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -110.52 -46.03 3.45 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.288 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.14 45.12 1.11 Allowed Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 85' ' ' GLN . . . -95.55 -178.15 4.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.374 -0.413 . . . . 0.0 110.686 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.486 ' OG1' ' HG3' ' A' ' 85' ' ' GLN . 68.3 p -115.99 168.3 10.2 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 174.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 16.5 p-80 -53.58 -40.95 66.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.428 0.632 . . . . 0.0 110.192 173.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.04 -42.13 89.97 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.918 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.591 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 49.1 mt-30 -66.41 -32.47 73.87 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.507 0.594 . . . . 0.0 110.387 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.504 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -59.88 -50.46 73.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.494 0.664 . . . . 0.0 109.428 174.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.63 -30.55 50.56 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.098 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.57 -36.8 85.39 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.06 0.457 . . . . 0.0 110.22 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.1 m -69.62 -33.46 72.69 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 99' ' ' LEU . 90.2 mt -76.54 -23.58 53.63 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.344 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -82.05 -30.99 31.1 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -62.0 -43.85 97.98 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.721 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.493 HG21 HG13 ' A' ' 97' ' ' VAL . 34.9 p -70.64 154.21 42.08 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.67 176.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.46 -114.29 0.78 Allowed Glycine 0 N--CA 1.422 -2.258 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.756 -173.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -86.54 -39.82 15.84 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.851 -0.674 . . . . 0.0 110.961 -172.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.23 127.65 75.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.523 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 4.0 t -114.74 152.31 16.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.795 ' HD2' ' HG2' ' A' ' 17' ' ' GLU . 29.5 m80 -123.93 71.47 1.11 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 90' ' ' LEU . 4.8 mp -65.15 144.07 57.45 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.999 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.772 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.9 tm? -93.03 107.98 19.65 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.591 HD11 HG22 ' A' ' 70' ' ' VAL . 2.7 mp -122.6 147.84 45.94 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.872 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 35.3 tt0 -118.16 127.5 53.82 Favored 'General case' 0 N--CA 1.397 -3.086 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 172.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 103' ' ' LYS . 5.5 tmtm? -54.29 114.36 1.61 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.092 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.426 -1.99 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.338 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 37.6 t70 . . . . . 0 CA--C 1.5 -0.974 0 N-CA-C 111.246 0.091 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p -93.35 124.42 37.32 Favored 'General case' 0 N--CA 1.425 -1.722 0 O-C-N 124.079 0.862 . . . . 0.0 110.143 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CE1' ' HD2' ' A' ' 63' ' ' ARG . 46.9 p90 -140.79 152.17 44.98 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.203 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.472 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 52.4 mt-10 -110.95 90.96 3.48 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.645 HG11 HD11 ' A' ' 64' ' ' ILE . 6.5 p -71.07 136.57 25.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.827 -175.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -96.13 93.58 7.03 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.88 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -97.56 116.85 30.56 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.63 131.37 44.26 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.9 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HD2' HD23 ' A' ' 25' ' ' LEU . 1.6 mptm? -66.8 124.25 22.4 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.081 172.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 t -113.75 10.57 17.88 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 34.1 t70 -155.47 -152.67 0.4 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' H ' ' CG ' ' A' ' 22' ' ' ASP . . . -104.81 15.54 48.43 Favored Glycine 0 C--N 1.296 -1.639 0 CA-C-N 119.83 1.196 . . . . 0.0 110.302 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -142.64 165.76 26.52 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.63 HD22 HD12 ' A' ' 18' ' ' LEU . 92.4 mt -85.7 173.74 9.88 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 170.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.83 32.66 5.46 Favored Glycine 0 C--N 1.289 -2.052 0 C-N-CA 120.024 -1.084 . . . . 0.0 111.141 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 64' ' ' ILE . 15.0 pt -139.47 143.4 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-O 121.35 0.595 . . . . 0.0 111.905 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.41 ' HB2' HD11 ' A' ' 53' ' ' ILE . 32.9 t -103.01 128.3 49.9 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 49' ' ' VAL . 26.9 m -125.08 151.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-O 120.872 0.368 . . . . 0.0 110.691 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.7 t -133.25 173.53 11.35 Favored 'General case' 0 N--CA 1.392 -3.359 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.55 ' HB ' ' H ' ' A' ' 83' ' ' HIS . 10.0 p . . . . . 0 C--N 1.26 -3.302 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -171.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.957 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.5 mm -123.72 149.29 27.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.415 ' CE2' ' HG2' ' A' ' 69' ' ' ARG . 79.1 m-85 -130.22 139.35 50.81 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 122.036 -0.415 . . . . 0.0 111.089 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 29' ' ' VAL . 58.2 t -72.39 110.8 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -78.38 -39.8 38.04 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.018 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.69 170.44 14.1 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 -174.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.6 mm -102.65 115.47 44.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.494 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 33.6 mm -75.25 124.8 89.4 Favored Pre-proline 0 C--N 1.31 -1.15 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 5.6 Cg_exo -74.48 77.49 2.92 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 122.802 2.334 . . . . 0.0 112.479 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 50.5 mmtt -136.18 12.71 3.31 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.78 173.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.12 -139.6 19.24 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.72 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 67.51 -93.53 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 123.674 0.789 . . . . 0.0 112.0 173.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.88 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -75.1 -32.27 61.38 Favored 'General case' 0 C--O 1.256 1.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.21 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.49 -39.21 65.03 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 125.191 1.557 . . . . 0.0 110.003 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -73.75 -41.29 62.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.73 -31.13 69.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.37 34.37 79.69 Favored Glycine 0 CA--C 1.49 -1.517 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.707 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.431 ' HG2' ' CG2' ' A' ' 16' ' ' VAL . 15.8 tpp180 -101.23 -37.86 8.35 Favored 'General case' 1 N--CA 1.362 -4.837 0 CA-C-O 121.091 0.472 . . . . 0.0 110.876 -174.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 27' ' ' ILE . 22.8 mm -96.29 138.12 22.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.011 -173.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -124.48 161.7 25.52 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -76.4 137.23 39.62 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.861 -1.136 . . . . 0.0 109.885 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.15 -10.61 47.63 Favored Glycine 0 N--CA 1.425 -2.1 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.469 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -68.15 143.39 55.41 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.442 0.639 . . . . 0.0 111.176 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.415 ' HG2' ' CE2' ' A' ' 48' ' ' TYR . 43.4 mtp180 -95.07 125.97 40.09 Favored 'General case' 0 CA--C 1.469 -2.147 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.347 -174.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.545 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 44.4 t -94.22 106.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.832 0 CA-C-N 114.077 -1.42 . . . . 0.0 107.477 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.636 HD12 HD22 ' A' ' 100' ' ' LEU . 56.2 mt -84.44 -35.86 22.74 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.74 -175.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' A' ' 77' ' ' SER . . . -166.8 170.81 12.0 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.856 ' HA ' HD12 ' A' ' 99' ' ' LEU . 49.0 t -111.56 103.16 15.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 174.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.991 ' HB3' ' HB2' ' A' ' 98' ' ' HIS 0.283 1.1 p-10 39.43 70.58 0.21 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -178.226 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.61 -32.19 2.91 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.098 -0.956 . . . . 0.0 114.645 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.4 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 60.3 t -81.39 108.38 14.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 118.008 0.904 . . . . 0.0 109.582 -176.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.412 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 13.7 p -63.28 139.18 58.74 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.609 HD11 HG23 ' A' ' 73' ' ' VAL . 71.9 mt -104.03 27.62 7.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.923 0.868 . . . . 0.0 109.158 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -49.63 -33.38 15.22 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.027 1.731 . . . . 0.0 113.081 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.78 46.15 1.07 Allowed Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HB1' ' HG3' ' A' ' 85' ' ' GLN . . . -106.26 154.85 20.15 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.56 0.219 . . . . 0.0 111.155 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.497 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.2 t -100.71 160.52 14.29 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 168.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.55 ' H ' ' HB ' ' A' ' 31' ' ' VAL . 39.0 p-80 -51.23 -48.33 62.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 18.8 ptmt -67.46 -30.28 69.95 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.434 ' HG3' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -73.97 -36.65 64.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.457 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.548 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.6 -46.61 83.85 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.71 -32.73 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.684 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 41.8 mt-10 -73.28 -26.46 61.1 Favored 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.198 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.463 HG22 HG11 ' A' ' 73' ' ' VAL . 47.4 m -74.19 -26.88 60.53 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.638 HD22 HG11 ' A' ' 97' ' ' VAL . 68.3 mt -74.93 -26.33 59.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -84.25 -28.77 26.98 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.11 -35.26 79.37 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.163 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.7 p -72.06 -66.33 0.66 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.392 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.38 -136.73 7.39 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.435 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.425 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 29.4 tt0 -69.9 -51.38 33.62 Favored 'General case' 0 C--O 1.211 -0.966 0 O-C-N 124.167 0.569 . . . . 0.0 111.117 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.0 125.46 66.08 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 117.863 -1.535 . . . . 0.0 111.348 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.638 HG11 HD22 ' A' ' 90' ' ' LEU . 35.4 t -113.18 126.19 70.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.4 -177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.991 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 11.2 m170 -89.99 125.5 35.41 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 171.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.856 HD12 ' HA ' ' A' ' 73' ' ' VAL . 8.3 tp -123.77 136.28 54.32 Favored 'General case' 0 C--N 1.259 -3.339 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 71' ' ' LEU . 1.3 tt -93.8 113.48 25.54 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.738 HD11 HD23 ' A' ' 99' ' ' LEU . 7.2 mp -125.25 165.78 17.68 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.341 0.591 . . . . 0.0 111.884 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' A' ' 71' ' ' LEU . 37.0 tt0 -130.99 134.06 46.35 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 54.4 mmtt -56.2 125.38 21.51 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.631 0.729 . . . . 0.0 112.823 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.094 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.883 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 . . . . . 0 CA--C 1.496 -1.126 0 CA-C-O 120.344 0.116 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 7.9 p -89.0 145.96 25.17 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.176 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.403 ' CE1' ' HD2' ' A' ' 103' ' ' LYS . 2.6 p90 -143.75 136.29 27.09 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -97.26 110.71 23.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 33.9 t -89.56 119.56 36.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.08 -172.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -101.62 88.6 3.46 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 169.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.846 HD11 ' HB1' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -93.22 117.0 29.56 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -174.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.54 116.77 29.17 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -62.9 139.06 58.71 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.981 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.563 HG21 ' HG3' ' A' ' 55' ' ' LYS . 1.8 m -67.34 -68.85 0.35 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.011 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' H ' ' HB ' ' A' ' 21' ' ' THR . 20.7 t70 -103.64 -79.21 0.54 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.44 16.49 2.27 Favored Glycine 0 C--N 1.3 -1.464 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m -117.78 144.11 45.64 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.453 -174.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.435 HD12 HD13 ' A' ' 90' ' ' LEU . 90.4 mt -86.14 175.69 8.38 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.526 ' HA3' ' H ' ' A' ' 58' ' ' ALA . . . -108.69 32.86 6.59 Favored Glycine 0 C--N 1.291 -1.93 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.145 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.47 HG23 ' CB ' ' A' ' 58' ' ' ALA . 7.6 pt -137.13 138.37 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.77 0 CA-C-O 121.222 0.534 . . . . 0.0 111.721 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 11.8 t -111.7 109.34 19.16 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 176.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 34.6 m -100.12 168.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.549 -174.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -147.8 169.01 20.69 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 171.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 82' ' ' THR . 11.1 p . . . . . 0 C--N 1.293 -1.887 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.305 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.799 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 48.1 mm -105.25 140.29 23.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.447 ' CE2' ' HG3' ' A' ' 69' ' ' ARG . 81.1 m-85 -135.33 112.71 10.59 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.687 HG21 HG21 ' A' ' 64' ' ' ILE . 59.9 t -46.33 120.14 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.587 0.708 . . . . 0.0 111.278 172.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -91.18 -34.6 14.95 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.491 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 28' ' ' SER . . . -154.69 158.2 39.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.203 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.0 mm -108.68 118.59 56.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 49.1 mm -87.84 134.29 35.76 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.473 ' HB2' ' H ' ' A' ' 55' ' ' LYS . 16.0 Cg_exo -69.19 -102.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 121.763 1.642 . . . . 0.0 111.836 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HG3' HG21 ' A' ' 21' ' ' THR . 16.1 tppt? 67.86 -59.48 0.42 Allowed 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 125.719 1.608 . . . . 0.0 110.885 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.84 48.24 0.03 OUTLIER Glycine 0 N--CA 1.424 -2.127 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.846 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -135.59 -98.39 0.23 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.801 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -69.22 -33.59 73.53 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 118.171 0.441 . . . . 0.0 111.324 -174.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -70.42 -45.57 65.63 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 124.172 0.92 . . . . 0.0 109.193 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 t -72.5 -44.35 62.35 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.483 -174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -74.87 -19.21 60.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.898 0.856 . . . . 0.0 108.94 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.72 67.8 2.02 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.491 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.529 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -119.92 -67.54 0.97 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.097 0.475 . . . . 0.0 110.734 -179.158 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.687 HG21 HG21 ' A' ' 49' ' ' VAL . 63.7 mt -85.5 139.63 17.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.41 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -124.77 178.45 5.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -71.25 129.6 39.29 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.765 0.317 . . . . 0.0 110.697 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.55 -15.49 53.18 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.934 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.486 ' HA ' ' H ' ' A' ' 104' ' ' GLY . 75.9 m-20 -64.54 138.01 58.17 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 121.658 0.742 . . . . 0.0 112.033 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HG3' ' CE2' ' A' ' 48' ' ' TYR . 36.3 ttm180 -90.41 129.38 36.61 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 114.603 -1.181 . . . . 0.0 110.376 -173.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.799 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.2 t -97.01 104.35 15.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.609 HD12 HD22 ' A' ' 100' ' ' LEU . 93.7 mt -78.09 -39.56 41.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.094 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 77' ' ' SER . . . -159.11 166.74 30.89 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.956 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.911 HG23 HD21 ' A' ' 78' ' ' LEU . 98.7 t -119.05 97.71 5.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 52.4 t30 54.2 60.37 3.63 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 124.247 1.019 . . . . 0.0 109.987 -178.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.89 -36.02 2.32 Favored Glycine 0 CA--C 1.548 2.105 0 CA-C-N 114.517 -1.219 . . . . 0.0 114.398 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.86 108.79 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 20.9 m -85.38 142.82 29.02 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.479 0.657 . . . . 0.0 112.602 -173.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.911 HD21 HG23 ' A' ' 73' ' ' VAL . 1.6 mm? -99.21 22.98 9.73 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.977 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -67.36 -22.24 65.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.114 0.483 . . . . 0.0 112.283 -175.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.55 25.68 8.97 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 174.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 85' ' ' GLN . . . -105.99 -172.03 2.01 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.515 0.674 . . . . 0.0 111.509 -176.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.64 ' HA ' HG21 ' A' ' 31' ' ' VAL . 6.6 t -144.91 178.85 7.72 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -50.55 -55.89 14.14 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.968 0.907 . . . . 0.0 111.847 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 33.0 mmtp -65.23 -25.09 67.53 Favored 'General case' 0 C--O 1.211 -0.969 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HB2' ' H ' ' A' ' 82' ' ' THR . 16.3 mm100 -76.59 -44.89 32.55 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.498 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -58.26 -54.32 48.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.444 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.59 -27.69 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.827 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 84' ' ' LYS . 34.1 tt0 -70.88 -34.75 71.92 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 121.702 -0.624 . . . . 0.0 109.317 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.7 m -71.4 -30.59 66.27 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.72 HD21 HD21 ' A' ' 99' ' ' LEU . 94.0 mt -76.8 -12.28 59.95 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.203 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.456 ' HD3' ' HA ' ' A' ' 91' ' ' ARG . 14.0 mmt180 -92.93 -31.7 14.83 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.75 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.01 -38.35 90.65 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.708 0.766 . . . . 0.0 109.199 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.2 p -74.42 146.35 42.96 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.91 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -79.16 -135.06 1.07 Allowed Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 121.453 -0.403 . . . . 0.0 113.65 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -72.87 -49.33 30.63 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.104 0.478 . . . . 0.0 110.484 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 45.8 t -98.93 112.73 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 t -108.52 137.94 37.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.124 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 12.7 m-70 -96.05 129.49 43.32 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 173.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.72 HD21 HD21 ' A' ' 90' ' ' LEU . 5.9 mp -127.11 141.81 51.67 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.609 HD22 HD12 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -99.78 113.81 26.55 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.714 ' HG ' ' HA ' ' A' ' 70' ' ' VAL . 7.3 mp -127.43 163.07 24.88 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 118.727 0.694 . . . . 0.0 112.299 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.664 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 36.0 tt0 -131.01 128.77 41.03 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.482 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 6.4 tptp -49.93 113.15 0.79 Allowed 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.267 0.979 . . . . 0.0 110.404 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 C--N 1.29 -1.996 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.936 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 CA--C 1.499 -1.0 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 40.2 p -92.6 140.89 29.09 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -139.95 141.64 36.44 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.378 0.609 . . . . 0.0 111.343 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.675 ' HB3' ' HE2' ' A' ' 98' ' ' HIS . 3.1 mp0 -83.89 108.47 16.9 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.356 -1.293 . . . . 0.0 107.953 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.24 125.8 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.063 0 CA-C-O 121.628 0.728 . . . . 0.0 111.519 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -102.37 113.63 27.11 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 57' ' ' ALA . 2.7 tm? -109.57 116.27 31.44 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.43 118.54 33.16 Favored 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 94.1 mttt -59.51 119.29 7.24 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 124.059 0.849 . . . . 0.0 110.304 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.715 ' HB ' ' O ' ' A' ' 56' ' ' GLY . 19.0 m -76.13 -67.44 0.68 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.643 -176.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -152.65 -48.49 0.1 Allowed 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.73 35.65 2.68 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.253 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.8 p 71.64 -132.23 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.616 1.966 . . . . 0.0 111.977 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.542 ' HG ' HD13 ' A' ' 90' ' ' LEU . 3.3 mm? -72.3 -30.64 64.98 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.836 0.826 . . . . 0.0 109.547 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.73 22.33 62.04 Favored Glycine 0 N--CA 1.402 -3.615 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.431 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.449 ' HB ' HG13 ' A' ' 49' ' ' VAL . 19.9 pt -135.2 143.26 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.692 0 CA-C-O 121.677 0.751 . . . . 0.0 111.056 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.3 t -97.11 118.01 32.57 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.72 140.89 47.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.416 0.627 . . . . 0.0 112.062 -173.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 47' ' ' ILE . 11.4 t -138.61 -171.84 3.16 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -172.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.864 ' HA ' HD13 ' A' ' 47' ' ' ILE . 79.5 t . . . . . 0 C--N 1.301 -1.52 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 79' ' ' GLU . . . . . . . . 0 CA--C 1.471 -2.704 0 N-CA-C 111.773 -0.531 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.864 HD13 ' HA ' ' A' ' 31' ' ' VAL . 17.4 mm -141.15 152.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.46 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 39.1 t80 -139.41 138.15 36.27 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.331 0.652 . . . . 0.0 111.094 -174.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.449 HG13 ' HB ' ' A' ' 27' ' ' ILE . 44.2 t -78.48 103.1 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.459 ' HB2' HG22 ' A' ' 30' ' ' THR . 88.1 tttt -68.89 -41.24 78.57 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.844 -174.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.84 159.39 32.49 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.212 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 23.4 mm -113.24 134.87 54.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 55' ' ' LYS . 1.8 mp -79.44 128.4 75.35 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.55 -15.61 9.24 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 125.26 3.974 . . . . 0.0 115.27 -175.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' H ' HG22 ' A' ' 53' ' ' ILE . 22.9 tptm -162.59 64.44 0.21 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.938 0.875 . . . . 0.0 109.644 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.715 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -114.49 -54.34 0.41 Allowed Glycine 0 C--N 1.303 -1.264 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.651 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.554 ' HB2' ' H ' ' A' ' 21' ' ' THR . . . 176.65 -68.13 0.01 OUTLIER 'General case' 0 C--O 1.173 -2.957 0 O-C-N 125.48 1.341 . . . . 0.0 111.641 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.885 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -49.47 -37.29 25.57 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -173.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -78.84 -48.6 14.41 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -71.6 -35.97 70.66 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.795 -172.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.56 -37.23 56.94 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.41 77.04 1.08 Allowed Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 114.418 -1.265 . . . . 0.0 114.001 173.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -157.98 -47.0 0.06 Allowed 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.885 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 77.1 mt -88.63 132.41 33.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -120.19 164.61 15.97 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 123.533 0.521 . . . . 0.0 109.61 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -63.44 128.96 38.19 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.568 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.621 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 98.92 -8.59 61.36 Favored Glycine 0 N--CA 1.419 -2.482 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.545 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.441 ' HB3' HD23 ' A' ' 101' ' ' LEU . 80.7 m-20 -66.67 139.81 57.87 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-O 121.244 0.545 . . . . 0.0 110.603 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.656 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . 27.7 ttm-85 -98.67 143.63 28.84 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -174.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.44 HG12 HD21 ' A' ' 78' ' ' LEU . 48.5 t -109.9 120.03 60.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.558 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -177.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 100' ' ' LEU . 57.6 mt -101.82 -33.8 9.67 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.963 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -151.75 160.06 43.72 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.188 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.993 HG11 HG21 ' A' ' 89' ' ' THR . 2.6 p -116.65 104.6 16.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 174.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HA ' ' ND1' ' A' ' 98' ' ' HIS . 61.6 t30 55.12 37.68 29.29 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.438 1.114 . . . . 0.0 109.901 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.68 -23.73 35.08 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 120.275 -0.964 . . . . 0.0 114.182 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.562 ' HB ' HG13 ' A' ' 73' ' ' VAL . 44.1 t -80.96 113.15 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 118.458 1.129 . . . . 0.0 109.021 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.3 t -72.82 109.61 6.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.106 0.479 . . . . 0.0 110.134 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.77 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.5 pt? -97.63 33.12 2.12 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 122.233 1.016 . . . . 0.0 110.935 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.547 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 11.8 pt-20 -58.25 -28.65 65.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.131 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.9 30.97 7.07 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.54 -164.12 1.12 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.548 ' H ' ' HB2' ' A' ' 85' ' ' GLN . 13.5 t -144.18 177.72 8.4 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -50.3 -53.15 30.68 Favored 'General case' 0 C--O 1.265 1.913 0 C-N-CA 124.897 1.279 . . . . 0.0 110.67 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 97.5 mttt -59.36 -47.92 83.59 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.019 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.548 ' HB2' ' H ' ' A' ' 82' ' ' THR . 28.8 mm-40 -64.3 -42.69 96.25 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.542 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -50.55 -60.32 3.14 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-O 121.428 0.632 . . . . 0.0 110.387 175.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.07 -31.8 55.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.428 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 42.6 mm-40 -69.58 -34.15 73.73 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 122.097 -0.377 . . . . 0.0 111.016 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.993 HG21 HG11 ' A' ' 73' ' ' VAL . 45.0 m -65.14 -38.48 90.74 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 177.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.77 HD21 HD21 ' A' ' 99' ' ' LEU . 81.6 mt -72.84 -23.49 60.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.731 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -84.11 -30.55 25.86 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.893 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.97 -41.13 87.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.089 0.471 . . . . 0.0 109.892 175.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 20.1 p -68.92 155.04 40.98 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.916 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -71.24 -147.57 0.51 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 114.84 0.696 . . . . 0.0 114.84 -176.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 62.4 tt0 -74.38 -35.89 63.51 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.21 -0.495 . . . . 0.0 110.907 -177.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.71 111.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 t -110.0 146.23 15.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.675 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 58.5 t-80 -109.68 134.47 51.94 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 175.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.77 HD21 HD21 ' A' ' 90' ' ' LEU . 6.4 mp -130.28 153.36 48.72 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 173.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.739 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.3 tm? -106.09 109.79 21.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.441 HD23 ' HB3' ' A' ' 68' ' ' ASP . 8.0 mp -111.38 171.43 7.48 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-O 121.668 0.747 . . . . 0.0 111.939 -175.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.656 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 29.3 tt0 -128.4 132.69 48.5 Favored 'General case' 0 N--CA 1.396 -3.164 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 175.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -63.05 112.79 2.76 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . . . . . . 0 N--CA 1.409 -3.163 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.31 -172.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 23.1 t0 . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.8 p -92.09 144.75 25.12 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 123.599 0.562 . . . . 0.0 109.706 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -157.77 153.67 26.89 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 41.4 mt-10 -110.73 89.2 2.97 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.456 HG12 HD13 ' A' ' 101' ' ' LEU . 14.1 p -81.47 143.18 12.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.433 -175.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB3' ' HD2' ' A' ' 98' ' ' HIS . 11.1 pt-20 -104.2 111.4 23.98 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.784 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -111.34 126.72 55.22 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.054 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -101.47 142.05 33.43 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.461 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.748 ' HB2' ' HG3' ' A' ' 95' ' ' GLN . 29.5 mmtm -65.36 118.14 8.92 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.6 m -90.18 -61.39 1.69 Allowed 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.117 0.484 . . . . 0.0 111.804 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -152.88 -45.65 0.1 Allowed 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 121.762 0.792 . . . . 0.0 109.009 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 24' ' ' SER . . . -123.48 51.28 0.81 Allowed Glycine 0 N--CA 1.418 -2.51 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.57 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.543 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 25.7 m 80.45 -147.67 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.753 1.221 . . . . 0.0 110.279 175.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 90' ' ' LEU . 28.6 mt -80.46 -10.95 59.74 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.135 0.493 . . . . 0.0 109.73 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.55 8.99 84.03 Favored Glycine 0 N--CA 1.42 -2.405 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.059 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 25' ' ' LEU . 25.7 pt -114.76 134.33 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 121.997 0.903 . . . . 0.0 112.766 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.2 t -97.12 107.59 20.14 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.843 -1.526 . . . . 0.0 106.921 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.485 ' HB ' ' CG2' ' A' ' 47' ' ' ILE . 34.1 m -96.84 152.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 120.737 0.303 . . . . 0.0 110.561 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 50' ' ' LYS . 11.1 t -142.84 156.03 44.88 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 81' ' ' ALA . 7.2 p . . . . . 0 C--N 1.283 -2.305 0 CA-C-O 121.38 0.61 . . . . 0.0 110.212 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.796 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.897 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 49.9 mm -114.35 154.18 15.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 123.433 0.693 . . . . 0.0 109.368 -175.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -128.35 133.5 48.68 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 122.941 0.496 . . . . 0.0 109.79 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.456 HG21 ' CG2' ' A' ' 64' ' ' ILE . 58.8 t -80.06 111.65 17.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HB2' HG22 ' A' ' 30' ' ' THR . 38.7 ttpt -79.88 -41.71 25.68 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.034 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.64 41.41 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.848 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 46.0 mm -113.47 124.16 69.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -81.2 122.18 81.16 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 38.5 Cg_endo -69.16 80.26 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.666 2.244 . . . . 0.0 112.099 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -143.3 -42.93 0.29 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.147 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.51 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 156.09 -160.17 29.89 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.359 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.528 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 67.67 -102.68 0.07 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.347 1.459 . . . . 0.0 112.819 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.784 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -65.79 -36.69 84.24 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.355 0.525 . . . . 0.0 111.081 -176.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.464 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 45.1 tt0 -67.56 -47.6 69.35 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.265 1.026 . . . . 0.0 111.289 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 52.1 m -69.74 -42.68 73.6 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.694 -177.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -71.17 -27.72 63.73 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.048 0.928 . . . . 0.0 108.887 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.51 43.33 94.86 Favored Glycine 0 CA--C 1.498 -0.981 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.657 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.518 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -107.19 -51.04 2.98 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.769 -178.491 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.692 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 59.1 mt -101.66 126.67 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -125.23 166.19 16.94 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -63.13 125.73 25.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.32 -23.61 15.61 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.683 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.493 ' HB3' HD23 ' A' ' 101' ' ' LEU . 37.8 m-20 -66.82 141.53 57.66 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.32 0.581 . . . . 0.0 110.73 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -106.4 143.79 34.01 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.545 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.897 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 51.4 t -107.93 123.02 63.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.159 -175.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 102' ' ' GLU . 90.1 mt -99.36 -33.8 10.56 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.84 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.672 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -160.65 163.7 32.33 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.952 HG23 HD11 ' A' ' 78' ' ' LEU . 94.2 t -111.4 115.47 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 173.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 47.03 39.35 7.67 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 126.996 2.119 . . . . 0.0 110.983 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.83 -18.46 56.56 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 119.848 -1.168 . . . . 0.0 114.78 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t -81.58 112.95 20.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 45.7 m -64.31 133.83 53.46 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.862 0.839 . . . . 0.0 113.06 -171.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.952 HD11 HG23 ' A' ' 73' ' ' VAL . 79.4 mt -107.39 15.49 24.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.733 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.26 97.54 1.57 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.81 25.79 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.424 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -86.45 142.96 28.01 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.0 t -85.56 168.09 14.8 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 172.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . 57.0 t-80 -50.38 -49.87 53.16 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.652 0.781 . . . . 0.0 110.915 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -53.79 -38.62 64.69 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.939 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -70.58 -51.8 25.89 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 120.707 -0.397 . . . . 0.0 109.951 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.57 -57.93 8.99 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 123.97 0.794 . . . . 0.0 111.804 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 83' ' ' HIS . 37.9 t -65.84 -43.35 93.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.359 -173.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -72.49 -30.58 64.65 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.756 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.638 ' O ' HG23 ' A' ' 93' ' ' THR . 93.6 m -68.22 -43.18 78.55 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 25' ' ' LEU . 2.3 tp -75.25 -18.07 60.18 Favored 'General case' 0 N--CA 1.425 -1.712 0 C-N-CA 124.015 0.926 . . . . 0.0 111.445 -177.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -92.24 -33.35 14.7 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.829 -0.544 . . . . 0.0 109.729 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -82.32 -15.91 51.18 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 89' ' ' THR . 5.4 p -53.47 -63.17 1.23 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.442 0.639 . . . . 0.0 111.121 177.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.45 -162.92 32.25 Favored Glycine 0 N--CA 1.411 -2.97 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.748 ' HG3' ' HB2' ' A' ' 20' ' ' LYS . 63.5 tt0 -72.3 -44.59 62.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 117.257 0.529 . . . . 0.0 109.99 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 46.1 t -102.02 118.09 48.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 90' ' ' LEU . 4.1 t -112.71 141.99 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.524 ' HD2' ' HB3' ' A' ' 17' ' ' GLU . 37.7 m80 -96.8 125.32 41.16 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 171.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.623 HD11 HG22 ' A' ' 73' ' ' VAL . 2.8 tp -120.58 132.91 55.38 Favored 'General case' 0 C--N 1.253 -3.597 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.4 tt -95.35 114.28 26.04 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.493 HD23 ' HB3' ' A' ' 68' ' ' ASP . 10.2 mp -119.64 171.3 8.47 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.556 0.693 . . . . 0.0 112.199 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.552 ' HB2' HD11 ' A' ' 71' ' ' LEU . 35.7 tt0 -131.4 123.08 27.44 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 101.618 -3.475 . . . . 0.0 101.618 171.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -58.13 126.34 27.06 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 123.683 0.614 . . . . 0.0 110.375 -173.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.687 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.197 -175.339 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 21.8 p -95.38 148.27 22.63 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.22 0.533 . . . . 0.0 111.34 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -149.42 147.69 28.56 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -103.91 98.06 7.96 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.477 HG12 HD13 ' A' ' 101' ' ' LEU . 8.4 p -82.87 127.56 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.825 -175.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.35 87.98 3.35 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.785 HD12 HD12 ' A' ' 25' ' ' LEU . 1.4 tm? -87.41 113.9 23.53 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -175.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.12 113.96 26.01 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.4 127.14 30.27 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 123.986 0.804 . . . . 0.0 110.455 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.6 p -82.3 -71.74 0.47 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.463 1.125 . . . . 0.0 111.506 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -156.61 -36.27 0.08 Allowed 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 113.547 -1.66 . . . . 0.0 106.678 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . -89.14 28.42 6.71 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.517 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.3 p 65.97 -142.31 0.18 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.103 1.761 . . . . 0.0 111.525 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.785 HD12 HD12 ' A' ' 18' ' ' LEU . 7.7 tp -67.82 -28.35 67.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.934 0.873 . . . . 0.0 109.306 -176.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.27 18.51 66.64 Favored Glycine 0 N--CA 1.411 -2.995 0 C-N-CA 119.951 -1.118 . . . . 0.0 114.693 172.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.432 HG22 HD13 ' A' ' 52' ' ' ILE . 12.3 pt -131.84 145.86 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 CA-C-O 121.303 0.573 . . . . 0.0 111.404 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.5 t -111.89 136.36 51.31 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 49' ' ' VAL . 32.1 m -126.14 149.9 31.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.581 0.705 . . . . 0.0 112.358 -175.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 13.5 t -125.41 145.36 50.09 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 83' ' ' HIS . 46.0 t . . . . . 0 C--N 1.293 -1.872 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.053 -176.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.711 0 N-CA-C 112.034 -0.426 . . . . 0.0 112.034 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.01 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 50.5 mm -87.26 121.74 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -121.31 131.17 54.05 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.547 -0.861 . . . . 0.0 113.3 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.508 ' HA ' HG12 ' A' ' 29' ' ' VAL . 45.3 t -70.04 112.81 5.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.465 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 61.9 tttp -86.04 -36.86 19.44 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.359 -176.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.99 148.81 28.83 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.408 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.679 HG12 ' HB3' ' A' ' 66' ' ' LYS . 46.5 mm -110.57 127.73 67.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.746 HG22 ' H ' ' A' ' 55' ' ' LYS . 44.9 mm -83.62 138.61 40.99 Favored Pre-proline 0 C--N 1.286 -2.165 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.957 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -60.0 -16.52 39.48 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 124.13 3.22 . . . . 0.0 112.391 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.746 ' H ' HG22 ' A' ' 53' ' ' ILE . 51.3 tptt -121.16 35.97 4.74 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.87 128.57 6.73 Favored Glycine 1 N--CA 1.387 -4.575 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.445 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 18' ' ' LEU . . . -45.91 -33.61 3.36 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 126.578 1.951 . . . . 0.0 114.392 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.624 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -60.16 -36.06 76.71 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.202 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.607 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 31.7 tt0 -91.97 -40.01 11.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.425 0.631 . . . . 0.0 109.646 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.1 m -75.71 -48.49 21.71 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.148 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -74.92 -36.88 62.15 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.35 67.77 1.16 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.757 -1.11 . . . . 0.0 113.103 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.443 ' HB3' HG23 ' A' ' 16' ' ' VAL . 18.8 mmt180 -132.64 -75.65 0.5 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.337 0.589 . . . . 0.0 111.119 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.46 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 60.5 mt -78.62 146.76 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.099 0.959 . . . . 0.0 111.994 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -116.35 163.75 15.56 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.679 ' HB3' HG12 ' A' ' 52' ' ' ILE . 51.5 pttt -81.88 135.0 35.45 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.436 0.636 . . . . 0.0 110.581 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.33 -11.52 43.57 Favored Glycine 0 N--CA 1.424 -2.145 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.054 -174.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.567 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 18.3 m-20 -66.44 146.44 54.55 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -96.49 125.48 41.0 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.38 -1.736 . . . . 0.0 109.028 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.01 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 48.3 t -108.91 123.28 64.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.9 mt -96.8 -39.98 9.17 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.088 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.28 178.63 7.39 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.628 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.798 ' HA ' HD12 ' A' ' 99' ' ' LEU . 24.5 t -116.01 105.37 18.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.693 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 10.7 p30 50.02 34.15 7.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 124.387 1.075 . . . . 0.0 113.116 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.01 -21.69 43.56 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.569 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.43 100.67 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.66 ' HB2' ' HG2' ' A' ' 79' ' ' GLU . 2.9 p -58.39 128.64 38.18 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.212 1.005 . . . . 0.0 113.269 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.8 mt -97.04 21.26 10.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.516 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.66 ' HG2' ' HB2' ' A' ' 77' ' ' SER . 7.7 pt-20 -74.36 126.34 30.46 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.793 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.16 12.92 62.73 Favored Glycine 0 C--N 1.298 -1.563 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 85' ' ' GLN . . . -108.35 142.39 38.76 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 84' ' ' LYS . 7.6 t -96.25 174.15 7.03 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.414 ' HB3' HG23 ' A' ' 31' ' ' VAL . 17.2 p-80 -51.3 -43.39 61.64 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.4 ' HG2' HG23 ' A' ' 82' ' ' THR . 20.9 ptmt -64.47 -33.4 75.8 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.408 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.426 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 77.6 mm-40 -72.62 -42.08 64.85 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.102 0.477 . . . . 0.0 109.848 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -60.01 -53.94 51.91 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.252 176.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.493 ' HA ' HD12 ' A' ' 90' ' ' LEU . 57.9 t -67.07 -34.32 68.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -176.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -72.45 -26.85 61.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.27 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.9 m -70.35 -34.62 72.85 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 87.6 mt -71.69 -32.43 67.83 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.75 0.785 . . . . 0.0 109.8 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -69.05 -39.84 78.91 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.111 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -67.42 -40.19 85.5 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.482 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -65.32 147.37 53.56 Favored 'General case' 0 C--O 1.253 1.237 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 175.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.38 -133.68 0.22 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -172.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -74.26 -52.59 11.9 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.031 0.532 . . . . 0.0 111.293 -175.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.74 111.86 35.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.1 t -100.76 129.55 51.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.295 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 50.5 m80 -93.51 119.12 32.2 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.798 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.2 tp -121.98 138.48 54.41 Favored 'General case' 0 N--CA 1.401 -2.902 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.21 109.4 22.16 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.605 HD11 HD23 ' A' ' 99' ' ' LEU . 11.2 mp -118.32 169.02 10.08 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.982 0.896 . . . . 0.0 111.988 -177.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 36.0 tt0 -131.72 137.82 48.4 Favored 'General case' 0 N--CA 1.39 -3.459 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 173.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.567 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 15.7 tppt? -64.33 113.44 3.62 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -1.973 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.677 -173.63 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 . . . . . 0 CA--C 1.491 -1.324 0 CA-C-O 120.416 0.151 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 p -87.18 117.5 25.97 Favored 'General case' 0 C--N 1.279 -2.465 0 O-C-N 124.064 0.852 . . . . 0.0 109.942 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -134.25 149.37 50.94 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 50.2 mt-10 -106.1 110.98 23.41 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.675 HG11 HD11 ' A' ' 64' ' ' ILE . 10.5 p -89.39 124.02 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.854 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -174.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.31 89.06 7.84 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.027 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -96.05 115.45 27.45 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -175.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.19 115.46 29.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.007 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.513 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -64.1 146.34 54.37 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.612 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -122.1 90.16 3.25 Favored 'General case' 0 N--CA 1.408 -2.574 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.094 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.7 t70 65.85 -65.81 0.17 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.51 1.524 . . . . 0.0 114.275 -177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.07 67.8 0.23 Allowed Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.513 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 84.8 p 70.34 -173.73 0.18 Allowed 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.794 1.638 . . . . 0.0 114.224 169.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.587 HD22 ' HB3' ' A' ' 18' ' ' LEU . 80.9 mt -72.02 160.33 32.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.1 41.16 2.64 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.212 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.515 HG23 ' CB ' ' A' ' 58' ' ' ALA . 14.7 pt -135.13 137.6 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.806 0 CA-C-O 121.419 0.628 . . . . 0.0 111.426 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -94.87 123.63 38.44 Favored 'General case' 0 N--CA 1.41 -2.432 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.527 HG22 ' H ' ' A' ' 30' ' ' THR . 12.3 p -93.54 175.87 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 O-C-N 123.321 0.388 . . . . 0.0 110.064 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.922 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 14.8 t -166.12 148.75 7.16 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' A' ' 82' ' ' THR . 12.2 p . . . . . 0 N--CA 1.424 -1.74 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . . . . . . 0 N--CA 1.428 -1.871 0 N-CA-C 111.704 -0.558 . . . . 0.0 111.704 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.642 HG13 ' HG ' ' A' ' 78' ' ' LEU . 43.4 mm -102.19 138.0 28.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -137.68 163.77 30.47 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.955 0.407 . . . . 0.0 110.122 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.459 HG21 HG21 ' A' ' 64' ' ' ILE . 56.9 t -88.3 113.61 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.952 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 169.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.922 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 59.3 tttm -76.24 -35.4 59.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.602 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.734 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . . . -168.1 167.18 12.64 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.946 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.999 HG21 ' HB2' ' A' ' 59' ' ' GLU . 49.0 mm -108.47 122.82 63.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.0 mm -83.97 145.71 47.19 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -56.88 -133.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 123.548 2.832 . . . . 0.0 114.389 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 75.3 -52.23 0.66 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.556 1.142 . . . . 0.0 110.716 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.19 -50.19 0.87 Allowed Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.688 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -8.97 -75.83 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 127.903 2.481 . . . . 0.0 116.149 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.027 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -96.02 -29.15 14.29 Favored 'General case' 0 C--O 1.255 1.359 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -172.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.999 ' HB2' HG21 ' A' ' 52' ' ' ILE . 39.6 tt0 -82.93 -53.21 6.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 123.331 0.394 . . . . 0.0 111.542 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 m -86.95 -35.14 19.05 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.633 -171.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 9.5 m-20 -101.3 -28.73 12.46 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.28 -174.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.94 -131.21 6.6 Favored Glycine 0 N--CA 1.398 -3.876 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -154.32 2.65 0.23 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.675 HD11 HG11 ' A' ' 16' ' ' VAL . 31.4 mt -90.45 148.44 4.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.525 -165.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -137.95 173.33 11.75 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.734 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 22.6 pttp -73.2 130.44 40.23 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.283 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.97 -20.77 8.5 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.115 -1.04 . . . . 0.0 113.507 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.611 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 53.9 m-20 -71.78 138.52 48.45 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 117.453 0.626 . . . . 0.0 110.619 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -90.54 135.04 33.95 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.41 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 47' ' ' ILE . 57.8 t -106.41 120.9 58.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.505 HD11 ' HB2' ' A' ' 102' ' ' GLU . 62.7 mt -96.41 -37.97 10.23 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.582 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.756 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -154.64 162.29 41.2 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.495 -173.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.786 ' HA ' HD12 ' A' ' 99' ' ' LEU . 56.3 t -115.39 106.95 21.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.3 t30 62.56 31.85 16.72 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.368 1.08 . . . . 0.0 109.761 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.56 -21.46 45.57 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 114.855 -1.066 . . . . 0.0 114.162 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.6 t -82.97 114.36 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 117.736 0.768 . . . . 0.0 109.725 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.9 t -72.1 127.68 33.31 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 123.069 0.548 . . . . 0.0 110.723 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.642 ' HG ' HG13 ' A' ' 47' ' ' ILE . 2.0 pt? -131.46 30.07 4.49 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 42.5 mt-10 -69.32 -11.31 60.71 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.618 0.723 . . . . 0.0 110.643 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.57 21.51 25.84 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.825 174.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . -93.17 -154.48 0.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.177 0.513 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.751 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.1 t -146.36 173.0 12.66 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 175.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.518 ' CD2' HG13 ' A' ' 29' ' ' VAL . 51.7 t-80 -50.72 -60.29 3.2 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.78 1.232 . . . . 0.0 111.582 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.412 ' HA ' HG12 ' A' ' 87' ' ' VAL . 57.0 tptt -59.67 -36.98 77.52 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.576 0.75 . . . . 0.0 110.945 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.402 ' HB2' ' H ' ' A' ' 82' ' ' THR . 15.1 mm100 -67.29 -45.06 77.69 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.399 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.458 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -60.21 -51.29 70.2 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.931 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 3.1 p -68.81 -34.63 65.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.085 -173.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.718 ' HA ' ' HG2' ' A' ' 91' ' ' ARG . 20.5 mm-40 -77.64 -23.47 49.73 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.436 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.412 HG22 HG11 ' A' ' 73' ' ' VAL . 86.5 m -70.91 -28.5 64.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.555 HD13 HD12 ' A' ' 25' ' ' LEU . 86.8 mt -73.58 -24.71 60.11 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.752 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.718 ' HG2' ' HA ' ' A' ' 88' ' ' GLU . 36.7 mmt180 -73.64 -49.84 24.04 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.65 -32.06 73.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.578 -174.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.496 HG21 HG12 ' A' ' 73' ' ' VAL . 1.3 p -63.87 -36.26 83.35 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.39 -140.42 13.41 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 119.712 -1.232 . . . . 0.0 113.427 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -88.46 -52.19 5.32 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.674 0.79 . . . . 0.0 109.933 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 65.5 t -99.31 111.49 29.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 43.6 t -105.86 120.94 57.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -93.08 70.54 4.54 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 73' ' ' VAL . 6.7 tp -71.55 139.27 49.38 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 122.249 -0.282 . . . . 0.0 110.55 -172.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.756 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 55.9 tp -94.17 113.32 25.24 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.658 HD11 HD23 ' A' ' 99' ' ' LEU . 10.0 mp -117.66 166.66 12.14 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-O 121.551 0.691 . . . . 0.0 110.144 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.505 ' HB2' HD11 ' A' ' 71' ' ' LEU . 37.1 tt0 -128.48 124.44 36.12 Favored 'General case' 0 N--CA 1.389 -3.491 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 174.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -49.07 123.52 7.34 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 124.572 1.17 . . . . 0.0 110.409 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.421 -2.322 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 27.0 t70 . . . . . 0 CA--C 1.505 -0.775 0 N-CA-C 110.816 -0.068 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -93.1 114.18 26.64 Favored 'General case' 0 N--CA 1.426 -1.667 0 O-C-N 123.491 0.494 . . . . 0.0 109.803 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.433 ' HE2' ' HD2' ' A' ' 63' ' ' ARG . 5.6 p90 -127.78 159.61 34.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.152 0.501 . . . . 0.0 111.463 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -106.05 130.44 53.97 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.412 HG22 ' CE2' ' A' ' 14' ' ' PHE . 12.4 t -110.88 132.3 59.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -175.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 26.1 mp0 -97.76 87.06 3.93 Favored 'General case' 0 C--O 1.248 1.009 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 171.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.085 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -96.94 116.64 29.54 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -92.9 125.12 37.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 86.7 mttt -67.66 163.92 20.37 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-O 121.844 0.831 . . . . 0.0 111.571 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.422 HG21 ' O ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -88.52 33.1 0.76 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.616 175.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 t70 67.99 -28.82 0.15 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.307 2.243 . . . . 0.0 113.024 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.04 -58.53 3.39 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 t -167.05 -175.29 2.95 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.628 HD12 HG12 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -85.85 139.55 31.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.328 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.48 43.02 2.84 Favored Glycine 0 C--N 1.295 -1.743 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.717 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.628 HG12 HD12 ' A' ' 25' ' ' LEU . 18.9 pt -138.32 148.69 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-N 118.133 0.967 . . . . 0.0 111.765 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.67 ' HB2' HD11 ' A' ' 53' ' ' ILE . 39.4 t -108.5 109.65 20.96 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' HG23 ' A' ' 47' ' ' ILE . 26.9 m -104.87 144.82 14.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 123.877 0.736 . . . . 0.0 110.296 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 50' ' ' LYS . 12.8 t -144.0 157.88 44.06 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 46' ' ' GLY . 56.1 t . . . . . 0 C--N 1.298 -1.648 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.671 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . . . . . . 0 CA--C 1.476 -2.398 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.591 HG23 ' HB ' ' A' ' 29' ' ' VAL . 18.9 mm -139.29 142.76 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 173.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.468 ' OH ' ' HA2' ' A' ' 67' ' ' GLY . 52.9 t80 -140.52 141.93 35.27 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.28 108.09 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.53 ' HB2' HG22 ' A' ' 30' ' ' THR . 53.3 tttp -82.27 -35.8 27.7 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.811 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.87 36.28 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.735 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.068 HG21 ' HB2' ' A' ' 59' ' ' GLU . 31.7 mm -111.7 113.45 44.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 28' ' ' SER . 2.0 mp -83.41 128.33 64.77 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 53.2 Cg_exo -59.94 88.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 124.14 3.227 . . . . 0.0 115.142 -177.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' O ' HG21 ' A' ' 21' ' ' THR . 2.4 mptm? -125.09 -27.23 3.57 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.681 170.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.633 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 93.89 49.12 2.54 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -175.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -122.26 -77.77 0.59 Allowed 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.166 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.085 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -83.25 -31.44 26.98 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -170.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.068 ' HB2' HG21 ' A' ' 52' ' ' ILE . 40.0 tt0 -80.02 -45.39 18.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 124.645 1.216 . . . . 0.0 110.268 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.633 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 1.2 m -85.09 -47.86 9.76 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.264 -168.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -100.7 -21.5 15.2 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.931 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.84 -132.26 6.36 Favored Glycine 1 N--CA 1.393 -4.219 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.93 -173.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.433 ' HD2' ' HE2' ' A' ' 14' ' ' PHE . 40.1 mtt180 -156.24 -1.54 0.13 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -169.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.773 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 60.2 mt -96.22 132.05 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.145 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.546 -169.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.421 ' HA ' HG13 ' A' ' 52' ' ' ILE . 81.4 m-70 -139.67 170.48 15.82 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -69.22 129.79 40.84 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.459 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.468 ' HA2' ' OH ' ' A' ' 48' ' ' TYR . . . 123.8 -26.08 6.01 Favored Glycine 0 C--N 1.291 -1.972 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.848 -172.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.473 ' HB3' HD23 ' A' ' 101' ' ' LEU . 18.2 m-20 -72.86 133.91 44.62 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.471 ' CG ' ' HB3' ' A' ' 102' ' ' GLU . 4.5 ptm180 -100.84 151.15 22.06 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.536 HG22 ' HG ' ' A' ' 101' ' ' LEU . 47.3 t -112.83 127.2 70.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.443 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -176.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.9 mt -100.87 -34.3 9.86 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.345 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -159.55 175.11 13.64 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.466 -175.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.991 HG11 HG21 ' A' ' 89' ' ' THR . 4.7 p -130.64 110.21 18.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 124.943 1.297 . . . . 0.0 109.523 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 62.68 30.17 16.86 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.412 1.101 . . . . 0.0 108.151 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.04 -18.69 46.59 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.259 -0.882 . . . . 0.0 114.079 -174.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.0 t -81.82 122.76 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.4 t -58.17 140.45 52.93 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.686 HD11 ' HB ' ' A' ' 73' ' ' VAL . 81.2 mt -118.06 -3.02 11.14 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.865 175.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.671 ' HA ' ' HA3' ' A' ' 46' ' ' GLY 0.261 1.0 OUTLIER -76.97 103.95 7.19 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 122.475 1.131 . . . . 0.0 110.43 177.888 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.45 -6.28 12.83 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -173.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.81 149.61 24.72 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 84' ' ' LYS . 5.1 t -79.14 154.14 29.55 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 42.8 p-80 -51.55 -36.73 46.41 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 120.759 0.314 . . . . 0.0 111.826 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.447 ' HB2' HG23 ' A' ' 82' ' ' THR . 94.6 mttt -48.9 -53.61 18.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.36 173.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -66.89 -35.7 80.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 123.375 0.422 . . . . 0.0 111.458 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -58.47 -49.84 75.89 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.433 0.635 . . . . 0.0 109.805 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.92 -32.94 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.392 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 45.1 mt-10 -66.56 -34.14 77.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 110.091 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.991 HG21 HG11 ' A' ' 73' ' ' VAL . 50.6 m -71.01 -29.15 65.02 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.328 0.585 . . . . 0.0 109.491 174.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.1 mt -71.41 -24.03 61.97 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-O 121.077 0.465 . . . . 0.0 109.982 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -90.74 -15.49 30.12 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.058 0.456 . . . . 0.0 111.092 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.27 -35.08 31.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 p -75.01 154.67 37.94 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.169 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.27 -136.79 1.67 Allowed Glycine 0 C--N 1.314 -0.66 0 N-CA-C 114.349 0.5 . . . . 0.0 114.349 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.448 ' OE1' ' HB2' ' A' ' 20' ' ' LYS . 5.2 tp-100 -72.39 -46.84 53.48 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.745 0.784 . . . . 0.0 109.361 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 52.4 t -102.19 119.0 49.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.481 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 41.4 t -104.57 129.62 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.092 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.805 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.54 ' CD2' ' HG3' ' A' ' 17' ' ' GLU . 26.6 m170 -89.5 122.62 32.86 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 169.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.71 HD23 HD11 ' A' ' 101' ' ' LEU . 4.9 tp -130.0 147.86 51.8 Favored 'General case' 0 C--N 1.271 -2.844 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.7 tt -110.11 116.56 31.76 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -177.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.71 HD11 HD23 ' A' ' 99' ' ' LEU . 7.5 mp -122.64 175.38 6.53 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.472 0.653 . . . . 0.0 111.001 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 26.9 tt0 -128.3 119.99 26.19 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.512 ' HE3' ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -50.02 106.46 0.12 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.006 1.322 . . . . 0.0 110.656 -173.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.512 ' N ' ' HE3' ' A' ' 103' ' ' LYS . . . . . . . . 0 N--CA 1.424 -2.133 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.868 -177.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 59.0 t0 . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 p -96.78 116.07 28.51 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 123.639 0.775 . . . . 0.0 110.397 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.35 132.44 21.64 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.35 0.595 . . . . 0.0 112.259 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.507 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 41.8 mt-10 -81.13 99.21 8.4 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.095 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.502 HG11 HG13 ' A' ' 64' ' ' ILE . 55.5 t -68.38 131.08 33.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.143 -177.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -92.61 98.96 11.76 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.977 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -110.95 118.76 36.97 Favored 'General case' 0 N--CA 1.415 -2.207 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.998 -179.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.8 126.33 41.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.294 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.644 ' HE2' HD22 ' A' ' 25' ' ' LEU . 95.3 mttt -76.11 137.99 40.48 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.086 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -73.58 -41.04 63.41 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -173.05 -65.01 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.399 0.619 . . . . 0.0 109.844 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.85 63.7 3.17 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.555 -176.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.547 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 23.3 t 69.48 -168.11 0.17 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.867 1.267 . . . . 0.0 112.691 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.644 HD22 ' HE2' ' A' ' 20' ' ' LYS . 2.5 mm? -73.51 159.28 33.41 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.743 0.817 . . . . 0.0 110.757 -177.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.7 38.37 3.13 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.472 HD13 HD13 ' A' ' 64' ' ' ILE . 23.8 pt -137.1 144.51 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.666 0 CA-C-O 121.454 0.645 . . . . 0.0 111.343 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB2' HG12 ' A' ' 53' ' ' ILE . 28.3 t -106.17 115.22 29.84 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.77 148.65 16.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.869 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.1 t -150.0 167.84 25.56 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 82' ' ' THR . 13.6 p . . . . . 0 C--N 1.292 -1.898 0 CA-C-O 121.337 0.589 . . . . 0.0 110.227 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 31' ' ' VAL . . . . . . . . 0 C--O 1.217 -0.947 0 N-CA-C 113.693 0.237 . . . . 0.0 113.693 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.889 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.6 mm -101.87 148.67 7.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 79.7 t80 -125.13 128.02 47.78 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 122.004 -0.435 . . . . 0.0 111.679 -176.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.99 105.66 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 171.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.6 ' HB2' HG22 ' A' ' 30' ' ' THR . 87.1 tttt -77.93 -40.17 40.48 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.521 -175.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.6 165.06 33.56 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.781 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.1 mm -102.8 109.75 27.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.509 HG23 ' HD2' ' A' ' 54' ' ' PRO . 27.1 mm -72.86 154.24 91.06 Favored Pre-proline 0 C--N 1.294 -1.816 0 C-N-CA 124.601 1.161 . . . . 0.0 110.087 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HD2' HG23 ' A' ' 53' ' ' ILE . 87.4 Cg_exo -52.4 -158.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.44 0 C-N-CA 123.383 2.722 . . . . 0.0 113.572 170.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? 76.53 -51.44 0.59 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.684 1.194 . . . . 0.0 111.273 -173.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 130.44 -120.5 3.04 Favored Glycine 0 N--CA 1.414 -2.798 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.821 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 70.05 -91.13 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.102 0.961 . . . . 0.0 112.897 170.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.977 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -75.34 -37.42 60.7 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.61 -46.36 66.43 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 124.985 1.428 . . . . 0.0 108.702 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 m -70.41 -43.63 69.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.268 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -73.86 -30.12 62.49 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.1 33.44 36.28 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.514 175.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -95.21 -59.32 1.92 Allowed 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.716 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.738 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.7 mt -86.51 131.48 34.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -119.72 161.93 19.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -81.85 144.72 30.82 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 118.751 -1.18 . . . . 0.0 110.555 -177.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.417 ' HA2' ' CZ ' ' A' ' 48' ' ' TYR . . . 102.6 -6.94 52.99 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -176.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -87.4 154.21 20.84 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.39 0.614 . . . . 0.0 111.837 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -100.45 141.73 32.9 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.896 0.855 . . . . 0.0 112.784 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.889 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 58.9 t -106.55 125.56 62.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.013 -1.448 . . . . 0.0 107.22 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 102' ' ' GLU . 28.3 mt -100.94 -35.5 9.37 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.991 -176.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -160.7 166.52 28.65 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.874 HG23 HD11 ' A' ' 78' ' ' LEU . 48.1 t -119.13 108.09 23.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 124.841 1.256 . . . . 0.0 108.333 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.5 t30 56.98 52.9 8.62 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.048 0.939 . . . . 0.0 110.559 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.6 -25.08 3.45 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 114.85 -1.068 . . . . 0.0 114.33 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.9 t -81.11 110.85 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 117.686 0.743 . . . . 0.0 109.826 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.532 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 38.6 m -63.13 140.04 58.83 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.268 0.98 . . . . 0.0 112.106 -175.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.874 HD11 HG23 ' A' ' 73' ' ' VAL . 55.2 mt -110.52 76.32 0.98 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -107.1 125.47 51.1 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.27 32.96 81.16 Favored Glycine 0 C--N 1.31 -0.907 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.14 138.18 39.43 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.858 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.8 t -82.82 159.35 22.46 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 173.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.869 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 39.2 p-80 -52.09 -39.13 59.3 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 123.073 0.233 . . . . 0.0 111.599 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.99 -39.94 91.58 Favored 'General case' 0 C--O 1.206 -1.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.785 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.52 ' HG2' HG22 ' A' ' 82' ' ' THR . 74.8 mm-40 -67.23 -44.7 78.85 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.39 -51.51 69.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.421 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.509 ' HA ' HD12 ' A' ' 90' ' ' LEU . 85.6 t -68.16 -31.83 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.514 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -66.58 -30.67 71.02 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 121.768 -0.582 . . . . 0.0 110.243 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.8 m -76.74 -28.14 55.65 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.183 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 87' ' ' VAL . 95.9 mt -73.37 -33.54 65.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.75 0.785 . . . . 0.0 109.68 175.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.26 -29.45 57.48 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.526 176.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -72.63 -31.81 65.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.85 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.5 p -72.3 163.35 28.1 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.18 -123.8 0.5 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.887 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -94.64 -42.11 8.95 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 122.794 -0.239 . . . . 0.0 111.14 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.36 110.71 27.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.42 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 39.4 t -99.58 121.51 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.199 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.726 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.439 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 42.4 m80 -91.29 98.88 11.98 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 174.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.823 HD12 ' HA ' ' A' ' 73' ' ' VAL . 9.6 tp -101.13 129.36 47.02 Favored 'General case' 0 C--N 1.268 -2.959 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -172.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.767 HD22 HD12 ' A' ' 71' ' ' LEU . 1.8 tt -86.38 109.11 18.79 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.692 HD11 HD23 ' A' ' 99' ' ' LEU . 8.9 mp -115.62 164.89 13.67 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-O 121.504 0.669 . . . . 0.0 111.621 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.899 ' HB2' HD11 ' A' ' 71' ' ' LEU . 35.0 tt0 -131.25 135.64 47.52 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 172.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 39.5 tptt -58.67 114.78 2.66 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.482 -1.984 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.79 -167.837 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 CA--C 1.504 -0.811 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.9 p -86.94 135.88 33.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 123.776 0.672 . . . . 0.0 110.534 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -146.85 145.88 30.01 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.078 0.466 . . . . 0.0 110.049 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.75 132.15 52.23 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.9 t -118.71 135.91 57.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.796 -175.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.544 ' HG2' HG11 ' A' ' 96' ' ' VAL . 43.6 tt0 -109.48 86.61 2.32 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 172.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.915 HD11 ' HB1' ' A' ' 57' ' ' ALA . 1.3 tm? -99.14 125.73 44.75 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -98.3 144.5 27.64 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 120.649 0.262 . . . . 0.0 111.076 -175.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.684 ' HE2' HD11 ' A' ' 25' ' ' LEU . 1.2 mptm? -68.2 143.52 55.3 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.966 177.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 57' ' ' ALA . 59.0 p -91.58 -165.89 1.45 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.22 -26.11 49.97 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.126 0.57 . . . . 0.0 111.118 173.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.88 56.96 0.73 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.284 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.4 t 77.43 -168.59 0.06 Allowed 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.232 1.413 . . . . 0.0 109.429 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.684 HD11 ' HE2' ' A' ' 20' ' ' LYS . 4.3 mp -66.17 -76.81 0.07 Allowed 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 122.04 0.924 . . . . 0.0 109.787 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.97 ' HA2' ' HD2' ' A' ' 54' ' ' PRO . . . 147.31 -8.58 1.22 Allowed Glycine 0 CA--C 1.463 -3.187 0 C-N-CA 119.757 -1.211 . . . . 0.0 111.181 -172.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.409 HG22 ' CD1' ' A' ' 52' ' ' ILE . 16.7 pt -102.71 112.73 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.607 0 CA-C-O 122.722 1.248 . . . . 0.0 112.851 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.7 m -101.31 126.13 48.03 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-N 112.59 -2.096 . . . . 0.0 106.686 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 49' ' ' VAL . 33.7 m -110.91 153.87 12.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.055 0.455 . . . . 0.0 111.586 -173.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.665 ' HB ' ' HD3' ' A' ' 50' ' ' LYS . 11.2 t -121.31 156.46 32.5 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 174.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.518 HG12 HD13 ' A' ' 47' ' ' ILE . 33.1 m . . . . . 0 N--CA 1.42 -1.93 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.939 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.402 ' HA3' ' N ' ' A' ' 80' ' ' GLY . . . . . . . . 0 N--CA 1.427 -1.913 0 N-CA-C 113.662 0.225 . . . . 0.0 113.662 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.689 HG13 ' HG ' ' A' ' 78' ' ' LEU . 50.8 mm -102.37 123.78 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.057 -175.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.467 ' CZ ' ' HD3' ' A' ' 69' ' ' ARG . 81.4 m-85 -131.21 114.22 14.81 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.506 ' HA ' HG12 ' A' ' 29' ' ' VAL . 50.1 t -47.86 117.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.481 0.658 . . . . 0.0 109.983 171.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.665 ' HD3' ' HB ' ' A' ' 30' ' ' THR . 38.0 ttpt -92.76 -31.11 15.18 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.331 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . . . -167.64 156.99 10.03 Favored 'General case' 0 C--O 1.249 1.03 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.759 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.862 HG21 ' HB2' ' A' ' 59' ' ' GLU . 16.7 mm -109.88 119.29 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.925 ' HB ' ' HD3' ' A' ' 54' ' ' PRO . 2.7 mp -108.43 -71.06 0.03 OUTLIER Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -172.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.97 ' HD2' ' HA2' ' A' ' 26' ' ' GLY . 45.3 Cg_exo -60.18 -163.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 124.882 3.722 . . . . 0.0 117.692 -172.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -35.61 -50.75 0.62 Allowed 'General case' 0 C--N 1.352 0.71 0 C-N-CA 127.892 2.477 . . . . 0.0 113.455 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.96 -98.77 0.11 Allowed Glycine 0 N--CA 1.415 -2.738 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.915 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 66.08 -92.34 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.051 1.34 . . . . 0.0 111.314 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.626 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -70.61 -39.84 73.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.862 ' HB2' HG21 ' A' ' 52' ' ' ILE . 35.4 tt0 -76.43 -42.58 43.6 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 123.556 0.535 . . . . 0.0 111.629 -178.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.0 p -74.94 -35.31 62.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.855 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -73.65 -26.57 60.82 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.326 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.07 44.94 86.64 Favored Glycine 0 CA--C 1.49 -1.483 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.996 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -111.25 -54.62 2.59 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.348 0.594 . . . . 0.0 109.556 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.626 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 64.9 mt -101.26 130.1 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.461 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -132.14 173.33 11.34 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 61.3 pttt -74.83 132.03 41.22 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.089 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.27 -20.66 13.8 Favored Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.729 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.429 ' OD1' ' HD2' ' A' ' 103' ' ' LYS . 78.8 m-20 -69.47 138.15 53.2 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.556 0.694 . . . . 0.0 111.683 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 33.1 ttp180 -95.5 133.88 38.99 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.313 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 71.0 t -101.74 103.94 15.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 102' ' ' GLU . 84.9 mt -76.87 -36.01 57.04 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.217 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.51 167.36 19.52 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.16 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.702 ' HA ' HD12 ' A' ' 99' ' ' LEU . 44.3 t -113.33 115.53 50.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 172.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 10.6 p30 47.01 35.36 3.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.424 1.49 . . . . 0.0 112.768 -176.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.62 -6.24 82.18 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.506 -0.854 . . . . 0.0 114.092 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.8 t -92.6 109.64 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.7 m -69.64 134.67 48.99 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -173.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.689 ' HG ' HG13 ' A' ' 47' ' ' ILE . 1.6 pt? -130.34 17.24 5.45 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.099 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.9 97.89 0.12 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.518 175.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.402 ' N ' ' HA3' ' A' ' 46' ' ' GLY . . . 119.01 17.35 5.02 Favored Glycine 0 N--CA 1.433 -1.524 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.598 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.493 ' HB3' HD11 ' A' ' 47' ' ' ILE . . . -94.34 176.74 6.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.46 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.8 t -97.18 158.75 15.29 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 169.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -51.16 -44.19 61.41 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.595 0.758 . . . . 0.0 112.381 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 23.8 tptp -55.91 -43.45 77.34 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 123.92 0.888 . . . . 0.0 110.986 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -69.28 -43.9 72.93 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.622 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -55.24 -54.48 42.9 Favored 'General case' 0 C--O 1.243 0.72 0 O-C-N 124.08 0.862 . . . . 0.0 111.468 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.56 -26.75 36.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.919 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 91.0 mt-10 -72.04 -28.49 63.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.809 177.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.517 HG22 HG11 ' A' ' 73' ' ' VAL . 22.5 m -70.5 -31.41 68.5 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.3 mt -72.72 -24.4 60.98 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.105 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -79.56 -34.24 41.12 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -63.15 -40.63 98.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.71 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.441 ' OG1' HG22 ' A' ' 97' ' ' VAL . 19.4 p -68.94 138.25 54.45 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.8 -121.6 0.02 OUTLIER Glycine 0 CA--C 1.52 0.381 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.806 ' HG3' HG23 ' A' ' 96' ' ' VAL . 14.1 pt20 -77.11 -27.51 54.1 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.512 0.672 . . . . 0.0 110.463 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.806 HG23 ' HG3' ' A' ' 95' ' ' GLN . 21.5 t -125.44 150.02 30.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.533 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 35.8 t -120.26 126.03 74.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 122.921 0.489 . . . . 0.0 109.853 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 41.2 m80 -86.77 119.09 26.63 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 167.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.702 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.2 tp -127.93 147.91 50.49 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -110.71 117.86 34.6 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.699 HD11 HD23 ' A' ' 99' ' ' LEU . 6.0 mp -124.77 174.31 7.99 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.526 0.679 . . . . 0.0 111.37 -178.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HB2' HD11 ' A' ' 71' ' ' LEU . 31.0 tt0 -131.6 130.62 42.42 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 102.761 -3.051 . . . . 0.0 102.761 173.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 40.6 tptt -64.09 126.25 27.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -175.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.378 0 C-N-CA 121.016 -0.612 . . . . 0.0 113.314 -172.898 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 CA--C 1.504 -0.82 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 17.3 p -102.3 111.13 23.3 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-O 121.74 0.781 . . . . 0.0 110.451 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.415 ' CE2' ' HB ' ' A' ' 16' ' ' VAL . 44.8 p90 -125.61 162.96 23.81 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.858 -177.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 40.1 mt-10 -108.07 94.12 4.9 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 12.4 p -80.09 135.07 26.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.408 -175.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -90.18 108.33 19.68 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 58' ' ' ALA . 2.1 tm? -113.9 108.12 16.62 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.32 149.69 22.88 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.591 ' HD2' ' HA ' ' A' ' 24' ' ' SER . 27.3 mmtp -71.07 114.9 9.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 56' ' ' GLY . 2.9 t -74.88 -33.06 62.0 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 118.173 -1.411 . . . . 0.0 108.722 -177.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -174.74 -35.85 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.676 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.7 48.52 0.98 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.673 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.591 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 22.6 t 58.93 -152.99 0.39 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.818 0.847 . . . . 0.0 110.561 177.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.552 HD12 HD12 ' A' ' 18' ' ' LEU . 2.9 mm? -71.33 111.01 6.32 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.699 ' H ' ' HB3' ' A' ' 57' ' ' ALA . . . -78.02 46.33 2.66 Favored Glycine 0 C--N 1.296 -1.692 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.401 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.71 HG22 HG13 ' A' ' 52' ' ' ILE . 14.1 pt -141.11 148.64 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 CA-C-O 121.253 0.549 . . . . 0.0 110.197 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 32.4 t -117.85 124.25 47.88 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.6 m -115.59 150.55 17.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.564 -175.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.632 HG22 ' HB2' ' A' ' 50' ' ' LYS . 10.3 t -130.04 153.41 48.46 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.517 HG21 ' O ' ' A' ' 81' ' ' ALA . 8.3 p . . . . . 0 C--N 1.287 -2.113 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.715 -174.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 31' ' ' VAL . . . . . . . . 0 CA--C 1.471 -2.703 0 N-CA-C 104.507 -3.437 . . . . 0.0 104.507 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.796 HG13 HD12 ' A' ' 78' ' ' LEU . 38.6 mm -81.93 114.61 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 167.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.41 ' OH ' ' HA2' ' A' ' 67' ' ' GLY . 66.5 t80 -119.86 131.16 55.19 Favored 'General case' 0 C--N 1.275 -2.661 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.762 -169.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.496 HG21 ' CG2' ' A' ' 64' ' ' ILE . 46.5 t -75.16 107.38 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-O 121.557 0.694 . . . . 0.0 109.28 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.632 ' HB2' HG22 ' A' ' 30' ' ' THR . 87.2 tttt -89.06 -34.95 16.6 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.407 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 28' ' ' SER . . . -154.32 156.36 36.8 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.397 -176.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.945 HG21 ' HB2' ' A' ' 59' ' ' GLU . 1.9 mp -116.98 124.48 73.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 O-C-N 123.31 0.381 . . . . 0.0 110.093 174.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.38 121.93 85.79 Favored Pre-proline 0 C--O 1.257 1.491 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.181 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -55.12 129.19 33.96 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 123.368 2.712 . . . . 0.0 112.103 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 tptp 65.33 11.45 7.31 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.631 1.172 . . . . 0.0 112.049 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.591 ' O ' HG22 ' A' ' 21' ' ' THR . . . -76.43 -56.16 4.38 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.11 176.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.699 ' HB3' ' H ' ' A' ' 26' ' ' GLY . . . -178.23 -69.08 0.01 OUTLIER 'General case' 0 C--O 1.188 -2.14 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.591 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -50.31 -42.63 52.92 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.945 ' HB2' HG21 ' A' ' 52' ' ' ILE . 35.4 tt0 -82.86 -40.49 20.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.963 0.887 . . . . 0.0 109.869 -177.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.28 -44.0 66.06 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.899 -173.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.81 -34.41 57.92 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.078 0.942 . . . . 0.0 108.469 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.06 56.08 2.26 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.263 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -121.6 -73.41 0.65 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.813 0.816 . . . . 0.0 110.739 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.496 ' CG2' HG21 ' A' ' 49' ' ' VAL . 53.1 mt -94.74 148.01 5.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.266 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -143.8 172.6 12.62 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.462 1.105 . . . . 0.0 108.131 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 50' ' ' LYS . 56.4 mtpt -64.78 133.01 51.11 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 123.521 0.513 . . . . 0.0 110.624 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.41 ' HA2' ' OH ' ' A' ' 48' ' ' TYR . . . 111.94 -20.73 21.6 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 119.966 -1.112 . . . . 0.0 113.833 176.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.52 ' OD2' ' HA ' ' A' ' 103' ' ' LYS . 0.5 OUTLIER -85.51 149.21 25.54 Favored 'General case' 0 C--O 1.253 1.268 0 CA-C-O 121.754 0.787 . . . . 0.0 113.099 -179.266 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.459 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 78.5 ttt180 -102.81 138.73 39.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.498 -171.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 58.7 t -111.04 127.1 68.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.692 HD11 ' HB2' ' A' ' 102' ' ' GLU . 66.1 mt -110.3 -30.78 7.56 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.796 0.808 . . . . 0.0 109.837 -177.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.756 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -161.22 172.4 16.74 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.325 -174.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.732 HG11 ' CG2' ' A' ' 89' ' ' THR . 4.7 p -118.32 114.35 44.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 125.261 1.424 . . . . 0.0 107.487 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.859 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 32.1 p30 35.26 46.39 0.24 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.98 -11.0 64.18 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.597 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.533 ' HB ' HG13 ' A' ' 73' ' ' VAL . 43.1 t -101.33 114.94 42.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.2 m -75.79 145.01 41.06 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -173.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.796 HD12 HG13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.25 31.67 4.59 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.693 -1.139 . . . . 0.0 112.113 174.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -69.04 95.18 0.7 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.275 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.02 16.63 7.76 Favored Glycine 0 C--N 1.302 -1.34 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.517 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -88.6 171.1 10.28 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 27.9 p -96.46 162.56 13.43 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 173.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -51.8 -41.12 61.47 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.35 0.595 . . . . 0.0 110.491 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.47 -36.95 79.71 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.75 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.486 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 11.9 mm-40 -66.39 -41.18 89.72 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.014 0.435 . . . . 0.0 110.255 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -52.75 -60.24 3.5 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.14 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.98 -30.65 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.219 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 91' ' ' ARG . 10.2 tp10 -67.76 -38.71 83.8 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.732 ' CG2' HG11 ' A' ' 73' ' ' VAL . 27.0 m -71.87 -36.62 70.16 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.5 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 61.5 mt -72.97 -19.46 61.22 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.454 0.645 . . . . 0.0 110.794 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -92.43 -26.8 17.84 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.451 0.643 . . . . 0.0 110.814 -179.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -84.31 -21.44 31.0 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -69.14 -42.93 75.33 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.33 -156.59 27.02 Favored Glycine 0 CA--C 1.487 -1.66 0 C-N-CA 120.263 -0.97 . . . . 0.0 110.928 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.491 ' HA ' ' HG2' ' A' ' 20' ' ' LYS . 3.4 pt20 -88.06 -37.27 16.42 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.719 0.259 . . . . 0.0 111.515 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 43.9 t -106.91 109.47 28.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.66 119.67 60.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.613 -172.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.859 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 31.4 m170 -81.84 137.28 35.29 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 168.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 7.6 mp -122.41 148.88 44.57 Favored 'General case' 0 C--N 1.264 -3.131 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.756 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.4 tm? -99.04 109.05 21.85 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 13' ' ' THR . 7.3 mp -110.65 162.79 14.38 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.181 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.692 ' HB2' HD11 ' A' ' 71' ' ' LEU . 39.7 tt0 -123.34 124.76 43.67 Favored 'General case' 0 N--CA 1.404 -2.766 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 173.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.52 ' HA ' ' OD2' ' A' ' 68' ' ' ASP . 4.6 tmtm? -55.96 113.41 1.5 Allowed 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 124.286 0.991 . . . . 0.0 108.363 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.427 -1.925 0 CA-C-N 114.603 -1.18 . . . . 0.0 113.318 -174.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 24.0 t70 . . . . . 0 CA--C 1.51 -0.57 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.442 HG22 HD11 ' A' ' 71' ' ' LEU . 4.5 p -91.44 139.72 30.45 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 123.812 0.845 . . . . 0.0 111.335 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.593 ' HE2' ' HB2' ' A' ' 103' ' ' LYS . 48.2 p90 -157.51 154.43 28.62 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 39.7 mt-10 -110.06 148.51 31.57 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.493 HG23 HD13 ' A' ' 101' ' ' LEU . 59.9 t -127.25 124.97 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.51 ' HG2' ' HD2' ' A' ' 98' ' ' HIS . 43.1 mt-10 -96.76 91.56 5.74 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.928 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -102.57 122.03 43.57 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.21 141.51 31.89 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.112 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 1.5 mptm? -71.75 138.2 48.28 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.935 0.874 . . . . 0.0 112.526 177.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 23' ' ' GLY . 3.7 t -135.69 143.55 45.47 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 171.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 21' ' ' THR . 9.6 t70 77.93 -35.67 0.2 Allowed 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 123.651 0.781 . . . . 0.0 110.469 -173.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 21' ' ' THR . . . 119.7 11.39 7.18 Favored Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -127.6 151.53 48.8 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 115.241 -0.479 . . . . 0.0 109.897 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.548 HD11 ' HB3' ' A' ' 18' ' ' LEU . 13.7 tp -91.05 121.33 32.76 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 170.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.433 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -71.91 46.62 0.96 Allowed Glycine 0 C--O 1.211 -1.341 0 N-CA-C 115.451 0.941 . . . . 0.0 115.451 -173.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.432 HG22 ' CD1' ' A' ' 52' ' ' ILE . 6.9 pt -139.3 134.37 40.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 117.706 0.753 . . . . 0.0 111.461 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 53' ' ' ILE . 33.7 t -104.09 119.26 38.55 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.469 HG12 HG22 ' A' ' 49' ' ' VAL . 22.7 m -114.23 151.44 16.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.028 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.4 t -134.7 177.2 7.97 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 172.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.632 HG12 HD13 ' A' ' 47' ' ' ILE . 16.2 m . . . . . 0 C--N 1.294 -1.808 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . . . . . . 0 N--CA 1.431 -1.658 0 N-CA-C 113.474 0.15 . . . . 0.0 113.474 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.942 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.1 mm -119.13 142.78 32.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -128.7 113.37 15.29 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 174.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 29' ' ' VAL . 58.8 t -51.47 114.97 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 169.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -91.11 -30.38 16.76 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.905 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -158.34 159.99 36.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.928 HG21 ' HB2' ' A' ' 59' ' ' GLU . 45.3 mm -110.1 120.49 61.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 55' ' ' LYS . 1.8 mp -68.16 131.2 92.16 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.65 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 30.5 Cg_exo -69.35 60.12 1.45 Allowed 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 124.009 3.139 . . . . 0.0 112.267 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -138.95 19.62 2.64 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.7 -147.28 25.1 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.492 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 73.71 -91.05 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 125.329 1.452 . . . . 0.0 112.273 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.928 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -76.44 -36.85 57.74 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.326 -172.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.928 ' HB2' HG21 ' A' ' 52' ' ' ILE . 27.7 tt0 -78.85 -38.97 36.61 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 120.806 0.336 . . . . 0.0 110.655 -176.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -76.73 -27.83 55.57 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.109 0.481 . . . . 0.0 112.031 -175.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -87.98 -14.43 39.16 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.21 56.58 20.7 Favored Glycine 0 CA--C 1.497 -1.077 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.014 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -120.47 -46.48 2.38 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.168 0.509 . . . . 0.0 110.007 -177.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.551 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 53.3 mt -110.78 136.28 47.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.408 ' HA ' HD11 ' A' ' 52' ' ' ILE . 32.3 m-70 -134.56 177.85 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.814 0.696 . . . . 0.0 109.155 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -67.05 125.16 25.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.744 0.783 . . . . 0.0 110.237 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.82 21.0 17.19 Favored Glycine 0 N--CA 1.416 -2.669 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.016 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -97.58 142.44 29.39 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.962 -1.317 . . . . 0.0 110.424 167.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.639 ' HB2' ' HA3' ' A' ' 104' ' ' GLY . 6.7 ttm180 -92.83 138.58 31.36 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.942 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 55.9 t -106.93 115.67 48.95 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.476 HD12 HD22 ' A' ' 100' ' ' LEU . 96.8 mt -86.45 -37.54 18.22 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.955 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.712 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . . . -167.31 176.06 6.93 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.097 -175.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.574 ' HA ' HD12 ' A' ' 99' ' ' LEU . 21.1 t -118.94 118.69 58.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 175.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.411 HD22 HG12 ' A' ' 73' ' ' VAL . 9.6 p30 47.48 40.45 11.23 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 124.513 1.125 . . . . 0.0 113.771 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.65 -6.68 79.72 Favored Glycine 0 C--N 1.315 -0.636 0 C-N-CA 120.849 -0.691 . . . . 0.0 114.344 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 48.7 t -91.49 104.25 15.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.57 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 19.7 m -50.43 123.17 8.13 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.603 1.161 . . . . 0.0 113.3 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.712 ' HB3' ' HA ' ' A' ' 72' ' ' ALA . 22.3 tp -117.68 1.36 12.2 Favored 'General case' 1 N--CA 1.366 -4.64 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.844 -172.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.454 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 19.1 mt-10 -74.22 113.88 11.93 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.18 -0.16 11.54 Favored Glycine 0 C--N 1.298 -1.566 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -172.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.1 164.82 12.71 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.467 HG22 ' HG2' ' A' ' 85' ' ' GLN . 15.3 t -101.01 160.08 14.68 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 170.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 21.8 p80 -50.65 -45.43 57.89 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -58.94 -39.14 80.7 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.537 0.335 . . . . 0.0 110.1 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.467 ' HG2' HG22 ' A' ' 82' ' ' THR . 16.2 mm-40 -71.8 -36.41 70.28 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.106 0.479 . . . . 0.0 110.137 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.59 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -59.85 -47.09 87.12 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' A' ' 90' ' ' LEU . 95.8 t -67.48 -28.77 43.24 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.252 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.22 -30.2 69.22 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.26 0.552 . . . . 0.0 110.336 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -78.55 -25.21 45.36 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 80.8 mt -74.81 -23.51 58.49 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.712 0.768 . . . . 0.0 109.182 173.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -84.72 -29.34 25.64 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.462 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.66 -45.44 92.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.822 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.416 ' OG1' HG22 ' A' ' 97' ' ' VAL . 40.1 p -71.44 153.64 42.11 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.07 -119.55 0.91 Allowed Glycine 0 N--CA 1.426 -1.996 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.31 -175.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -79.8 -34.87 39.25 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.221 -0.489 . . . . 0.0 110.489 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -116.33 126.27 73.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.087 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.429 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 39.3 t -101.63 126.76 55.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.51 ' HD2' ' HG2' ' A' ' 17' ' ' GLU . 63.1 m80 -101.19 52.95 0.84 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.759 HD23 HD11 ' A' ' 101' ' ' LEU . 7.7 tp -61.84 149.47 40.11 Favored 'General case' 0 C--O 1.206 -1.227 0 C-N-CA 125.062 1.345 . . . . 0.0 111.18 -172.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.476 HD22 HD12 ' A' ' 71' ' ' LEU . 2.4 tt -110.43 118.77 37.16 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.759 HD11 HD23 ' A' ' 99' ' ' LEU . 6.4 mp -124.24 174.34 7.76 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.341 1.067 . . . . 0.0 112.567 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 30.8 tt0 -133.07 148.74 52.18 Favored 'General case' 0 N--CA 1.403 -2.824 0 N-CA-C 101.846 -3.39 . . . . 0.0 101.846 171.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.593 ' HB2' ' HE2' ' A' ' 14' ' ' PHE . 0.1 OUTLIER -82.38 84.77 7.04 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 172.572 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 69' ' ' ARG . . . . . . . . 0 CA--C 1.47 -2.732 0 CA-C-N 112.859 -1.973 . . . . 0.0 113.67 -170.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.3 t70 . . . . . 0 C--O 1.242 0.667 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 2.9 p -105.0 114.89 29.37 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.372 0.606 . . . . 0.0 112.026 -176.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' HE1' ' HB2' ' A' ' 103' ' ' LYS . 24.3 p90 -147.37 153.1 39.25 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.261 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.531 ' HG3' ' HG ' ' A' ' 100' ' ' LEU . 2.5 mp0 -91.26 108.57 19.97 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 t -76.1 136.47 24.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.49 96.47 8.01 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 175.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.708 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -117.66 117.59 29.8 Favored 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -178.227 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.09 171.07 7.55 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -176.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.82 111.81 6.53 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 172.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.9 m -117.16 97.41 5.91 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.62 -176.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t70 67.64 -61.45 0.36 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.711 1.204 . . . . 0.0 112.605 175.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.69 35.04 5.2 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 178.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.3 p 64.48 -155.43 0.3 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.986 1.714 . . . . 0.0 112.321 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 18' ' ' LEU . 13.5 tp -73.6 104.63 4.61 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.737 ' H ' ' HB3' ' A' ' 57' ' ' ALA . . . -74.48 53.17 2.35 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.046 -0.979 . . . . 0.0 115.167 -174.052 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.488 HG23 ' HB2' ' A' ' 58' ' ' ALA . 4.8 pt -136.45 133.88 49.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.231 0.539 . . . . 0.0 111.763 177.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 t -104.15 111.32 23.87 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.7 m -106.4 152.9 7.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.039 -174.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.9 t -134.08 167.86 19.88 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.734 HG11 ' HA ' ' A' ' 82' ' ' THR . 5.7 p . . . . . 0 C--N 1.271 -2.805 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 31' ' ' VAL . . . . . . . . 0 N--CA 1.429 -1.811 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.959 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.7 mm -102.53 143.14 15.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -178.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.465 ' CE2' ' HG3' ' A' ' 69' ' ' ARG . 79.4 m-85 -131.73 108.13 9.26 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.9 t -49.62 116.11 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.533 0.682 . . . . 0.0 109.675 171.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 86.2 tttt -92.2 -33.19 14.8 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.856 -175.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.73 153.29 31.03 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.029 -176.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.015 HG21 ' HB2' ' A' ' 59' ' ' GLU . 31.7 mm -110.67 132.07 60.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.8 mm -79.31 121.98 83.56 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.16 144.14 95.38 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 123.057 2.505 . . . . 0.0 111.146 178.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 24.0 tptp 59.27 30.16 19.85 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.883 1.325 . . . . 0.0 109.651 -178.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.87 -115.32 4.04 Favored Glycine 0 N--CA 1.406 -3.358 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.55 -177.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.737 ' HB3' ' H ' ' A' ' 26' ' ' GLY . . . -132.15 -65.1 0.75 Allowed 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.924 -0.638 . . . . 0.0 111.629 -172.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.768 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -54.33 -36.28 63.6 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -171.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.015 ' HB2' HG21 ' A' ' 52' ' ' ILE . 38.1 tt0 -95.54 -40.91 9.21 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 122.341 1.067 . . . . 0.0 110.304 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.6 m -79.71 -44.11 21.4 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.426 -168.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -101.17 -35.04 9.44 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.92 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.86 -128.64 6.43 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 116.519 1.368 . . . . 0.0 116.519 -167.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -147.79 -23.1 0.36 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.893 -1.153 . . . . 0.0 110.693 -165.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.768 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.6 mt -69.74 141.33 17.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.915 -173.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -134.64 -176.66 4.3 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.037 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 50' ' ' LYS . 81.0 tttt -67.83 121.69 16.55 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 123.41 0.684 . . . . 0.0 111.296 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.58 -6.94 31.75 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.442 -0.885 . . . . 0.0 114.179 177.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.769 ' HB3' HD23 ' A' ' 101' ' ' LEU . 66.3 m-20 -64.64 130.96 45.58 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-O 121.682 0.753 . . . . 0.0 112.067 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.465 ' HG3' ' CE2' ' A' ' 48' ' ' TYR . 48.3 ttt180 -92.22 129.92 38.05 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.997 -174.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.959 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 64.3 t -109.36 126.65 66.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -107.43 -34.91 6.92 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.128 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.623 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -150.32 157.07 42.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.596 0.713 . . . . 0.0 112.132 -176.107 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.816 ' HA ' HD12 ' A' ' 99' ' ' LEU . 61.7 t -109.82 100.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 173.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 t30 59.54 34.37 22.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.55 1.14 . . . . 0.0 110.504 176.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.22 -23.18 35.25 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.478 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.9 t -84.25 106.5 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 20.0 m -75.2 138.24 41.82 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 121.616 0.722 . . . . 0.0 112.106 -175.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.1 pt? -130.75 74.22 1.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.649 1.214 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -90.39 96.36 10.62 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.084 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.29 39.18 4.31 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.1 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.5 147.38 27.22 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.734 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.9 t -69.04 146.66 52.47 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 18.4 p80 -50.95 -35.45 33.56 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -177.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 54.6 mtmt -62.48 -38.91 91.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.257 176.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -76.21 -31.27 58.33 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -55.29 -53.69 52.9 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.662 ' HA ' HD12 ' A' ' 90' ' ' LEU . 86.0 t -64.48 -29.02 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.002 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 43.6 mm-40 -70.85 -33.19 70.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.164 0.507 . . . . 0.0 110.253 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.6 m -69.67 -35.15 74.9 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.68 HD13 HD23 ' A' ' 25' ' ' LEU . 81.3 mt -67.66 -34.57 77.2 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 123.918 0.887 . . . . 0.0 109.375 178.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -66.9 -35.39 79.9 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.7 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.11 -34.32 66.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.122 176.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.6 m -57.77 -51.65 68.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 123.702 0.801 . . . . 0.0 110.636 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.19 -150.32 17.62 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 120.079 -1.058 . . . . 0.0 112.893 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -77.78 -39.64 43.34 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 122.961 0.504 . . . . 0.0 110.765 -178.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.3 t -106.7 119.73 56.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.2 175.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.62 HG11 HD22 ' A' ' 90' ' ' LEU . 58.2 t -104.26 127.54 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-O 121.509 0.671 . . . . 0.0 110.213 -176.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -97.4 120.22 37.36 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 169.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.816 HD12 ' HA ' ' A' ' 73' ' ' VAL . 9.0 tp -121.54 133.3 55.02 Favored 'General case' 0 C--N 1.261 -3.24 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.1 tt -94.15 110.31 22.04 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -175.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 68' ' ' ASP . 10.1 mp -115.11 170.4 8.39 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.834 0.826 . . . . 0.0 111.774 -176.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 36.6 tt0 -129.64 103.33 6.79 Favored 'General case' 0 N--CA 1.4 -2.931 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 171.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.451 ' HB2' ' HE1' ' A' ' 14' ' ' PHE . 22.4 tptm -48.65 121.38 4.52 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 124.194 0.934 . . . . 0.0 112.353 -170.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.213 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.292 -172.598 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.6 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 32.1 t0 . . . . . 0 N--CA 1.442 -0.827 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 10.4 p -93.92 115.18 27.53 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-O 122.224 1.011 . . . . 0.0 110.375 177.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.556 ' CE1' ' HB ' ' A' ' 16' ' ' VAL . 44.8 p90 -123.49 159.72 28.48 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.699 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 41.2 mt-10 -102.1 109.11 20.73 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.556 ' HB ' ' CE1' ' A' ' 14' ' ' PHE . 7.5 p -89.98 119.83 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 121.378 0.609 . . . . 0.0 111.084 -174.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HG3' ' CG1' ' A' ' 96' ' ' VAL . 33.3 tt0 -87.47 91.92 8.9 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.516 -178.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.463 HD12 HD13 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -108.77 114.95 29.16 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.461 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.19 141.35 32.07 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -72.94 130.55 40.63 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.079 177.937 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.2 p -112.48 -158.78 0.66 Allowed 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -53.69 -30.01 41.56 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 123.497 0.719 . . . . 0.0 111.573 175.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.28 16.56 49.08 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.84 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 t 70.28 -143.9 0.08 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.663 ' HG ' HD13 ' A' ' 90' ' ' LEU . 3.6 mm? -64.44 -31.61 72.89 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.92 0.782 . . . . 0.0 109.725 177.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.36 5.14 79.88 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.152 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.0 pt -125.38 144.99 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-O 122.418 1.104 . . . . 0.0 113.193 -175.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.577 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 66.0 m -104.63 114.69 29.07 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 113.081 -1.872 . . . . 0.0 106.861 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.4 m -102.85 147.94 8.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-O 121.134 0.493 . . . . 0.0 111.531 -178.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 13.6 t -118.08 171.05 8.36 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.852 ' HA ' HD13 ' A' ' 47' ' ' ILE . 4.1 t . . . . . 0 C--N 1.289 -2.042 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 177.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.48 -2.151 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.852 HD13 ' HA ' ' A' ' 31' ' ' VAL . 24.7 mm -137.58 149.64 25.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 178.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -136.05 151.62 50.03 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 118.324 0.511 . . . . 0.0 110.688 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.539 HG21 ' CG2' ' A' ' 64' ' ' ILE . 21.6 t -79.31 109.03 13.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.55 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 87.6 tttt -83.14 -37.13 24.15 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.768 -175.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 28' ' ' SER . . . -153.37 148.05 26.28 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.994 -178.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.561 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 49.8 mm -112.72 122.07 66.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.69 129.03 46.12 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.99 139.26 34.07 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.198 2.598 . . . . 0.0 111.299 177.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.0 tptt 67.8 -0.35 2.02 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.915 0.886 . . . . 0.0 111.803 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.42 102.57 2.94 Favored Glycine 0 N--CA 1.419 -2.484 0 CA-C-O 119.422 -0.654 . . . . 0.0 112.946 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . 26.49 -76.26 0.0 OUTLIER 'General case' 0 C--O 1.181 -2.526 0 C-N-CA 128.312 2.645 . . . . 0.0 115.028 170.16 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -50.28 -39.0 44.08 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.561 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 9.7 tp10 -76.59 -43.66 37.7 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.136 0.575 . . . . 0.0 110.201 178.207 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -67.23 -50.27 61.35 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.29 -177.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.43 -36.96 79.81 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.5 179.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.72 53.99 4.76 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.088 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.489 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 1.0 OUTLIER -115.87 -74.61 0.6 Allowed 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.442 0.639 . . . . 0.0 109.341 -176.878 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.597 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 62.5 mt -86.26 140.95 15.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -144.71 -172.57 3.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.265 176.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.538 ' O ' ' HD2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -65.94 129.27 39.21 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.326 0.584 . . . . 0.0 112.522 -175.076 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.39 -7.77 62.01 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.203 174.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.607 ' HB3' HD23 ' A' ' 101' ' ' LEU . 10.1 m-20 -64.02 138.1 58.3 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-N 117.472 0.636 . . . . 0.0 112.452 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -88.19 115.86 25.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.779 -175.025 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.421 HG22 HD11 ' A' ' 101' ' ' LEU . 43.9 t -100.1 112.7 33.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.29 -37.55 10.94 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.594 -178.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -157.99 -179.79 8.46 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.382 -175.105 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.986 HG11 HG21 ' A' ' 89' ' ' THR . 2.4 p -130.13 102.69 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 125.561 1.544 . . . . 0.0 110.192 -178.182 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t30 58.95 37.61 24.57 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.247 1.022 . . . . 0.0 111.057 174.084 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.9 -12.0 70.3 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.574 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.596 ' HB ' HG13 ' A' ' 73' ' ' VAL . 59.0 t -93.25 125.41 45.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.5 m -71.02 145.13 50.16 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.267 0.556 . . . . 0.0 112.457 -174.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 61.9 mt -111.91 27.21 9.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.721 0.772 . . . . 0.0 110.304 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -78.11 118.1 20.04 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.126 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.4 19.74 51.25 Favored Glycine 0 C--N 1.309 -0.917 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.98 -171.27 2.19 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.51 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 15.2 t -150.32 175.48 11.78 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -50.37 -55.58 15.05 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.892 0.745 . . . . 0.0 111.151 -179.161 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -53.26 -45.45 68.82 Favored 'General case' 0 C--O 1.21 -1.0 0 O-C-N 123.898 0.749 . . . . 0.0 110.92 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -70.12 -43.96 69.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.618 0.247 . . . . 0.0 111.466 -176.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -58.42 -50.05 75.1 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.492 178.194 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 89.5 t -66.83 -37.21 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.178 -178.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -63.45 -36.54 84.08 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.093 0.473 . . . . 0.0 109.981 178.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.986 HG21 HG11 ' A' ' 73' ' ' VAL . 89.8 m -68.89 -37.82 79.24 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.576 177.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.663 HD13 ' HG ' ' A' ' 25' ' ' LEU . 83.8 mt -71.23 -19.84 62.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.661 0.743 . . . . 0.0 109.858 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -85.29 -47.67 9.82 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.64 177.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.68 -12.09 60.13 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -29.98 65.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.09 -138.26 10.66 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.617 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.46 ' O ' ' HE3' ' A' ' 20' ' ' LYS . 24.3 tp60 -86.39 -35.7 19.62 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.858 0.361 . . . . 0.0 110.365 -176.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.4 t -124.44 147.76 28.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -175.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.403 ' CG1' HG23 ' A' ' 73' ' ' VAL . 6.0 t -129.46 146.72 33.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.234 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 11.9 m-70 -115.75 70.08 0.74 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.155 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.61 HD21 HD21 ' A' ' 90' ' ' LEU . 5.0 mp -63.61 150.98 42.89 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.727 -175.2 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 62.7 tp -93.99 108.98 20.74 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 68' ' ' ASP . 8.1 mp -127.1 147.39 50.17 Favored 'General case' 0 CA--C 1.474 -1.971 0 CA-C-O 121.476 0.655 . . . . 0.0 111.71 -175.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 38.0 tt0 -113.66 115.44 27.87 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 103.769 -2.678 . . . . 0.0 103.769 174.11 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HA ' ' OD1' ' A' ' 68' ' ' ASP . 2.8 tmtm? -49.36 116.6 1.79 Allowed 'General case' 0 C--O 1.245 0.849 0 O-C-N 124.324 1.015 . . . . 0.0 111.721 -172.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.424 -2.146 0 CA-C-N 114.129 -1.396 . . . . 0.0 113.112 -174.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 N--CA 1.466 0.367 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.463 HG22 HD11 ' A' ' 71' ' ' LEU . 18.5 p -88.05 110.52 20.69 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.372 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -114.51 143.45 44.94 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 121.308 0.575 . . . . 0.0 111.564 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -101.99 121.38 42.05 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.501 HG11 HD11 ' A' ' 64' ' ' ILE . 30.0 t -110.95 129.66 65.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.207 -174.441 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 95.39 5.8 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.023 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -97.06 119.37 35.41 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.808 -173.649 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.21 117.98 30.9 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 24' ' ' SER . 94.5 mttt -56.29 121.82 10.4 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.006 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.6 m -92.28 -78.95 0.4 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.437 -174.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -126.38 -56.32 1.42 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.51 30.83 6.52 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 177.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.564 ' HA ' ' HB3' ' A' ' 20' ' ' LYS 0.286 97.8 p 66.19 -105.97 0.11 Allowed 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 126.367 1.867 . . . . 0.0 112.107 -179.988 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 90' ' ' LEU . 81.8 mt -96.83 128.43 43.78 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 176.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 52' ' ' ILE . . . -81.56 8.36 59.19 Favored Glycine 0 C--N 1.294 -1.804 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.761 -176.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.7 pt -99.55 115.69 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.32 -177.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.498 ' HB2' HG12 ' A' ' 53' ' ' ILE . 23.4 t -88.7 124.18 33.86 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 175.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.76 -174.68 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -173.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -170.75 150.48 3.28 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 178.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.618 HG11 ' HA ' ' A' ' 82' ' ' THR . 7.3 p . . . . . 0 C--N 1.287 -2.148 0 CA-C-O 121.209 0.528 . . . . 0.0 110.252 177.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 79' ' ' GLU . . . . . . . . 0 N--CA 1.416 -2.696 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.861 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.5 mm -101.38 148.29 7.42 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 179.207 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -133.35 147.23 51.81 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 118.385 0.539 . . . . 0.0 109.874 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.429 HG21 HG21 ' A' ' 64' ' ' ILE . 59.7 t -81.29 115.3 23.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -85.69 -34.48 21.27 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.594 -177.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.93 169.85 12.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.04 -176.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.063 HG21 ' HB2' ' A' ' 59' ' ' GLU . 20.5 mm -114.36 116.2 51.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 177.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.825 ' HB ' ' HD3' ' A' ' 54' ' ' PRO . 42.2 mm -84.5 -71.91 0.1 OUTLIER Pre-proline 0 CA--C 1.562 1.426 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -169.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 53' ' ' ILE . 6.2 Cg_exo -78.74 -160.87 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.715 2.277 . . . . 0.0 113.306 -172.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -36.44 -55.46 0.83 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.082 1.353 . . . . 0.0 112.132 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.617 ' HA3' ' OG ' ' A' ' 60' ' ' SER . . . -171.71 -87.26 0.07 OUTLIER Glycine 0 N--CA 1.403 -3.565 0 C-N-CA 119.556 -1.306 . . . . 0.0 111.964 176.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.674 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 68.53 -85.28 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 124.486 1.114 . . . . 0.0 108.949 -177.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.023 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -78.14 -29.44 48.74 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.717 -177.606 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.063 ' HB2' HG21 ' A' ' 52' ' ' ILE . 43.6 tt0 -73.75 -63.14 1.27 Allowed 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 124.602 1.189 . . . . 0.0 111.608 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.617 ' OG ' ' HA3' ' A' ' 56' ' ' GLY . 6.8 p -86.21 -30.38 22.44 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -168.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -100.54 -35.77 9.41 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -174.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.25 -128.52 3.35 Favored Glycine 1 N--CA 1.393 -4.229 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.301 -175.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -157.84 3.94 0.12 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -170.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.616 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 61.5 mt -94.78 138.94 19.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.388 -168.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.58 179.01 6.19 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -70.43 128.38 35.99 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.295 0.569 . . . . 0.0 109.999 176.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.13 -20.48 12.75 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.726 -178.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.641 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 50.5 m-20 -64.65 136.83 57.39 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.504 0.668 . . . . 0.0 112.411 -177.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -93.84 135.93 34.65 Favored 'General case' 0 C--O 1.195 -1.785 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.473 -176.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.861 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 62.2 t -106.53 119.51 56.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.601 HD12 HD22 ' A' ' 100' ' ' LEU . 82.8 mt -97.43 -44.38 6.88 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.55 -1.205 . . . . 0.0 108.781 -177.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -152.26 165.08 36.01 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.011 -173.453 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.753 ' HA ' HD12 ' A' ' 99' ' ' LEU . 39.0 t -116.28 111.27 34.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 173.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 98' ' ' HIS . 9.2 p30 47.27 35.91 4.22 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.02 1.328 . . . . 0.0 112.354 -176.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.09 -16.23 61.22 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.121 -1.038 . . . . 0.0 114.393 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.39 109.29 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -70.23 137.51 50.91 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.358 0.411 . . . . 0.0 111.235 -174.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.609 HD22 HG23 ' A' ' 73' ' ' VAL . 1.7 pt? -130.6 22.24 5.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.654 177.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.523 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 32.4 mt-10 -68.48 105.14 2.11 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.26 16.63 6.04 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.796 -176.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.581 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -98.94 167.52 10.69 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 175.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.618 ' HA ' HG11 ' A' ' 31' ' ' VAL . 9.0 t -90.78 170.17 10.34 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -50.3 -49.54 53.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.465 1.106 . . . . 0.0 109.667 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 10.9 mptt -64.13 -35.17 79.89 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.15 -176.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.52 ' HG3' HG22 ' A' ' 82' ' ' THR . 56.2 mt-30 -70.02 -42.59 72.79 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -54.26 -58.79 6.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.023 178.096 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.42 -28.5 43.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.191 -177.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 66.1 mm-40 -68.75 -34.38 75.49 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.537 177.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.519 HG22 HG11 ' A' ' 73' ' ' VAL . 37.8 m -69.51 -29.94 67.68 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.694 ' HB3' HD12 ' A' ' 25' ' ' LEU . 81.4 mt -77.0 -16.55 59.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.961 177.22 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -93.25 -26.94 17.13 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.6 176.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -67.28 -42.22 84.15 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.6 p -65.92 146.23 54.97 Favored 'General case' 0 C--O 1.252 1.208 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.958 177.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.9 -128.98 0.88 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -172.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -69.3 -54.4 14.82 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.44 0.696 . . . . 0.0 111.803 -174.385 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -106.2 115.51 48.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.587 HG21 HD11 ' A' ' 25' ' ' LEU . 46.0 t -99.0 126.5 52.21 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 74' ' ' ASN . 53.8 t-80 -91.96 123.39 35.28 Favored 'General case' 0 N--CA 1.404 -2.729 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 175.216 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.753 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.6 tp -126.53 143.36 51.23 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.601 HD22 HD12 ' A' ' 71' ' ' LEU . 1.6 tt -105.1 116.1 31.39 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.596 HD11 HD23 ' A' ' 99' ' ' LEU . 6.6 mp -121.46 176.07 5.86 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.51 0.671 . . . . 0.0 111.873 -177.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -131.27 126.85 36.49 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 172.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.641 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 15.1 mmtt -57.3 127.01 29.83 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.545 0.528 . . . . 0.0 111.433 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.561 -178.6 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 38.0 t70 . . . . . 0 CA--C 1.494 -1.198 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.577 HG22 HD11 ' A' ' 71' ' ' LEU . 6.1 p -80.65 137.53 36.34 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.071 0.463 . . . . 0.0 111.887 -175.105 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -139.39 140.7 37.5 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.119 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.547 ' HB3' ' NE2' ' A' ' 98' ' ' HIS . 45.3 mt-10 -106.41 114.23 28.23 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.919 -179.168 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.409 HG12 HD13 ' A' ' 101' ' ' LEU . 7.7 p -113.44 131.71 64.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.127 -175.31 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.696 ' HA ' ' HA ' ' A' ' 98' ' ' HIS . 40.8 tt0 -110.52 99.56 8.53 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 175.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -93.66 124.14 37.45 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -173.17 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -98.31 116.07 29.75 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 14.9 ptmt -79.79 145.88 32.59 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.466 -175.009 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -84.87 -55.27 4.16 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.339 0.59 . . . . 0.0 109.963 -175.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.477 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 9.1 p-10 -111.11 -145.77 0.4 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.22 20.08 11.43 Favored Glycine 0 C--N 1.305 -1.189 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.237 178.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 20.0 m -122.42 130.38 53.03 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.764 HD11 ' HB3' ' A' ' 18' ' ' LEU . 22.0 tp -81.26 -5.28 57.61 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.012 0.911 . . . . 0.0 108.904 178.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.71 7.25 69.07 Favored Glycine 0 N--CA 1.421 -2.354 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.196 175.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.486 HG22 ' CD1' ' A' ' 52' ' ' ILE . 19.2 pt -132.59 148.21 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 CA-C-O 121.252 0.549 . . . . 0.0 110.495 179.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.5 t -116.79 120.41 38.46 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 176.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 49' ' ' VAL . 35.0 m -111.97 170.34 3.89 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-O 120.71 0.29 . . . . 0.0 110.966 -176.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -145.45 169.71 17.81 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 171.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.461 HG11 ' HA ' ' A' ' 82' ' ' THR . 30.8 m . . . . . 0 C--N 1.299 -1.599 0 C-N-CA 118.709 -1.196 . . . . 0.0 108.858 173.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.168 0 N-CA-C 107.504 -2.238 . . . . 0.0 107.504 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.666 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 30.7 mm -145.24 134.49 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 174.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -125.45 139.88 53.26 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.554 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.493 HG21 ' CG2' ' A' ' 64' ' ' ILE . 40.1 t -75.17 117.76 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.169 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -93.02 -31.66 14.79 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.087 -174.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . . . -158.06 162.67 38.09 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.875 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 65' ' ' HIS . 49.4 mm -107.52 120.11 58.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 177.584 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.507 HG22 ' HD3' ' A' ' 55' ' ' LYS . 50.0 mm -77.53 124.15 86.71 Favored Pre-proline 0 C--O 1.252 1.216 0 C-N-CA 122.956 0.502 . . . . 0.0 110.741 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 4.9 Cg_exo -74.84 74.3 3.96 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 124.192 3.261 . . . . 0.0 115.53 -174.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HD3' HG22 ' A' ' 53' ' ' ILE . 2.1 mptm? -116.59 -82.3 0.62 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.204 0.526 . . . . 0.0 110.108 171.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.571 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 172.59 49.59 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 119.781 -1.2 . . . . 0.0 112.142 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . -126.36 -96.4 0.43 Allowed 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.967 -179.211 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.916 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -61.05 -36.13 78.77 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.617 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 40.5 tt0 -72.13 -46.87 54.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.557 0.743 . . . . 0.0 110.465 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.571 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 13.5 m -77.88 -35.85 50.42 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.209 -173.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.13 -23.89 47.63 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.9 59.77 4.93 Favored Glycine 0 CA--C 1.498 -1.03 0 CA-C-N 113.98 -1.464 . . . . 0.0 113.471 171.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -120.5 -69.81 0.82 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.948 0.88 . . . . 0.0 108.797 -178.581 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.493 ' CG2' HG21 ' A' ' 49' ' ' VAL . 68.6 mt -90.36 141.73 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.783 -178.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.672 ' HA ' HD11 ' A' ' 52' ' ' ILE . 33.1 t-80 -139.45 176.15 8.96 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 175.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 51' ' ' ALA . 51.5 pttt -73.56 142.87 46.63 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.835 -178.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.48 -22.68 21.86 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.957 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 39.1 m-20 -72.63 142.35 48.33 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.91 0.386 . . . . 0.0 112.035 -178.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -101.09 136.58 40.7 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.666 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.1 t -103.97 121.44 55.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -175.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD11 HG22 ' A' ' 13' ' ' THR . 90.2 mt -83.47 -42.16 17.21 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.452 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 76' ' ' VAL . . . -170.07 176.09 4.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.703 -175.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 1.054 HG11 HG21 ' A' ' 89' ' ' THR . 2.7 p -112.92 105.96 19.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 124.038 0.935 . . . . 0.0 109.901 178.18 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.9 t30 52.41 40.95 30.45 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.771 1.272 . . . . 0.0 110.765 178.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.93 -18.24 41.09 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.538 -178.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.71 ' HB ' HG13 ' A' ' 73' ' ' VAL . 49.1 t -77.67 109.09 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.0 m -61.57 122.51 15.44 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.905 -173.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.0 mt -90.6 74.74 6.72 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -85.37 96.68 9.63 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.649 -174.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.17 47.86 69.27 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -178.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.72 147.57 24.42 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.709 HG22 ' HG2' ' A' ' 85' ' ' GLN . 13.9 t -91.06 164.55 13.91 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 172.118 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -43.48 -54.74 4.62 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.409 1.484 . . . . 0.0 112.538 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 36.8 ttmt -63.66 -34.99 79.07 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -176.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.709 ' HG2' HG22 ' A' ' 82' ' ' THR . 82.5 mm-40 -68.85 -43.26 75.79 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.168 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.603 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -55.0 -54.52 41.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.391 176.105 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.73 -35.88 76.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.725 -177.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 36.8 mt-10 -69.39 -32.53 71.62 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.521 179.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 1.054 HG21 HG11 ' A' ' 73' ' ' VAL . 60.2 m -66.86 -36.74 83.02 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 60.3 mt -75.74 -15.11 60.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 0.0 110.011 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -89.11 -45.83 9.3 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.607 176.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -69.18 -35.92 76.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.687 -176.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -53.41 -51.91 61.07 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 122.918 0.487 . . . . 0.0 112.185 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.57 -154.24 25.84 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.604 177.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 51.1 tt0 -76.61 -44.94 32.18 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.61 0.719 . . . . 0.0 109.748 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 21.3 t -106.08 116.31 49.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.8 131.97 65.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -174.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 9.5 t60 -96.91 136.97 36.71 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 175.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.545 HD11 HD22 ' A' ' 90' ' ' LEU . 6.5 mp -130.44 154.3 47.88 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.123 0.487 . . . . 0.0 109.823 174.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HG ' ' HB2' ' A' ' 71' ' ' LEU . 55.3 tp -110.14 118.95 37.75 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.497 ' HG ' ' HA ' ' A' ' 70' ' ' VAL . 7.4 mp -130.25 178.83 6.28 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.377 0.608 . . . . 0.0 110.527 -178.189 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 9.2 pt-20 -130.49 153.43 48.82 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 172.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -61.52 109.95 1.33 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.957 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 N--CA 1.431 -1.68 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.596 -177.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--O 1.251 1.153 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 p -89.1 109.06 19.96 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 166.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -109.55 100.59 9.62 Favored 'General case' 0 N--CA 1.408 -2.536 0 CA-C-O 122.334 1.064 . . . . 0.0 111.028 -173.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.774 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 45.4 mt-10 -71.51 91.87 1.08 Allowed 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.177 174.269 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.619 HG12 HD13 ' A' ' 101' ' ' LEU . 14.9 p -84.62 138.77 18.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.536 -174.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -108.13 107.73 18.5 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 177.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.83 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -116.38 130.94 57.03 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.441 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -103.77 132.34 50.11 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.231 -0.293 . . . . 0.0 110.873 -178.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 95' ' ' GLN . 1.7 mptm? -60.42 136.44 58.04 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.09 0.471 . . . . 0.0 112.097 175.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.411 HG21 ' HA3' ' A' ' 56' ' ' GLY . 17.6 p -104.11 100.3 10.05 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 169.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 t70 73.06 -49.44 0.7 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.875 1.27 . . . . 0.0 112.203 -177.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.96 0.78 0.03 OUTLIER Glycine 0 C--N 1.306 -1.138 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.927 177.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.3 m -108.21 144.0 36.26 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 122.169 -0.606 . . . . 0.0 110.207 -177.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.83 HD11 ' HB3' ' A' ' 18' ' ' LEU . 19.6 tp -93.98 -11.14 31.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.7 13.9 66.39 Favored Glycine 0 N--CA 1.429 -1.797 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.048 175.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.498 HG22 HD13 ' A' ' 52' ' ' ILE . 14.1 pt -139.66 146.25 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.667 0.746 . . . . 0.0 112.487 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.422 ' OG ' HD11 ' A' ' 53' ' ' ILE . 19.6 m -107.02 135.04 49.26 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.412 172.48 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.0 165.23 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 123.772 0.67 . . . . 0.0 109.64 -176.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.998 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 6.0 t -149.37 141.8 24.27 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 177.406 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.769 HG12 HD13 ' A' ' 47' ' ' ILE . 32.6 m . . . . . 0 C--N 1.299 -1.6 0 C-N-CA 119.204 -0.998 . . . . 0.0 113.514 -176.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.418 -2.522 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.769 HD13 HG12 ' A' ' 31' ' ' VAL . 42.2 mm -115.43 136.12 53.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.669 ' HB3' ' HA ' ' A' ' 69' ' ' ARG 0.27 38.5 p90 -158.52 169.3 24.74 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 169.295 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.553 HG21 ' CG2' ' A' ' 64' ' ' ILE . 31.8 t -80.59 121.76 34.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.694 -178.111 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.998 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 57.8 tptt -91.32 -38.09 12.85 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.468 178.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -156.03 158.58 38.06 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.577 -175.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.498 HD13 HG22 ' A' ' 27' ' ' ILE . 45.9 mm -104.05 117.97 50.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.242 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 43.6 mm -93.29 134.18 27.34 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.726 -179.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 14.9 Cg_exo -72.36 -172.68 0.94 Allowed 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 122.792 2.328 . . . . 0.0 112.186 178.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.5 tptt 92.74 5.35 0.05 Allowed 'General case' 0 C--O 1.242 0.661 0 C-N-CA 126.367 1.867 . . . . 0.0 109.309 176.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.569 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 124.89 -163.83 18.68 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 114.677 -1.147 . . . . 0.0 113.256 173.375 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.503 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 71.66 -114.04 0.07 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 171.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.819 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -60.42 -39.48 87.58 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 117.942 0.337 . . . . 0.0 111.354 -174.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.11 -55.88 16.2 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.38 1.472 . . . . 0.0 110.115 178.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.569 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 20.4 m -73.25 -36.68 66.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -171.349 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -74.17 -28.85 61.49 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.58 51.09 22.35 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.382 176.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.561 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 3.1 mmp_? -104.99 -56.85 2.11 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.672 0.748 . . . . 0.0 110.842 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.553 ' CG2' HG21 ' A' ' 49' ' ' VAL . 56.2 mt -95.04 144.06 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.243 -176.023 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -137.0 168.7 19.08 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 173.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -65.74 141.98 58.15 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.279 0.561 . . . . 0.0 111.215 -176.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.7 -40.71 2.44 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.027 -1.083 . . . . 0.0 113.77 176.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 48' ' ' TYR 0.289 8.1 m-20 -67.21 144.52 55.93 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -174.919 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.669 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 34.6 ttp180 -102.19 149.43 24.31 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.694 -165.506 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 48' ' ' TYR . 22.0 t -115.52 133.36 62.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -173.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.487 HD12 HD22 ' A' ' 100' ' ' LEU . 85.1 mt -96.12 -37.23 10.68 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.148 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.837 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . . . -167.44 179.54 4.91 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.925 -176.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.858 HG23 HD22 ' A' ' 78' ' ' LEU . 60.3 t -123.89 110.33 25.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.021 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.4 t30 59.43 34.94 22.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.666 1.222 . . . . 0.0 109.923 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 -15.43 61.19 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.478 -1.237 . . . . 0.0 114.221 178.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 57.7 t -85.65 112.47 22.41 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.119 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 17.5 m -53.96 122.84 10.93 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 124.37 1.044 . . . . 0.0 112.354 -174.149 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.858 HD22 HG23 ' A' ' 73' ' ' VAL . 18.4 tp -118.11 8.95 12.53 Favored 'General case' 0 N--CA 1.379 -3.983 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.695 -173.07 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.74 118.09 15.24 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.47 20.03 11.53 Favored Glycine 0 C--N 1.302 -1.326 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.035 -176.295 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.54 ' HB3' HD11 ' A' ' 47' ' ' ILE . . . -101.01 149.84 23.52 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.435 ' C ' HG11 ' A' ' 31' ' ' VAL . 14.9 t -99.14 174.88 6.11 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -50.34 -54.17 23.52 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.785 0.834 . . . . 0.0 111.172 -173.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 59.2 mtpt -63.45 -32.39 73.82 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.063 -176.004 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -72.34 -46.54 55.09 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.526 ' O ' HD13 ' A' ' 90' ' ' LEU . . . -54.88 -56.29 21.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.606 177.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.98 -29.32 46.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.932 -178.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 34.2 mm-40 -72.28 -26.85 62.14 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.967 177.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.1 m -72.78 -39.75 66.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.748 ' HG ' HG11 ' A' ' 97' ' ' VAL . 8.6 mp -69.97 -18.44 63.34 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.677 1.191 . . . . 0.0 110.883 176.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -82.15 -43.13 18.14 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.706 175.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -66.03 -36.07 82.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.316 -177.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -58.89 -55.22 37.89 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.368 -179.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 134.35 -142.73 14.24 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 178.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.516 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 58.9 tt0 -73.09 -55.76 6.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.063 0.459 . . . . 0.0 110.615 178.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 61.6 t -92.09 113.44 27.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.367 -179.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.748 HG11 ' HG ' ' A' ' 90' ' ' LEU . 3.0 t -105.66 128.0 60.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.011 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.532 ' CE1' ' HB3' ' A' ' 15' ' ' GLU . 34.9 t-80 -99.16 130.62 45.48 Favored 'General case' 0 C--N 1.258 -3.372 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.48 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 90' ' ' LEU . 5.2 mp -128.26 146.17 50.82 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.346 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.774 ' HG ' ' HG2' ' A' ' 15' ' ' GLU . 3.3 tt -98.91 112.67 24.71 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -177.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.619 HD13 HG12 ' A' ' 16' ' ' VAL . 9.9 mp -115.27 166.51 11.77 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.237 0.541 . . . . 0.0 111.727 -177.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -133.14 152.11 51.96 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 176.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.486 ' NZ ' ' HB3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -54.05 115.26 1.95 Allowed 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.543 0.687 . . . . 0.0 110.334 171.827 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 69' ' ' ARG . . . . . . . . 0 C--N 1.292 -1.902 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 176.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 11.4 t70 . . . . . 0 CA--C 1.503 -0.841 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 p -91.18 133.45 35.36 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.383 0.611 . . . . 0.0 111.902 -174.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -143.88 149.22 36.57 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.425 177.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -106.33 117.84 35.09 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.75 115.63 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.08 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.406 178.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.5 91.28 5.38 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.229 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.983 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -100.7 119.69 38.96 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.138 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.44 124.09 34.16 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.133 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.479 ' HG2' HD23 ' A' ' 25' ' ' LEU . 92.9 mttt -65.52 144.13 57.21 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.145 0.498 . . . . 0.0 111.607 -179.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.564 HG21 ' HG3' ' A' ' 55' ' ' LYS . 6.2 m -61.89 -42.1 98.67 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.568 177.139 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -163.05 -49.45 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.785 176.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.31 -9.24 0.68 Allowed Glycine 0 C--O 1.242 0.597 0 C-N-CA 119.524 -1.322 . . . . 0.0 113.538 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 m -132.73 150.64 52.13 Favored 'General case' 0 N--CA 1.433 -1.314 0 O-C-N 122.062 -0.669 . . . . 0.0 110.828 -175.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.622 HD12 HD23 ' A' ' 90' ' ' LEU . 72.6 mt -89.74 145.34 25.27 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 169.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.83 51.92 4.62 Favored Glycine 0 C--N 1.288 -2.116 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.902 -177.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.541 HD13 HD13 ' A' ' 64' ' ' ILE . 12.2 pt -140.58 142.29 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 CA-C-N 117.87 0.835 . . . . 0.0 111.904 177.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 t -117.53 140.95 48.93 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 175.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 49' ' ' VAL . 27.1 m -126.28 147.96 31.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.4 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 15.1 t -118.84 158.31 25.9 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 82' ' ' THR . 3.3 t . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -176.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.529 HD13 HG13 ' A' ' 31' ' ' VAL . 42.1 mm -101.53 133.44 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -176.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -129.25 120.3 25.48 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.491 HG21 ' CG2' ' A' ' 64' ' ' ILE . 28.6 t -47.84 113.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 122.036 0.922 . . . . 0.0 109.971 170.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.769 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 88.4 tttt -87.41 -37.95 16.57 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.994 -174.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.86 151.44 32.25 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.363 -176.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 47.4 mm -109.39 128.61 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 O-C-N 123.731 0.644 . . . . 0.0 109.444 178.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.93 133.58 20.97 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 175.629 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 55' ' ' LYS . 22.6 Cg_exo -65.59 -86.6 0.01 OUTLIER 'Trans proline' 0 C--O 1.255 1.349 0 C-N-CA 121.907 1.738 . . . . 0.0 111.57 176.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HG3' HG21 ' A' ' 21' ' ' THR . 17.8 tptp 65.04 -67.51 0.12 Allowed 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 127.605 2.362 . . . . 0.0 110.481 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.07 38.15 0.02 OUTLIER Glycine 0 C--N 1.277 -2.729 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -179.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.587 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -134.52 -99.39 0.25 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -174.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.983 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -68.71 -38.69 80.43 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -168.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.571 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 36.4 tt0 -84.54 -29.39 25.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.313 0.578 . . . . 0.0 110.162 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.8 m -71.92 -46.26 58.26 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.117 -177.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.57 -24.3 34.05 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.551 0.691 . . . . 0.0 109.853 178.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.08 53.43 14.55 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.263 175.046 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -98.96 -46.76 5.5 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.675 1.226 . . . . 0.0 109.345 178.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.541 HD13 HD13 ' A' ' 27' ' ' ILE . 39.8 mt -112.8 140.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-N 113.154 -1.839 . . . . 0.0 109.752 -171.706 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -133.87 154.93 50.7 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 176.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 144.25 56.36 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.48 -175.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.37 -16.45 38.08 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.975 -178.486 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -80.28 144.45 32.83 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-O 121.034 0.445 . . . . 0.0 111.081 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -90.93 137.33 32.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.813 -175.546 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 38.5 t -101.18 112.32 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 176.606 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.444 HD12 ' HG ' ' A' ' 100' ' ' LEU . 85.2 mt -85.29 -39.47 17.66 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.668 -177.352 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.707 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -163.37 175.06 11.2 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.144 -176.069 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.708 HG13 ' HG ' ' A' ' 99' ' ' LEU . 23.8 t -130.76 117.87 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 65.32 27.15 12.06 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.455 1.102 . . . . 0.0 110.093 176.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.87 -6.82 79.81 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.557 -177.017 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.21 105.06 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.612 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 47.6 m -62.07 130.79 47.14 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.355 -174.244 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.707 ' HG ' ' HA ' ' A' ' 72' ' ' ALA . 98.0 mt -87.74 40.54 0.94 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.797 0.808 . . . . 0.0 110.574 -178.093 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 77' ' ' SER . 36.2 mt-10 -76.3 112.27 12.62 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.01 32.37 17.79 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -175.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.54 177.78 5.06 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.977 0.894 . . . . 0.0 110.92 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.649 ' HA ' HG21 ' A' ' 31' ' ' VAL . 10.0 t -153.87 -179.52 7.92 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -50.7 -54.17 25.28 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.064 0.853 . . . . 0.0 110.142 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 40.7 ttmt -58.35 -43.6 88.41 Favored 'General case' 0 C--O 1.204 -1.298 0 O-C-N 123.596 0.56 . . . . 0.0 111.638 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.543 ' HG2' HG22 ' A' ' 82' ' ' THR . 13.1 mm-40 -66.23 -47.82 72.56 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.936 -176.427 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.529 ' O ' HD13 ' A' ' 90' ' ' LEU . . . -56.91 -57.37 12.8 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.749 178.052 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.48 -32.68 58.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.378 -175.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 53.0 mm-40 -76.44 -19.48 58.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.656 178.27 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 m -76.44 -35.51 58.45 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.622 HD23 HD12 ' A' ' 25' ' ' LEU . 8.7 mp -70.22 -22.14 62.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.622 0.769 . . . . 0.0 110.239 175.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -84.61 -31.09 24.45 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.572 0.701 . . . . 0.0 109.729 174.811 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -70.33 -42.37 72.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.565 178.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.6 p -65.07 152.97 42.13 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.88 177.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.67 -157.05 1.07 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 114.678 0.631 . . . . 0.0 114.678 -179.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.443 ' HG3' HG23 ' A' ' 96' ' ' VAL . 20.2 pt20 -68.02 -35.22 77.94 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.463 -0.368 . . . . 0.0 111.581 -177.105 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.443 HG23 ' HG3' ' A' ' 95' ' ' GLN . 48.4 t -105.2 108.52 25.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.095 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.6 t -99.95 134.5 39.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.105 -173.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -104.29 128.09 52.02 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.708 ' HG ' HG13 ' A' ' 73' ' ' VAL . 5.4 mp -123.89 145.29 49.22 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 172.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 56.5 tp -91.82 109.18 20.51 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 mp -117.66 160.2 21.69 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.401 0.62 . . . . 0.0 110.42 -177.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 9.4 pt-20 -131.69 156.6 45.59 Favored 'General case' 0 C--N 1.264 -3.111 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 170.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.45 117.1 6.23 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.637 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.693 -176.118 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 . . . . . 0 CA--C 1.488 -1.405 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 p -101.9 145.08 29.72 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 165.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -149.04 153.76 38.34 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.433 -176.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -103.47 133.46 48.47 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 179.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 64' ' ' ILE . 11.0 p -131.56 132.47 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.143 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.5 ' HG3' ' HD2' ' A' ' 98' ' ' HIS . 49.1 mt-10 -101.46 85.43 2.77 Favored 'General case' 0 CA--C 1.472 -2.039 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 174.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -77.32 120.91 23.0 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.624 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.74 123.61 36.14 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.243 -175.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -68.49 112.48 5.33 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 t -111.35 89.01 2.93 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.196 -175.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 t70 79.76 -40.37 0.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.797 -1.547 . . . . 0.0 113.641 178.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.76 -98.5 0.99 Allowed Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.489 -0.863 . . . . 0.0 114.078 -179.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.0 m -162.65 -162.17 0.77 Allowed 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 -173.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.797 HD11 ' HB3' ' A' ' 18' ' ' LEU . 1.6 tp -89.34 109.38 20.29 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 171.514 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.586 ' HA3' ' O ' ' A' ' 56' ' ' GLY . . . -75.07 50.85 2.36 Favored Glycine 0 C--N 1.292 -1.866 0 CA-C-N 114.697 -1.138 . . . . 0.0 115.383 -172.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.504 HG21 HG21 ' A' ' 64' ' ' ILE . 10.7 pt -130.11 122.11 53.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 121.749 0.785 . . . . 0.0 111.071 177.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.531 ' HB2' HD11 ' A' ' 53' ' ' ILE . 7.7 t -94.86 124.99 39.23 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 -178.087 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 83' ' ' HIS . 33.7 m -118.67 156.56 20.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 120.687 0.28 . . . . 0.0 111.41 -174.39 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.421 HG22 ' HB2' ' A' ' 50' ' ' LYS . 10.2 t -141.74 159.37 42.35 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.398 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.591 ' CG2' HD13 ' A' ' 47' ' ' ILE . 21.4 t . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 120.915 0.388 . . . . 0.0 110.797 177.012 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.44 0 N-CA-C 115.477 0.951 . . . . 0.0 115.477 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.648 ' HB ' HG22 ' A' ' 70' ' ' VAL . 18.0 mm -100.33 147.22 7.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -164.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -129.43 107.68 9.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.94 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.4 t -48.15 121.76 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.608 0.718 . . . . 0.0 110.521 169.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.421 ' HB2' HG22 ' A' ' 30' ' ' THR . 85.5 tttt -92.63 -37.31 12.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.702 -178.598 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.85 161.83 34.54 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.825 -175.217 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 20.1 mm -116.08 125.73 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.531 HD11 ' HB2' ' A' ' 28' ' ' SER . 2.0 mp -76.48 134.28 70.0 Favored Pre-proline 0 C--N 1.302 -1.469 0 C-N-CA 122.573 0.349 . . . . 0.0 111.473 -176.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.65 130.62 36.11 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 123.107 2.538 . . . . 0.0 110.034 175.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 69.74 -4.99 1.29 Allowed 'General case' 0 C--O 1.249 1.043 0 CA-C-O 122.006 0.907 . . . . 0.0 110.654 -177.207 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.586 ' O ' ' HA3' ' A' ' 26' ' ' GLY . . . -85.48 68.34 3.45 Favored Glycine 0 N--CA 1.403 -3.551 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.209 -175.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 58.82 -75.41 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.698 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 167.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.677 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -58.12 -35.11 70.98 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 125.219 1.407 . . . . 0.0 113.342 -171.793 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.512 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 34.7 tt0 -85.64 -39.96 16.72 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.032 0.444 . . . . 0.0 110.138 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -68.52 -37.32 79.94 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.282 -177.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -82.62 -34.61 27.52 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.714 177.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.89 52.02 3.81 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.688 -0.687 . . . . 0.0 114.242 175.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -116.58 -56.8 2.25 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.24 0.543 . . . . 0.0 111.658 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.559 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 21.2 mm -84.07 145.52 8.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.11 -176.635 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -125.33 162.61 24.38 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -77.97 143.1 37.87 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.42 -179.005 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.488 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 103.74 -28.0 17.28 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.478 -179.395 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.756 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 39.5 m-20 -64.53 146.91 53.87 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.687 0.756 . . . . 0.0 111.825 -176.709 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . 59.9 mtp180 -96.84 146.53 24.83 Favored 'General case' 0 CA--C 1.461 -2.456 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.017 -173.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.648 HG22 ' HB ' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -112.74 123.79 68.77 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.132 0 CA-C-N 114.229 -1.35 . . . . 0.0 107.461 176.191 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HB2' HD12 ' A' ' 100' ' ' LEU . 65.9 mt -107.96 -24.23 11.7 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.792 -176.195 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -169.06 173.23 6.98 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.927 -176.032 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' HG ' ' A' ' 99' ' ' LEU . 99.4 t -130.29 116.98 38.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 173.56 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 98' ' ' HIS 0.265 10.3 p30 51.31 38.43 21.5 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.331 1.453 . . . . 0.0 112.513 -177.648 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.79 -8.02 77.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 119.928 -1.129 . . . . 0.0 113.881 -179.052 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.54 106.03 14.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 49.7 m -63.91 136.79 57.65 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.122 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.705 HD11 HG23 ' A' ' 73' ' ' VAL . 81.3 mt -118.95 16.85 13.4 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.584 178.355 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.38 119.47 12.27 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.472 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.5 15.16 58.91 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.301 -177.266 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.78 159.13 15.09 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 117.474 0.637 . . . . 0.0 109.587 179.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.9 t -97.0 158.78 15.26 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 171.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.571 ' HB2' HG23 ' A' ' 29' ' ' VAL 0.272 8.4 p80 -51.1 -45.4 61.49 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -172.197 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.58 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -64.56 -32.4 74.03 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.614 -178.651 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -67.14 -37.67 84.21 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.676 0.75 . . . . 0.0 109.718 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -63.61 -46.59 85.05 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.565 176.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.5 t -64.37 -34.44 69.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.985 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.137 -178.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.58 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 45.6 mt-10 -60.01 -47.34 86.24 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 93' ' ' THR . 14.0 m -60.7 -39.28 87.94 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.974 0.892 . . . . 0.0 109.739 178.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 25' ' ' LEU . 4.2 tp -79.27 -9.8 59.66 Favored 'General case' 0 N--CA 1.413 -2.279 0 C-N-CA 124.224 1.01 . . . . 0.0 110.431 -177.105 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -101.13 -18.11 16.35 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -92.71 -11.8 33.07 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.817 179.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 89' ' ' THR . 32.1 p -73.16 -177.82 2.65 Favored 'General case' 0 C--O 1.252 1.195 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.407 173.281 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.52 -123.25 2.63 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.166 178.736 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -98.15 -45.86 6.06 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.8 m -95.9 118.07 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.658 0 CA-C-O 121.655 0.74 . . . . 0.0 109.374 176.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.523 HG21 HD12 ' A' ' 90' ' ' LEU . 45.8 t -101.15 113.3 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.481 -178.748 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.5 ' HD2' ' HG3' ' A' ' 17' ' ' GLU . 17.3 t-80 -84.31 58.35 4.76 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.815 ' HG ' HG22 ' A' ' 73' ' ' VAL . 3.8 tt -70.58 142.55 51.72 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.703 -172.42 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.592 HD12 ' HB2' ' A' ' 71' ' ' LEU . 3.0 tm? -101.77 114.3 28.24 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.475 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.48 HD13 HG12 ' A' ' 16' ' ' VAL . 7.7 mp -111.3 166.43 11.11 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.502 0.668 . . . . 0.0 112.758 -177.199 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 69' ' ' ARG . 36.5 tt0 -132.38 151.32 51.91 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.548 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.424 ' HD3' ' C ' ' A' ' 103' ' ' LYS . 11.3 tmtt? -44.44 123.84 3.78 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 124.1 0.96 . . . . 0.0 111.811 171.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.756 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . . . . . . 0 C--N 1.295 -1.701 0 C-N-CA 119.605 -1.283 . . . . 0.0 111.312 171.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 20.9 t0 . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.3 p -91.09 144.92 25.13 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 123.899 0.749 . . . . 0.0 112.74 -174.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.553 ' HE1' ' HG2' ' A' ' 103' ' ' LYS . 17.8 p90 -168.82 134.44 1.69 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.291 175.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 46.1 mt-10 -88.11 104.01 16.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.657 0.742 . . . . 0.0 109.592 175.766 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 5.0 t -71.82 138.85 20.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.647 -178.23 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.18 95.25 5.99 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 173.303 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.711 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -102.5 125.88 49.36 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -174.333 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -97.47 143.72 27.9 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.525 0.678 . . . . 0.0 111.849 -177.372 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 1.2 mptm? -71.73 93.13 1.25 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 124.938 1.295 . . . . 0.0 112.417 176.393 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.444 HG22 ' HB2' ' A' ' 57' ' ' ALA . 13.3 t -64.88 -30.15 71.13 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-O 121.755 0.788 . . . . 0.0 109.466 169.019 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 16.4 t70 -112.13 -155.85 0.58 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -178.676 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.41 17.39 58.56 Favored Glycine 0 C--N 1.299 -1.518 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 176.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -155.65 174.75 14.83 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -177.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 18' ' ' LEU . 11.6 tp -94.14 150.31 20.44 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -178.256 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.624 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -81.26 41.52 2.65 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.173 -174.311 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.4 pt -137.39 130.93 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-O 121.625 0.726 . . . . 0.0 111.941 177.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.609 ' HB2' HD11 ' A' ' 53' ' ' ILE . 48.5 t -99.25 124.23 44.15 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 49' ' ' VAL . 29.7 m -118.62 152.4 20.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.541 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 7.6 t -131.93 171.62 13.35 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.513 HG22 ' CD1' ' A' ' 47' ' ' ILE . 2.5 t . . . . . 0 C--N 1.303 -1.426 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.426 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.602 0 CA-C-O 120.253 -0.193 . . . . 0.0 113.177 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.513 ' CD1' HG22 ' A' ' 31' ' ' VAL . 38.0 mm -101.13 126.86 54.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.097 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.732 ' CE1' ' HG2' ' A' ' 69' ' ' ARG . 61.5 m-85 -132.85 124.17 27.45 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.953 -176.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.458 HG21 ' CG2' ' A' ' 64' ' ' ILE . 41.0 t -48.32 118.97 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 CA-C-O 121.547 0.689 . . . . 0.0 110.586 172.456 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -92.51 -35.46 13.6 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.97 -176.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.33 165.75 30.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.818 -177.294 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.946 HG21 ' HB2' ' A' ' 59' ' ' GLU . 42.6 mm -110.75 116.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.624 ' HB ' ' HA2' ' A' ' 26' ' ' GLY . 47.4 mm -70.43 116.88 49.63 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.851 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 6.9 Cg_exo -75.4 77.85 3.15 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 123.721 2.947 . . . . 0.0 114.015 -175.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HD3' HG22 ' A' ' 53' ' ' ILE . 2.1 mptm? -122.53 -23.61 5.14 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.697 170.685 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.647 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 116.62 43.93 0.61 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.479 -179.207 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . . . -117.94 -87.92 0.62 Allowed 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 117.214 0.507 . . . . 0.0 110.897 -177.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.711 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -77.09 -27.85 54.34 Favored 'General case' 0 C--O 1.257 1.498 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -171.278 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.946 ' HB2' HG21 ' A' ' 52' ' ' ILE . 40.9 tt0 -83.0 -33.3 26.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.402 0.62 . . . . 0.0 109.808 -179.721 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.647 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 7.4 m -81.84 -26.89 33.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.559 0.695 . . . . 0.0 109.228 -178.373 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.1 -41.19 59.2 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.072 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.08 39.79 9.07 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.072 -1.422 . . . . 0.0 114.579 170.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -120.42 -45.53 2.42 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.067 178.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.557 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 60.5 mt -94.02 132.16 38.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.003 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.488 ' HA ' HD11 ' A' ' 52' ' ' ILE . 16.4 t-80 -135.43 -174.87 3.75 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -73.54 131.53 41.85 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.27 0.557 . . . . 0.0 110.501 -176.099 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.03 -17.39 35.12 Favored Glycine 0 N--CA 1.425 -2.085 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.756 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.488 ' HB3' HD23 ' A' ' 101' ' ' LEU . 11.3 m-20 -63.89 136.02 57.03 Favored 'General case' 0 C--O 1.261 1.666 0 CA-C-O 122.031 0.92 . . . . 0.0 112.783 -177.512 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.732 ' HG2' ' CE1' ' A' ' 48' ' ' TYR . 41.8 mtp180 -86.17 118.79 25.85 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.373 -173.026 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.55 108.81 20.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.465 178.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 102' ' ' GLU . 66.8 mt -86.79 -41.79 13.81 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -160.4 177.19 10.83 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.607 -175.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 1.147 HG11 HG21 ' A' ' 89' ' ' THR . 2.9 p -128.95 102.17 7.55 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 C-N-CA 124.106 0.962 . . . . 0.0 109.51 177.426 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.7 t30 51.78 57.21 6.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.186 0.993 . . . . 0.0 109.897 179.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.47 -38.31 3.02 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 114.484 -1.235 . . . . 0.0 114.146 -178.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.473 ' HB ' HG13 ' A' ' 73' ' ' VAL . 43.2 t -72.84 111.57 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.066 0.933 . . . . 0.0 109.773 -175.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.3 p -81.59 113.45 19.62 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.298 0.571 . . . . 0.0 111.265 -178.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.869 HD23 ' H ' ' A' ' 78' ' ' LEU 0.269 0.7 OUTLIER -88.28 92.63 9.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 122.29 1.043 . . . . 0.0 108.957 176.865 . . . . . . . . 4 4 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -101.1 111.08 23.2 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.79 -169.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.8 46.31 94.29 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -177.11 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.605 ' HB1' ' HG3' ' A' ' 85' ' ' GLN . . . -89.73 167.16 13.1 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 -177.357 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 85' ' ' GLN . 70.8 p -79.7 144.99 33.19 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.725 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 11.1 p-80 -53.08 -37.45 61.68 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.388 0.613 . . . . 0.0 110.021 173.195 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 58.3 tttm -54.41 -54.54 39.32 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.297 -1.32 . . . . 0.0 110.633 173.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.605 ' HG3' ' HB1' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -72.51 -28.71 63.04 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.227 -175.624 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.67 -52.12 64.92 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.779 0.8 . . . . 0.0 109.388 174.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.65 -28.43 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.933 177.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 63.2 mm-40 -64.54 -35.8 82.14 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 176.079 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 1.147 HG21 HG11 ' A' ' 73' ' ' VAL . 23.1 m -69.03 -32.72 72.42 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.4 mt -72.12 -19.75 61.74 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.849 177.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -102.76 -6.12 22.96 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.167 175.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -90.33 -20.92 22.34 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 122.481 1.134 . . . . 0.0 108.435 178.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.574 HG21 HG13 ' A' ' 97' ' ' VAL . 2.2 p -83.07 171.12 14.09 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.486 -1.233 . . . . 0.0 109.923 176.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.22 -149.18 11.07 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.222 -176.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.624 ' HG3' HG23 ' A' ' 96' ' ' VAL . 3.7 pt20 -69.03 -36.64 77.96 Favored 'General case' 0 C--O 1.207 -1.176 0 CA-C-O 120.823 0.344 . . . . 0.0 110.787 -178.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.624 HG23 ' HG3' ' A' ' 95' ' ' GLN . 59.0 t -116.44 118.83 60.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.342 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.574 HG13 HG21 ' A' ' 93' ' ' THR . 40.1 t -100.53 130.1 50.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.082 -177.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 47.6 m80 -93.99 117.17 29.74 Favored 'General case' 0 C--N 1.272 -2.802 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 172.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.795 HD23 HD11 ' A' ' 101' ' ' LEU . 5.2 tp -120.76 133.07 55.35 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -176.676 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 45.9 tp -89.84 112.52 23.89 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -176.4 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.795 HD11 HD23 ' A' ' 99' ' ' LEU . 7.1 mp -124.06 165.56 17.28 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.329 0.585 . . . . 0.0 110.569 -179.577 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.776 ' HB2' HD11 ' A' ' 71' ' ' LEU . 28.3 tt0 -131.63 127.99 38.16 Favored 'General case' 0 N--CA 1.397 -3.079 0 N-CA-C 102.646 -3.094 . . . . 0.0 102.646 174.525 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.922 ' HE2' ' HA ' ' A' ' 103' ' ' LYS . 4.4 mmpt? -46.43 110.01 0.24 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -177.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.417 -2.631 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.217 -175.418 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 18.2 t70 . . . . . 0 N--CA 1.439 -0.991 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 5.6 p -100.81 119.27 38.4 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 123.945 0.778 . . . . 0.0 110.346 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -150.72 145.84 26.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.555 -178.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.489 ' HG3' HD23 ' A' ' 100' ' ' LEU . 50.0 mt-10 -77.61 97.04 4.95 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.394 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 12.6 p -75.08 138.92 19.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.289 -178.684 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -107.0 114.56 28.71 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.939 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -115.34 124.03 50.24 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.659 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.67 111.59 23.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 99.1 mttt -58.65 153.12 17.12 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.818 HG23 ' H ' ' A' ' 23' ' ' GLY . 9.0 t -93.93 -164.86 1.23 Allowed 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 171.845 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.47 4.66 17.51 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 118.816 0.735 . . . . 0.0 110.718 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.818 ' H ' HG23 ' A' ' 21' ' ' THR . . . -140.03 56.37 0.62 Allowed Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.007 179.363 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.316 80.3 p 74.9 -176.63 0.15 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 126.404 1.882 . . . . 0.0 115.715 172.47 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.743 HD22 ' HB3' ' A' ' 18' ' ' LEU . 69.6 mt -65.78 -16.98 64.3 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -177.095 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.535 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . 78.52 24.84 62.08 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 178.372 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.529 HG21 HG21 ' A' ' 64' ' ' ILE . 19.3 pt -136.64 123.23 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 CA-C-O 121.992 0.901 . . . . 0.0 112.395 177.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 69.8 m -100.34 121.18 41.08 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 113.347 -1.752 . . . . 0.0 108.247 177.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 49' ' ' VAL . 32.0 m -114.73 152.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.269 -173.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 t -129.35 155.66 45.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 82' ' ' THR . 8.5 t . . . . . 0 C--N 1.297 -1.68 0 CA-C-N 119.242 0.928 . . . . 0.0 109.219 179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.12 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.932 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 43.0 mm -101.27 146.38 9.77 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.356 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.518 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 53.6 t80 -131.77 110.23 10.71 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -174.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.505 ' HA ' HG12 ' A' ' 29' ' ' VAL . 42.1 t -52.3 114.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 171.683 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -94.64 -32.8 13.23 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.805 -173.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 28' ' ' SER . . . -149.17 143.07 25.71 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -176.466 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.653 HG22 ' HB2' ' A' ' 59' ' ' GLU . 45.8 mm -104.83 125.21 59.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.261 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.535 ' HB ' ' HA2' ' A' ' 26' ' ' GLY . 30.0 mm -99.49 135.24 20.7 Favored Pre-proline 0 C--N 1.289 -2.029 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.033 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.12 -155.75 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.32 2.68 . . . . 0.0 112.448 174.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? 97.36 -44.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.629 1.572 . . . . 0.0 111.232 171.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . 156.2 35.52 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 118.12 -1.99 . . . . 0.0 115.452 176.337 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -129.51 -105.8 0.29 Allowed 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.348 177.595 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.939 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -62.87 -35.55 80.38 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -173.437 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.653 ' HB2' HG22 ' A' ' 52' ' ' ILE . 39.4 tt0 -86.43 -26.31 24.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.232 0.539 . . . . 0.0 109.789 -178.156 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.7 t -79.27 -46.17 18.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.812 -178.457 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.57 -31.0 66.5 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.51 44.41 8.62 Favored Glycine 0 CA--C 1.499 -0.954 0 CA-C-N 114.18 -1.373 . . . . 0.0 114.267 170.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -108.99 -62.34 1.49 Allowed 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.406 178.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.576 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 25.8 mm -72.11 137.37 23.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.648 -173.227 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -122.32 151.08 41.5 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 173.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 133.91 46.11 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.782 178.518 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.518 ' HA2' ' CZ ' ' A' ' 48' ' ' TYR . . . 111.64 -18.58 24.66 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -172.637 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.502 ' HB3' HD23 ' A' ' 101' ' ' LEU . 89.4 m-20 -66.41 131.23 45.62 Favored 'General case' 0 C--O 1.252 1.206 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 73.0 mtm-85 -93.12 138.07 31.89 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.86 0.838 . . . . 0.0 111.21 -177.439 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.932 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 49.2 t -99.75 111.84 30.49 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 102' ' ' GLU . 48.2 mt -95.06 -33.68 12.6 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.633 -175.404 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -162.56 176.36 10.48 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.927 -177.635 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 1.07 HG11 HG21 ' A' ' 89' ' ' THR . 3.1 p -123.97 112.37 32.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 125.172 1.389 . . . . 0.0 107.793 175.187 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.9 p30 50.51 29.33 3.92 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 125.008 1.323 . . . . 0.0 113.582 177.141 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.05 -19.13 41.42 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.1 -177.219 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.521 ' HB ' HG13 ' A' ' 73' ' ' VAL . 52.5 t -86.19 113.86 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.0 m -61.97 136.69 58.07 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.317 0.579 . . . . 0.0 112.517 -175.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.493 HD11 ' HB ' ' A' ' 73' ' ' VAL . 76.2 mt -114.21 32.21 6.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.204 -178.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.51 113.28 22.3 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.108 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.97 16.43 35.76 Favored Glycine 0 C--N 1.303 -1.255 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.24 146.35 26.99 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -179.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.558 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 23.0 p -82.76 162.63 21.67 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 173.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -52.27 -42.95 64.14 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -61.09 -39.96 91.91 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.332 178.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.558 ' HG2' ' OG1' ' A' ' 82' ' ' THR . 14.7 mm100 -67.07 -47.14 72.2 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.206 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.3 -48.95 77.6 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.379 178.221 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.82 -28.66 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.122 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.48 -43.01 86.58 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 1.07 HG21 HG11 ' A' ' 73' ' ' VAL . 28.5 m -64.87 -34.34 78.14 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.589 176.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 68.7 mt -74.52 -17.95 60.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.23 0.538 . . . . 0.0 110.972 -178.645 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -94.02 -33.16 13.53 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.363 0.602 . . . . 0.0 110.296 174.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -75.85 -19.8 58.61 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.955 -178.106 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -75.94 -77.59 0.13 Allowed 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 171.84 -149.74 12.33 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.527 -179.301 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.481 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 46.1 tt0 -88.75 -39.94 13.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.58 104.76 16.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.042 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.492 HG23 HD21 ' A' ' 25' ' ' LEU . 3.5 t -106.2 142.38 19.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.429 -174.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 78.4 m80 -110.27 127.95 55.27 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.481 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.663 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 5.8 mp -129.03 150.22 50.52 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.156 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.4 tm? -98.82 111.04 23.55 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 68' ' ' ASP . 10.5 mp -119.48 169.74 9.77 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.136 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.557 ' HB2' HD11 ' A' ' 71' ' ' LEU . 34.0 tt0 -130.45 128.23 40.86 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 172.626 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.512 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 26.5 tptt -59.03 123.79 17.76 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 123.991 0.807 . . . . 0.0 109.748 -177.369 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.043 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.575 -173.657 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 32.4 t70 . . . . . 0 CA--C 1.492 -1.266 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.2 p -103.42 126.15 50.42 Favored 'General case' 0 N--CA 1.413 -2.311 0 O-C-N 124.531 1.144 . . . . 0.0 110.35 178.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -137.02 160.61 38.43 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.836 -177.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -107.71 97.54 7.26 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 176.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.407 HG12 HD13 ' A' ' 101' ' ' LEU . 13.3 p -76.03 134.39 29.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.119 -176.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -91.71 97.69 11.17 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.624 HD11 ' HB1' ' A' ' 57' ' ' ALA . 2.4 tm? -101.76 111.35 23.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.02 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.67 118.9 31.99 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.285 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HE2' ' CD2' ' A' ' 25' ' ' LEU . 94.1 mttt -52.67 119.34 4.44 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 122.032 0.92 . . . . 0.0 112.811 -177.711 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.828 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 93.1 m -120.57 103.71 9.37 Favored 'General case' 0 N--CA 1.403 -2.824 0 CA-C-N 113.687 -1.597 . . . . 0.0 108.184 -175.61 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 t70 62.05 -73.51 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 177.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.97 26.47 12.83 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 20' ' ' LYS 0.27 87.5 p 62.68 -98.45 0.07 Allowed 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.974 1.31 . . . . 0.0 112.881 178.922 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.638 ' HG ' HD13 ' A' ' 90' ' ' LEU . 2.7 mm? -100.92 110.38 22.43 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 118.63 0.65 . . . . 0.0 109.368 175.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.512 ' H ' ' HB3' ' A' ' 57' ' ' ALA . . . -84.25 36.07 2.94 Favored Glycine 0 C--N 1.295 -1.713 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.274 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.456 HD13 HG21 ' A' ' 27' ' ' ILE . 14.6 pt -125.4 121.13 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.903 0 CA-C-O 121.886 0.85 . . . . 0.0 112.085 -176.428 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.9 t -86.94 119.94 27.68 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 177.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.54 149.78 31.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.54 -173.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 t -128.63 179.6 5.59 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 172.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.467 HG12 HD13 ' A' ' 47' ' ' ILE . 8.9 m . . . . . 0 C--N 1.3 -1.556 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 174.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.321 0 CA-C-O 120.983 0.213 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.009 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 47.1 mm -116.85 156.16 18.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 C-N-CA 123.307 0.643 . . . . 0.0 109.807 -172.776 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -135.62 109.56 8.18 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 123.736 0.814 . . . . 0.0 109.562 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -51.25 109.46 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.861 0 CA-C-O 122.247 1.022 . . . . 0.0 110.623 171.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -80.65 -40.83 24.87 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 113.699 -1.591 . . . . 0.0 109.255 -176.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -160.23 161.58 33.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.246 -176.757 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.593 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 38.7 mm -115.75 139.8 40.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.503 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.6 mm -95.6 141.73 23.6 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -177.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.81 137.97 71.33 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.4 2.067 . . . . 0.0 109.483 171.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 5.2 tppp? 59.44 21.26 9.66 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 123.472 1.606 . . . . 0.0 108.393 -172.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.501 ' C ' ' HA3' ' A' ' 26' ' ' GLY . . . -109.18 81.84 0.29 Allowed Glycine 0 N--CA 1.396 -3.999 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.528 -175.178 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.828 ' HA ' ' HB ' ' A' ' 21' ' ' THR . . . 32.56 -72.45 0.0 OUTLIER 'General case' 0 C--O 1.186 -2.265 0 C-N-CA 127.817 2.447 . . . . 0.0 116.264 171.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -55.56 -32.11 62.73 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.734 0.814 . . . . 0.0 111.753 -177.647 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.593 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 6.5 tp10 -89.44 -37.87 14.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.172 0.511 . . . . 0.0 109.662 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 m -74.04 -44.73 53.3 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.49 -175.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -76.44 -36.77 57.78 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.76 59.56 1.5 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.833 176.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.419 ' HB2' ' H ' ' A' ' 64' ' ' ILE . 14.4 mmt180 -121.53 -87.02 0.65 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.619 0.723 . . . . 0.0 110.409 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.455 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 53.1 mt -74.94 146.52 9.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.961 -176.351 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -129.95 172.57 11.57 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.683 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.608 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 35.8 mtmm -71.84 126.29 29.35 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 -177.615 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 120.15 -28.13 6.45 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.046 -1.073 . . . . 0.0 113.17 177.864 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.693 ' HB3' HD23 ' A' ' 101' ' ' LEU . 28.9 m-20 -64.45 133.34 52.29 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 122.043 0.925 . . . . 0.0 112.782 -176.183 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -91.88 135.4 33.96 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.127 -175.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.009 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 60.8 t -105.66 125.14 61.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -174.068 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.819 ' HB2' HD12 ' A' ' 100' ' ' LEU . 67.9 mt -104.64 -21.6 13.38 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.971 -177.313 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.748 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -168.35 167.62 11.87 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.044 0.449 . . . . 0.0 112.086 -177.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.687 ' HA ' HD12 ' A' ' 99' ' ' LEU . 46.7 t -120.83 117.88 54.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 174.412 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.353 30.7 p-10 38.44 63.4 0.87 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.411 1.484 . . . . 0.0 114.859 -179.375 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.05 -21.4 3.38 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.004 -0.998 . . . . 0.0 114.861 178.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.31 100.08 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.714 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 20.0 m -58.1 132.27 53.02 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.261 -178.28 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.748 ' HG ' ' HA ' ' A' ' 72' ' ' ALA . 74.5 mt -93.33 80.25 4.42 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.105 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -77.42 -30.16 53.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.49 -171.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.26 58.68 0.31 Allowed Glycine 0 CA--C 1.474 -2.53 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.67 138.07 40.06 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.178 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.749 HG22 ' HG2' ' A' ' 85' ' ' GLN . 14.6 t -85.05 161.35 19.75 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 171.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.429 ' HA ' HD12 ' A' ' 47' ' ' ILE 0.287 10.6 p80 -50.89 -41.67 58.51 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.431 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -67.85 -24.02 65.21 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 177.466 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.749 ' HG2' HG22 ' A' ' 82' ' ' THR . 30.1 mm-40 -70.8 -40.75 72.34 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.554 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -62.61 -45.06 94.59 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.463 176.498 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.426 ' HA ' HD12 ' A' ' 90' ' ' LEU . 91.6 t -69.03 -34.37 63.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.351 -177.645 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 85' ' ' GLN . 7.9 pt-20 -71.59 -27.89 63.44 Favored 'General case' 0 C--O 1.217 -0.623 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.193 178.404 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.8 m -72.74 -25.72 61.31 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.638 HD13 ' HG ' ' A' ' 25' ' ' LEU . 96.0 mt -79.41 -23.33 43.29 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.659 0.742 . . . . 0.0 109.727 174.592 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -79.12 -38.29 36.51 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.756 175.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -66.92 -36.52 82.43 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.317 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 p -69.56 159.23 33.75 Favored 'General case' 0 C--O 1.252 1.225 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.93 -129.32 0.29 Allowed Glycine 0 C--N 1.33 0.222 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.816 -175.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -87.78 -44.91 10.78 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.344 0.592 . . . . 0.0 110.436 -178.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.38 119.43 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 C-N-CA 118.824 -1.15 . . . . 0.0 110.053 -178.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.411 HG11 ' CD2' ' A' ' 90' ' ' LEU . 22.8 t -103.19 126.27 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.372 -176.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -94.43 115.71 27.94 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 174.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.687 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.0 tp -113.09 136.16 53.01 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.819 HD12 ' HB2' ' A' ' 71' ' ' LEU . 2.6 tm? -89.28 109.98 20.8 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 -176.343 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.693 HD23 ' HB3' ' A' ' 68' ' ' ASP . 11.0 mp -122.79 165.2 16.99 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.836 0.827 . . . . 0.0 112.673 -175.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 41.3 tt0 -131.74 142.66 49.84 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 174.859 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -51.53 130.0 26.8 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 177.0 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . . . . . . 0 N--CA 1.422 -2.267 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.457 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.594 ' HG2' ' HB2' ' A' ' 12' ' ' ASP . 20.2 ptmt . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.83 55.9 2.3 Favored 'Trans proline' 0 CA--C 1.554 1.516 0 C-N-CA 122.634 2.222 . . . . 0.0 113.145 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.94 35.85 0.02 OUTLIER Glycine 0 N--CA 1.429 -1.797 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 175.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 22.7 t0 -101.82 148.57 25.14 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.461 -0.369 . . . . 0.0 110.462 -177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 37.5 p -91.04 115.45 28.03 Favored 'General case' 0 N--CA 1.413 -2.295 0 O-C-N 123.858 0.724 . . . . 0.0 110.458 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.479 ' CE1' ' HD2' ' A' ' 103' ' ' LYS . 16.4 p90 -125.67 116.8 22.24 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.061 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 45.3 mt-10 -77.96 92.54 4.32 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.709 0.766 . . . . 0.0 109.397 173.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.486 HG11 HD11 ' A' ' 64' ' ' ILE . 9.6 p -74.81 138.13 21.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 CA-C-N 114.394 -1.275 . . . . 0.0 111.269 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.559 ' HG2' ' CD2' ' A' ' 98' ' ' HIS . 38.5 mt-10 -96.45 96.29 8.61 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 175.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.841 HD11 ' HB1' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -96.6 111.11 23.38 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -176.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.96 130.39 40.08 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.101 -176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.452 ' HE2' ' HG ' ' A' ' 25' ' ' LEU . 94.9 mttt -86.01 127.87 34.74 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.729 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 t -77.63 -42.06 36.26 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -164.84 -68.8 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.11 0.481 . . . . 0.0 110.36 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.21 60.56 4.87 Favored Glycine 0 C--O 1.246 0.882 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.971 -173.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 89.8 p 62.01 -170.34 0.17 Allowed 'General case' 0 C--O 1.246 0.919 0 C-N-CA 126.521 1.928 . . . . 0.0 113.14 175.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.654 HD22 HD12 ' A' ' 18' ' ' LEU . 92.2 mt -68.65 150.68 47.68 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.155 0.502 . . . . 0.0 109.883 177.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.15 6.47 82.57 Favored Glycine 0 C--N 1.309 -0.941 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.826 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.481 HG22 HG13 ' A' ' 52' ' ' ILE . 15.7 pt -103.52 128.98 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.754 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.255 -178.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.411 ' HB2' HD13 ' A' ' 53' ' ' ILE . 32.2 t -98.34 114.64 27.03 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.59 HG12 ' HA ' ' A' ' 49' ' ' VAL . 35.0 m -112.2 157.81 12.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.364 -175.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.64 HG21 ' HD1' ' A' ' 33' ' ' PHE . 12.9 t -127.27 161.89 27.51 Favored 'General case' 0 N--CA 1.396 -3.134 0 N-CA-C 103.637 -2.727 . . . . 0.0 103.637 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.667 HG13 ' H ' ' A' ' 32' ' ' LEU . 2.0 p -73.1 -62.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.775 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.667 ' H ' HG13 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -170.82 124.19 0.65 Allowed 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 173.07 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.64 ' HD1' HG21 ' A' ' 30' ' ' THR . 9.4 p90 -85.58 109.05 18.26 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 172.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.55 99.36 0.14 Allowed 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -135.87 25.36 3.34 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 173.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.18 -111.76 3.83 Favored Glycine 0 N--CA 1.425 -2.045 0 CA-C-N 113.35 -1.75 . . . . 0.0 109.242 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.57 131.01 1.89 Allowed Glycine 0 N--CA 1.425 -2.075 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.442 HG23 HD22 ' A' ' 39' ' ' ASN . 27.2 m -78.7 1.4 2.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.071 0.462 . . . . 0.0 111.961 -178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.442 HD22 HG23 ' A' ' 38' ' ' VAL . 8.5 p30 -166.17 -30.93 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 123.589 0.756 . . . . 0.0 110.182 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 p -130.25 101.13 5.64 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-O 121.046 0.451 . . . . 0.0 111.579 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.1 m -105.17 -46.26 4.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.371 0.605 . . . . 0.0 109.766 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.9 p -78.0 -25.01 14.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.871 0.843 . . . . 0.0 108.934 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -95.79 154.88 17.0 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -66.02 149.55 50.08 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.278 0.561 . . . . 0.0 111.319 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.649 ' HA3' HD12 ' A' ' 32' ' ' LEU . . . -86.14 163.37 36.03 Favored Glycine 0 N--CA 1.415 -2.734 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 176.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.49 -98.19 2.51 Favored Glycine 0 N--CA 1.419 -2.496 0 N-CA-C 108.508 -1.837 . . . . 0.0 108.508 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.831 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 33.8 mm -141.39 147.89 21.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 176.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.503 ' CE1' ' HG ' ' A' ' 32' ' ' LEU . 67.6 m-85 -129.66 139.42 51.4 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 118.533 0.606 . . . . 0.0 111.715 177.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.59 ' HA ' HG12 ' A' ' 29' ' ' VAL . 44.1 t -74.67 116.48 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 173.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -85.02 -37.06 20.83 Favored 'General case' 0 C--N 1.284 -2.283 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.29 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.729 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -165.38 163.97 19.77 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.538 -175.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.933 HG21 ' HB2' ' A' ' 59' ' ' GLU . 1.9 mp -116.96 124.19 72.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.43 ' O ' ' HD3' ' A' ' 55' ' ' LYS . 2.0 mp -108.05 128.57 25.5 Favored Pre-proline 0 C--N 1.293 -1.863 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -17.25 -110.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.953 1 C-N-CA 126.123 4.548 . . . . 0.0 117.16 -173.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HD3' ' O ' ' A' ' 53' ' ' ILE . 3.4 mptp? 70.69 -67.06 0.26 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.627 1.171 . . . . 0.0 110.183 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.15 -117.67 0.99 Allowed Glycine 0 N--CA 1.401 -3.682 1 N-CA-C 102.762 -4.135 . . . . 0.0 102.762 -172.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.841 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 59.04 -110.29 0.49 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 164.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.795 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -68.27 -41.46 81.0 Favored 'General case' 0 C--O 1.255 1.367 0 C-N-CA 122.674 0.39 . . . . 0.0 111.513 -173.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.933 ' HB2' HG21 ' A' ' 52' ' ' ILE . 42.1 tt0 -73.73 -37.06 65.23 Favored 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 124.437 1.086 . . . . 0.0 110.794 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.7 t -70.88 -49.51 45.16 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.122 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 63' ' ' ARG . 6.4 t70 -65.11 -31.28 72.4 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.02 35.25 54.17 Favored Glycine 0 CA--C 1.488 -1.653 0 CA-C-N 114.348 -1.296 . . . . 0.0 112.989 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.439 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 6.7 mmp_? -103.02 -49.69 3.7 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.196 -1.002 . . . . 0.0 110.023 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.64 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 65.9 mt -92.98 138.14 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 CA-C-N 114.463 -1.244 . . . . 0.0 111.173 -172.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -126.38 -173.21 2.8 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.729 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 52.6 mtpt -79.76 43.35 0.58 Allowed 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 124.422 1.089 . . . . 0.0 112.515 -172.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.581 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . -172.88 5.71 0.03 OUTLIER Glycine 0 C--N 1.301 -1.411 0 C-N-CA 118.836 -1.649 . . . . 0.0 115.066 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -74.66 144.37 43.84 Favored 'General case' 0 C--O 1.251 1.156 0 CA-C-N 117.728 0.764 . . . . 0.0 110.324 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 102' ' ' GLU . 56.4 ttt180 -89.32 135.01 33.82 Favored 'General case' 0 C--O 1.201 -1.497 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -176.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.831 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 47.9 t -105.74 122.7 59.57 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.589 HD12 HD22 ' A' ' 100' ' ' LEU . 65.6 mt -97.04 -39.05 9.52 Favored 'General case' 0 C--N 1.285 -2.204 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.233 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.613 ' HB2' ' HA ' ' A' ' 77' ' ' SER . . . -164.87 178.37 7.22 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.472 -174.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.608 HG23 HD11 ' A' ' 78' ' ' LEU . 48.0 t -121.04 112.9 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 10.4 p30 45.6 37.2 3.03 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 125.529 1.531 . . . . 0.0 113.828 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 94.84 -9.04 70.84 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 119.856 -1.164 . . . . 0.0 114.235 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.3 t -85.3 97.07 5.29 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.613 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 11.9 m -59.92 125.68 24.61 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 124.09 0.869 . . . . 0.0 112.436 -173.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.608 HD11 HG23 ' A' ' 73' ' ' VAL . 59.1 mt -94.89 69.68 3.34 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -111.0 104.68 13.27 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.695 -177.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.34 26.71 11.71 Favored Glycine 0 C--N 1.299 -1.492 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.74 146.05 30.31 Favored 'General case' 0 CA--C 1.484 -1.568 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.507 HG22 ' HG2' ' A' ' 85' ' ' GLN . 11.8 t -88.2 164.11 15.81 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 170.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.53 ' HB3' ' N ' ' A' ' 31' ' ' VAL . 16.4 p-80 -51.15 -40.01 57.6 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 17.2 tppt? -60.54 -39.89 89.54 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.615 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.507 ' HG2' HG22 ' A' ' 82' ' ' THR . 82.1 mm-40 -70.66 -36.48 73.38 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.261 0.553 . . . . 0.0 110.397 -175.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.403 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -59.44 -52.37 65.88 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.75 174.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 90' ' ' LEU . 60.2 t -66.57 -28.18 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.509 -0.768 . . . . 0.0 111.027 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 46.9 mm-40 -65.32 -39.2 92.14 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.0 m -70.96 -31.85 68.53 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.763 0.792 . . . . 0.0 109.079 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 96.0 mt -76.18 -11.68 59.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.126 177.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -99.09 -28.95 13.15 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -66.52 -30.1 70.35 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.026 175.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 p -76.78 144.84 38.91 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.719 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.66 -120.72 0.13 Allowed Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 116.139 1.216 . . . . 0.0 116.139 -171.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -81.21 -45.08 16.86 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 123.452 0.701 . . . . 0.0 111.459 -172.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.6 p -118.73 124.23 72.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.066 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.416 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 7.4 t -108.42 139.22 31.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.782 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.559 ' CD2' ' HG2' ' A' ' 17' ' ' GLU . 66.6 m80 -101.49 125.46 48.14 Favored 'General case' 0 C--N 1.269 -2.917 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 176.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 15' ' ' GLU . 6.5 mp -123.02 143.64 49.8 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.589 HD22 HD12 ' A' ' 71' ' ' LEU . 1.3 tt -96.46 109.5 22.04 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 105.107 -2.183 . . . . 0.0 105.107 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 13' ' ' THR . 10.8 mp -117.4 171.33 8.06 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.061 0.458 . . . . 0.0 112.134 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 48.1 mt-10 -130.52 143.37 50.72 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 171.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HD2' ' CE1' ' A' ' 14' ' ' PHE . 28.1 mmmt -60.42 125.19 22.75 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.109 177.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.581 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . -103.06 -160.49 25.45 Favored Glycine 0 N--CA 1.425 -2.099 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.299 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.502 ' O ' ' HA3' ' A' ' 67' ' ' GLY . 78.0 mm-40 -115.06 147.9 39.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -177.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 29.8 m -97.0 154.97 38.02 Favored Pre-proline 0 C--N 1.295 -1.796 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 -176.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 5.6 Cg_exo . . . . . 0 C--O 1.251 1.166 0 C-N-CA 123.167 2.578 . . . . 0.0 111.481 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.73 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 95.5 mttt . . . . . 0 CA--C 1.495 -1.154 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.596 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 17.2 Cg_exo -67.38 125.6 13.67 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 N-CA-C 108.003 -1.576 . . . . 0.0 108.003 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.38 12.04 61.85 Favored Glycine 0 C--N 1.308 -1.021 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.108 -173.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.73 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 36.3 t70 -102.27 143.26 32.27 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.0 p -89.41 141.77 28.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.213 0.53 . . . . 0.0 111.552 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -149.28 146.56 27.62 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.753 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.422 ' HB3' ' HE2' ' A' ' 98' ' ' HIS . 38.0 mt-10 -100.13 125.4 46.23 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.1 t -113.3 129.08 69.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -98.36 81.99 2.83 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.957 HD11 ' HB1' ' A' ' 57' ' ' ALA . 1.6 tm? -85.14 126.7 33.84 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 -171.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.09 110.1 21.47 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.844 ' HE3' HD12 ' A' ' 25' ' ' LEU . 15.0 ptmt -79.14 153.94 29.7 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.767 HG23 ' HB3' ' A' ' 55' ' ' LYS . 7.2 t -140.23 139.84 35.68 Favored 'General case' 0 C--N 1.286 -2.16 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.209 -176.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 3.7 m-20 71.63 9.33 6.32 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.948 0.899 . . . . 0.0 112.712 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.24 1.34 23.58 Favored Glycine 0 C--N 1.311 -0.829 0 C-N-CA 120.66 -0.781 . . . . 0.0 114.55 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.2 t -160.49 175.01 13.23 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.844 HD12 ' HE3' ' A' ' 20' ' ' LYS . 7.6 mp -89.49 177.48 6.55 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 176.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -93.12 33.43 5.09 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.456 ' HB ' HG13 ' A' ' 49' ' ' VAL . 19.5 pt -138.14 139.95 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.639 0 CA-C-O 121.949 0.88 . . . . 0.0 112.012 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.1 m -104.25 118.22 36.1 Favored 'General case' 0 C--N 1.269 -2.91 0 CA-C-N 113.68 -1.6 . . . . 0.0 107.274 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.0 m -108.01 145.96 14.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.393 0.616 . . . . 0.0 111.731 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -122.9 172.23 8.63 Favored 'General case' 0 N--CA 1.403 -2.822 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG13 ' H ' ' A' ' 32' ' ' LEU . 2.0 p -94.04 -63.64 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.258 -3.389 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.626 HD11 ' HA3' ' A' ' 45' ' ' GLY . 13.6 mt -172.04 151.4 2.69 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 128.139 2.576 . . . . 0.0 107.21 175.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -105.46 93.49 4.7 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 172.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -70.78 -41.87 71.11 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.607 0.718 . . . . 0.0 109.278 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -131.17 76.98 1.75 Allowed 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 171.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.65 -53.45 1.67 Allowed Glycine 0 N--CA 1.426 -2.02 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.08 -80.45 0.05 OUTLIER Glycine 0 N--CA 1.426 -1.971 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.6 t -80.84 124.94 39.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -69.03 137.61 53.77 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.188 0.518 . . . . 0.0 109.985 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.5 m -155.06 141.97 19.13 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.2 m -115.44 98.32 6.67 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.138 0.494 . . . . 0.0 110.635 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.4 t -95.07 132.45 39.02 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -80.66 121.82 26.33 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 77.3 132.38 0.05 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.039 1.736 . . . . 0.0 110.222 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.626 ' HA3' HD11 ' A' ' 32' ' ' LEU . . . -141.97 134.77 6.34 Favored Glycine 0 N--CA 1.414 -2.769 0 C-N-CA 120.054 -1.07 . . . . 0.0 112.585 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -137.09 -91.28 0.28 Allowed Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 176.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.611 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 33.6 mm -131.12 142.48 43.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 174.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.443 ' OH ' ' HD3' ' A' ' 69' ' ' ARG . 45.8 m-85 -126.23 143.77 51.02 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.456 HG13 ' HB ' ' A' ' 27' ' ' ILE . 61.7 t -78.93 108.48 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -80.7 -37.28 30.97 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.783 -176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.19 153.0 31.87 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 120.161 -0.616 . . . . 0.0 112.122 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.18 113.63 40.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.2 mm -92.27 154.48 43.0 Favored Pre-proline 0 C--N 1.28 -2.456 0 C-N-CA 125.261 1.424 . . . . 0.0 109.726 -175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -56.4 -152.97 0.0 OUTLIER 'Trans proline' 0 CA--C 1.567 2.161 0 C-N-CA 123.446 2.764 . . . . 0.0 113.801 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.767 ' HB3' HG23 ' A' ' 21' ' ' THR . 3.7 mppt? 72.8 -44.97 0.61 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.614 1.166 . . . . 0.0 112.1 -169.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.02 -126.88 4.2 Favored Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 108.176 -1.969 . . . . 0.0 108.176 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.957 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 71.27 -99.48 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 171.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.856 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -73.12 -35.26 66.52 Favored 'General case' 0 C--O 1.265 1.906 0 O-C-N 121.86 -0.525 . . . . 0.0 111.576 -172.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -74.95 -40.03 61.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 125.07 1.481 . . . . 0.0 107.448 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.8 t -67.97 -44.03 77.65 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.056 -175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.63 -39.69 80.67 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.44 27.0 49.68 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 114.735 -1.121 . . . . 0.0 112.725 176.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -108.91 -39.65 5.26 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.115 -1.034 . . . . 0.0 113.156 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.856 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.4 mt -94.97 127.25 47.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 31.1 m170 -132.3 178.41 6.84 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 123.5 0.5 . . . . 0.0 110.115 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -67.52 128.21 35.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.314 0.578 . . . . 0.0 111.94 -174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.617 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 101.05 -4.24 55.75 Favored Glycine 0 N--CA 1.422 -2.267 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.006 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.589 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 31.8 m-20 -68.93 146.07 53.1 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.472 HH21 ' CD ' ' A' ' 102' ' ' GLU . 34.7 ttp180 -96.65 129.21 44.09 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.795 -178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.611 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 59.0 t -101.77 118.3 48.37 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.9 mt -93.76 -31.87 14.23 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.265 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -164.49 167.78 19.08 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -174.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.7 ' HA ' HD12 ' A' ' 99' ' ' LEU . 31.7 t -118.04 110.44 30.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 173.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 59.39 37.49 23.23 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.393 1.077 . . . . 0.0 109.966 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.46 -6.19 80.88 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.163 -0.926 . . . . 0.0 114.162 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.5 t -91.07 108.66 20.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.514 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 35.4 p -64.95 135.68 55.94 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.699 HD11 HG23 ' A' ' 73' ' ' VAL . 67.5 mt -106.75 25.71 10.92 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.618 -1.174 . . . . 0.0 108.469 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -53.88 -32.03 51.83 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 113.96 -1.473 . . . . 0.0 113.452 -177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.63 40.71 1.56 Allowed Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.108 -1.197 . . . . 0.0 110.108 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -98.15 155.63 17.06 Favored 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.554 -0.323 . . . . 0.0 110.325 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.581 HG22 ' HG2' ' A' ' 85' ' ' GLN . 9.0 t -92.72 160.75 14.83 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 167.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.424 ' O ' HG23 ' A' ' 87' ' ' VAL . 52.1 p-80 -51.28 -43.43 61.61 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.141 0.496 . . . . 0.0 111.917 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -59.72 -37.8 79.92 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.581 ' HG2' HG22 ' A' ' 82' ' ' THR . 14.9 mm100 -71.63 -36.05 70.62 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.52 -45.71 90.97 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.348 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 83' ' ' HIS . 64.1 t -66.24 -39.53 84.53 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.035 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.776 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -62.51 -39.09 92.41 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.847 0.355 . . . . 0.0 111.038 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.443 ' HB ' HG21 ' A' ' 73' ' ' VAL . 12.1 m -69.91 -38.13 76.16 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.884 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.866 HD13 HD13 ' A' ' 99' ' ' LEU . 19.2 tp -82.95 -3.08 56.67 Favored 'General case' 0 N--CA 1.415 -2.175 0 C-N-CA 125.154 1.382 . . . . 0.0 109.878 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.36 -21.05 13.31 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.487 172.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -82.84 -25.21 32.84 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.458 ' OG1' HG12 ' A' ' 97' ' ' VAL . 3.2 p -67.18 -177.81 0.72 Allowed 'General case' 0 C--O 1.255 1.359 0 C-N-CA 123.705 0.802 . . . . 0.0 110.517 174.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -78.56 -162.63 21.8 Favored Glycine 0 C--O 1.244 0.764 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.582 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 29.6 tt0 -73.41 -34.53 65.53 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.717 0.77 . . . . 0.0 108.969 177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.8 t -90.19 110.83 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.186 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 172.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.642 HG21 HD11 ' A' ' 25' ' ' LEU . 8.8 m -99.05 117.54 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.427 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.071 -174.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 41.1 t-80 -84.57 122.0 28.41 Favored 'General case' 0 N--CA 1.406 -2.67 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.866 HD13 HD13 ' A' ' 90' ' ' LEU . 7.2 tp -127.35 146.14 50.56 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 53.1 tp -102.13 117.1 34.06 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.751 HD11 HD23 ' A' ' 99' ' ' LEU . 6.6 mp -123.47 165.63 16.76 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.667 0.746 . . . . 0.0 111.761 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.472 ' CD ' HH21 ' A' ' 69' ' ' ARG . 88.1 tt0 -132.95 143.93 49.79 Favored 'General case' 0 N--CA 1.391 -3.42 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 175.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.596 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 40.3 mmtt -64.3 125.6 25.11 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.593 -0.843 . . . . 0.0 112.09 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.617 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . -91.22 -123.51 2.89 Favored Glycine 0 N--CA 1.42 -2.376 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.377 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -87.52 -45.91 10.05 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . 0.323 20.8 m 44.06 87.86 0.11 Allowed Pre-proline 0 N--CA 1.481 1.08 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 C--O 1.247 0.963 0 C-N-CA 123.53 2.82 . . . . 0.0 110.522 178.653 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.495 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 28.2 mtpp . . . . . 0 N--CA 1.432 -1.329 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 58.0 Cg_endo -76.44 125.45 8.37 Favored 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 121.346 1.364 . . . . 0.0 109.389 169.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.754 ' H ' ' HB3' ' A' ' 103' ' ' LYS . . . 73.25 18.79 79.43 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.186 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 28.7 t70 -88.97 143.49 26.82 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 3.1 p -99.21 108.26 20.8 Favored 'General case' 0 N--CA 1.416 -2.164 0 O-C-N 123.895 0.747 . . . . 0.0 110.154 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -138.49 140.34 39.14 Favored 'General case' 0 C--N 1.279 -2.495 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.123 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 4.4 mp0 -75.53 106.36 7.04 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 59.5 t -69.47 122.51 21.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 CA-C-N 114.359 -1.291 . . . . 0.0 108.841 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -96.16 93.96 7.24 Favored 'General case' 0 N--CA 1.415 -2.183 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.545 HD11 ' CB ' ' A' ' 57' ' ' ALA . 2.6 tm? -100.53 115.14 29.43 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -177.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.84 117.3 33.86 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 24' ' ' SER . 99.5 mttt -54.52 121.16 7.8 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 124.185 0.928 . . . . 0.0 111.696 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.9 p -90.36 -84.0 0.24 Allowed 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.547 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.76 -54.83 2.41 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.515 ' CA ' ' HA2' ' A' ' 56' ' ' GLY . . . -87.87 25.73 8.34 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.698 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 20' ' ' LYS . 39.7 t 76.69 -109.94 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 123.992 0.917 . . . . 0.0 113.326 172.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.739 ' HG ' HD13 ' A' ' 90' ' ' LEU . 3.3 mm? -85.38 -31.69 22.8 Favored 'General case' 0 CA--C 1.485 -1.54 0 CA-C-N 120.065 1.302 . . . . 0.0 110.403 -179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.531 ' CA ' ' HA3' ' A' ' 56' ' ' GLY . . . 73.55 21.58 79.33 Favored Glycine 0 N--CA 1.411 -2.986 0 C-N-CA 119.552 -1.309 . . . . 0.0 112.105 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.537 HG22 ' CD1' ' A' ' 52' ' ' ILE . 17.1 pt -128.71 121.86 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.696 0 CA-C-O 122.079 0.942 . . . . 0.0 112.825 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.642 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 25.7 t -90.26 112.18 23.63 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 49' ' ' VAL . 33.4 m -118.82 154.53 21.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -172.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.744 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 9.4 t -143.51 174.99 10.28 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.699 HG22 ' CD1' ' A' ' 47' ' ' ILE . 4.4 t -102.24 147.0 9.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.554 ' HG ' ' HB2' ' A' ' 48' ' ' TYR . 64.9 mt -79.31 92.76 5.19 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.569 ' CD1' ' HB ' ' A' ' 31' ' ' VAL . 25.5 p90 -166.88 13.89 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -75.13 -80.58 0.08 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.496 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -169.89 115.84 0.54 Allowed 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.261 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -102.04 167.08 18.03 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -125.17 -51.93 0.18 Allowed Glycine 0 C--N 1.306 -1.116 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.574 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.8 t -104.83 36.42 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.2 t30 70.05 164.78 0.27 Allowed 'General case' 0 C--O 1.24 0.576 0 CA-C-N 114.304 -1.317 . . . . 0.0 109.864 -175.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.6 m -141.05 109.91 6.09 Favored 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.3 t -59.85 -90.22 0.0 OUTLIER 'General case' 0 C--O 1.244 0.783 0 O-C-N 124.004 0.815 . . . . 0.0 109.091 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.9 p -41.23 110.77 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 122.094 0.949 . . . . 0.0 113.559 168.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -136.47 173.14 12.03 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.896 176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 81.6 t60 53.63 -102.14 0.13 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 124.281 1.033 . . . . 0.0 111.195 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.23 -52.28 1.4 Allowed Glycine 0 C--N 1.34 0.801 0 CA-C-O 121.219 0.344 . . . . 0.0 113.02 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.476 ' O ' HG13 ' A' ' 31' ' ' VAL . . . 161.81 -70.63 0.22 Allowed Glycine 0 N--CA 1.406 -3.357 0 N-CA-C 107.764 -2.134 . . . . 0.0 107.764 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.74 HG13 ' HB2' ' A' ' 86' ' ' ALA . 21.0 mm -145.76 159.36 12.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 C-N-CA 125.273 1.429 . . . . 0.0 107.654 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.554 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . 67.4 t80 -134.45 135.25 42.38 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 123.333 0.653 . . . . 0.0 110.612 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.49 ' HA ' HG12 ' A' ' 29' ' ' VAL . 51.6 t -79.67 108.84 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.497 ' HB2' HG22 ' A' ' 30' ' ' THR . 63.1 tttp -80.8 -37.44 30.2 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.19 -177.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 28' ' ' SER . . . -148.54 148.18 29.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.47 -176.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.835 HG23 ' HB2' ' A' ' 59' ' ' GLU . 1.4 tp -110.86 131.97 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-O 121.4 0.619 . . . . 0.0 111.758 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 56' ' ' GLY . 2.1 mp -106.25 126.44 30.52 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.967 ' HA ' ' HB3' ' A' ' 59' ' ' GLU . 33.8 Cg_exo -59.47 -77.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 123.133 2.555 . . . . 0.0 113.169 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 23.8 mmtp -55.13 -10.09 0.49 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 176.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.531 ' HA3' ' CA ' ' A' ' 26' ' ' GLY . . . -63.32 -59.37 9.0 Favored Glycine 0 N--CA 1.42 -2.429 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 173.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' CB ' HD11 ' A' ' 18' ' ' LEU . . . 167.25 -71.31 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.733 0 C-N-CA 125.117 1.367 . . . . 0.0 111.78 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.775 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -48.66 -38.22 20.57 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 -167.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.967 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 8.2 tp10 -74.49 -52.4 12.06 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.91 0.484 . . . . 0.0 111.222 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.6 m -76.96 -29.77 55.71 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.097 -175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -72.6 -45.87 56.97 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.88 59.24 1.61 Allowed Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 114.301 -1.318 . . . . 0.0 114.882 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -128.7 -58.87 1.16 Allowed 'General case' 0 CA--C 1.498 -1.027 0 CA-C-O 121.598 0.714 . . . . 0.0 109.144 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.775 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 51.9 mt -94.1 141.61 14.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.89 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -137.31 168.53 19.45 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 176.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -58.26 125.29 22.6 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 120.687 0.28 . . . . 0.0 110.439 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.544 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 115.59 -21.19 12.93 Favored Glycine 0 N--CA 1.432 -1.633 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.968 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.482 ' HB3' HD23 ' A' ' 101' ' ' LEU . 54.2 m-20 -64.72 137.28 57.71 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.88 0.848 . . . . 0.0 113.228 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -96.47 132.33 42.15 Favored 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.0 -175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 39.3 t -108.72 126.06 65.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.5 -34.65 10.17 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.635 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -162.94 175.64 10.98 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.291 -177.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.974 HG23 HD11 ' A' ' 78' ' ' LEU . 95.3 t -128.48 111.47 23.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 173.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.4 t30 51.73 58.72 5.17 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 124.821 1.248 . . . . 0.0 111.684 176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.7 -10.2 13.84 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 114.798 -1.092 . . . . 0.0 115.104 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.402 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 85.4 t -95.81 108.21 20.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 118.242 1.021 . . . . 0.0 108.828 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.548 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 34.7 m -62.42 137.06 58.19 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 123.818 0.699 . . . . 0.0 112.254 -176.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.974 HD11 HG23 ' A' ' 73' ' ' VAL . 91.6 mt -104.97 16.19 26.37 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.456 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 38.8 mt-10 -72.17 94.76 1.58 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.58 14.1 13.35 Favored Glycine 0 C--N 1.304 -1.202 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.38 159.59 14.93 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 177.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.408 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 74.4 p -92.54 162.25 14.28 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.744 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 52.5 p-80 -51.47 -41.92 61.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.68 0.752 . . . . 0.0 109.807 174.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.401 ' NZ ' ' HB2' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -70.0 -37.07 75.59 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.009 -0.996 . . . . 0.0 113.149 178.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.408 ' HG2' ' OG1' ' A' ' 82' ' ' THR . 74.7 mm-40 -64.26 -40.32 95.76 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.347 174.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.74 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -55.48 -52.25 64.25 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 121.104 0.478 . . . . 0.0 110.417 176.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.0 t -64.54 -34.07 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.002 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -68.65 -30.0 68.6 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.04 0.448 . . . . 0.0 110.577 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.4 m -72.25 -37.51 69.09 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.739 HD13 ' HG ' ' A' ' 25' ' ' LEU . 97.9 mt -71.06 -25.44 62.64 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.577 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -77.76 -43.36 31.06 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.232 178.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.81 -46.97 64.53 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.983 -1.008 . . . . 0.0 112.984 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 p -48.24 -65.88 0.49 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -175.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 163.64 -154.18 24.96 Favored Glycine 0 CA--C 1.496 -1.099 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.825 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.466 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 57.9 tt0 -87.53 -43.8 11.75 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.505 0.669 . . . . 0.0 109.288 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 55.5 t -102.65 106.04 19.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -105.61 138.29 31.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.22 -173.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.553 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 56.7 m80 -100.39 130.16 46.45 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 174.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.608 HD21 HD21 ' A' ' 90' ' ' LEU . 6.5 mp -124.21 141.4 52.1 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.54 106.31 18.41 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 13' ' ' THR . 8.4 mp -115.64 165.56 12.9 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.697 0.761 . . . . 0.0 112.36 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 42.6 tt0 -131.15 114.04 14.63 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 103.675 -2.713 . . . . 0.0 103.675 172.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.754 ' HB3' ' H ' ' A' ' 11' ' ' GLY . 40.9 tptt -47.5 121.36 3.89 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 123.872 0.732 . . . . 0.0 110.643 -176.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . -93.93 32.41 5.88 Favored Glycine 0 CA--C 1.498 -0.973 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.446 -171.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -151.43 113.75 4.57 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 10' ' ' PRO . 40.6 t -120.34 90.82 45.67 Favored Pre-proline 0 C--N 1.296 -1.729 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 N--CA 1.43 -2.259 0 C-N-CA 123.105 2.537 . . . . 0.0 111.006 -178.89 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 31.8 mmtp . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 111.27 0.1 . . . . 0.0 111.27 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.61 ' HG3' ' HB3' ' A' ' 107' ' ' PRO . 16.7 Cg_exo -70.1 44.38 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 124.388 3.392 . . . . 0.0 113.14 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.36 18.52 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.45 139.07 31.8 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 122.862 0.465 . . . . 0.0 110.802 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 p -92.77 117.46 30.04 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.8 177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -133.89 154.52 51.01 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 120.815 0.34 . . . . 0.0 110.545 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -110.46 114.09 27.24 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.611 HG11 HD11 ' A' ' 64' ' ' ILE . 11.6 p -86.84 132.02 33.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.743 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -102.1 105.37 16.08 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.881 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -117.23 124.94 50.29 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -176.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -100.85 132.21 46.36 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.008 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.567 ' HE3' HG21 ' A' ' 97' ' ' VAL . 1.2 mptm? -65.73 139.46 58.36 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 123.484 0.714 . . . . 0.0 110.821 177.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.0 p -75.45 -68.94 0.51 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 170.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -105.75 -72.01 0.73 Allowed 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -145.92 19.28 1.78 Allowed Glycine 0 C--N 1.306 -1.116 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 175.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.0 m -114.57 140.33 48.87 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.783 HD11 ' HB3' ' A' ' 18' ' ' LEU . 12.3 tp -93.66 -8.64 40.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.57 -7.4 76.67 Favored Glycine 0 N--CA 1.441 -1.033 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.944 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.564 HG21 HG21 ' A' ' 64' ' ' ILE . 20.1 pt -119.68 155.76 22.32 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.995 0 CA-C-O 121.914 0.864 . . . . 0.0 112.437 -178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.4 m -132.08 128.53 38.41 Favored 'General case' 0 N--CA 1.399 -3.001 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.206 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -109.18 162.4 6.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.206 -175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.654 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 14.1 t -141.39 168.78 18.95 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 175.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.745 HG21 ' HA ' ' A' ' 82' ' ' THR . 4.5 t -103.05 119.95 52.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.1 mt -114.05 85.97 2.32 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 173.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -95.33 -58.21 2.2 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.42 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -152.88 116.72 4.79 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.169 178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -170.94 -50.41 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 177.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.07 81.98 0.05 OUTLIER Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.219 -1.152 . . . . 0.0 110.219 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -82.44 -157.79 22.34 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.658 HG23 ' H ' ' A' ' 39' ' ' ASN . 10.8 m -78.8 -84.0 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.658 ' H ' HG23 ' A' ' 38' ' ' VAL . 16.3 m120 -122.13 -69.37 0.84 Allowed 'General case' 0 CA--C 1.492 -1.258 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.8 m -105.61 86.14 2.35 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.5 m -110.25 92.74 4.17 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.89 149.56 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.451 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -92.05 81.68 5.08 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -151.25 -81.55 0.1 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.32 150.97 23.08 Favored Glycine 0 N--CA 1.432 -1.578 0 N-CA-C 106.442 -2.663 . . . . 0.0 106.442 172.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 31' ' ' VAL . . . -158.67 15.87 0.26 Allowed Glycine 0 N--CA 1.418 -2.52 0 C-N-CA 117.357 -2.354 . . . . 0.0 114.207 -170.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.594 ' CD1' HG22 ' A' ' 31' ' ' VAL . 36.6 mm -94.63 125.97 47.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -129.21 147.09 51.02 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.401 HG21 HG23 ' A' ' 64' ' ' ILE . 52.5 t -72.66 113.2 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 173.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.444 ' HB2' HG22 ' A' ' 30' ' ' THR . 55.7 tttm -86.02 -40.43 15.8 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.132 -176.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.51 156.26 37.76 Favored 'General case' 0 C--O 1.25 1.091 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.242 -173.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.1 mm -113.89 118.02 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.07 136.23 20.61 Favored Pre-proline 0 C--N 1.292 -1.932 0 C-N-CA 123.543 0.737 . . . . 0.0 109.518 -177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.475 ' O ' ' HD2' ' A' ' 55' ' ' LYS . 39.0 Cg_exo -65.25 78.55 0.23 Allowed 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.253 2.635 . . . . 0.0 112.603 177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 54' ' ' PRO . 4.3 mptp? -135.53 20.81 3.35 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.0 -151.83 44.63 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.54 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 69.79 -103.48 0.05 OUTLIER 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.558 1.143 . . . . 0.0 113.393 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.881 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -66.48 -37.04 84.22 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 117.963 0.347 . . . . 0.0 111.887 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.59 -48.31 67.22 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 124.66 1.184 . . . . 0.0 109.009 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.9 m -68.9 -46.12 69.14 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.129 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.6 -25.31 62.12 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.12 36.2 51.76 Favored Glycine 0 CA--C 1.5 -0.898 0 CA-C-N 114.449 -1.251 . . . . 0.0 113.271 174.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.491 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 1.8 mmp_? -95.7 -48.99 5.55 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.034 0.445 . . . . 0.0 111.215 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.8 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 33.1 mm -100.54 137.44 28.07 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.661 -173.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.517 ' NE2' ' HB ' ' A' ' 106' ' ' VAL . 7.7 p-80 -137.92 169.79 17.17 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 172.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -79.49 142.4 35.86 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.745 -1.182 . . . . 0.0 110.889 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.07 -17.72 12.64 Favored Glycine 0 C--N 1.306 -1.138 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.288 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.411 ' OD2' ' HA ' ' A' ' 103' ' ' LYS . 2.3 m-20 -89.48 147.04 24.22 Favored 'General case' 0 C--O 1.251 1.138 0 CA-C-N 117.118 0.459 . . . . 0.0 110.619 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.525 ' HD3' ' OE1' ' A' ' 102' ' ' GLU . 4.3 ptm180 -106.98 158.39 17.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.148 0.499 . . . . 0.0 111.485 -175.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -114.21 127.71 71.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -175.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' A' ' 102' ' ' GLU . 85.7 mt -96.27 -37.15 10.64 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.418 ' HA ' HD23 ' A' ' 78' ' ' LEU . . . -160.54 174.56 13.86 Favored 'General case' 0 N--CA 1.424 -1.748 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.713 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 1.021 HG11 HG21 ' A' ' 89' ' ' THR . 2.7 p -124.08 105.37 15.33 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 C-N-CA 124.224 1.009 . . . . 0.0 108.549 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.0 t30 57.43 32.54 21.95 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 122.587 1.184 . . . . 0.0 110.564 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.27 -11.66 67.1 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.515 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.615 ' HB ' HG13 ' A' ' 73' ' ' VAL . 59.8 t -86.34 107.28 16.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 m -72.31 119.34 16.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 120.938 0.399 . . . . 0.0 111.598 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.652 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.4 pt? -119.18 83.52 2.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.965 0.888 . . . . 0.0 111.674 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.41 -35.88 11.56 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.744 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -100.62 36.66 4.01 Favored Glycine 0 CA--C 1.495 -1.165 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.433 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . -101.28 146.3 27.73 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -178.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.818 HG22 ' HG2' ' A' ' 85' ' ' GLN . 9.0 t -94.34 166.4 12.1 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 170.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.654 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 48.2 p-80 -51.54 -41.19 60.89 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 122.798 0.439 . . . . 0.0 111.347 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -60.07 -38.34 82.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.668 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.818 ' HG2' HG22 ' A' ' 82' ' ' THR . 13.6 mm100 -71.46 -47.81 53.29 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.65 75.64 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.209 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.7 t -65.5 -29.79 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.678 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -80.87 -16.24 54.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 119.352 -0.939 . . . . 0.0 112.34 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 1.021 HG21 HG11 ' A' ' 73' ' ' VAL . 25.4 m -73.16 -32.16 64.7 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.969 HD21 HD21 ' A' ' 99' ' ' LEU . 84.3 mt -76.45 -20.45 57.02 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.221 176.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -77.16 -44.15 31.34 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.419 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -64.41 -41.6 96.54 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.379 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.452 HG21 HG13 ' A' ' 97' ' ' VAL . 6.6 p -64.7 158.62 24.15 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.578 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -79.05 -150.62 5.5 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.912 -173.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -65.07 -42.23 94.37 Favored 'General case' 0 C--O 1.209 -1.052 0 C-N-CA 122.94 0.496 . . . . 0.0 109.807 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 48.2 t -114.4 122.51 68.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.567 HG21 ' HE3' ' A' ' 20' ' ' LYS . 5.9 t -112.58 149.89 14.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 48.0 m80 -115.13 132.85 56.47 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.969 HD21 HD21 ' A' ' 90' ' ' LEU . 6.4 mp -126.83 145.45 50.64 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 174.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 1.3 tt -99.5 109.91 22.41 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 -177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.524 HD13 HG12 ' A' ' 16' ' ' VAL . 11.0 mp -112.59 170.71 7.99 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.607 0.718 . . . . 0.0 110.65 -177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.525 ' OE1' ' HD3' ' A' ' 69' ' ' ARG . 42.6 tt0 -129.87 132.18 46.34 Favored 'General case' 0 N--CA 1.404 -2.75 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.411 ' HA ' ' OD2' ' A' ' 68' ' ' ASP . 19.4 tptp -57.38 122.24 12.1 Favored 'General case' 0 N--CA 1.421 -1.89 0 O-C-N 124.285 0.99 . . . . 0.0 110.17 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.94 -122.72 4.95 Favored Glycine 0 N--CA 1.417 -2.614 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -71.4 170.37 13.35 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.517 ' HB ' ' NE2' ' A' ' 65' ' ' HIS . 35.3 t 52.02 80.0 0.32 Allowed Pre-proline 0 C--O 1.246 0.917 0 C-N-CA 124.87 1.268 . . . . 0.0 111.34 -175.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.61 ' HB3' ' HG3' ' A' ' 10' ' ' PRO . 5.2 Cg_exo . . . . . 0 N--CA 1.451 -1.026 0 C-N-CA 123.319 2.679 . . . . 0.0 110.994 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.919 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 53.2 mtpt . . . . . 0 N--CA 1.431 -1.378 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.919 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 1.2 Cg_endo -85.88 137.93 5.75 Favored 'Trans proline' 0 N--CA 1.435 -1.913 0 N-CA-C 107.827 -1.643 . . . . 0.0 107.827 171.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.58 8.27 80.66 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 120.21 -0.995 . . . . 0.0 111.083 -176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 26.1 t0 -98.05 144.45 27.55 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 177.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 4.4 p -103.86 132.59 49.96 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 123.438 0.461 . . . . 0.0 112.209 -175.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -154.99 147.64 24.3 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.266 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -77.46 98.58 5.35 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.686 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 7.2 p -71.94 130.25 35.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -95.26 95.0 8.21 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.91 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -101.72 120.44 40.35 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.82 117.82 31.28 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 5.8 ptmt -71.06 146.55 49.24 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.742 0.782 . . . . 0.0 113.032 -172.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m -87.69 -51.43 5.88 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.294 -176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -111.65 -154.84 0.55 Allowed 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -85.35 16.69 37.95 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.811 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.0 m -148.94 176.56 10.32 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.637 HD22 HD12 ' A' ' 18' ' ' LEU . 32.8 mt -93.2 152.31 19.29 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 118.19 0.45 . . . . 0.0 109.816 172.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.409 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -82.84 28.61 3.54 Favored Glycine 0 C--O 1.212 -1.259 0 CA-C-N 115.212 -0.903 . . . . 0.0 112.558 -178.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.454 ' HB ' HG13 ' A' ' 49' ' ' VAL . 22.0 pt -131.71 133.95 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 CA-C-O 121.325 0.583 . . . . 0.0 110.826 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.3 t -91.13 117.88 29.98 Favored 'General case' 0 C--N 1.268 -2.968 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.468 ' HB ' ' CG2' ' A' ' 47' ' ' ILE . 30.8 m -109.3 136.12 46.17 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.236 0 O-C-N 123.656 0.597 . . . . 0.0 110.192 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.552 HG22 ' HB2' ' A' ' 50' ' ' LYS . 10.5 t -126.57 161.34 28.23 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.499 HG22 ' CD1' ' A' ' 47' ' ' ILE . 3.1 t -103.99 114.77 44.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.837 -177.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mp -108.39 85.59 2.14 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 45' ' ' GLY . 13.5 t80 -86.38 -164.64 1.08 Allowed 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 114.331 -1.304 . . . . 0.0 108.713 -171.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 43' ' ' ARG . 2.6 m-20 -68.11 90.83 0.34 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.866 0.841 . . . . 0.0 110.404 174.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -161.88 141.89 10.21 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 113.436 -1.711 . . . . 0.0 106.529 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.66 43.77 8.22 Favored Glycine 0 N--CA 1.428 -1.876 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.732 177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.4 101.33 2.33 Favored Glycine 0 N--CA 1.427 -1.929 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.7 t -117.82 -50.64 4.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -77.14 -26.79 53.52 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.006 0.431 . . . . 0.0 110.432 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.9 p -148.88 169.2 21.06 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 37.5 m -88.47 -39.21 14.39 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 118.543 0.61 . . . . 0.0 110.282 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.7 p -87.62 147.35 5.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 34' ' ' ASP . 1.0 OUTLIER -122.23 -34.82 3.24 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 62.34 17.07 9.07 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.342 1.057 . . . . 0.0 109.948 178.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . -69.34 143.49 39.2 Favored Glycine 0 N--CA 1.426 -2.001 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.759 -175.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.25 -108.21 1.59 Allowed Glycine 0 N--CA 1.419 -2.441 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.538 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.7 mm -101.52 147.21 8.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -136.11 136.4 40.08 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 123.788 0.835 . . . . 0.0 109.45 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.454 HG13 ' HB ' ' A' ' 27' ' ' ILE . 43.7 t -75.6 109.0 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.552 ' HB2' HG22 ' A' ' 30' ' ' THR . 61.3 tttp -83.93 -38.15 21.41 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.977 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.24 165.08 36.87 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.589 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.401 HG21 ' HG2' ' A' ' 59' ' ' GLU . 40.7 mm -111.87 120.1 61.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.58 HG22 ' H ' ' A' ' 55' ' ' LYS . 1.8 mp -67.78 136.0 92.4 Favored Pre-proline 0 C--N 1.315 -0.927 0 C-N-CA 123.187 0.595 . . . . 0.0 110.522 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.54 -25.88 20.66 Favored 'Trans proline' 0 C--N 1.363 1.298 0 C-N-CA 124.511 3.474 . . . . 0.0 113.629 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.58 ' H ' HG22 ' A' ' 53' ' ' ILE . 44.1 tptt -82.51 63.8 6.84 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.704 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.66 -109.4 0.7 Allowed Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 117.926 1.931 . . . . 0.0 117.926 171.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.646 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 37.66 -86.02 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 126.847 2.059 . . . . 0.0 113.987 -169.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.91 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -80.47 -28.01 37.7 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 122.3 -0.25 . . . . 0.0 110.416 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.401 ' HG2' HG21 ' A' ' 52' ' ' ILE . 0.3 OUTLIER -78.73 -43.91 24.66 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -178.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.6 p -73.56 -38.89 65.06 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.811 -174.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -73.04 -33.28 65.61 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.78 49.95 5.16 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 114.216 -1.356 . . . . 0.0 113.667 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -118.19 -68.67 0.9 Allowed 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.548 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 63.6 mt -74.13 140.22 18.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.845 -175.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -123.33 159.15 29.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 133.87 40.26 Favored 'General case' 0 N--CA 1.419 -2.024 0 C-N-CA 118.554 -1.258 . . . . 0.0 108.854 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.81 -16.9 12.15 Favored Glycine 0 N--CA 1.425 -2.095 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -72.9 140.65 47.64 Favored 'General case' 0 C--O 1.248 1.023 0 CA-C-O 121.26 0.553 . . . . 0.0 111.361 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -92.6 133.05 36.35 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.796 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 38.3 t -107.68 118.55 55.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 -178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt -94.85 -34.85 12.3 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.422 -176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.672 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -158.71 172.43 18.29 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.547 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.824 HG23 HD11 ' A' ' 78' ' ' LEU . 88.5 t -123.17 104.29 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 123.564 0.745 . . . . 0.0 109.197 176.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.3 t30 61.36 34.19 18.5 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 109.417 171.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.2 -24.1 33.05 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.184 -1.008 . . . . 0.0 113.565 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.37 107.43 14.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.557 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 2.8 p -66.9 133.35 49.85 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.607 0.718 . . . . 0.0 112.891 -175.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.824 HD11 HG23 ' A' ' 73' ' ' VAL . 77.4 mt -100.63 30.3 4.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.927 0.87 . . . . 0.0 108.86 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.78 -27.1 49.25 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 125.675 1.59 . . . . 0.0 112.67 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -141.03 44.94 0.99 Allowed Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -107.39 156.66 18.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.239 0.542 . . . . 0.0 112.199 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.461 ' HA ' HG21 ' A' ' 31' ' ' VAL . 11.4 t -113.49 177.24 4.7 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 170.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -51.26 -54.81 22.29 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.807 1.243 . . . . 0.0 111.467 -174.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -57.41 -39.22 75.69 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.316 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 -70.56 -45.31 65.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.88 -56.42 20.78 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.13 176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.445 ' HA ' HD23 ' A' ' 90' ' ' LEU . 90.4 t -62.18 -32.85 55.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.151 -177.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -66.04 -34.69 78.65 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 107.867 -1.161 . . . . 0.0 107.867 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 25.3 m -70.6 -35.62 73.1 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.078 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.593 HD11 HD21 ' A' ' 99' ' ' LEU . 3.6 mm? -68.14 -24.21 64.97 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 121.709 -0.62 . . . . 0.0 111.171 174.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -79.44 -40.14 30.62 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.231 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -71.08 -38.19 72.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.908 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.1 p -64.84 -58.12 7.03 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 149.92 -150.47 22.54 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 118.906 -1.616 . . . . 0.0 114.989 175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.479 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 52.9 tt0 -84.38 -55.77 3.98 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.794 0.838 . . . . 0.0 110.405 -176.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.4 t -93.61 101.48 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 25' ' ' LEU . 2.1 m -100.83 134.0 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.877 0 CA-C-N 113.713 -1.585 . . . . 0.0 110.57 -173.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.686 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 12.0 m170 -101.37 139.62 36.78 Favored 'General case' 0 C--N 1.268 -2.945 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 174.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.593 HD21 HD11 ' A' ' 90' ' ' LEU . 5.9 mp -130.25 143.73 50.95 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 172.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 61.0 tp -86.65 107.2 18.09 Favored 'General case' 0 N--CA 1.411 -2.389 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.627 ' O ' ' HA ' ' A' ' 13' ' ' THR . 8.4 mp -112.05 155.41 23.86 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.063 0.459 . . . . 0.0 110.431 -178.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 31.7 tt0 -130.79 107.62 9.28 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 174.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.765 ' HB2' ' HA ' ' A' ' 10' ' ' PRO . 31.9 mmmt -47.7 138.04 8.74 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -172.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -106.67 -159.07 21.74 Favored Glycine 0 N--CA 1.413 -2.845 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.552 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 83.8 mm-40 -114.74 -172.07 2.05 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.4 m -108.91 88.94 5.93 Favored Pre-proline 0 C--N 1.297 -1.681 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 105' ' ' GLN . 13.4 Cg_endo . . . . . 0 N--CA 1.436 -1.905 0 C-N-CA 123.285 2.656 . . . . 0.0 111.214 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt . . . . . 0 N--CA 1.447 -0.605 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.545 ' HA ' ' HG3' ' A' ' 103' ' ' LYS . 20.4 Cg_endo -63.4 108.81 0.88 Allowed 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.451 2.101 . . . . 0.0 110.43 176.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 126.59 -11.18 7.12 Favored Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -79.8 129.37 34.43 Favored 'General case' 0 C--O 1.255 1.381 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 p -98.9 114.48 27.11 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 170.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -109.73 107.33 17.3 Favored 'General case' 0 C--N 1.28 -2.442 0 CA-C-O 121.656 0.741 . . . . 0.0 111.846 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -65.78 115.83 6.33 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 170.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.4 p -110.8 137.29 43.84 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.373 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.509 -171.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -107.0 117.52 34.28 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.87 HD21 ' HA ' ' A' ' 58' ' ' ALA . 1.1 tm? -117.87 123.88 46.94 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 118.679 -1.208 . . . . 0.0 108.953 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.402 ' N ' HD13 ' A' ' 18' ' ' LEU . . . -97.45 119.38 35.88 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.728 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -59.85 132.37 53.74 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.415 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 t -66.43 -58.0 6.2 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.283 -178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -170.2 -50.35 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.69 50.32 2.6 Favored Glycine 0 N--CA 1.438 -1.205 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.715 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.728 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 21.5 t 69.1 -160.15 0.18 Allowed 'General case' 0 C--O 1.254 1.322 0 C-N-CA 124.336 1.054 . . . . 0.0 110.711 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.582 ' HG ' ' HE2' ' A' ' 20' ' ' LYS . 86.5 mt -65.7 142.19 58.1 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.24 0.543 . . . . 0.0 110.946 -178.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 56' ' ' GLY . . . -92.42 33.07 5.13 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.33 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 pt -135.37 135.18 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.579 0 CA-C-O 121.303 0.573 . . . . 0.0 110.127 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.454 ' HB2' HD11 ' A' ' 53' ' ' ILE . 19.4 t -102.37 102.07 12.37 Favored 'General case' 0 C--N 1.259 -3.355 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 177.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.5 m -92.2 159.59 2.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -140.57 172.15 13.11 Favored 'General case' 0 N--CA 1.413 -2.279 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 p -113.24 136.91 48.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-O 121.065 0.46 . . . . 0.0 111.751 -175.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.516 HD23 ' CD1' ' A' ' 48' ' ' TYR . 3.9 mm? -117.03 83.08 1.91 Allowed 'General case' 0 N--CA 1.422 -1.844 0 CA-C-O 122.473 1.13 . . . . 0.0 108.767 170.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.502 ' CD1' ' HA2' ' A' ' 80' ' ' GLY . 50.1 t80 -117.71 100.98 7.96 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.213 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.554 ' HB3' HG22 ' A' ' 38' ' ' VAL . 10.1 t70 -143.2 143.9 31.96 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -174.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -134.18 16.01 3.8 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.81 -35.53 0.31 Allowed Glycine 0 C--N 1.318 -0.459 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.169 -174.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.29 -40.08 4.07 Favored Glycine 0 N--CA 1.43 -1.745 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.554 HG22 ' HB3' ' A' ' 34' ' ' ASP . 26.9 m -84.96 89.46 2.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 122.705 1.24 . . . . 0.0 110.768 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -115.32 -56.47 2.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.839 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.5 p -80.83 -35.53 32.77 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.252 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.491 ' O ' ' HB ' ' A' ' 38' ' ' VAL . 13.5 m -87.7 105.93 17.7 Favored 'General case' 0 N--CA 1.424 -1.735 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 174.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.8 m -89.79 134.42 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 C-N-CA 120.394 -0.523 . . . . 0.0 112.003 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.3 ptt85 -82.12 105.43 13.21 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.578 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 69' ' ' ARG . 65.2 m-70 -82.78 -18.19 41.49 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.364 0.602 . . . . 0.0 109.959 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.503 ' HA3' ' HG3' ' A' ' 69' ' ' ARG . . . -133.03 166.7 23.6 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.51 -40.87 1.83 Allowed Glycine 0 C--N 1.303 -1.286 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.952 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.615 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 49.1 mm -109.7 141.78 24.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -178.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.516 ' CD1' HD23 ' A' ' 32' ' ' LEU . 92.7 m-85 -136.17 148.77 48.32 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 66' ' ' LYS . 28.4 t -75.58 117.45 20.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -88.52 -34.15 17.51 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.85 -177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . . . -159.28 157.25 30.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.049 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.44 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 50.8 mm -105.94 120.59 57.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.5 HG22 ' H ' ' A' ' 55' ' ' LYS . 51.7 mm -75.4 124.3 89.01 Favored Pre-proline 0 C--N 1.295 -1.783 0 C-N-CA 122.698 0.399 . . . . 0.0 110.823 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.0 -8.66 12.37 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 C-N-CA 124.149 3.233 . . . . 0.0 114.9 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.5 ' H ' HG22 ' A' ' 53' ' ' ILE . 1.1 mptm? -65.45 -28.42 69.21 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.475 ' O ' ' HA3' ' A' ' 26' ' ' GLY . . . 133.13 -147.43 18.98 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.172 177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.764 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 75.98 -86.71 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 125.525 1.53 . . . . 0.0 110.916 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.87 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -78.67 -29.63 45.73 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.631 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 39.3 tt0 -78.85 -44.53 22.76 Favored 'General case' 0 N--CA 1.434 -1.264 0 O-C-N 124.673 1.233 . . . . 0.0 110.799 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.8 p -71.98 -40.53 68.53 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.968 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -70.63 -39.24 73.81 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.11 66.75 1.85 Allowed Glycine 0 N--CA 1.43 -1.744 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.843 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.553 ' HG3' HG13 ' A' ' 64' ' ' ILE . 18.6 ptp180 -136.43 -39.19 0.66 Allowed 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.431 176.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.656 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 61.2 mt -101.52 141.22 18.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.2 p-80 -133.55 173.42 11.51 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 173.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 51' ' ' ALA . 62.2 pttt -85.69 151.65 23.7 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.861 -0.736 . . . . 0.0 112.367 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.07 -20.2 43.94 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.477 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.936 ' HA ' ' HA3' ' A' ' 104' ' ' GLY 0.271 1.0 OUTLIER -78.7 152.93 31.31 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.7 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.503 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 41.9 ttm180 -92.5 134.21 35.19 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 113.962 -1.472 . . . . 0.0 113.921 -168.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.615 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 60.8 t -106.72 120.34 57.77 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.3 mt -96.79 -38.52 9.84 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.458 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -157.64 170.2 22.94 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.727 -175.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 99' ' ' LEU . 87.0 t -129.27 120.35 51.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 63.96 27.64 14.36 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 122.354 1.074 . . . . 0.0 109.169 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.97 -7.16 60.3 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.606 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.6 t -86.91 113.6 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.9 m -64.68 131.0 45.71 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.683 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 86' ' ' ALA 0.42 0.3 OUTLIER -128.38 67.96 1.37 Allowed 'General case' 0 N--CA 1.425 -1.675 0 CA-C-O 122.875 1.321 . . . . 0.0 113.974 174.219 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -108.97 114.89 29.04 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.502 ' HA2' ' CD1' ' A' ' 33' ' ' PHE . . . 100.4 15.24 30.49 Favored Glycine 0 C--N 1.297 -1.589 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -174.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.89 -177.21 4.89 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.9 p -113.36 168.67 9.55 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -51.76 -50.79 59.98 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.8 -44.34 94.01 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.624 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -68.28 -41.57 80.8 Favored 'General case' 0 C--O 1.246 0.887 0 CA-C-N 118.314 0.506 . . . . 0.0 110.704 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.68 -56.55 20.46 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.975 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -62.99 -33.13 58.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.11 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -68.61 -33.65 74.41 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.921 178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 59.1 m -68.67 -33.3 73.75 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.613 HD21 HD21 ' A' ' 99' ' ' LEU . 92.9 mt -72.94 -17.23 61.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.833 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -91.87 -37.42 12.92 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -68.53 -27.48 66.13 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.53 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -46.91 65.68 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 132.86 -156.03 21.92 Favored Glycine 0 C--N 1.311 -0.834 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.08 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.5 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 34.8 tt0 -75.0 -48.11 25.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.934 0.367 . . . . 0.0 110.936 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.4 t -96.83 105.82 17.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 t -100.14 136.45 31.44 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -176.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -102.64 130.66 49.61 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 175.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.613 HD21 HD21 ' A' ' 90' ' ' LEU . 5.8 mp -126.98 154.85 44.05 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 173.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.1 tt -106.21 112.08 24.96 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.63 163.22 15.26 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.065 0.46 . . . . 0.0 111.972 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.602 ' HG2' ' HD3' ' A' ' 103' ' ' LYS . 30.2 tt0 -132.55 154.01 50.41 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.602 ' HD3' ' HG2' ' A' ' 102' ' ' GLU . 0.0 OUTLIER -50.6 121.83 6.33 Favored 'General case' 0 CA--C 1.558 1.286 0 CA-C-O 121.802 0.81 . . . . 0.0 111.95 176.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.936 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -104.29 47.61 1.07 Allowed Glycine 0 C--N 1.298 -1.542 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.422 ' OE1' ' HB3' ' A' ' 10' ' ' PRO . 49.0 tt0 -66.31 -44.22 84.04 Favored 'General case' 0 N--CA 1.411 -2.396 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.8 m -124.29 91.19 49.89 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 175.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo . . . . . 0 C--O 1.263 1.735 0 C-N-CA 123.137 2.558 . . . . 0.0 112.068 -175.835 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 70.4 mmtt . . . . . 0 N--CA 1.445 -0.695 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 9' ' ' LYS . 8.2 Cg_exo -72.4 73.64 2.73 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.294 1.996 . . . . 0.0 109.18 174.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.52 33.22 0.03 OUTLIER Glycine 0 C--N 1.287 -2.153 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -95.68 153.06 17.92 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 11.4 p -87.84 133.02 33.98 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.281 0.363 . . . . 0.0 111.475 -175.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -156.62 119.4 4.08 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.325 0.583 . . . . 0.0 111.8 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -72.21 120.21 17.49 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.103 173.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.568 HG21 HD11 ' A' ' 64' ' ' ILE . 33.5 m -96.39 133.64 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.098 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.95 104.75 16.39 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 170.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.862 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -112.24 117.77 33.45 Favored 'General case' 0 N--CA 1.415 -2.219 0 C-N-CA 119.313 -0.955 . . . . 0.0 108.696 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.74 114.25 25.87 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.556 ' HB3' ' HA ' ' A' ' 24' ' ' SER . 98.6 mttt -56.57 136.31 54.48 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 124.14 0.9 . . . . 0.0 112.398 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.547 HG23 ' HB2' ' A' ' 57' ' ' ALA . 61.2 p -91.71 -163.85 1.1 Allowed 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 176.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.84 -19.11 65.02 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.627 0.727 . . . . 0.0 109.106 174.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 54' ' ' PRO . . . -104.5 19.21 42.84 Favored Glycine 0 N--CA 1.429 -1.832 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.59 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.556 ' HA ' ' HB3' ' A' ' 20' ' ' LYS . 73.8 m 72.4 -153.73 0.08 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 124.364 1.066 . . . . 0.0 111.054 177.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 18' ' ' LEU . 89.5 mt -61.54 -24.55 66.71 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.764 ' HA2' ' HD2' ' A' ' 54' ' ' PRO . . . 86.82 -6.05 83.72 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.006 -1.093 . . . . 0.0 111.82 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.491 ' HB ' HG13 ' A' ' 49' ' ' VAL . 22.6 pt -109.51 136.08 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 C-N-CA 119.228 -0.989 . . . . 0.0 112.544 -177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.1 t -109.03 128.87 55.34 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.44 149.04 18.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 O-C-N 123.15 0.281 . . . . 0.0 111.037 -175.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.7 t -130.83 161.21 32.29 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 175.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.714 HG12 HD13 ' A' ' 47' ' ' ILE . 31.2 m -106.15 127.49 61.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.685 -176.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.9 mt -103.13 164.94 11.32 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 172.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -127.96 132.19 49.23 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -79.69 158.94 26.85 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -116.25 18.87 15.14 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.972 0.891 . . . . 0.0 109.463 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.63 -61.17 4.6 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.38 160.97 19.03 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.47 ' HA ' HG11 ' A' ' 42' ' ' VAL . 5.2 p -107.36 -63.72 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 117.789 0.794 . . . . 0.0 112.373 -177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.546 ' O ' ' HB ' ' A' ' 40' ' ' THR . 26.2 t-20 63.39 -77.08 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.689 0.796 . . . . 0.0 109.458 -172.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.546 ' HB ' ' O ' ' A' ' 39' ' ' ASN . 5.8 t 165.84 -20.54 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.905 1.282 . . . . 0.0 109.581 176.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.2 m -80.46 33.25 0.3 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.177 0.591 . . . . 0.0 110.872 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.47 HG11 ' HA ' ' A' ' 38' ' ' VAL . 13.0 p -136.43 148.29 27.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.747 -0.596 . . . . 0.0 110.775 -172.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -114.09 75.08 0.9 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -84.68 169.41 14.33 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.403 -1.271 . . . . 0.0 111.821 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 138.51 -138.91 9.83 Favored Glycine 0 N--CA 1.42 -2.425 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.183 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -161.05 -98.92 0.14 Allowed Glycine 0 CA--C 1.487 -1.685 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.898 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 48.7 mm -83.83 123.02 38.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -124.43 128.09 48.5 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.271 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.491 HG13 ' HB ' ' A' ' 27' ' ' ILE . 55.4 t -74.44 110.84 9.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -82.42 -35.93 27.13 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.291 -177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.44 161.04 35.46 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.031 HG21 ' HB2' ' A' ' 59' ' ' GLU . 16.2 mm -116.32 115.68 49.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 N-CA-C 105.52 -2.029 . . . . 0.0 105.52 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.905 ' HB ' ' HD3' ' A' ' 54' ' ' PRO 0.301 2.1 mp -103.3 -89.38 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.673 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 -170.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.905 ' HD3' ' HB ' ' A' ' 53' ' ' ILE . 8.5 Cg_endo -91.88 129.79 1.12 Allowed 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.757 2.305 . . . . 0.0 115.352 -167.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt 78.09 -63.62 0.31 Allowed 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 125.726 1.61 . . . . 0.0 110.901 175.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 159.08 -83.54 0.13 Allowed Glycine 0 N--CA 1.405 -3.41 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.769 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 68.51 -83.11 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 125.652 1.581 . . . . 0.0 109.744 175.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.991 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -68.03 -38.3 82.37 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 176.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.031 ' HB2' HG21 ' A' ' 52' ' ' ILE . 39.3 tt0 -72.98 -43.94 61.65 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.986 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.6 p -76.88 -36.31 56.81 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -174.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -71.16 -34.12 70.66 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 174.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.47 43.85 11.89 Favored Glycine 0 N--CA 1.434 -1.489 0 CA-C-N 114.367 -1.288 . . . . 0.0 113.18 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -110.83 -46.66 3.32 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.991 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 44.4 mt -104.42 127.01 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.695 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.465 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -125.57 157.84 36.12 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 136.3 51.3 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.451 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 112.12 -24.56 14.16 Favored Glycine 0 C--N 1.289 -2.058 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -171.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.747 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 78.2 m-20 -67.73 145.06 55.11 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-O 121.247 0.546 . . . . 0.0 111.745 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.411 ' HD2' ' N ' ' A' ' 70' ' ' VAL . 1.9 tmm_? -109.95 149.11 30.41 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.4 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.898 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.9 t -117.46 135.45 57.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.704 HD12 HD22 ' A' ' 100' ' ' LEU . 95.5 mt -98.24 -42.56 7.35 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.678 -1.146 . . . . 0.0 108.513 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -155.58 172.2 18.68 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.816 -172.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 1.0 HG11 HG21 ' A' ' 89' ' ' THR . 3.3 p -114.41 113.63 44.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 172.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.769 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 31.3 p30 39.4 42.37 0.83 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.36 1.464 . . . . 0.0 114.432 -177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.62 -15.01 62.6 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 120.567 -0.825 . . . . 0.0 114.592 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.557 ' HB ' HG13 ' A' ' 73' ' ' VAL . 46.9 t -92.8 110.07 22.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 66.5 m -67.62 127.22 31.92 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.739 HD13 HG13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.17 21.01 5.3 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.04 175.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -57.39 -27.34 62.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.452 -0.795 . . . . 0.0 112.118 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.51 23.77 21.62 Favored Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.726 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -91.97 157.55 16.74 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.9 t -83.7 170.93 13.71 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -49.96 -53.02 29.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.77 1.628 . . . . 0.0 110.787 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -63.33 -31.76 73.0 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.854 -178.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -76.98 -39.18 51.43 Favored 'General case' 0 CA--C 1.504 -0.824 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.259 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.693 ' HA ' HD22 ' A' ' 78' ' ' LEU . . . -52.09 -60.34 3.32 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 123.85 0.719 . . . . 0.0 109.896 173.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.14 -33.23 61.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.549 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -65.28 -34.72 79.01 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.271 0.558 . . . . 0.0 111.453 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 1.0 HG21 HG11 ' A' ' 73' ' ' VAL . 29.7 m -76.28 -33.95 59.1 Favored 'General case' 0 N--CA 1.42 -1.972 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 62.5 mt -73.42 -20.07 60.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.609 0.719 . . . . 0.0 110.194 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -81.98 -40.52 22.05 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.593 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -69.78 -33.37 72.31 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.8 p -59.07 -63.07 1.44 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.24 -151.51 23.69 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.053 -1.07 . . . . 0.0 112.531 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -66.33 -45.33 80.63 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 124.071 0.512 . . . . 0.0 111.647 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.5 t -108.76 114.51 46.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.421 HG23 HD21 ' A' ' 25' ' ' LEU . 6.0 t -107.44 136.54 42.32 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.769 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 54.2 m80 -104.14 131.77 51.08 Favored 'General case' 0 N--CA 1.4 -2.934 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 174.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.475 HD11 HD22 ' A' ' 90' ' ' LEU . 6.1 mp -127.09 156.71 41.28 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 173.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.704 HD22 HD12 ' A' ' 71' ' ' LEU . 1.8 tt -108.42 114.09 27.67 Favored 'General case' 0 C--N 1.27 -2.857 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 13' ' ' THR . 11.1 mp -109.21 165.47 11.59 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.933 0.873 . . . . 0.0 112.799 -175.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -130.27 108.99 10.43 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 102.418 -3.178 . . . . 0.0 102.418 175.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.481 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 38.8 tptt -44.31 129.31 6.4 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 123.962 0.789 . . . . 0.0 110.667 -174.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.747 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -77.52 175.53 54.18 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 -169.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -148.28 145.58 28.24 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.1 m -107.42 104.96 54.64 Favored Pre-proline 0 N--CA 1.421 -1.875 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 172.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 C--O 1.258 1.515 0 C-N-CA 122.841 2.36 . . . . 0.0 111.913 -177.759 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 16.9 Cg_exo -71.28 45.77 0.67 Allowed 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 124.214 3.276 . . . . 0.0 113.363 -176.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.74 17.98 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.569 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -80.16 134.78 36.18 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.254 -1.388 . . . . 0.0 107.254 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.1 116.01 31.12 Favored 'General case' 0 C--N 1.285 -2.238 0 O-C-N 123.445 0.466 . . . . 0.0 110.386 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.454 ' CE2' HG22 ' A' ' 16' ' ' VAL . 29.8 p90 -158.47 157.77 32.82 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 100' ' ' LEU . 43.0 mt-10 -86.59 106.52 17.62 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.454 HG22 ' CE2' ' A' ' 14' ' ' PHE . 32.0 t -69.52 134.4 30.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.286 177.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -104.64 100.8 10.45 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -109.08 118.6 37.18 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.95 125.01 40.21 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.849 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -63.05 131.99 50.46 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.049 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 t -59.57 -50.72 72.79 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.957 -1.02 . . . . 0.0 112.339 -176.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 177.15 -24.51 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.73 71.99 0.46 Allowed Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.168 177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.849 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 21.1 t 68.0 -166.29 0.2 Allowed 'General case' 0 C--O 1.251 1.138 0 C-N-CA 125.099 1.36 . . . . 0.0 111.647 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.492 HD22 HD12 ' A' ' 18' ' ' LEU . 96.2 mt -80.05 163.8 23.91 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.403 0.62 . . . . 0.0 110.518 -176.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -100.91 30.94 9.26 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -137.97 162.32 31.43 Favored 'Isoleucine or valine' 0 CA--C 1.465 -2.298 0 CA-C-O 121.624 0.726 . . . . 0.0 110.785 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 m -140.17 136.73 33.77 Favored 'General case' 0 N--CA 1.394 -3.269 0 CA-C-N 113.924 -1.489 . . . . 0.0 107.877 172.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 49' ' ' VAL . 26.9 m -109.77 -165.74 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.741 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.156 -176.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.608 ' HA ' ' ND1' ' A' ' 83' ' ' HIS . 14.1 t -165.91 167.64 16.54 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 171.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 81' ' ' ALA . 13.5 p -117.24 137.05 52.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.18 121.22 41.46 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -89.98 -160.08 0.66 Allowed 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.109 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -59.33 -36.51 75.82 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.094 0.473 . . . . 0.0 111.497 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -92.74 110.58 22.02 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -67.66 -46.26 70.0 Favored Glycine 0 N--CA 1.435 -1.412 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.788 -175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.3 -60.18 4.84 Favored Glycine 0 C--N 1.313 -0.738 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -99.27 24.4 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 123.564 0.746 . . . . 0.0 109.193 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 78.69 129.82 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.781 1.632 . . . . 0.0 109.379 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.0 t -94.24 140.76 29.36 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.015 0.912 . . . . 0.0 112.31 -176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.1 m -128.2 22.08 6.16 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 172.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.2 t -90.0 77.16 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.018 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -92.33 -24.22 19.0 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 172.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -166.57 143.88 5.02 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 104.633 -2.358 . . . . 0.0 104.633 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.62 97.69 0.51 Allowed Glycine 0 C--N 1.306 -1.102 0 C-N-CA 120.31 -0.947 . . . . 0.0 111.58 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.31 -13.18 42.81 Favored Glycine 0 CA--C 1.501 -0.824 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.832 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.758 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.8 mm -100.33 126.48 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HE1' ' HA2' ' A' ' 67' ' ' GLY . 1.5 t80 -120.11 114.31 21.78 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.393 -172.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.427 ' HA ' HG12 ' A' ' 29' ' ' VAL . 46.1 t -56.46 108.06 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.403 ' H ' ' HA ' ' A' ' 29' ' ' VAL . 37.5 ttpt -86.59 -36.31 18.93 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.117 -1.402 . . . . 0.0 110.697 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.757 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -155.69 154.79 32.06 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.219 -0.592 . . . . 0.0 112.397 -174.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.594 HD11 ' HA ' ' A' ' 65' ' ' HIS . 47.5 mm -109.12 114.35 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 175.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.713 HG22 ' HB2' ' A' ' 55' ' ' LYS . 1.7 mp -84.81 146.18 45.68 Favored Pre-proline 0 C--N 1.283 -2.302 0 C-N-CA 124.006 0.922 . . . . 0.0 112.059 -172.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . 0.261 16.4 Cg_exo -52.67 52.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.512 2.599 1 C-N-CA 126.456 4.77 . . . . 0.0 113.768 172.92 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.713 ' HB2' HG22 ' A' ' 53' ' ' ILE . 38.1 tptt -137.69 1.16 2.31 Favored 'General case' 0 N--CA 1.388 -3.528 0 O-C-N 121.764 -0.585 . . . . 0.0 109.594 -171.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.69 -136.75 24.85 Favored Glycine 0 N--CA 1.429 -1.774 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.163 -177.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.743 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 67.73 -90.5 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.094 0.958 . . . . 0.0 111.096 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.916 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -71.3 -34.37 70.56 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.486 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 40.5 tt0 -72.19 -42.79 65.42 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 124.325 1.015 . . . . 0.0 110.525 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -70.11 -50.03 44.85 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.348 -175.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.7 -20.91 61.85 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.138 0.494 . . . . 0.0 110.182 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.89 43.8 97.02 Favored Glycine 0 CA--C 1.502 -0.742 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.006 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -105.06 -41.67 5.52 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.616 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 56.4 mt -115.64 136.34 52.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.673 ' HD2' HG23 ' A' ' 106' ' ' VAL . 63.4 t60 -138.41 172.09 13.41 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.757 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 55.0 mtmt -58.96 116.13 3.59 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 123.48 0.712 . . . . 0.0 110.552 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.547 ' HA2' ' HE1' ' A' ' 48' ' ' TYR . . . 116.26 -11.88 16.79 Favored Glycine 0 N--CA 1.427 -1.958 0 C-N-CA 119.611 -1.281 . . . . 0.0 112.957 -178.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.728 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 5.9 m-20 -64.57 137.42 57.84 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.751 0.786 . . . . 0.0 112.652 176.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -93.44 122.96 36.4 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.315 -176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.758 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 61.3 t -100.47 119.61 48.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.0 mt -97.83 -43.99 6.9 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.548 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -154.96 172.07 18.68 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -173.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.897 HG23 HD21 ' A' ' 78' ' ' LEU . 39.5 t -121.06 114.05 41.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 172.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.2 p30 48.27 29.91 2.07 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.287 1.435 . . . . 0.0 112.9 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.58 -30.03 8.89 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.912 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 56.0 t -80.27 113.8 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 117.819 0.809 . . . . 0.0 109.821 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.9 p -74.98 131.46 40.67 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -176.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.897 HD21 HG23 ' A' ' 73' ' ' VAL . 1.9 mm? -85.27 9.46 15.18 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.349 176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.59 106.5 5.39 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 113.25 2.74 24.65 Favored Glycine 0 N--CA 1.434 -1.468 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.482 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -106.52 155.21 19.84 Favored 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.9 t -91.78 172.28 8.58 Favored 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.608 ' ND1' ' HA ' ' A' ' 30' ' ' THR . 4.2 t60 -50.46 -50.01 53.59 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.26 1.024 . . . . 0.0 109.577 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.582 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 78.2 tttt -50.73 -50.32 55.75 Favored 'General case' 0 C--O 1.204 -1.328 0 O-C-N 124.476 1.11 . . . . 0.0 111.017 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 17.2 mm100 -70.73 -34.9 72.37 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -172.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -56.72 -53.95 51.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.611 0.72 . . . . 0.0 109.385 173.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.531 ' HA ' HD12 ' A' ' 90' ' ' LEU . 97.9 t -65.94 -31.77 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.779 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 19.1 mm-40 -65.81 -31.26 72.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.046 0.451 . . . . 0.0 109.986 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.439 HG22 HG11 ' A' ' 73' ' ' VAL . 24.2 m -78.42 -30.66 47.76 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 87' ' ' VAL . 91.0 mt -71.23 -24.9 62.28 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 122.18 0.991 . . . . 0.0 109.45 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -86.03 -27.73 24.59 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.144 -1.389 . . . . 0.0 108.821 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -77.52 -34.37 54.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.405 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -58.5 -74.85 0.06 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.1 -131.83 4.1 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 119.714 -1.231 . . . . 0.0 112.658 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -73.35 -48.47 34.0 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.645 0.778 . . . . 0.0 112.151 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.64 128.74 75.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.453 0.644 . . . . 0.0 109.741 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.3 t -103.54 122.89 56.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.497 -175.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -94.28 111.57 23.31 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 172.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 73' ' ' VAL . 8.5 tp -118.63 127.01 53.18 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -174.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.9 tt -85.87 111.6 20.36 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.671 HD23 ' HB3' ' A' ' 68' ' ' ASP . 11.1 mp -120.43 174.59 6.45 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-O 122.121 0.962 . . . . 0.0 111.578 -177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -128.53 125.73 38.92 Favored 'General case' 0 N--CA 1.393 -3.318 0 N-CA-C 101.863 -3.384 . . . . 0.0 101.863 169.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 18.5 tptp -52.4 131.62 33.62 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 124.096 0.873 . . . . 0.0 111.191 -173.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.728 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -76.47 -172.0 34.16 Favored Glycine 0 N--CA 1.416 -2.666 0 N-CA-C 115.987 1.155 . . . . 0.0 115.987 -175.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -65.41 -38.0 88.63 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 113.437 -1.381 . . . . 0.0 114.287 -173.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.673 HG23 ' HD2' ' A' ' 65' ' ' HIS . 30.6 m -126.55 135.09 26.74 Favored Pre-proline 0 C--N 1.307 -1.243 0 C-N-CA 120.659 -0.417 . . . . 0.0 110.646 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.2 Cg_endo . . . . . 0 C--O 1.253 1.266 0 C-N-CA 123.468 2.778 . . . . 0.0 111.097 177.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.674 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 69.5 mmtt . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.674 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 59.6 Cg_endo -73.07 102.61 1.48 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 121.855 1.703 . . . . 0.0 114.548 -162.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.631 ' H ' ' HB3' ' A' ' 103' ' ' LYS . . . 80.88 13.5 81.18 Favored Glycine 0 N--CA 1.43 -1.745 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.27 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 4.2 t70 -90.28 143.71 26.51 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 16.9 p -101.65 112.18 24.66 Favored 'General case' 0 N--CA 1.426 -1.636 0 O-C-N 123.738 0.648 . . . . 0.0 111.914 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -138.96 172.21 13.18 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.328 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 2.1 mp0 -104.61 117.87 35.19 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.4 HG21 HD11 ' A' ' 64' ' ' ILE . 13.4 m -87.95 117.55 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.318 0 CA-C-O 121.179 0.514 . . . . 0.0 110.358 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.795 ' HG2' ' HD2' ' A' ' 98' ' ' HIS . 42.4 mt-10 -86.76 98.65 11.28 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.522 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.65 HD11 ' HA ' ' A' ' 58' ' ' ALA . 3.5 mm? -111.13 120.54 42.65 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.662 176.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.21 140.74 29.19 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.523 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -68.04 90.82 0.33 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.27 0.557 . . . . 0.0 111.256 178.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.8 t -58.21 -31.23 67.13 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.069 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -162.78 -68.21 0.05 OUTLIER 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.152 0.501 . . . . 0.0 110.325 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -127.54 86.04 0.33 Allowed Glycine 0 N--CA 1.42 -2.425 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.5 t 79.01 -159.12 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.77 1.228 . . . . 0.0 109.572 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.587 HD22 ' CB ' ' A' ' 18' ' ' LEU . 63.8 mt -87.44 -4.26 59.01 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.045 0.45 . . . . 0.0 111.567 -174.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.92 13.24 78.14 Favored Glycine 0 N--CA 1.419 -2.481 0 C-N-CA 119.859 -1.163 . . . . 0.0 110.689 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.507 ' HB ' HG13 ' A' ' 49' ' ' VAL . 20.1 pt -119.99 130.44 74.24 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.666 0 CA-C-O 122.193 0.996 . . . . 0.0 112.584 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.406 ' OG ' HD11 ' A' ' 53' ' ' ILE . 45.0 m -96.09 110.76 22.96 Favored 'General case' 0 C--N 1.262 -3.233 0 CA-C-N 113.775 -1.557 . . . . 0.0 107.536 175.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -104.42 153.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.982 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.588 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 7.9 t -137.78 157.85 45.59 Favored 'General case' 0 N--CA 1.41 -2.466 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.78 127.5 52.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 48' ' ' TYR . 9.8 mp -105.84 92.7 4.28 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 122.142 0.972 . . . . 0.0 109.806 178.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -100.57 -28.59 12.8 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 113.621 -1.627 . . . . 0.0 108.097 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -165.28 -41.78 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.205 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -95.95 142.84 27.7 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.155 -174.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 134.58 -17.0 4.26 Favored Glycine 0 CA--C 1.498 -0.994 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.36 -160.37 32.49 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 105.618 -2.993 . . . . 0.0 105.618 177.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.3 74.35 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 118.907 1.354 . . . . 0.0 109.047 173.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -116.94 42.55 2.48 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.357 -172.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 12.9 m -72.75 -33.9 66.66 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.9 p -79.48 147.28 32.3 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 171.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -148.8 85.12 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -167.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.84 69.7 6.48 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.1 0.476 . . . . 0.0 109.745 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.7 m80 69.39 162.65 0.23 Allowed 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.902 -177.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.569 ' HA3' ' HG3' ' A' ' 69' ' ' ARG . . . 88.39 76.05 1.29 Allowed Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.46 -36.69 54.37 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.559 -1.017 . . . . 0.0 110.559 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 47.9 mm -110.11 139.81 31.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.309 -0.445 . . . . 0.0 109.997 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.695 ' HB2' HD13 ' A' ' 32' ' ' LEU . 8.9 m-85 -129.53 148.33 51.42 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 175.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.651 HG21 HG21 ' A' ' 64' ' ' ILE . 49.1 t -81.6 116.61 26.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 175.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' HG22 ' A' ' 30' ' ' THR . 61.5 tttp -79.15 -38.7 35.37 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.642 -176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.72 158.45 28.71 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.328 -175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.867 HG21 ' HB2' ' A' ' 59' ' ' GLU . 32.9 mm -109.07 121.79 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.468 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 48.4 mm -76.31 131.32 75.27 Favored Pre-proline 0 C--N 1.293 -1.872 0 C-N-CA 123.265 0.626 . . . . 0.0 110.698 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 24.6 Cg_exo -67.66 63.53 0.85 Allowed 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 124.067 3.178 . . . . 0.0 113.059 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -130.25 -55.76 1.1 Allowed 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.578 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 166.26 -160.74 34.35 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . 0.252 . . 71.26 -95.97 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 125.324 1.45 . . . . 0.0 113.114 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.65 ' HA ' HD11 ' A' ' 18' ' ' LEU . . . -61.33 -40.62 94.88 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -173.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.867 ' HB2' HG21 ' A' ' 52' ' ' ILE . 31.2 tt0 -86.32 -33.9 20.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.144 0.497 . . . . 0.0 110.559 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.578 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 29.5 m -74.72 -39.25 62.02 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.403 -177.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -78.47 -32.32 48.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 175.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.97 64.25 1.81 Allowed Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 114.7 -1.136 . . . . 0.0 113.874 173.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.3 mmt180 -121.65 -60.94 1.56 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.812 0.815 . . . . 0.0 108.926 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.651 HG21 HG21 ' A' ' 49' ' ' VAL . 34.7 mt -96.27 146.76 6.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.247 -1.342 . . . . 0.0 110.715 -174.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -136.58 -170.34 2.66 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 174.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.7 ptpp? -80.82 139.39 36.02 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.131 -1.027 . . . . 0.0 110.623 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.5 -10.31 61.08 Favored Glycine 0 N--CA 1.429 -1.828 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.957 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.478 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 30.9 m-20 -64.45 141.91 58.61 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 117.625 0.712 . . . . 0.0 112.271 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.569 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 40.5 ttm180 -92.41 121.86 34.29 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.239 -173.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.591 HG22 HD11 ' A' ' 101' ' ' LEU . 49.6 t -100.09 111.63 30.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.413 ' HB2' HD12 ' A' ' 100' ' ' LEU . 83.4 mt -91.72 -41.49 10.67 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.772 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -152.25 168.72 24.46 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.376 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.847 HG23 HD21 ' A' ' 78' ' ' LEU . 93.8 t -124.14 104.42 13.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 173.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.455 ' HB3' ' HB2' ' A' ' 98' ' ' HIS 0.311 1.8 p-10 47.12 45.86 16.1 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 122.219 1.009 . . . . 0.0 113.711 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.1 -16.92 60.09 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.205 -1.361 . . . . 0.0 114.269 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 49.1 t -90.97 108.49 19.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 118.016 0.908 . . . . 0.0 108.78 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 5.0 p -78.28 137.24 37.99 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -174.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.847 HD21 HG23 ' A' ' 73' ' ' VAL . 2.2 mm? -93.09 97.51 10.73 Favored 'General case' 0 N--CA 1.405 -2.704 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -110.52 -46.03 3.45 Favored 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.288 -175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -136.14 45.12 1.11 Allowed Glycine 0 N--CA 1.434 -1.481 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 85' ' ' GLN . . . -95.55 -178.15 4.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.374 -0.413 . . . . 0.0 110.686 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.486 ' OG1' ' HG3' ' A' ' 85' ' ' GLN . 68.3 p -115.99 168.3 10.2 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 174.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 16.5 p-80 -53.58 -40.95 66.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.428 0.632 . . . . 0.0 110.192 173.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.04 -42.13 89.97 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.918 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.591 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 49.1 mt-30 -66.41 -32.47 73.87 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 118.507 0.594 . . . . 0.0 110.387 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.504 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -59.88 -50.46 73.71 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 121.494 0.664 . . . . 0.0 109.428 174.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 90.5 t -64.63 -30.55 50.56 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.098 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -64.57 -36.8 85.39 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.06 0.457 . . . . 0.0 110.22 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.1 m -69.62 -33.46 72.69 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 99' ' ' LEU . 90.2 mt -76.54 -23.58 53.63 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.344 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -82.05 -30.99 31.1 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -62.0 -43.85 97.98 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.721 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.493 HG21 HG13 ' A' ' 97' ' ' VAL . 34.9 p -70.64 154.21 42.08 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.67 176.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.46 -114.29 0.78 Allowed Glycine 0 N--CA 1.422 -2.258 0 C-N-CA 120.52 -0.847 . . . . 0.0 113.756 -173.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -86.54 -39.82 15.84 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.851 -0.674 . . . . 0.0 110.961 -172.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.23 127.65 75.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.523 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 4.0 t -114.74 152.31 16.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.795 ' HD2' ' HG2' ' A' ' 17' ' ' GLU . 29.5 m80 -123.93 71.47 1.11 Allowed 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 90' ' ' LEU . 4.8 mp -65.15 144.07 57.45 Favored 'General case' 0 C--N 1.316 -0.887 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.999 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.772 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.9 tm? -93.03 107.98 19.65 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 -177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.591 HD11 HG22 ' A' ' 70' ' ' VAL . 2.7 mp -122.6 147.84 45.94 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.872 -170.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 35.3 tt0 -118.16 127.5 53.82 Favored 'General case' 0 N--CA 1.397 -3.086 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 172.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.631 ' HB3' ' H ' ' A' ' 11' ' ' GLY . 5.5 tmtm? -54.29 114.36 1.61 Allowed 'General case' 0 C--O 1.244 0.77 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.092 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -87.96 86.03 1.5 Allowed Glycine 0 N--CA 1.426 -1.99 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.338 -177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -49.89 -62.48 1.54 Allowed 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.303 0.641 . . . . 0.0 110.342 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.9 t 63.47 125.96 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.187 0.995 . . . . 0.0 112.51 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 N--CA 1.45 -1.052 0 C-N-CA 122.487 2.125 . . . . 0.0 109.943 174.663 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.435 ' C ' ' H ' ' A' ' 11' ' ' GLY . 51.1 mtpt . . . . . 0 N--CA 1.434 -1.242 0 N-CA-C 104.529 -2.397 . . . . 0.0 104.529 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.722 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 32.8 Cg_exo -68.91 42.48 0.29 Allowed 'Trans proline' 0 CA--C 1.56 1.814 0 C-N-CA 123.156 2.571 . . . . 0.0 111.789 172.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 9' ' ' LYS . . . -169.8 32.51 0.16 Allowed Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 37.6 t70 -90.53 143.67 26.52 Favored 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 122.766 -0.256 . . . . 0.0 111.246 -178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 p -93.35 124.42 37.32 Favored 'General case' 0 N--CA 1.425 -1.722 0 O-C-N 124.079 0.862 . . . . 0.0 110.143 176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CE1' ' HD2' ' A' ' 63' ' ' ARG . 46.9 p90 -140.79 152.17 44.98 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.203 -177.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.472 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 52.4 mt-10 -110.95 90.96 3.48 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 176.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.645 HG11 HD11 ' A' ' 64' ' ' ILE . 6.5 p -71.07 136.57 25.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.389 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.827 -175.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -96.13 93.58 7.03 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 174.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.88 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -97.56 116.85 30.56 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.309 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.63 131.37 44.26 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.9 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.521 ' HD2' HD23 ' A' ' 25' ' ' LEU . 1.6 mptm? -66.8 124.25 22.4 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.081 172.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.8 t -113.75 10.57 17.88 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 34.1 t70 -155.47 -152.67 0.4 Allowed 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' H ' ' CG ' ' A' ' 22' ' ' ASP . . . -104.81 15.54 48.43 Favored Glycine 0 C--N 1.296 -1.639 0 CA-C-N 119.83 1.196 . . . . 0.0 110.302 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.3 t -142.64 165.76 26.52 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -174.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.63 HD22 HD12 ' A' ' 18' ' ' LEU . 92.4 mt -85.7 173.74 9.88 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 170.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.83 32.66 5.46 Favored Glycine 0 C--N 1.289 -2.052 0 C-N-CA 120.024 -1.084 . . . . 0.0 111.141 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 64' ' ' ILE . 15.0 pt -139.47 143.4 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.303 0 CA-C-O 121.35 0.595 . . . . 0.0 111.905 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.41 ' HB2' HD11 ' A' ' 53' ' ' ILE . 32.9 t -103.01 128.3 49.9 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 49' ' ' VAL . 26.9 m -125.08 151.2 30.59 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 CA-C-O 120.872 0.368 . . . . 0.0 110.691 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.7 t -133.25 173.53 11.35 Favored 'General case' 0 N--CA 1.392 -3.359 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.59 HG13 ' HG ' ' A' ' 32' ' ' LEU . 10.0 p -86.28 -48.14 15.99 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.302 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -171.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.59 ' HG ' HG13 ' A' ' 31' ' ' VAL . 1.4 pp -120.11 147.51 44.77 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -146.36 99.81 3.28 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 125.544 1.537 . . . . 0.0 107.177 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -119.55 108.27 14.3 Favored 'General case' 0 C--N 1.294 -1.804 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.646 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -112.35 31.65 6.14 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -99.05 -39.39 3.55 Favored Glycine 0 N--CA 1.424 -2.144 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.595 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.81 -88.42 0.46 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 177.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.6 -43.73 77.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -93.6 143.81 25.96 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.4 p -94.71 139.63 30.98 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-O 121.061 0.458 . . . . 0.0 111.905 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 m -79.04 104.64 9.82 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 171.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.35 -176.71 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -171.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.579 ' HD3' ' HB2' ' A' ' 79' ' ' GLU . 30.2 ttm180 -70.65 87.38 0.67 Allowed 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.909 177.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.424 ' HB3' ' NH2' ' A' ' 69' ' ' ARG . 9.8 t60 -136.49 94.21 2.98 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.98 ' HA2' ' HA ' ' A' ' 71' ' ' LEU . . . 107.07 -96.07 1.06 Allowed Glycine 0 N--CA 1.412 -2.961 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.95 -37.69 2.01 Favored Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.545 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.5 mm -123.72 149.29 27.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.415 ' CE2' ' HG2' ' A' ' 69' ' ' ARG . 79.1 m-85 -130.22 139.35 50.81 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 122.036 -0.415 . . . . 0.0 111.089 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.467 ' HA ' HG12 ' A' ' 29' ' ' VAL . 58.2 t -72.39 110.8 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -78.38 -39.8 38.04 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.814 -1.084 . . . . 0.0 110.018 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -165.69 170.44 14.1 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 -174.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 49.6 mm -102.65 115.47 44.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.494 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 33.6 mm -75.25 124.8 89.4 Favored Pre-proline 0 C--N 1.31 -1.15 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 177.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 5.6 Cg_exo -74.48 77.49 2.92 Favored 'Trans proline' 0 N--CA 1.442 -1.513 0 C-N-CA 122.802 2.334 . . . . 0.0 112.479 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' A' ' 55' ' ' LYS . 50.5 mmtt -136.18 12.71 3.31 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.78 173.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.12 -139.6 19.24 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -173.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.72 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 67.51 -93.53 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 123.674 0.789 . . . . 0.0 112.0 173.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.88 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -75.1 -32.27 61.38 Favored 'General case' 0 C--O 1.256 1.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.21 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.49 -39.21 65.03 Favored 'General case' 0 N--CA 1.437 -1.103 0 O-C-N 125.191 1.557 . . . . 0.0 110.003 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -73.75 -41.29 62.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.978 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -68.73 -31.13 69.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.37 34.37 79.69 Favored Glycine 0 CA--C 1.49 -1.517 0 CA-C-N 114.38 -1.282 . . . . 0.0 111.707 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.431 ' HG2' ' CG2' ' A' ' 16' ' ' VAL . 15.8 tpp180 -101.23 -37.86 8.35 Favored 'General case' 1 N--CA 1.362 -4.837 0 CA-C-O 121.091 0.472 . . . . 0.0 110.876 -174.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.696 HG21 HG21 ' A' ' 27' ' ' ILE . 22.8 mm -96.29 138.12 22.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.011 -173.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -124.48 161.7 25.52 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -76.4 137.23 39.62 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 118.861 -1.136 . . . . 0.0 109.885 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.15 -10.61 47.63 Favored Glycine 0 N--CA 1.425 -2.1 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.469 -176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -68.15 143.39 55.41 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.442 0.639 . . . . 0.0 111.176 178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.424 ' NH2' ' HB3' ' A' ' 44' ' ' HIS . 43.4 mtp180 -95.07 125.97 40.09 Favored 'General case' 0 CA--C 1.469 -2.147 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.347 -174.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.545 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 44.4 t -94.22 106.78 18.49 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.832 0 CA-C-N 114.077 -1.42 . . . . 0.0 107.477 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.98 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 56.2 mt -84.44 -35.86 22.74 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.74 -175.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' A' ' 77' ' ' SER . . . -166.8 170.81 12.0 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -176.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.856 ' HA ' HD12 ' A' ' 99' ' ' LEU . 49.0 t -111.56 103.16 15.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 174.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.991 ' HB3' ' HB2' ' A' ' 98' ' ' HIS 0.283 1.1 p-10 39.43 70.58 0.21 Allowed 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -178.226 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.61 -32.19 2.91 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 115.098 -0.956 . . . . 0.0 114.645 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.4 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 60.3 t -81.39 108.38 14.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 118.008 0.904 . . . . 0.0 109.582 -176.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.412 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 13.7 p -63.28 139.18 58.74 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.609 HD11 HG23 ' A' ' 73' ' ' VAL . 71.9 mt -104.03 27.62 7.48 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.923 0.868 . . . . 0.0 109.158 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.579 ' HB2' ' HD3' ' A' ' 43' ' ' ARG . 9.3 pt-20 -49.63 -33.38 15.22 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.027 1.731 . . . . 0.0 113.081 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -133.78 46.15 1.07 Allowed Glycine 0 N--CA 1.428 -1.868 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.434 ' HB1' ' HG3' ' A' ' 85' ' ' GLN . . . -106.26 154.85 20.15 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.56 0.219 . . . . 0.0 111.155 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.497 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.2 t -100.71 160.52 14.29 Favored 'General case' 0 N--CA 1.42 -1.945 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 168.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.55 ' H ' ' HB ' ' A' ' 31' ' ' VAL . 39.0 p-80 -51.23 -48.33 62.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -175.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 18.8 ptmt -67.46 -30.28 69.95 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.434 ' HG3' ' HB1' ' A' ' 81' ' ' ALA . 0.0 OUTLIER -73.97 -36.65 64.58 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.457 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.548 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.6 -46.61 83.85 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 175.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.71 -32.73 59.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.684 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 41.8 mt-10 -73.28 -26.46 61.1 Favored 'General case' 0 C--O 1.211 -0.94 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.198 177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.463 HG22 HG11 ' A' ' 73' ' ' VAL . 47.4 m -74.19 -26.88 60.53 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.638 HD22 HG11 ' A' ' 97' ' ' VAL . 68.3 mt -74.93 -26.33 59.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -84.25 -28.77 26.98 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -67.11 -35.26 79.37 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.163 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.7 p -72.06 -66.33 0.66 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.392 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 142.38 -136.73 7.39 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.435 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.425 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 29.4 tt0 -69.9 -51.38 33.62 Favored 'General case' 0 C--O 1.211 -0.966 0 O-C-N 124.167 0.569 . . . . 0.0 111.117 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.0 125.46 66.08 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 C-N-CA 117.863 -1.535 . . . . 0.0 111.348 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.638 HG11 HD22 ' A' ' 90' ' ' LEU . 35.4 t -113.18 126.19 70.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.4 -177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.991 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 11.2 m170 -89.99 125.5 35.41 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 171.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.856 HD12 ' HA ' ' A' ' 73' ' ' VAL . 8.3 tp -123.77 136.28 54.32 Favored 'General case' 0 C--N 1.259 -3.339 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 71' ' ' LEU . 1.3 tt -93.8 113.48 25.54 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -175.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.738 HD11 HD23 ' A' ' 99' ' ' LEU . 7.2 mp -125.25 165.78 17.68 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.341 0.591 . . . . 0.0 111.884 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' A' ' 71' ' ' LEU . 37.0 tt0 -130.99 134.06 46.35 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 103' ' ' LYS . 54.4 mmtt -56.2 125.38 21.51 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.631 0.729 . . . . 0.0 112.823 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -113.26 67.91 0.24 Allowed Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.722 ' HB2' ' HB3' ' A' ' 10' ' ' PRO . 85.2 mt-30 -111.85 -150.03 0.46 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 122.89 -0.182 . . . . 0.0 110.658 -178.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.685 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 49.6 t -88.89 -65.05 0.19 Allowed Pre-proline 0 CA--C 1.562 1.442 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -172.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.685 ' HD3' ' HB ' ' A' ' 106' ' ' VAL . 5.9 Cg_endo . . . . . 0 C--O 1.255 1.353 0 C-N-CA 122.269 1.979 . . . . 0.0 112.294 -177.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp . . . . . 0 N--CA 1.434 -1.238 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.876 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 32.4 Cg_exo -62.67 135.76 54.42 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 N-CA-C 107.778 -1.662 . . . . 0.0 107.778 170.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.73 -1.63 52.52 Favored Glycine 0 N--CA 1.426 -2.011 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.051 -171.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -100.11 149.63 23.32 Favored 'General case' 0 CA--C 1.496 -1.126 0 CA-C-N 117.443 0.622 . . . . 0.0 111.242 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 7.9 p -89.0 145.96 25.17 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.176 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.403 ' CE1' ' HD2' ' A' ' 103' ' ' LYS . 2.6 p90 -143.75 136.29 27.09 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -97.26 110.71 23.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 33.9 t -89.56 119.56 36.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.08 -172.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -101.62 88.6 3.46 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 169.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.846 HD11 ' HB1' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -93.22 117.0 29.56 Favored 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -174.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.54 116.77 29.17 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -62.9 139.06 58.71 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.981 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.563 HG21 ' HG3' ' A' ' 55' ' ' LYS . 1.8 m -67.34 -68.85 0.35 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.011 179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' H ' ' HB ' ' A' ' 21' ' ' THR . 20.7 t70 -103.64 -79.21 0.54 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 175.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.44 16.49 2.27 Favored Glycine 0 C--N 1.3 -1.464 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.8 m -117.78 144.11 45.64 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.453 -174.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.435 HD12 HD13 ' A' ' 90' ' ' LEU . 90.4 mt -86.14 175.69 8.38 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 172.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.526 ' HA3' ' H ' ' A' ' 58' ' ' ALA . . . -108.69 32.86 6.59 Favored Glycine 0 C--N 1.291 -1.93 0 C-N-CA 119.558 -1.306 . . . . 0.0 111.145 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.47 HG23 ' CB ' ' A' ' 58' ' ' ALA . 7.6 pt -137.13 138.37 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.77 0 CA-C-O 121.222 0.534 . . . . 0.0 111.721 -178.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 11.8 t -111.7 109.34 19.16 Favored 'General case' 0 C--N 1.277 -2.549 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 176.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 34.6 m -100.12 168.47 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.549 -174.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -147.8 169.01 20.69 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 171.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' A' ' 82' ' ' THR . 11.1 p -121.25 147.08 25.35 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.628 HD13 ' CD1' ' A' ' 48' ' ' TYR . 9.5 mp -91.47 92.94 8.76 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 122.582 1.182 . . . . 0.0 109.197 172.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -124.41 -50.42 1.77 Allowed 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 112.88 -1.964 . . . . 0.0 108.173 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.88 -38.57 32.36 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.825 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -102.34 150.2 23.57 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 156.59 -171.61 34.22 Favored Glycine 0 C--N 1.293 -1.85 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.2 -67.27 1.03 Allowed Glycine 0 C--N 1.3 -1.427 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.7 p -85.51 -43.7 16.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -64.19 -46.78 82.47 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t -162.08 126.47 3.25 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.9 m -65.72 -54.2 30.53 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.032 0.444 . . . . 0.0 110.311 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 35.0 m -92.7 163.51 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.168 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.677 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 84.0 mtt180 -83.19 83.36 7.88 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.47 ' O ' ' HD3' ' A' ' 69' ' ' ARG . 12.1 t-80 -71.25 108.1 4.57 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 71' ' ' LEU . . . 87.13 -56.94 4.59 Favored Glycine 0 N--CA 1.434 -1.436 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -172.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.677 ' HA2' ' HB3' ' A' ' 43' ' ' ARG . . . 105.31 -49.59 0.89 Allowed Glycine 0 N--CA 1.436 -1.305 0 CA-C-N 115.203 -0.499 . . . . 0.0 112.407 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.799 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 48.1 mm -105.25 140.29 23.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -174.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.628 ' CD1' HD13 ' A' ' 32' ' ' LEU . 81.1 m-85 -135.33 112.71 10.59 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.687 HG21 HG21 ' A' ' 64' ' ' ILE . 59.9 t -46.33 120.14 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.587 0.708 . . . . 0.0 111.278 172.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -91.18 -34.6 14.95 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.491 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 28' ' ' SER . . . -154.69 158.2 39.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.203 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 46.0 mm -108.68 118.59 56.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 49.1 mm -87.84 134.29 35.76 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.473 ' HB2' ' H ' ' A' ' 55' ' ' LYS . 16.0 Cg_exo -69.19 -102.54 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 121.763 1.642 . . . . 0.0 111.836 177.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HG3' HG21 ' A' ' 21' ' ' THR . 16.1 tppt? 67.86 -59.48 0.42 Allowed 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 125.719 1.608 . . . . 0.0 110.885 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.84 48.24 0.03 OUTLIER Glycine 0 N--CA 1.424 -2.127 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.846 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -135.59 -98.39 0.23 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.801 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -69.22 -33.59 73.53 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 118.171 0.441 . . . . 0.0 111.324 -174.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -70.42 -45.57 65.63 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 124.172 0.92 . . . . 0.0 109.193 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.7 t -72.5 -44.35 62.35 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.483 -174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -74.87 -19.21 60.26 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.898 0.856 . . . . 0.0 108.94 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 57.72 67.8 2.02 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.491 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.529 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -119.92 -67.54 0.97 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.097 0.475 . . . . 0.0 110.734 -179.158 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.687 HG21 HG21 ' A' ' 49' ' ' VAL . 63.7 mt -85.5 139.63 17.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.41 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -124.77 178.45 5.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -71.25 129.6 39.29 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.765 0.317 . . . . 0.0 110.697 -176.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.55 -15.49 53.18 Favored Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.934 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.486 ' HA ' ' H ' ' A' ' 104' ' ' GLY . 75.9 m-20 -64.54 138.01 58.17 Favored 'General case' 0 C--O 1.251 1.171 0 CA-C-O 121.658 0.742 . . . . 0.0 112.033 -176.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.47 ' HD3' ' O ' ' A' ' 44' ' ' HIS . 36.3 ttm180 -90.41 129.38 36.61 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 114.603 -1.181 . . . . 0.0 110.376 -173.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.799 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.2 t -97.01 104.35 15.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.609 HD12 HD22 ' A' ' 100' ' ' LEU . 93.7 mt -78.09 -39.56 41.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.094 -178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 77' ' ' SER . . . -159.11 166.74 30.89 Favored 'General case' 0 N--CA 1.428 -1.525 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.956 -177.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.911 HG23 HD21 ' A' ' 78' ' ' LEU . 98.7 t -119.05 97.71 5.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 52.4 t30 54.2 60.37 3.63 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 124.247 1.019 . . . . 0.0 109.987 -178.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.89 -36.02 2.32 Favored Glycine 0 CA--C 1.548 2.105 0 CA-C-N 114.517 -1.219 . . . . 0.0 114.398 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.86 108.79 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 20.9 m -85.38 142.82 29.02 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.479 0.657 . . . . 0.0 112.602 -173.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.911 HD21 HG23 ' A' ' 73' ' ' VAL . 1.6 mm? -99.21 22.98 9.73 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.977 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 43' ' ' ARG . 26.5 mt-10 -67.36 -22.24 65.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.114 0.483 . . . . 0.0 112.283 -175.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.55 25.68 8.97 Favored Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 174.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' A' ' 85' ' ' GLN . . . -105.99 -172.03 2.01 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.515 0.674 . . . . 0.0 111.509 -176.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.64 ' HA ' HG21 ' A' ' 31' ' ' VAL . 6.6 t -144.91 178.85 7.72 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -50.55 -55.89 14.14 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.968 0.907 . . . . 0.0 111.847 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 88' ' ' GLU . 33.0 mmtp -65.23 -25.09 67.53 Favored 'General case' 0 C--O 1.211 -0.969 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HB2' ' H ' ' A' ' 82' ' ' THR . 16.3 mm100 -76.59 -44.89 32.55 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.479 -0.564 . . . . 0.0 109.479 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.498 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -58.26 -54.32 48.3 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.444 178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.59 -27.69 43.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.827 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 84' ' ' LYS . 34.1 tt0 -70.88 -34.75 71.92 Favored 'General case' 0 N--CA 1.419 -1.998 0 O-C-N 121.702 -0.624 . . . . 0.0 109.317 178.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.7 m -71.4 -30.59 66.27 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.72 HD21 HD21 ' A' ' 99' ' ' LEU . 94.0 mt -76.8 -12.28 59.95 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.203 175.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.456 ' HD3' ' HA ' ' A' ' 91' ' ' ARG . 14.0 mmt180 -92.93 -31.7 14.83 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.75 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -65.01 -38.35 90.65 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.708 0.766 . . . . 0.0 109.199 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.2 p -74.42 146.35 42.96 Favored 'General case' 0 N--CA 1.429 -1.506 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.91 176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -79.16 -135.06 1.07 Allowed Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 121.453 -0.403 . . . . 0.0 113.65 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -72.87 -49.33 30.63 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.104 0.478 . . . . 0.0 110.484 -175.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 45.8 t -98.93 112.73 31.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 t -108.52 137.94 37.82 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.124 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 74' ' ' ASN . 12.7 m-70 -96.05 129.49 43.32 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 173.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.72 HD21 HD21 ' A' ' 90' ' ' LEU . 5.9 mp -127.11 141.81 51.67 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.609 HD22 HD12 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -99.78 113.81 26.55 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -177.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.714 ' HG ' ' HA ' ' A' ' 70' ' ' VAL . 7.3 mp -127.43 163.07 24.88 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 118.727 0.694 . . . . 0.0 112.299 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.664 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 36.0 tt0 -131.01 128.77 41.03 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 172.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.876 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 6.4 tptp -49.93 113.15 0.79 Allowed 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.267 0.979 . . . . 0.0 110.404 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 68' ' ' ASP . . . -115.48 18.28 15.55 Favored Glycine 0 C--N 1.29 -1.996 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.936 -173.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -63.32 107.13 1.02 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.345 0.593 . . . . 0.0 112.182 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 54.4 t -92.57 105.3 13.94 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-N 114.349 -1.296 . . . . 0.0 109.18 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 5.3 Cg_exo . . . . . 0 C--O 1.255 1.342 0 C-N-CA 123.239 2.626 . . . . 0.0 110.957 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.585 ' CB ' ' HD3' ' A' ' 10' ' ' PRO 0.362 66.6 mttm . . . . . 0 CA--C 1.54 0.587 0 CA-C-O 117.011 -1.471 . . . . 0.0 110.658 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HD3' ' CB ' ' A' ' 9' ' ' LYS . 17.8 Cg_exo -67.06 134.8 35.34 Favored 'Trans proline' 0 C--N 1.377 2.044 0 CA-C-N 122.899 2.071 . . . . 0.0 110.093 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 94.21 -13.39 67.43 Favored Glycine 0 C--N 1.3 -1.457 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.227 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -82.59 141.41 32.58 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 40.2 p -92.6 140.89 29.09 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -177.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -139.95 141.64 36.44 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.378 0.609 . . . . 0.0 111.343 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.675 ' HB3' ' HE2' ' A' ' 98' ' ' HIS . 3.1 mp0 -83.89 108.47 16.9 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.356 -1.293 . . . . 0.0 107.953 178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.24 125.8 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.063 0 CA-C-O 121.628 0.728 . . . . 0.0 111.519 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -102.37 113.63 27.11 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 176.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 57' ' ' ALA . 2.7 tm? -109.57 116.27 31.44 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.43 118.54 33.16 Favored 'General case' 0 N--CA 1.413 -2.295 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 176.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 94.1 mttt -59.51 119.29 7.24 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 124.059 0.849 . . . . 0.0 110.304 -177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.715 ' HB ' ' O ' ' A' ' 56' ' ' GLY . 19.0 m -76.13 -67.44 0.68 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.643 -176.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -152.65 -48.49 0.1 Allowed 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -82.73 35.65 2.68 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.253 177.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.8 p 71.64 -132.23 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.616 1.966 . . . . 0.0 111.977 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.542 ' HG ' HD13 ' A' ' 90' ' ' LEU . 3.3 mm? -72.3 -30.64 64.98 Favored 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 121.836 0.826 . . . . 0.0 109.547 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.73 22.33 62.04 Favored Glycine 0 N--CA 1.402 -3.615 0 C-N-CA 119.991 -1.1 . . . . 0.0 110.431 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.449 ' HB ' HG13 ' A' ' 49' ' ' VAL . 19.9 pt -135.2 143.26 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.692 0 CA-C-O 121.677 0.751 . . . . 0.0 111.056 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.3 t -97.11 118.01 32.57 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 174.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.72 140.89 47.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-O 121.416 0.627 . . . . 0.0 112.062 -173.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 47' ' ' ILE . 11.4 t -138.61 -171.84 3.16 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -172.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.864 ' HA ' HD13 ' A' ' 47' ' ' ILE . 79.5 t -79.6 -51.08 17.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 174.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.621 HD11 ' HA ' ' A' ' 44' ' ' HIS . 46.1 mt -169.89 -57.15 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 127.784 2.433 . . . . 0.0 104.865 175.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.1 p90 179.71 165.66 1.13 Allowed 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -83.87 113.18 20.77 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 119.544 -0.863 . . . . 0.0 109.618 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.832 ' HE3' HG21 ' A' ' 42' ' ' VAL . 24.4 ttmm -94.4 -69.92 0.73 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.416 -175.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.34 -140.03 14.68 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.35 27.61 16.46 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.659 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 m -104.28 87.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-O 121.306 0.574 . . . . 0.0 111.937 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.8 t30 67.38 92.65 0.08 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.849 1.259 . . . . 0.0 111.152 -176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.2 t -103.24 13.2 34.45 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.921 -176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.3 t -85.6 16.43 3.89 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 122.083 0.944 . . . . 0.0 109.528 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.832 HG21 ' HE3' ' A' ' 35' ' ' LYS . 36.0 m -96.05 153.34 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.947 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.817 -178.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -96.51 101.36 12.97 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.621 ' HA ' HD11 ' A' ' 32' ' ' LEU . 66.3 m80 -64.53 -38.88 92.54 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.95 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.26 -56.15 3.57 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 -173.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 79' ' ' GLU . . . 155.22 -63.41 0.34 Allowed Glycine 0 CA--C 1.471 -2.704 0 CA-C-N 114.968 -0.616 . . . . 0.0 111.773 173.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.864 HD13 ' HA ' ' A' ' 31' ' ' VAL . 17.4 mm -141.15 152.61 20.02 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.087 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.595 ' HB2' HD23 ' A' ' 32' ' ' LEU . 39.1 t80 -139.41 138.15 36.27 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.331 0.652 . . . . 0.0 111.094 -174.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.449 HG13 ' HB ' ' A' ' 27' ' ' ILE . 44.2 t -78.48 103.1 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 174.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.459 ' HB2' HG22 ' A' ' 30' ' ' THR . 88.1 tttt -68.89 -41.24 78.57 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 113.506 -1.679 . . . . 0.0 110.844 -174.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.84 159.39 32.49 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.212 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 23.4 mm -113.24 134.87 54.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 55' ' ' LYS . 1.8 mp -79.44 128.4 75.35 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 176.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.55 -15.61 9.24 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 125.26 3.974 . . . . 0.0 115.27 -175.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' H ' HG22 ' A' ' 53' ' ' ILE . 22.9 tptm -162.59 64.44 0.21 Allowed 'General case' 0 N--CA 1.434 -1.256 0 CA-C-O 121.938 0.875 . . . . 0.0 109.644 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.715 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . -114.49 -54.34 0.41 Allowed Glycine 0 C--N 1.303 -1.264 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.651 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.554 ' HB2' ' H ' ' A' ' 21' ' ' THR . . . 176.65 -68.13 0.01 OUTLIER 'General case' 0 C--O 1.173 -2.957 0 O-C-N 125.48 1.341 . . . . 0.0 111.641 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.885 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -49.47 -37.29 25.57 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -173.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -78.84 -48.6 14.41 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.147 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.5 m -71.6 -35.97 70.66 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.795 -172.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -76.56 -37.23 56.94 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.41 77.04 1.08 Allowed Glycine 0 N--CA 1.433 -1.532 0 CA-C-N 114.418 -1.265 . . . . 0.0 114.001 173.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -157.98 -47.0 0.06 Allowed 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.885 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 77.1 mt -88.63 132.41 33.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 174.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -120.19 164.61 15.97 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 123.533 0.521 . . . . 0.0 109.61 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -63.44 128.96 38.19 Favored 'General case' 0 N--CA 1.402 -2.862 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.568 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.621 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 98.92 -8.59 61.36 Favored Glycine 0 N--CA 1.419 -2.482 0 C-N-CA 119.996 -1.097 . . . . 0.0 113.545 177.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.441 ' HB3' HD23 ' A' ' 101' ' ' LEU . 80.7 m-20 -66.67 139.81 57.87 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-O 121.244 0.545 . . . . 0.0 110.603 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.656 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . 27.7 ttm-85 -98.67 143.63 28.84 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -174.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.44 HG12 HD21 ' A' ' 78' ' ' LEU . 48.5 t -109.9 120.03 60.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.558 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -177.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 100' ' ' LEU . 57.6 mt -101.82 -33.8 9.67 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.963 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -151.75 160.06 43.72 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.188 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.993 HG11 HG21 ' A' ' 89' ' ' THR . 2.6 p -116.65 104.6 16.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 174.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HA ' ' ND1' ' A' ' 98' ' ' HIS . 61.6 t30 55.12 37.68 29.29 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.438 1.114 . . . . 0.0 109.901 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.68 -23.73 35.08 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 120.275 -0.964 . . . . 0.0 114.182 -178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.562 ' HB ' HG13 ' A' ' 73' ' ' VAL . 44.1 t -80.96 113.15 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 118.458 1.129 . . . . 0.0 109.021 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.3 t -72.82 109.61 6.54 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.106 0.479 . . . . 0.0 110.134 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.77 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.5 pt? -97.63 33.12 2.12 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 122.233 1.016 . . . . 0.0 110.935 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.547 ' HA ' ' CA ' ' A' ' 46' ' ' GLY . 11.8 pt-20 -58.25 -28.65 65.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.07 -1.423 . . . . 0.0 112.131 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.9 30.97 7.07 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 -178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.54 -164.12 1.12 Allowed 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.548 ' H ' ' HB2' ' A' ' 85' ' ' GLN . 13.5 t -144.18 177.72 8.4 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 177.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -50.3 -53.15 30.68 Favored 'General case' 0 C--O 1.265 1.913 0 C-N-CA 124.897 1.279 . . . . 0.0 110.67 -178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 97.5 mttt -59.36 -47.92 83.59 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.019 177.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.548 ' HB2' ' H ' ' A' ' 82' ' ' THR . 28.8 mm-40 -64.3 -42.69 96.25 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.542 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -50.55 -60.32 3.14 Favored 'General case' 0 C--O 1.254 1.29 0 CA-C-O 121.428 0.632 . . . . 0.0 110.387 175.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.6 t -66.07 -31.8 55.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.428 -178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 42.6 mm-40 -69.58 -34.15 73.73 Favored 'General case' 0 CA--C 1.507 -0.702 0 O-C-N 122.097 -0.377 . . . . 0.0 111.016 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.993 HG21 HG11 ' A' ' 73' ' ' VAL . 45.0 m -65.14 -38.48 90.74 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 177.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.77 HD21 HD21 ' A' ' 99' ' ' LEU . 81.6 mt -72.84 -23.49 60.77 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.731 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -84.11 -30.55 25.86 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.893 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.97 -41.13 87.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.089 0.471 . . . . 0.0 109.892 175.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 20.1 p -68.92 155.04 40.98 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.916 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -71.24 -147.57 0.51 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 114.84 0.696 . . . . 0.0 114.84 -176.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.474 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 62.4 tt0 -74.38 -35.89 63.51 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.21 -0.495 . . . . 0.0 110.907 -177.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.71 111.36 35.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.3 t -110.0 146.23 15.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -176.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.675 ' HE2' ' HB3' ' A' ' 15' ' ' GLU . 58.5 t-80 -109.68 134.47 51.94 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 175.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.77 HD21 HD21 ' A' ' 90' ' ' LEU . 6.4 mp -130.28 153.36 48.72 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 173.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.739 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.3 tm? -106.09 109.79 21.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.441 HD23 ' HB3' ' A' ' 68' ' ' ASP . 8.0 mp -111.38 171.43 7.48 Favored 'General case' 0 C--N 1.279 -2.483 0 CA-C-O 121.668 0.747 . . . . 0.0 111.939 -175.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.656 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 29.3 tt0 -128.4 132.69 48.5 Favored 'General case' 0 N--CA 1.396 -3.164 0 N-CA-C 103.359 -2.83 . . . . 0.0 103.359 175.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 15.6 tppt? -63.05 112.79 2.76 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 175.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . -91.32 -158.18 34.41 Favored Glycine 0 N--CA 1.409 -3.163 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.31 -172.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -161.31 -167.33 1.74 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -172.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.652 ' HB ' ' HD3' ' A' ' 107' ' ' PRO . 89.8 t -65.72 -55.2 24.48 Favored Pre-proline 0 CA--C 1.566 1.584 0 C-N-CA 120.494 -0.483 . . . . 0.0 110.236 171.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.652 ' HD3' ' HB ' ' A' ' 106' ' ' VAL . 4.3 Cg_exo . . . . . 0 C--N 1.371 1.748 0 C-N-CA 123.173 2.582 . . . . 0.0 111.899 176.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.574 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 63.4 mttp . . . . . 0 CA--C 1.547 0.858 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.58 ' HB3' ' HG3' ' A' ' 105' ' ' GLN . 12.2 Cg_exo -75.01 40.49 0.66 Allowed 'Trans proline' 0 C--N 1.395 3.003 0 C-N-CA 123.969 3.113 . . . . 0.0 113.05 -176.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 165.98 43.1 0.02 OUTLIER Glycine 0 C--N 1.283 -2.381 0 N-CA-C 109.066 -1.613 . . . . 0.0 109.066 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 23.1 t0 -116.73 153.73 31.87 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.8 p -92.09 144.75 25.12 Favored 'General case' 0 N--CA 1.421 -1.892 0 O-C-N 123.599 0.562 . . . . 0.0 109.706 -177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -157.77 153.67 26.89 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 41.4 mt-10 -110.73 89.2 2.97 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.456 HG12 HD13 ' A' ' 101' ' ' LEU . 14.1 p -81.47 143.18 12.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.433 -175.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HB3' ' HD2' ' A' ' 98' ' ' HIS . 11.1 pt-20 -104.2 111.4 23.98 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.784 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -111.34 126.72 55.22 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.054 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -101.47 142.05 33.43 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.461 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.748 ' HB2' ' HG3' ' A' ' 95' ' ' GLN . 29.5 mmtm -65.36 118.14 8.92 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.6 m -90.18 -61.39 1.69 Allowed 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.117 0.484 . . . . 0.0 111.804 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -152.88 -45.65 0.1 Allowed 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 121.762 0.792 . . . . 0.0 109.009 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 24' ' ' SER . . . -123.48 51.28 0.81 Allowed Glycine 0 N--CA 1.418 -2.51 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.57 176.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.543 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 25.7 m 80.45 -147.67 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 124.753 1.221 . . . . 0.0 110.279 175.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 90' ' ' LEU . 28.6 mt -80.46 -10.95 59.74 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 121.135 0.493 . . . . 0.0 109.73 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.55 8.99 84.03 Favored Glycine 0 N--CA 1.42 -2.405 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.059 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.468 HG12 ' HB2' ' A' ' 25' ' ' LEU . 25.7 pt -114.76 134.33 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.57 0 CA-C-O 121.997 0.903 . . . . 0.0 112.766 -177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.2 t -97.12 107.59 20.14 Favored 'General case' 0 C--N 1.276 -2.589 0 CA-C-N 113.843 -1.526 . . . . 0.0 106.921 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.485 ' HB ' ' CG2' ' A' ' 47' ' ' ILE . 34.1 m -96.84 152.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-O 120.737 0.303 . . . . 0.0 110.561 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.437 HG22 ' HB2' ' A' ' 50' ' ' LYS . 11.1 t -142.84 156.03 44.88 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 81' ' ' ALA . 7.2 p -118.9 111.17 32.45 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 CA-C-O 121.38 0.61 . . . . 0.0 110.212 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 mp -79.37 132.92 36.56 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -97.15 1.03 49.4 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.745 -173.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -76.13 26.46 0.12 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HE3' ' CB ' ' A' ' 44' ' ' HIS . 56.8 mttp -81.14 102.39 10.25 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 176.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.52 53.39 4.82 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.078 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.48 -46.92 2.57 Favored Glycine 0 N--CA 1.435 -1.395 0 N-CA-C 112.025 -0.43 . . . . 0.0 112.025 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.9 p -147.1 159.24 9.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.458 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . 22.9 p-10 -69.52 142.78 53.6 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.315 0.578 . . . . 0.0 110.245 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.5 t -127.56 -115.2 0.27 Allowed 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.94 -176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -62.45 -58.11 8.8 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.1 m -84.62 168.92 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.682 175.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.458 ' HG2' ' HB2' ' A' ' 39' ' ' ASN . 84.5 mtt180 -137.78 140.19 40.46 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.419 ' CB ' ' HE3' ' A' ' 35' ' ' LYS . 35.6 m80 -122.33 -48.01 2.1 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.21 -81.92 1.04 Allowed Glycine 0 CA--C 1.495 -1.207 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.33 -80.28 0.09 OUTLIER Glycine 0 N--CA 1.414 -2.796 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.897 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 49.9 mm -114.35 154.18 15.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 123.433 0.693 . . . . 0.0 109.368 -175.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -128.35 133.5 48.68 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 122.941 0.496 . . . . 0.0 109.79 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.456 HG21 ' CG2' ' A' ' 64' ' ' ILE . 58.8 t -80.06 111.65 17.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 175.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' HB2' HG22 ' A' ' 30' ' ' THR . 38.7 ttpt -79.88 -41.71 25.68 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.034 -175.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.64 41.41 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.848 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 46.0 mm -113.47 124.16 69.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -81.2 122.18 81.16 Favored Pre-proline 0 C--N 1.3 -1.568 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' HA ' ' OE1' ' A' ' 59' ' ' GLU . 38.5 Cg_endo -69.16 80.26 0.72 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.666 2.244 . . . . 0.0 112.099 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -143.3 -42.93 0.29 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.147 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.51 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 156.09 -160.17 29.89 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 120.005 -1.093 . . . . 0.0 111.359 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.528 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 67.67 -102.68 0.07 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.347 1.459 . . . . 0.0 112.819 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.784 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -65.79 -36.69 84.24 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 118.355 0.525 . . . . 0.0 111.081 -176.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.464 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 45.1 tt0 -67.56 -47.6 69.35 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.265 1.026 . . . . 0.0 111.289 177.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 52.1 m -69.74 -42.68 73.6 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.694 -177.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -71.17 -27.72 63.73 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.048 0.928 . . . . 0.0 108.887 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.51 43.33 94.86 Favored Glycine 0 CA--C 1.498 -0.981 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.657 177.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.518 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 0.3 OUTLIER -107.19 -51.04 2.98 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.371 -0.415 . . . . 0.0 110.769 -178.491 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.692 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 59.1 mt -101.66 126.67 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.981 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -125.23 166.19 16.94 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -63.13 125.73 25.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.32 -23.61 15.61 Favored Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.683 -175.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.493 ' HB3' HD23 ' A' ' 101' ' ' LEU . 37.8 m-20 -66.82 141.53 57.66 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.32 0.581 . . . . 0.0 110.73 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -106.4 143.79 34.01 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.545 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.897 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 51.4 t -107.93 123.02 63.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.159 -175.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 102' ' ' GLU . 90.1 mt -99.36 -33.8 10.56 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.84 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.672 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -160.65 163.7 32.33 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.952 HG23 HD11 ' A' ' 78' ' ' LEU . 94.2 t -111.4 115.47 49.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 173.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 47.03 39.35 7.67 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 126.996 2.119 . . . . 0.0 110.983 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.83 -18.46 56.56 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 119.848 -1.168 . . . . 0.0 114.78 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.8 t -81.58 112.95 20.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 45.7 m -64.31 133.83 53.46 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.862 0.839 . . . . 0.0 113.06 -171.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.952 HD11 HG23 ' A' ' 73' ' ' VAL . 79.4 mt -107.39 15.49 24.88 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.733 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -71.26 97.54 1.57 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 178.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 108.84 9.81 25.79 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -175.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.424 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -86.45 142.96 28.01 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.0 t -85.56 168.09 14.8 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 172.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.418 ' O ' HG23 ' A' ' 87' ' ' VAL . 57.0 t-80 -50.38 -49.87 53.16 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.652 0.781 . . . . 0.0 110.915 -178.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -53.79 -38.62 64.69 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.939 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -70.58 -51.8 25.89 Favored 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 120.707 -0.397 . . . . 0.0 109.951 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.57 -57.93 8.99 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 123.97 0.794 . . . . 0.0 111.804 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 83' ' ' HIS . 37.9 t -65.84 -43.35 93.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.359 -173.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -72.49 -30.58 64.65 Favored 'General case' 0 CA--C 1.504 -0.811 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.756 -176.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.638 ' O ' HG23 ' A' ' 93' ' ' THR . 93.6 m -68.22 -43.18 78.55 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 25' ' ' LEU . 2.3 tp -75.25 -18.07 60.18 Favored 'General case' 0 N--CA 1.425 -1.712 0 C-N-CA 124.015 0.926 . . . . 0.0 111.445 -177.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -92.24 -33.35 14.7 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.829 -0.544 . . . . 0.0 109.729 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -82.32 -15.91 51.18 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 89' ' ' THR . 5.4 p -53.47 -63.17 1.23 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.442 0.639 . . . . 0.0 111.121 177.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 157.45 -162.92 32.25 Favored Glycine 0 N--CA 1.411 -2.97 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.748 ' HG3' ' HB2' ' A' ' 20' ' ' LYS . 63.5 tt0 -72.3 -44.59 62.51 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 117.257 0.529 . . . . 0.0 109.99 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 46.1 t -102.02 118.09 48.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.666 HG21 HD12 ' A' ' 90' ' ' LEU . 4.1 t -112.71 141.99 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.524 ' HD2' ' HB3' ' A' ' 17' ' ' GLU . 37.7 m80 -96.8 125.32 41.16 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 171.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.623 HD11 HG22 ' A' ' 73' ' ' VAL . 2.8 tp -120.58 132.91 55.38 Favored 'General case' 0 C--N 1.253 -3.597 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.4 tt -95.35 114.28 26.04 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -175.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.493 HD23 ' HB3' ' A' ' 68' ' ' ASP . 10.2 mp -119.64 171.3 8.47 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 121.556 0.693 . . . . 0.0 112.199 -177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.552 ' HB2' HD11 ' A' ' 71' ' ' LEU . 35.7 tt0 -131.4 123.08 27.44 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 101.618 -3.475 . . . . 0.0 101.618 171.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -58.13 126.34 27.06 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 123.683 0.614 . . . . 0.0 110.375 -173.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -113.78 24.81 11.54 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.197 -175.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.58 ' HG3' ' HB3' ' A' ' 10' ' ' PRO . 17.2 pt20 -69.39 115.15 8.32 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 121.545 0.688 . . . . 0.0 110.351 178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 99.8 t -123.7 116.02 27.96 Favored Pre-proline 0 N--CA 1.424 -1.76 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.927 -175.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.439 -1.705 0 C-N-CA 122.497 2.132 . . . . 0.0 109.36 174.619 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.1 mttp . . . . . 0 N--CA 1.432 -1.331 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 85.4 Cg_exo -46.64 127.94 12.36 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.473 2.115 . . . . 0.0 112.587 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.43 -16.36 41.35 Favored Glycine 0 C--O 1.244 0.768 0 C-N-CA 120.55 -0.833 . . . . 0.0 114.635 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -87.5 142.48 27.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 117.85 0.825 . . . . 0.0 109.297 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 102' ' ' GLU . 21.8 p -95.38 148.27 22.63 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.22 0.533 . . . . 0.0 111.34 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -149.42 147.69 28.56 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -103.91 98.06 7.96 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.477 HG12 HD13 ' A' ' 101' ' ' LEU . 8.4 p -82.87 127.56 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.825 -175.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -101.35 87.98 3.35 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.785 HD12 HD12 ' A' ' 25' ' ' LEU . 1.4 tm? -87.41 113.9 23.53 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -175.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.12 113.96 26.01 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.4 127.14 30.27 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 123.986 0.804 . . . . 0.0 110.455 -178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.6 p -82.3 -71.74 0.47 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 122.463 1.125 . . . . 0.0 111.506 -176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -156.61 -36.27 0.08 Allowed 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 113.547 -1.66 . . . . 0.0 106.678 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . -89.14 28.42 6.71 Favored Glycine 0 N--CA 1.432 -1.571 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.517 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 90.3 p 65.97 -142.31 0.18 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 126.103 1.761 . . . . 0.0 111.525 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.785 HD12 HD12 ' A' ' 18' ' ' LEU . 7.7 tp -67.82 -28.35 67.5 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.934 0.873 . . . . 0.0 109.306 -176.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.27 18.51 66.64 Favored Glycine 0 N--CA 1.411 -2.995 0 C-N-CA 119.951 -1.118 . . . . 0.0 114.693 172.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.432 HG22 HD13 ' A' ' 52' ' ' ILE . 12.3 pt -131.84 145.86 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 CA-C-O 121.303 0.573 . . . . 0.0 111.404 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 32.5 t -111.89 136.36 51.31 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 49' ' ' VAL . 32.1 m -126.14 149.9 31.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.581 0.705 . . . . 0.0 112.358 -175.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 13.5 t -125.41 145.36 50.09 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 83' ' ' HIS . 46.0 t -121.05 148.63 24.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.053 -176.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.509 HD13 ' HA ' ' A' ' 40' ' ' THR . 71.7 mt -95.51 115.15 27.03 Favored 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -147.58 -0.31 0.65 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.654 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -89.1 -167.11 1.78 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt -72.19 -49.64 33.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 67.17 -144.27 44.37 Favored Glycine 0 N--CA 1.44 -1.1 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.337 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -169.36 -90.04 0.08 OUTLIER Glycine 0 C--N 1.299 -1.524 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 40' ' ' THR . 28.1 m -111.16 153.54 12.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 177.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 75.96 -31.39 0.2 Allowed 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 124.93 1.292 . . . . 0.0 111.236 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.509 ' HA ' HD13 ' A' ' 32' ' ' LEU . 38.5 p -83.55 74.43 10.12 Favored 'General case' 0 N--CA 1.425 -1.719 0 C-N-CA 123.4 0.68 . . . . 0.0 109.488 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.3 p -77.22 -78.56 0.13 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.061 0.458 . . . . 0.0 109.814 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.6 m -48.37 130.01 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.365 0 CA-C-N 114.25 -1.341 . . . . 0.0 112.055 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 14.1 ptp180 -139.28 -5.22 1.44 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.92 175.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.646 ' CD2' ' HB2' ' A' ' 79' ' ' GLU . 84.7 t60 -94.38 -53.39 3.94 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 172.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -106.57 -158.97 21.83 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.16 63.87 0.81 Allowed Glycine 0 N--CA 1.415 -2.711 0 C-N-CA 118.995 -1.574 . . . . 0.0 112.034 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.01 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 50.5 mm -87.26 121.74 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 N-CA-C 104.577 -2.379 . . . . 0.0 104.577 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -121.31 131.17 54.05 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 119.547 -0.861 . . . . 0.0 113.3 -177.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.508 ' HA ' HG12 ' A' ' 29' ' ' VAL . 45.3 t -70.04 112.81 5.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.465 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 61.9 tttp -86.04 -36.86 19.44 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.359 -176.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.99 148.81 28.83 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.408 -175.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.679 HG12 ' HB3' ' A' ' 66' ' ' LYS . 46.5 mm -110.57 127.73 67.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 176.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.746 HG22 ' H ' ' A' ' 55' ' ' LYS . 44.9 mm -83.62 138.61 40.99 Favored Pre-proline 0 C--N 1.286 -2.165 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.957 -177.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -60.0 -16.52 39.48 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 124.13 3.22 . . . . 0.0 112.391 173.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.746 ' H ' HG22 ' A' ' 53' ' ' ILE . 51.3 tptt -121.16 35.97 4.74 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.87 128.57 6.73 Favored Glycine 1 N--CA 1.387 -4.575 0 CA-C-N 113.315 -1.766 . . . . 0.0 111.445 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.701 ' HB3' HD11 ' A' ' 18' ' ' LEU . . . -45.91 -33.61 3.36 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 126.578 1.951 . . . . 0.0 114.392 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.624 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -60.16 -36.06 76.71 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.202 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.607 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 31.7 tt0 -91.97 -40.01 11.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.425 0.631 . . . . 0.0 109.646 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.1 m -75.71 -48.49 21.71 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.148 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -74.92 -36.88 62.15 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.35 67.77 1.16 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.757 -1.11 . . . . 0.0 113.103 173.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.443 ' HB3' HG23 ' A' ' 16' ' ' VAL . 18.8 mmt180 -132.64 -75.65 0.5 Allowed 'General case' 0 CA--C 1.55 0.961 0 CA-C-O 121.337 0.589 . . . . 0.0 111.119 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.46 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 60.5 mt -78.62 146.76 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.099 0.959 . . . . 0.0 111.994 -174.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -116.35 163.75 15.56 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.679 ' HB3' HG12 ' A' ' 52' ' ' ILE . 51.5 pttt -81.88 135.0 35.45 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.436 0.636 . . . . 0.0 110.581 178.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.33 -11.52 43.57 Favored Glycine 0 N--CA 1.424 -2.145 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.054 -174.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.567 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 18.3 m-20 -66.44 146.44 54.55 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 -177.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.9 ttm180 -96.49 125.48 41.0 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-N 113.38 -1.736 . . . . 0.0 109.028 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.01 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 48.3 t -108.91 123.28 64.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 78.9 mt -96.8 -39.98 9.17 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.088 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.28 178.63 7.39 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.628 -175.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.798 ' HA ' HD12 ' A' ' 99' ' ' LEU . 24.5 t -116.01 105.37 18.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 175.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.693 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 10.7 p30 50.02 34.15 7.78 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 124.387 1.075 . . . . 0.0 113.116 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.01 -21.69 43.56 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.569 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.3 t -73.43 100.67 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.66 ' HB2' ' HG2' ' A' ' 79' ' ' GLU . 2.9 p -58.39 128.64 38.18 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 124.212 1.005 . . . . 0.0 113.269 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.8 mt -97.04 21.26 10.01 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.516 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.66 ' HG2' ' HB2' ' A' ' 77' ' ' SER . 7.7 pt-20 -74.36 126.34 30.46 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.793 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.16 12.92 62.73 Favored Glycine 0 C--N 1.298 -1.563 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 85' ' ' GLN . . . -108.35 142.39 38.76 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -178.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 84' ' ' LYS . 7.6 t -96.25 174.15 7.03 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 174.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.414 ' HB3' HG23 ' A' ' 31' ' ' VAL . 17.2 p-80 -51.3 -43.39 61.64 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -176.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.4 ' HG2' HG23 ' A' ' 82' ' ' THR . 20.9 ptmt -64.47 -33.4 75.8 Favored 'General case' 0 C--O 1.198 -1.648 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.408 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.426 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 77.6 mm-40 -72.62 -42.08 64.85 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.102 0.477 . . . . 0.0 109.848 -175.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -60.01 -53.94 51.91 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.252 176.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.493 ' HA ' HD12 ' A' ' 90' ' ' LEU . 57.9 t -67.07 -34.32 68.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -176.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -72.45 -26.85 61.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.27 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 85.9 m -70.35 -34.62 72.85 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 87.6 mt -71.69 -32.43 67.83 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.75 0.785 . . . . 0.0 109.8 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -69.05 -39.84 78.91 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.111 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -67.42 -40.19 85.5 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.482 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.4 p -65.32 147.37 53.56 Favored 'General case' 0 C--O 1.253 1.237 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 175.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.38 -133.68 0.22 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 115.785 1.074 . . . . 0.0 115.785 -172.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -74.26 -52.59 11.9 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.031 0.532 . . . . 0.0 111.293 -175.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.74 111.86 35.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.1 t -100.76 129.55 51.46 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.295 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 50.5 m80 -93.51 119.12 32.2 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 175.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.798 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.2 tp -121.98 138.48 54.41 Favored 'General case' 0 N--CA 1.401 -2.902 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.21 109.4 22.16 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -176.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.605 HD11 HD23 ' A' ' 99' ' ' LEU . 11.2 mp -118.32 169.02 10.08 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-O 121.982 0.896 . . . . 0.0 111.988 -177.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 36.0 tt0 -131.72 137.82 48.4 Favored 'General case' 0 N--CA 1.39 -3.459 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 173.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.567 ' HD3' ' OD1' ' A' ' 68' ' ' ASP . 15.7 tppt? -64.33 113.44 3.62 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.81 6.86 17.69 Favored Glycine 0 CA--C 1.482 -1.973 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.677 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -57.71 143.6 41.11 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 121.355 0.598 . . . . 0.0 111.659 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.3 t -120.32 82.54 31.53 Favored Pre-proline 0 N--CA 1.417 -2.124 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 N--CA 1.436 -1.901 0 C-N-CA 122.599 2.199 . . . . 0.0 110.002 -179.764 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.481 ' HE2' ' HB3' ' A' ' 9' ' ' LYS . 48.9 mtpt . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -68.34 42.78 0.27 Allowed 'Trans proline' 0 N--CA 1.509 2.404 0 C-N-CA 123.714 2.943 . . . . 0.0 112.028 172.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 9' ' ' LYS . . . -171.08 29.07 0.11 Allowed Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -84.24 136.47 33.93 Favored 'General case' 0 CA--C 1.491 -1.324 0 C-N-CA 123.378 0.671 . . . . 0.0 110.936 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 p -87.18 117.5 25.97 Favored 'General case' 0 C--N 1.279 -2.465 0 O-C-N 124.064 0.852 . . . . 0.0 109.942 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -134.25 149.37 50.94 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 50.2 mt-10 -106.1 110.98 23.41 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.675 HG11 HD11 ' A' ' 64' ' ' ILE . 10.5 p -89.39 124.02 41.91 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.854 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -174.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.31 89.06 7.84 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.027 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -96.05 115.45 27.45 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -175.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.19 115.46 29.9 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.007 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.513 ' HD3' ' HA ' ' A' ' 24' ' ' SER . 99.1 mttt -64.1 146.34 54.37 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.612 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -122.1 90.16 3.25 Favored 'General case' 0 N--CA 1.408 -2.574 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.094 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.7 t70 65.85 -65.81 0.17 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.51 1.524 . . . . 0.0 114.275 -177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.07 67.8 0.23 Allowed Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 -172.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.513 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 84.8 p 70.34 -173.73 0.18 Allowed 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.794 1.638 . . . . 0.0 114.224 169.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.587 HD22 ' HB3' ' A' ' 18' ' ' LEU . 80.9 mt -72.02 160.33 32.67 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -94.1 41.16 2.64 Favored Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.212 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.515 HG23 ' CB ' ' A' ' 58' ' ' ALA . 14.7 pt -135.13 137.6 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.806 0 CA-C-O 121.419 0.628 . . . . 0.0 111.426 177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -94.87 123.63 38.44 Favored 'General case' 0 N--CA 1.41 -2.432 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 174.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.527 HG22 ' H ' ' A' ' 30' ' ' THR . 12.3 p -93.54 175.87 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.114 0 O-C-N 123.321 0.388 . . . . 0.0 110.064 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.922 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 14.8 t -166.12 148.75 7.16 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' A' ' 82' ' ' THR . 12.2 p -113.66 122.83 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.74 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.527 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 90.5 mt -115.54 103.28 10.58 Favored 'General case' 0 C--N 1.282 -2.334 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -75.15 162.26 28.66 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.418 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.85 -8.49 43.31 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -66.95 139.77 57.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.659 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 155.81 -50.32 0.46 Allowed Glycine 0 N--CA 1.433 -1.502 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.76 -171.79 32.37 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 177.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.8 t -88.75 22.39 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 CA-C-O 122.512 1.148 . . . . 0.0 109.484 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -143.51 -64.58 0.38 Allowed 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.8 m 68.33 127.86 0.02 OUTLIER 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 124.467 1.107 . . . . 0.0 112.116 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.3 p -66.98 -34.89 78.75 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.243 0.544 . . . . 0.0 110.668 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 32' ' ' LEU . 59.3 t -56.21 137.82 17.47 Favored 'Isoleucine or valine' 0 C--O 1.255 1.373 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.212 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.505 ' HD2' ' N ' ' A' ' 43' ' ' ARG . 3.0 mpt_? -74.7 117.38 16.47 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -56.37 134.4 53.63 Favored 'General case' 0 C--N 1.319 -0.731 0 O-C-N 123.888 0.743 . . . . 0.0 111.272 -178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.97 -107.68 0.27 Allowed Glycine 0 N--CA 1.423 -2.222 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 -178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . 179.36 -83.1 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.871 0 C-N-CA 120.247 -0.978 . . . . 0.0 111.704 178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.642 HG13 ' HG ' ' A' ' 78' ' ' LEU . 43.4 mm -102.19 138.0 28.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -137.68 163.77 30.47 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.955 0.407 . . . . 0.0 110.122 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.459 HG21 HG21 ' A' ' 64' ' ' ILE . 56.9 t -88.3 113.61 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.952 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 169.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.922 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 59.3 tttm -76.24 -35.4 59.0 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.602 -177.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.734 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . . . -168.1 167.18 12.64 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.946 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.999 HG21 ' HB2' ' A' ' 59' ' ' GLU . 49.0 mm -108.47 122.82 63.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.0 mm -83.97 145.71 47.19 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -56.88 -133.36 0.0 OUTLIER 'Trans proline' 0 CA--C 1.561 1.872 0 C-N-CA 123.548 2.832 . . . . 0.0 114.389 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 75.3 -52.23 0.66 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.556 1.142 . . . . 0.0 110.716 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.19 -50.19 0.87 Allowed Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.688 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -8.97 -75.83 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 127.903 2.481 . . . . 0.0 116.149 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.027 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -96.02 -29.15 14.29 Favored 'General case' 0 C--O 1.255 1.359 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 -172.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.999 ' HB2' HG21 ' A' ' 52' ' ' ILE . 39.6 tt0 -82.93 -53.21 6.02 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 123.331 0.394 . . . . 0.0 111.542 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 m -86.95 -35.14 19.05 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.633 -171.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' ALA . 9.5 m-20 -101.3 -28.73 12.46 Favored 'General case' 0 CA--C 1.492 -1.287 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.28 -174.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -95.94 -131.21 6.6 Favored Glycine 0 N--CA 1.398 -3.876 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -154.32 2.65 0.23 Allowed 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -171.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.675 HD11 HG11 ' A' ' 16' ' ' VAL . 31.4 mt -90.45 148.44 4.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-N 115.848 -0.615 . . . . 0.0 112.525 -165.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -137.95 173.33 11.75 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 173.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.734 ' HB3' ' HA ' ' A' ' 51' ' ' ALA . 22.6 pttp -73.2 130.44 40.23 Favored 'General case' 0 N--CA 1.432 -1.335 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.283 176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.97 -20.77 8.5 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 120.115 -1.04 . . . . 0.0 113.507 -175.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.611 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 53.9 m-20 -71.78 138.52 48.45 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 117.453 0.626 . . . . 0.0 110.619 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -90.54 135.04 33.95 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.41 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.426 ' HB ' HG22 ' A' ' 47' ' ' ILE . 57.8 t -106.41 120.9 58.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.505 HD11 ' HB2' ' A' ' 102' ' ' GLU . 62.7 mt -96.41 -37.97 10.23 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.582 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.756 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -154.64 162.29 41.2 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.495 -173.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.786 ' HA ' HD12 ' A' ' 99' ' ' LEU . 56.3 t -115.39 106.95 21.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.3 t30 62.56 31.85 16.72 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 122.368 1.08 . . . . 0.0 109.761 174.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.56 -21.46 45.57 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 114.855 -1.066 . . . . 0.0 114.162 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 36.6 t -82.97 114.36 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 117.736 0.768 . . . . 0.0 109.725 -177.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.9 t -72.1 127.68 33.31 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 123.069 0.548 . . . . 0.0 110.723 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.642 ' HG ' HG13 ' A' ' 47' ' ' ILE . 2.0 pt? -131.46 30.07 4.49 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 42.5 mt-10 -69.32 -11.31 60.71 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.618 0.723 . . . . 0.0 110.643 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.57 21.51 25.84 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.825 174.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . -93.17 -154.48 0.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.177 0.513 . . . . 0.0 110.454 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.751 ' HA ' HG21 ' A' ' 31' ' ' VAL . 15.1 t -146.36 173.0 12.66 Favored 'General case' 0 N--CA 1.428 -1.566 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 175.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.518 ' CD2' HG13 ' A' ' 29' ' ' VAL . 51.7 t-80 -50.72 -60.29 3.2 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.78 1.232 . . . . 0.0 111.582 -176.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.412 ' HA ' HG12 ' A' ' 87' ' ' VAL . 57.0 tptt -59.67 -36.98 77.52 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 123.576 0.75 . . . . 0.0 110.945 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.402 ' HB2' ' H ' ' A' ' 82' ' ' THR . 15.1 mm100 -67.29 -45.06 77.69 Favored 'General case' 0 CA--C 1.503 -0.852 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.399 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.458 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -60.21 -51.29 70.2 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.931 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 3.1 p -68.81 -34.63 65.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.085 -173.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.718 ' HA ' ' HG2' ' A' ' 91' ' ' ARG . 20.5 mm-40 -77.64 -23.47 49.73 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.241 -0.583 . . . . 0.0 111.436 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.412 HG22 HG11 ' A' ' 73' ' ' VAL . 86.5 m -70.91 -28.5 64.57 Favored 'General case' 0 N--CA 1.437 -1.105 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.555 HD13 HD12 ' A' ' 25' ' ' LEU . 86.8 mt -73.58 -24.71 60.11 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.752 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.718 ' HG2' ' HA ' ' A' ' 88' ' ' GLU . 36.7 mmt180 -73.64 -49.84 24.04 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.65 -32.06 73.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.578 -174.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.496 HG21 HG12 ' A' ' 73' ' ' VAL . 1.3 p -63.87 -36.26 83.35 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 122.39 -140.42 13.41 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 119.712 -1.232 . . . . 0.0 113.427 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -88.46 -52.19 5.32 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 123.674 0.79 . . . . 0.0 109.933 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 65.5 t -99.31 111.49 29.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 43.6 t -105.86 120.94 57.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -93.08 70.54 4.54 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.786 HD12 ' HA ' ' A' ' 73' ' ' VAL . 6.7 tp -71.55 139.27 49.38 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 122.249 -0.282 . . . . 0.0 110.55 -172.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.756 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 55.9 tp -94.17 113.32 25.24 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.658 HD11 HD23 ' A' ' 99' ' ' LEU . 10.0 mp -117.66 166.66 12.14 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-O 121.551 0.691 . . . . 0.0 110.144 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.505 ' HB2' HD11 ' A' ' 71' ' ' LEU . 37.1 tt0 -128.48 124.44 36.12 Favored 'General case' 0 N--CA 1.389 -3.491 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 174.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -49.07 123.52 7.34 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 124.572 1.17 . . . . 0.0 110.409 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.611 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -115.37 -168.26 15.47 Favored Glycine 0 N--CA 1.421 -2.322 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -177.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -157.65 -57.76 0.08 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 26.1 t -118.14 127.4 26.62 Favored Pre-proline 0 N--CA 1.436 -1.161 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.073 -177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo . . . . . 0 N--CA 1.445 -1.345 0 C-N-CA 122.988 2.459 . . . . 0.0 111.705 178.552 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.515 -0.38 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.747 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 22.2 Cg_exo -63.78 139.9 71.17 Favored 'Trans proline' 0 C--O 1.245 0.848 0 C-N-CA 121.525 1.483 . . . . 0.0 111.918 -177.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.14 6.85 74.41 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.87 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.526 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 27.0 t70 -97.11 145.55 25.89 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 122.799 -0.236 . . . . 0.0 110.816 -178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -93.1 114.18 26.64 Favored 'General case' 0 N--CA 1.426 -1.667 0 O-C-N 123.491 0.494 . . . . 0.0 109.803 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.433 ' HE2' ' HD2' ' A' ' 63' ' ' ARG . 5.6 p90 -127.78 159.61 34.29 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-O 121.152 0.501 . . . . 0.0 111.463 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -106.05 130.44 53.97 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.412 HG22 ' CE2' ' A' ' 14' ' ' PHE . 12.4 t -110.88 132.3 59.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -175.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' HG3' ' CD2' ' A' ' 98' ' ' HIS . 26.1 mp0 -97.76 87.06 3.93 Favored 'General case' 0 C--O 1.248 1.009 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 171.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.085 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -96.94 116.64 29.54 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -176.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.478 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -92.9 125.12 37.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 86.7 mttt -67.66 163.92 20.37 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-O 121.844 0.831 . . . . 0.0 111.571 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.422 HG21 ' O ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -88.52 33.1 0.76 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.616 175.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.7 t70 67.99 -28.82 0.15 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.307 2.243 . . . . 0.0 113.024 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -77.04 -58.53 3.39 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.7 t -167.05 -175.29 2.95 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.628 HD12 HG12 ' A' ' 27' ' ' ILE . 0.2 OUTLIER -85.85 139.55 31.17 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.328 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.48 43.02 2.84 Favored Glycine 0 C--N 1.295 -1.743 0 C-N-CA 120.665 -0.778 . . . . 0.0 113.717 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.628 HG12 HD12 ' A' ' 25' ' ' LEU . 18.9 pt -138.32 148.69 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.132 0 CA-C-N 118.133 0.967 . . . . 0.0 111.765 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.67 ' HB2' HD11 ' A' ' 53' ' ' ILE . 39.4 t -108.5 109.65 20.96 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' HG23 ' A' ' 47' ' ' ILE . 26.9 m -104.87 144.82 14.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 123.877 0.736 . . . . 0.0 110.296 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 50' ' ' LYS . 12.8 t -144.0 157.88 44.06 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 46' ' ' GLY . 56.1 t -89.6 113.29 25.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.9 mt -94.03 99.57 11.86 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.249 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -126.91 22.65 6.72 Favored 'General case' 0 N--CA 1.423 -1.795 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -73.51 108.12 6.19 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.15 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -90.51 103.84 16.49 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.162 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 134.55 161.39 9.49 Favored Glycine 0 N--CA 1.425 -2.068 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.222 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.38 -139.11 4.57 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.5 t -79.65 -42.38 22.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -136.51 178.6 6.94 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 113.358 -1.746 . . . . 0.0 106.809 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.0 m -89.14 81.47 6.76 Favored 'General case' 0 N--CA 1.417 -2.083 0 C-N-CA 119.65 -0.82 . . . . 0.0 108.957 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.6 t -106.4 132.34 52.55 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.49 80.05 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 CA-C-O 122.505 1.145 . . . . 0.0 109.651 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -93.18 29.6 1.85 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.309 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -87.78 155.37 19.93 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 113.811 -1.541 . . . . 0.0 110.39 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.59 147.05 11.5 Favored Glycine 0 N--CA 1.418 -2.53 0 N-CA-C 108.243 -1.943 . . . . 0.0 108.243 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.671 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . -53.37 -50.69 51.59 Favored Glycine 0 CA--C 1.476 -2.398 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 178.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.591 HG23 ' HB ' ' A' ' 29' ' ' VAL . 18.9 mm -139.29 142.76 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 173.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.468 ' OH ' ' HA2' ' A' ' 67' ' ' GLY . 52.9 t80 -140.52 141.93 35.27 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.3 t -79.28 108.09 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.358 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.53 ' HB2' HG22 ' A' ' 30' ' ' THR . 53.3 tttp -82.27 -35.8 27.7 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.811 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -157.65 158.87 36.28 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.735 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.068 HG21 ' HB2' ' A' ' 59' ' ' GLU . 31.7 mm -111.7 113.45 44.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 28' ' ' SER . 2.0 mp -83.41 128.33 64.77 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 53.2 Cg_exo -59.94 88.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 124.14 3.227 . . . . 0.0 115.142 -177.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' O ' HG21 ' A' ' 21' ' ' THR . 2.4 mptm? -125.09 -27.23 3.57 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.681 170.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.633 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 93.89 49.12 2.54 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -175.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -122.26 -77.77 0.59 Allowed 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.166 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.085 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -83.25 -31.44 26.98 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -170.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.068 ' HB2' HG21 ' A' ' 52' ' ' ILE . 40.0 tt0 -80.02 -45.39 18.46 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 124.645 1.216 . . . . 0.0 110.268 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.633 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 1.2 m -85.09 -47.86 9.76 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.264 -168.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -100.7 -21.5 15.2 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.931 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.84 -132.26 6.36 Favored Glycine 1 N--CA 1.393 -4.219 0 C-N-CA 120.128 -1.034 . . . . 0.0 113.93 -173.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.433 ' HD2' ' HE2' ' A' ' 14' ' ' PHE . 40.1 mtt180 -156.24 -1.54 0.13 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -169.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.773 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 60.2 mt -96.22 132.05 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.145 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.546 -169.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.421 ' HA ' HG13 ' A' ' 52' ' ' ILE . 81.4 m-70 -139.67 170.48 15.82 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.6 pttt -69.22 129.79 40.84 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.459 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.468 ' HA2' ' OH ' ' A' ' 48' ' ' TYR . . . 123.8 -26.08 6.01 Favored Glycine 0 C--N 1.291 -1.972 0 C-N-CA 120.081 -1.057 . . . . 0.0 111.848 -172.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.473 ' HB3' HD23 ' A' ' 101' ' ' LEU . 18.2 m-20 -72.86 133.91 44.62 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.471 ' CG ' ' HB3' ' A' ' 102' ' ' GLU . 4.5 ptm180 -100.84 151.15 22.06 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.536 HG22 ' HG ' ' A' ' 101' ' ' LEU . 47.3 t -112.83 127.2 70.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.443 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 -176.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.9 mt -100.87 -34.3 9.86 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.345 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -159.55 175.11 13.64 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.466 -175.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.991 HG11 HG21 ' A' ' 89' ' ' THR . 4.7 p -130.64 110.21 18.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 124.943 1.297 . . . . 0.0 109.523 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 62.68 30.17 16.86 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 122.412 1.101 . . . . 0.0 108.151 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.04 -18.69 46.59 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.259 -0.882 . . . . 0.0 114.079 -174.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.0 t -81.82 122.76 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.4 t -58.17 140.45 52.93 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.686 HD11 ' HB ' ' A' ' 73' ' ' VAL . 81.2 mt -118.06 -3.02 11.14 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.865 175.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.671 ' HA ' ' HA3' ' A' ' 46' ' ' GLY 0.261 1.0 OUTLIER -76.97 103.95 7.19 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 122.475 1.131 . . . . 0.0 110.43 177.888 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 119.45 -6.28 12.83 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -173.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -86.81 149.61 24.72 Favored 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 84' ' ' LYS . 5.1 t -79.14 154.14 29.55 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 169.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 42.8 p-80 -51.55 -36.73 46.41 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 120.759 0.314 . . . . 0.0 111.826 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.447 ' HB2' HG23 ' A' ' 82' ' ' THR . 94.6 mttt -48.9 -53.61 18.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.36 173.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -66.89 -35.7 80.6 Favored 'General case' 0 CA--C 1.5 -0.961 0 O-C-N 123.375 0.422 . . . . 0.0 111.458 -175.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.519 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -58.47 -49.84 75.89 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.433 0.635 . . . . 0.0 109.805 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.6 t -69.92 -32.94 53.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.392 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 45.1 mt-10 -66.56 -34.14 77.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 110.091 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.991 HG21 HG11 ' A' ' 73' ' ' VAL . 50.6 m -71.01 -29.15 65.02 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.328 0.585 . . . . 0.0 109.491 174.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 95.1 mt -71.41 -24.03 61.97 Favored 'General case' 0 C--O 1.207 -1.148 0 CA-C-O 121.077 0.465 . . . . 0.0 109.982 176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -90.74 -15.49 30.12 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.058 0.456 . . . . 0.0 111.092 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -81.27 -35.08 31.59 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 p -75.01 154.67 37.94 Favored 'General case' 0 C--O 1.252 1.228 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.169 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.27 -136.79 1.67 Allowed Glycine 0 C--N 1.314 -0.66 0 N-CA-C 114.349 0.5 . . . . 0.0 114.349 -174.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.448 ' OE1' ' HB2' ' A' ' 20' ' ' LYS . 5.2 tp-100 -72.39 -46.84 53.48 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.745 0.784 . . . . 0.0 109.361 -177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 52.4 t -102.19 119.0 49.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.481 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 41.4 t -104.57 129.62 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.092 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.805 -178.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.54 ' CD2' ' HG3' ' A' ' 17' ' ' GLU . 26.6 m170 -89.5 122.62 32.86 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 169.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.71 HD23 HD11 ' A' ' 101' ' ' LEU . 4.9 tp -130.0 147.86 51.8 Favored 'General case' 0 C--N 1.271 -2.844 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.7 tt -110.11 116.56 31.76 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 -177.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.71 HD11 HD23 ' A' ' 99' ' ' LEU . 7.5 mp -122.64 175.38 6.53 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.472 0.653 . . . . 0.0 111.001 -176.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 26.9 tt0 -128.3 119.99 26.19 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.747 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -50.02 106.46 0.12 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.006 1.322 . . . . 0.0 110.656 -173.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.512 ' N ' ' HE3' ' A' ' 103' ' ' LYS . . . -113.13 89.85 0.53 Allowed Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.868 -177.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.427 ' HG3' ' HD3' ' A' ' 103' ' ' LYS . 21.8 mt-30 -95.88 100.33 12.03 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 173.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 47.4 t -126.03 115.77 24.03 Favored Pre-proline 0 C--N 1.292 -1.935 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 2.7 Cg_exo . . . . . 0 C--O 1.26 1.6 0 C-N-CA 122.703 2.269 . . . . 0.0 110.89 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.783 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 53.1 mtmt . . . . . 0 CA--C 1.547 0.843 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.783 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 53.8 Cg_endo -87.18 34.86 0.44 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.958 2.438 . . . . 0.0 112.889 -170.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.88 30.19 0.06 OUTLIER Glycine 0 C--N 1.292 -1.882 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 59.0 t0 -88.93 143.16 27.06 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -176.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 p -96.78 116.07 28.51 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 123.639 0.775 . . . . 0.0 110.397 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -144.35 132.44 21.64 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.35 0.595 . . . . 0.0 112.259 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.507 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 41.8 mt-10 -81.13 99.21 8.4 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.095 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.502 HG11 HG13 ' A' ' 64' ' ' ILE . 55.5 t -68.38 131.08 33.76 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.143 -177.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -92.61 98.96 11.76 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.977 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -110.95 118.76 36.97 Favored 'General case' 0 N--CA 1.415 -2.207 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.998 -179.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.8 126.33 41.87 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.294 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.644 ' HE2' HD22 ' A' ' 25' ' ' LEU . 95.3 mttt -76.11 137.99 40.48 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.086 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -73.58 -41.04 63.41 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -173.05 -65.01 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.399 0.619 . . . . 0.0 109.844 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.85 63.7 3.17 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.555 -176.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.547 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 23.3 t 69.48 -168.11 0.17 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 124.867 1.267 . . . . 0.0 112.691 175.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.644 HD22 ' HE2' ' A' ' 20' ' ' LYS . 2.5 mm? -73.51 159.28 33.41 Favored 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 123.743 0.817 . . . . 0.0 110.757 -177.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -98.7 38.37 3.13 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.472 HD13 HD13 ' A' ' 64' ' ' ILE . 23.8 pt -137.1 144.51 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.666 0 CA-C-O 121.454 0.645 . . . . 0.0 111.343 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.425 ' HB2' HG12 ' A' ' 53' ' ' ILE . 28.3 t -106.17 115.22 29.84 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.77 148.65 16.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.869 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.1 t -150.0 167.84 25.56 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.858 HG11 ' HA ' ' A' ' 82' ' ' THR . 13.6 p -120.88 114.12 42.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 121.337 0.589 . . . . 0.0 110.227 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.81 86.23 7.37 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 36' ' ' GLY . 55.8 t80 -161.82 108.37 1.34 Allowed 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.334 -1.303 . . . . 0.0 108.919 -174.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -88.59 -63.94 1.22 Allowed 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -135.4 9.98 3.45 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.397 -1.335 . . . . 0.0 107.397 171.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 33' ' ' PHE . . . 162.72 -145.23 10.4 Favored Glycine 0 N--CA 1.423 -2.225 0 N-CA-C 107.989 -2.044 . . . . 0.0 107.989 -177.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.87 164.41 26.55 Favored Glycine 0 N--CA 1.431 -1.67 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.148 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 t -89.94 66.27 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-O 122.389 1.09 . . . . 0.0 108.759 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -144.26 108.5 4.79 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 p -82.25 79.57 8.69 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-O 121.985 0.898 . . . . 0.0 111.782 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.5 t -162.17 94.48 0.91 Allowed 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.5 t -139.65 89.64 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 -175.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -134.43 -58.09 0.84 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.018 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.54 ' HD2' HD22 ' A' ' 71' ' ' LEU . 1.7 p-80 -153.71 134.97 14.09 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.524 -176.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.786 ' HA3' ' HA ' ' A' ' 71' ' ' LEU . . . 71.69 -159.02 53.69 Favored Glycine 0 C--O 1.247 0.929 0 C-N-CA 121.325 -0.464 . . . . 0.0 112.654 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 31' ' ' VAL . . . 156.71 26.95 0.03 OUTLIER Glycine 0 C--O 1.217 -0.947 0 C-N-CA 119.9 -1.143 . . . . 0.0 113.693 179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.889 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.6 mm -101.87 148.67 7.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 79.7 t80 -125.13 128.02 47.78 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 122.004 -0.435 . . . . 0.0 111.679 -176.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 47.7 t -71.99 105.66 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 171.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.6 ' HB2' HG22 ' A' ' 30' ' ' THR . 87.1 tttt -77.93 -40.17 40.48 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.521 -175.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.6 165.06 33.56 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.781 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.1 mm -102.8 109.75 27.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.509 HG23 ' HD2' ' A' ' 54' ' ' PRO . 27.1 mm -72.86 154.24 91.06 Favored Pre-proline 0 C--N 1.294 -1.816 0 C-N-CA 124.601 1.161 . . . . 0.0 110.087 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HD2' HG23 ' A' ' 53' ' ' ILE . 87.4 Cg_exo -52.4 -158.32 0.0 OUTLIER 'Trans proline' 0 CA--C 1.573 2.44 0 C-N-CA 123.383 2.722 . . . . 0.0 113.572 170.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? 76.53 -51.44 0.59 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.684 1.194 . . . . 0.0 111.273 -173.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 130.44 -120.5 3.04 Favored Glycine 0 N--CA 1.414 -2.798 0 N-CA-C 107.728 -2.149 . . . . 0.0 107.728 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.821 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 70.05 -91.13 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 124.102 0.961 . . . . 0.0 112.897 170.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.977 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -75.34 -37.42 60.7 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.61 -46.36 66.43 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 124.985 1.428 . . . . 0.0 108.702 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 17.1 m -70.41 -43.63 69.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.268 -174.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -73.86 -30.12 62.49 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.1 33.44 36.28 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.514 175.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -95.21 -59.32 1.92 Allowed 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.716 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.738 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.7 mt -86.51 131.48 34.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -119.72 161.93 19.89 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.9 pttt -81.85 144.72 30.82 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 118.751 -1.18 . . . . 0.0 110.555 -177.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.417 ' HA2' ' CZ ' ' A' ' 48' ' ' TYR . . . 102.6 -6.94 52.99 Favored Glycine 0 N--CA 1.419 -2.481 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -176.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -87.4 154.21 20.84 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.39 0.614 . . . . 0.0 111.837 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -100.45 141.73 32.9 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.896 0.855 . . . . 0.0 112.784 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.889 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 58.9 t -106.55 125.56 62.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 114.013 -1.448 . . . . 0.0 107.22 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.899 HD11 ' HB2' ' A' ' 102' ' ' GLU . 28.3 mt -100.94 -35.5 9.37 Favored 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.991 -176.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.557 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -160.7 166.52 28.65 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.874 HG23 HD11 ' A' ' 78' ' ' LEU . 48.1 t -119.13 108.09 23.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 124.841 1.256 . . . . 0.0 108.333 176.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.5 t30 56.98 52.9 8.62 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 124.048 0.939 . . . . 0.0 110.559 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.6 -25.08 3.45 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 114.85 -1.068 . . . . 0.0 114.33 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.9 t -81.11 110.85 17.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 117.686 0.743 . . . . 0.0 109.826 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.532 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 38.6 m -63.13 140.04 58.83 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.268 0.98 . . . . 0.0 112.106 -175.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.874 HD11 HG23 ' A' ' 73' ' ' VAL . 55.2 mt -110.52 76.32 0.98 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.505 ' HG2' ' H ' ' A' ' 45' ' ' GLY . 38.9 mt-10 -107.1 125.47 51.1 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.27 32.96 81.16 Favored Glycine 0 C--N 1.31 -0.907 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 -175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.14 138.18 39.43 Favored 'General case' 0 CA--C 1.485 -1.529 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.858 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.8 t -82.82 159.35 22.46 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 173.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.869 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 39.2 p-80 -52.09 -39.13 59.3 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 123.073 0.233 . . . . 0.0 111.599 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.99 -39.94 91.58 Favored 'General case' 0 C--O 1.206 -1.234 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.785 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.52 ' HG2' HG22 ' A' ' 82' ' ' THR . 74.8 mm-40 -67.23 -44.7 78.85 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -57.39 -51.51 69.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.421 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.509 ' HA ' HD12 ' A' ' 90' ' ' LEU . 85.6 t -68.16 -31.83 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.514 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -66.58 -30.67 71.02 Favored 'General case' 0 CA--C 1.504 -0.822 0 O-C-N 121.768 -0.582 . . . . 0.0 110.243 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.8 m -76.74 -28.14 55.65 Favored 'General case' 0 N--CA 1.426 -1.637 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.183 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 87' ' ' VAL . 95.9 mt -73.37 -33.54 65.1 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.75 0.785 . . . . 0.0 109.68 175.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -76.26 -29.45 57.48 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.526 176.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -72.63 -31.81 65.42 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.85 177.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 16.5 p -72.3 163.35 28.1 Favored 'General case' 0 C--O 1.248 1.01 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 174.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.18 -123.8 0.5 Allowed Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.887 -178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -94.64 -42.11 8.95 Favored 'General case' 0 C--N 1.308 -1.223 0 O-C-N 122.794 -0.239 . . . . 0.0 111.14 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.36 110.71 27.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.42 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 39.4 t -99.58 121.51 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.199 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.726 -178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.439 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 42.4 m80 -91.29 98.88 11.98 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 174.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.823 HD12 ' HA ' ' A' ' 73' ' ' VAL . 9.6 tp -101.13 129.36 47.02 Favored 'General case' 0 C--N 1.268 -2.959 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -172.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.767 HD22 HD12 ' A' ' 71' ' ' LEU . 1.8 tt -86.38 109.11 18.79 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.692 HD11 HD23 ' A' ' 99' ' ' LEU . 8.9 mp -115.62 164.89 13.67 Favored 'General case' 0 CA--C 1.488 -1.432 0 CA-C-O 121.504 0.669 . . . . 0.0 111.621 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.899 ' HB2' HD11 ' A' ' 71' ' ' LEU . 35.0 tt0 -131.25 135.64 47.52 Favored 'General case' 0 N--CA 1.409 -2.512 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 172.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 39.5 tptt -58.67 114.78 2.66 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -104.17 12.05 51.94 Favored Glycine 0 CA--C 1.482 -1.984 0 C-N-CA 120.868 -0.682 . . . . 0.0 113.79 -167.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -63.88 135.27 56.42 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 31.9 m -70.04 150.39 96.22 Favored Pre-proline 0 C--N 1.303 -1.415 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.534 -175.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo . . . . . 0 C--O 1.25 1.084 0 C-N-CA 122.777 2.318 . . . . 0.0 110.992 179.171 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.564 ' CD ' ' HB2' ' A' ' 12' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.422 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.729 ' HG3' HG22 ' A' ' 106' ' ' VAL . 17.1 Cg_endo -55.49 131.55 46.83 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.939 2.426 . . . . 0.0 112.977 -178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.2 8.44 71.75 Favored Glycine 0 C--N 1.314 -0.691 0 CA-C-N 116.047 -0.524 . . . . 0.0 113.066 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.564 ' HB2' ' CD ' ' A' ' 9' ' ' LYS . 6.5 t70 -110.59 154.37 23.85 Favored 'General case' 0 CA--C 1.504 -0.811 0 O-C-N 122.395 -0.473 . . . . 0.0 110.001 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.9 p -86.94 135.88 33.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 123.776 0.672 . . . . 0.0 110.534 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -146.85 145.88 30.01 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.078 0.466 . . . . 0.0 110.049 178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -105.75 132.15 52.23 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.9 t -118.71 135.91 57.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.796 -175.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.544 ' HG2' HG11 ' A' ' 96' ' ' VAL . 43.6 tt0 -109.48 86.61 2.32 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 172.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.915 HD11 ' HB1' ' A' ' 57' ' ' ALA . 1.3 tm? -99.14 125.73 44.75 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -171.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -98.3 144.5 27.64 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 120.649 0.262 . . . . 0.0 111.076 -175.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.684 ' HE2' HD11 ' A' ' 25' ' ' LEU . 1.2 mptm? -68.2 143.52 55.3 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.966 177.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.615 HG23 ' HB2' ' A' ' 57' ' ' ALA . 59.0 p -91.58 -165.89 1.45 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.22 -26.11 49.97 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.126 0.57 . . . . 0.0 111.118 173.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.88 56.96 0.73 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.284 -178.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.4 t 77.43 -168.59 0.06 Allowed 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.232 1.413 . . . . 0.0 109.429 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.684 HD11 ' HE2' ' A' ' 20' ' ' LYS . 4.3 mp -66.17 -76.81 0.07 Allowed 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 122.04 0.924 . . . . 0.0 109.787 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.97 ' HA2' ' HD2' ' A' ' 54' ' ' PRO . . . 147.31 -8.58 1.22 Allowed Glycine 0 CA--C 1.463 -3.187 0 C-N-CA 119.757 -1.211 . . . . 0.0 111.181 -172.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.409 HG22 ' CD1' ' A' ' 52' ' ' ILE . 16.7 pt -102.71 112.73 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.607 0 CA-C-O 122.722 1.248 . . . . 0.0 112.851 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.7 m -101.31 126.13 48.03 Favored 'General case' 0 C--N 1.263 -3.191 0 CA-C-N 112.59 -2.096 . . . . 0.0 106.686 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 49' ' ' VAL . 33.7 m -110.91 153.87 12.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.055 0.455 . . . . 0.0 111.586 -173.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.665 ' HB ' ' HD3' ' A' ' 50' ' ' LYS . 11.2 t -121.31 156.46 32.5 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 174.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.518 HG12 HD13 ' A' ' 47' ' ' ILE . 33.1 m -110.69 128.59 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.93 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.939 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 pp -163.48 -178.83 6.09 Favored 'General case' 0 C--N 1.271 -2.843 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 43' ' ' ARG . 16.8 p90 -137.49 -34.73 0.69 Allowed 'General case' 0 C--N 1.274 -2.714 0 C-N-CA 119.134 -1.026 . . . . 0.0 112.337 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -80.86 118.84 22.72 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 41' ' ' SER . 22.5 ttpp -140.37 147.8 40.32 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.92 -112.95 1.59 Allowed Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.76 -124.2 6.72 Favored Glycine 0 C--N 1.299 -1.478 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -81.96 -24.94 9.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 121.295 0.569 . . . . 0.0 110.8 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -135.46 159.74 40.63 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.4 m -72.07 93.79 1.44 Allowed 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.389 0.614 . . . . 0.0 109.863 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 35' ' ' LYS . 27.0 m -78.52 141.26 38.3 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.555 177.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.2 m -66.15 151.19 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.827 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 33' ' ' PHE . 1.9 ptm180 -94.62 1.89 55.6 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.224 -176.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -88.78 91.66 8.91 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 174.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.439 ' HA2' ' OE2' ' A' ' 79' ' ' GLU . . . -158.02 173.48 35.26 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.402 ' HA3' ' N ' ' A' ' 80' ' ' GLY . . . -139.09 -54.42 0.05 OUTLIER Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.165 -1.017 . . . . 0.0 113.662 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.689 HG13 ' HG ' ' A' ' 78' ' ' LEU . 50.8 mm -102.37 123.78 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.057 -175.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.467 ' CZ ' ' HD3' ' A' ' 69' ' ' ARG . 81.4 m-85 -131.21 114.22 14.81 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.506 ' HA ' HG12 ' A' ' 29' ' ' VAL . 50.1 t -47.86 117.74 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.481 0.658 . . . . 0.0 109.983 171.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.665 ' HD3' ' HB ' ' A' ' 30' ' ' THR . 38.0 ttpt -92.76 -31.11 15.18 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.331 -176.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . . . -167.64 156.99 10.03 Favored 'General case' 0 C--O 1.249 1.03 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.759 -177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.862 HG21 ' HB2' ' A' ' 59' ' ' GLU . 16.7 mm -109.88 119.29 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 174.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.925 ' HB ' ' HD3' ' A' ' 54' ' ' PRO . 2.7 mp -108.43 -71.06 0.03 OUTLIER Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -172.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.97 ' HD2' ' HA2' ' A' ' 26' ' ' GLY . 45.3 Cg_exo -60.18 -163.35 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 124.882 3.722 . . . . 0.0 117.692 -172.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -35.61 -50.75 0.62 Allowed 'General case' 0 C--N 1.352 0.71 0 C-N-CA 127.892 2.477 . . . . 0.0 113.455 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -175.96 -98.77 0.11 Allowed Glycine 0 N--CA 1.415 -2.738 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.915 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 66.08 -92.34 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.051 1.34 . . . . 0.0 111.314 177.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.626 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -70.61 -39.84 73.52 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -177.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.862 ' HB2' HG21 ' A' ' 52' ' ' ILE . 35.4 tt0 -76.43 -42.58 43.6 Favored 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 123.556 0.535 . . . . 0.0 111.629 -178.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 34.0 p -74.94 -35.31 62.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.855 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -73.65 -26.57 60.82 Favored 'General case' 0 CA--C 1.506 -0.716 0 C-N-CA 119.489 -0.884 . . . . 0.0 109.326 172.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.07 44.94 86.64 Favored Glycine 0 CA--C 1.49 -1.483 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.996 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -111.25 -54.62 2.59 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.348 0.594 . . . . 0.0 109.556 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.626 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 64.9 mt -101.26 130.1 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.461 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -132.14 173.33 11.34 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 61.3 pttt -74.83 132.03 41.22 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.326 -0.95 . . . . 0.0 112.089 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.27 -20.66 13.8 Favored Glycine 0 N--CA 1.428 -1.835 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.729 -174.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.429 ' OD1' ' HD2' ' A' ' 103' ' ' LYS . 78.8 m-20 -69.47 138.15 53.2 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-O 121.556 0.694 . . . . 0.0 111.683 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.467 ' HD3' ' CZ ' ' A' ' 48' ' ' TYR . 33.1 ttp180 -95.5 133.88 38.99 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.313 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 71.0 t -101.74 103.94 15.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 102' ' ' GLU . 84.9 mt -76.87 -36.01 57.04 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.217 -176.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -164.51 167.36 19.52 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.16 -176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.702 ' HA ' HD12 ' A' ' 99' ' ' LEU . 44.3 t -113.33 115.53 50.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 172.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 10.6 p30 47.01 35.36 3.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.424 1.49 . . . . 0.0 112.768 -176.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.62 -6.24 82.18 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.506 -0.854 . . . . 0.0 114.092 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 39.8 t -92.6 109.64 21.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.7 m -69.64 134.67 48.99 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -173.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.689 ' HG ' HG13 ' A' ' 47' ' ' ILE . 1.6 pt? -130.34 17.24 5.45 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.099 176.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.439 ' OE2' ' HA2' ' A' ' 45' ' ' GLY . 5.4 mm-40 -62.9 97.89 0.12 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.518 175.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' N ' ' HA3' ' A' ' 46' ' ' GLY . . . 119.01 17.35 5.02 Favored Glycine 0 N--CA 1.433 -1.524 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.598 -177.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.493 ' HB3' HD11 ' A' ' 47' ' ' ILE . . . -94.34 176.74 6.19 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 176.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.46 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.8 t -97.18 158.75 15.29 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 169.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -51.16 -44.19 61.41 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.595 0.758 . . . . 0.0 112.381 -177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 23.8 tptp -55.91 -43.45 77.34 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 123.92 0.888 . . . . 0.0 110.986 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 -69.28 -43.9 72.93 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.622 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -55.24 -54.48 42.9 Favored 'General case' 0 C--O 1.243 0.72 0 O-C-N 124.08 0.862 . . . . 0.0 111.468 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -67.56 -26.75 36.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.919 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 91.0 mt-10 -72.04 -28.49 63.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.809 177.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.517 HG22 HG11 ' A' ' 73' ' ' VAL . 22.5 m -70.5 -31.41 68.5 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 89.3 mt -72.72 -24.4 60.98 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.105 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -79.56 -34.24 41.12 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -63.15 -40.63 98.13 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.71 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.441 ' OG1' HG22 ' A' ' 97' ' ' VAL . 19.4 p -68.94 138.25 54.45 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.8 -121.6 0.02 OUTLIER Glycine 0 CA--C 1.52 0.381 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 -172.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.806 ' HG3' HG23 ' A' ' 96' ' ' VAL . 14.1 pt20 -77.11 -27.51 54.1 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.512 0.672 . . . . 0.0 110.463 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.806 HG23 ' HG3' ' A' ' 95' ' ' GLN . 21.5 t -125.44 150.02 30.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.533 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 35.8 t -120.26 126.03 74.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 122.921 0.489 . . . . 0.0 109.853 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 41.2 m80 -86.77 119.09 26.63 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 167.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.702 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.2 tp -127.93 147.91 50.49 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -110.71 117.86 34.6 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.699 HD11 HD23 ' A' ' 99' ' ' LEU . 6.0 mp -124.77 174.31 7.99 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.526 0.679 . . . . 0.0 111.37 -178.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HB2' HD11 ' A' ' 71' ' ' LEU . 31.0 tt0 -131.6 130.62 42.42 Favored 'General case' 0 N--CA 1.396 -3.165 0 N-CA-C 102.761 -3.051 . . . . 0.0 102.761 173.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 103' ' ' LYS . 40.6 tptt -64.09 126.25 27.11 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -175.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -116.68 16.37 14.02 Favored Glycine 0 C--N 1.301 -1.378 0 C-N-CA 121.016 -0.612 . . . . 0.0 113.314 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.472 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -168.38 165.68 12.65 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.729 HG22 ' HG3' ' A' ' 10' ' ' PRO . 48.2 t -103.24 121.72 47.78 Favored Pre-proline 0 C--N 1.303 -1.413 0 O-C-N 123.148 0.28 . . . . 0.0 110.739 177.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 5.1 Cg_endo . . . . . 0 N--CA 1.437 -1.804 0 C-N-CA 122.671 2.248 . . . . 0.0 109.634 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.5 mttm . . . . . 0 N--CA 1.446 -0.673 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.669 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 37.8 Cg_exo -56.57 128.85 31.73 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 121.143 1.229 . . . . 0.0 109.82 175.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 105.82 -13.81 45.74 Favored Glycine 0 N--CA 1.432 -1.583 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.178 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.23 134.29 42.69 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 117.053 0.426 . . . . 0.0 110.398 177.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 17.3 p -102.3 111.13 23.3 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-O 121.74 0.781 . . . . 0.0 110.451 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.415 ' CE2' ' HB ' ' A' ' 16' ' ' VAL . 44.8 p90 -125.61 162.96 23.81 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.858 -177.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 40.1 mt-10 -108.07 94.12 4.9 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 12.4 p -80.09 135.07 26.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.408 -175.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -90.18 108.33 19.68 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 58' ' ' ALA . 2.1 tm? -113.9 108.12 16.62 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.32 149.69 22.88 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.591 ' HD2' ' HA ' ' A' ' 24' ' ' SER . 27.3 mmtp -71.07 114.9 9.59 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 178.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 56' ' ' GLY . 2.9 t -74.88 -33.06 62.0 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 118.173 -1.411 . . . . 0.0 108.722 -177.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -174.74 -35.85 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.676 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.7 48.52 0.98 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.604 -0.808 . . . . 0.0 113.673 -177.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.591 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 22.6 t 58.93 -152.99 0.39 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.818 0.847 . . . . 0.0 110.561 177.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.552 HD12 HD12 ' A' ' 18' ' ' LEU . 2.9 mm? -71.33 111.01 6.32 Favored 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.699 ' H ' ' HB3' ' A' ' 57' ' ' ALA . . . -78.02 46.33 2.66 Favored Glycine 0 C--N 1.296 -1.692 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.401 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.71 HG22 HG13 ' A' ' 52' ' ' ILE . 14.1 pt -141.11 148.64 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.608 0 CA-C-O 121.253 0.549 . . . . 0.0 110.197 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.53 ' HB3' ' HB3' ' A' ' 51' ' ' ALA . 32.4 t -117.85 124.25 47.88 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.6 m -115.59 150.55 17.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 120.469 -0.492 . . . . 0.0 111.564 -175.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.632 HG22 ' HB2' ' A' ' 50' ' ' LYS . 10.3 t -130.04 153.41 48.46 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.517 HG21 ' O ' ' A' ' 81' ' ' ALA . 8.3 p -114.29 118.59 58.94 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 C-N-CA 119.99 -0.684 . . . . 0.0 111.715 -174.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.422 HD21 HG23 ' A' ' 30' ' ' THR . 1.9 mm? -121.88 118.83 29.89 Favored 'General case' 0 C--O 1.211 -0.949 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.606 -178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -122.8 29.28 6.9 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 122.383 1.087 . . . . 0.0 108.886 173.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -80.96 166.71 20.59 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.989 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -111.75 155.53 23.36 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 176.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.68 115.21 5.63 Favored Glycine 0 C--O 1.241 0.561 0 O-C-N 123.833 0.708 . . . . 0.0 112.306 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.71 -25.53 2.82 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.432 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.13 -79.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.075 0.464 . . . . 0.0 110.657 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -97.55 -47.2 5.74 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 p -132.4 159.22 39.89 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.217 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.7 p -99.43 -37.18 9.32 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 121.199 0.524 . . . . 0.0 110.397 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.3 m -98.48 79.69 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -177.55 170.96 1.98 Allowed 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.098 173.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -154.86 179.12 9.41 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 158.14 -163.29 32.77 Favored Glycine 0 N--CA 1.417 -2.627 0 C-N-CA 118.252 -1.928 . . . . 0.0 114.17 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 31' ' ' VAL . . . -168.21 -101.95 0.15 Allowed Glycine 0 CA--C 1.471 -2.703 0 N-CA-C 104.507 -3.437 . . . . 0.0 104.507 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.796 HG13 HD12 ' A' ' 78' ' ' LEU . 38.6 mm -81.93 114.61 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.776 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 167.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.41 ' OH ' ' HA2' ' A' ' 67' ' ' GLY . 66.5 t80 -119.86 131.16 55.19 Favored 'General case' 0 C--N 1.275 -2.661 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.762 -169.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.496 HG21 ' CG2' ' A' ' 64' ' ' ILE . 46.5 t -75.16 107.38 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-O 121.557 0.694 . . . . 0.0 109.28 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.632 ' HB2' HG22 ' A' ' 30' ' ' THR . 87.2 tttt -89.06 -34.95 16.6 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.407 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 28' ' ' SER . . . -154.32 156.36 36.8 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.397 -176.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.945 HG21 ' HB2' ' A' ' 59' ' ' GLU . 1.9 mp -116.98 124.48 73.04 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 O-C-N 123.31 0.381 . . . . 0.0 110.093 174.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.38 121.93 85.79 Favored Pre-proline 0 C--O 1.257 1.491 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.181 177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -55.12 129.19 33.96 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 123.368 2.712 . . . . 0.0 112.103 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.4 tptp 65.33 11.45 7.31 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 124.631 1.172 . . . . 0.0 112.049 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.591 ' O ' HG22 ' A' ' 21' ' ' THR . . . -76.43 -56.16 4.38 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.11 176.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.699 ' HB3' ' H ' ' A' ' 26' ' ' GLY . . . -178.23 -69.08 0.01 OUTLIER 'General case' 0 C--O 1.188 -2.14 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.591 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -50.31 -42.63 52.92 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 115.183 1.549 . . . . 0.0 115.183 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.945 ' HB2' HG21 ' A' ' 52' ' ' ILE . 35.4 tt0 -82.86 -40.49 20.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.963 0.887 . . . . 0.0 109.869 -177.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.28 -44.0 66.06 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.093 -1.412 . . . . 0.0 109.899 -173.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.81 -34.41 57.92 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.078 0.942 . . . . 0.0 108.469 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.06 56.08 2.26 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 114.354 -1.294 . . . . 0.0 112.263 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -121.6 -73.41 0.65 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.813 0.816 . . . . 0.0 110.739 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.496 ' CG2' HG21 ' A' ' 49' ' ' VAL . 53.1 mt -94.74 148.01 5.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.266 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.3 p-80 -143.8 172.6 12.62 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.462 1.105 . . . . 0.0 108.131 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 50' ' ' LYS . 56.4 mtpt -64.78 133.01 51.11 Favored 'General case' 0 C--N 1.317 -0.826 0 O-C-N 123.521 0.513 . . . . 0.0 110.624 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.41 ' HA2' ' OH ' ' A' ' 48' ' ' TYR . . . 111.94 -20.73 21.6 Favored Glycine 0 C--N 1.304 -1.228 0 C-N-CA 119.966 -1.112 . . . . 0.0 113.833 176.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.52 ' OD2' ' HA ' ' A' ' 103' ' ' LYS . 0.5 OUTLIER -85.51 149.21 25.54 Favored 'General case' 0 C--O 1.253 1.268 0 CA-C-O 121.754 0.787 . . . . 0.0 113.099 -179.266 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.459 ' O ' ' HG ' ' A' ' 101' ' ' LEU . 78.5 ttt180 -102.81 138.73 39.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.498 -171.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.536 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 58.7 t -111.04 127.1 68.4 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.692 HD11 ' HB2' ' A' ' 102' ' ' GLU . 66.1 mt -110.3 -30.78 7.56 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-O 121.796 0.808 . . . . 0.0 109.837 -177.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.756 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -161.22 172.4 16.74 Favored 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.325 -174.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.732 HG11 ' CG2' ' A' ' 89' ' ' THR . 4.7 p -118.32 114.35 44.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 125.261 1.424 . . . . 0.0 107.487 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.859 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 32.1 p30 35.26 46.39 0.24 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.98 -11.0 64.18 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.597 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.533 ' HB ' HG13 ' A' ' 73' ' ' VAL . 43.1 t -101.33 114.94 42.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.2 m -75.79 145.01 41.06 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -173.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.796 HD12 HG13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -130.25 31.67 4.59 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.693 -1.139 . . . . 0.0 112.113 174.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -69.04 95.18 0.7 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.275 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 114.02 16.63 7.76 Favored Glycine 0 C--N 1.302 -1.34 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.517 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -88.6 171.1 10.28 Favored 'General case' 0 CA--C 1.496 -1.124 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 27.9 p -96.46 162.56 13.43 Favored 'General case' 0 N--CA 1.422 -1.863 0 N-CA-C 105.782 -1.932 . . . . 0.0 105.782 173.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -51.8 -41.12 61.47 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.35 0.595 . . . . 0.0 110.491 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -68.47 -36.95 79.71 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.75 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.486 ' HB2' ' HB1' ' A' ' 81' ' ' ALA . 11.9 mm-40 -66.39 -41.18 89.72 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.014 0.435 . . . . 0.0 110.255 177.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -52.75 -60.24 3.5 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.14 177.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.98 -30.65 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.219 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 91' ' ' ARG . 10.2 tp10 -67.76 -38.71 83.8 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.732 ' CG2' HG11 ' A' ' 73' ' ' VAL . 27.0 m -71.87 -36.62 70.16 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.5 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 61.5 mt -72.97 -19.46 61.22 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.454 0.645 . . . . 0.0 110.794 -179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -92.43 -26.8 17.84 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 121.451 0.643 . . . . 0.0 110.814 -179.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -84.31 -21.44 31.0 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -69.14 -42.93 75.33 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 145.33 -156.59 27.02 Favored Glycine 0 CA--C 1.487 -1.66 0 C-N-CA 120.263 -0.97 . . . . 0.0 110.928 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.491 ' HA ' ' HG2' ' A' ' 20' ' ' LYS . 3.4 pt20 -88.06 -37.27 16.42 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.719 0.259 . . . . 0.0 111.515 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 43.9 t -106.91 109.47 28.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.66 119.67 60.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.613 -172.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.859 ' HB2' ' HB3' ' A' ' 74' ' ' ASN . 31.4 m170 -81.84 137.28 35.29 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 168.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 7.6 mp -122.41 148.88 44.57 Favored 'General case' 0 C--N 1.264 -3.131 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.756 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.4 tm? -99.04 109.05 21.85 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 13' ' ' THR . 7.3 mp -110.65 162.79 14.38 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.181 -176.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.692 ' HB2' HD11 ' A' ' 71' ' ' LEU . 39.7 tt0 -123.34 124.76 43.67 Favored 'General case' 0 N--CA 1.404 -2.766 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 173.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.669 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 4.6 tmtm? -55.96 113.41 1.5 Allowed 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 124.286 0.991 . . . . 0.0 108.363 -179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -84.36 -162.56 34.71 Favored Glycine 0 N--CA 1.427 -1.925 0 CA-C-N 114.603 -1.18 . . . . 0.0 113.318 -174.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -138.39 145.3 40.86 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 -177.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 34.4 m -83.05 144.22 47.04 Favored Pre-proline 0 C--N 1.293 -1.89 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.49 -170.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.408 ' HG3' ' OH ' ' A' ' 48' ' ' TYR . 13.0 Cg_exo . . . . . 0 C--O 1.25 1.121 0 C-N-CA 122.8 2.334 . . . . 0.0 110.637 178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.394 61.2 mtpt . . . . . 0 N--CA 1.477 0.919 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.907 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 87.2 Cg_exo -50.41 113.59 1.1 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.231 1.954 . . . . 0.0 112.13 171.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.01 9.41 65.79 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.699 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 24.0 t70 -121.39 162.21 20.79 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.442 HG22 HD11 ' A' ' 71' ' ' LEU . 4.5 p -91.44 139.72 30.45 Favored 'General case' 0 N--CA 1.428 -1.528 0 C-N-CA 123.812 0.845 . . . . 0.0 111.335 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.593 ' HE2' ' HB2' ' A' ' 103' ' ' LYS . 48.2 p90 -157.51 154.43 28.62 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 39.7 mt-10 -110.06 148.51 31.57 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.493 HG23 HD13 ' A' ' 101' ' ' LEU . 59.9 t -127.25 124.97 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -175.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.51 ' HG2' ' HD2' ' A' ' 98' ' ' HIS . 43.1 mt-10 -96.76 91.56 5.74 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.928 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -102.57 122.03 43.57 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -175.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.21 141.51 31.89 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.112 -177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 1.5 mptm? -71.75 138.2 48.28 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.935 0.874 . . . . 0.0 112.526 177.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 23' ' ' GLY . 3.7 t -135.69 143.55 45.47 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 103.018 -2.956 . . . . 0.0 103.018 171.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 21' ' ' THR . 9.6 t70 77.93 -35.67 0.2 Allowed 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 123.651 0.781 . . . . 0.0 110.469 -173.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 21' ' ' THR . . . 119.7 11.39 7.18 Favored Glycine 0 N--CA 1.423 -2.206 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -178.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -127.6 151.53 48.8 Favored 'General case' 0 N--CA 1.414 -2.241 0 CA-C-N 115.241 -0.479 . . . . 0.0 109.897 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.548 HD11 ' HB3' ' A' ' 18' ' ' LEU . 13.7 tp -91.05 121.33 32.76 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 170.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.433 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -71.91 46.62 0.96 Allowed Glycine 0 C--O 1.211 -1.341 0 N-CA-C 115.451 0.941 . . . . 0.0 115.451 -173.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.432 HG22 ' CD1' ' A' ' 52' ' ' ILE . 6.9 pt -139.3 134.37 40.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 117.706 0.753 . . . . 0.0 111.461 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 53' ' ' ILE . 33.7 t -104.09 119.26 38.55 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 176.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.469 HG12 HG22 ' A' ' 49' ' ' VAL . 22.7 m -114.23 151.44 16.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.028 -174.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.41 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.4 t -134.7 177.2 7.97 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 172.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.632 HG12 HD13 ' A' ' 47' ' ' ILE . 16.2 m -88.72 -56.55 5.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 174.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 31' ' ' VAL . 17.5 mt -171.85 132.85 0.72 Allowed 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 128.059 2.544 . . . . 0.0 107.392 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -83.41 -36.63 24.11 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 176.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -127.03 96.66 4.68 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.301 0.572 . . . . 0.0 110.529 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -108.42 95.13 5.46 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 174.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -140.43 163.9 26.36 Favored Glycine 0 N--CA 1.429 -1.767 0 N-CA-C 110.959 -0.857 . . . . 0.0 110.959 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.61 31.38 58.71 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 42' ' ' VAL . 39.7 t -107.06 82.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 CA-C-O 121.107 0.479 . . . . 0.0 110.448 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -128.3 -70.36 0.69 Allowed 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.6 p -91.3 -35.86 14.21 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.1 p -89.31 88.18 7.4 Favored 'General case' 0 N--CA 1.411 -2.379 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 174.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.52 ' HA ' HG13 ' A' ' 38' ' ' VAL . 22.0 t -77.65 81.98 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 121.932 0.872 . . . . 0.0 109.542 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 43' ' ' ARG . 10.1 ptt180 -99.7 82.35 2.6 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.954 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -110.78 148.16 32.94 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.4 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.597 ' HA3' ' HE1' ' A' ' 48' ' ' TYR . . . -147.64 144.26 12.23 Favored Glycine 0 N--CA 1.413 -2.841 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 79' ' ' GLU . . . -67.59 -83.0 0.13 Allowed Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.474 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.942 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 46.1 mm -119.13 142.78 32.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.597 ' HE1' ' HA3' ' A' ' 45' ' ' GLY . 50.4 m-85 -128.7 113.37 15.29 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 110.454 -0.202 . . . . 0.0 110.454 174.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.469 HG22 HG12 ' A' ' 29' ' ' VAL . 58.8 t -51.47 114.97 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 169.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -91.11 -30.38 16.76 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.905 -175.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -158.34 159.99 36.47 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 -176.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.928 HG21 ' HB2' ' A' ' 59' ' ' GLU . 45.3 mm -110.1 120.49 61.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.546 HG22 ' HB2' ' A' ' 55' ' ' LYS . 1.8 mp -68.16 131.2 92.16 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.65 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 30.5 Cg_exo -69.35 60.12 1.45 Allowed 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 124.009 3.139 . . . . 0.0 112.267 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.546 ' HB2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -138.95 19.62 2.64 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.7 -147.28 25.1 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.492 -177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 73.71 -91.05 0.02 OUTLIER 'General case' 0 N--CA 1.427 -1.585 0 C-N-CA 125.329 1.452 . . . . 0.0 112.273 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.928 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -76.44 -36.85 57.74 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 120.467 -0.493 . . . . 0.0 112.326 -172.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.928 ' HB2' HG21 ' A' ' 52' ' ' ILE . 27.7 tt0 -78.85 -38.97 36.61 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 120.806 0.336 . . . . 0.0 110.655 -176.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.6 p -76.73 -27.83 55.57 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.109 0.481 . . . . 0.0 112.031 -175.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -87.98 -14.43 39.16 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.21 56.58 20.7 Favored Glycine 0 CA--C 1.497 -1.077 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.014 177.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -120.47 -46.48 2.38 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.168 0.509 . . . . 0.0 110.007 -177.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.551 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 53.3 mt -110.78 136.28 47.31 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.408 ' HA ' HD11 ' A' ' 52' ' ' ILE . 32.3 m-70 -134.56 177.85 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 123.814 0.696 . . . . 0.0 109.155 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -67.05 125.16 25.13 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.744 0.783 . . . . 0.0 110.237 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.82 21.0 17.19 Favored Glycine 0 N--CA 1.416 -2.669 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.016 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -97.58 142.44 29.39 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 120.962 -1.317 . . . . 0.0 110.424 167.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.639 ' HB2' ' HA3' ' A' ' 104' ' ' GLY . 6.7 ttm180 -92.83 138.58 31.36 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.942 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 55.9 t -106.93 115.67 48.95 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.782 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.476 HD12 HD22 ' A' ' 100' ' ' LEU . 96.8 mt -86.45 -37.54 18.22 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.955 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.712 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . . . -167.31 176.06 6.93 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.097 -175.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.574 ' HA ' HD12 ' A' ' 99' ' ' LEU . 21.1 t -118.94 118.69 58.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 175.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.411 HD22 HG12 ' A' ' 73' ' ' VAL . 9.6 p30 47.48 40.45 11.23 Favored 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 124.513 1.125 . . . . 0.0 113.771 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.65 -6.68 79.72 Favored Glycine 0 C--N 1.315 -0.636 0 C-N-CA 120.849 -0.691 . . . . 0.0 114.344 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.423 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 48.7 t -91.49 104.25 15.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.57 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 19.7 m -50.43 123.17 8.13 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.603 1.161 . . . . 0.0 113.3 -173.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.712 ' HB3' ' HA ' ' A' ' 72' ' ' ALA . 22.3 tp -117.68 1.36 12.2 Favored 'General case' 1 N--CA 1.366 -4.64 0 CA-C-N 114.363 -1.289 . . . . 0.0 110.844 -172.88 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.454 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 19.1 mt-10 -74.22 113.88 11.93 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 121.18 -0.16 11.54 Favored Glycine 0 C--N 1.298 -1.566 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -172.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -95.1 164.82 12.71 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.467 HG22 ' HG2' ' A' ' 85' ' ' GLN . 15.3 t -101.01 160.08 14.68 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 170.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 21.8 p80 -50.65 -45.43 57.89 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -176.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -58.94 -39.14 80.7 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 122.537 0.335 . . . . 0.0 110.1 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.467 ' HG2' HG22 ' A' ' 82' ' ' THR . 16.2 mm-40 -71.8 -36.41 70.28 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.106 0.479 . . . . 0.0 110.137 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.59 ' HA ' HD11 ' A' ' 78' ' ' LEU . . . -59.85 -47.09 87.12 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.444 ' HA ' HD12 ' A' ' 90' ' ' LEU . 95.8 t -67.48 -28.77 43.24 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.252 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.22 -30.2 69.22 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-O 121.26 0.552 . . . . 0.0 110.336 176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -78.55 -25.21 45.36 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 80.8 mt -74.81 -23.51 58.49 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.712 0.768 . . . . 0.0 109.182 173.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -84.72 -29.34 25.64 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.462 174.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.66 -45.44 92.81 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.231 -0.895 . . . . 0.0 108.822 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.416 ' OG1' HG22 ' A' ' 97' ' ' VAL . 40.1 p -71.44 153.64 42.11 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.07 -119.55 0.91 Allowed Glycine 0 N--CA 1.426 -1.996 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.31 -175.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -79.8 -34.87 39.25 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.221 -0.489 . . . . 0.0 110.489 -177.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -116.33 126.27 73.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 120.45 -0.5 . . . . 0.0 110.087 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.429 ' CG2' ' HE3' ' A' ' 20' ' ' LYS . 39.3 t -101.63 126.76 55.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.51 ' HD2' ' HG2' ' A' ' 17' ' ' GLU . 63.1 m80 -101.19 52.95 0.84 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.759 HD23 HD11 ' A' ' 101' ' ' LEU . 7.7 tp -61.84 149.47 40.11 Favored 'General case' 0 C--O 1.206 -1.227 0 C-N-CA 125.062 1.345 . . . . 0.0 111.18 -172.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.476 HD22 HD12 ' A' ' 71' ' ' LEU . 2.4 tt -110.43 118.77 37.16 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.759 HD11 HD23 ' A' ' 99' ' ' LEU . 6.4 mp -124.24 174.34 7.76 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 122.341 1.067 . . . . 0.0 112.567 -175.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 69' ' ' ARG . 30.8 tt0 -133.07 148.74 52.18 Favored 'General case' 0 N--CA 1.403 -2.824 0 N-CA-C 101.846 -3.39 . . . . 0.0 101.846 171.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.907 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -82.38 84.77 7.04 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 103.824 -2.658 . . . . 0.0 103.824 172.572 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 69' ' ' ARG . . . -77.07 102.13 1.65 Allowed Glycine 0 CA--C 1.47 -2.732 0 CA-C-N 112.859 -1.973 . . . . 0.0 113.67 -170.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -65.72 178.06 1.12 Allowed 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.211 0.529 . . . . 0.0 110.261 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.5 t -75.7 126.92 86.69 Favored Pre-proline 0 C--N 1.296 -1.728 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo . . . . . 0 C--O 1.258 1.492 0 C-N-CA 123.127 2.551 . . . . 0.0 112.579 -178.017 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.966 ' HG3' ' HD3' ' A' ' 10' ' ' PRO 0.282 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.833 0 CA-C-O 119.506 -0.283 . . . . 0.0 111.625 . . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.966 ' HD3' ' HG3' ' A' ' 9' ' ' LYS . 21.4 Cg_exo -70.05 125.84 12.44 Favored 'Trans proline' 0 C--N 1.355 0.892 0 N-CA-C 108.247 -1.482 . . . . 0.0 108.247 169.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.18 7.78 84.66 Favored Glycine 0 C--N 1.31 -0.891 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.135 -177.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 13.3 t70 -92.4 145.56 24.37 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 2.9 p -105.0 114.89 29.37 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.372 0.606 . . . . 0.0 112.026 -176.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' HE1' ' HB2' ' A' ' 103' ' ' LYS . 24.3 p90 -147.37 153.1 39.25 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.261 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.531 ' HG3' ' HG ' ' A' ' 100' ' ' LEU . 2.5 mp0 -91.26 108.57 19.97 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 t -76.1 136.47 24.71 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.107 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -98.49 96.47 8.01 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 175.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.708 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -117.66 117.59 29.8 Favored 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 -178.227 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.09 171.07 7.55 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -176.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.82 111.81 6.53 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 172.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.9 m -117.16 97.41 5.91 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.62 -176.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.9 t70 67.64 -61.45 0.36 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.711 1.204 . . . . 0.0 112.605 175.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.69 35.04 5.2 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 178.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.3 p 64.48 -155.43 0.3 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.986 1.714 . . . . 0.0 112.321 176.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.708 HD11 ' HB3' ' A' ' 18' ' ' LEU . 13.5 tp -73.6 104.63 4.61 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 -179.314 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.737 ' H ' ' HB3' ' A' ' 57' ' ' ALA . . . -74.48 53.17 2.35 Favored Glycine 0 C--N 1.308 -1.016 0 CA-C-N 115.046 -0.979 . . . . 0.0 115.167 -174.052 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.488 HG23 ' HB2' ' A' ' 58' ' ' ALA . 4.8 pt -136.45 133.88 49.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.231 0.539 . . . . 0.0 111.763 177.35 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.4 t -104.15 111.32 23.87 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 174.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.7 m -106.4 152.9 7.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-N 116.758 -0.201 . . . . 0.0 111.039 -174.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 13.9 t -134.08 167.86 19.88 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 173.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.734 HG11 ' HA ' ' A' ' 82' ' ' THR . 5.7 p -121.13 147.15 25.17 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.511 HD23 ' CD1' ' A' ' 48' ' ' TYR . 4.6 mm? -99.52 88.02 3.75 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 122.042 0.925 . . . . 0.0 109.034 173.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -109.62 -36.17 6.02 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.937 -1.483 . . . . 0.0 107.523 179.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -87.3 75.07 9.36 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 175.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -163.19 -48.3 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -176.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.43 -144.38 24.43 Favored Glycine 0 N--CA 1.427 -1.916 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.143 175.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.85 25.92 26.56 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 -177.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.5 t -118.16 90.31 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.7 t30 173.81 -53.71 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -178.411 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 42' ' ' VAL . 1.4 m -118.58 178.51 4.44 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 178.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.3 m -78.79 -43.66 24.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 120.189 1.359 . . . . 0.0 108.158 175.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.566 ' O ' ' HB ' ' A' ' 40' ' ' THR . 27.7 m -82.24 159.1 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 171.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -98.31 23.36 8.46 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.777 0.798 . . . . 0.0 109.6 -179.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -63.77 108.04 1.34 Allowed 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.361 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -142.6 108.03 0.51 Allowed Glycine 0 N--CA 1.412 -2.928 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' O ' HG23 ' A' ' 31' ' ' VAL . . . -90.05 -130.05 4.12 Favored Glycine 0 N--CA 1.429 -1.811 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.959 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.7 mm -102.53 143.14 15.44 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -178.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.511 ' CD1' HD23 ' A' ' 32' ' ' LEU . 79.4 m-85 -131.73 108.13 9.26 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 39.9 t -49.62 116.11 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 121.533 0.682 . . . . 0.0 109.675 171.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 66' ' ' LYS . 86.2 tttt -92.2 -33.19 14.8 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.856 -175.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -154.73 153.29 31.03 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.029 -176.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.015 HG21 ' HB2' ' A' ' 59' ' ' GLU . 31.7 mm -110.67 132.07 60.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.8 mm -79.31 121.98 83.56 Favored Pre-proline 0 C--N 1.304 -1.408 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -179.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.16 144.14 95.38 Favored 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 123.057 2.505 . . . . 0.0 111.146 178.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 24.0 tptp 59.27 30.16 19.85 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.883 1.325 . . . . 0.0 109.651 -178.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -105.87 -115.32 4.04 Favored Glycine 0 N--CA 1.406 -3.358 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.55 -177.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.737 ' HB3' ' H ' ' A' ' 26' ' ' GLY . . . -132.15 -65.1 0.75 Allowed 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.924 -0.638 . . . . 0.0 111.629 -172.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.768 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -54.33 -36.28 63.6 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -171.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.015 ' HB2' HG21 ' A' ' 52' ' ' ILE . 38.1 tt0 -95.54 -40.91 9.21 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 122.341 1.067 . . . . 0.0 110.304 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.6 m -79.71 -44.11 21.4 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-N 114.108 -1.405 . . . . 0.0 110.426 -168.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -101.17 -35.04 9.44 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.92 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.86 -128.64 6.43 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 116.519 1.368 . . . . 0.0 116.519 -167.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -147.79 -23.1 0.36 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 113.893 -1.153 . . . . 0.0 110.693 -165.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.768 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 71.6 mt -69.74 141.33 17.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.915 -173.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -134.64 -176.66 4.3 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.037 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 50' ' ' LYS . 81.0 tttt -67.83 121.69 16.55 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 123.41 0.684 . . . . 0.0 111.296 -179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.58 -6.94 31.75 Favored Glycine 0 N--CA 1.428 -1.836 0 C-N-CA 120.442 -0.885 . . . . 0.0 114.179 177.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.769 ' HB3' HD23 ' A' ' 101' ' ' LEU . 66.3 m-20 -64.64 130.96 45.58 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-O 121.682 0.753 . . . . 0.0 112.067 179.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.465 ' HG3' ' CE2' ' A' ' 48' ' ' TYR . 48.3 ttt180 -92.22 129.92 38.05 Favored 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.997 -174.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.959 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 64.3 t -109.36 126.65 66.45 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -107.43 -34.91 6.92 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.128 -178.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.623 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -150.32 157.07 42.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.596 0.713 . . . . 0.0 112.132 -176.107 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.816 ' HA ' HD12 ' A' ' 99' ' ' LEU . 61.7 t -109.82 100.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 173.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 t30 59.54 34.37 22.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.55 1.14 . . . . 0.0 110.504 176.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.22 -23.18 35.25 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 114.944 -1.025 . . . . 0.0 113.478 -178.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.9 t -84.25 106.5 14.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 72' ' ' ALA . 20.0 m -75.2 138.24 41.82 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-O 121.616 0.722 . . . . 0.0 112.106 -175.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.537 HD23 ' H ' ' A' ' 78' ' ' LEU . 1.1 pt? -130.75 74.22 1.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.649 1.214 . . . . 0.0 110.98 179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -90.39 96.36 10.62 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.084 -176.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.29 39.18 4.31 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.1 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -103.5 147.38 27.22 Favored 'General case' 0 CA--C 1.484 -1.57 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.106 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.734 ' HA ' HG11 ' A' ' 31' ' ' VAL . 8.9 t -69.04 146.66 52.47 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 18.4 p80 -50.95 -35.45 33.56 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -177.398 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 54.6 mtmt -62.48 -38.91 91.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.257 176.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -76.21 -31.27 58.33 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -55.29 -53.69 52.9 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.662 ' HA ' HD12 ' A' ' 90' ' ' LEU . 86.0 t -64.48 -29.02 46.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.002 178.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 43.6 mm-40 -70.85 -33.19 70.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.164 0.507 . . . . 0.0 110.253 178.169 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.6 m -69.67 -35.15 74.9 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.68 HD13 HD23 ' A' ' 25' ' ' LEU . 81.3 mt -67.66 -34.57 77.2 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 123.918 0.887 . . . . 0.0 109.375 178.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -66.9 -35.39 79.9 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.7 -179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -73.11 -34.32 66.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.122 176.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.6 m -57.77 -51.65 68.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 123.702 0.801 . . . . 0.0 110.636 -179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.19 -150.32 17.62 Favored Glycine 0 N--CA 1.434 -1.499 0 C-N-CA 120.079 -1.058 . . . . 0.0 112.893 176.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -77.78 -39.64 43.34 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 122.961 0.504 . . . . 0.0 110.765 -178.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.3 t -106.7 119.73 56.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.2 175.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.62 HG11 HD22 ' A' ' 90' ' ' LEU . 58.2 t -104.26 127.54 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 CA-C-O 121.509 0.671 . . . . 0.0 110.213 -176.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -97.4 120.22 37.36 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 169.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.816 HD12 ' HA ' ' A' ' 73' ' ' VAL . 9.0 tp -121.54 133.3 55.02 Favored 'General case' 0 C--N 1.261 -3.24 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.624 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 2.1 tt -94.15 110.31 22.04 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 -175.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 68' ' ' ASP . 10.1 mp -115.11 170.4 8.39 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.834 0.826 . . . . 0.0 111.774 -176.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 36.6 tt0 -129.64 103.33 6.79 Favored 'General case' 0 N--CA 1.4 -2.931 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 171.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.451 ' HB2' ' HE1' ' A' ' 14' ' ' PHE . 22.4 tptm -48.65 121.38 4.52 Favored 'General case' 0 C--N 1.311 -1.106 0 O-C-N 124.194 0.934 . . . . 0.0 112.353 -170.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.14 37.57 3.55 Favored Glycine 0 N--CA 1.438 -1.213 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.292 -172.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -93.33 154.2 18.12 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.452 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 34.8 m -73.47 129.23 85.97 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 123.363 0.414 . . . . 0.0 110.249 176.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 6.2 Cg_exo . . . . . 0 N--CA 1.444 -1.39 0 C-N-CA 122.898 2.398 . . . . 0.0 110.389 177.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.867 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 95.6 mttt . . . . . 0 CA--C 1.553 1.078 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.867 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 17.4 Cg_exo -63.43 111.87 1.59 Allowed 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.989 2.459 . . . . 0.0 114.462 -168.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.17 0.89 63.11 Favored Glycine 0 N--CA 1.427 -1.933 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.07 174.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.6 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 32.1 t0 -108.95 158.86 17.3 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -176.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 10.4 p -93.92 115.18 27.53 Favored 'General case' 0 N--CA 1.41 -2.45 0 CA-C-O 122.224 1.011 . . . . 0.0 110.375 177.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.556 ' CE1' ' HB ' ' A' ' 16' ' ' VAL . 44.8 p90 -123.49 159.72 28.48 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.699 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 41.2 mt-10 -102.1 109.11 20.73 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.556 ' HB ' ' CE1' ' A' ' 14' ' ' PHE . 7.5 p -89.98 119.83 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.274 0 CA-C-O 121.378 0.609 . . . . 0.0 111.084 -174.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.4 ' HG3' ' CG1' ' A' ' 96' ' ' VAL . 33.3 tt0 -87.47 91.92 8.9 Favored 'General case' 0 N--CA 1.418 -2.055 0 CA-C-N 114.327 -1.306 . . . . 0.0 108.516 -178.585 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.463 HD12 HD13 ' A' ' 25' ' ' LEU . 0.8 OUTLIER -108.77 114.95 29.16 Favored 'General case' 0 N--CA 1.412 -2.356 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 -179.461 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -99.19 141.35 32.07 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 95' ' ' GLN . 0.2 OUTLIER -72.94 130.55 40.63 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.079 177.937 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 55.2 p -112.48 -158.78 0.66 Allowed 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -53.69 -30.01 41.56 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 123.497 0.719 . . . . 0.0 111.573 175.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.28 16.56 49.08 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.84 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 13.5 t 70.28 -143.9 0.08 Allowed 'General case' 0 C--N 1.354 0.794 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.663 ' HG ' HD13 ' A' ' 90' ' ' LEU . 3.6 mm? -64.44 -31.61 72.89 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.92 0.782 . . . . 0.0 109.725 177.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.36 5.14 79.88 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 178.152 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.0 pt -125.38 144.99 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 CA-C-O 122.418 1.104 . . . . 0.0 113.193 -175.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.577 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 66.0 m -104.63 114.69 29.07 Favored 'General case' 0 C--N 1.268 -2.943 0 CA-C-N 113.081 -1.872 . . . . 0.0 106.861 173.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.4 m -102.85 147.94 8.71 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-O 121.134 0.493 . . . . 0.0 111.531 -178.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 13.6 t -118.08 171.05 8.36 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.852 ' HA ' HD13 ' A' ' 47' ' ' ILE . 4.1 t -90.5 -41.48 13.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 177.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 42' ' ' VAL . 23.4 tp -164.48 -21.08 0.03 OUTLIER 'General case' 0 C--O 1.244 0.796 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.506 174.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -80.28 73.82 7.13 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.043 0.925 . . . . 0.0 113.118 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -87.24 143.41 27.29 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 172.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -75.58 113.86 13.48 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.237 0.541 . . . . 0.0 111.896 -174.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.57 -128.6 1.74 Allowed Glycine 0 N--CA 1.428 -1.889 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 177.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -118.05 -127.81 3.85 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 176.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.4 t -102.71 117.64 48.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 177.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HA ' HG23 ' A' ' 42' ' ' VAL . 5.3 m-20 68.69 26.65 6.13 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.859 0.863 . . . . 0.0 112.913 178.037 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.3 m -70.19 -43.12 71.4 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 176.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.3 m -128.36 95.94 4.29 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.277 177.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.502 ' HA ' HD21 ' A' ' 32' ' ' LEU . 11.6 t -142.0 33.51 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 177.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -98.21 124.7 42.93 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 113.824 -1.534 . . . . 0.0 108.651 177.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 57.6 m80 -74.78 130.12 38.9 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 121.298 0.571 . . . . 0.0 112.062 -175.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.87 -50.13 0.01 OUTLIER Glycine 0 CA--C 1.492 -1.385 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -178.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 145.82 -65.63 0.43 Allowed Glycine 0 CA--C 1.48 -2.151 0 N-CA-C 111.538 -0.625 . . . . 0.0 111.538 174.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.852 HD13 ' HA ' ' A' ' 31' ' ' VAL . 24.7 mm -137.58 149.64 25.5 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 178.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -136.05 151.62 50.03 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 118.324 0.511 . . . . 0.0 110.688 -179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.539 HG21 ' CG2' ' A' ' 64' ' ' ILE . 21.6 t -79.31 109.03 13.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.55 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 87.6 tttt -83.14 -37.13 24.15 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.768 -175.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 28' ' ' SER . . . -153.37 148.05 26.28 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.994 -178.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.561 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 49.8 mm -112.72 122.07 66.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 175.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.69 129.03 46.12 Favored Pre-proline 0 C--N 1.297 -1.676 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -49.99 139.26 34.07 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.198 2.598 . . . . 0.0 111.299 177.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.0 tptt 67.8 -0.35 2.02 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.915 0.886 . . . . 0.0 111.803 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -92.42 102.57 2.94 Favored Glycine 0 N--CA 1.419 -2.484 0 CA-C-O 119.422 -0.654 . . . . 0.0 112.946 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 25' ' ' LEU . . . 26.49 -76.26 0.0 OUTLIER 'General case' 0 C--O 1.181 -2.526 0 C-N-CA 128.312 2.645 . . . . 0.0 115.028 170.16 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 64' ' ' ILE . . . -50.28 -39.0 44.08 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.561 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 9.7 tp10 -76.59 -43.66 37.7 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.136 0.575 . . . . 0.0 110.201 178.207 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.9 m -67.23 -50.27 61.35 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.29 -177.554 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.43 -36.96 79.81 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.5 179.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.72 53.99 4.76 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.088 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.489 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 1.0 OUTLIER -115.87 -74.61 0.6 Allowed 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.442 0.639 . . . . 0.0 109.341 -176.878 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.597 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 62.5 mt -86.26 140.95 15.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -144.71 -172.57 3.85 Favored 'General case' 0 N--CA 1.418 -2.063 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.265 176.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.538 ' O ' ' HD2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -65.94 129.27 39.21 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 121.326 0.584 . . . . 0.0 112.522 -175.076 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.39 -7.77 62.01 Favored Glycine 0 N--CA 1.431 -1.644 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.203 174.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.607 ' HB3' HD23 ' A' ' 101' ' ' LEU . 10.1 m-20 -64.02 138.1 58.3 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-N 117.472 0.636 . . . . 0.0 112.452 179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -88.19 115.86 25.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.779 -175.025 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.421 HG22 HD11 ' A' ' 101' ' ' LEU . 43.9 t -100.1 112.7 33.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.7 mt -95.29 -37.55 10.94 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.594 -178.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -157.99 -179.79 8.46 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.382 -175.105 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.986 HG11 HG21 ' A' ' 89' ' ' THR . 2.4 p -130.13 102.69 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 C-N-CA 125.561 1.544 . . . . 0.0 110.192 -178.182 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t30 58.95 37.61 24.57 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 122.247 1.022 . . . . 0.0 111.057 174.084 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.9 -12.0 70.3 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.574 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.596 ' HB ' HG13 ' A' ' 73' ' ' VAL . 59.0 t -93.25 125.41 45.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.5 m -71.02 145.13 50.16 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.267 0.556 . . . . 0.0 112.457 -174.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 61.9 mt -111.91 27.21 9.86 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.721 0.772 . . . . 0.0 110.304 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -78.11 118.1 20.04 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.045 -0.979 . . . . 0.0 109.126 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.4 19.74 51.25 Favored Glycine 0 C--N 1.309 -0.917 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.98 -171.27 2.19 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.51 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 15.2 t -150.32 175.48 11.78 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 177.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -50.37 -55.58 15.05 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.892 0.745 . . . . 0.0 111.151 -179.161 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -53.26 -45.45 68.82 Favored 'General case' 0 C--O 1.21 -1.0 0 O-C-N 123.898 0.749 . . . . 0.0 110.92 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -70.12 -43.96 69.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.618 0.247 . . . . 0.0 111.466 -176.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -58.42 -50.05 75.1 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.492 178.194 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 89.5 t -66.83 -37.21 79.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.178 -178.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -63.45 -36.54 84.08 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 121.093 0.473 . . . . 0.0 109.981 178.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.986 HG21 HG11 ' A' ' 73' ' ' VAL . 89.8 m -68.89 -37.82 79.24 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.576 177.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.663 HD13 ' HG ' ' A' ' 25' ' ' LEU . 83.8 mt -71.23 -19.84 62.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.661 0.743 . . . . 0.0 109.858 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -85.29 -47.67 9.82 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.64 177.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -75.68 -12.09 60.13 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.66 -29.98 65.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.09 -138.26 10.66 Favored Glycine 0 N--CA 1.431 -1.662 0 C-N-CA 120.373 -0.917 . . . . 0.0 111.617 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.46 ' O ' ' HE3' ' A' ' 20' ' ' LYS . 24.3 tp60 -86.39 -35.7 19.62 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.858 0.361 . . . . 0.0 110.365 -176.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.4 t -124.44 147.76 28.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -175.527 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.403 ' CG1' HG23 ' A' ' 73' ' ' VAL . 6.0 t -129.46 146.72 33.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 177.234 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 11.9 m-70 -115.75 70.08 0.74 Allowed 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 175.155 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.61 HD21 HD21 ' A' ' 90' ' ' LEU . 5.0 mp -63.61 150.98 42.89 Favored 'General case' 0 C--O 1.215 -0.758 0 C-N-CA 120.338 -0.545 . . . . 0.0 111.727 -175.2 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.591 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 62.7 tp -93.99 108.98 20.74 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.607 HD23 ' HB3' ' A' ' 68' ' ' ASP . 8.1 mp -127.1 147.39 50.17 Favored 'General case' 0 CA--C 1.474 -1.971 0 CA-C-O 121.476 0.655 . . . . 0.0 111.71 -175.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 38.0 tt0 -113.66 115.44 27.87 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 103.769 -2.678 . . . . 0.0 103.769 174.11 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.746 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 2.8 tmtm? -49.36 116.6 1.79 Allowed 'General case' 0 C--O 1.245 0.849 0 O-C-N 124.324 1.015 . . . . 0.0 111.721 -172.66 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -102.43 80.24 0.37 Allowed Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 114.129 -1.396 . . . . 0.0 113.112 -174.291 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.723 ' HG3' ' HD2' ' A' ' 103' ' ' LYS . 88.7 mt-30 -99.38 101.94 13.37 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.43 0.633 . . . . 0.0 110.112 175.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.8 m -127.81 103.2 21.67 Favored Pre-proline 0 N--CA 1.422 -1.864 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.59 -179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 C--O 1.244 0.784 0 C-N-CA 122.759 2.306 . . . . 0.0 110.27 178.008 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 94.1 mttt . . . . . 0 N--CA 1.422 -1.871 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 1.025 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 9.4 Cg_endo -51.5 131.48 37.01 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.257 2.638 . . . . 0.0 113.671 -177.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.63 4.84 60.41 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 116.222 -0.444 . . . . 0.0 113.009 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -106.93 152.12 24.36 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.463 HG22 HD11 ' A' ' 71' ' ' LEU . 18.5 p -88.05 110.52 20.69 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.372 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -114.51 143.45 44.94 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-O 121.308 0.575 . . . . 0.0 111.564 -178.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -101.99 121.38 42.05 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.501 HG11 HD11 ' A' ' 64' ' ' ILE . 30.0 t -110.95 129.66 65.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.207 -174.441 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 95.39 5.8 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 171.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.023 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -97.06 119.37 35.41 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.808 -173.649 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.21 117.98 30.9 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.198 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.564 ' HB3' ' HA ' ' A' ' 24' ' ' SER . 94.5 mttt -56.29 121.82 10.4 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.006 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.6 m -92.28 -78.95 0.4 Allowed 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.437 -174.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -126.38 -56.32 1.42 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -178.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.51 30.83 6.52 Favored Glycine 0 N--CA 1.434 -1.457 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 177.231 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.564 ' HA ' ' HB3' ' A' ' 20' ' ' LYS 0.286 97.8 p 66.19 -105.97 0.11 Allowed 'General case' 0 N--CA 1.419 -2.023 0 C-N-CA 126.367 1.867 . . . . 0.0 112.107 -179.988 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.694 HD12 ' HB3' ' A' ' 90' ' ' LEU . 81.8 mt -96.83 128.43 43.78 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 176.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 52' ' ' ILE . . . -81.56 8.36 59.19 Favored Glycine 0 C--N 1.294 -1.804 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.761 -176.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.7 pt -99.55 115.69 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.122 0 C-N-CA 119.075 -1.05 . . . . 0.0 113.32 -177.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.498 ' HB2' HG12 ' A' ' 53' ' ' ILE . 23.4 t -88.7 124.18 33.86 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 175.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.76 -174.68 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -173.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -170.75 150.48 3.28 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 178.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.618 HG11 ' HA ' ' A' ' 82' ' ' THR . 7.3 p -120.79 117.45 53.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-O 121.209 0.528 . . . . 0.0 110.252 177.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . 0.275 0.9 OUTLIER -128.98 95.08 3.98 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 122.282 1.039 . . . . 0.0 113.744 177.798 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -83.5 -18.16 39.45 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 169.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -174.81 142.12 0.66 Allowed 'General case' 0 CA--C 1.496 -1.106 0 C-N-CA 128.457 2.703 . . . . 0.0 104.785 174.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -144.34 13.73 1.6 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.97 81.56 0.53 Allowed Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -177.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -92.58 -172.7 41.26 Favored Glycine 0 C--N 1.301 -1.386 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.074 -179.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.34 -36.97 15.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -169.71 34.33 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 175.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.2 m -85.15 94.46 8.88 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 113.044 -1.889 . . . . 0.0 108.229 -176.158 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.3 m -84.23 68.01 10.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.851 0.834 . . . . 0.0 112.792 -174.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.5 t -82.56 129.7 37.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -117.29 -43.36 2.84 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -117.22 115.99 26.39 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.66 140.59 11.75 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -178.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 79' ' ' GLU . . . -104.12 -134.18 8.08 Favored Glycine 0 N--CA 1.416 -2.696 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.127 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.861 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 45.5 mm -101.38 148.29 7.42 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.635 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 179.207 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -133.35 147.23 51.81 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 118.385 0.539 . . . . 0.0 109.874 179.458 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.429 HG21 HG21 ' A' ' 64' ' ' ILE . 59.7 t -81.29 115.3 23.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 174.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -85.69 -34.48 21.27 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.594 -177.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -166.93 169.85 12.7 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.04 -176.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.063 HG21 ' HB2' ' A' ' 59' ' ' GLU . 20.5 mm -114.36 116.2 51.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 177.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.825 ' HB ' ' HD3' ' A' ' 54' ' ' PRO . 42.2 mm -84.5 -71.91 0.1 OUTLIER Pre-proline 0 CA--C 1.562 1.426 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -169.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 53' ' ' ILE . 6.2 Cg_exo -78.74 -160.87 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.715 2.277 . . . . 0.0 113.306 -172.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -36.44 -55.46 0.83 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.082 1.353 . . . . 0.0 112.132 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.617 ' HA3' ' OG ' ' A' ' 60' ' ' SER . . . -171.71 -87.26 0.07 OUTLIER Glycine 0 N--CA 1.403 -3.565 0 C-N-CA 119.556 -1.306 . . . . 0.0 111.964 176.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.674 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . 68.53 -85.28 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 124.486 1.114 . . . . 0.0 108.949 -177.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.023 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -78.14 -29.44 48.74 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.717 -177.606 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.063 ' HB2' HG21 ' A' ' 52' ' ' ILE . 43.6 tt0 -73.75 -63.14 1.27 Allowed 'General case' 0 N--CA 1.439 -0.989 0 O-C-N 124.602 1.189 . . . . 0.0 111.608 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.617 ' OG ' ' HA3' ' A' ' 56' ' ' GLY . 6.8 p -86.21 -30.38 22.44 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -168.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -100.54 -35.77 9.41 Favored 'General case' 0 CA--C 1.486 -1.488 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 -174.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.25 -128.52 3.35 Favored Glycine 1 N--CA 1.393 -4.229 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.301 -175.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -157.84 3.94 0.12 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -170.07 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.616 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 61.5 mt -94.78 138.94 19.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.388 -168.028 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -130.58 179.01 6.19 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 177.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -70.43 128.38 35.99 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.295 0.569 . . . . 0.0 109.999 176.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 116.13 -20.48 12.75 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.726 -178.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.641 ' OD1' ' HD3' ' A' ' 103' ' ' LYS . 50.5 m-20 -64.65 136.83 57.39 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.504 0.668 . . . . 0.0 112.411 -177.375 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -93.84 135.93 34.65 Favored 'General case' 0 C--O 1.195 -1.785 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.473 -176.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.861 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 62.2 t -106.53 119.51 56.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.601 HD12 HD22 ' A' ' 100' ' ' LEU . 82.8 mt -97.43 -44.38 6.88 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.55 -1.205 . . . . 0.0 108.781 -177.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -152.26 165.08 36.01 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.011 -173.453 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.753 ' HA ' HD12 ' A' ' 99' ' ' LEU . 39.0 t -116.28 111.27 34.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 173.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 98' ' ' HIS . 9.2 p30 47.27 35.91 4.22 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.02 1.328 . . . . 0.0 112.354 -176.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 97.09 -16.23 61.22 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.121 -1.038 . . . . 0.0 114.393 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.39 109.29 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.2 t -70.23 137.51 50.91 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 123.358 0.411 . . . . 0.0 111.235 -174.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.609 HD22 HG23 ' A' ' 73' ' ' VAL . 1.7 pt? -130.6 22.24 5.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.654 177.734 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.523 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 32.4 mt-10 -68.48 105.14 2.11 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 117.26 16.63 6.04 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 120.567 -0.825 . . . . 0.0 111.796 -176.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.581 ' O ' HG21 ' A' ' 31' ' ' VAL . . . -98.94 167.52 10.69 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 175.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.618 ' HA ' HG11 ' A' ' 31' ' ' VAL . 9.0 t -90.78 170.17 10.34 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 171.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -50.3 -49.54 53.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.465 1.106 . . . . 0.0 109.667 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 10.9 mptt -64.13 -35.17 79.89 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 114.63 -1.168 . . . . 0.0 112.15 -176.119 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.52 ' HG3' HG22 ' A' ' 82' ' ' THR . 56.2 mt-30 -70.02 -42.59 72.79 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.589 ' HA ' HD12 ' A' ' 78' ' ' LEU . . . -54.26 -58.79 6.06 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.023 178.096 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.42 -28.5 43.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.191 -177.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 66.1 mm-40 -68.75 -34.38 75.49 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.537 177.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.519 HG22 HG11 ' A' ' 73' ' ' VAL . 37.8 m -69.51 -29.94 67.68 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 176.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.694 ' HB3' HD12 ' A' ' 25' ' ' LEU . 81.4 mt -77.0 -16.55 59.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.961 177.22 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -93.25 -26.94 17.13 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.6 176.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -67.28 -42.22 84.15 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 175.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.6 p -65.92 146.23 54.97 Favored 'General case' 0 C--O 1.252 1.208 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.958 177.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.9 -128.98 0.88 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 114.527 0.571 . . . . 0.0 114.527 -172.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -69.3 -54.4 14.82 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.44 0.696 . . . . 0.0 111.803 -174.385 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.9 t -106.2 115.51 48.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.406 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.587 HG21 HD11 ' A' ' 25' ' ' LEU . 46.0 t -99.0 126.5 52.21 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -177.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 74' ' ' ASN . 53.8 t-80 -91.96 123.39 35.28 Favored 'General case' 0 N--CA 1.404 -2.729 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 175.216 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.753 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.6 tp -126.53 143.36 51.23 Favored 'General case' 0 C--N 1.273 -2.754 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.601 HD22 HD12 ' A' ' 71' ' ' LEU . 1.6 tt -105.1 116.1 31.39 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.5 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.596 HD11 HD23 ' A' ' 99' ' ' LEU . 6.6 mp -121.46 176.07 5.86 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.51 0.671 . . . . 0.0 111.873 -177.242 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -131.27 126.85 36.49 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 172.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 1.025 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 15.1 mmtt -57.3 127.01 29.83 Favored 'General case' 0 C--N 1.309 -1.154 0 O-C-N 123.545 0.528 . . . . 0.0 111.433 179.742 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -132.32 97.6 0.34 Allowed Glycine 0 N--CA 1.418 -2.554 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.561 -178.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -86.62 -172.18 3.89 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 171.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.83 83.68 59.17 Favored Pre-proline 0 C--N 1.295 -1.801 0 CA-C-O 121.474 0.654 . . . . 0.0 110.716 177.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 N--CA 1.433 -2.067 0 C-N-CA 123.205 2.603 . . . . 0.0 111.513 -177.287 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt . . . . . 0 CA--C 1.508 -0.646 0 N-CA-C 104.122 -2.548 . . . . 0.0 104.122 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.31 130.29 28.12 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 CA-C-N 120.932 1.369 . . . . 0.0 109.875 177.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.39 9.22 87.18 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.222 -176.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.425 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 38.0 t70 -90.97 147.28 23.2 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.577 HG22 HD11 ' A' ' 71' ' ' LEU . 6.1 p -80.65 137.53 36.34 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.071 0.463 . . . . 0.0 111.887 -175.105 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -139.39 140.7 37.5 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.119 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.547 ' HB3' ' NE2' ' A' ' 98' ' ' HIS . 45.3 mt-10 -106.41 114.23 28.23 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.418 -0.81 . . . . 0.0 108.919 -179.168 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.409 HG12 HD13 ' A' ' 101' ' ' LEU . 7.7 p -113.44 131.71 64.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.127 -175.31 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.696 ' HA ' ' HA ' ' A' ' 98' ' ' HIS . 40.8 tt0 -110.52 99.56 8.53 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 175.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.2 OUTLIER -93.66 124.14 37.45 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -173.17 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -98.31 116.07 29.75 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 177.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 95' ' ' GLN . 14.9 ptmt -79.79 145.88 32.59 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.466 -175.009 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 t -84.87 -55.27 4.16 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.339 0.59 . . . . 0.0 109.963 -175.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.477 ' OD1' ' HG2' ' A' ' 55' ' ' LYS . 9.1 p-10 -111.11 -145.77 0.4 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 174.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -83.22 20.08 11.43 Favored Glycine 0 C--N 1.305 -1.189 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.237 178.344 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 20.0 m -122.42 130.38 53.03 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.764 HD11 ' HB3' ' A' ' 18' ' ' LEU . 22.0 tp -81.26 -5.28 57.61 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.012 0.911 . . . . 0.0 108.904 178.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.71 7.25 69.07 Favored Glycine 0 N--CA 1.421 -2.354 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.196 175.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.486 HG22 ' CD1' ' A' ' 52' ' ' ILE . 19.2 pt -132.59 148.21 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.723 0 CA-C-O 121.252 0.549 . . . . 0.0 110.495 179.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 26.5 t -116.79 120.41 38.46 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 176.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 49' ' ' VAL . 35.0 m -111.97 170.34 3.89 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-O 120.71 0.29 . . . . 0.0 110.966 -176.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.0 t -145.45 169.71 17.81 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 171.414 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.605 HG23 ' H ' ' A' ' 32' ' ' LEU . 30.8 m -72.43 -65.67 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 118.709 -1.196 . . . . 0.0 108.858 173.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.605 ' H ' HG23 ' A' ' 31' ' ' VAL . 43.4 tp -172.21 146.4 1.88 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 172.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -156.8 -76.51 0.09 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.513 -176.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -82.71 145.88 29.35 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.805 -179.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -114.61 -1.07 13.44 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.81 -173.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.26 -104.65 1.78 Allowed Glycine 0 N--CA 1.44 -1.075 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -176.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -136.15 24.01 3.29 Favored Glycine 0 N--CA 1.438 -1.21 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.858 178.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 40' ' ' THR . 66.8 t -108.57 142.29 21.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -72.98 -33.03 65.57 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 122.783 0.433 . . . . 0.0 111.595 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.556 ' H ' HG12 ' A' ' 38' ' ' VAL . 4.8 t -118.0 96.43 5.34 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-O 122.456 1.122 . . . . 0.0 111.029 -179.734 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.4 m -131.05 81.77 2.01 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.755 177.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.4 p -160.85 108.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.426 -1.651 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.174 177.804 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -127.43 40.84 3.63 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 -178.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.447 ' HB3' ' NH2' ' A' ' 69' ' ' ARG . 56.2 t-80 75.55 101.63 0.07 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 111.499 -2.591 . . . . 0.0 109.983 -172.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.63 ' HA2' ' HE1' ' A' ' 48' ' ' TYR . . . -81.12 73.25 2.61 Favored Glycine 0 N--CA 1.424 -2.139 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.862 -177.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -74.87 -75.75 0.79 Allowed Glycine 0 N--CA 1.423 -2.168 0 N-CA-C 107.504 -2.238 . . . . 0.0 107.504 175.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.666 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 30.7 mm -145.24 134.49 17.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 174.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.63 ' HE1' ' HA2' ' A' ' 45' ' ' GLY . 39.3 m-85 -125.45 139.88 53.26 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 174.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.493 HG21 ' CG2' ' A' ' 64' ' ' ILE . 40.1 t -75.17 117.76 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.169 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 58.5 tttp -93.02 -31.66 14.79 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.087 -174.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . . . -158.06 162.67 38.09 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.875 -178.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.672 HD11 ' HA ' ' A' ' 65' ' ' HIS . 49.4 mm -107.52 120.11 58.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 177.584 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.507 HG22 ' HD3' ' A' ' 55' ' ' LYS . 50.0 mm -77.53 124.15 86.71 Favored Pre-proline 0 C--O 1.252 1.216 0 C-N-CA 122.956 0.502 . . . . 0.0 110.741 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 4.9 Cg_exo -74.84 74.3 3.96 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 124.192 3.261 . . . . 0.0 115.53 -174.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HD3' HG22 ' A' ' 53' ' ' ILE . 2.1 mptm? -116.59 -82.3 0.62 Allowed 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.204 0.526 . . . . 0.0 110.108 171.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.571 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 172.59 49.59 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 119.781 -1.2 . . . . 0.0 112.142 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . -126.36 -96.4 0.43 Allowed 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.967 -179.211 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.916 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -61.05 -36.13 78.77 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -176.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.617 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 40.5 tt0 -72.13 -46.87 54.85 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.557 0.743 . . . . 0.0 110.465 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.571 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 13.5 m -77.88 -35.85 50.42 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.209 -173.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.13 -23.89 47.63 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.9 59.77 4.93 Favored Glycine 0 CA--C 1.498 -1.03 0 CA-C-N 113.98 -1.464 . . . . 0.0 113.471 171.379 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -120.5 -69.81 0.82 Allowed 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.948 0.88 . . . . 0.0 108.797 -178.581 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.493 ' CG2' HG21 ' A' ' 49' ' ' VAL . 68.6 mt -90.36 141.73 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.783 -178.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.672 ' HA ' HD11 ' A' ' 52' ' ' ILE . 33.1 t-80 -139.45 176.15 8.96 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 175.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 51' ' ' ALA . 51.5 pttt -73.56 142.87 46.63 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.096 -0.642 . . . . 0.0 110.835 -178.521 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.48 -22.68 21.86 Favored Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -177.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.957 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 39.1 m-20 -72.63 142.35 48.33 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.91 0.386 . . . . 0.0 112.035 -178.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.447 ' NH2' ' HB3' ' A' ' 44' ' ' HIS . 1.3 tmt_? -101.09 136.58 40.7 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 -179.018 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.666 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 56.1 t -103.97 121.44 55.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 -175.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.577 HD11 HG22 ' A' ' 13' ' ' THR . 90.2 mt -83.47 -42.16 17.21 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.452 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 76' ' ' VAL . . . -170.07 176.09 4.79 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.703 -175.329 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 1.054 HG11 HG21 ' A' ' 89' ' ' THR . 2.7 p -112.92 105.96 19.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 124.038 0.935 . . . . 0.0 109.901 178.18 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.9 t30 52.41 40.95 30.45 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.771 1.272 . . . . 0.0 110.765 178.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.93 -18.24 41.09 Favored Glycine 0 N--CA 1.434 -1.457 0 CA-C-N 114.734 -1.121 . . . . 0.0 113.538 -178.497 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.71 ' HB ' HG13 ' A' ' 73' ' ' VAL . 49.1 t -77.67 109.09 11.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.0 m -61.57 122.51 15.44 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.922 -1.035 . . . . 0.0 112.905 -173.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 48.0 mt -90.6 74.74 6.72 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -85.37 96.68 9.63 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.649 -174.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.17 47.86 69.27 Favored Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -178.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.72 147.57 24.42 Favored 'General case' 0 CA--C 1.476 -1.876 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -178.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.709 HG22 ' HG2' ' A' ' 85' ' ' GLN . 13.9 t -91.06 164.55 13.91 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 172.118 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -43.48 -54.74 4.62 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.409 1.484 . . . . 0.0 112.538 179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 36.8 ttmt -63.66 -34.99 79.07 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -176.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.709 ' HG2' HG22 ' A' ' 82' ' ' THR . 82.5 mm-40 -68.85 -43.26 75.79 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.168 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.603 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -55.0 -54.52 41.95 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.391 176.105 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.9 t -65.73 -35.88 76.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.725 -177.082 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 36.8 mt-10 -69.39 -32.53 71.62 Favored 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.521 179.219 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 1.054 HG21 HG11 ' A' ' 73' ' ' VAL . 60.2 m -66.86 -36.74 83.02 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 175.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 60.3 mt -75.74 -15.11 60.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 0.0 110.011 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -89.11 -45.83 9.3 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.607 176.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -69.18 -35.92 76.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.687 -176.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -53.41 -51.91 61.07 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 122.918 0.487 . . . . 0.0 112.185 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 146.57 -154.24 25.84 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.604 177.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 51.1 tt0 -76.61 -44.94 32.18 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.61 0.719 . . . . 0.0 109.748 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 21.3 t -106.08 116.31 49.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.8 131.97 65.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -174.457 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 9.5 t60 -96.91 136.97 36.71 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 175.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.545 HD11 HD22 ' A' ' 90' ' ' LEU . 6.5 mp -130.44 154.3 47.88 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 121.123 0.487 . . . . 0.0 109.823 174.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HG ' ' HB2' ' A' ' 71' ' ' LEU . 55.3 tp -110.14 118.95 37.75 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.497 ' HG ' ' HA ' ' A' ' 70' ' ' VAL . 7.4 mp -130.25 178.83 6.28 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.377 0.608 . . . . 0.0 110.527 -178.189 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 9.2 pt-20 -130.49 153.43 48.82 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 172.582 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -61.52 109.95 1.33 Allowed 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 177.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.957 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -73.95 -178.51 38.11 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.596 -177.084 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -147.58 132.31 17.91 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 -175.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.463 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 30.0 m -84.78 135.8 39.83 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -168.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 26.2 Cg_exo . . . . . 0 C--O 1.245 0.848 0 C-N-CA 123.472 2.781 . . . . 0.0 109.754 173.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 51.8 mtpt . . . . . 0 C--O 1.246 0.878 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -64.81 111.11 1.61 Allowed 'Trans proline' 0 N--CA 1.446 -1.31 0 C-N-CA 121.819 1.68 . . . . 0.0 109.894 173.117 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.488 ' H ' ' HB2' ' A' ' 103' ' ' LYS . . . 119.21 3.07 13.32 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.314 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -92.36 148.26 22.27 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 122.55 -0.382 . . . . 0.0 110.116 179.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 p -89.1 109.06 19.96 Favored 'General case' 0 N--CA 1.415 -2.2 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 166.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -109.55 100.59 9.62 Favored 'General case' 0 N--CA 1.408 -2.536 0 CA-C-O 122.334 1.064 . . . . 0.0 111.028 -173.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.774 ' HG2' ' HG ' ' A' ' 100' ' ' LEU . 45.4 mt-10 -71.51 91.87 1.08 Allowed 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.526 -1.67 . . . . 0.0 108.177 174.269 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.619 HG12 HD13 ' A' ' 101' ' ' LEU . 14.9 p -84.62 138.77 18.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.536 -174.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -108.13 107.73 18.5 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 177.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.83 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -116.38 130.94 57.03 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -176.441 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -103.77 132.34 50.11 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 122.231 -0.293 . . . . 0.0 110.873 -178.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 95' ' ' GLN . 1.7 mptm? -60.42 136.44 58.04 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.09 0.471 . . . . 0.0 112.097 175.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.411 HG21 ' HA3' ' A' ' 56' ' ' GLY . 17.6 p -104.11 100.3 10.05 Favored 'General case' 0 N--CA 1.415 -2.199 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 169.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.7 t70 73.06 -49.44 0.7 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.875 1.27 . . . . 0.0 112.203 -177.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.96 0.78 0.03 OUTLIER Glycine 0 C--N 1.306 -1.138 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.927 177.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 39.3 m -108.21 144.0 36.26 Favored 'General case' 0 C--N 1.317 -0.844 0 O-C-N 122.169 -0.606 . . . . 0.0 110.207 -177.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.83 HD11 ' HB3' ' A' ' 18' ' ' LEU . 19.6 tp -93.98 -11.14 31.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 174.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 86.7 13.9 66.39 Favored Glycine 0 N--CA 1.429 -1.797 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.048 175.545 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.498 HG22 HD13 ' A' ' 52' ' ' ILE . 14.1 pt -139.66 146.25 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-O 121.667 0.746 . . . . 0.0 112.487 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.422 ' OG ' HD11 ' A' ' 53' ' ' ILE . 19.6 m -107.02 135.04 49.26 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 114.226 -1.352 . . . . 0.0 108.412 172.48 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.0 165.23 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 123.772 0.67 . . . . 0.0 109.64 -176.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.998 ' HB ' ' HB2' ' A' ' 50' ' ' LYS . 6.0 t -149.37 141.8 24.27 Favored 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 177.406 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.769 HG12 HD13 ' A' ' 47' ' ' ILE . 32.6 m -121.49 133.67 67.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.204 -0.998 . . . . 0.0 113.514 -176.207 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 43' ' ' ARG . 61.0 mt -110.53 93.97 4.76 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 171.318 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -142.02 -49.91 0.38 Allowed 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -178.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -81.51 162.79 23.08 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.644 -1.162 . . . . 0.0 108.136 173.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -70.23 107.28 3.65 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -178.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 168.46 -176.98 42.68 Favored Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.277 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.82 -131.44 43.28 Favored Glycine 0 C--O 1.249 1.032 0 O-C-N 124.087 0.522 . . . . 0.0 112.291 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.2 t -82.97 114.29 23.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 175.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -137.43 97.92 3.58 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.965 -175.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.1 p -77.01 -52.13 9.89 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 172.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 t -164.11 -49.05 0.03 OUTLIER 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.0 p -106.5 166.45 3.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 173.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.526 ' HB3' ' HB3' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -99.87 140.5 33.99 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -176.634 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -84.35 118.01 23.96 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.83 -88.83 0.65 Allowed Glycine 0 N--CA 1.438 -1.19 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.573 177.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 32' ' ' LEU . . . 149.34 -48.32 0.6 Allowed Glycine 0 N--CA 1.418 -2.522 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -178.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.769 HD13 HG12 ' A' ' 31' ' ' VAL . 42.2 mm -115.43 136.12 53.25 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.669 ' HB3' ' HA ' ' A' ' 69' ' ' ARG 0.27 38.5 p90 -158.52 169.3 24.74 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 169.295 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.553 HG21 ' CG2' ' A' ' 64' ' ' ILE . 31.8 t -80.59 121.76 34.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.694 -178.111 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.998 ' HB2' ' HB ' ' A' ' 30' ' ' THR . 57.8 tptt -91.32 -38.09 12.85 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.468 178.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -156.03 158.58 38.06 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 119.966 -0.693 . . . . 0.0 111.577 -175.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.498 HD13 HG22 ' A' ' 27' ' ' ILE . 45.9 mm -104.05 117.97 50.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.242 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.476 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 43.6 mm -93.29 134.18 27.34 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 115.236 -0.893 . . . . 0.0 108.726 -179.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 14.9 Cg_exo -72.36 -172.68 0.94 Allowed 'Trans proline' 0 C--O 1.251 1.163 0 C-N-CA 122.792 2.328 . . . . 0.0 112.186 178.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.5 tptt 92.74 5.35 0.05 Allowed 'General case' 0 C--O 1.242 0.661 0 C-N-CA 126.367 1.867 . . . . 0.0 109.309 176.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.569 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 124.89 -163.83 18.68 Favored Glycine 0 N--CA 1.432 -1.615 0 CA-C-N 114.677 -1.147 . . . . 0.0 113.256 173.375 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.503 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 71.66 -114.04 0.07 Allowed 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 171.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.819 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -60.42 -39.48 87.58 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 117.942 0.337 . . . . 0.0 111.354 -174.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.11 -55.88 16.2 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.38 1.472 . . . . 0.0 110.115 178.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.569 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 20.4 m -73.25 -36.68 66.44 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -171.349 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -74.17 -28.85 61.49 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 175.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.58 51.09 22.35 Favored Glycine 0 N--CA 1.429 -1.82 0 CA-C-N 113.957 -1.474 . . . . 0.0 112.382 176.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.561 ' HA ' ' NE ' ' A' ' 63' ' ' ARG . 3.1 mmp_? -104.99 -56.85 2.11 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.672 0.748 . . . . 0.0 110.842 179.028 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.553 ' CG2' HG21 ' A' ' 49' ' ' VAL . 56.2 mt -95.04 144.06 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.243 -176.023 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -137.0 168.7 19.08 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 105.89 -1.892 . . . . 0.0 105.89 173.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -65.74 141.98 58.15 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.279 0.561 . . . . 0.0 111.215 -176.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.7 -40.71 2.44 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.027 -1.083 . . . . 0.0 113.77 176.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 48' ' ' TYR 0.289 8.1 m-20 -67.21 144.52 55.93 Favored 'General case' 0 CA--C 1.497 -1.096 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -174.919 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.669 ' HA ' ' HB3' ' A' ' 48' ' ' TYR . 34.6 ttp180 -102.19 149.43 24.31 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.694 -165.506 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 48' ' ' TYR . 22.0 t -115.52 133.36 62.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -173.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.487 HD12 HD22 ' A' ' 100' ' ' LEU . 85.1 mt -96.12 -37.23 10.68 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.148 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.837 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . . . -167.44 179.54 4.91 Favored 'General case' 0 C--O 1.212 -0.87 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.925 -176.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.858 HG23 HD22 ' A' ' 78' ' ' LEU . 60.3 t -123.89 110.33 25.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.021 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.4 t30 59.43 34.94 22.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.666 1.222 . . . . 0.0 109.923 175.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 -15.43 61.19 Favored Glycine 0 N--CA 1.44 -1.085 0 CA-C-N 114.478 -1.237 . . . . 0.0 114.221 178.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.495 ' O ' ' HB1' ' A' ' 72' ' ' ALA . 57.7 t -85.65 112.47 22.41 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.119 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.433 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 17.5 m -53.96 122.84 10.93 Favored 'General case' 0 C--O 1.241 0.647 0 O-C-N 124.37 1.044 . . . . 0.0 112.354 -174.149 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.858 HD22 HG23 ' A' ' 73' ' ' VAL . 18.4 tp -118.11 8.95 12.53 Favored 'General case' 0 N--CA 1.379 -3.983 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.695 -173.07 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.74 118.09 15.24 Favored 'General case' 0 C--O 1.247 0.97 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.47 20.03 11.53 Favored Glycine 0 C--N 1.302 -1.326 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.035 -176.295 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.54 ' HB3' HD11 ' A' ' 47' ' ' ILE . . . -101.01 149.84 23.52 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.435 ' C ' HG11 ' A' ' 31' ' ' VAL . 14.9 t -99.14 174.88 6.11 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -50.34 -54.17 23.52 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.785 0.834 . . . . 0.0 111.172 -173.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 59.2 mtpt -63.45 -32.39 73.82 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.063 -176.004 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -72.34 -46.54 55.09 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.526 ' O ' HD13 ' A' ' 90' ' ' LEU . . . -54.88 -56.29 21.11 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.606 177.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 74.9 t -62.98 -29.32 46.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.932 -178.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 34.2 mm-40 -72.28 -26.85 62.14 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.967 177.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 19.1 m -72.78 -39.75 66.48 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.748 ' HG ' HG11 ' A' ' 97' ' ' VAL . 8.6 mp -69.97 -18.44 63.34 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 124.677 1.191 . . . . 0.0 110.883 176.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 25.2 tpt180 -82.15 -43.13 18.14 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.706 175.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -66.03 -36.07 82.26 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.316 -177.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 p -58.89 -55.22 37.89 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.368 -179.486 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 134.35 -142.73 14.24 Favored Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 178.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.516 ' O ' ' HD3' ' A' ' 20' ' ' LYS . 58.9 tt0 -73.09 -55.76 6.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.063 0.459 . . . . 0.0 110.615 178.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 61.6 t -92.09 113.44 27.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.367 -179.396 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.748 HG11 ' HG ' ' A' ' 90' ' ' LEU . 3.0 t -105.66 128.0 60.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.011 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.532 ' CE1' ' HB3' ' A' ' 15' ' ' GLU . 34.9 t-80 -99.16 130.62 45.48 Favored 'General case' 0 C--N 1.258 -3.372 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 175.48 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.629 HD21 HD11 ' A' ' 90' ' ' LEU . 5.2 mp -128.26 146.17 50.82 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.346 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.774 ' HG ' ' HG2' ' A' ' 15' ' ' GLU . 3.3 tt -98.91 112.67 24.71 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -177.758 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.619 HD13 HG12 ' A' ' 16' ' ' VAL . 9.9 mp -115.27 166.51 11.77 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.237 0.541 . . . . 0.0 111.727 -177.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -133.14 152.11 51.96 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 176.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.488 ' HB2' ' H ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -54.05 115.26 1.95 Allowed 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.543 0.687 . . . . 0.0 110.334 171.827 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 69' ' ' ARG . . . -126.2 1.84 7.75 Favored Glycine 0 C--N 1.292 -1.902 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 176.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -49.93 -37.59 32.51 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 126.856 2.062 . . . . 0.0 111.98 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.79 98.75 49.58 Favored Pre-proline 0 N--CA 1.422 -1.833 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.825 -178.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 N--CA 1.448 -1.163 0 C-N-CA 122.12 1.88 . . . . 0.0 110.546 174.01 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.414 ' HB2' ' NZ ' ' A' ' 9' ' ' LYS . 9.8 mtmp? . . . . . 0 N--CA 1.427 -1.58 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.829 ' HA ' ' HB3' ' A' ' 103' ' ' LYS . 73.3 Cg_exo -50.76 128.62 24.74 Favored 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 121.481 1.454 . . . . 0.0 110.522 179.497 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.55 -15.54 58.54 Favored Glycine 0 C--N 1.31 -0.885 0 C-N-CA 120.816 -0.707 . . . . 0.0 113.68 -175.342 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 11.4 t70 -73.9 131.57 41.6 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 p -91.18 133.45 35.36 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.383 0.611 . . . . 0.0 111.902 -174.128 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -143.88 149.22 36.57 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.425 177.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -106.33 117.84 35.09 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.8 m -87.75 115.63 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.08 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.406 178.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -97.5 91.28 5.38 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.229 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.983 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -100.7 119.69 38.96 Favored 'General case' 0 N--CA 1.416 -2.157 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -174.138 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.44 124.09 34.16 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 179.133 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.479 ' HG2' HD23 ' A' ' 25' ' ' LEU . 92.9 mttt -65.52 144.13 57.21 Favored 'General case' 0 CA--C 1.486 -1.487 0 CA-C-O 121.145 0.498 . . . . 0.0 111.607 -179.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.564 HG21 ' HG3' ' A' ' 55' ' ' LYS . 6.2 m -61.89 -42.1 98.67 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.568 177.139 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -163.05 -49.45 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.785 176.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -141.31 -9.24 0.68 Allowed Glycine 0 C--O 1.242 0.597 0 C-N-CA 119.524 -1.322 . . . . 0.0 113.538 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.5 m -132.73 150.64 52.13 Favored 'General case' 0 N--CA 1.433 -1.314 0 O-C-N 122.062 -0.669 . . . . 0.0 110.828 -175.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.622 HD12 HD23 ' A' ' 90' ' ' LEU . 72.6 mt -89.74 145.34 25.27 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 169.081 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.83 51.92 4.62 Favored Glycine 0 C--N 1.288 -2.116 0 C-N-CA 120.26 -0.971 . . . . 0.0 112.902 -177.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.541 HD13 HD13 ' A' ' 64' ' ' ILE . 12.2 pt -140.58 142.29 30.98 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 CA-C-N 117.87 0.835 . . . . 0.0 111.904 177.569 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 17.8 t -117.53 140.95 48.93 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 175.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.425 HG12 ' HA ' ' A' ' 49' ' ' VAL . 27.1 m -126.28 147.96 31.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -173.4 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.769 ' HB ' ' HD2' ' A' ' 50' ' ' LYS . 15.1 t -118.84 158.31 25.9 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 82' ' ' THR . 3.3 t -114.04 127.7 71.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -176.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 mp -116.06 106.92 14.29 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.158 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -70.43 134.55 47.91 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.607 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -65.98 134.69 53.47 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -177.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -114.18 1.94 14.7 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.091 179.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -77.18 83.6 1.08 Allowed Glycine 0 CA--C 1.507 -0.452 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.418 -177.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -92.71 -6.93 63.45 Favored Glycine 0 N--CA 1.436 -1.364 0 C-N-CA 121.226 -0.512 . . . . 0.0 113.955 -174.866 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.57 -60.04 3.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.125 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -166.13 -50.08 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.5 p -76.43 113.63 14.25 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.333 0.587 . . . . 0.0 110.757 177.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 m -118.26 140.19 50.19 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.429 -178.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.9 m -79.38 92.77 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-O 122.901 1.334 . . . . 0.0 108.306 174.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -97.43 171.37 8.44 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.663 -171.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.582 ' HB2' HD22 ' A' ' 71' ' ' LEU . 59.5 m80 74.31 95.64 0.07 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.296 173.409 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' A' ' 78' ' ' LEU . . . 87.92 -67.11 3.23 Favored Glycine 0 N--CA 1.426 -1.971 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.352 176.699 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.85 19.14 77.99 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -175.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.529 HD13 HG13 ' A' ' 31' ' ' VAL . 42.1 mm -101.53 133.44 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.823 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -176.811 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -129.25 120.3 25.48 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.491 HG21 ' CG2' ' A' ' 64' ' ' ILE . 28.6 t -47.84 113.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 122.036 0.922 . . . . 0.0 109.971 170.732 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.769 ' HD2' ' HB ' ' A' ' 30' ' ' THR . 88.4 tttt -87.41 -37.95 16.57 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.994 -174.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -150.86 151.44 32.25 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.363 -176.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.571 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 47.4 mm -109.39 128.61 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 O-C-N 123.731 0.644 . . . . 0.0 109.444 178.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.93 133.58 20.97 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 175.629 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HB2' ' H ' ' A' ' 55' ' ' LYS . 22.6 Cg_exo -65.59 -86.6 0.01 OUTLIER 'Trans proline' 0 C--O 1.255 1.349 0 C-N-CA 121.907 1.738 . . . . 0.0 111.57 176.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HG3' HG21 ' A' ' 21' ' ' THR . 17.8 tptp 65.04 -67.51 0.12 Allowed 'General case' 0 N--CA 1.434 -1.232 0 C-N-CA 127.605 2.362 . . . . 0.0 110.481 179.495 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.07 38.15 0.02 OUTLIER Glycine 0 C--N 1.277 -2.729 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -179.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.587 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -134.52 -99.39 0.25 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 -174.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.983 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -68.71 -38.69 80.43 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -168.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.571 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 36.4 tt0 -84.54 -29.39 25.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.313 0.578 . . . . 0.0 110.162 -179.65 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.8 m -71.92 -46.26 58.26 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.117 -177.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.57 -24.3 34.05 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.551 0.691 . . . . 0.0 109.853 178.631 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.08 53.43 14.55 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.263 175.046 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -98.96 -46.76 5.5 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 122.675 1.226 . . . . 0.0 109.345 178.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.541 HD13 HD13 ' A' ' 27' ' ' ILE . 39.8 mt -112.8 140.93 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.265 0 CA-C-N 113.154 -1.839 . . . . 0.0 109.752 -171.706 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -133.87 154.93 50.7 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 176.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 144.25 56.36 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.48 -175.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.37 -16.45 38.08 Favored Glycine 0 N--CA 1.432 -1.578 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.975 -178.486 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -80.28 144.45 32.83 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-O 121.034 0.445 . . . . 0.0 111.081 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -90.93 137.33 32.44 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.813 -175.546 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 38.5 t -101.18 112.32 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 176.606 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.582 HD22 ' HB2' ' A' ' 44' ' ' HIS . 85.2 mt -85.29 -39.47 17.66 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.668 -177.352 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.707 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -163.37 175.06 11.2 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.144 -176.069 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.708 HG13 ' HG ' ' A' ' 99' ' ' LEU . 23.8 t -130.76 117.87 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.617 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 65.32 27.15 12.06 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.455 1.102 . . . . 0.0 110.093 176.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.87 -6.82 79.81 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.557 -177.017 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.1 t -87.21 105.06 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.612 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 47.6 m -62.07 130.79 47.14 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.355 -174.244 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.707 ' HG ' ' HA ' ' A' ' 72' ' ' ALA . 98.0 mt -87.74 40.54 0.94 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.797 0.808 . . . . 0.0 110.574 -178.093 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 77' ' ' SER . 36.2 mt-10 -76.3 112.27 12.62 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.582 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.01 32.37 17.79 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 -175.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -99.54 177.78 5.06 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 121.977 0.894 . . . . 0.0 110.92 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.649 ' HA ' HG21 ' A' ' 31' ' ' VAL . 10.0 t -153.87 -179.52 7.92 Favored 'General case' 0 N--CA 1.407 -2.592 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 179.561 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -50.7 -54.17 25.28 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.064 0.853 . . . . 0.0 110.142 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 40.7 ttmt -58.35 -43.6 88.41 Favored 'General case' 0 C--O 1.204 -1.298 0 O-C-N 123.596 0.56 . . . . 0.0 111.638 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.543 ' HG2' HG22 ' A' ' 82' ' ' THR . 13.1 mm-40 -66.23 -47.82 72.56 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.936 -176.427 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.529 ' O ' HD13 ' A' ' 90' ' ' LEU . . . -56.91 -57.37 12.8 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.749 178.052 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.48 -32.68 58.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.378 -175.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 53.0 mm-40 -76.44 -19.48 58.03 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.656 178.27 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.4 m -76.44 -35.51 58.45 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.622 HD23 HD12 ' A' ' 25' ' ' LEU . 8.7 mp -70.22 -22.14 62.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.622 0.769 . . . . 0.0 110.239 175.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -84.61 -31.09 24.45 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.572 0.701 . . . . 0.0 109.729 174.811 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -70.33 -42.37 72.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.565 178.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.6 p -65.07 152.97 42.13 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.88 177.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -68.67 -157.05 1.07 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 114.678 0.631 . . . . 0.0 114.678 -179.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.443 ' HG3' HG23 ' A' ' 96' ' ' VAL . 20.2 pt20 -68.02 -35.22 77.94 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.463 -0.368 . . . . 0.0 111.581 -177.105 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.443 HG23 ' HG3' ' A' ' 95' ' ' GLN . 48.4 t -105.2 108.52 25.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 176.095 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.6 t -99.95 134.5 39.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.105 -173.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -104.29 128.09 52.02 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 173.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.708 ' HG ' HG13 ' A' ' 73' ' ' VAL . 5.4 mp -123.89 145.29 49.22 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 172.789 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 56.5 tp -91.82 109.18 20.51 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.714 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 mp -117.66 160.2 21.69 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.401 0.62 . . . . 0.0 110.42 -177.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 9.4 pt-20 -131.69 156.6 45.59 Favored 'General case' 0 C--N 1.264 -3.111 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 170.189 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.829 ' HB3' ' HA ' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -63.45 117.1 6.23 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.215 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -86.34 -162.12 36.51 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.693 -176.118 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.54 HE21 ' HB3' ' A' ' 10' ' ' PRO . 20.5 mp0 -137.67 149.81 46.85 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.54 ' H ' ' HD2' ' A' ' 107' ' ' PRO . 92.3 t -90.57 -54.79 0.28 Allowed Pre-proline 0 C--N 1.288 -2.077 0 CA-C-O 118.754 -0.641 . . . . 0.0 112.081 -179.495 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.54 ' HD2' ' H ' ' A' ' 106' ' ' VAL . 8.9 Cg_endo . . . . . 0 C--N 1.379 2.178 0 C-N-CA 123.767 2.978 . . . . 0.0 112.993 178.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.672 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 35.7 mmtp . . . . . 0 CA--C 1.542 0.661 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 9' ' ' LYS . 3.2 Cg_exo -71.36 88.33 0.73 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.44 2.093 . . . . 0.0 114.625 -171.095 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.55 ' H ' ' HB2' ' A' ' 103' ' ' LYS . . . 118.0 -6.38 15.44 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.88 175.219 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -102.79 160.89 14.2 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -174.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 p -101.9 145.08 29.72 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 165.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -149.04 153.76 38.34 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 120.322 -0.551 . . . . 0.0 111.433 -176.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -103.47 133.46 48.47 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 179.145 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.496 HG11 HD11 ' A' ' 64' ' ' ILE . 11.0 p -131.56 132.47 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.489 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.143 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.5 ' HG3' ' HD2' ' A' ' 98' ' ' HIS . 49.1 mt-10 -101.46 85.43 2.77 Favored 'General case' 0 CA--C 1.472 -2.039 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 174.582 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.797 ' HB3' HD11 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -77.32 120.91 23.0 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.624 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.74 123.61 36.14 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.243 -175.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -68.49 112.48 5.33 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 174.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 t -111.35 89.01 2.93 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.196 -175.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 t70 79.76 -40.37 0.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 113.797 -1.547 . . . . 0.0 113.641 178.259 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.76 -98.5 0.99 Allowed Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 120.489 -0.863 . . . . 0.0 114.078 -179.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.0 m -162.65 -162.17 0.77 Allowed 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 -173.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.797 HD11 ' HB3' ' A' ' 18' ' ' LEU . 1.6 tp -89.34 109.38 20.29 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 171.514 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.586 ' HA3' ' O ' ' A' ' 56' ' ' GLY . . . -75.07 50.85 2.36 Favored Glycine 0 C--N 1.292 -1.866 0 CA-C-N 114.697 -1.138 . . . . 0.0 115.383 -172.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.504 HG21 HG21 ' A' ' 64' ' ' ILE . 10.7 pt -130.11 122.11 53.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 121.749 0.785 . . . . 0.0 111.071 177.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.531 ' HB2' HD11 ' A' ' 53' ' ' ILE . 7.7 t -94.86 124.99 39.23 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 -178.087 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 83' ' ' HIS . 33.7 m -118.67 156.56 20.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 120.687 0.28 . . . . 0.0 111.41 -174.39 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.421 HG22 ' HB2' ' A' ' 50' ' ' LYS . 10.2 t -141.74 159.37 42.35 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.398 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.591 ' CG2' HD13 ' A' ' 47' ' ' ILE . 21.4 t -120.93 115.65 47.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 120.915 0.388 . . . . 0.0 110.797 177.012 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.419 HD22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -142.65 122.0 13.11 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.206 178.453 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.528 ' HZ ' ' HA2' ' A' ' 46' ' ' GLY . 76.5 m-85 -113.54 -68.24 0.94 Allowed 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 176.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -156.23 -169.89 3.19 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -177.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -101.73 7.97 41.71 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.389 0.614 . . . . 0.0 110.983 -174.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 88.13 38.77 7.16 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -177.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.04 -111.9 0.35 Allowed Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 121.234 -0.508 . . . . 0.0 112.27 -176.41 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -128.7 98.71 4.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 122.025 0.916 . . . . 0.0 111.927 -178.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -138.91 136.56 35.61 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 177.6 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.9 t -82.21 73.23 9.25 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 122.902 1.334 . . . . 0.0 111.252 177.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 65.3 m -157.23 85.67 0.94 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.215 -1.357 . . . . 0.0 107.461 176.15 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 p -137.84 73.71 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.133 0 CA-C-O 123.362 1.553 . . . . 0.0 108.97 -176.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -91.43 126.19 36.43 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 113.857 -1.52 . . . . 0.0 107.434 178.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -71.68 120.21 16.94 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.067 0.46 . . . . 0.0 110.004 178.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.55 ' HA2' ' HG2' ' A' ' 79' ' ' GLU . . . 156.53 -132.04 3.17 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 -178.298 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.528 ' HA2' ' HZ ' ' A' ' 33' ' ' PHE . . . -159.78 -68.08 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.44 0 C-N-CA 117.872 -2.109 . . . . 0.0 115.477 -179.765 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.648 ' HB ' HG22 ' A' ' 70' ' ' VAL . 18.0 mm -100.33 147.22 7.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -164.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -129.43 107.68 9.68 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.94 179.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 50.4 t -48.15 121.76 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.608 0.718 . . . . 0.0 110.521 169.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.421 ' HB2' HG22 ' A' ' 30' ' ' THR . 85.5 tttt -92.63 -37.31 12.5 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.702 -178.598 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -159.85 161.83 34.54 Favored 'General case' 0 C--O 1.244 0.811 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.825 -175.217 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 20.1 mm -116.08 125.73 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.531 HD11 ' HB2' ' A' ' 28' ' ' SER . 2.0 mp -76.48 134.28 70.0 Favored Pre-proline 0 C--N 1.302 -1.469 0 C-N-CA 122.573 0.349 . . . . 0.0 111.473 -176.813 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -59.65 130.62 36.11 Favored 'Trans proline' 0 C--N 1.359 1.12 0 C-N-CA 123.107 2.538 . . . . 0.0 110.034 175.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 69.74 -4.99 1.29 Allowed 'General case' 0 C--O 1.249 1.043 0 CA-C-O 122.006 0.907 . . . . 0.0 110.654 -177.207 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.586 ' O ' ' HA3' ' A' ' 26' ' ' GLY . . . -85.48 68.34 3.45 Favored Glycine 0 N--CA 1.403 -3.551 0 CA-C-N 115.34 -0.845 . . . . 0.0 113.209 -175.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 18' ' ' LEU . . . 58.82 -75.41 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.698 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 167.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.677 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -58.12 -35.11 70.98 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 125.219 1.407 . . . . 0.0 113.342 -171.793 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.512 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 34.7 tt0 -85.64 -39.96 16.72 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.032 0.444 . . . . 0.0 110.138 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 4.1 m -68.52 -37.32 79.94 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.282 -177.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -82.62 -34.61 27.52 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.714 177.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.89 52.02 3.81 Favored Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.688 -0.687 . . . . 0.0 114.242 175.256 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -116.58 -56.8 2.25 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.24 0.543 . . . . 0.0 111.658 179.673 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.559 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 21.2 mm -84.07 145.52 8.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.11 -176.635 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -125.33 162.61 24.38 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 175.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -77.97 143.1 37.87 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.42 -179.005 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.488 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 103.74 -28.0 17.28 Favored Glycine 0 N--CA 1.42 -2.391 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.478 -179.395 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.756 ' HA ' ' HA3' ' A' ' 104' ' ' GLY . 39.5 m-20 -64.53 146.91 53.87 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.687 0.756 . . . . 0.0 111.825 -176.709 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 102' ' ' GLU . 59.9 mtp180 -96.84 146.53 24.83 Favored 'General case' 0 CA--C 1.461 -2.456 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.017 -173.964 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.648 HG22 ' HB ' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -112.74 123.79 68.77 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.132 0 CA-C-N 114.229 -1.35 . . . . 0.0 107.461 176.191 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HB2' HD12 ' A' ' 100' ' ' LEU . 65.9 mt -107.96 -24.23 11.7 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.792 -176.195 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -169.06 173.23 6.98 Favored 'General case' 0 C--O 1.206 -1.204 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.927 -176.032 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.815 HG22 ' HG ' ' A' ' 99' ' ' LEU . 99.4 t -130.29 116.98 38.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 173.56 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 98' ' ' HIS 0.265 10.3 p30 51.31 38.43 21.5 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.331 1.453 . . . . 0.0 112.513 -177.648 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.79 -8.02 77.49 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 119.928 -1.129 . . . . 0.0 113.881 -179.052 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.54 106.03 14.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 176.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 49.7 m -63.91 136.79 57.65 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -172.122 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.705 HD11 HG23 ' A' ' 73' ' ' VAL . 81.3 mt -118.95 16.85 13.4 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.584 178.355 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HG2' ' HA2' ' A' ' 45' ' ' GLY . 44.2 mt-10 -67.38 119.47 12.27 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.472 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.5 15.16 58.91 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.301 -177.266 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.78 159.13 15.09 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-N 117.474 0.637 . . . . 0.0 109.587 179.42 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.9 t -97.0 158.78 15.26 Favored 'General case' 0 N--CA 1.416 -2.151 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 171.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.571 ' HB2' HG23 ' A' ' 29' ' ' VAL 0.272 8.4 p80 -51.1 -45.4 61.49 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 -172.197 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.58 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -64.56 -32.4 74.03 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.614 -178.651 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -67.14 -37.67 84.21 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.676 0.75 . . . . 0.0 109.718 178.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -63.61 -46.59 85.05 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.565 176.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 86.5 t -64.37 -34.44 69.32 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.985 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.137 -178.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.58 ' HG3' ' O ' ' A' ' 84' ' ' LYS . 45.6 mt-10 -60.01 -47.34 86.24 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 177.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.532 ' O ' HG23 ' A' ' 93' ' ' THR . 14.0 m -60.7 -39.28 87.94 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-O 121.974 0.892 . . . . 0.0 109.739 178.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.614 HD11 ' HB2' ' A' ' 25' ' ' LEU . 4.2 tp -79.27 -9.8 59.66 Favored 'General case' 0 N--CA 1.413 -2.279 0 C-N-CA 124.224 1.01 . . . . 0.0 110.431 -177.105 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -101.13 -18.11 16.35 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 176.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -92.71 -11.8 33.07 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.817 179.456 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 89' ' ' THR . 32.1 p -73.16 -177.82 2.65 Favored 'General case' 0 C--O 1.252 1.195 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.407 173.281 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -90.52 -123.25 2.63 Favored Glycine 0 N--CA 1.433 -1.509 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.166 178.736 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -98.15 -45.86 6.06 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -178.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.8 m -95.9 118.07 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.658 0 CA-C-O 121.655 0.74 . . . . 0.0 109.374 176.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.523 HG21 HD12 ' A' ' 90' ' ' LEU . 45.8 t -101.15 113.3 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.436 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.481 -178.748 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.5 ' HD2' ' HG3' ' A' ' 17' ' ' GLU . 17.3 t-80 -84.31 58.35 4.76 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.815 ' HG ' HG22 ' A' ' 73' ' ' VAL . 3.8 tt -70.58 142.55 51.72 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.703 -172.42 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.592 HD12 ' HB2' ' A' ' 71' ' ' LEU . 3.0 tm? -101.77 114.3 28.24 Favored 'General case' 0 N--CA 1.424 -1.74 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 -175.475 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.48 HD13 HG12 ' A' ' 16' ' ' VAL . 7.7 mp -111.3 166.43 11.11 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.502 0.668 . . . . 0.0 112.758 -177.199 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 69' ' ' ARG . 36.5 tt0 -132.38 151.32 51.91 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 174.548 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.55 ' HB2' ' H ' ' A' ' 11' ' ' GLY . 11.3 tmtt? -44.44 123.84 3.78 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 124.1 0.96 . . . . 0.0 111.811 171.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.756 ' HA3' ' HA ' ' A' ' 68' ' ' ASP . . . -126.4 -10.22 4.2 Favored Glycine 0 C--N 1.295 -1.701 0 C-N-CA 119.605 -1.283 . . . . 0.0 111.312 171.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.526 ' O ' ' HE2' ' A' ' 103' ' ' LYS . 10.2 pt20 -89.12 151.17 22.36 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 123.768 0.827 . . . . 0.0 109.698 -178.4 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.4 t 52.84 84.99 0.2 Allowed Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.245 1.018 . . . . 0.0 110.789 -172.01 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo . . . . . 0 C--O 1.253 1.264 0 C-N-CA 124.254 3.303 . . . . 0.0 114.221 -175.964 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt . . . . . 0 C--O 1.242 0.682 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -71.21 135.66 27.54 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 N-CA-C 106.731 -2.065 . . . . 0.0 106.731 165.08 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.78 22.49 39.14 Favored Glycine 0 C--N 1.307 -1.07 0 C-N-CA 119.451 -1.357 . . . . 0.0 111.25 -171.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 20.9 t0 -111.59 147.09 36.2 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.851 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.3 p -91.09 144.92 25.13 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 123.899 0.749 . . . . 0.0 112.74 -174.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.553 ' HE1' ' HG2' ' A' ' 103' ' ' LYS . 17.8 p90 -168.82 134.44 1.69 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.291 175.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' A' ' 99' ' ' LEU . 46.1 mt-10 -88.11 104.01 16.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.657 0.742 . . . . 0.0 109.592 175.766 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 5.0 t -71.82 138.85 20.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.647 -178.23 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.18 95.25 5.99 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 173.303 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.711 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -102.5 125.88 49.36 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -174.333 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 96' ' ' VAL . . . -97.47 143.72 27.9 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.525 0.678 . . . . 0.0 111.849 -177.372 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.572 ' HE3' ' CG2' ' A' ' 97' ' ' VAL . 1.2 mptm? -71.73 93.13 1.25 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 124.938 1.295 . . . . 0.0 112.417 176.393 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.444 HG22 ' HB2' ' A' ' 57' ' ' ALA . 13.3 t -64.88 -30.15 71.13 Favored 'General case' 0 C--N 1.274 -2.712 0 CA-C-O 121.755 0.788 . . . . 0.0 109.466 169.019 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 20' ' ' LYS . 16.4 t70 -112.13 -155.85 0.58 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 105.547 -2.02 . . . . 0.0 105.547 -178.676 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.41 17.39 58.56 Favored Glycine 0 C--N 1.299 -1.518 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 176.155 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -155.65 174.75 14.83 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -177.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' A' ' 18' ' ' LEU . 11.6 tp -94.14 150.31 20.44 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -178.256 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.624 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . -81.26 41.52 2.65 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 114.173 -174.311 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.4 pt -137.39 130.93 44.07 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.175 0 CA-C-O 121.625 0.726 . . . . 0.0 111.941 177.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.609 ' HB2' HD11 ' A' ' 53' ' ' ILE . 48.5 t -99.25 124.23 44.15 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 175.763 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 49' ' ' VAL . 29.7 m -118.62 152.4 20.81 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.541 ' HA ' ' HB3' ' A' ' 83' ' ' HIS . 7.6 t -131.93 171.62 13.35 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 175.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.513 HG22 ' CD1' ' A' ' 47' ' ' ILE . 2.5 t -110.45 134.79 51.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.426 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.0 tt -140.1 71.66 1.38 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -114.92 19.54 15.76 Favored 'General case' 0 C--N 1.258 -3.384 0 CA-C-N 113.174 -1.83 . . . . 0.0 107.898 -177.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -73.93 -17.76 60.98 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.57 -1.195 . . . . 0.0 111.743 -174.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -105.55 6.4 32.2 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.598 0.713 . . . . 0.0 110.522 178.129 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.63 35.93 4.73 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -135.95 94.81 0.24 Allowed Glycine 0 N--CA 1.44 -1.091 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.0 t -110.11 -73.92 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -139.26 -58.43 0.59 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.239 0.542 . . . . 0.0 109.745 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.489 HG23 HG13 ' A' ' 42' ' ' VAL . 8.8 t -116.25 153.26 32.23 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.342 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.1 m -69.29 104.39 2.22 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.389 0.614 . . . . 0.0 110.288 -178.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.489 HG13 HG23 ' A' ' 40' ' ' THR . 16.3 m -117.78 -4.1 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.781 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.788 176.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.442 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 2.8 tpm_? -118.4 122.58 43.14 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.562 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.9 m170 -105.54 160.77 14.91 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 174.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.88 -144.09 15.74 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -178.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.91 -19.98 7.29 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 119.709 -1.234 . . . . 0.0 113.177 174.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.513 ' CD1' HG22 ' A' ' 31' ' ' VAL . 38.0 mm -101.13 126.86 54.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.097 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.732 ' CE1' ' HG2' ' A' ' 69' ' ' ARG . 61.5 m-85 -132.85 124.17 27.45 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 116.202 -0.454 . . . . 0.0 109.953 -176.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.458 HG21 ' CG2' ' A' ' 64' ' ' ILE . 41.0 t -48.32 118.97 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.468 0 CA-C-O 121.547 0.689 . . . . 0.0 110.586 172.456 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -92.51 -35.46 13.6 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.97 -176.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -160.33 165.75 30.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.818 -177.294 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.946 HG21 ' HB2' ' A' ' 59' ' ' GLU . 42.6 mm -110.75 116.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.624 ' HB ' ' HA2' ' A' ' 26' ' ' GLY . 47.4 mm -70.43 116.88 49.63 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -177.851 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 53' ' ' ILE . 6.9 Cg_exo -75.4 77.85 3.15 Favored 'Trans proline' 0 C--O 1.243 0.761 0 C-N-CA 123.721 2.947 . . . . 0.0 114.015 -175.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.592 ' HD3' HG22 ' A' ' 53' ' ' ILE . 2.1 mptm? -122.53 -23.61 5.14 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.697 170.685 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.647 ' HA2' ' OG ' ' A' ' 60' ' ' SER . . . 116.62 43.93 0.61 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 119.984 -1.103 . . . . 0.0 113.479 -179.207 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.461 ' HB3' ' HA3' ' A' ' 26' ' ' GLY . . . -117.94 -87.92 0.62 Allowed 'General case' 0 C--O 1.206 -1.219 0 CA-C-N 117.214 0.507 . . . . 0.0 110.897 -177.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.711 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -77.09 -27.85 54.34 Favored 'General case' 0 C--O 1.257 1.498 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -171.278 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.946 ' HB2' HG21 ' A' ' 52' ' ' ILE . 40.9 tt0 -83.0 -33.3 26.59 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.402 0.62 . . . . 0.0 109.808 -179.721 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.647 ' OG ' ' HA2' ' A' ' 56' ' ' GLY . 7.4 m -81.84 -26.89 33.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.559 0.695 . . . . 0.0 109.228 -178.373 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -75.1 -41.19 59.2 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 172.072 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.08 39.79 9.07 Favored Glycine 0 N--CA 1.44 -1.086 0 CA-C-N 114.072 -1.422 . . . . 0.0 114.579 170.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -120.42 -45.53 2.42 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.043 -1.063 . . . . 0.0 112.067 178.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.557 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 60.5 mt -94.02 132.16 38.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.003 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.488 ' HA ' HD11 ' A' ' 52' ' ' ILE . 16.4 t-80 -135.43 -174.87 3.75 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 176.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -73.54 131.53 41.85 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.27 0.557 . . . . 0.0 110.501 -176.099 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 108.03 -17.39 35.12 Favored Glycine 0 N--CA 1.425 -2.085 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.756 -179.179 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.488 ' HB3' HD23 ' A' ' 101' ' ' LEU . 11.3 m-20 -63.89 136.02 57.03 Favored 'General case' 0 C--O 1.261 1.666 0 CA-C-O 122.031 0.92 . . . . 0.0 112.783 -177.512 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.732 ' HG2' ' CE1' ' A' ' 48' ' ' TYR . 41.8 mtp180 -86.17 118.79 25.85 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.373 -173.026 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.8 t -93.55 108.81 20.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 113.88 -1.509 . . . . 0.0 107.465 178.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 102' ' ' GLU . 66.8 mt -86.79 -41.79 13.81 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -160.4 177.19 10.83 Favored 'General case' 0 N--CA 1.419 -2.016 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.607 -175.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 1.147 HG11 HG21 ' A' ' 89' ' ' THR . 2.9 p -128.95 102.17 7.55 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 C-N-CA 124.106 0.962 . . . . 0.0 109.51 177.426 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 52.7 t30 51.78 57.21 6.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.186 0.993 . . . . 0.0 109.897 179.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.47 -38.31 3.02 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 114.484 -1.235 . . . . 0.0 114.146 -178.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.473 ' HB ' HG13 ' A' ' 73' ' ' VAL . 43.2 t -72.84 111.57 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.066 0.933 . . . . 0.0 109.773 -175.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.3 p -81.59 113.45 19.62 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-O 121.298 0.571 . . . . 0.0 111.265 -178.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.869 HD23 ' H ' ' A' ' 78' ' ' LEU 0.269 0.7 OUTLIER -88.28 92.63 9.24 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-O 122.29 1.043 . . . . 0.0 108.957 176.865 . . . . . . . . 4 4 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -101.1 111.08 23.2 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.79 -169.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.8 46.31 94.29 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -177.11 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.605 ' HB1' ' HG3' ' A' ' 85' ' ' GLN . . . -89.73 167.16 13.1 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 -177.357 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 85' ' ' GLN . 70.8 p -79.7 144.99 33.19 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 171.725 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 30' ' ' THR . 11.1 p-80 -53.08 -37.45 61.68 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.388 0.613 . . . . 0.0 110.021 173.195 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 58.3 tttm -54.41 -54.54 39.32 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.297 -1.32 . . . . 0.0 110.633 173.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.605 ' HG3' ' HB1' ' A' ' 81' ' ' ALA . 0.7 OUTLIER -72.51 -28.71 63.04 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.227 -175.624 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -55.67 -52.12 64.92 Favored 'General case' 0 C--O 1.246 0.916 0 CA-C-O 121.779 0.8 . . . . 0.0 109.388 174.048 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 94.7 t -68.65 -28.43 40.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.933 177.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 84' ' ' LYS . 63.2 mm-40 -64.54 -35.8 82.14 Favored 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 109.101 -0.704 . . . . 0.0 109.101 176.079 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 1.147 HG21 HG11 ' A' ' 73' ' ' VAL . 23.1 m -69.03 -32.72 72.42 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.4 mt -72.12 -19.75 61.74 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.849 177.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -102.76 -6.12 22.96 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.167 175.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -90.33 -20.92 22.34 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 122.481 1.134 . . . . 0.0 108.435 178.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.574 HG21 HG13 ' A' ' 97' ' ' VAL . 2.2 p -83.07 171.12 14.09 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-N 114.486 -1.233 . . . . 0.0 109.923 176.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.22 -149.18 11.07 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.222 -176.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.624 ' HG3' HG23 ' A' ' 96' ' ' VAL . 3.7 pt20 -69.03 -36.64 77.96 Favored 'General case' 0 C--O 1.207 -1.176 0 CA-C-O 120.823 0.344 . . . . 0.0 110.787 -178.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.624 HG23 ' HG3' ' A' ' 95' ' ' GLN . 59.0 t -116.44 118.83 60.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.342 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.574 HG13 HG21 ' A' ' 93' ' ' THR . 40.1 t -100.53 130.1 50.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.082 -177.784 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.495 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 47.6 m80 -93.99 117.17 29.74 Favored 'General case' 0 C--N 1.272 -2.802 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 172.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.795 HD23 HD11 ' A' ' 101' ' ' LEU . 5.2 tp -120.76 133.07 55.35 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -176.676 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 45.9 tp -89.84 112.52 23.89 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -176.4 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.795 HD11 HD23 ' A' ' 99' ' ' LEU . 7.1 mp -124.06 165.56 17.28 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-O 121.329 0.585 . . . . 0.0 110.569 -179.577 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.776 ' HB2' HD11 ' A' ' 71' ' ' LEU . 28.3 tt0 -131.63 127.99 38.16 Favored 'General case' 0 N--CA 1.397 -3.079 0 N-CA-C 102.646 -3.094 . . . . 0.0 102.646 174.525 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.922 ' HE2' ' HA ' ' A' ' 103' ' ' LYS . 4.4 mmpt? -46.43 110.01 0.24 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -177.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -119.9 91.57 0.5 Allowed Glycine 0 N--CA 1.417 -2.631 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.217 -175.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -95.1 -9.13 34.55 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-O 122.491 1.138 . . . . 0.0 109.352 173.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 16.4 m -144.84 139.74 15.6 Favored Pre-proline 0 C--N 1.297 -1.68 0 CA-C-N 113.004 -1.907 . . . . 0.0 107.945 177.19 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 1.7 Cg_endo . . . . . 0 C--O 1.248 1.007 0 C-N-CA 123.151 2.567 . . . . 0.0 110.996 176.314 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.563 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 26.7 mtpp . . . . . 0 CA--C 1.56 1.361 0 CA-C-O 119.028 -0.51 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.89 ' HB3' ' HB2' ' A' ' 105' ' ' GLN . 26.5 Cg_exo -68.66 66.0 1.2 Allowed 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 121.785 1.657 . . . . 0.0 112.013 172.522 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -176.33 24.58 0.06 OUTLIER Glycine 0 N--CA 1.434 -1.473 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 175.062 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 18.2 t70 -90.38 139.76 30.36 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.884 -0.658 . . . . 0.0 110.474 -177.599 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 5.6 p -100.81 119.27 38.4 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 123.945 0.778 . . . . 0.0 110.346 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -150.72 145.84 26.05 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.555 -178.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.489 ' HG3' HD23 ' A' ' 100' ' ' LEU . 50.0 mt-10 -77.61 97.04 4.95 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 172.394 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 12.6 p -75.08 138.92 19.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.289 -178.684 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -107.0 114.56 28.71 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.939 HD21 ' HA ' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -115.34 124.03 50.24 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 178.659 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.67 111.59 23.91 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.075 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.481 ' HD2' ' HA ' ' A' ' 95' ' ' GLN . 99.1 mttt -58.65 153.12 17.12 Favored 'General case' 0 C--O 1.249 1.075 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -176.86 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.818 HG23 ' H ' ' A' ' 23' ' ' GLY . 9.0 t -93.93 -164.86 1.23 Allowed 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 171.845 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.47 4.66 17.51 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 118.816 0.735 . . . . 0.0 110.718 179.008 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.818 ' H ' HG23 ' A' ' 21' ' ' THR . . . -140.03 56.37 0.62 Allowed Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.628 -0.715 . . . . 0.0 113.007 179.363 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . 0.316 80.3 p 74.9 -176.63 0.15 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 126.404 1.882 . . . . 0.0 115.715 172.47 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.743 HD22 ' HB3' ' A' ' 18' ' ' LEU . 69.6 mt -65.78 -16.98 64.3 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -177.095 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.535 ' HA2' ' HB ' ' A' ' 53' ' ' ILE . . . 78.52 24.84 62.08 Favored Glycine 0 N--CA 1.418 -2.547 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 178.372 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.529 HG21 HG21 ' A' ' 64' ' ' ILE . 19.3 pt -136.64 123.23 30.25 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 CA-C-O 121.992 0.901 . . . . 0.0 112.395 177.853 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 69.8 m -100.34 121.18 41.08 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 113.347 -1.752 . . . . 0.0 108.247 177.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 49' ' ' VAL . 32.0 m -114.73 152.74 16.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.269 -173.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.5 t -129.35 155.66 45.28 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 82' ' ' THR . 8.5 t -95.94 129.77 45.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 119.242 0.928 . . . . 0.0 109.219 179.753 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 33.9 mt -105.09 88.23 2.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.027 -1.069 . . . . 0.0 111.571 174.395 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.662 ' CE2' ' HA2' ' A' ' 46' ' ' GLY . 26.0 m-85 -149.32 91.97 1.89 Allowed 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 113.565 -1.652 . . . . 0.0 107.781 174.396 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -100.82 88.19 3.51 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 122.873 1.32 . . . . 0.0 109.826 179.334 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -71.83 109.08 5.46 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 113.848 -1.524 . . . . 0.0 109.243 -177.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 126.55 -14.95 6.76 Favored Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -176.778 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -123.39 -94.81 1.16 Allowed Glycine 0 N--CA 1.431 -1.689 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.863 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.2 t -93.76 53.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 CA-C-O 122.434 1.111 . . . . 0.0 108.623 -177.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -106.85 28.39 8.0 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.771 0.796 . . . . 0.0 110.054 -178.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 48.7 m -73.11 -42.48 62.88 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.7 m -106.47 126.45 52.26 Favored 'General case' 0 N--CA 1.414 -2.251 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 172.668 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.0 t -130.5 13.12 2.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -176.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.55 161.64 23.3 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.53 -1.214 . . . . 0.0 107.951 -178.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 68.4 m-70 73.37 14.09 4.5 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.584 1.154 . . . . 0.0 112.158 177.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -142.34 -154.0 6.05 Favored Glycine 0 N--CA 1.432 -1.595 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.662 ' HA2' ' CE2' ' A' ' 33' ' ' PHE . . . 148.21 -95.77 0.17 Allowed Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 178.352 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.932 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 43.0 mm -101.27 146.38 9.77 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -179.356 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.518 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 53.6 t80 -131.77 110.23 10.71 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -174.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.505 ' HA ' HG12 ' A' ' 29' ' ' VAL . 42.1 t -52.3 114.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 171.683 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -94.64 -32.8 13.23 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.805 -173.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 28' ' ' SER . . . -149.17 143.07 25.71 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.068 -176.466 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.653 HG22 ' HB2' ' A' ' 59' ' ' GLU . 45.8 mm -104.83 125.21 59.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.261 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.535 ' HB ' ' HA2' ' A' ' 26' ' ' GLY . 30.0 mm -99.49 135.24 20.7 Favored Pre-proline 0 C--N 1.289 -2.029 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -177.033 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.12 -155.75 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.32 2.68 . . . . 0.0 112.448 174.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? 97.36 -44.6 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.629 1.572 . . . . 0.0 111.232 171.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.494 ' O ' ' HB ' ' A' ' 21' ' ' THR . . . 156.2 35.52 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 118.12 -1.99 . . . . 0.0 115.452 176.337 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' A' ' 18' ' ' LEU . . . -129.51 -105.8 0.29 Allowed 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.348 177.595 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.939 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -62.87 -35.55 80.38 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -173.437 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.653 ' HB2' HG22 ' A' ' 52' ' ' ILE . 39.4 tt0 -86.43 -26.31 24.77 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.232 0.539 . . . . 0.0 109.789 -178.156 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.7 t -79.27 -46.17 18.3 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.812 -178.457 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -71.57 -31.0 66.5 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 177.674 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.51 44.41 8.62 Favored Glycine 0 CA--C 1.499 -0.954 0 CA-C-N 114.18 -1.373 . . . . 0.0 114.267 170.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -108.99 -62.34 1.49 Allowed 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.406 178.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.576 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 25.8 mm -72.11 137.37 23.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.648 -173.227 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -122.32 151.08 41.5 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 173.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.54 133.91 46.11 Favored 'General case' 0 N--CA 1.421 -1.919 0 C-N-CA 118.782 -1.167 . . . . 0.0 109.782 178.518 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.518 ' HA2' ' CZ ' ' A' ' 48' ' ' TYR . . . 111.64 -18.58 24.66 Favored Glycine 0 N--CA 1.42 -2.382 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -172.637 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.502 ' HB3' HD23 ' A' ' 101' ' ' LEU . 89.4 m-20 -66.41 131.23 45.62 Favored 'General case' 0 C--O 1.252 1.206 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.592 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 73.0 mtm-85 -93.12 138.07 31.89 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.86 0.838 . . . . 0.0 111.21 -177.439 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.932 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 49.2 t -99.75 111.84 30.49 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -177.972 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 102' ' ' GLU . 48.2 mt -95.06 -33.68 12.6 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.633 -175.404 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.72 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . . . -162.56 176.36 10.48 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.927 -177.635 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 1.07 HG11 HG21 ' A' ' 89' ' ' THR . 3.1 p -123.97 112.37 32.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 C-N-CA 125.172 1.389 . . . . 0.0 107.793 175.187 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.9 p30 50.51 29.33 3.92 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 125.008 1.323 . . . . 0.0 113.582 177.141 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.05 -19.13 41.42 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.599 -0.81 . . . . 0.0 114.1 -177.219 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.521 ' HB ' HG13 ' A' ' 73' ' ' VAL . 52.5 t -86.19 113.86 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.0 m -61.97 136.69 58.07 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.317 0.579 . . . . 0.0 112.517 -175.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.493 HD11 ' HB ' ' A' ' 73' ' ' VAL . 76.2 mt -114.21 32.21 6.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.204 -178.708 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.51 113.28 22.3 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.108 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 96.97 16.43 35.76 Favored Glycine 0 C--N 1.303 -1.255 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.24 146.35 26.99 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -179.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.558 ' OG1' ' HG2' ' A' ' 85' ' ' GLN . 23.0 p -82.76 162.63 21.67 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 173.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -52.27 -42.95 64.14 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 174.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -61.09 -39.96 91.91 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.332 178.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.558 ' HG2' ' OG1' ' A' ' 82' ' ' THR . 14.7 mm100 -67.07 -47.14 72.2 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 178.206 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.652 ' O ' ' HG ' ' A' ' 90' ' ' LEU . . . -57.3 -48.95 77.6 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.379 178.221 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 84.0 t -65.82 -28.66 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.122 179.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -66.48 -43.01 86.58 Favored 'General case' 0 N--CA 1.409 -2.503 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 1.07 HG21 HG11 ' A' ' 73' ' ' VAL . 28.5 m -64.87 -34.34 78.14 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.589 176.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 86' ' ' ALA . 68.7 mt -74.52 -17.95 60.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.23 0.538 . . . . 0.0 110.972 -178.645 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -94.02 -33.16 13.53 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.363 0.602 . . . . 0.0 110.296 174.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -75.85 -19.8 58.61 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.955 -178.106 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -75.94 -77.59 0.13 Allowed 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 178.305 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 171.84 -149.74 12.33 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.527 -179.301 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.481 ' HA ' ' HD2' ' A' ' 20' ' ' LYS . 46.1 tt0 -88.75 -39.94 13.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -178.711 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.58 104.76 16.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.042 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.492 HG23 HD21 ' A' ' 25' ' ' LEU . 3.5 t -106.2 142.38 19.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.429 -174.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 78.4 m80 -110.27 127.95 55.27 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.481 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.663 ' HA ' ' HA ' ' A' ' 73' ' ' VAL . 5.8 mp -129.03 150.22 50.52 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.156 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 72' ' ' ALA . 3.4 tm? -98.82 111.04 23.55 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 179.277 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 68' ' ' ASP . 10.5 mp -119.48 169.74 9.77 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.136 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.557 ' HB2' HD11 ' A' ' 71' ' ' LEU . 34.0 tt0 -130.45 128.23 40.86 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 104.176 -2.527 . . . . 0.0 104.176 172.626 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.512 ' HA ' ' HD2' ' A' ' 103' ' ' LYS . 26.5 tptt -59.03 123.79 17.76 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 123.991 0.807 . . . . 0.0 109.748 -177.369 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -119.52 36.58 3.44 Favored Glycine 0 CA--C 1.497 -1.043 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.575 -173.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.89 ' HB2' ' HB3' ' A' ' 10' ' ' PRO . 46.8 mt-30 -81.0 29.1 0.34 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 123.592 0.757 . . . . 0.0 111.885 -179.105 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 11.8 m -143.73 129.22 9.86 Favored Pre-proline 0 C--N 1.28 -2.432 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -178.399 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 106' ' ' VAL . 3.1 Cg_exo . . . . . 0 C--O 1.252 1.21 0 C-N-CA 122.755 2.303 . . . . 0.0 110.998 179.221 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 103' ' ' LYS . 14.4 mmmm . . . . . 0 N--CA 1.442 -0.828 0 N-CA-C 102.433 -3.173 . . . . 0.0 102.433 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.68 115.64 3.18 Favored 'Trans proline' 0 C--N 1.322 -0.851 0 CA-C-N 121.401 1.536 . . . . 0.0 110.656 -177.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.26 1.53 54.13 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.2 -176.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 102' ' ' GLU . 32.4 t70 -83.11 134.56 35.0 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.054 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.2 p -103.42 126.15 50.42 Favored 'General case' 0 N--CA 1.413 -2.311 0 O-C-N 124.531 1.144 . . . . 0.0 110.35 178.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -137.02 160.61 38.43 Favored 'General case' 0 C--N 1.279 -2.489 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.836 -177.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -107.71 97.54 7.26 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 176.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.407 HG12 HD13 ' A' ' 101' ' ' LEU . 13.3 p -76.03 134.39 29.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.119 -176.86 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -91.71 97.69 11.17 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.624 HD11 ' HB1' ' A' ' 57' ' ' ALA . 2.4 tm? -101.76 111.35 23.57 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.02 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.67 118.9 31.99 Favored 'General case' 0 C--N 1.269 -2.923 0 CA-C-N 114.072 -1.422 . . . . 0.0 107.285 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.58 ' HE2' ' CD2' ' A' ' 25' ' ' LEU . 94.1 mttt -52.67 119.34 4.44 Favored 'General case' 0 CA--C 1.488 -1.433 0 CA-C-O 122.032 0.92 . . . . 0.0 112.811 -177.711 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.828 ' HB ' ' HA ' ' A' ' 57' ' ' ALA . 93.1 m -120.57 103.71 9.37 Favored 'General case' 0 N--CA 1.403 -2.824 0 CA-C-N 113.687 -1.597 . . . . 0.0 108.184 -175.61 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 t70 62.05 -73.51 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 177.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -91.97 26.47 12.83 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 20' ' ' LYS 0.27 87.5 p 62.68 -98.45 0.07 Allowed 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 124.974 1.31 . . . . 0.0 112.881 178.922 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.638 ' HG ' HD13 ' A' ' 90' ' ' LEU . 2.7 mm? -100.92 110.38 22.43 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 118.63 0.65 . . . . 0.0 109.368 175.547 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.512 ' H ' ' HB3' ' A' ' 57' ' ' ALA . . . -84.25 36.07 2.94 Favored Glycine 0 C--N 1.295 -1.713 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.274 179.683 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.456 HD13 HG21 ' A' ' 27' ' ' ILE . 14.6 pt -125.4 121.13 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.903 0 CA-C-O 121.886 0.85 . . . . 0.0 112.085 -176.428 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.9 t -86.94 119.94 27.68 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 177.935 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.9 m -126.54 149.78 31.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.54 -173.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 t -128.63 179.6 5.59 Favored 'General case' 0 N--CA 1.42 -1.942 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 172.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.467 HG12 HD13 ' A' ' 47' ' ' ILE . 8.9 m -80.49 -53.45 12.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 174.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.421 ' H ' HG23 ' A' ' 31' ' ' VAL . 39.6 tp -170.86 -54.06 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 171.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -134.94 126.06 27.91 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 173.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -45.31 -56.34 5.01 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -172.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 35' ' ' LYS . 52.6 mtpt -140.63 100.06 3.77 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 177.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.21 -61.1 2.56 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 172.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.1 -79.25 0.28 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 116.169 1.228 . . . . 0.0 116.169 174.119 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.3 p -60.54 -27.76 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 123.955 0.902 . . . . 0.0 112.905 -173.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -126.16 146.15 50.07 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.8 m -90.05 80.26 6.38 Favored 'General case' 0 N--CA 1.428 -1.571 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.53 175.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.0 m -90.27 -10.98 42.24 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 176.06 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.8 t -63.89 104.46 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 CA-C-N 113.879 -1.51 . . . . 0.0 109.256 176.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -92.45 144.22 25.58 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.24 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -77.08 87.77 3.57 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 121.738 0.78 . . . . 0.0 112.51 -175.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.27 -70.85 0.1 Allowed Glycine 0 N--CA 1.426 -2.016 0 N-CA-C 107.152 -2.379 . . . . 0.0 107.152 173.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.5 -91.45 0.13 Allowed Glycine 0 N--CA 1.421 -2.321 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.979 170.341 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.009 ' HB ' ' HB ' ' A' ' 70' ' ' VAL . 47.1 mm -116.85 156.16 18.17 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 C-N-CA 123.307 0.643 . . . . 0.0 109.807 -172.776 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.439 ' CE1' ' HG3' ' A' ' 107' ' ' PRO . 68.9 t80 -135.62 109.56 8.18 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 123.736 0.814 . . . . 0.0 109.562 179.573 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.0 t -51.25 109.46 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.861 0 CA-C-O 122.247 1.022 . . . . 0.0 110.623 171.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -80.65 -40.83 24.87 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 113.699 -1.591 . . . . 0.0 109.255 -176.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.608 ' HA ' ' HG2' ' A' ' 66' ' ' LYS . . . -160.23 161.58 33.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.246 -176.757 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.593 ' CG2' ' HB2' ' A' ' 59' ' ' GLU . 38.7 mm -115.75 139.8 40.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.503 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.6 mm -95.6 141.73 23.6 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -177.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.81 137.97 71.33 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.4 2.067 . . . . 0.0 109.483 171.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 55' ' ' LYS . 5.2 tppp? 59.44 21.26 9.66 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-O 123.472 1.606 . . . . 0.0 108.393 -172.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.501 ' C ' ' HA3' ' A' ' 26' ' ' GLY . . . -109.18 81.84 0.29 Allowed Glycine 0 N--CA 1.396 -3.999 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.528 -175.178 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.828 ' HA ' ' HB ' ' A' ' 21' ' ' THR . . . 32.56 -72.45 0.0 OUTLIER 'General case' 0 C--O 1.186 -2.265 0 C-N-CA 127.817 2.447 . . . . 0.0 116.264 171.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' A' ' 18' ' ' LEU . . . -55.56 -32.11 62.73 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.734 0.814 . . . . 0.0 111.753 -177.647 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.593 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 6.5 tp10 -89.44 -37.87 14.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.172 0.511 . . . . 0.0 109.662 -179.342 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.2 m -74.04 -44.73 53.3 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.49 -175.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -76.44 -36.77 57.78 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.76 59.56 1.5 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.833 176.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.419 ' HB2' ' H ' ' A' ' 64' ' ' ILE . 14.4 mmt180 -121.53 -87.02 0.65 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.619 0.723 . . . . 0.0 110.409 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.455 ' HB ' ' HB1' ' A' ' 58' ' ' ALA . 53.1 mt -74.94 146.52 9.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.961 -176.351 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -129.95 172.57 11.57 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.683 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.608 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 35.8 mtmm -71.84 126.29 29.35 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 -177.615 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.419 ' O ' ' HA3' ' A' ' 104' ' ' GLY . . . 120.15 -28.13 6.45 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.046 -1.073 . . . . 0.0 113.17 177.864 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.693 ' HB3' HD23 ' A' ' 101' ' ' LEU . 28.9 m-20 -64.45 133.34 52.29 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 122.043 0.925 . . . . 0.0 112.782 -176.183 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -91.88 135.4 33.96 Favored 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.127 -175.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.009 ' HB ' ' HB ' ' A' ' 47' ' ' ILE . 60.8 t -105.66 125.14 61.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 -174.068 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.819 ' HB2' HD12 ' A' ' 100' ' ' LEU . 67.9 mt -104.64 -21.6 13.38 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.971 -177.313 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.748 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . . . -168.35 167.62 11.87 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.044 0.449 . . . . 0.0 112.086 -177.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.687 ' HA ' HD12 ' A' ' 99' ' ' LEU . 46.7 t -120.83 117.88 54.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 174.412 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.353 30.7 p-10 38.44 63.4 0.87 Allowed 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.411 1.484 . . . . 0.0 114.859 -179.375 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.05 -21.4 3.38 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 115.004 -0.998 . . . . 0.0 114.861 178.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.5 t -85.31 100.08 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.714 ' HA ' ' HB2' ' A' ' 72' ' ' ALA . 20.0 m -58.1 132.27 53.02 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.261 -178.28 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.748 ' HG ' ' HA ' ' A' ' 72' ' ' ALA . 74.5 mt -93.33 80.25 4.42 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.105 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -77.42 -30.16 53.35 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.49 -171.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.26 58.68 0.31 Allowed Glycine 0 CA--C 1.474 -2.53 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.67 138.07 40.06 Favored 'General case' 0 CA--C 1.476 -1.902 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.178 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.749 HG22 ' HG2' ' A' ' 85' ' ' GLN . 14.6 t -85.05 161.35 19.75 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 171.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.429 ' HA ' HD12 ' A' ' 47' ' ' ILE 0.287 10.6 p80 -50.89 -41.67 58.51 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.431 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -67.85 -24.02 65.21 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 177.466 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.749 ' HG2' HG22 ' A' ' 82' ' ' THR . 30.1 mm-40 -70.8 -40.75 72.34 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 175.619 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.554 ' HB2' HG13 ' A' ' 47' ' ' ILE . . . -62.61 -45.06 94.59 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.463 176.498 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.426 ' HA ' HD12 ' A' ' 90' ' ' LEU . 91.6 t -69.03 -34.37 63.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.351 -177.645 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 85' ' ' GLN . 7.9 pt-20 -71.59 -27.89 63.44 Favored 'General case' 0 C--O 1.217 -0.623 0 C-N-CA 118.994 -1.082 . . . . 0.0 110.193 178.404 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 30.8 m -72.74 -25.72 61.31 Favored 'General case' 0 CA--C 1.559 1.325 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 175.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.638 HD13 ' HG ' ' A' ' 25' ' ' LEU . 96.0 mt -79.41 -23.33 43.29 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.659 0.742 . . . . 0.0 109.727 174.592 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -79.12 -38.29 36.51 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.28 -0.873 . . . . 0.0 108.756 175.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -66.92 -36.52 82.43 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.317 176.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 p -69.56 159.23 33.75 Favored 'General case' 0 C--O 1.252 1.225 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -179.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.93 -129.32 0.29 Allowed Glycine 0 C--N 1.33 0.222 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.816 -175.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -87.78 -44.91 10.78 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.344 0.592 . . . . 0.0 110.436 -178.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.8 p -108.38 119.43 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.842 0 C-N-CA 118.824 -1.15 . . . . 0.0 110.053 -178.791 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.411 HG11 ' CD2' ' A' ' 90' ' ' LEU . 22.8 t -103.19 126.27 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.003 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.372 -176.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -94.43 115.71 27.94 Favored 'General case' 0 C--N 1.275 -2.654 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 174.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.687 HD12 ' HA ' ' A' ' 73' ' ' VAL . 7.0 tp -113.09 136.16 53.01 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -174.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.819 HD12 ' HB2' ' A' ' 71' ' ' LEU . 2.6 tm? -89.28 109.98 20.8 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 -176.343 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.693 HD23 ' HB3' ' A' ' 68' ' ' ASP . 11.0 mp -122.79 165.2 16.99 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.836 0.827 . . . . 0.0 112.673 -175.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 41.3 tt0 -131.74 142.66 49.84 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 174.859 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.524 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -51.53 130.0 26.8 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 177.0 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 67' ' ' GLY . . . -123.53 62.94 0.56 Allowed Glycine 0 N--CA 1.422 -2.267 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.457 176.446 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -72.99 -35.17 66.82 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 176.011 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 84.2 t -144.07 114.19 5.38 Favored Pre-proline 0 N--CA 1.422 -1.87 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 177.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.439 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 37.4 Cg_exo . . . . . 0 C--O 1.249 1.042 0 C-N-CA 123.06 2.507 . . . . 0.0 111.661 -178.625 . . . . . . . . 1 1 . 1 stop_ save_